PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Richmond, JE; Davis, WS; Jorgensen, EM				Richmond, JE; Davis, WS; Jorgensen, EM			UNC-13 is required for synaptic vesicle fusion in C-elegans	NATURE NEUROSCIENCE			English	Article							PHORBOL ESTER RECEPTOR; CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; GENE; SYNTAXIN; PROTEINS; HOMOLOG; MUNC13-1; COMPLEX; MUTANTS	We analyzed the synaptic physiology of unc-13 mutants in the nematode C, elegans. Mutants of unc-13 had normal nervous system architecture, and the densities of synapses and postsynaptic receptors were normal at the neuromuscular junction. However, the number of synaptic vesicles at neuromuscular junctions was two- to threefold greater in unc-13 mutants than in wild-type animals. Most importantly, evoked release at both GABAergic and cholinergic synapses was almost absent in unc-13 null alleles, as determined by whole-cell, voltage-clamp techniques. Although mutant synapses had morphologically docked vesicles, these vesicles were not competent for release as assayed by spontaneous release in calcium-free solution or by the application of hyperosmotic saline. These experiments support models in which UNC-13 mediates either fusion of vesicles during exocytosis or priming of vesicles for fusion.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			AHRQ HHS [R03 HS009820] Funding Source: Medline; NIMH NIH HHS [R03 MH059820-01, R03 MHS9820-01, R03 MH059820-02] Funding Source: Medline; NIMH NIH HHS [R03 MH29820-01, R03 MH059820-01] Funding Source: Medline; NINDS NIH HHS [R01 NS34307, R01 NS034307] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS009820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED S, 1992, BIOCHEM J, V287, P995, DOI 10.1042/bj2870995; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bamber BA, 1999, J NEUROSCI, V19, P5348; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BRENNER S, 1974, GENETICS, V77, P71; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HOSONO R, 1989, ZOOL SCI, V6, P697; Jin YS, 1999, J NEUROSCI, V19, P539; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NGUYEN M, 1995, GENETICS, V140, P527; NILES WD, 1982, J PHYSIOL-LONDON, V329, P185, DOI 10.1113/jphysiol.1982.sp014297; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSE AM, 1980, GENETICS, V96, P639; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297	33	670	696	2	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					959	964		10.1038/12160	http://dx.doi.org/10.1038/12160			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10461217	Green Accepted			2022-12-24	WOS:000083883300011
J	Richmond, JE; Jorgensen, EM				Richmond, JE; Jorgensen, EM			One GABA and two acetylcholine receptors function at the C-elegans neuromuscular junction	NATURE NEUROSCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SYMPATHETIC NEURONS; LEVAMISOLE RESISTANCE; SEGREGATION; MUSCLE; PHOSPHORYLATION; GENETICS; SUBUNITS; SYNAPSES; GENES	We describe an electrophysiological preparation of the neuromuscular junction of the nematode C. elegans, which adds to its considerable genetic and genomic resources. Mutant analysis, pharmacology and patch-clamp recording showed that the body wall muscles of wild-type animals expressed a GABA receptor and two acetylcholine receptors. The muscle GABA response was abolished in animals lacking the GABA receptor gene unc-49. One acetylcholine receptor was activated by the nematocide levamisole. This response was eliminated in mutants lacking either the unc-38 or unc-29 genes, which encode alpha and non-alpha acetylcholine receptor subunits, respectively. The second, previously undescribed, acetylcholine receptor was activated by nicotine, desensitized rapidly and was selectively blocked by dihydro-beta-erythroidine, thus explaining the residual motility of unc-38 and unc-29 mutants. By recording spontaneous endogenous currents and selectively eliminating each of these receptors, we demonstrated that all three receptor types function at neuromuscular synapses.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Richmond, JE (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	richmond@biology.utah.edu			AHRQ HHS [R03 HS009820] Funding Source: Medline; NIMH NIH HHS [R03 MH059820-01, R03 MHS9820-01, R03 MH059820-02] Funding Source: Medline; NIMH NIH HHS [R03 MH29820-01, R03 MH059820-01] Funding Source: Medline; NINDS NIH HHS [R01 NS34307, R01 NS034307] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS009820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber BA, 1999, J NEUROSCI, V19, P5348; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1979, J PHYSIOL-LONDON, V288, P263; Chalfie M, 1998, TRENDS GENET, V14, P506, DOI 10.1016/S0168-9525(98)01623-0; DeKoninck P, 1995, J NEUROSCI, V15, P7966; ESHHAR N, 1993, NEUROSCIENCE, V57, P943, DOI 10.1016/0306-4522(93)90040-M; Fleming JT, 1997, J NEUROSCI, V17, P5843; GARDETTE R, 1991, DEV BIOL, V147, P83, DOI 10.1016/S0012-1606(05)80009-0; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; HUME RI, 1991, J NEUROBIOL, V22, P249, DOI 10.1002/neu.480220305; Jorgensen Erik M., 1995, Seminars in Developmental Biology, V6, P207, DOI 10.1016/S1044-5781(06)80030-7; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LEWIS JA, 1987, J NEUROSCI, V7, P3059; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MOSS BL, 1993, J NEUROSCI, V13, P13; Nimnual AS, 1998, BIOCHEMISTRY-US, V37, P14823, DOI 10.1021/bi9802824; Nishizaki T, 1998, BRAIN RES, V812, P242, DOI 10.1016/S0006-8993(98)00836-1; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nusser Z, 1998, J NEUROSCI, V18, P1693; OWENS JL, 1989, J NEUROSCI, V9, P2575; Paradiso K, 1998, J NEUROSCI, V18, P9227; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; ROBERTSON SJ, 1993, BRIT J PHARMACOL, V108, P170, DOI 10.1111/j.1476-5381.1993.tb13458.x; Role L W, 1992, Curr Opin Neurobiol, V2, P254, DOI 10.1016/0959-4388(92)90112-X; SILLAR KT, 1991, BRAIN RES, V545, P24, DOI 10.1016/0006-8993(91)91265-3; Tempia F, 1996, EUR J NEUROSCI, V8, P2690, DOI 10.1111/j.1460-9568.1996.tb01564.x; WALROND JP, 1985, J NEUROSCI, V5, P16; Zoli M, 1998, J NEUROSCI, V18, P4461	32	670	696	2	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					791	797		10.1038/12160	http://dx.doi.org/10.1038/12160			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461217	Green Accepted			2022-12-24	WOS:000083882900009
J	Li, P; Kerchner, GA; Sala, C; Wei, F; Huettner, JE; Sheng, M; Zhuo, M				Li, P; Kerchner, GA; Sala, C; Wei, F; Huettner, JE; Sheng, M; Zhuo, M			AMPA receptor-PDZ interactions in facilitation of spinal sensory synapses	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; SPINOTHALAMIC TRACT NEURONS; LONG-TERM POTENTIATION; DORSAL HORN; SILENT SYNAPSES; GLUTAMATE RECEPTORS; RAT; CORD; TRANSMISSION; DOMAIN	Silent synapses form between some primary sensory afferents and dorsal horn neurons in the spinal cord. Molecular mechanisms for activation or conversion of silent synapses to conducting synapses are unknown. Serotonin can trigger activation of silent synapses in dorsal horn neurons by recruiting AMPA receptors. AMPA-receptor subunits GluR2 and GluR3 interact via their cytoplasmic C termini with PDZ-domain-containing proteins such as GRIP (glutamate receptor interacting protein), but the functional significance of these interactions is unclear. Here we demonstrate that protein interactions involving the GluR2/3 C terminus are important for serotonin-induced activation of silent synapses in the spinal cord. Furthermore, PKC is a necessary and sufficient trigger for this activation. These results implicate AMPA receptor-PDZ interactions in mechanisms underlying sensory synaptic potentiation and provide insights into the pathogenesis of chronic pain.	Washington Univ, Sch Med, Dept Anesthesiol Anat & Neurobiol, St Louis, MO 63110 USA; Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol Anat & Neurobiol, Campus Box 8054,660 S Euclid Ave, St Louis, MO 63110 USA.		Zhuo, Min/A-2072-2008; Huettner, James E/C-5219-2012; Sala, Carlo/A-2493-2009	Zhuo, Min/0000-0001-9062-3241; Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [R01 NS030888] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030888] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bardoni R, 1998, J NEUROSCI, V18, P6558; Calejesan AA, 1998, BRAIN RES, V798, P46, DOI 10.1016/S0006-8993(98)00394-1; Carlton SM, 1998, NEUROSCI LETT, V242, P21, DOI 10.1016/S0304-3940(98)00036-6; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; GERBER G, 1989, J NEUROSCI, V9, P3606; GOBEL S, 1984, J NEUROSCI, V4, P2281; Harris JA, 1996, NEUROSCIENCE, V74, P7, DOI 10.1016/0306-4522(96)00196-0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hori Y, 1996, J PHYSIOL-LONDON, V492, P867, DOI 10.1113/jphysiol.1996.sp021352; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HOYER D, 1994, PHARMACOL REV, V46, P157; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; Lin Q, 1996, J NEUROSCI, V16, P3026; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MENETREY D, 1982, PAIN, V13, P343, DOI 10.1016/0304-3959(82)90003-3; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PALECEK J, 1992, J NEUROPHYSIOL, V68, P1951, DOI 10.1152/jn.1992.68.6.1951; Perl E, 1996, NEUROBIOLOGY NOCICEP, P5; Popratiloff A, 1996, J NEUROSCI, V16, P3363; Rumpel S, 1998, J NEUROSCI, V18, P8863; Sandkuhler J, 1996, PROG NEUROBIOL, V50, P49; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; TACHIBANA M, 1994, J COMP NEUROL, V344, P431, DOI 10.1002/cne.903440307; Urban MO, 1996, BRAIN RES, V737, P83, DOI 10.1016/0006-8993(96)00631-2; WALL PD, 1977, PHILOS T R SOC B, V278, P361, DOI 10.1098/rstb.1977.0048; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; YAKSH TL, 1985, EUR J PHARMACOL, V117, P81, DOI 10.1016/0014-2999(85)90474-1; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293; Zhuo M, 1997, J NEUROPHYSIOL, V78, P746, DOI 10.1152/jn.1997.78.2.746; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C	46	153	157	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					972	977		10.1038/14771	http://dx.doi.org/10.1038/14771			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526335				2022-12-24	WOS:000083883300013
J	Lamb, BT; Bardel, KA; Kulnane, LS; Anderson, JJ; Holtz, G; Wagner, SL; Sisodia, SS; Hoeger, EJ				Lamb, BT; Bardel, KA; Kulnane, LS; Anderson, JJ; Holtz, G; Wagner, SL; Sisodia, SS; Hoeger, EJ			Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice	NATURE NEUROSCIENCE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; ELECTROPHORETIC SEPARATION; IN-VIVO; VARIANTS; BRAINS; GENE		Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; SIBIA Neurosci Inc, La Jolla, CA 92037 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Case Western Reserve University; University Hospitals of Cleveland; University of Chicago	Lamb, BT (corresponding author), Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA.	btl@po.cwru.edu			NIA NIH HHS [AG14451, AG08012] Funding Source: Medline; NIGMS NIH HHS [T32 GM08613] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014451, R29AG014451, P50AG008012] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Klafki HW, 1996, ANAL BIOCHEM, V237, P24, DOI 10.1006/abio.1996.0195; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rogaev EI, 1997, GENOMICS, V40, P415, DOI 10.1006/geno.1996.4523; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332	15	80	87	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					695	697		10.1038/11154	http://dx.doi.org/10.1038/11154			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412057				2022-12-24	WOS:000083882800007
J	Nishino, J; Mochida, K; Ohfuji, Y; Shimazaki, T; Meno, C; Ohishi, S; Matsuda, Y; Fujii, H; Saijoh, Y; Hamada, H				Nishino, J; Mochida, K; Ohfuji, Y; Shimazaki, T; Meno, C; Ohishi, S; Matsuda, Y; Fujii, H; Saijoh, Y; Hamada, H			GFR alpha 3, a component of the artemin receptor, is required for migration and survival of the superior cervical ganglion	NEURON			English	Article							C-RET PROTOONCOGENE; MICE LACKING GDNF; MIDBRAIN DOPAMINERGIC-NEURONS; ENTERIC NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; TYROSINE KINASE; PERIPHERAL NEURONS; AUTONOMIC GANGLIA; IN-VIVO; NEURTURIN	GFR alpha 3 is a component of the receptor for the neurotrophic factor artemin. The role of GFR alpha 3 in nervous system development was examined by generating mice in which the Gfr alpha 3 gene was disrupted. The Gfr alpha 3(-/-) mice exhibited severe defects in the superior cervical ganglion (SCG), whereas other ganglia appeared normal. SCG precursor cells in the mutant embryos failed to migrate to the correct position, and they subsequently failed to innervate the target organs. In wildtype embryos, Gfr alpha 3 was expressed in migrating SCG precursors, and artemin was expressed in and near the SCG. After birth, SCG neurons in the mutant mice underwent progressive cell death. These observations suggest that GFR alpha 3-mediated signaling is required both for the rostral migration of SCG precursors and for the survival of mature SCG neurons.	Osaka Univ, Inst Mol & Cellular Biol, Div Mol Biol, Osaka, Japan; Japan Sci & Technol Corp, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 113, Japan; Nagoya Univ, Sch Agr Sci, Lab Anim Genet, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Osaka University; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science; Nagoya University	Hamada, H (corresponding author), Osaka Univ, Inst Mol & Cellular Biol, Div Mol Biol, Osaka, Japan.		Shimazaki, Takuya/L-1159-2013	Shimazaki, Takuya/0000-0002-3936-2098; da shi, xiang zi/0000-0002-2256-905X; Saijoh, Yukio/0000-0002-7548-4789				Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Durbec PL, 1996, DEVELOPMENT, V122, P349; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Heuckeroth RO, 1999, NEURON, V22, P253, DOI 10.1016/S0896-6273(00)81087-9; Horger BA, 1998, J NEUROSCI, V18, P4929; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Nomoto S, 1998, BIOCHEM BIOPH RES CO, V244, P849, DOI 10.1006/bbrc.1998.8361; NOMURA S, 1993, ACTA HISTOCHEM CYTOC, V26, P303, DOI 10.1267/ahc.26.303; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rosenthal A, 1999, NEURON, V22, P201, DOI 10.1016/S0896-6273(00)81077-6; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; RUBIN E, 1985, J NEUROSCI, V5, P673; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SAWAI S, 1991, NEW BIOL, V3, P861; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1997, J NEUROSCI, V17, P3554; Widenfalk J, 1998, EUR J NEUROSCI, V10, P1508, DOI 10.1046/j.1460-9568.1998.00192.x; Widenfalk J, 1997, J NEUROSCI, V17, P8506; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502	48	99	111	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					725	736		10.1016/S0896-6273(01)80031-3	http://dx.doi.org/10.1016/S0896-6273(01)80031-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482239	Bronze			2022-12-24	WOS:000082280900016
J	Chawla, D; Rees, G; Friston, KJ				Chawla, D; Rees, G; Friston, KJ			The physiological basis of attentional modulation in extrastriate visual areas	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; FUNCTIONAL-ANALYSIS; DIRECTED ATTENTION; HUMAN MT; CORTEX; FMRI; RESPONSES; PARIETAL; ANATOMY; NETWORK	Selective attention to color or motion enhances activity in specialized areas of extrastriate cortex, but mechanisms of attentional modulation remain unclear. By dissociating modulation of visually evoked transient activity from the baseline for a particular attentional set, human functional neuroimaging was used to investigate the physiological basis of such effects. Baseline activity in motion- and color-sensitive areas of extrastriate cortex was enhanced by selective attention to these attributes, even without moving or colored stimuli. Further, visually evoked responses increased along with baseline activity. These results are consistent with the hypothesis that attention modulates sensitivity of neuronal populations to inputs by changing background activity.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London	Chawla, D (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, Queen Sq, London WC1N 3BG, England.	dave@fil.ion.ucl.ac.uk	Rees, Geraint/C-1493-2008; Friston, Karl/D-9230-2011	Rees, Geraint/0000-0002-9623-7007; Friston, Karl/0000-0001-7984-8909	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Chawla D, 1998, NEUROIMAGE, V7, P86, DOI 10.1006/nimg.1997.0319; CHAWLA D, IN PRESS NEURAL COMP; CORBETTA M, 1991, J NEUROSCI, V11, P2383; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; FERRERA VP, 1994, J NEUROSCI, V14, P6171; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 2014, COGNITIVE ELECTROPHYSIOLOGY OF ATTENTION: SIGNALS OF THE MIND, P1; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Talairach J., 1988, COPLANAR STEREOTAXIC; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; ZEKI S, 1991, J NEUROSCI, V11, P641	26	432	437	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					671	676		10.1038/10230	http://dx.doi.org/10.1038/10230			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404202				2022-12-24	WOS:000083882600020
J	Yeckel, MF; Kapur, A; Johnston, D				Yeckel, MF; Kapur, A; Johnston, D			Multiple forms of LTP in hippocampal CA3 neurons use a common postsynaptic mechanism	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MOSSY-FIBER SYNAPSES; DEPENDENT LATE-PHASE; RAT HIPPOCAMPUS; PYRAMIDAL NEURONS; SYNAPTIC TRANSMISSION; KAINATE RECEPTORS; ACTIVATION; INDUCTION; CHANNELS	We investigated long-term potentiation (LTP) at mossy fiber synapses on CA3 pyramidal neurons in the hippocampus. Using Ca2+ imaging techniques, we show here that when postsynaptic Ca2+ was sufficiently buffered so that [Ca2+](i) did not rise during synaptic stimulation, the induction of mossy fiber LTP was prevented. In addition, induction of mossy fiber LTP was suppressed by postsynaptic injection of a peptide inhibitor of cAMP-dependent protein kinase. Finally, when ionotropic glutamate receptors were blocked, LTP depended on the postsynaptic release of Ca2+ from internal stores triggered by activation of metabotropic glutamate receptors. These results support the conclusion that mossy fiber LTP and LTP at other hippocampal synapses share a common induction mechanism involving an initial rise in postsynaptic [Ca2+].	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Johnston, D (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044754, F32MH011390, R01MH048432] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH011390, MH11390, R37 MH044754, R01 MH048432, MH44754, F32 MH011390-03, MH48432] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acsady L, 1998, J NEUROSCI, V18, P3386; Amaral D.G., 1990, PROG BRAIN RES, P1; Bao JX, 1998, J NEUROSCI, V18, P458; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BLISS T V P, 1988, P3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; GROVER LM, 1992, NEUROSCIENCE, V49, P7, DOI 10.1016/0306-4522(92)90072-A; HOPKINS WF, 1988, J NEUROPHYSIOL, V59, P667, DOI 10.1152/jn.1988.59.2.667; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; Jaffe DB, 1997, J NEUROPHYSIOL, V78, P10, DOI 10.1152/jn.1997.78.1.10; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kapur A, 1998, J NEUROPHYSIOL, V79, P2181, DOI 10.1152/jn.1998.79.4.2181; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; LANGDON RB, 1995, J NEUROBIOL, V26, P370, DOI 10.1002/neu.480260309; LASSERROSS N, 1991, J NEUROSCI METH, V36, P253, DOI 10.1016/0165-0270(91)90051-Z; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LopezGarcia JC, 1996, P NATL ACAD SCI USA, V93, P4712, DOI 10.1073/pnas.93.10.4712; Miller LDP, 1996, J NEUROPHYSIOL, V76, P554, DOI 10.1152/jn.1996.76.1.554; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Urban NN, 1996, J NEUROSCI, V16, P4293; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Villacres EC, 1998, J NEUROSCI, V18, P3186; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; Wilsch VW, 1998, J NEUROSCI, V18, P6071; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552, DOI 10.1152/jn.1994.71.6.2552; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeckel MF, 1998, J NEUROSCI, V18, P438; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	50	261	265	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					625	633		10.1038/10180	http://dx.doi.org/10.1038/10180			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404192	Green Accepted			2022-12-24	WOS:000083882600013
J	Zitnan, D; Ross, LS; Zitnanova, I; Hermesman, JL; Gill, SS; Adams, ME				Zitnan, D; Ross, LS; Zitnanova, I; Hermesman, JL; Gill, SS; Adams, ME			Steroid induction of a peptide hormone gene leads to orchestration of a defined behavioral sequence	NEURON			English	Article							ECDYSIS-TRIGGERING HORMONE; PROGRAMMED CELL-DEATH; LARVAL MANDUCA-SEXTA; ECLOSION HORMONE; RECEPTOR ISOFORMS; TOBACCO HORNWORM; ENDOCRINE SYSTEM; MESSENGER-RNAS; DIRECT REPEATS; PRE-ECDYSIS	At the end of each molt, insects shed the old cuticle by performing preecdysis and ecdysis behaviors. Regulation of these centrally patterned movements involves peptide signaling between endocrine Inka cells and the CNS. In Inka cells, we have identified the cDNA and gene encoding preecdysis-triggering hormone (PETH) and ecdysis-triggering hormone (ETH), which activate these behaviors. Prior to behavioral onset, rising ecdysteroid levels induce expression of the ecdysone receptor (EcR) and ETH gene in Inka cells and evoke CNS sensitivity to PETH and ETH. Subsequent ecdysteroid decline is required for peptide release, which initiates three motor patterns in specific order: PETH triggers preecdysis I, while ETH activates preecdysis II and ecdysis. The Inka cell provides a model for linking steroid regulation of peptide hormone expression and release with activation of a defined behavioral sequence.	Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Neurosci, Riverside, CA 92521 USA; Slovak Acad Sci, Inst Zool, Bratislava 84206, Slovakia	University of California System; University of California Riverside; University of California System; University of California Riverside; Slovak Academy of Sciences	Zitnan, D (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.		Adams, Michael/ABF-6728-2020	Adams, Michael/0000-0003-0519-6113	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI040555, R01AI040555] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 40555] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams ME, 1997, BIOCHEM BIOPH RES CO, V230, P188, DOI 10.1006/bbrc.1996.5915; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; ANTIN J, 1975, J COMP PHYSIOL PSYCH, V89, P784, DOI 10.1037/h0077040; Antoniewski C, 1996, MOL CELL BIOL, V16, P2977; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Camhi JM, 1984, NEUROETHOLOGY; CARLSON JR, 1977, J COMP PHYSIOL, V115, P299, DOI 10.1007/BF00656847; DAVINO PP, 1995, MOL CELL ENDOCRINOL, V113, P1; Dellovade TL, 1999, J NEUROENDOCRINOL, V11, P1, DOI 10.1046/j.1365-2826.1999.00250.x; EWER J, 1994, J NEUROSCI, V14, P7704; Ewer J, 1996, J COMP NEUROL, V370, P330; Ewer J, 1997, J EXP BIOL, V200, P869; FLANAGAN LM, 1995, NEUROBIOLOGICAL EFFE, P142; FROHMAN MA, 1990, PCR PROTOCOLS GUIDE, P21; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Gammie SC, 1999, J EXP BIOL, V202, P343; Gammie SC, 1997, J NEUROSCI, V17, P4389; HARLAN RE, 1988, MOL NEUROBIOL, V2, P183, DOI 10.1007/BF02935345; Hegstrom CD, 1996, J NEUROBIOL, V29, P535; HEWES RS, 1994, J NEUROSCI, V14, P1812, DOI 10.1523/JNEUROSCI.14-03-01812.1994; Jindra M, 1996, DEV BIOL, V180, P258, DOI 10.1006/dbio.1996.0299; Kaczmarek LK, 1987, NEUROMODULATION BIOC; Kingan TG, 1997, J EXP BIOL, V200, P3245; KINGAN TG, 1989, ANAL BIOCHEM, V183, P283, DOI 10.1016/0003-2697(89)90481-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MCCARTHY MM, 1995, OXYTOCIN CELLULAR MO; MCEWEN BS, 1994, HORM BEHAV, V28, P396, DOI 10.1006/hbeh.1994.1036; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; MICEVYCH PE, 1988, EXP NEUROL, V100, P416, DOI 10.1016/0014-4886(88)90119-7; NOVICKI A, 1995, J COMP PHYSIOL A, V176, P45, DOI 10.1007/BF00197751; Novicki A, 1996, J EXP BIOL, V199, P1757; O'Brien MA, 1998, J EXP BIOL, V201, P193; RICHARD S, 1991, J BIOL CHEM, V266, P21428; RICHARD S, 1990, J BIOL CHEM, V265, P6098; RIDDIFORD LM, 1986, DEV BIOL, V118, P82, DOI 10.1016/0012-1606(86)90075-8; ROBINOW S, 1993, DEVELOPMENT, V119, P1251; Ross LS, 1996, BIOTECHNIQUES, V21, P382; SCHELLER RH, 1983, CELL, V32, P7, DOI 10.1016/0092-8674(83)90492-0; Schulkin Jay, 1993, P13; SLAMA K, 1980, ACTA ENTOMOL BOHEMOS, V77, P145; Streichert LC, 1997, DEV BIOL, V183, P95, DOI 10.1006/dbio.1996.8467; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; TRUMAN JW, 1981, NATURE, V291, P70, DOI 10.1038/291070a0; TRUMAN JW, 1983, J INSECT PHYSIOL, V29, P895, DOI 10.1016/0022-1910(83)90052-5; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; VOLICER L, 1971, NEUROPHARMACOLOGY, V10, P631, DOI 10.1016/0028-3908(71)90029-3; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zitnan D, 1996, SCIENCE, V271, P88, DOI 10.1126/science.271.5245.88; ZITNAN D, 1993, DEV BIOL, V156, P117, DOI 10.1006/dbio.1993.1063	52	139	144	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					523	535		10.1016/S0896-6273(00)80805-3	http://dx.doi.org/10.1016/S0896-6273(00)80805-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433264	Bronze			2022-12-24	WOS:000081701000016
J	Bichot, NP; Schall, JD				Bichot, NP; Schall, JD			Effects of similarity and history on neural mechanisms of visual selection	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE FIELD; SACCADE TARGET SELECTION; FEATURE CONJUNCTIONS; SPATIAL ATTENTION; GUIDED SEARCH; NEURONS; PARALLEL; MACAQUE; MOVEMENTS; CORTEX	To investigate how the brain combines knowledge with visual processing to locate eye movement targets, we trained monkeys to search for a target defined by a conjunction of color and shape. On successful trials, neurons in the frontal eye field not only discriminated the target from distracters, but also discriminated distracters that shared a target feature as well as distracters that had been the search target during the previous session. Likewise, occasional errant saccades tended to direct gaze to distracters that either resembled the current target or had been the previous target. These findings show that the frontal eye field is involved in visual and not just motor selection and that visual selection is influenced by long-term priming. The data support the hypothesis that visual selection can be accomplished by parallel processing of objects based on their elementary features.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, 301 Wilson Hall, Nashville, TN 37240 USA.				NEI NIH HHS [P30-EY08126, T32-EY07135] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY008126, T32EY007135] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAIZER JS, 1991, J NEUROSCI, V11, P168; Bichot NP, 1999, VISUAL NEUROSCI, V16, P81, DOI 10.1017/S0952523899161042; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BUTTNERENNEVER JA, 1988, J COMP NEUROL, V267, P307, DOI 10.1002/cne.902670302; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; CAVE KR, IN PRESS PSYCHOL RES; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Kim MS, 1995, PSYCHOL SCI, V6, P376, DOI 10.1111/j.1467-9280.1995.tb00529.x; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; MCLEOD P, 1988, NATURE, V332, P154, DOI 10.1038/332154a0; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; SAYER RJ, 1990, J NEUROSCI, V10, P826; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 1997, CEREBR CORT, V12, P527; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SEGRAVES MA, 1992, J NEUROPHYSIOL, V68, P1967, DOI 10.1152/jn.1992.68.6.1967; SHELIGA BM, 1995, EXP BRAIN RES, V105, P261; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; THOMPSON KG, IN PRESS BEHAV BRAIN; TOWNSEND JT, 1990, PSYCHOL SCI, V1, P46, DOI 10.1111/j.1467-9280.1990.tb00067.x; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TREISMAN AM, 1990, J EXPT PSYCHOL HUMAN, V16, P456; WILLIAMS LG, 1967, ACTA PSYCHOL, V27, P355, DOI 10.1016/0001-6918(67)90080-7; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	36	233	237	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					549	554		10.1038/9205	http://dx.doi.org/10.1038/9205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273YA	10448220				2022-12-24	WOS:000084735900015
J	Isaacson, JS				Isaacson, JS			Glutamate spillover mediates excitatory transmission in the rat olfactory bulb	NEURON			English	Article							METHYL-D-ASPARTATE; NON-NMDA RECEPTORS; DENDRODENDRITIC INHIBITION; CURRENT FLUCTUATIONS; HIPPOCAMPAL-NEURONS; SYNAPTIC CURRENTS; SILENT SYNAPSES; NERVOUS-SYSTEM; ACTIVATION; RELEASE	In the CNS, glutamate typically mediates excitatory transmission via local actions at synaptic contacts. In the olfactory bulb, mitral cell dendrites release glutamate at synapses formed only onto the dendrites of inhibitory granule cells, Here, I show excitatory transmission mediated solely by transmitter spillover between mitral cells in olfactory bulb slices. Dendritic glutamate release from individual mitral cells causes self-excitation via local activation of N-methyl-D-aspartate (NMDA) receptors. Paired recordings reveal that glutamate release from one cell generates NMDA receptor-mediated responses in neighboring mitral cells that are enhanced by blockade of glutamate uptake. Furthermore, spillover generates spontaneous NMDA receptor-mediated population responses. This simultaneous activation of neighboring mitral cells by a diffuse action of glutamate provides a mechanism for synchronizing olfactory principal cells.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Isaacson, JS (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.							Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; Dzubay JA, 1996, J NEUROSCI, V16, P4129; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Haas K, 1998, NEUROPHARMACOLOGY, V37, P1393, DOI 10.1016/S0028-3908(98)00137-3; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HESTRIN S, 1990, NEURON, V5, P247, DOI 10.1016/0896-6273(90)90162-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; ISAACSON JS, 1995, J NEUROPHYSIOL, V73, P964, DOI 10.1152/jn.1995.73.3.964; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; LESTER RAJ, 1992, J NEUROSCI, V12, P635; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; OBrien JA, 1997, NEUROSCI LETT, V227, P5, DOI 10.1016/S0304-3940(97)00293-0; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PETRALIA RS, 1994, J NEUROSCI, V14, P667; PRICE JL, 1970, J CELL SCI, V7, P631; PRICE JL, 1970, J CELL SCI, V7, P125; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; ROBINSON HPC, 1991, BIOPHYS J, V59, P295, DOI 10.1016/S0006-3495(91)82223-8; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; SILBERBERG SD, 1993, BIOPHYS J, V65, P1570, DOI 10.1016/S0006-3495(93)81196-2; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	46	163	166	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					377	384		10.1016/S0896-6273(00)80787-4	http://dx.doi.org/10.1016/S0896-6273(00)80787-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399942	Bronze			2022-12-24	WOS:000081218600021
J	Vetter, DE; Liberman, MC; Mann, J; Barhanin, J; Boulter, J; Brown, MC; Saffiote-Kolman, J; Heinemann, SF; Elgoyhen, AB				Vetter, DE; Liberman, MC; Mann, J; Barhanin, J; Boulter, J; Brown, MC; Saffiote-Kolman, J; Heinemann, SF; Elgoyhen, AB			Role of alpha 9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation	NEURON			English	Article							GUINEA-PIG COCHLEA; CROSSED OLIVOCOCHLEAR BUNDLE; PRODUCT OTOACOUSTIC EMISSIONS; COMPOUND ACTION-POTENTIALS; EMBRYONIC STEM-CELLS; INNER HAIR-CELLS; CONTRALATERAL SOUND; BRAIN-STEM; ACETYLCHOLINE-RECEPTOR; CHOLINERGIC RECEPTOR	Cochlear outer hair cells (OHCs) express alpha 9 nACh receptors and are contacted by descending, predominately cholinergic, efferent fibers originating in the CNS. Mice carrying a null mutation for the nACh alpha 9 gene were produced to investigate its role(s) in auditory processing and development of hair cell innervation. In alpha 9 knockout mice, most OHCs were innervated by one large terminal instead of multiple smaller terminals as in wild types, suggesting a role for the nACh alpha 9 subunit in development of mature synaptic connections. alpha 9 knockout mice also failed to show suppression of cochlear responses (compound action potentials, distortion product otoacoustic emissions) during efferent fiber activation, demonstrating the key role alpha 9 receptors play in mediating the only known effects of the olivocochlear system.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; Beckman Res Inst, Duarte, CA 92010 USA; Inst Pharmacol Mol & Cellulare, CNRS, F-06560 Valbonne, France; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Buenos Aires, CONICET, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina	Salk Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; City of Hope; Beckman Research Institute of City of Hope; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Los Angeles; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Vetter, DE (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vetter@salk.edu	Vetter, Douglas E./O-8150-2019		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER; NIDA NIH HHS [P50 DA005010] Funding Source: Medline; NIDCD NIH HHS [DC02871, DC00188] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASCHOFF A, 1987, J COMP NEUROL, V264, P56, DOI 10.1002/cne.902640106; ASCHOFF A, 1988, EXP BRAIN RES, V71, P241; ASCHOFF A, 1988, EXP BRAIN RES, V71, P252; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BOBBIN RP, 1974, ACTA OTO-LARYNGOL, V77, P56, DOI 10.3109/00016487409124598; BROWN MC, 1984, J PHYSIOL-LONDON, V354, P625, DOI 10.1113/jphysiol.1984.sp015396; BROWN MC, 1983, SCIENCE, V222, P69, DOI 10.1126/science.6623058; CAMPBELL JP, 1988, HEARING RES, V35, P271, DOI 10.1016/0378-5955(88)90124-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CODY AR, 1982, J ACOUST SOC AM, V72, P280, DOI 10.1121/1.387993; Dallos P, 1997, J NEUROSCI, V17, P2212; DESMEDT J. E., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1478, DOI 10.1121/1.1918374; DESMEDT JE, 1961, NATURE, V192, P1263, DOI 10.1038/1921263a0; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; EMMERLING MR, 1990, J ELECTRON MICR TECH, V15, P123, DOI 10.1002/jemt.1060150205; EROSTEGUI C, 1994, HEARING RES, V74, P135, DOI 10.1016/0378-5955(94)90182-1; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; FEX J, 1978, BRAIN RES, V159, P440, DOI 10.1016/0006-8993(78)90555-3; FREDETTE B, 1993, J CELL BIOL, V123, P1867, DOI 10.1083/jcb.123.6.1867; FRITZSCH B, 1993, HEARING RES, V65, P51, DOI 10.1016/0378-5955(93)90200-K; FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039; GALAMBOS R, 1956, J NEUROPHYSIOL, V19, P424, DOI 10.1152/jn.1956.19.5.424; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V262, P141, DOI 10.1098/rspb.1995.0188; GUINAN JJ, 1983, J COMP NEUROL, V221, P358, DOI 10.1002/cne.902210310; HASHIMOTO S, 1990, ACTA OTO-LARYNGOL, V109, P228, DOI 10.3109/00016489009107438; Hiel H, 1996, BRAIN RES, V738, P347, DOI 10.1016/S0006-8993(96)01046-3; Hienz RD, 1998, HEARING RES, V116, P10, DOI 10.1016/S0378-5955(97)00197-4; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; HOUSLEY GD, 1991, P ROY SOC B-BIOL SCI, V244, P161, DOI 10.1098/rspb.1991.0065; KLINKE R, 1974, PHYSIOL REV, V54, P316, DOI 10.1152/physrev.1974.54.2.316; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; KUJAWA SG, 1992, HEARING RES, V61, P106, DOI 10.1016/0378-5955(92)90041-K; KUJAWA SG, 1994, HEARING RES, V74, P122, DOI 10.1016/0378-5955(94)90181-3; KUJAWA SG, 1993, HEARING RES, V68, P97, DOI 10.1016/0378-5955(93)90068-C; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LIBERMAN MC, 1989, HEARING RES, V38, P47, DOI 10.1016/0378-5955(89)90127-5; LIBERMAN MC, 1991, J NEUROPHYSIOL, V65, P123, DOI 10.1152/jn.1991.65.1.123; LIPTON SA, 1988, SCIENCE, V239, P1293, DOI 10.1126/science.3344435; Lonsbury-Martin B. L., 1997, OTOACOUSTIC EMISSION, P83; Luo L, 1998, J COMP NEUROL, V393, P320; MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3; May Bradford J, 1995, Audit Neurosci, V1, P385; Morley BJ, 1998, MOL BRAIN RES, V53, P78, DOI 10.1016/S0169-328X(97)00272-6; MOUNTAIN DC, 1980, SCIENCE, V210, P71, DOI 10.1126/science.7414321; MOUNTAIN DC, 1980, HEARING RES, V3, P231, DOI 10.1016/0378-5955(80)90049-0; Murugasu E, 1996, J NEUROSCI, V16, P325; OATMAN LC, 1971, EXP NEUROL, V32, P341, DOI 10.1016/0014-4886(71)90003-3; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Puria S, 1996, J ACOUST SOC AM, V99, P500, DOI 10.1121/1.414508; RASMUSSEN GL, 1946, J COMP NEUROL, V84, P141, DOI 10.1002/cne.900840204; RASMUSSEN GL, 1942, ANAT REC, V82, P441; ROBERTSON D, 1985, HEARING RES, V20, P79, DOI 10.1016/0378-5955(85)90060-7; RUGGERO MA, 1992, PHILOS T ROY SOC B, V336, P307, DOI 10.1098/rstb.1992.0063; SCHARF B, 1987, PERCEPT PSYCHOPHYS, V42, P215, DOI 10.3758/BF03203073; SCHARF B, 1994, HEARING RES, V75, P11, DOI 10.1016/0378-5955(94)90051-5; SIEGEL JH, 1982, HEARING RES, V6, P171, DOI 10.1016/0378-5955(82)90052-1; Slepecky N. B., 1996, COCHLEA, V8, P44; SOBKOWICZ HM, 1992, DEV AUDITORY VESTIBU, V2, P59; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; SZABO P, 1994, DEVELOPMENT, V120, P1651; THOMPSON GC, 1986, J COMP NEUROL, V254, P246, DOI 10.1002/cne.902540208; Ulfendahl M, 1997, PROG NEUROBIOL, V53, P331, DOI 10.1016/S0301-0082(97)00040-3; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Walsh EJ, 1998, J NEUROSCI, V18, P3859; WARREN EH, 1989, HEARING RES, V37, P105, DOI 10.1016/0378-5955(89)90033-6; WHITE JS, 1983, J COMP NEUROL, V219, P203, DOI 10.1002/cne.902190206; Whitlon DS, 1997, INT J DEV NEUROSCI, V15, P657, DOI 10.1016/S0736-5748(96)00119-0; WHITLON DS, 1990, J NEUROCYTOL, V19, P970, DOI 10.1007/BF01186824; WIEDERHOLD ML, 1970, J ACOUST SOC AM, V48, P950, DOI 10.1121/1.1912234; WINSLOW RL, 1988, HEARING RES, V35, P165, DOI 10.1016/0378-5955(88)90116-5; XIE DH, 1994, HEARING RES, V75, P61, DOI 10.1016/0378-5955(94)90056-6	72	222	227	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1999	23	1					93	103		10.1016/S0896-6273(00)80756-4	http://dx.doi.org/10.1016/S0896-6273(00)80756-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402196	Bronze			2022-12-24	WOS:000080681200013
J	Wichterle, H; Garcia-Verdugo, JM; Herrera, DG; Alvarez-Buylla, A				Wichterle, H; Garcia-Verdugo, JM; Herrera, DG; Alvarez-Buylla, A			Young neurons from medial ganglionic eminence disperse in adult and embryonic brain	NATURE NEUROSCIENCE			English	Article							NEURAL TRANSPLANTATION; STRIATAL PRECURSORS; CELL-MIGRATION; MONOCLONAL-ANTIBODY; SUBVENTRICULAR ZONE; PROGENITOR CELLS; MAMMALIAN BRAIN; CEREBRAL-CORTEX; RADIAL GLIA; FOREBRAIN	In this study, we identified neuronal precursors that can disperse through adult mammalian brain tissue. Transplanted neuronal precursors from embryonic medial ganglionic eminence (MGE), but not from lateral ganglionic eminence (LGE) or neocortex, dispersed and differentiated into neurons in multiple adult brain regions. In contrast, only LGE cells were able to migrate efficiently from the adult subventricular zone to the olfactory bulb. In embryonic brain slices, MGE cells migrated extensively toward cortex. Our results demonstrate that cells in different germinal regions have unique migratory potentials, and that adult mammalian brain can support widespread dispersion of specific populations of neuronal precursors. These findings could be useful in repair of diffuse brain damage.	Rockefeller Univ, New York, NY 10021 USA; Univ Valencia, E-46100 Burjassot, Spain; Cornell Med Ctr, New York Hosp, Dept Psychiat, New York, NY 10021 USA	Rockefeller University; University of Valencia; Cornell University; NewYork-Presbyterian Hospital	Wichterle, H (corresponding author), Rockefeller Univ, Box 23,1230 York Ave, New York, NY 10021 USA.		García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925	NICHD NIH HHS [HD32116] Funding Source: Medline; NINDS NIH HHS [NS28478] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R37NS028478, R01NS028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; ALVAREZBUYLLA A, 1987, J COMP NEUROL, V264, P159, DOI 10.1002/cne.902640203; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ANDERSSON C, 1993, INT J DEV NEUROSCI, V11, P555, DOI 10.1016/0736-5748(93)90045-F; BJORKLUND A, 1991, TRENDS NEUROSCI, V14, P319, DOI 10.1016/0166-2236(91)90154-M; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; FISHELL G, 1995, DEVELOPMENT, V121, P803; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GRAYBIEL AM, 1989, J NEUROSCI, V9, P3250; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Isacson O, 1997, TRENDS NEUROSCI, V20, P477, DOI 10.1016/S0166-2236(97)01081-3; KAWAMURA K, 1988, EXP BRAIN RES, V70, P477; Letinic K, 1997, J COMP NEUROL, V384, P373; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; LIN RCS, 1994, NEUROSCIENCE, V60, P11, DOI 10.1016/0306-4522(94)90199-6; LINDVALL O, 1991, TRENDS NEUROSCI, V14, P376, DOI 10.1016/0166-2236(91)90167-S; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MartinezSerrano A, 1997, TRENDS NEUROSCI, V20, P530, DOI 10.1016/S0166-2236(97)01119-3; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Olsson M, 1997, NEUROSCIENCE, V79, P57, DOI 10.1016/S0306-4522(96)00606-9; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; PAKZABAN P, 1993, EXP BRAIN RES, V97, P13; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Peters E, 1991, FINE STRUCTURE NERVO; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; RAISMAN G, 1993, INT J DEV NEUROSCI, V11, P651, DOI 10.1016/0736-5748(93)90053-G; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1969, Z ANAT ENTWICKLUNGS, V129, P53, DOI 10.1007/BF00521955; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Rubin BP, 1995, EUR J NEUROSCI, V7, P2524, DOI 10.1111/j.1460-9568.1995.tb01052.x; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Zigova T, 1998, CELL TRANSPLANT, V7, P137, DOI 10.1016/S0963-6897(98)00009-8; ZIGOVA T, 1996, DEV BIOL, V173, P1	45	380	387	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					461	466		10.1038/8131	http://dx.doi.org/10.1038/8131			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321251				2022-12-24	WOS:000084609400017
J	Khakh, BS; Bao, XR; Labarca, C; Lester, HA				Khakh, BS; Bao, XR; Labarca, C; Lester, HA			Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds	NATURE NEUROSCIENCE			English	Article							FAST SYNAPTIC TRANSMISSION; ATP RECEPTOR; EXTRACELLULAR K+; SENSORY NEURONS; POTASSIUM CHANGES; NERVOUS-SYSTEM; RAT; BRAIN; RELEASE; ADENOSINE	Fast synaptic transmission depends on the selective ionic permeability of transmitter-gated ion channels. Here we show changes in the ion selectivity of neuronal P2X transmitter-gated cation channels as a function of time (on the order of seconds) and previous ATP exposure. Heterologously expressed P2X2 P2X2/P2X3 and P2X4 channels as well as native neuronal P2X channels possess various combinations of mono- or biphasic responses and permeability changes, measured by NMDG(+) and fluorescent dye. Furthermore, in P2X4 receptors, this ability to alter ion selectivity can be increased or decreased by altering an amino-acid residue thought to line the ion permeation pathway, identifying a region that governs this activity-dependent change.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Khakh, BS (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-11756] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bardoni R, 1997, J NEUROSCI, V17, P5297; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Braun N, 1998, J NEUROSCI, V18, P4891; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Collo G, 1996, J NEUROSCI, V16, P2495; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Cunha RA, 1996, J NEUROCHEM, V67, P2180; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Egan TM, 1998, J NEUROSCI, V18, P2350; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; GALLIGAN JJ, 1994, J NEUROSCI, V14, P7563; Green T, 1998, NEURON, V20, P427, DOI 10.1016/S0896-6273(00)80986-1; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Hille B., 1992, IONIC CHANNELS EXCIT; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; KIDD EJ, 1995, MOL PHARMACOL, V48, P569; KRNJEVIC K, 1982, CAN J PHYSIOL PHARM, V60, P1643, DOI 10.1139/y82-243; KRNJEVIC K, 1980, CAN J PHYSIOL PHARM, V58, P579, DOI 10.1139/y80-097; KRNJEVIC K, 1982, CAN J PHYSIOL PHARM, V60, P1658, DOI 10.1139/y82-244; Le KT, 1998, NEUROSCIENCE, V83, P177, DOI 10.1016/S0306-4522(97)00365-5; Le KT, 1998, J NEUROSCI, V18, P7152; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lutz PL, 1997, BRAIN RES, V769, P281, DOI 10.1016/S0006-8993(97)00719-1; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MORRIS ME, 1993, AM J PHYSIOL, V264, pR761, DOI 10.1152/ajpregu.1993.264.4.R761; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Nieber K, 1997, BRIT J PHARMACOL, V122, P423, DOI 10.1038/sj.bjp.0701386; North RA, 1996, CURR OPIN CELL BIOL, V8, P474, DOI 10.1016/S0955-0674(96)80023-8; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; QUICK MW, 1994, ION CHANNELS EXCITAB, P261; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Seguela P, 1996, J NEUROSCI, V16, P448; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; SURPRENANT A, 1995, TRENDS NEUROSCI, V18, P224, DOI 10.1016/0166-2236(95)93907-F; TERRIAN DM, 1989, J NEUROCHEM, V53, P1390, DOI 10.1111/j.1471-4159.1989.tb08529.x; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3; Vulchanova L, 1997, NEUROPHARMACOLOGY, V36, P1229, DOI 10.1016/S0028-3908(97)00126-3; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; WICRASZKO A, 1989, BRAIN RES, V485, P244	50	304	311	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					322	330		10.1038/7233	http://dx.doi.org/10.1038/7233			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204538				2022-12-24	WOS:000080532000010
J	Kunes, S				Kunes, S			Stop or go in the target zone	NEURON			English	Article							AXON GUIDANCE; DROSOPHILA		Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kunes, S (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gibbs SM, 1998, NEURON, V20, P83, DOI 10.1016/S0896-6273(00)80436-5; Hu S, 1999, NEURON, V22, P419, DOI 10.1016/S0896-6273(00)80696-0; Meinertzhagen Ian A., 1993, P1363; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763	10	3	3	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					639	640		10.1016/S0896-6273(00)80719-9	http://dx.doi.org/10.1016/S0896-6273(00)80719-9			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230780	Bronze			2022-12-24	WOS:000079976200003
J	Lu, WY; Xiong, ZG; Lei, S; Orser, BA; Dudek, E; Browning, MD; MacDonald, JF				Lu, WY; Xiong, ZG; Lei, S; Orser, BA; Dudek, E; Browning, MD; MacDonald, JF			G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CA1 HIPPOCAMPAL-NEURONS; D-ASPARTATE RECEPTORS; TYROSINE KINASE; GLUTAMATE RECEPTORS; MAP KINASE; ACTIVATION; CURRENTS; PYK2	The N-methyl-D-aspartate (NMDA) receptor contributes to synaptic plasticity in the central nervous system and is both serine-threonine and tyrosine phosphorylated. In CA1 pyramidal neurons of the hippocampus, activators of protein kinase C (PKC) as well as the G-protein-coupled receptor ligands muscarine and lysophosphatidic acid enhanced NMDA-evoked currents. Unexpectedly, this effect was blocked by inhibitors of tyrosine kinases, including a Src required sequence and an antibody selective for Src itself. In neurons from mice lacking c-Src, PKC-dependent upregulation was absent. Thus, G-protein-coupled receptors can regulate NMDA receptor function indirectly through a PKC-dependent activation of the non-receptor tyrosine kinase (Src) signaling cascade.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Anaesthesia, Toronto, ON M5S 1A8, Canada; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Program Neurosci, Denver, CO 80262 USA	University of Toronto; University of Toronto; University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	MacDonald, JF (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.		Lu, Wei-Yang/K-4404-2013					Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CONSTANTINEPATON M, 1990, COLD SPRING HARB SYM, V55, P431; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HEMMINGS HCJ, 1997, REGULATORY PROTEIN M, P121; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Igishi T, 1998, BIOCHEM BIOPH RES CO, V244, P5, DOI 10.1006/bbrc.1998.8208; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKRAM H, 1992, J PHYSIOL-LONDON, V457, P491, DOI 10.1113/jphysiol.1992.sp019389; ODELL TJ, 1992, COLD SPRING HARB SYM, V57, P517, DOI 10.1101/SQB.1992.057.01.057; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; Wheal HV, 1998, PROG NEUROBIOL, V55, P611, DOI 10.1016/S0301-0082(98)00026-4; Xiong ZG, 1998, MOL PHARMACOL, V54, P1055, DOI 10.1124/mol.54.6.1055; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	36	334	344	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					331	338		10.1038/7243	http://dx.doi.org/10.1038/7243			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204539				2022-12-24	WOS:000080532000011
J	Chance, FS; Nelson, SB; Abbott, LF				Chance, FS; Nelson, SB; Abbott, LF			Complex cells as cortically amplified simple cells	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; RECEPTIVE-FIELD PROPERTIES; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; SYNAPTIC DEPRESSION; THALAMIC INPUT; AREA 17; ORGANIZATION; AFFERENTS; NEURONS	The majority of synapses in primary visual cortex mediate excitation between nearby neurons, yet the role of local recurrent connections in visual processing remains unclear. We propose that these connections are responsible for the spatial-phase invariance of complex-cell responses. In a network model with selective cortical amplification, neurons exhibit simple-cell responses when recurrent connections are weak and complex-cell responses when they are strong, suggesting that simple and complex cells are the low- and high-gain limits of the same basic cortical circuit. Given the ubiquity of invariant responses in cognitive processing, the recurrent mechanism we propose for complex cells may be widely applicable.	Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA.			Nelson, Sacha/0000-0002-0108-8599	NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11116] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Braitenberg V, 1991, ANATOMY CORTEX; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; HAMMOND P, 1977, EXP BRAIN RES, V30, P275; HAMMOND P, 1975, EXP BRAIN RES, V22, P427; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HOFFMANN KP, 1971, BRAIN RES, V32, P460, DOI 10.1016/0006-8993(71)90340-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; LEVAY S, 1986, J NEUROSCI, V6, P3564; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; MALPELI JG, 1986, J NEUROPHYSIOL, V56, P1062, DOI 10.1152/jn.1986.56.4.1062; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; Mel BW, 1998, J NEUROSCI, V18, P4325; MIGNARD M, 1991, SCIENCE, V251, P1249, DOI 10.1126/science.1848727; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; MOVSHON JA, 1975, J PHYSIOL-LONDON, V249, P445, DOI 10.1113/jphysiol.1975.sp011025; PETERS A, 1994, CEREB CORTEX, V4, P215, DOI 10.1093/cercor/4.3.215; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; TREVES A, 1993, NETWORK-COMP NEURAL, V4, P259, DOI 10.1088/0954-898X/4/3/002; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; White E.L., 1989, CORTICAL CIRCUITS SY	39	153	154	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					277	282		10.1038/6381	http://dx.doi.org/10.1038/6381			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195222				2022-12-24	WOS:000081684500017
J	Chang, YC; Weiss, DS				Chang, YC; Weiss, DS			Channel opening locks agonist onto the GABA(C) receptor	NATURE NEUROSCIENCE			English	Article							ACETYLCHOLINE-RECEPTOR; ION CHANNELS; MUSCLE ENDPLATE; SYNAPTIC CLEFT; ACTIVATION; KINETICS; BINDING; RAT; STOICHIOMETRY; DEACTIVATION	Determination of the activation mechanism of neurotransmitter-operated ion channels has been hindered by a limited understanding of the relationship between agonist binding and the gating of the integral ion pore. Here we describe a [H-3]ligand binding assay that enables us to make repeated binding measurements from the same intact oocyte expressing recombinant human rho 1 GABA(C) receptors and directly correlate the binding kinetics with electrophysiological measurements. We have determined an association rate for GABA of about 10(5) M(-1)s(-1); this is four orders of magnitude slower than diffusion, indicating GABA has restricted access to its binding site. We also demonstrate that GABA dissociates at two rates. Our data are consistent with the faster rate being the true microscopic dissociation rate of GABA, with the slower rate occurring because the opening of the pore detains agonist release.	Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Weiss, DS (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Neurobiol, 1719 6th Ave S, Birmingham, AL 35294 USA.	dweiss@nrc.uab.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035291, R01NS035291] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36196, NS35291] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amin J, 1996, P ROY SOC B-BIOL SCI, V263, P273, DOI 10.1098/rspb.1996.0042; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; ARMSTRONG DL, 1979, J PHYSIOL-LONDON, V294, P365, DOI 10.1113/jphysiol.1979.sp012935; AUERBACH A, 1993, J PHYSIOL-LONDON, V461, P339, DOI 10.1113/jphysiol.1993.sp019517; BEAN BP, 1990, J NEUROSCI, V10, P1; Chang YC, 1996, J NEUROSCI, V16, P5415; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; COLQUHOUN D, 1975, NATURE, V253, P204, DOI 10.1038/253204a0; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; COLQUHOUN D, 1985, TRENDS PHARMACOL SCI, V6, P197, DOI 10.1016/0165-6147(85)90092-6; Colquhoun D, 1998, NEURON, V20, P381, DOI 10.1016/S0896-6273(00)80982-4; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; COLQUHOUN D, 1977, J PHYSIOL-LONDON, V266, P361, DOI 10.1113/jphysiol.1977.sp011772; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; ENNA SJ, 1975, BRAIN RES, V100, P81, DOI 10.1016/0006-8993(75)90243-7; HABER JE, 1967, P NATL ACAD SCI USA, V58, P2087, DOI 10.1073/pnas.58.5.2087; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEUBIG RR, 1980, BIOCHEMISTRY-US, V19, P2770, DOI 10.1021/bi00553a036; OLSEN RW, 1982, ANNU REV PHARMACOL, V22, P245, DOI 10.1146/annurev.pa.22.040182.001333; RANG HP, 1966, PROC R SOC SER B-BIO, V164, P488, DOI 10.1098/rspb.1966.0045; SHERIDAN RE, 1982, J GEN PHYSIOL, V80, P499, DOI 10.1085/jgp.80.4.499; SHERIDAN RE, 1975, P NATL ACAD SCI USA, V72, P3496, DOI 10.1073/pnas.72.9.3496; SHIMIZU T, 1992, J RECONSTR MICROSURG, V8, P41, DOI 10.1055/s-2007-1006682; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; THRON CD, 1968, J PHARMACOL EXP THER, V160, P91; Tia S, 1996, NEUROPHARMACOLOGY, V35, P1375, DOI 10.1016/S0028-3908(96)00018-4; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; WEISS DS, 1989, J NEUROSCI, V9, P1314	34	92	94	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					219	225		10.1038/6313	http://dx.doi.org/10.1038/6313			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195213				2022-12-24	WOS:000081684500008
J	Rushton, SK; Wann, JP				Rushton, SK; Wann, JP			Weighted combination of size and disparity: a computational model for timing a ball catch	NATURE NEUROSCIENCE			English	Article							CHANGING-SIZE; TIME; CONTACT; PERCEPTION; MOTION; DEPTH; TASKS	How do we time hand closure to catch a ball? Binocular disparity and optical looming provide two sources of information about an object's motion in depth, but the relative effectiveness of the two cues depends on ball size. Based on results from a virtual reality ball-catching task, we derive a simple model that uses both cues. The model is sensitive to the relative effectiveness of size and disparity and implicitly switches its response to the cue that specifies the earliest arrival and away from a cue that is lost or below threshold. We demonstrate the model's robustness by predicting the response of participants to some very unusual ball trajectories in a virtual reality task.	Univ Reading, Dept Psychol, Reading RG6 6AL, Berks, England; Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Reading; University of Edinburgh	Wann, JP (corresponding author), Univ Reading, Dept Psychol, 3 Earley Gate, Reading RG6 6AL, Berks, England.	J.P.Wann@reading.ac.uk	Rushton, Simon/A-1659-2010					ALDERSON GJ, 1974, J MOTOR BEHAV, V6, P217, DOI 10.1080/00222895.1974.10734998; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; HEUER H, 1993, PERCEPTION, V22, P549, DOI 10.1068/p220549; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Laurent M, 1996, PERCEPTION, V25, P1437, DOI 10.1068/p251437; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; MILNER AD, 1996, VISUAL BRAIN ACTION; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; REGAN D, 1979, VISION RES, V19, P1331, DOI 10.1016/0042-6989(79)90205-0; REGAN D, 1986, INVEST OPHTH VIS SCI, V27, P584; REGAN D, 1993, VISION RES, V33, P447, DOI 10.1016/0042-6989(93)90252-R; REGAN D, 1992, PERCEPTION, V21, P91, DOI 10.1068/p210091; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; TRESILIAN JR, 1995, PERCEPT PSYCHOPHYS, V57, P231, DOI 10.3758/BF03206510; TRESILIAN JR, 1994, HUM MOVEMENT SCI, V13, P335, DOI 10.1016/0167-9457(94)90045-0; Wann JP, 1996, J EXP PSYCHOL HUMAN, V22, P1031, DOI 10.1037/0096-1523.22.4.1031	18	121	121	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					186	190		10.1038/5750	http://dx.doi.org/10.1038/5750			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	160LF	10195204				2022-12-24	WOS:000078231600019
J	Faber, T; Joerges, J; Menzel, R				Faber, T; Joerges, J; Menzel, R			Associative learning modifies neural representations of odors in the insect brain	NATURE NEUROSCIENCE			English	Article							MUSHROOM BODIES; APIS-MELLIFERA; IDENTIFIED NEURON; HONEYBEE BRAIN; MEMORY; DISCRIMINATION; INFORMATION; ASSEMBLIES; MODULATION; BEHAVIOR	Recording brain activity in vivo during learning is fundamental to understanding how memories are formed. We used functional calcium imaging to track odor representations in the primary chemosensory center of the honeybee, the antennal robe, while training animals to discriminate a rewarded odor from an unrewarded one. Our results show that associative learning transforms odor representations and decorrelates activity patterns for the rewarded versus the unrewarded odor, making them less similar. Additionally, activity for the rewarded but not for the unrewarded odor is increased. These results indicate that neural representations of the environment may be modified through associative learning.	Free Univ Berlin, Inst Neurobiol, D-14195 Berlin, Germany	Free University of Berlin	Faber, T (corresponding author), Free Univ Berlin, Inst Neurobiol, Konigin Luise Str 28-30, D-14195 Berlin, Germany.	faber@zedat.fu-berlin.de						BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brennan PA, 1998, NEUROSCIENCE, V87, P583, DOI 10.1016/S0306-4522(98)00182-1; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Galizia CG, 1997, J NEUROSCI METH, V76, P61, DOI 10.1016/S0165-0270(97)00080-0; GALIZIA G, IN PRESS CELL TISSUE; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1994, BEHAV NEURAL BIOL, V62, P210, DOI 10.1016/S0163-1047(05)80019-6; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; KARNI A, 1995, NATURE, V377, P155; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Linster C, 1997, BEHAV BRAIN RES, V84, P117, DOI 10.1016/S0166-4328(97)83331-1; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Menzel Randolf, 1994, Progress in Zoology, V39, P81; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; REHDER V, 1987, J INSECT PHYSIOL, V33, P501, DOI 10.1016/0022-1910(87)90115-6; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; SMITH BH, 1991, J EXP BIOL, V161, P367; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	36	238	243	0	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					74	78		10.1038/4576	http://dx.doi.org/10.1038/4576			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195183				2022-12-24	WOS:000078409300016
J	David-Gray, ZK; Janssen, JWH; DeGrip, WJ; Nevo, E; Foster, RG				David-Gray, ZK; Janssen, JWH; DeGrip, WJ; Nevo, E; Foster, RG			Light detection in a 'blind' mammal	NATURE NEUROSCIENCE			English	Article							COLOR-VISION		Univ London Imperial Coll Sci Technol & Med, Dept Biol, London SW7 2AZ, England; Univ Nijmegen, Inst Cellular Signaling, Dept Biochem 160FWM, Nijmegen, Netherlands; Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel; Univ Virginia, Ctr Biol Timing, NSF, Charlottesville, VA 22901 USA	Imperial College London; Radboud University Nijmegen; University of Haifa; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia	David-Gray, ZK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Sir Alexander Fleming Bldg,Imperial Coll Rd, London SW7 2AZ, England.		DeGrip, Willem/L-4335-2015	DeGrip, Willem/0000-0001-7637-4920				COOPER HM, 1993, NATURE, V361, P156, DOI 10.1038/361156a0; Crandall KA, 1997, NATURE, V387, P667, DOI 10.1038/42628; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; JACOBS GH, 1994, BEHAV NEUROSCI, V108, P993, DOI 10.1037/0735-7044.108.5.993; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; NEVO E, 1991, EVOLUTIONARY BIOL, V25; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; RADO R, 1989, ENV QUALITY ECOSYSTE; SANYAL S, 1990, INVEST OPHTH VIS SCI, V31, P1398; VIGHTEICHMANN I, 1980, Z MIKROSK ANAT FORSC, V94, P623; VISSERS PMA, 1996, THESIS U NIJMEGEN	12	76	77	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					655	656		10.1038/3656	http://dx.doi.org/10.1038/3656			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196579				2022-12-24	WOS:000077323400007
J	Ffytche, DH; Howard, RJ; Brammer, MJ; David, A; Woodruff, P; Williams, S				Ffytche, DH; Howard, RJ; Brammer, MJ; David, A; Woodruff, P; Williams, S			The anatomy of conscious vision: an fMRI study of visual hallucinations	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL NEUROANATOMY; CORTICAL RESPONSE; BRAIN ACTIVITY; CORTEX; SCHIZOPHRENIA; STIMULATION; PERCEPTION; FACE	Despite recent advances in functional neuroimaging, the apparently simple question of how and where we see-the neurobiology of visual consciousness-continues to challenge neuroscientists. Without a method to differentiate neural processing specific to consciousness from unconscious afferent sensory signals, the issue has been difficult to resolve experimentally. Here we use functional magnetic resonance imaging (fMRI) to study patients with the Charles Bonnet syndrome, for whom visual perception and sensory input have become dissociated. We found that hallucinations of color, faces, textures and objects correlate with cerebral activity in ventral extrastriate visual cortex, that the content of the hallucinations reflects the functional specializations of the region and that patients who hallucinate have increased ventral extrastriate activity, which persists between hallucinations.	Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Ffytche, DH (corresponding author), Inst Psychiat, De Crespigny Pk,Denmark Hill, London SE5 8AF, England.		Woodruff, Peter WR/B-5998-2009; Howard, Robert/E-4890-2010; Brammer, Michael J/B-7128-2012; ffytche, Dominic/ABD-8214-2021; Williams, Steve C/D-6979-2011; David, Anthony S/C-1315-2011; David, Anthony/O-1750-2019	Brammer, Michael J/0000-0001-9800-2052; Williams, Steve C/0000-0003-4299-1941; David, Anthony S/0000-0003-0967-774X; David, Anthony/0000-0003-0967-774X; Howard, Robert/0000-0002-3071-2338; ffytche, Dominic/0000-0002-4214-9642; opoku, anita/0000-0001-7243-8157	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brammer MJ, 1997, MAGN RESON IMAGING, V15, P763, DOI 10.1016/S0730-725X(97)00135-5; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; DEMORSIER G, 1936, SCHWEIZ MED WOCHENSC, V66, P700; Ffytche DH, 1996, BRAIN, V119, P1971, DOI 10.1093/brain/119.6.1971; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; HOLROYD S, 1992, AM J PSYCHIAT, V149, P1701; HOWARD R, 1995, LANCET, V345, P70, DOI 10.1016/S0140-6736(95)91198-7; Howard RJ, 1998, NEUROREPORT, V9, P1019, DOI 10.1097/00001756-199804200-00012; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KOLMEL HW, 1985, J NEUROL NEUROSUR PS, V48, P29, DOI 10.1136/jnnp.48.1.29; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEPORE FE, 1990, NEUROLOGY, V40, P444, DOI 10.1212/WNL.40.3_Part_1.444; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; PENFIELD W, 1980, CEREBRAL CORTEX MAN; Puce A, 1996, J NEUROSCI, V16, P5205; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; Talairach J., 1988, COPLANAR STEREOTAXIC; Teunisse RJ, 1996, LANCET, V347, P794, DOI 10.1016/S0140-6736(96)90869-7; Woodruff PWR, 1997, AM J PSYCHIAT, V154, P1676, DOI 10.1176/ajp.154.12.1676; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; Zeki S., 1993, VISION BRAIN	29	325	331	1	73	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					738	742		10.1038/3738	http://dx.doi.org/10.1038/3738			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196592				2022-12-24	WOS:000077323400020
J	Roy, JE; Cullen, KE				Roy, JE; Cullen, KE			A neural correlate for vestibulo-ocular reflex suppression during voluntary eye-head gaze shifts	NATURE NEUROSCIENCE			English	Article							INHIBITORY BURST NEURONS; ALERT SQUIRREL-MONKEY; BRAIN-STEM NEURONS; FIRING BEHAVIOR; RHESUS-MONKEYS; QUICK PHASE; MOVEMENTS; NUCLEUS; PRIMATE; COORDINATION	The vestibule-ocular reflex (VOR) is classically associated with stabilizing the visual world on the retina by producing an eye movement of equal and opposite amplitude to the motion of the head. Here we have directly measured the efficacy of VOR pathways during voluntary combined eye-head gaze shifts by recording from individual vestibular neurons in monkeys whose heads were unrestrained. We found that the head-velocity signal carried by VOR pathways is reduced during gaze shifts in an amplitude-dependent manner, consistent with results from behavioral studies in humans and mon keys. Our data support the hypothesis that the VOR is not a hard-wired reflex, but rather a pathway that is modulated in a manner that depends on the current gaze strategy.	McGill Univ, Aerosp Med Res Unit, Montreal, PQ H3G 1Y6, Canada	McGill University	Cullen, KE (corresponding author), McGill Univ, Aerosp Med Res Unit, Montreal, PQ H3G 1Y6, Canada.	cullen@medcor.mcgill.ca		Roy, Jefferson/0000-0002-0776-3372				ANDREDESHAYS C, 1988, EXP BRAIN RES, V69, P399; BARNES GR, 1979, J PHYSIOL-LONDON, V287, P127, DOI 10.1113/jphysiol.1979.sp012650; BIZZI E, 1971, SCIENCE, V173, P452, DOI 10.1126/science.173.3995.452; Cullen KE, 1997, J NEUROPHYSIOL, V78, P3283, DOI 10.1152/jn.1997.78.6.3283; CULLEN KE, 1993, J NEUROPHYSIOL, V70, P828, DOI 10.1152/jn.1993.70.2.828; CULLEN KE, 1993, J NEUROPHYSIOL, V70, P844, DOI 10.1152/jn.1993.70.2.844; Cullen KE, 1996, J COMPUT NEUROSCI, V3, P347, DOI 10.1007/BF00161093; de No RL, 1933, ARCH NEURO PSYCHIATR, V30, P245, DOI 10.1001/archneurpsyc.1933.02240140009001; DICHGANS J, 1973, EXP BRAIN RES, V18, P548; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; FUCHS AF, 1975, J NEUROPHYSIOL, V38, P1140, DOI 10.1152/jn.1975.38.5.1140; GROSSMAN GE, 1989, J NEUROPHYSIOL, V62, P264, DOI 10.1152/jn.1989.62.1.264; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; Hays AV, 1982, WESCON C P, V2, P1; HIKOSAKA O, 1978, EXP BRAIN RES, V33, P337; HIKOSAKA O, 1977, EXP BRAIN RES, V27, P377; IGUSA Y, 1980, BRAIN RES, V182, P451, DOI 10.1016/0006-8993(80)91202-0; KELLER EL, 1975, EXP NEUROL, V46, P187, DOI 10.1016/0014-4886(75)90041-2; KING WM, 1976, J NEUROPHYSIOL, V39, P1135, DOI 10.1152/jn.1976.39.6.1135; LAURUTIS VP, 1986, J PHYSIOL-LONDON, V373, P209, DOI 10.1113/jphysiol.1986.sp016043; LEFEVRE P, 1992, EXP BRAIN RES, V91, P496; LISBERGER SG, 1980, J NEUROPHYSIOL, V43, P1725, DOI 10.1152/jn.1980.43.6.1725; MCCREA RA, 1987, J COMP NEUROL, V264, P547, DOI 10.1002/cne.902640408; McCrea RA, 1996, ANN NY ACAD SCI, V781, P292, DOI 10.1111/j.1749-6632.1996.tb15707.x; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; MORASSO P, 1973, EXP BRAIN RES, V16, P492, DOI 10.1007/BF00234475; NAKAO S, 1982, EXP BRAIN RES, V45, P371, DOI 10.1007/BF01208597; PELISSON D, 1986, BRAIN RES, V380, P397, DOI 10.1016/0006-8993(86)90244-1; PELISSON D, 1988, J NEUROPHYSIOL, V59, P997, DOI 10.1152/jn.1988.59.3.997; Phillips JO, 1996, ANN NY ACAD SCI, V781, P276, DOI 10.1111/j.1749-6632.1996.tb15706.x; SASAKI S, 1981, ANN NY ACAD SCI, V374, P130, DOI 10.1111/j.1749-6632.1981.tb30866.x; SCUDDER CA, 1992, J NEUROPHYSIOL, V68, P244, DOI 10.1152/jn.1992.68.1.244; SCUDDER CA, 1988, J NEUROPHYSIOL, V59, P1430, DOI 10.1152/jn.1988.59.5.1430; STRASSMAN A, 1986, J COMP NEUROL, V249, P337, DOI 10.1002/cne.902490303; STRASSMAN A, 1986, J COMP NEUROL, V249, P358, DOI 10.1002/cne.902490304; Tabak S, 1996, J NEUROPHYSIOL, V76, P3249, DOI 10.1152/jn.1996.76.5.3249; TOMLINSON RD, 1986, J NEUROPHYSIOL, V56, P1542, DOI 10.1152/jn.1986.56.6.1542; TOMLINSON RD, 1986, J NEUROPHYSIOL, V56, P1558, DOI 10.1152/jn.1986.56.6.1558; TOMLINSON RD, 1990, J NEUROPHYSIOL, V64, P1873, DOI 10.1152/jn.1990.64.6.1873; YOSHIDA K, 1982, J NEUROPHYSIOL, V48, P761, DOI 10.1152/jn.1982.48.3.761; ZANGEMEISTER WH, 1982, EXP NEUROL, V75, P389, DOI 10.1016/0014-4886(82)90169-8; ZANGEMEISTER WH, 1982, EXP NEUROL, V77, P563, DOI 10.1016/0014-4886(82)90228-X	43	109	111	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					404	410		10.1038/1619	http://dx.doi.org/10.1038/1619			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196531				2022-12-24	WOS:000076361400019
J	Reyes, A; Lujan, R; Rozov, A; Burnashev, N; Somogyi, P; Sakmann, B				Reyes, A; Lujan, R; Rozov, A; Burnashev, N; Somogyi, P; Sakmann, B			Target-cell-specific facilitation and depression in neocortical circuits	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; STRATUM-ORIENS; IN-VITRO; SYNAPSES; CONNECTIONS; INTERNEURONS; PLASTICITY	In neocortical circuits, repetitively active neurons evoke unitary postsynaptic potentials (PSPs) whose peak amplitudes either increase (facilitate) or decrease (depress) progressively. To examine the basis for these different synaptic responses, we made simultaneous recordings from three classes of neurons in cortical layer 2/3. We induced repetitive action potentials in pyramidal cells and recorded the evoked unitary excitatory (E)PSPs in two classes of GABAergic neurons. We observed facilitation of EPSPs in bitufted GABAergic interneurons, many of which expressed somatostatin immunoreactivity. EPSPs recorded from multipolar interneurons, however, showed depression. Some of these neurons were immunopositive for parvalbumin. Unitary inhibitory (I)PSPs evoked by repetitive stimulation of a bitufted neuron also showed a less pronounced but significant difference between the two target neurons. Facilitation and depression involve presynaptic mechanisms, and because a single neuron can express both behaviors simultaneously, we infer that local differences in the molecular structure of presynaptic nerve terminals are induced by retrograde signals from different classes of target neurons. Because bitufted and multipolar neurons both formed reciprocal inhibitory connections with pyramidal cells, the results imply that the balance of activation between two recurrent inhibitory pathways in the neocortex depends on the frequency of action potentials in pyramidal cells.	Max Planck Inst Med Forsch, Zellphysiol Abt, D-69120 Heidelberg, Germany; Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford, England	Max Planck Society; University of Oxford	Sakmann, B (corresponding author), Max Planck Inst Med Forsch, Zellphysiol Abt, Jahnstr 29, D-69120 Heidelberg, Germany.	zpsecr@sunny.mpimf-heidelberg.mpg.de	Rozov, Andrei/C-1997-2015; Lujan, Rafael/G-2555-2015; Burnashev, Nail/G-4056-2013	Lujan Miras, Rafael/0000-0003-2001-9545				Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1997, J PHYSIOL-LONDON, V501P, pP9; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Atluri PP, 1996, J NEUROSCI, V16, P5661; ATWOOD HL, 1971, J NEUROPHYSIOL, V34, P157, DOI 10.1152/jn.1971.34.1.157; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; BOWER JM, 1986, P NATL ACAD SCI USA, V83, P1115, DOI 10.1073/pnas.83.4.1115; BRODIN L, 1994, J NEUROPHYSIOL, V72, P592, DOI 10.1152/jn.1994.72.2.592; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; DAVIS GW, 1993, J NEUROSCI, V13, P3827; DAVIS GW, 1994, TRENDS NEUROSCI, V17, P9, DOI 10.1016/0166-2236(94)90028-0; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; FRANK E, 1973, J PHYSIOL-LONDON, V233, P635, DOI 10.1113/jphysiol.1973.sp010327; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KATZ PS, 1993, J NEUROSCI, V13, P3075; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KOERBER HR, 1991, J NEUROPHYSIOL, V65, P590, DOI 10.1152/jn.1991.65.3.590; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MASON A, 1991, J NEUROSCI, V11, P72; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; MULLER KJ, 1974, J PHYSIOL-LONDON, V238, P357, DOI 10.1113/jphysiol.1974.sp010529; RAHAMIMOFF R, 1968, J PHYSIOL-LONDON, V195, P471, DOI 10.1113/jphysiol.1968.sp008468; Schroder R, 1997, EUR J NEUROSCI, V9, P163, DOI 10.1111/j.1460-9568.1997.tb01364.x; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SOMOGYI P, 1984, J NEUROSCI, V4, P2590; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; VINCENT SR, 1985, J COMP NEUROL, V238, P169, DOI 10.1002/cne.902380205; WINSLOW JL, 1994, J NEUROPHYSIOL, V72, P1769, DOI 10.1152/jn.1994.72.4.1769; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	43	546	552	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					279	285		10.1038/1092	http://dx.doi.org/10.1038/1092			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195160				2022-12-24	WOS:000076361300010
J	Mitchell, JM; Basbaum, AI; Fields, HL				Mitchell, JM; Basbaum, AI; Fields, HL			A locus and mechanism of action for associative morphine tolerance	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; CCK-B RECEPTOR; HIPPOCAMPAL-FORMATION; ANTAGONIST L-365,260; NUCLEUS-ACCUMBENS; OPIATE ANALGESIA; HEROIN OVERDOSE; CHOLECYSTOKININ; MEMORY; NEURONS	Repeated administration of an opioid in the presence of specific environmental cues can induce tolerance specific to that setting (associative tolerance). Prolonged or repeated administration of an opioid without consistent contextual pairing yields non-associative tolerance. Here we demonstrate that cholecystokinin acting at the cholecystokinin-B receptor is required for associative but not nonassociative morphine tolerance. Morphine given in the morphine-associated context increased Fos-like immunoreactivity in the lateral amygdala and hippocampal area CA1. Microinjection of the cholecystokinin B antagonist L-365,260 into the amygdala blocked associative tolerance. These results indicate that cholecystokinin acting in the amygdala is necessary for associative tolerance to morphine's analgesic effect.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fields, HL (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.		Fields, Howard/ABG-9073-2020		NIDA NIH HHS [R37 DA001949-15, DA 01949, R37 DA001949] Funding Source: Medline; NINDS NIH HHS [P50 NS021445, NS 21445, P50 NS021445-15] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS021445, P01NS021445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA001949, R01DA001949] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALVAREZ P, 1995, J NEUROSCI, V15, P3796; BABER NS, 1989, PAIN, V39, P307, DOI 10.1016/0304-3959(89)90045-6; BELCHEVA I, 1994, NEUROPHARMACOLOGY, V33, P995, DOI 10.1016/0028-3908(94)90158-9; Ben Ari Y., 1986, EXCITATORY AMINO ACI, P3, DOI 10.1007/978-1-4684-7971-3_1; BRANCHEREAU P, 1993, J NEUROPHYSIOL, V70, P2584, DOI 10.1152/jn.1993.70.6.2584; Carter BL, 1996, PSYCHOPHARMACOLOGY, V123, P289, DOI 10.1007/BF02246583; CHAPMAN V, 1995, NEUROSCIENCE, V67, P731, DOI 10.1016/0306-4522(95)00085-W; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; DOURISH CT, 1988, EUR J PHARMACOL, V147, P469, DOI 10.1016/0014-2999(88)90183-5; DOURISH CT, 1990, EUR J PHARMACOL, V176, P35, DOI 10.1016/0014-2999(90)90129-T; FARIS PL, 1983, SCIENCE, V219, P310, DOI 10.1126/science.6294831; Huston JP, 1998, PEPTIDES, V19, P27, DOI 10.1016/S0196-9781(97)00270-2; INTROINICOLLISON IB, 1989, BRAIN RES, V476, P94, DOI 10.1016/0006-8993(89)91540-0; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KATSUURA G, 1985, EUR J PHARMACOL, V107, P363, DOI 10.1016/0014-2999(85)90263-8; KELLSTEIN DE, 1991, BRAIN RES, V540, P302, DOI 10.1016/0006-8993(91)90524-Y; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LeDoux JE, 1986, MIND BRAIN, P301; LEMAIRE M, 1994, PSYCHOPHARMACOLOGY, V115, P435, DOI 10.1007/BF02245565; LLEWELLYNSMITH IJ, 1993, J NEUROSCI METH, V46, P27, DOI 10.1016/0165-0270(93)90138-H; MAGNUSON DSK, 1990, NEUROPEPTIDES, V16, P213, DOI 10.1016/0143-4179(90)90065-7; MALDONADO R, 1994, PHARMACOL BIOCHEM BE, V48, P363, DOI 10.1016/0091-3057(94)90539-8; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; McGaugh JL, 1997, BEHAV BRAIN RES, V83, P31, DOI 10.1016/S0166-4328(97)86042-1; Mercer LD, 1996, BRAIN RES, V738, P313, DOI 10.1016/S0006-8993(96)00477-5; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; OBRIEN CP, 1975, DRUG ALCOHOL DEPEN, V1, P115, DOI 10.1016/0376-8716(75)90013-7; OBrien Cp E.R., 1986, BEHAV ANAL DRUG DEPE, P329; PANERAI AE, 1987, BRAIN RES, V410, P52, DOI 10.1016/S0006-8993(87)80019-7; PU SF, 1994, MOL BRAIN RES, V21, P183, DOI 10.1016/0169-328X(94)90249-6; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Reum T, 1997, NEUROPEPTIDES, V31, P82, DOI 10.1016/S0143-4179(97)90025-1; Rolls E.T., 1986, EMOTIONS NEURAL CHEM, P325; ROLLS ET, 1981, AMYGDALOID COMPLEX, P383; SAUNDERS RC, 1988, J COMP NEUROL, V271, P153, DOI 10.1002/cne.902710202; SHIGEYOSHI Y, 1994, BRAIN RES, V640, P81, DOI 10.1016/0006-8993(94)91859-7; SIEGEL S, 1982, SCIENCE, V216, P436, DOI 10.1126/science.7200260; SIEGEL S, 1981, SCIENCE, V212, P1533, DOI 10.1126/science.7233244; SIEGEL S, 1984, B PSYCHONOMIC SOC, V22, P428; SIEGEL S, 1976, SCIENCE, V193, P323, DOI 10.1126/science.935870; SPIEGLER BJ, 1981, BEHAV BRAIN RES, V3, P303, DOI 10.1016/0166-4328(81)90002-4; TANG J, 1984, NEUROPHARMACOLOGY, V23, P715, DOI 10.1016/0028-3908(84)90171-0; VALVERDE O, 1994, J PHARMACOL EXP THER, V270, P77; Vanderah TW, 1996, J PHARMACOL EXP THER, V278, P212; WATKINS LR, 1984, SCIENCE, V224, P395, DOI 10.1126/science.6546809; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; XU XJ, 1992, BRIT J PHARMACOL, V105, P591, DOI 10.1111/j.1476-5381.1992.tb09024.x; Young BJ, 1997, J NEUROSCI, V17, P5183; ZHOU Y, 1993, EUR J PHARMACOL, V234, P147, DOI 10.1016/0014-2999(93)90948-H	50	64	64	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					47	53		10.1038/71120	http://dx.doi.org/10.1038/71120			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607394	Green Accepted			2022-12-24	WOS:000085810200011
J	Heuss, C; Scanziani, M; Gahwiler, BH; Gerber, U				Heuss, C; Scanziani, M; Gahwiler, BH; Gerber, U			G-protein-independent signaling mediated by metabotropic glutamate receptors	NATURE NEUROSCIENCE			English	Article							SLOW SYNAPTIC RESPONSE; CA3 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; POSTSYNAPTIC CURRENT; KAINATE RECEPTORS; TYROSINE KINASES; BINDING PROTEIN; NMDA RECEPTORS; ACTIVATION; STIMULATION	Synaptically released glutamate activates ionotropic and metabotropic receptors at central synapses. Metabotropic glutamate receptors (mGluRs) are thought to modulate membrane conductances through transduction cascades involving G proteins. Here we show, in CA3 pyramidal cells from rat hippocampus, that synaptic activation of type 1 mGluRs by mossy fiber stimulation evokes an excitatory postsynaptic response independent of G-protein function, while inhibiting an afterhyperpolarization current through a G-protein-coupled mechanism. Experiments using peptide activators and specific inhibitors identified a Src-family protein tyrosine kinase as a component of the G-protein-independent transduction pathway. These results represent the first functional evidence for a dual signaling mechanism associated with a heptahelical receptor such as mGluR1, in which intracellular transduction involves activation of either G proteins or tyrosine kinases.	Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland	University of Zurich	Heuss, C (corresponding author), Univ Zurich, Inst Brain Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	heuss@hifo.unizh.ch						Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Boxall AR, 1998, EUR J NEUROSCI, V10, P2; BRABET I, 1995, NEUROPHARMACOLOGY, V34, P895, DOI 10.1016/0028-3908(95)00079-L; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CHARPAK S, 1991, P ROY SOC B-BIOL SCI, V243, P221, DOI 10.1098/rspb.1991.0035; Congar P, 1997, J NEUROSCI, V17, P5366; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale TC, 1998, BIOCHEM J, V329, P209; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; ECCLES JC, 1979, TRENDS NEUROSCI, V2, P39, DOI 10.1016/0166-2236(79)90017-1; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; GAHWILER BH, 1998, CULTURING NERVE CELL, P379; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GERBER U, 1993, P ROY SOC B-BIOL SCI, V254, P169, DOI 10.1098/rspb.1993.0142; GUERINEAU NC, 1995, J NEUROSCI, V15, P4395; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KEHOE J, 1994, NEURON, V13, P691, DOI 10.1016/0896-6273(94)90036-1; Lancaster B, 1998, EUR J NEUROSCI, V10, P2302, DOI 10.1046/j.1460-9568.1998.00241.x; LIU XQ, 1993, ONCOGENE, V8, P1119; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Miller LDP, 1995, J NEUROSCI, V15, P8320; Milne JLS, 1997, ADV SEC MESS PHOSPH, V31, P83; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; Pankratov Y, 1998, EUR J NEUROSCI, V10, P3898, DOI 10.1046/j.1460-9568.1998.00419.x; Peavy RD, 1998, J NEUROCHEM, V71, P603; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; SLADECZEK F, 1985, NATURE, V317, P717, DOI 10.1038/317717a0; SWARUP G, 1982, J BIOL CHEM, V257, P7298; TRUDEL S, 1991, BIOCHEM J, V276, P611, DOI 10.1042/bj2760611; TRUSSELL LO, 1987, J NEUROSCI, V7, P3306; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; WINSLOW JW, 1987, J BIOL CHEM, V262, P4501; ZHENG F, 1995, NEUROPHARMACOLOGY, V34, P905, DOI 10.1016/0028-3908(95)00047-A	50	131	132	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1070	1077		10.1038/15996	http://dx.doi.org/10.1038/15996			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570483				2022-12-24	WOS:000085810100010
J	Shen, SL; Wiemelt, AP; McMorris, FA; Barres, BA				Shen, SL; Wiemelt, AP; McMorris, FA; Barres, BA			Retinal ganglion cells lose trophic responsiveness after axotomy	NEURON			English	Article							NEUROTROPHIC FACTOR; OPTIC-NERVE; ADULT-RATS; TRANSGENIC MICE; CYCLIC-AMP; SURVIVAL; GROWTH; NEURONS; DEATH; BRAIN	Whereas PNS neurons in culture are intrinsically responsive to peptide trophic factors, retinal ganglion cells (RGCs) are not unless they are depolarized, or their intracellular levels of cyclic AMP (cAMP) are elevated, We show here that depolarization increases cAMP in cultured RGCs sufficiently to enhance their responsiveness and that the trophic responsiveness of developing RGCs in intact retinas depends on physiological levels of activity and cAMP elevation. Responsiveness is lost after axotomy but is restored by cAMP elevation. The death of axotomized RGCs can be prevented if they ate simultaneously stimulated by several trophic factors together with cAMP elevation. Thus, the death of RGCs after axotomy is not caused solely by the loss of retrograde trophic stimuli but also by a profound loss of trophic responsiveness.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Wistar Inst, Philadelphia, PA 19104 USA	Stanford University; The Wistar Institute	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.				NATIONAL CANCER INSTITUTE [T32CA009171] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY011030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032122] Funding Source: NIH RePORTER; NCI NIH HHS [CA09171] Funding Source: Medline; NEI NIH HHS [R01 EY11030] Funding Source: Medline; NINDS NIH HHS [NS32122] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], [No title captured]; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Bonfanti L, 1996, J NEUROSCI, V16, P4186; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRAY GM, 1991, ANN NY ACAD SCI, V633, P214; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Clarke DB, 1998, VISION RES, V38, P1517, DOI 10.1016/S0042-6989(97)00341-6; Cui Q, 1995, J NEUROSCI, V15, P8143; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; DOCHERTY RJ, 1986, NEUROSCI LETT, V70, P239, DOI 10.1016/0304-3940(86)90470-2; Fabbri E, 1991, J Enzyme Inhib, V5, P87, DOI 10.3109/14756369109069062; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Hanson MG, 1998, J NEUROSCI, V18, P7361; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; POTTS RA, 1982, DEV BRAIN RES, V3, P481, DOI 10.1016/0165-3806(82)90013-X; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; THANOS S, 1993, J NEUROSCI, V13, P455; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; WEIBEL D, 1995, BRAIN RES, V679, P249, DOI 10.1016/0006-8993(95)00238-L; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Wiemelt AP, 1997, J BIOL CHEM, V272, P31489, DOI 10.1074/jbc.272.50.31489; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T	40	168	180	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					285	295		10.1016/S0896-6273(00)80780-1	http://dx.doi.org/10.1016/S0896-6273(00)80780-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399935	Bronze			2022-12-24	WOS:000081218600014
J	Hardingham, GE; Chawla, S; Cruzalegui, FH; Bading, H				Hardingham, GE; Chawla, S; Cruzalegui, FH; Bading, H			Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; PROTEIN-KINASE; CREB PHOSPHORYLATION; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; CYTOPLASMIC CALCIUM; INDUCED STIMULATION; NUCLEAR CALCIUM; DENTATE GYRUS	Recruitment of the coactivator CBP by signal-regulated transcription factors and stimulation of CBP activity are key regulatory events in the induction of gene transcription following Ca2+ flux through ligand- and/or voltage-gated ion channels in hippocampal neurons. The mode of Ca2+ entry (L-type Ca2+ channels versus NMDA receptors) differentially controls the CBP recruitment step to CREB, providing a molecular basis for the observed Ca2+ channel type-dependent differences in gene expression. In contrast, activation of CBP is triggered irrespective of the route of Ca2+ entry, as is activation of c-Jun, that recruits CBP independently of phosphorylation at major regulatory c-Jun phosphorylation sites, serines 63 and 73. This control of CBP recruitment and activation is likely relevant to other CBP-interacting transcription factors and represents a general mechanism through which Ca2+ signals associated with electrical activity may regulate the expression of many genes.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Hardingham, Giles/0000-0002-7629-5314				Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; Bading H, 1997, BIOCHEM BIOPH RES CO, V236, P541, DOI 10.1006/bbrc.1997.7037; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bannister AJ, 1995, ONCOGENE, V11, P2509; BENDOTTI C, 1993, EUR J NEUROSCI, V5, P1312, DOI 10.1111/j.1460-9568.1993.tb00917.x; BENGZON J, 1993, NEUROSCIENCE, V53, P433, DOI 10.1016/0306-4522(93)90207-V; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHAWLA S, 1998, INTEGRATIVE ASPECTS, P59; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gold CS, 1997, AFR ENTOMOL, V5, P103; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1998, BIOMETALS, V11, P345, DOI 10.1023/A:1009257909785; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; Janknecht R, 1996, CURR BIOL, V6, P951, DOI 10.1016/S0960-9822(02)00636-X; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Johnson CM, 1997, J NEUROSCI, V17, P6189; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; LYNCH MA, 1994, NEUROSCIENCE, V60, P1, DOI 10.1016/0306-4522(94)90197-X; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parker D, 1996, MOL CELL BIOL, V16, P694; PRATT GD, 1993, NEUROSCIENCE, V57, P307, DOI 10.1016/0306-4522(93)90064-M; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RADLERPOHL A, 1993, EMBO J, V12, P1005, DOI 10.1002/j.1460-2075.1993.tb05741.x; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Schwarzschild MA, 1997, J NEUROSCI, V17, P3455; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; YAN MH, 1994, J BIOL CHEM, V269, P19067; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	55	248	251	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					789	798		10.1016/S0896-6273(00)80737-0	http://dx.doi.org/10.1016/S0896-6273(00)80737-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230798	Bronze			2022-12-24	WOS:000079976200021
J	Zito, K; Parnas, D; Fetter, RD; Isacoff, EY; Goodman, CS				Zito, K; Parnas, D; Fetter, RD; Isacoff, EY; Goodman, CS			Watching a synapse grow: Noninvasive confocal imaging of synaptic growth in Drosophila	NEURON			English	Article							DEVELOPING NEUROMUSCULAR-JUNCTION; FASCICLIN-II; GENETIC-ANALYSIS; LIVING MICE; FUNCTIONAL COMPONENTS; INVIVO OBSERVATIONS; PLASTICITY; MUTANTS; ULTRASTRUCTURE; NEURONS	The glutamatergic neuromuscular junction (NMJ) in Drosophila adds new boutons and branches during larval development. We generated transgenic fruit flies that express a novel green fluorescent membrane protein at the postsynaptic specialization, allowing for repeated noninvasive confocal imaging of synapses in live, developing larvae. As synapses grow, existing synaptic boutons stretch apart and new boutons insert between them; in addition, new boutons are added at the ends of existing strings of boutons. Some boutons are added de novo, while others bud from existing boutons. New branches form as multiple boutons bud from existing boutons. Nascent boutons contain active zones, T bars, and synaptic vesicles; we observe no specialized growth structures. Some new boutons exhibit a lower level of Fasciclin II, suggesting that the levels of this synaptic cell adhesion molecule vary locally during synaptic growth.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.		isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359; Zito, Karen/0000-0002-0799-0460				ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; HARRIS WA, 1987, DEVELOPMENT, V101, P123; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Landgraf M, 1997, J NEUROSCI, V17, P9642; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1986, J NEUROSCI, V6, P1051; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Speidel CC, 1933, AM J ANAT, V52, P1, DOI 10.1002/aja.1000520102; SPEIDEL CC, 1941, HARVEY LECT, V36, P126; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STREICHERT LC, 1989, J COMP NEUROL, V281, P159, DOI 10.1002/cne.902810113; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; WASSENBERG DR, 1987, J BIOL CHEM, V262, P10741; Witte S, 1996, J NEUROBIOL, V31, P219, DOI 10.1002/(SICI)1097-4695(199610)31:2<219::AID-NEU7>3.0.CO;2-E; Yoshihara M, 1997, J NEUROSCI, V17, P8408; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; [No title captured]	39	175	176	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					719	729		10.1016/S0896-6273(00)80731-X	http://dx.doi.org/10.1016/S0896-6273(00)80731-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230792	Bronze			2022-12-24	WOS:000079976200015
J	Donaldson, DI; Buckner, RL				Donaldson, DI; Buckner, RL			Trying versus succeeding: Event-related designs dissociate memory processes	NEURON			English	Article							EPISODIC MEMORY; RETRIEVAL		Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Donaldson, DI (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.		Donaldson, David I/A-5249-2009	Donaldson, David I/0000-0002-8036-3455				Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Johnson MK, 1997, PSYCHOL SCI, V8, P250, DOI 10.1111/j.1467-9280.1997.tb00421.x; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; TUIVING E, 1983, ELEMENTS EPISODIC ME; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; WILDING EL, 1999, IN PRESS NEUROPSYCHO	10	5	5	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					412	414		10.1016/S0896-6273(00)80693-5	http://dx.doi.org/10.1016/S0896-6273(00)80693-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197518	Bronze			2022-12-24	WOS:000079483900002
J	Lu, T; Nguyen, B; Zhang, XM; Yang, J				Lu, T; Nguyen, B; Zhang, XM; Yang, J			Architecture of a K+ channel inner pore revealed by stoichiometric covalent modification	NEURON			English	Article							RECTIFYING POTASSIUM CHANNELS; INWARD-RECTIFIER; CYTOPLASMIC POLYAMINES; SUBUNIT STOICHIOMETRY; MOLECULAR-BASIS; INTERNAL MG-2+; ION-CHANNEL; RECTIFICATION; BLOCK; CELLS	Inwardly rectifying K+ channels bind intracellular magnesium and polyamines to generate inward rectification. We have examined the architecture of the inner pore of Kir2.1 channels by covalently attaching a constrained number (from one to four) of positively charged moieties of different sizes to the channel. Our results indicate that the inner pore is formed solely by the second transmembrane segment and is unprecedentedly wide. At a position critical for inward rectification (D172), the pore is sufficiently wide to bind three Mg2+ ions or polyamine molecules simultaneously. Single-channel recordings directly demonstrate that partially modified channels exhibit distinct subconductance levels. Such a wide inner pore may greatly facilitate ion permeation and high-affinity binding of multiple pore blockers to generate strong inward rectification.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Yang, J (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jy160@columbia.edu						ADRIAN RH, 1969, PROG BIOPHYS MOL BIO, V19, P340; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145; HAGIWARA S, 1979, ANNU REV BIOPHYS BIO, V8, P385, DOI 10.1146/annurev.bb.08.060179.002125; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 1992, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISHIHARA K, 1989, J PHYSIOL-LONDON, V419, P297, DOI 10.1113/jphysiol.1989.sp017874; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; JORDAN PC, 1982, BIOPHYS J, V39, P157, DOI 10.1016/S0006-3495(82)84503-7; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KOSOWER NS, 1979, P NATL ACAD SCI USA, V76, P3382, DOI 10.1073/pnas.76.7.3382; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LEVITT DG, 1978, BIOPHYS J, V22, P209, DOI 10.1016/S0006-3495(78)85485-X; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MATSUDA H, 1988, J PHYSIOL-LONDON, V397, P237, DOI 10.1113/jphysiol.1988.sp016998; NICHOLS CG, 1994, J PHYSIOL-LONDON, V476, P399, DOI 10.1113/jphysiol.1994.sp020141; Oishi K, 1998, J PHYSIOL-LONDON, V510, P675, DOI 10.1111/j.1469-7793.1998.675bj.x; Oliver D, 1998, BIOPHYS J, V74, P2318, DOI 10.1016/S0006-3495(98)77941-X; Omori K, 1997, J PHYSIOL-LONDON, V499, P369, DOI 10.1113/jphysiol.1997.sp021934; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; SILVER MR, 1990, J GEN PHYSIOL, V96, P109, DOI 10.1085/jgp.96.1.109; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7	43	85	85	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					571	580		10.1016/S0896-6273(00)80711-4	http://dx.doi.org/10.1016/S0896-6273(00)80711-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197536	hybrid			2022-12-24	WOS:000079483900020
J	Svoboda, K; Helmchen, F; Denk, W; Tank, DW				Svoboda, K; Helmchen, F; Denk, W; Tank, DW			Spread of dendritic excitation in layer 2/3 pyramidal neurons in rat barrel cortex in vivo	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS; NUCLEUS BASALIS; SPIKE BACKPROPAGATION; NEOCORTICAL NEURONS; EXCITABLE DENDRITES; APICAL DENDRITES; FIRING PATTERNS; CELL DENDRITES; AREA CA1	In layer 2/3 pyramidal neurons of barrel cortex in vivo, calcium ion concentration ([Ca2+]) transients in apical dendrites evoked by sodium action potentials are limited to regions close to the soma. To study the mechanisms underlying this restricted pattern of calcium influx, we combined two-photon imaging of dendritic [Ca2+] dynamics with dendritic membrane potential measurements. We found that sodium action potentials attenuated and broadened rapidly with distance from the soma. However, dendrites of layer 2/3 cells were electrically excitable, and direct current injections could evoke large [Ca2+] transients. The restricted pattern of dendritic [Ca2+] transients is therefore due to a failure of sodium action-potential propagation into dendrites. Also, stimulating subcortical activating systems by tail pinch can enhance dendritic [Ca2+] influx induced by a sensory stimulus by increasing cellular excitability, consistent with the importance of these systems in plasticity and learning.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Cold Spring Harbor Laboratory; Alcatel-Lucent; Lucent Technologies; AT&T	Svoboda, K (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.org	denk, winfried/I-6627-2012; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569				ANDREASEN M, 1993, J NEUROPHYSIOL, V69, P1966, DOI 10.1152/jn.1993.69.6.1966; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Cauller LJ, 1992, SINGLE NEURON COMPUT, P199; Colbert CM, 1997, J NEUROSCI, V17, P6512; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Contreras D, 1997, NEUROSCIENCE, V76, P11; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Crevier DW, 1998, J NEUROPHYSIOL, V79, P1869, DOI 10.1152/jn.1998.79.4.1869; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DETARI L, 1987, BRAIN RES, V437, P1, DOI 10.1016/0006-8993(87)91521-6; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holscher C, 1997, J NEUROSCI, V17, P6470; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Juliano S. L., 1995, BARREL CORTEX RODENT, P411; Jung HY, 1997, J NEUROSCI, V17, P6639; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; METHERATE R, 1992, J NEUROSCI, V12, P4701; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; MULLER W, 1991, NEURON, V6, P901, DOI 10.1016/0896-6273(91)90230-W; MULLIN WJ, 1975, J PHYSIOL-LONDON, V244, P741, DOI 10.1113/jphysiol.1975.sp010823; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURNER RW, 1991, J NEUROSCI, V11, P2270; White E.L., 1989, CORTICAL CIRCUITS, DOI [10.1007/978-1-4684-8721-3, DOI 10.1007/978-1-4684-8721-3]; WINKLER J, 1995, NATURE, V375, P484, DOI 10.1038/375484a0; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	50	180	181	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					65	73		10.1038/4569	http://dx.doi.org/10.1038/4569			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195182				2022-12-24	WOS:000078409300015
J	Yoshihara, Y; Mizuno, T; Nakahira, M; Kawasaki, M; Watanabe, Y; Kagamiyama, H; Jishage, K; Ueda, O; Suzuki, H; Tabuchi, K; Sawamoto, K; Okano, H; Noda, T; Mori, K				Yoshihara, Y; Mizuno, T; Nakahira, M; Kawasaki, M; Watanabe, Y; Kagamiyama, H; Jishage, K; Ueda, O; Suzuki, H; Tabuchi, K; Sawamoto, K; Okano, H; Noda, T; Mori, K			A genetic approach to visualization of multisynaptic neural pathways using plant lectin transgene	NEURON			English	Article							WHEAT-GERM-AGGLUTININ; OLFACTORY MARKER PROTEIN; WGA-HRP; NEURONAL TRANSPORT; DROSOPHILA EYE; EXPRESSION; PURKINJE; MICE; RAT; PROMOTER	The wiring patterns among various types of neurons via specific synaptic connections are the basis of functional logic employed by the brain for information processing. This study introduces a powerful method of analyzing the neuronal connectivity patterns by delivering a tracer selectively to specific types of neurons while simultaneously transsynaptically labeling their target neurons. We developed a novel genetic approach introducing cDNA for a plant lectin, wheat germ agglutinin (WGA), as a transgene under the control of specific promoter elements. Using this method, we demonstrate three examples of visualization of specific transsynaptic neural pathways: the mouse cerebellar efferent pathways, the mouse olfactory pathways, and the Drosophila visual pathways. This strategy should greatly facilitate studies on the anatomical and functional organization of the developing and mature nervous system.	RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Lab Neuronal Recognit Mol, Wako, Saitama 3510198, Japan; Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan; Osaka Biosci Inst, Dept Neurosci, Osaka 5650874, Japan; Chugai Pharmaceut Co Ltd, Shizuoka 4120038, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Dept Neuroanat, Osaka 5650871, Japan; Inst Canc, Dept Cell Biol, Tokyo 1700012, Japan	RIKEN; RIKEN; Osaka Medical College; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Osaka University	Yoshihara, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan.		Okano, Hideyuki/I-7584-2019; Yoshihara, Yoshihiro/N-6481-2015; Noda, Tetsuo/B-1667-2016	Yoshihara, Yoshihiro/0000-0002-0319-7166; Mori, Kensaku/0000-0001-7853-9370; Sawamoto, Kazunobu/0000-0003-1984-5129				Altman J., 1996, RELATION ITS EVOLUTI; BAKER H, 1986, EXP BRAIN RES, V63, P461, DOI 10.1007/BF00237470; BRAND A, 1995, TRENDS GENET, V11, P324, DOI 10.1016/S0168-9525(00)89091-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADWELL RD, 1985, J COMP NEUROL, V242, P632, DOI 10.1002/cne.902420410; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CHRISPEELS MJ, 1991, PLANT CELL, V3, P1, DOI 10.1105/tpc.3.1.1; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; FABIAN RH, 1985, BRAIN RES, V344, P41, DOI 10.1016/0006-8993(85)91187-4; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Holtmaat AJGD, 1995, J NEUROSCI, V15, P7953; ITAYA SK, 1987, BRAIN RES, V409, P205, DOI 10.1016/0006-8993(87)90703-7; ITAYA SK, 1982, BRAIN RES, V236, P199, DOI 10.1016/0006-8993(82)90046-4; Ito K, 1997, DEVELOPMENT, V124, P761; Ito M, 1984, CEREBELLUM NEURAL CO; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; MANSFIELD MA, 1988, PLANTA, V173, P482, DOI 10.1007/BF00958961; MARGOLIS FL, 1985, TRENDS NEUROSCI, V8, P542, DOI 10.1016/0166-2236(85)90192-4; MARGOLIS FL, 1993, CYTOTECHNOLOGY, V11, P17, DOI 10.1007/BF00749053; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; MEINERTZHAGEN MA, 1993, DEV DROSOPHILA MELAG, P1363; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MISMER D, 1987, GENETICS, V116, P565; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nohmi T, 1996, ENVIRON MOL MUTAGEN, V28, P465, DOI 10.1002/(SICI)1098-2280(1996)28:4<465::AID-EM24>3.0.CO;2-C; OBERDICK J, 1993, NEURON, V10, P1007, DOI 10.1016/0896-6273(93)90050-2; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; RUDA M, 1982, NEUROSCI LETT, V28, P237; SAWAMOTO K, 1994, DEV BIOL, V164, P267, DOI 10.1006/dbio.1994.1197; Shipley Michael T., 1995, P899; SHIPLEY MT, 1985, BRAIN RES BULL, V15, P129, DOI 10.1016/0361-9230(85)90129-7; SMITH JJ, 1989, PLANT MOL BIOL, V13, P601, DOI 10.1007/BF00027321; TROJANOWSKI JQ, 1983, J NEUROSCI METH, V9, P185, DOI 10.1016/0165-0270(83)90082-1; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; Walters E, 1996, J NEUROSCI RES, V43, P146; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	38	136	139	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					33	41		10.1016/S0896-6273(00)80676-5	http://dx.doi.org/10.1016/S0896-6273(00)80676-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027287	Bronze			2022-12-24	WOS:000078410300010
J	Elias, CF; Lee, C; Kelly, J; Aschkenasi, C; Ahima, RS; Couceyro, PR; Kuhar, MJ; Saper, CB; Elmquist, JK				Elias, CF; Lee, C; Kelly, J; Aschkenasi, C; Ahima, RS; Couceyro, PR; Kuhar, MJ; Saper, CB; Elmquist, JK			Leptin activates hypothalamic CART neurons projecting to the spinal cord	NEURON			English	Article							BROWN ADIPOSE-TISSUE; PROOPIOMELANOCORTIN MESSENGER-RNA; MELANOCYTE-STIMULATING HORMONE; IN-SITU HYBRIDIZATION; OBESE GENE; RAT-BRAIN; IMMUNOHISTOCHEMICAL IDENTIFICATION; INTRAVENOUS LIPOPOLYSACCHARIDE; PARAVENTRICULAR NUCLEUS; MELANOCORTIN RECEPTORS	The adipocyte-derived hormone leptin decreases body weight in part by activating the sympathetic nervous system, resulting in increased thermogenesis and energy expenditure. We investigated hypothalamic pathways underlying leptin's effects on stimulating the sympathetic nervous system. We found that leptin activates neurons in the retrochiasmatic area (RCA) and lateral arcuate nucleus (Arc) that innervate the thoracic spinal cord and also contain cocaine- and amphetamine-regulated transcript (CART). We also found that most CART-containing neurons in the RCA and Are of the hypothalamus also contain proopiomelanocortin (POMC) mRNA. The finding that leptin activates CART/POMC neurons innervating sympathetic preganglionic neurons in the thoracic spinal cord suggests that this pathway may contribute to the increased thermogenesis and energy expenditure and decreased body weight observed following leptin administration.	Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Neurol, Program Neurosci, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Div Endocrinol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Emory University	Elmquist, JK (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	jelmquis@bidmc.harvard.edu	Ahima, Rexford/W-1394-2019; Saper, Clifford/L-3815-2019	Elias, Carol F/0000-0001-9878-9203	NCRR NIH HHS [RR00165] Funding Source: Medline; NIDA NIH HHS [DA10732] Funding Source: Medline; NIDDK NIH HHS [DK53301] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010732] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; BREDER CD, 1992, J COMP NEUROL, V322, P409, DOI 10.1002/cne.903220309; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Campfield LA, 1998, SCIENCE, V280, P1383, DOI 10.1126/science.280.5368.1383; Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Casto RM, 1998, NEUROSCI LETT, V246, P29, DOI 10.1016/S0304-3940(98)00223-7; CECHETTO DF, 1988, J COMP NEUROL, V272, P579, DOI 10.1002/cne.902720410; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; CHAN RKW, 1995, NEUROSCIENCE, V66, P377, DOI 10.1016/0306-4522(94)00600-A; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Collins S, 1996, NATURE, V380, P677, DOI 10.1038/380677a0; Couceyro PR, 1997, J CHEM NEUROANAT, V12, P229, DOI 10.1016/S0891-0618(97)00212-3; Dawson R, 1997, AM J PHYSIOL-ENDOC M, V273, pE202, DOI 10.1152/ajpendo.1997.273.1.E202; DELACALLE S, 1993, J COMP NEUROL, V328, P364, DOI 10.1002/cne.903280304; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; ELIAS CF, 1998, IN PRESS J COMP NEUR; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1996, J COMP NEUROL, V374, P315, DOI 10.1002/(SICI)1096-9861(19961021)374:3<315::AID-CNE1>3.0.CO;2-4; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FOSTER DO, 1982, CAN J PHYSIOL PHARM, V60, P747, DOI 10.1139/y82-104; GOLD RM, 1973, SCIENCE, V182, P488, DOI 10.1126/science.182.4111.488; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hakansson ML, 1998, J NEUROSCI, V18, P559; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; Kelly AB, 1996, J COMP NEUROL, V370, P231, DOI 10.1002/(SICI)1096-9861(19960624)370:2<231::AID-CNE7>3.0.CO;2-3; Koylu EO, 1997, J NEUROENDOCRINOL, V9, P823, DOI 10.1046/j.1365-2826.1997.00651.x; Koylu EO, 1998, J COMP NEUROL, V391, P115; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; Lambert R., 1997, NEUROPEPTIDES, V31, P620; LEIBOWITZ SF, 1991, BRAIN RES BULL, V27, P333, DOI 10.1016/0361-9230(91)90121-Y; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; LOEWY AD, 1991, PROG BRAIN RES, V87, P253; Lowell BB, 1997, ANNU REV MED, V48, P307; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; LUITEN PGM, 1985, BRAIN RES, V329, P374, DOI 10.1016/0006-8993(85)90554-2; MARKS DL, 1992, MOL CELL NEUROSCI, V3, P395, DOI 10.1016/1044-7431(92)90051-3; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; ROTHWELL NJ, 1984, J PHYSIOL-LONDON, V355, P457, DOI 10.1113/jphysiol.1984.sp015431; SAITO M, 1989, BRAIN RES, V481, P298, DOI 10.1016/0006-8993(89)90806-8; SAKAGUCHI T, 1988, BRAIN RES BULL, V20, P461, DOI 10.1016/0361-9230(88)90135-9; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; Saper Clifford B., 1995, P107; Satoh N, 1998, NEUROSCI LETT, V249, P107, DOI 10.1016/S0304-3940(98)00401-7; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Scarpace PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE226, DOI 10.1152/ajpendo.1997.273.1.E226; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; STRACK AM, 1989, BRAIN RES, V491, P156, DOI 10.1016/0006-8993(89)90098-X; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1980, NEUROSCI LETT, V17, P307, DOI 10.1016/0304-3940(80)90041-5; SWANSON LW, 1980, BRAIN RES, V198, P190, DOI 10.1016/0006-8993(80)90354-6; SWANSON LW, 1992, BRAIN MAPS STRUCTURE, V1; TATRO JB, 1987, ENDOCRINOLOGY, V121, P1900, DOI 10.1210/endo-121-5-1900; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; vanDijk G, 1996, AM J PHYSIOL-REG I, V271, pR1096, DOI 10.1152/ajpregu.1996.271.4.R1096; Wang L, 1998, BRAIN RES, V791, P157, DOI 10.1016/S0006-8993(98)00091-2; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; YOSHIMATSU H, 1993, BRAIN RES, V601, P121, DOI 10.1016/0006-8993(93)91702-T; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	76	610	624	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1375	1385		10.1016/S0896-6273(00)80656-X	http://dx.doi.org/10.1016/S0896-6273(00)80656-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883730	Bronze			2022-12-24	WOS:000077910600019
J	Dehaene, S; Le Clec'H, G; Cohen, L; Poline, JB; van de Moortele, PF; Le Bihan, D				Dehaene, S; Le Clec'H, G; Cohen, L; Poline, JB; van de Moortele, PF; Le Bihan, D			Inferring behavior from functional brain images	NATURE NEUROSCIENCE			English	Article							NEURAL-NETWORK; MOVEMENT; CORTEX		Serv Hosp Frederic Joliot, CEA, DRM, DSV,INSERM,U334, F-91401 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Dehaene, S (corresponding author), Serv Hosp Frederic Joliot, CEA, DRM, DSV,INSERM,U334, 4 Pl Gen Leclerc, F-91401 Orsay, France.		Van de Moortele, Pierre-François/H-5087-2011	Van de Moortele, Pierre-François/0000-0002-6941-5947; cohen, laurent/0000-0002-5010-9085				Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; CHEYNE D, 1995, NEUROSCI LETT, V188, P81, DOI 10.1016/0304-3940(95)11401-H; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; GEVINS AS, 1987, SCIENCE, V235, P580, DOI 10.1126/science.3810158; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V99, P416, DOI 10.1016/S0013-4694(96)95689-8; Portin K, 1996, ELECTROEN CLIN NEURO, V98, P273, DOI 10.1016/0013-4694(95)00272-3	9	25	25	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					549	550		10.1038/2785	http://dx.doi.org/10.1038/2785			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196560				2022-12-24	WOS:000077437100008
J	Fleidervish, IA; Binshtok, AM; Gutnick, MJ				Fleidervish, IA; Binshtok, AM; Gutnick, MJ			Functionally distinct NMDA receptors mediate horizontal connectivity within layer 4 of mouse barrel cortex	NEURON			English	Article							CAT VISUAL-CORTEX; SERIAL THIN-SECTIONS; SPINY STELLATE CELL; NEOCORTICAL NEURONS; PYRAMIDAL NEURONS; SMI CORTEX; RAT-BRAIN; CHANNELS; SYNAPSES; INVITRO	In sensory areas of neocortex, thalamocortical afferents project primarily onto the spiny stellate neurons of Layer 4. Anatomical evidence indicates that these cells receive most of their excitatory input from other cortical neurons, including other spiny stellate cells. Although this local network must play an important role in sensory processing, little is known about the properties of the neurons and synapses involved. We have produced a slice preparation of mouse barrel cortex that isolates Layer 4. We report that excitatory interaction between spiny stellate neurons is largely via N-methyl-D-aspartate receptors (NMDARs) and that a given neuron contains more than one type of NMDAR, as distinguished by voltage dependence. Thus, spiny stellate cells act as effective integrators of powerful and persistent NMDAR-mediated recurrent excitation.	Ben Gurion Univ Negev, Fac Hlth Sci, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Fleidervish, IA (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.		FLEIDERVISH, Ilya/F-2324-2012; Gutnick, Michael/P-7910-2019	Binshtok, Alexander/0000-0002-3620-8116; Gutnick, Michael/0000-0003-2564-5094; Fleidervish, Ilya/0000-0002-5501-726X				Agmon A, 1996, J NEUROSCI, V16, P4684; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; BENARDO LS, 1982, J NEUROSCI, V2, P1614; BIELEFELDT K, 1992, J PHYSIOL-LONDON, V458, P41, DOI 10.1113/jphysiol.1992.sp019405; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Connors Barry W., 1995, P123; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DENO RL, 1938, PHYSL NERVOUS SYSTEM, P91; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FARRANT M, 1994, NATURE, V368, P335, DOI 10.1038/368335a0; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gil Z, 1996, J NEUROPHYSIOL, V76, P2547, DOI 10.1152/jn.1996.76.4.2547; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; Gottmann K, 1997, J NEUROSCI, V17, P2766; GUTNICK MJ, 1972, SCIENCE, V176, P424, DOI 10.1126/science.176.4033.424; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; HARRIS RM, 1983, J COMP NEUROL, V220, P63, DOI 10.1002/cne.902200107; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kang J, 1996, J NEUROPHYSIOL, V76, P4194, DOI 10.1152/jn.1996.76.6.4194; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KONNERTH A, 1986, J NEUROPHYSIOL, V56, P409, DOI 10.1152/jn.1986.56.2.409; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PASTERNAK JF, 1975, J COMP NEUROL, V160, P291, DOI 10.1002/cne.901600303; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; Simons DJ, 1997, NEWS PHYSIOL SCI, V12, P268; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Suchanek B, 1997, BIOL CHEM, V378, P929; THOMSON AM, 1989, BRIT J PHARMACOL, V96, P406, DOI 10.1111/j.1476-5381.1989.tb11831.x; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; White E.L., 1989, CORTICAL CIRCUITS SY; WHITE EL, 1980, J NEUROCYTOL, V9, P615, DOI 10.1007/BF01205029; WHITE EL, 1978, J COMP NEUROL, V181, P627, DOI 10.1002/cne.901810310; White EL, 1997, SOMATOSENS MOT RES, V14, P34, DOI 10.1080/08990229771204; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942	56	85	86	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1055	1065		10.1016/S0896-6273(00)80623-6	http://dx.doi.org/10.1016/S0896-6273(00)80623-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856461	Bronze			2022-12-24	WOS:000077386100016
J	Salem, N; Faundez, V; Horng, JT; Kelly, RB				Salem, N; Faundez, V; Horng, JT; Kelly, RB			A v-SNARE participates in synaptic vesicle formation mediated by the AP3 adaptor complex	NATURE NEUROSCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; PROTEIN COMPLEX; NEUROTRANSMITTER RELEASE; PLASMA-MEMBRANE; SYNAPTOBREVIN; SNAP-25; FUSION; AP-3; SYNAPTOPHYSIN; SYNAPTOTAGMIN	Reconstitution of synaptic vesicle formation in vitro has revealed a pathway of synaptic vesicle biogenesis from endosomes that requires the heterotetrameric adaptor complex AP3. Because synaptic vesicles have a distinct protein composition, the AP3 complex should selectively recognize some or all of the synaptic vesicle proteins. Here we show that one element of this recognition process is the v-SNARE, VAMP-2, because tetanus toxin, which cleaves VAMP-2, inhibited the formation of synaptic vesicles and their coating with AP3 in vitro. Mutant tetanus toxin and botulinum toxins, which cleave t-SNAREs, did not inhibit synaptic vesicle production. AP3-containing complexes isolated from coated vesicles could be immunoprecipitated by a VAMP-2 antibody. These data imply that AP3 recognizes a component of the fusion machinery, which may prevent the production of inert synaptic vesicles.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Hormone Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kelly, RB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	rkelly@biochem.ucsf.edu		Faundez, Victor/0000-0002-2114-5271				BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DESNOS C, 1995, J CELL BIOL, V130, P1041, DOI 10.1083/jcb.130.5.1041; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Hao JC, 1997, J NEUROSCI, V17, P1596; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; KINGLAUF J, 1998, NATURE, V394, P581; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Lichtenstein Y, 1998, P NATL ACAD SCI USA, V95, P11223, DOI 10.1073/pnas.95.19.11223; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; MURPHY VN, 1998, NATURE, V392, P497; NOEBELS JL, 1989, J NEUROGENET, V6, P53, DOI 10.3109/01677068909107100; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	37	73	76	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					551	556		10.1038/2787	http://dx.doi.org/10.1038/2787			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196561				2022-12-24	WOS:000077437100009
J	Hollerman, JR; Schultz, W				Hollerman, JR; Schultz, W			Dopamine neurons report an error in the temporal prediction of reward during learning	NATURE NEUROSCIENCE			English	Article							LOCUS-COERULEUS NEURONS; DELAYED-RESPONSE TASK; VENTRAL STRIATUM; UNIT-ACTIVITY; MONKEY; STIMULI; EXPECTATION; REINFORCEMENT; MOTIVATION; PLASTICITY	Many behaviors are affected by rewards, undergoing long-term changes when rewards are different than predicted but remaining unchanged when rewards occur exactly as predicted. The discrepancy between reward occurrence and reward prediction is termed an 'error in reward prediction'. Dopamine neurons in the substantia nigra and the ventral tegmental area are believed to be involved in reward-dependent behaviors. Consistent with this role, they are activated by rewards, and because they are activated more strongly by unpredicted than by predicted rewards they may play a role in learning. The present study investigated whether monkey dopamine neurons code an error in reward prediction during the course of learning. Dopamine neuron responses reflected the changes in reward prediction during individual learning episodes; dopamine neurons were activated by rewards during early trials, when errors were frequent and rewards unpredictable, but activation was progressively reduced as performance was consolidated and rewards became more predictable. These neurons were also activated when rewards occurred at unpredicted times and were depressed when rewards were omitted at the predicted times. Thus, dopamine neurons code errors in the prediction of both the occurrence and the time of rewards. In this respect, their responses resemble the teaching signals that have been employed in particularly efficient computational learning models.	Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland	University of Fribourg	Schultz, W (corresponding author), Allegheny Coll, Dept Psychol, Meadville, PA 16335 USA.	Wolfram.Schultz@unifr.ch						AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1997, EXP BRAIN RES, V116, P456, DOI 10.1007/PL00005773; APICELLA P, 1991, EXP BRAIN RES, V85, P491; ASTONJONES G, 1981, J NEUROSCI, V1, P887; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; DICKINSON A, 1976, J EXP PSYCHOL ANIM B, V2, P313, DOI 10.1037/0097-7403.2.4.313; Dickinson A., 1980, CONT ANIMAL LEARNING; GRAFFAN EA, 1988, J NEUROSCI, V8, P3144; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; Houk JC, 1995, MODELS INFORMATION P, P249; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615, DOI 10.1152/jn.1992.67.6.1615; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; NISHIJO H, 1988, J NEUROSCI, V8, P3556; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; RICHARDSON RT, 1986, BRAIN RES, V399, P364, DOI 10.1016/0006-8993(86)91529-5; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; SARA SJ, 1991, PROG BRAIN RES, V88, P571; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SMITH MC, 1968, J COMP PHYSIOL PSYCH, V66, P679, DOI 10.1037/h0026550; STEINFELS GF, 1983, BRAIN RES, V258, P217, DOI 10.1016/0006-8993(83)91145-9; SURI RE, IN PRESS EXP BRAIN R; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; TESAURO G, 1994, NEURAL COMPUT, V6, P215, DOI 10.1162/neco.1994.6.2.215; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; WATANABE M, 1989, NEUROSCI LETT, V101, P113, DOI 10.1016/0304-3940(89)90450-3; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; WILLIAMS GV, 1993, BEHAV BRAIN RES, V55, P243, DOI 10.1016/0166-4328(93)90120-F; WILSON FAW, 1990, BRAIN RES, V509, P213, DOI 10.1016/0006-8993(90)90546-N; WISE RA, 1982, BEHAV BRAIN SCI, V5, P39, DOI 10.1017/S0140525X00010372; [No title captured]	47	775	779	2	116	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					304	309		10.1038/1124	http://dx.doi.org/10.1038/1124			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QD	10195164				2022-12-24	WOS:000076361300014
J	Zheng, F; Gingrich, MB; Traynelis, SF; Conn, PJ				Zheng, F; Gingrich, MB; Traynelis, SF; Conn, PJ			Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; ACTIVATED CHANNELS; GLUTAMATE-RECEPTOR; CORTICAL-NEURONS; PROTEIN; MODULATION; SENSITIVITY; RESPONSES	Activation of the tyrosine kinase Src potentiates NMDA receptor currents, which is thought to be necessary for induction of hippocampal long-term potentiation. Although the carboxy(C)-terminal domain of the NR2A subunit contains potential tyrosine phosphorylation sites, the mechanism by which Src modulates synaptic plasticity and NMDA receptor currents is not fully understood. Here we present evidence from NR1 mutants and splice variants that Src potentiates NMDA-receptor currents by reducing the tonic inhibition of receptors composed of NR1 and NR2A subunits by extracellular zinc. Using site-directed mutagenesis, we have identified three C-terminal tyrosine residues of NR2A that are required for Src's modulation of the zinc sensitivity of NMDA receptors. Our data link two modulatory sites of NMDA receptors that were previously thought to be independent.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Zheng, F (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.		Zheng, Fang/J-1400-2016; Conn, Peter/D-7848-2012	Zheng, Fang/0000-0002-6626-1938; 				BERS DM, 1994, METHOD CELL BIOL, V40, P3; BOGDEN JD, 1977, CLIN CHEM, V23, P485; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; EDMONDS B, 1992, P ROY SOC B-BIOL SCI, V250, P279, DOI 10.1098/rspb.1992.0160; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; Li CY, 1996, J NEUROPHYSIOL, V76, P3048, DOI 10.1152/jn.1996.76.5.3048; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Paoletti P, 1997, J NEUROSCI, V17, P5711; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; TRAYNELIS SF, IN PRESS J NEUROSCI; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	37	159	161	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					185	191		10.1038/634	http://dx.doi.org/10.1038/634			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195142				2022-12-24	WOS:000076361200008
J	Passafaro, M; Sala, C; Niethammer, M; Sheng, M				Passafaro, M; Sala, C; Niethammer, M; Sheng, M			Microtubule binding by CRIPT and its potential role in the synaptic clustering of PSD-95	NATURE NEUROSCIENCE			English	Article							NMDA RECEPTOR SUBUNITS; POSTSYNAPTIC DENSITY; NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL-NEURONS; GUANYLATE KINASES; PDZ DOMAIN; PROTEIN; CHANNEL; LOCALIZATION; MEMBRANE	CRIPT is a postsynaptic protein that binds selectively to the third PDZ domain (PDZ3) of PSD-95. Here we show that CRIPT also binds directly to microtubules, thereby linking PSD-95 to the microtubule cytoskeleton. Disrupting the CRIPT-PSD-95 interaction in cultured hippocampal neurons with a PDZ3-specific peptide prevented the association of PSD-95 with microtubules and inhibited the synaptic clustering of PSD-95, chapsyn-110/PSD-93 and GKAP (a PSD-95-binding protein). However, the number of synapses and the synaptic clustering of NMDA receptors were unaffected, suggesting that PSD-95-family proteins are not essential for the maintenance of synapses and the synaptic localization of NMDA receptors.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheng, M (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, HHMI Wellman 423,50 Blossom St, Boston, MA 02114 USA.		Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35050] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Brenman JE, 1998, J NEUROSCI, V18, P8805; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; CACERES A, 1984, J NEUROSCI, V4, P394; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Ehlers MD, 1998, J NEUROSCI, V18, P720; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; Lai SL, 1998, J NEUROCHEM, V71, P1694; Lin JW, 1998, J NEUROSCI, V18, P2017; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Missler M, 1998, J NEUROCHEM, V71, P1339; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Prochiantz A, 1996, CURR OPIN NEUROBIOL, V6, P629, DOI 10.1016/S0959-4388(96)80095-X; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; WALSH MJ, 1992, J NEUROCHEM, V59, P667, DOI 10.1111/j.1471-4159.1992.tb09421.x; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	39	94	97	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1063	1069		10.1038/15990	http://dx.doi.org/10.1038/15990			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570482				2022-12-24	WOS:000085810100009
J	Anderson, BL; Barth, HC				Anderson, BL; Barth, HC			Motion-based mechanisms of illusory contour synthesis	NEURON			English	Article							TEMPORAL VISUAL AREA; SPATIAL-DISTRIBUTION; SUBJECTIVE CONTOURS; INDUCED MOVEMENT; RELATIVE MOTION; NEURONS; PERCEPTION; DIRECTION; OCCLUSION; FIGURES	Neurophysiological studies and computational models of illusory contour formation have focused on contour orientation as the underlying determinant of illusory contour shape in both static and moving displays. Here, we report a class of motion-induced illusory contours that demonstrate the existence of novel mechanisms of illusory contour synthesis. In a series of experiments, we show that the velocity of contour terminations and the direction of motion of a partially occluded figure regulate the perceived shape and apparent movement of illusory contours formed from moving image sequences. These results demonstrate the existence of neural mechanisms that reconstruct occlusion relationships from both real and inferred image velocities, in contrast to the static geometric mechanisms that have been the focus of studies to date.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Barth, HC (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.			Anderson, Barton/0000-0003-0313-4285				ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Anderson BL, 1997, P NATL ACAD SCI USA, V94, P3477, DOI 10.1073/pnas.94.7.3477; ANSTIS SM, 1976, VISION RES, V16, P1391, DOI 10.1016/0042-6989(76)90157-7; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BROSS M, 1988, PERCEPTION, V17, P391; BRUNO N, 1990, PERCEPT PSYCHOPHYS, V48, P331, DOI 10.3758/BF03206684; BRUNO N, 1991, PERCEPTION, V20, P259, DOI 10.1068/p200259; BRUSSEL EM, 1977, PERCEPT PSYCHOPHYS, V47, P169; DUMAIS ST, 1976, PERCEPT PSYCHOPHYS, V19, P339, DOI 10.3758/BF03204240; DUNCKER K, 1938, SOURCE BOOK GESTALT, P161; FINKEL LH, 1989, J NEUROSCI, V9, P3188; FINKEL LH, 1992, NEURAL COMPUT, V4, P901, DOI 10.1162/neco.1992.4.6.901; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; GREGORY RL, 1972, NATURE, V238, P51, DOI 10.1038/238051a0; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; HEITGER F, 1993, INT C COMP VIS, P32; KAPLAN GA, 1969, PERCEPT PSYCHOPHYS, V6, P193, DOI 10.3758/BF03207015; KELLMAN PJ, 1984, PERCEPT PSYCHOPHYS, V35, P237, DOI 10.3758/BF03205937; KHURANA B, 1995, NATURE, V378, P565; LAGUE L, 1989, BRAIN RES, V496, P361; LESHER GW, 1993, VISION RES, V33, P2253, DOI 10.1016/0042-6989(93)90104-5; NAKAYAMA K, 1978, VISION RES, V18, P1663, DOI 10.1016/0042-6989(78)90258-4; NAWROT M, 1990, VISION RES, V30, P1439, DOI 10.1016/0042-6989(90)90025-G; Nijhawan R, 1997, NATURE, V386, P66, DOI 10.1038/386066a0; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; ORBAN GA, 1987, J NEUROPHYSIOL, V57, P1792, DOI 10.1152/jn.1987.57.6.1792; POST RB, 1989, PERCEPT PSYCHOPHYS, V45, P411, DOI 10.3758/BF03210714; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; REDIES C, 1986, EXP BRAIN RES, V61, P469; REINHARDTRUTLAND AH, 1983, PERCEPT MOTOR SKILL, V56, P239, DOI 10.2466/pms.1983.56.1.239; REINHARDTRUTLAND AH, 1981, PERCEPTION, V10, P173, DOI 10.1068/p100173; ROCK I, 1979, PERCEPTION, V8, P665, DOI 10.1068/p080665; Schumann F, 1900, Z PSYCHOL PHYSIOL SI, V23, P1; SHIPLEY TF, 1992, PERCEPT PSYCHOPHYS, V52, P97, DOI 10.3758/BF03206762; SHIPLEY TF, 1992, J EXP PSYCHOL HUMAN, V18, P106, DOI 10.1037/0096-1523.18.1.106; SIEGEL S, 1991, PERCEPTION, V20, P233, DOI 10.1068/p200233; Sillito AM, 1996, J PHYSIOL-PARIS, V90, P205, DOI 10.1016/S0928-4257(97)81424-6; SPILLMANN L, 1984, PERCEPTION, V13, P513, DOI 10.1068/p130513; TANAKA K, 1986, J NEUROSCI, V6, P134; TYNAN P, 1975, VISION RES, V15, P1231, DOI 10.1016/0042-6989(75)90167-4; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662; YONAS A, 1987, PERCEPT PSYCHOPHYS, V41, P53, DOI 10.3758/BF03208213; [No title captured]	45	19	21	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					433	441		10.1016/S0896-6273(00)80856-9	http://dx.doi.org/10.1016/S0896-6273(00)80856-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	251BA	10571236	Bronze			2022-12-24	WOS:000083423700017
J	Hosaka, M; Hammer, RE; Sudhof, TC				Hosaka, M; Hammer, RE; Sudhof, TC			A phospho-switch controls the dynamic association of synapsins with synaptic vesicles	NEURON			English	Article							TERMINAL-SPECIFIC PHOSPHOPROTEIN; PROTEIN-KINASE-II; NERVE-TERMINALS; F-ACTIN; PHOSPHORYLATION; BINDING; CA2+; CALMODULIN; RELEASE; RAT	Synapsins constitute a family of synaptic vesicle proteins essential for regulating neurotransmitter release. Only two domains are conserved in all synapsins: a short N-terminal A domain with a single phosphorylation site for cAMP-dependent protein kinase (PKA) and CaM Kinase I, and a large central C domain that binds ATP and may be enzymatic. We now demonstrate that synapsin phosphorylation in the A domain, at the only phosphorylation site shared by all synapsins, dissociates synapsins from synaptic vesicles. Furthermore, we show that the A domain binds phospholipids and is inhibited by phosphorylation. Our results suggest a novel mechanism by which proteins reversibly bind to membranes using a phosphorylation-dependent phospholipid-binding domain. The dynamic association of synapsins with synaptic vesicles correlates with their role in activity-dependent plasticity.	Univ Texas, SW Med Sch, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Sch, Dept Biochem, Ctr Basic Neurosci, Dallas, TX 75235 USA; Univ Texas, SW Med Sch, Howard Hughes Med Inst, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Sch, Dept Mol Genet, Dallas, TX 75235 USA.	tsudho@mednet.swmed.edu		Hosaka, Masahiro/0000-0002-1422-1774; Hammer, Robert E./0000-0001-5487-7551				BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENFENATI F, 1993, J CELL BIOL, V123, P1845, DOI 10.1083/jcb.123.6.1845; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; GEPPERT M, 1994, EMBO J, V13, P3720, DOI 10.1002/j.1460-2075.1994.tb06681.x; GOOLD R, 1995, BIOCHEMISTRY-US, V34, P1912, DOI 10.1021/bi00006a012; GREENGARD P, 1987, MOL NEUROBIOL, V1, P81, DOI 10.1007/BF02935265; HALL FL, 1990, J BIOL CHEM, V265, P6944; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; HUTTNER WB, 1981, J BIOL CHEM, V256, P1482; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSON EM, 1972, J BIOL CHEM, V247, P5650; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; KENNEDY MB, 1983, J NEUROSCI, V3, P818; Lonart G, 1998, J NEUROSCI, V18, P634; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; NAKAOKA T, 1995, J BIOL CHEM, V270, P12147, DOI 10.1074/jbc.270.20.12147; NAVONE F, 1984, SCIENCE, V226, P1209, DOI 10.1126/science.6438799; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; NESTLER EJ, 1982, NATURE, V296, P452, DOI 10.1038/296452a0; NESTLER EJ, 1983, NATURE, V305, P583, DOI 10.1038/305583a0; Nielander HB, 1997, EUR J NEUROSCI, V9, P2712, DOI 10.1111/j.1460-9568.1997.tb01700.x; PETRUCCI TC, 1987, J CELL BIOL, V105, P1355, DOI 10.1083/jcb.105.3.1355; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SUDHOF TC, 1996, P UEH MEM FDT S, P3; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; TORRITARELLI F, 1990, J CELL BIOL, V110, P449, DOI 10.1083/jcb.110.2.449	43	207	220	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1999	24	2					377	387		10.1016/S0896-6273(00)80851-X	http://dx.doi.org/10.1016/S0896-6273(00)80851-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571231	Bronze			2022-12-24	WOS:000083423700012
J	Minichiello, L; Korte, M; Wolfer, D; Kuhn, R; Unsicker, K; Cestari, V; Rossi-Arnaud, C; Lipp, HP; Bonhoeffer, T; Klein, R				Minichiello, L; Korte, M; Wolfer, D; Kuhn, R; Unsicker, K; Cestari, V; Rossi-Arnaud, C; Lipp, HP; Bonhoeffer, T; Klein, R			Essential role for TrkB receptors in hippocampus-mediated learning	NEURON			English	Article							LONG-TERM POTENTIATION; MORRIS WATER MAZE; NEUROTROPHIC FACTOR; MICE LACKING; MUTANT MICE; SYNAPTIC TRANSMISSION; PREFRONTAL CORTEX; TRANSGENIC MICE; NMDA RECEPTOR; BRAIN	Brain-derived neurotrophic factor (BDNF) and its receptor TrkB regulate both short-term synaptic functions and long-term potentiation (LTP) of brain synapses, raising the possibility that BDNF/TrkB may be involved in cognitive functions. We have generated conditionally gene targeted mice in which the knockout of the trkB gene is restricted to the forebrain and occurs only during postnatal development. Adult mutant mice show increasingly impaired learning behavior or inappropriate coping responses when facing complex and/or stressful learning paradigms but succeed in simple passive avoidance learning. Homozygous mutants show impaired LTP at CA1 hippocampal synapses. Interestingly, heterozygotes show a partial but substantial reduction of LTP but appear behaviorally normal. Thus, CA1 LTP may need to be reduced below a certain threshold before behavioral defects become apparent.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Heidelberg, Dept Anat & Cell Biol 3, D-69120 Heidelberg, Germany; CNR, Ist Psicobiol & Psicofarmacol, I-00137 Rome, Italy; Univ Rome La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy	European Molecular Biology Laboratory (EMBL); Max Planck Society; University of Zurich; University of Cologne; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	Klein, R (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Kühn, Ralf/U-1278-2017; Klein, Ruediger/C-6147-2008; ROSSI-ARNAUD, Clelia/J-7870-2019; Bonhoeffer, Tobias/B-9481-2009; Wolfer, David P/B-3293-2016; Minichiello, Liliana/AAA-7190-2022	Kühn, Ralf/0000-0003-1694-9803; Klein, Ruediger/0000-0002-3109-0163; ROSSI-ARNAUD, Clelia/0000-0001-5006-6583; Bonhoeffer, Tobias/0000-0001-7897-6634; Wolfer, David P/0000-0002-5957-1401; Cestari, Vincenzo/0000-0002-9623-157X				Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Alcantara S, 1997, J NEUROSCI, V17, P3623; AmmassariTeule M, 1997, PSYCHOBIOLOGY, V25, P118; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAHILL L, 1990, BEHAV NEUROSCI, V104, P532, DOI 10.1037/0735-7044.104.4.532; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Compton DM, 1997, NEUROBIOL LEARN MEM, V68, P117, DOI 10.1006/nlme.1997.3793; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; DAVIES AM, 1997, CURR BIOL, V7, P38; deBruin JPC, 1997, BEHAV BRAIN RES, V85, P47, DOI 10.1016/S0166-4328(96)00163-5; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Erickson JT, 1996, J NEUROSCI, V16, P5361; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fritzsch B, 1997, TRENDS NEUROSCI, V20, P159, DOI 10.1016/S0166-2236(96)01007-7; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; Gorba T, 1999, EUR J NEUROSCI, V11, P1179, DOI 10.1046/j.1460-9568.1999.00551.x; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; Hogan B, 1994, MANIPULATING MOUSE E; HOSTETTE.G, 1967, J COMP PHYSIOL PSYCH, V63, P105, DOI 10.1037/h0024144; Huang EJ, 1999, DEVELOPMENT, V126, P2191; INAGAWA K, 1988, BEHAV NEURAL BIOL, V50, P184, DOI 10.1016/S0163-1047(88)90871-0; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwasaki Y, 1998, J NEUROCHEM, V71, P106; JARRARD LE, 1976, J COMP PHYSIOL PSYCH, V90, P1035, DOI 10.1037/h0078659; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE E, 1998, P NATL ACAD SCI USA, V92, P8074; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Li YX, 1998, J NEUROSCI, V18, P10231; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; LIPSKA BK, 1994, PHARMACOL BIOCHEM BE, V48, P1053, DOI 10.1016/0091-3057(94)90220-8; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Mair RG, 1998, BEHAV NEUROSCI, V112, P772, DOI 10.1037/0735-7044.112.4.772; Martinez A, 1998, J NEUROSCI, V18, P7336; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MISSLIN R, 1981, PHYSIOL BEHAV, V27, P413, DOI 10.1016/0031-9384(81)90325-5; Montkowski A, 1997, NEUROREPORT, V8, P779, DOI 10.1097/00001756-199702100-00040; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; NAGAHARA AH, 1995, BEHAV NEUROSCI, V109, P3, DOI 10.1037/0735-7044.109.1.3; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Okabe S, 1998, J NEUROSCI, V18, P4177; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rossi-Arnaud C, 1998, EXP BRAIN RES, V123, P36, DOI 10.1007/s002210050542; Shieh PB, 1997, CURR BIOL, V7, pR627, DOI 10.1016/S0960-9822(06)00319-8; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	74	618	632	0	35	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					401	414		10.1016/S0896-6273(00)80853-3	http://dx.doi.org/10.1016/S0896-6273(00)80853-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571233	Bronze			2022-12-24	WOS:000083423700014
J	Schorge, S; Gupta, S; Lin, ZX; McEnery, MW; Lipscombe, D				Schorge, S; Gupta, S; Lin, ZX; McEnery, MW; Lipscombe, D			Calcium channel activation stabilizes a neuronal calcium channel mRNA	NATURE NEUROSCIENCE			English	Article							MESSENGER-RNA DEGRADATION; RAT SYMPATHETIC NEURONS; CA2+ CHANNELS; 3'-UNTRANSLATED REGION; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; PROTEIN-SYNTHESIS; SENSORY NEURONS; ALPHA-1 SUBUNIT; GROWTH CONES	We have identified a calcium-dependent pathway in neurons that regulates expression levels of the alpha(1B) subunit and N channel current. When neurons are depolarized and voltage-gated calcium channels activated, the half-life of cellular N channel alpha(1B) mRNA is prolonged. This stabilizing effect of depolarization is mediated through the 3' untranslated region of a long form of the alpha(1B) mRNA and may represent a form of modulation of N-channel levels that does not require changes in gene transcription. Increases in N channel expression would affect several key neuronal functions controlled by calcium, including transmitter release and neurite outgrowth.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Brown University; Case Western Reserve University	Lipscombe, D (corresponding author), Brown Univ, Dept Neurosci, 192 Thayer St,Box 1953, Providence, RI 02912 USA.		Schorge, Stephanie/C-8515-2009	Schorge, Stephanie/0000-0003-1541-5148	NIMH NIH HHS [MH19118] Funding Source: Medline; NINDS NIH HHS [NS 01927, NS 29967] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029967, K02NS001927, R01NS029967] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brosenitsch TA, 1998, J NEUROSCI, V18, P1047; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHU W, 1994, J IMMUNOL, V153, P4179; COPPOLA T, 1994, FEBS LETT, V338, P1, DOI 10.1016/0014-5793(94)80105-3; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; DAVIS L, 1992, J NEUROSCI, V12, P4867; DeKoninck P, 1995, J NEUROSCI, V15, P7966; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; ELLIOTT EM, 1995, J NEUROSCI, V15, P6433; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; Gao FB, 1998, BIOESSAYS, V20, P70, DOI 10.1002/(SICI)1521-1878(199801)20:1<70::AID-BIES10>3.0.CO;2-5; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; HEPLER JE, 1990, ENDOCRINOLOGY, V127, P1550, DOI 10.1210/endo-127-3-1550; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; IWAI Y, 1993, J IMMUNOL, V150, P4386; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Lin ZX, 1996, J MOL NEUROSCI, V7, P257, DOI 10.1007/BF02737063; Lin ZX, 1999, J NEUROSCI, V19, P5322; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; LUO ZG, 1994, J BIOL CHEM, V269, P27216; MCCALL WV, 1992, CONVULSIVE THER, V8, P12; MILLS LR, 1994, J NEUROSCI, V14, P6815; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; STOECKLIN G, 1994, J BIOL CHEM, V269, P28591; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TOLON RM, 1994, J NEUROSCI, V14, P1053, DOI 10.1523/JNEUROSCI.14-03-01053.1994; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; Tsai KC, 1997, J NEUROSCI, V17, P1950; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Wahle E, 1996, TRENDS BIOCHEM SCI, V21, P247, DOI 10.1016/S0968-0004(96)10030-X; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WODNARFILIPOWICZ A, 1990, P NATL ACAD SCI USA, V87, P777, DOI 10.1073/pnas.87.2.777	50	21	22	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					785	790		10.1038/12153	http://dx.doi.org/10.1038/12153			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461216				2022-12-24	WOS:000083882900008
J	Saberi, K; Takahashi, Y; Farahbod, H; Konishi, M				Saberi, K; Takahashi, Y; Farahbod, H; Konishi, M			Neural bases of an auditory illusion and its elimination in owls	NATURE NEUROSCIENCE			English	Article							INTERAURAL TIME DIFFERENCES; COMPLEX BINAURAL STIMULI; MEDIAL SUPERIOR OLIVE; BRAIN-STEM; DELAY-LINES; BARN OWL; LATERALIZATION; SENSITIVITY; MODEL; CIRCUIT	Humans and owls localize sounds by detecting the arrival time disparity between the ears. Both species determine the interaural time difference by finding the delay necessary to match the leading signal with the lagging one. This method produces ambiguity with periodic signals, because the two signals can be matched by delaying either one or the other. As predicted, owls localized periodic signals in illusory directions, whereas they always perceived the real source when signal bandwidth exceeded a certain value. This bandwidth also enabled higher-order auditory neurons to discriminate between real and illusory sources.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology	Saberi, K (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.		Saberi, Kourosh/GXG-0944-2022					CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; CARR CE, 1990, J NEUROSCI, V10, P3227; COLBURN HS, 1973, J ACOUST SOC AM, V54, P1458, DOI 10.1121/1.1914445; COLBURN HS, 1995, AUDITORY COMPUTATION, P332; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; GRANTHAM DW, 1995, SPATIAL HEARING RELA, P297; HAFTER ER, 1991, J ACOUST SOC AM, V90, P1901, DOI 10.1121/1.401669; Jeffress L. A., 1972, F MODERN AUDITORY TH, V2, P349; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Keller CH, 1996, J NEUROSCI, V16, P4300; KONISHI M, 1973, AM SCI, V61, P414; MAZER J, 1995, INTEGRATION PARALLEL; Mazer JA, 1998, P NATL ACAD SCI USA, V95, P10932, DOI 10.1073/pnas.95.18.10932; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; Mori K, 1997, HEARING RES, V111, P22, DOI 10.1016/S0378-5955(97)00090-7; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; OVERHOLT EM, 1992, J NEUROSCI, V12, P1698; Saberi K, 1996, PSYCHOL REV, V103, P137, DOI 10.1037/0033-295X.103.1.137; Saberi K, 1998, J ACOUST SOC AM, V103, P2551, DOI 10.1121/1.422776; Saberi K, 1998, P NATL ACAD SCI USA, V95, P6465, DOI 10.1073/pnas.95.11.6465; Saberi K, 1998, NEURON, V21, P789, DOI 10.1016/S0896-6273(00)80595-4; SAYERS BM, 1957, J ACOUST SOC AM, V29, P973, DOI 10.1121/1.1914990; SHACKLETON TM, 1992, J ACOUST SOC AM, V91, P2276, DOI 10.1121/1.403663; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; STERN RM, 1988, J ACOUST SOC AM, V84, P156, DOI 10.1121/1.396982; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; TRAHIOTIS C, 1994, J ACOUST SOC AM, V96, P3804, DOI 10.1121/1.410570; WAGNER H, 1987, J NEUROSCI, V7, P3105; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	29	42	42	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					656	659		10.1038/10212	http://dx.doi.org/10.1038/10212			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404199				2022-12-24	WOS:000083882600017
J	Horch, HW; Kruttgen, A; Portbury, SD; Katz, LC				Horch, HW; Kruttgen, A; Portbury, SD; Katz, LC			Destabilization of cortical dendrites and spines by BDNF	NEURON			English	Article							NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; KITTEN VISUAL-CORTEX; NEUROTROPHIC FACTOR; HIPPOCAMPAL-NEURONS; BRAIN-SLICES; ANTEROGRADE TRANSPORT; KINASE-ACTIVITY; STRIATE CORTEX; AREA 17	Particle-mediated gene transfer and two-photon microscopy were used to monitor the behavior of dendrites of individual cortical pyramidal neurons coexpressing green fluorescent protein (GFP) and brain-derived neurotrophic factor (BDNF). While the dendrites and spines of neurons expressing GFP alone grew modestly over 24-48 hr, coexpressing BDNF elicited dramatic sprouting of basal dendrites, accompanied by a regression of dendritic spines. Compared to GFP-transfected controls, the newly formed dendrites and spines were highly unstable. Experiments utilizing Trk receptor bodies, K252a, and overexpression of nerve growth factor (NGF) demonstrated that these effects were mediated by secreted BDNF interacting with extracellular TrkB receptors. Thus, BDNF induces structural instability in dendrites and spines, which, when restricted to particular portions of a dendritic arbor, may help translate activity patterns into specific morphological changes.	Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA; Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Duke University; Howard Hughes Medical Institute; Stanford University	Horch, HW (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Howard Hughes Med Inst, Durham, NC 27710 USA.	hwilson@neuro.duke.edu	Kruttgen, Alexander P/E-9232-2010	Portbury, Stuart/0000-0002-5470-6100	NATIONAL EYE INSTITUTE [R01EY011553] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11553] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; [Anonymous], [No title captured]; BACON JP, 1984, J PHYSIOL-LONDON, V352, P601, DOI 10.1113/jphysiol.1984.sp015312; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BERG MM, 1992, J BIOL CHEM, V267, P13; BIFFO S, 1995, DEVELOPMENT, V121, P2461; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CARMIGNOTO G, 1993, J PHYSIOL-LONDON, V464, P343, DOI 10.1113/jphysiol.1993.sp019638; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Dailey ME, 1996, J NEUROSCI, V16, P2983; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DESMOND NL, 1986, J COMP NEUROL, V253, P476, DOI 10.1002/cne.902530405; DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; EYSEL UT, 1982, NATURE, V299, P442, DOI 10.1038/299442a0; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FRIEDLANDER MJ, 1982, J NEUROSCI, V2, P321; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS RM, 1979, BRAIN RES, V161, P143, DOI 10.1016/0006-8993(79)90201-4; HOSOKAWA T, 1992, NEUROREPORT, V3, P477, DOI 10.1097/00001756-199206000-00005; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KASE H, 1986, J ANTIBIOT, V39, P1059, DOI 10.7164/antibiotics.39.1059; KATZ LC, 1988, J NEUROSCI, V8, P3160; KATZ LC, 1987, J NEUROSCI, V7, P1223; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; KOSSEL A, 1995, J NEUROSCI, V15, P3913; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MILLER MW, 1988, CEREB CORTEX, P140; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; Moller JC, 1998, J NEUROSCI RES, V51, P463, DOI 10.1002/(SICI)1097-4547(19980215)51:4<463::AID-JNR6>3.0.CO;2-A; PARNAVELAS JG, 1974, NATURE, V248, P71, DOI 10.1038/248071a0; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Shimada A, 1998, J NEUROSCI, V18, P8559; SHOLL DA, 1953, J ANAT, V87, P387; Sorra KE, 1998, J NEUROSCI, V18, P658; TAPLEY P, 1992, ONCOGENE, V7, P371; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; WETMORE C, 1991, P NATL ACAD SCI USA, V88, P9843, DOI 10.1073/pnas.88.21.9843; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	69	281	290	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1999	23	2					353	364						12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399940				2022-12-24	WOS:000081218600019
J	Galizia, CG; Sachse, S; Rappert, A; Menzel, R				Galizia, CG; Sachse, S; Rappert, A; Menzel, R			The glomerular code for odor representation is species specific in the honeybee Apis mellifera	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; ANTENNAL LOBES; 2-DEOXYGLUCOSE METHOD; NEURONAL-ACTIVITY; BEE; BRAIN; DISCRIMINATION; COMBINATORIAL; STIMULATION; INFORMATION	Odors are coded by glomerular activity patterns in the insect antennal lobe (AL) and in the mammalian olfactory bulb. We measured glomerular responses to 30 different odors in the AL of honeybees using calcium-sensitive dyes. By subsequently staining glomeruli and identifying individual glomerular outlines, we were able to compare the patterns between animals. Regardless of whether the odors were mixtures or pure substances, environmental odors or pheromones, their representations were highly conserved among individuals. Therefore, it may be possible to create a functional atlas of the AL in which particular molecular receptive ranges are attributed to each glomerulus.	Free Univ Berlin, Inst Neurobiol, D-14195 Berlin, Germany	Free University of Berlin	Galizia, CG (corresponding author), Free Univ Berlin, Inst Neurobiol, Konigin Luise Str 28-30, D-14195 Berlin, Germany.	galizia@zedat.fu-berlin.de	Galizia, C Giovanni/A-1771-2009; Sachse, Silke/M-8484-2014	Galizia, C Giovanni/0000-0001-8292-6031; Sachse, Silke/0000-0002-9769-8067				Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; Burrows M., 1996, NEUROBIOLOGY INSECT; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; Distler PG, 1998, BRAIN RES, V805, P263, DOI 10.1016/S0006-8993(98)00715-X; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Galizia CG, 1999, CELL TISSUE RES, V295, P383, DOI 10.1007/s004410051245; Galizia CG, 1997, J NEUROSCI METH, V76, P61, DOI 10.1016/S0165-0270(97)00080-0; Hildebrand JG, 1996, J COMP PHYSIOL A, V178, P5, DOI 10.1007/BF00189586; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Lu XCM, 1998, NEUROSCIENCE, V84, P849, DOI 10.1016/S0306-4522(97)00520-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; ROSPARS JP, 1988, INT J INSECT MORPHOL, V17, P243, DOI 10.1016/0020-7322(88)90041-4; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Sigg D, 1997, J NEUROSCI, V17, P7148; SLOTNICK BM, 1987, ANN NY ACAD SCI, V510, P630; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	29	243	243	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					473	478		10.1038/8144	http://dx.doi.org/10.1038/8144			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321253	Green Published			2022-12-24	WOS:000084609400019
J	Belvin, MP; Zhou, H; Yin, JCP				Belvin, MP; Zhou, H; Yin, JCP			The Drosophila dCREB2 gene affects the circadian clock	NEURON			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; MESSENGER-RNA LEVELS; PERIOD GENE; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION FACTORS; MOLECULAR MECHANISMS; RHYTHMIC EXPRESSION; PHOTIC REGULATION; TIMELESS PROTEIN	We report the role of dCREB2, the Drosophila homolog of CREB/CREM, in circadian rhythms, dCREB2 activity cycles with a 24 hr rhythm in flies, both in a light:dark cycle and in constant darkness. A mutation in dCREB2 shortens circadian locomotor rhythm in flies and dampens the oscillation of period, a known clock gene. Cycling dCREB2 activity is abolished in a period mutant, indicating that dCREB2 and Period affect each other and suggesting that the two genes participate in the same regulatory feedback loop. We propose that dCREB2 supports cycling of the Period/Timeless oscillator. These findings support CREB's role in mediating adaptive behavioral responses to a variety of environmental stimuli (stress, growth factors, drug addiction, circadian rhythms, and memory formation) in mammals and long-term memory formation and circadian rhythms in Drosophila.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Yin, JCP (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	yin@cshl.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059649] Funding Source: NIH RePORTER; NHLBI NIH HHS [1RO1 HL/AR59649] Funding Source: Medline; NINDS NIH HHS [5RO1 NS3557] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Amir S, 1996, NATURE, V379, P542, DOI 10.1038/379542a0; Ausubel F. M., 1988, CURRENT PROTOCOLS MO; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BORSOOK D, 1994, MOL ENDOCRINOL, V8, P240, DOI 10.1210/me.8.2.240; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Datto L, 1996, CAN MED ASSOC J, V154, P1193; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; EBERL DF, 1992, GENETICS, V130, P569; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Foulkes NS, 1996, NATURE, V381, P83, DOI 10.1038/381083a0; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Geusz ME, 1997, CURR BIOL, V7, P758, DOI 10.1016/S0960-9822(06)00334-4; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Hao HP, 1999, J NEUROSCI, V19, P987; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; HENIKOFF S, 1994, GENETICS, V138, P1; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; JACKSON FR, 1986, NATURE, V320, P185, DOI 10.1038/320185a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KOMHAUSER JM, 1990, NEURON, V5, P127; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KORNHAUSER JM, 1992, SCIENCE, V255, P1581, DOI 10.1126/science.1549784; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; Rouyer F, 1997, EMBO J, V16, P3944, DOI 10.1093/emboj/16.13.3944; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUSAK B, 1992, MOL BRAIN RES, V14, P124, DOI 10.1016/0169-328X(92)90019-8; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SEJNOWSKI TJ, 1995, CURR BIOL, V5, P832, DOI 10.1016/S0960-9822(95)00165-5; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; USUI T, 1993, DNA CELL BIOL, V12, P589, DOI 10.1089/dna.1993.12.589; VanGelder RN, 1995, CURR BIOL, V5, P1424, DOI 10.1016/S0960-9822(95)00280-6; VAZQUEZ J, 1994, EMBO J, V13, P5984, DOI 10.1002/j.1460-2075.1994.tb06944.x; WIDNELL KL, 1994, P NATL ACAD SCI USA, V91, P10947, DOI 10.1073/pnas.91.23.10947; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZWIEBEL LJ, 1991, P NATL ACAD SCI USA, V88, P3882, DOI 10.1073/pnas.88.9.3882	78	124	126	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					777	787		10.1016/S0896-6273(00)80736-9	http://dx.doi.org/10.1016/S0896-6273(00)80736-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230797	Bronze			2022-12-24	WOS:000079976200020
J	Anton, ES; Kreidberg, JA; Rakic, P				Anton, ES; Kreidberg, JA; Rakic, P			Distinct functions of alpha(3) and alpha(v) integrin receptors in neuronal migration and laminar organization of the cerebral cortex	NEURON			English	Review							CENTRAL-NERVOUS-SYSTEM; EPITHELIAL BASEMENT-MEMBRANES; MULTIPLE ADHESION MOLECULES; FETAL MONKEY NEOCORTEX; CELLS IN-VITRO; EXTRACELLULAR-MATRIX; ALPHA-3-BETA-1 INTEGRIN; CORTICAL DEVELOPMENT; NEURITE OUTGROWTH; BETA-SUBUNITS	Changes in specific cell-cell recognition and adhesion interactions between neurons and radial glial cells regulate neuronal migration as well as the establishment of distinct layers in the developing cerebral cortex. Here, we show that alpha(3)beta(1) integrin is necessary for neuron-glial recognition during neuronal migration and that a, integrins provide optimal levels of the basic neuron-glial adhesion needed to maintain neuronal migration on radial glial fibers. A gliophilic-to-neurophitic switch in the adhesive preference of developing cortical neurons occurs following the loss of alpha(3)beta(1) integrin function. Furthermore, the targeted mutation of the alpha(3) integrin gene results in abnormal layering of the cerebral cortex. These results suggest that alpha(3)beta(1) and alpha(v) integrins regulate distinct aspects of neuronal migration and neuron-glial interactions during corticogenesis.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Penn State Univ, Dept Biol, University Pk, PA 16803 USA; Penn State Univ, Dept Neurosci, University Pk, PA 16803 USA	Yale University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Anton, ES (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.	esa5@psu.edu	Messier, Claude/A-2322-2008; GARCION, Emmanuel/K-5417-2015	Messier, Claude/0000-0002-4791-1763; GARCION, Emmanuel/0000-0003-0887-272X	NINDS NIH HHS [NS02253] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anton ES, 1996, J NEUROSCI, V16, P2283; Anton ES, 1997, DEVELOPMENT, V124, P3501; Banerjee SA, 1997, J NEUROSCI, V17, P2756; BARTH PG, 1987, CAN J NEUROL SCI, V14, P1; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; BEAUVAIS A, 1995, J CELL BIOL, V128, P699, DOI 10.1083/jcb.128.4.699; Behrendtsen O, 1995, DEVELOPMENT, V121, P4137; BODARY SC, 1990, J BIOL CHEM, V265, P5938; BOSSY B, 1990, BIOCHEMISTRY-US, V29, P10191, DOI 10.1021/bi00496a006; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; Caric D, 1997, DEVELOPMENT, V124, P5087; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CAVINESS VS, 1989, ISS BIOL L, P405; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHAN BMC, 1993, J CELL BIOL, V120, P537, DOI 10.1083/jcb.120.2.537; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; CHUONG CM, 1990, EXPERIENTIA, V46, P892, DOI 10.1007/BF01939381; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COOPER D, 1995, P NATL ACAD SCI USA, V92, P3978, DOI 10.1073/pnas.92.9.3978; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DEDHAR S, 1992, J BIOL CHEM, V267, P18908; DEFREITAS MF, 1995, NEURON, V15, P333, DOI 10.1016/0896-6273(95)90038-1; DELANNET M, 1994, DEVELOPMENT, V120, P2687; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; EDELMAN GM, 1988, ANNU REV NEUROSCI, V7, P339; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; FISHELL G, 1991, DEVELOPMENT, V113, P755; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gerber DJ, 1996, P NATL ACAD SCI USA, V93, P14698, DOI 10.1073/pnas.93.25.14698; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; GRUMET M, 1992, J NEUROSCI RES, V31, P1, DOI 10.1002/jnr.490310102; Hadjiargyrou M, 1996, J NEUROCHEM, V67, P2505; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P615; Komuro H, 1998, J NEUROSCI, V18, P1478; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; Levitt P, 1993, Perspect Dev Neurobiol, V1, P65; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Mannion BA, 1996, J IMMUNOL, V157, P2039; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1989, TRENDS NEUROSCI, V12, P342, DOI 10.1016/0166-2236(89)90041-6; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MENDRICK DL, 1993, LAB INVEST, V69, P690; Milner R, 1996, J NEUROSCI, V16, P7240; MILNER R, 1994, DEVELOPMENT, V120, P3497; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; Montgomery AMP, 1996, J CELL BIOL, V132, P475, DOI 10.1083/jcb.132.3.475; MOYLE M, 1991, J BIOL CHEM, V266, P19650; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1988, PROG BRAIN RES, V73, P15; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; REINER O, 1995, J NEUROSCI, V15, P3730; RIVAS R J, 1991, Journal of Cell Biology, V115, p102A; RIVAS RJ, 1995, J NEUROSCI, V15, P981; ROSSINO P, 1990, EXP CELL RES, V189, P100, DOI 10.1016/0014-4827(90)90262-9; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; SCHMIDT CE, 1995, J NEUROSCI, V15, P3400; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; SHEPPARD AM, 1991, J NEUROSCI, V11, P3928; SRIRAMARAO P, 1993, J BIOL CHEM, V268, P22036; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; STEPHENS LE, 1993, J CELL BIOL, V123, P1607, DOI 10.1083/jcb.123.6.1607; STIPP CS, 1994, J CELL BIOL, V124, P149, DOI 10.1083/jcb.124.1.149; SUNADA Y, 1995, NEUROLOGY, V45, P2084, DOI 10.1212/WNL.45.11.2084; SYMINGTON BE, 1993, J CELL BIOL, V120, P523, DOI 10.1083/jcb.120.2.523; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; TOMASELLI KJ, 1993, J NEUROSCI, V13, P4880; TOMASELLI KJ, 1990, NEURON, V5, P651, DOI 10.1016/0896-6273(90)90219-6; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Volpe J., 1995, NEUROLOGY NEWBORN, P43; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH CA, 1995, BRAIN DEV EPILEPSY, P123; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WAYNER EA, 1993, J CELL BIOL, V121, P1141, DOI 10.1083/jcb.121.5.1141; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; YABKOWITZ R, 1993, J IMMUNOL, V151, P149; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Zhang ZQ, 1998, J NEUROSCI, V18, P6928; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	137	284	293	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					277	289		10.1016/S0896-6273(00)81089-2	http://dx.doi.org/10.1016/S0896-6273(00)81089-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069334	Bronze			2022-12-24	WOS:000078875200013
J	McKinney, RA; Capogna, M; Durr, R; Gahwiler, BH; Thompson, SM				McKinney, RA; Capogna, M; Durr, R; Gahwiler, BH; Thompson, SM			Miniature synaptic events maintain dendritic spines via AMPA receptor activation	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT CEREBRAL-CORTEX; PYRAMIDAL CELLS; HIPPOCAMPAL-NEURONS; SILENT SYNAPSES; IN-VITRO; CA1; PLASTICITY; EXPRESSION; GLUTAMATE	We investigated the influence of synaptically released glutamate on postsynaptic structure by comparing the effects of deafferentation, receptor antagonists and blockers of glutamate release in hippocampal Slice cultures. CA1 pyramidal cell spine density and length decreased after transection of Schaffer collaterals and after application of AMPA receptor antagonists or botulinum toxin to unlesioned cultures. Loss of spines induced by lesion or by botulinum toxin was prevented by simultaneous AMPA application. Tetrodotoxin did not affect spine density. Synaptically released glutamate thus exerts a trophic effect on spines by acting at AMPA receptors. We conclude that AMPA receptor activation by spontaneous vesicular glutamate release is sufficient to maintain dendritic spines.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University of Zurich; University System of Maryland; University of Maryland Baltimore	McKinney, RA (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Thompson, Scott M/K-8921-2015	Capogna, Marco/0000-0002-2742-5485				CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Capogna M, 1997, J NEUROSCI, V17, P7190; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FORSTER E, 1993, NEUROSCI LETT, V155, P216, DOI 10.1016/0304-3940(93)90711-S; GAHWILER BH, 1991, CULTURING NERVE CELL, P379; GERFINMOSER A, 1995, NEUROSCIENCE, V67, P849, DOI 10.1016/0306-4522(95)00130-B; GOLDOWITZ D, 1979, BRAIN RES, V170, P427, DOI 10.1016/0006-8993(79)90962-4; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi K, 1996, J NEUROSCI, V16, P7161; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HORN G, 1985, J NEUROSCI, V5, P3161; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; LOMO T, 1972, J PHYSIOL-LONDON, V221, P493, DOI 10.1113/jphysiol.1972.sp009764; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; PAPA M, 1995, J NEUROSCI, V15, P1; PARNAVELAS JG, 1974, NATURE, V248, P71, DOI 10.1038/248071a0; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; POULAIN B, 1995, CLOSTRIDIAL NEUROTOX, P243; RUSAKOV DA, 1995, J NEUROSCI METH, V60, P11, DOI 10.1016/0165-0270(94)00215-3; Sorra KE, 1998, J NEUROSCI, V18, P658; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; WESTRUM LE, 1962, J COMP NEUROL, V119, P281, DOI 10.1002/cne.901190303; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	36	427	434	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					44	49		10.1038/4548	http://dx.doi.org/10.1038/4548			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195179				2022-12-24	WOS:000078409300012
J	Blum, H				Blum, H			A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra	NATURE NEUROSCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; MICE LACKING GDNF; FACTOR RECEPTOR; RAT-BRAIN; VULNERABILITY; ABNORMALITIES; PROLIFERATION; COMPARTMENTS; DEVELOP; WEAVER	Transforming growth factor (TGF)-alpha is neurotrophic for midbrain dopaminergic neurons in vitro. Here I investigated whether a null mutation in the TGF-alpha gene affects the normal development or survival of dopaminergic neurons in either the substantial nigra (SN) or the ventral tegmental area (VTA). The SN of TGF-alpha knockout mice contained 58% fewer dopaminergic neurons than the control SN, but VTA neuron number was unchanged. In addition, the overall volume of the dorsal striatum was reduced by 20%. Newborn mice showed a similar decrease in the number of SN dopaminergic neurons, suggesting that TCF-alpha is unlikely to regulate developmental neuron death. These studies indicate that TGF-alpha is required for the normal proliferation or differentiation of a select population of dopaminergic neurons within the SN.	CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Blum, H (corresponding author), CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, 1 Gustave Levy Pl,box 1065, New York, NY 10029 USA.	blum@cortex.neuro.mssm.edu			NIA NIH HHS [AG08538] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG008538] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAYER SA, 1984, INT J DEV NEUROSCI, V2, P163, DOI 10.1016/0736-5748(84)90008-X; BAYER SA, 1995, P NATL ACAD SCI USA, V92, P9137, DOI 10.1073/pnas.92.20.9137; BLOOM FE, 1997, NEUROINFORMATICS OVE, P83; BOUVIER MM, 1995, J NEUROSCI, V15, P7141; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; GRAYBIEL AM, 1990, J NEUROSCI, V10, P720; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KORNBLUM HI, 1995, NEUROSCIENCE, V69, P1025, DOI 10.1016/0306-4522(95)00392-V; Kornblum HI, 1997, J COMP NEUROL, V380, P243, DOI 10.1002/(SICI)1096-9861(19970407)380:2<243::AID-CNE7>3.0.CO;2-3; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lieb K, 1996, DEV BRAIN RES, V94, P37, DOI 10.1016/0165-3806(96)00063-6; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MYTILINEOU C, 1992, NEUROSCI LETT, V135, P62, DOI 10.1016/0304-3940(92)90136-U; Oo TF, 1997, DEV BRAIN RES, V98, P191, DOI 10.1016/S0165-3806(96)00173-3; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHAMBRA B, 1994, NEUROSCIENCE, V62, P65, DOI 10.1016/0306-4522(94)90315-8; SEROOGY KB, 1995, BRAIN RES, V670, P157, DOI 10.1016/0006-8993(94)01300-7; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; WEICKERT CS, 1995, DEV BRAIN RES, V86, P203, DOI 10.1016/0165-3806(95)00026-A; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WESTERMEYER J, 1990, Advances in Alcohol and Substance Abuse, V8, P1	25	84	93	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					374	377		10.1038/1584	http://dx.doi.org/10.1038/1584			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196526				2022-12-24	WOS:000076361400014
J	Condron, BG				Condron, BG			Serotonergic neurons transiently require a midline-derived FGF signal	NEURON			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; COMMISSURAL GROWTH CONE; AXON GUIDANCE; CELL-FATE; DROSOPHILA-MELANOGASTER; FLOOR PLATE; CNS MIDLINE; TRANSPORTER; GRASSHOPPER; EXPRESSION	In the grasshopper CNS, serotonergic growth cones cross the midline early in development and initiate expression of serotonin uptake activity, or SERT. To test if the midline contains an activity that induces SERT, cuts were made that separated serotonergic cell bodies from the midline. SERT activity is completely lost when the midline is separated but is then rescued by bath-applied FGF2 (fibroblast growth factor 2), which can activate the heartless FGF receptor. heartless is expressed specifically in serotonergic neurons. A candidate FGF-like molecule was identified that is expressed in a subset of midline glia. SERT-expressing severed growth cones continue to migrate to their correct targets, which indicates that by the time SERT is activated, the serotonergic growth cones are committed to target-directed growth.	Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia	Condron, BG (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA.		Condron, Barry/AAX-3952-2020	Condron, Barry/0000-0003-2610-5065	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037223] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37223] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASTIANI MJ, 1992, DEV BIOL, V154, P129, DOI 10.1016/0012-1606(92)90054-K; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Bruning G, 1997, CELL TISSUE RES, V289, P211, DOI 10.1007/s004410050868; BUDNIK V, 1989, J NEUROSCI, V9, P2866; Condron B, 1999, DEVELOPMENT, V126, P4635; Condron BG, 1997, CURR BIOL, V7, P813, DOI 10.1016/S0960-9822(06)00343-5; CONDRON BG, 1994, J NEUROSCI, V14, P5766; CONDRON BG, 1995, CURR BIOL, V5, P51, DOI 10.1016/S0960-9822(95)00016-9; CONDRON BG, 1994, NEURON, V13, P541, DOI 10.1016/0896-6273(94)90024-8; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Cook EH, 1997, MOL PSYCHIATR, V2, P247; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; DEMCHYSHYN LL, 1994, P NATL ACAD SCI USA, V91, P5158, DOI 10.1073/pnas.91.11.5158; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Klauck SM, 1997, HUM MOL GENET, V6, P2233, DOI 10.1093/hmg/6.13.2233; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MYERS PZ, 1993, J NEUROSCI, V13, P127; MYERS PZ, 1993, J NEUROSCI, V13, P115; NATHANSON JA, 1993, P NATL ACAD SCI USA, V90, P9645, DOI 10.1073/pnas.90.20.9645; Reifers F, 1998, DEVELOPMENT, V125, P2381; TAGHERT PH, 1984, J NEUROSCI, V4, P989; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; VONBERNHARDI R, 1995, J COMP NEUROL, V357, P52, DOI 10.1002/cne.903570106; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	43	22	22	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					531	540		10.1016/S0896-6273(00)81110-1	http://dx.doi.org/10.1016/S0896-6273(00)81110-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595507	Bronze			2022-12-24	WOS:000083913000011
J	Firestein, BL; Brenman, JE; Aoki, C; Sanchez-Perez, AM; El-Husseini, AED; Bredt, DS				Firestein, BL; Brenman, JE; Aoki, C; Sanchez-Perez, AM; El-Husseini, AED; Bredt, DS			Cypin: A cytosolic regulator of PSD-95 postsynaptic targeting	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; NITRIC-OXIDE SYNTHASE; DENSITY PROTEIN PSD-95; LONG-TERM POTENTIATION; SEPTATE JUNCTIONS; MEMBRANE; NEURONS; SAP97; DLG; CHANNELS	Postsynaptic density 95 (PSD-95/SAP-90) is a membrane associated guanylate kinase (GK) PDZ protein that scaffolds glutamate receptors and associated signaling networks at excitatory synapses. Affinity chromatography identifies cypin as a major PSD-95-binding protein in brain extracts. Cypin is homologous to a family of hydrolytic bacterial enzymes and shares some similarity with collapsin response mediator protein (CRMP), a cytoplasmic mediator of semaphorin III signalling. Cypin is discretely expressed in neurons and is polarized to basal membranes in intestinal epithelial cells. Overexpression of cypin in hippocampal neurons specifically perturbs postsynaptic trafficking of PSD-95 and SAP-102, an effect not produced by overexpression of other PDZ ligands. In fact, PSD-95 can induce postsynaptic clustering of an otherwise diffusely localized K+ channel, Kv1.4. By regulating postsynaptic protein sorting, cypin may influence synaptic development and plasticity.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	University of California System; University of California San Francisco; New York University	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.		Aoki, Chiye/T-9405-2019; Sánchez-Pérez, Ana María/AAB-4454-2019; Sánchez-Pérez, Ana María M/N-2731-2017	Aoki, Chiye/0000-0003-4010-9425; Sánchez-Pérez, Ana María M/0000-0002-5811-0005; Firestein, Bonnie/0000-0002-1679-3565	NATIONAL EYE INSTITUTE [R01EY008055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036017] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY08055] Funding Source: Medline; NINDS NIH HHS [R01-NS36017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1998, J NEUROSCI, V18, P8805; Brenman JE, 1996, J NEUROSCI, V16, P7407; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; CHAN J, 1990, J NEUROSCI METH, V33, P113, DOI 10.1016/0165-0270(90)90015-8; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Firestein BL, 1999, J BIOL CHEM, V274, P10545, DOI 10.1074/jbc.274.15.10545; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; HILLER BJ, 1999, IN PRESS SCIENCE; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LI W, 1992, GENETICS, V132, P675; Maccaferri G, 1996, J NEUROSCI, V16, P5334; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Rao A, 1998, J NEUROSCI, V18, P1217; Reuver SM, 1998, J CELL SCI, V111, P1071; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; SHAO ZQ, 1995, J BACTERIOL, V177, P5748, DOI 10.1128/jb.177.20.5748-5755.1995; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Wang LH, 1997, J NEUROCHEM, V69, P2261; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu HJ, 1998, J CELL SCI, V111, P2365; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	39	81	85	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					659	672		10.1016/S0896-6273(00)81120-4	http://dx.doi.org/10.1016/S0896-6273(00)81120-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595517	Bronze			2022-12-24	WOS:000083913000021
J	Luscher, C; Xia, HH; Beattie, EC; Carroll, RC; von Zastrow, M; Malenka, RC; Nicoll, RA				Luscher, C; Xia, HH; Beattie, EC; Carroll, RC; von Zastrow, M; Malenka, RC; Nicoll, RA			Role of AMPA receptor cycling in synaptic transmission and plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; GLUR2; PROTEINS; DYNAMIN; ENDOCYTOSIS; CLATHRIN; BINDING	Compounds known to disrupt exocytosis or endocytosis were introduced into CA1 pyramidal cells while monitoring excitatory postsynaptic currents (EPSCs). Disrupting exocytosis or the interaction of GluR2 with NSF caused a gradual reduction in the AMPAR EPSC, while inhibition of endocytosis caused a gradual increase in the AMPAR EPSC. These manipulations had no effect on the NMDAR EPSC but prevented the subsequent induction of LTD. These results suggest that AMPARs, but not NMDARs, cycle into and out of the synaptic membrane at a rapid rate and that certain forms of synaptic plasticity may utilize this dynamic process.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@phy.ucsf.edu	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596				Allison DW, 1998, J NEUROSCI, V18, P2423; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gasman S, 1997, J BIOL CHEM, V272, P20564, DOI 10.1074/jbc.272.33.20564; He Y, 1998, EXP NEUROL, V150, P1, DOI 10.1006/exnr.1997.6720; HUTTNER WB, 1993, NATURE, V365, P104, DOI 10.1038/365104a0; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; Schmierer K, 1998, NEUROLOGY, V51, P250, DOI 10.1212/WNL.51.1.250; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8	39	550	569	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					649	658		10.1016/S0896-6273(00)81119-8	http://dx.doi.org/10.1016/S0896-6273(00)81119-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595516	Bronze			2022-12-24	WOS:000083913000020
J	Arber, S; Han, B; Mendelsohn, M; Smith, M; Jessell, TM; Sockanathan, S				Arber, S; Han, B; Mendelsohn, M; Smith, M; Jessell, TM; Sockanathan, S			Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity	NEURON			English	Article							RAT SPINAL-CORD; MUSCULATURE FOLLOWING TRANSPLANTATION; CHICK HIND LIMB; THORACIC MOTONEURONS; SUBTYPE IDENTITY; CULTURED-CELLS; LUMBAR REGION; EXPRESSION; SPECIFICATION; PATTERNS	The homeobox gene Hb9, like its close relative MNR2, is expressed selectively by motor neurons (MNs) in the developing vertebrate CNS. In embryonic chick spinal cord, the ectopic expression of MNR2 or Hb9 is sufficient to trigger MN differentiation and to repress the differentiation of an adjacent population of V2 interneurons. Here, we provide genetic evidence that Hb9 has an essential role in MN differentiation. In mice lacking Hb9 function, MNs are generated on schedule and in normal numbers but transiently acquire molecular features of V2 interneurons. The aberrant specification of MN identity is associated with defects in the migration of MNs, the emergence of the subtype identities of MNs, and the projection of motor axons. These findings show that HB9 has an essential function in consolidating the identity of postmitotic MNs.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Tuluc, Petronel/C-2527-2011	Arber, Silvia/0000-0002-6261-250X				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Appel B, 1999, NEURON, V22, P3, DOI 10.1016/S0896-6273(00)80669-8; BARBER RP, 1991, J COMP NEUROL, V311, P509, DOI 10.1002/cne.903110406; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; Goulding M, 1998, NEURON, V21, P943, DOI 10.1016/S0896-6273(00)80612-1; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Lo LC, 1998, DEVELOPMENT, V125, P609; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; MARKHAM JA, 1991, J NEUROBIOL, V22, P811, DOI 10.1002/neu.480220803; MOMBAERTS P, 1996, CELL, V87, P657; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; OBRIEN MK, 1990, J NEUROBIOL, V21, P341, DOI 10.1002/neu.480210208; OBRIEN MK, 1990, J NEUROBIOL, V21, P313, DOI 10.1002/neu.480210207; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; WETTS R, 1995, DEV DYNAM, V202, P215, DOI 10.1002/aja.1002020302; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	41	459	471	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					659	674		10.1016/S0896-6273(01)80026-X	http://dx.doi.org/10.1016/S0896-6273(01)80026-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482234	hybrid			2022-12-24	WOS:000082280900011
J	Lumeng, C; Phelps, S; Crawford, GE; Walden, PD; Barald, K; Chamberlain, JS				Lumeng, C; Phelps, S; Crawford, GE; Walden, PD; Barald, K; Chamberlain, JS			Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases	NATURE NEUROSCIENCE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; CENTRAL-NERVOUS-SYSTEM; SKELETAL-MUSCLE SARCOLEMMA; NITRIC-OXIDE SYNTHASE; POSTSYNAPTIC DENSITY; PDZ DOMAINS; RAT-BRAIN; DEFICIENT MICE; PROTEIN	A screen for proteins that interact with beta 2-syntrophin led to the isolation of MAST205 (microtubule-associated serine/threonine kinase-205 kD) and a newly identified homologue, SAST (syntrophin-associated serine/threonine kinase). Binding studies showed that beta 2-syntrophin and MAST205/SAST associated via a PDZ-PDZ domain interaction. MAST205 colocalized with beta 2-syntrophin and utrophin at neuromuscular junctions. SAST colocalized with syntrophin in cerebral vasculature, spermatic acrosomes and neuronal processes. SAST and syntrophin were highly associated with purified microtubules and microtubule-associated proteins, whereas utrophin and dystrophin were only partially associated with microtubules. Our data suggest that MAST205 and SAST link the dystrophin/utrophin network with microtubule filaments via the syntrophins.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Gene Therapy, Ann Arbor, MI 48109 USA; NYU, Sch Med, Dept Urol, New York, NY 10016 USA; Univ Michigan, Sch Med, Dept Anat & Cell Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; New York University; University of Michigan System; University of Michigan	Chamberlain, JS (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	chamberl@umich.edu		Lumeng, Carey/0000-0003-0303-6204; Chamberlain, Jeffrey/0000-0001-5299-0059	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044533, P60AR020557] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60AR20557, AR44533] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Amalfitano Andrea, 1997, P1; BARALD KF, 1989, DEV BIOL, V135, P349, DOI 10.1016/0012-1606(89)90185-1; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1998, J NEUROSCI, V18, P8805; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; Crosbie RH, 1997, J BIOL CHEM, V272, P31221, DOI 10.1074/jbc.272.50.31221; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gee SH, 1998, J NEUROSCI, V18, P128; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; JASMIN BJ, 1990, NATURE, V344, P673, DOI 10.1038/344673a0; KAMAKURA K, 1994, J NEUROSCI RES, V37, P728, DOI 10.1002/jnr.490370607; KIM TW, 1992, P NATL ACAD SCI USA, V89, P11642, DOI 10.1073/pnas.89.23.11642; KIRSCH J, 1995, J NEUROSCI, V15, P4148; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; LIDOV HGW, 1993, NEUROSCIENCE, V54, P167, DOI 10.1016/0306-4522(93)90392-S; Lin JW, 1998, J NEUROSCI, V18, P2017; Lumeng CN, 1999, HUM MOL GENET, V8, P593, DOI 10.1093/hmg/8.4.593; MAN NT, 1991, J CELL BIOL, V115, P1695; Mummery R, 1996, J NEUROCHEM, V66, P2455; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SUNADA Y, 1995, CURR OPIN NEUROL, V8, P379, DOI 10.1097/00019052-199510000-00010; TALIAN JC, 1983, J CELL BIOL, V97, P1277, DOI 10.1083/jcb.97.4.1277; UCHINO M, 1994, MUSCLE NERVE, V17, P533, DOI 10.1002/mus.880170511; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; WAGNER KR, 1994, J NEUROCHEM, V62, P1947; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WALDEN PD, 1993, MOL CELL BIOL, V13, P7625, DOI 10.1128/MCB.13.12.7625; Walden PD, 1996, BIOL REPROD, V55, P1039, DOI 10.1095/biolreprod55.5.1039; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Zimmerman CM, 1996, BIOCHEM SOC SYMP, P25	48	129	137	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					611	617		10.1038/10165	http://dx.doi.org/10.1038/10165			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404183				2022-12-24	WOS:000083882600011
J	Wu, MN; Fergestad, T; Lloyd, TE; He, YC; Broadie, K; Bellen, HJ				Wu, MN; Fergestad, T; Lloyd, TE; He, YC; Broadie, K; Bellen, HJ			Syntaxin 1A interacts with multiple exocytic proteins to regulate neurotransmitter release in vivo	NEURON			English	Article							SYNAPTIC VESICLE FUSION; SQUID GIANT SYNAPSE; N-TERMINAL DOMAIN; CALCIUM CHANNELS; MEMBRANE-FUSION; CA2+ CHANNELS; T-SNARE; SEC1 HOMOLOG; CORE COMPLEX; DROSOPHILA	Biochemical studies suggest that syntaxin 1A participates in multiple protein-protein interactions in the synaptic terminal, but the in vivo significance of these interactions is poorly understood. We used a targeted mutagenesis approach to eliminate specific syntaxin binding interactions and demonstrate that Drosophila syntaxin 1A plays multiple regulatory roles in neurotransmission in vivo. Syntaxin mutations that eliminate ROP/Munc-18 binding display increased neurotransmitter release, suggesting that ROP inhibits neurosecretion through its interaction with syntaxin. Syntaxin mutations that block Ca2+ channel binding also cause an increase in neurotransmitter release, suggesting that syntaxin normally functions in inhibiting Ca2+ channel opening. Additionally, we identify and characterize a syntaxin Ca2+ effector domain, which may spatially organize the Ca2+ channel, cysteine string protein, and synaptotagmin for effective excitation-secretion coupling in the presynaptic terminal.	Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA.			Lloyd, Thomas/0000-0003-4756-3700; Bellen, Hugo/0000-0001-5992-5989	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54544] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIAS AM, 1993, DEV DROSOPHILA MELAN, P517; ASHBURNER M, 1990, DROSOPHILA LAB HDB; ASSUBEL F, 1996, CURRENT PROTOCOLS MO, V5; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Betz A, 1997, J BIOL CHEM, V272, P2520; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROWN KA, 1993, P NATL ACAD SCI USA, V90, P11753, DOI 10.1073/pnas.90.24.11753; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Dresbach T, 1998, J NEUROSCI, V18, P2923; FERGESTAD T, 1999, IN PRESS J NEUROSCI; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P17386, DOI 10.1021/bi981369s; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GRINNELL AD, 1989, J PHYSIOL-LONDON, V418, P397, DOI 10.1113/jphysiol.1989.sp017848; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; Jahn R, 1998, NATURE, V393, P14, DOI 10.1038/29871; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; KIDOKORO Y, 1994, NEUROSCI RES, V19, P143, DOI 10.1016/0168-0102(94)90137-6; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; LOSAVIO L, 1997, AM J PHYSIOL, V273, pC1835; Marsal J, 1997, P NATL ACAD SCI USA, V94, P14871, DOI 10.1073/pnas.94.26.14871; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rettig J, 1997, J NEUROSCI, V17, P6647; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Schulze KL, 1996, GENETICS, V144, P1713; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stimson DT, 1998, J NEUROSCI, V18, P9638; Sugimori M, 1998, NEUROSCIENCE, V86, P39, DOI 10.1016/S0306-4522(97)00689-1; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Umbach JA, 1998, J NEUROSCI, V18, P3233; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	69	173	174	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					593	605		10.1016/S0896-6273(00)80811-9	http://dx.doi.org/10.1016/S0896-6273(00)80811-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433270	Bronze			2022-12-24	WOS:000081701000022
J	Burstyn-Cohen, T; Tzarfaty, V; Frumkin, A; Feinstein, Y; Stoeckli, E; Klar, A				Burstyn-Cohen, T; Tzarfaty, V; Frumkin, A; Feinstein, Y; Stoeckli, E; Klar, A			F-spondin is required for accurate pathfinding of commissural axons at the floor plate	NEURON			English	Article							GROWTH CONE GUIDANCE; SPINAL-CORD; C-ELEGANS; NERVOUS-SYSTEM; CNS MIDLINE; MOTOR AXONS; DROSOPHILA; PROTEINS; OUTGROWTH; ENCODES	The commissural axons project toward and across the floor plate. They then turn into the longitudinal axis, extending along the contralateral side of the floor plate. F-spondin, a protein produced and secreted by the floor plate, promotes adhesion and neurite extension of commissural neurons in vitro. Injection of purified F-spondin protein into the lumen of the spinal cord of chicken embryos in ovo resulted in longitudinal turning of commissural axons before reaching the floor plate, whereas neutralizing antibody (Ab) injections caused lateral turning at the contralateral floor plate boundary. These combined in vitro and in vivo results suggest that F-spondin is required to prevent the lateral drifting of the commissural axons after having crossed the floor plate.	Hebrew Univ Jerusalem, Dept Anat & Cell Biol, Hadassah Med Sch, IL-91120 Jerusalem, Israel; Univ Basel, Dept Integrat Biol, CH-4051 Basel, Switzerland	Hebrew University of Jerusalem; University of Basel	Klar, A (corresponding author), Hebrew Univ Jerusalem, Dept Anat & Cell Biol, Hadassah Med Sch, IL-91120 Jerusalem, Israel.	avihu@cc.huji.ac.il	Burstyn-Cohen, Tal/K-8846-2012; Klar, Avihu/AHC-4770-2022; Burstyn-Cohen, Tal/A-2848-2011	Burstyn-Cohen, Tal/0000-0002-2324-2921; Stoeckli, Esther/0000-0002-8485-0648				Bagnard D, 1998, DEVELOPMENT, V125, P5043; BERNHARDT RR, 1992, NEURON, V8, P869, DOI 10.1016/0896-6273(92)90201-N; BORNSTEIN P, 1991, J BIOL CHEM, V266, P12821; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; BOVOLENTA P, 1991, DEVELOPMENT, V113, P625; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burstyn-Cohen T, 1998, J NEUROSCI, V18, P8875; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Debby-Brafman A, 1999, NEURON, V22, P475, DOI 10.1016/S0896-6273(00)80703-5; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEINSTEIN Y, 1999, IN PRESS DEVELOPMENT; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; HOLLEY JA, 1987, DEV BIOL, V123, P375, DOI 10.1016/0012-1606(87)90396-4; IALTABA AR, 1993, P NATL ACAD SCI USA, V90, P8268; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; KLAR A, 1992, COLD SPRING HARB SYM, V57, P473, DOI 10.1101/SQB.1992.057.01.052; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Siegal, 1956, NONPARAMETRIC STAT B; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Umemiya T, 1997, DEV BIOL, V186, P165, DOI 10.1006/dbio.1997.8591; YAGINUMA H, 1991, J COMP NEUROL, V304, P78, DOI 10.1002/cne.903040107; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	48	101	105	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1999	23	2					233	246		10.1016/S0896-6273(00)80776-X	http://dx.doi.org/10.1016/S0896-6273(00)80776-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399931	Green Accepted, Bronze			2022-12-24	WOS:000081218600010
J	Francis, F; Koulakoff, A; Boucher, D; Chafey, P; Schaar, B; Vinet, MC; Friocourt, G; McDonnell, N; Reiner, O; Kahn, A; McConnell, SK; Berwald-Netter, Y; Denoulet, P; Chelly, J				Francis, F; Koulakoff, A; Boucher, D; Chafey, P; Schaar, B; Vinet, MC; Friocourt, G; McDonnell, N; Reiner, O; Kahn, A; McConnell, SK; Berwald-Netter, Y; Denoulet, P; Chelly, J			Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons	NEURON			English	Article							SUBCORTICAL LAMINAR HETEROTOPIA; DEVELOPING CEREBRAL-CORTEX; DIEKER LISSENCEPHALY GENE; GRANULE CELL-MIGRATION; MOUSE-BRAIN NEURONS; BETA-TUBULIN; ALPHA-TUBULIN; TAU-PROTEIN; ENCODES; REELER	Recently, we and others reported that the doublecortin gene is responsible for X-linked lissencephaly and subcortical laminar heterotopia. Here, we show that Doublecortin is expressed in the brain throughout the period of corticogenesis in migrating and differentiating neurons. Immunohistochemical studies show its localization in the soma and leading processes of tangentially migrating neurons, and a strong axonal labeling is observed in differentiating neurons. In cultured neurons, Doublecortin expression is highest in the distal parts of developing processes. We demonstrate by sedimentation and microscopy studies that Doublecortin is associated with microtubules (MTs) and postulate that it is a novel MAP. Our data suggest that the cortical dysgeneses associated with the loss of Doublecortin function might result from abnormal cytoskeletal dynamics in neuronal cell development.	Inst Cochin Genet Mol, INSERM, U129, F-75014 Paris, France; Coll France, CNRS, UPR 9065, Biochim Cellulaire Lab, F-75005 Paris, France; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Stanford University; Weizmann Institute of Science	Francis, F (corresponding author), Inst Cochin Genet Mol, INSERM, U129, 24 Rue Faubourg St Jacques, F-75014 Paris, France.		Reiner, Orly/E-9455-2010; Friocourt-Masse, Gaelle/M-8916-2017; Francis, Fiona/B-5854-2016	Reiner, Orly/0000-0001-7560-9599; Francis, Fiona/0000-0001-8542-7537; Friocourt, Gaelle/0000-0001-6681-7644	NIMH NIH HHS [MH51864] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051864] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; AUDEBERT S, 1994, J CELL SCI, V107, P2313; BAAS PW, 1994, J CELL SCI, V107, P135; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BERWALDNETTER Y, 1981, P NATL ACAD SCI-BIOL, V78, P1245, DOI 10.1073/pnas.78.2.1245; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; CAVINESS VS, 1997, NORMAL ABNORMAL DEV, P1; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; des Portes V, 1998, CELL, V92, P51; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Ferhat L, 1998, J NEUROSCI, V18, P7822; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; GORDONWEEKS PR, 1991, BIOESSAYS, V13, P235, DOI 10.1002/bies.950130506; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Harding B, 1996, DYSPLASIAS OF CEREBRAL CORTEX AND EPILEPSY, P81; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; KOMURO H, 1995, J NEUROSCI, V15, P1110; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; NOWAK L, 1987, J NEUROSCI, V7, P101; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PINARD JM, 1994, J NEUROL NEUROSUR PS, V57, P914, DOI 10.1136/jnnp.57.8.914; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; RIVAS RJ, 1995, J NEUROSCI, V15, P981; SAPIR T, 1997, EMBO J, V16, P101; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; WARE ML, 1997, NEURON, V19, P1; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	51	798	830	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					247	256		10.1016/S0896-6273(00)80777-1	http://dx.doi.org/10.1016/S0896-6273(00)80777-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399932	Bronze			2022-12-24	WOS:000081218600011
J	Steinhauer, K; Alter, K; Friederici, AD				Steinhauer, K; Alter, K; Friederici, AD			Brain potentials indicate immediate use of prosodic cues in natural speech processing	NATURE NEUROSCIENCE			English	Article							EYE-MOVEMENTS; GARDEN-PATH; SENTENCES; COMPREHENSION; INFORMATION; ATTACHMENT; LANGUAGE; CONTEXT	Spoken language, in contrast to written text, provides prosodic information such as rhythm, pauses, accents, amplitude and pitch variations. However, little is known about when and how these features are used by the listener to interpret the speech signal. Here we use event-related brain potentials (ERP) to demonstrate that intonational phrasing guides the initial analysis of sentence structure. Our finding of a positive shift in the ERP at intonational phrase boundaries suggests a specific on-line brain response to prosodic processing. Additional ERP components indicate that a false prosodic boundary is sufficient to mislead the listener's sentence processor. Thus, the application of ERP measures is a promising approach for revealing the time course and neural basis of prosodic information processing.	Max Planck Inst Cognit Neurosci, Dept Neuropsychol, D-04303 Leipzig, Germany	Max Planck Society	Steinhauer, K (corresponding author), Max Planck Inst Cognit Neurosci, Dept Neuropsychol, POB 500 355, D-04303 Leipzig, Germany.	steinhau@cns.mpg.de	Steinhauer, Karsten/B-2863-2008; lee, yujun/P-6069-2014	lee, yujun/0000-0002-5821-7355; Alter, Kai/0000-0003-4575-9494				ALTMANN GTM, 1992, J MEM LANG, V31, P685, DOI 10.1016/0749-596X(92)90035-V; BADER M, IN PRESS REANALYSIS; Beckman ME, 1996, LANG COGNITIVE PROC, V11, P17, DOI 10.1080/016909696387213; Blumstein Sheila E., 1995, P915; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Fodor JD, 1998, J PSYCHOLINGUIST RES, V27, P285, DOI 10.1023/A:1023258301588; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; FRAZIER L, 1987, ATTENTION PERFORM, V12, P559; Friederici AD, 1998, BIOL PSYCHOL, V47, P193, DOI 10.1016/S0301-0511(97)00033-1; FRIEDERICI AD, 1995, BRAIN LANG, V50, P259, DOI 10.1006/brln.1995.1048; FRIEDERICI AD, IN PRESS MEM COGN; FRIEDMAN D, 1975, ELECTROEN CLIN NEURO, V38, P255, DOI 10.1016/0013-4694(75)90246-1; GERNSBACHER MA, 1995, COGNITIVE PSYCHOL, V29, P24, DOI 10.1006/cogp.1995.1011; Hagoort P., 1995, HDB NEUROPSYCHOL, V10, P105; Halle Morris, 1987, AN ESSAY ON STRESS; HOLCOMB PJ, 1991, PSYCHOBIOLOGY, V19, P286; Hopf JM, 1998, J COGNITIVE NEUROSCI, V10, P264, DOI 10.1162/089892998562690; Huynh H., 1970, J AM STAT ASSOC, V65, P1582, DOI DOI 10.1080/01621459.1970.10481187; Keppel G, 1991, DESIGN ANAL RES HDB; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M., 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; MARSLENWILSON WD, 1992, Q J EXP PSYCHOL-A, V45, P73, DOI 10.1080/14640749208401316; Nespor Marina, 1986, PROSODIC PHONOLOGY; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1993, LANG COGNITIVE PROC, V8, P413, DOI 10.1080/01690969308407584; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; OSTERHOUT L, 1998, IN PRESS LANG COGN P; Osterhout L, 1995, ELECTROPHYSIOLOGY MI; Regan D., 1989, HUMAN BRAIN ELECTROP; ROSLER F, 1993, J COGNITIVE NEUROSCI, V5, P345, DOI 10.1162/jocn.1993.5.3.345; Rossi FMV, 1997, MOL BIOL CELL, V8, P699; Selkirk Elisabeth, 1984, PHONOLOGY SYNTAX REL; Stirling L, 1996, LANG COGNITIVE PROC, V11, P193, DOI 10.1080/016909696387268; SWAAB TY, 1996, FUNCTIONAL LOCUS COM; TARABAN R, 1988, J MEM LANG, V27, P597, DOI 10.1016/0749-596X(88)90011-3; VANPETTEN C, 1991, MEM COGNITION, V19, P95, DOI 10.3758/BF03198500; WARREN P, 1995, LANG COGNITIVE PROC, V10, P457, DOI 10.1080/01690969508407112	37	327	338	7	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					191	196		10.1038/5757	http://dx.doi.org/10.1038/5757			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	160LF	10195205				2022-12-24	WOS:000078231600020
J	Chiang, MY; Misner, D; Kempermann, G; Schikorski, T; Giguere, V; Sucov, HM; Gage, FH; Stevens, CF; Evans, RM				Chiang, MY; Misner, D; Kempermann, G; Schikorski, T; Giguere, V; Sucov, HM; Gage, FH; Stevens, CF; Evans, RM			An essential role for retinoid receptors RAR beta and RXR gamma in long-term potentiation and depression	NEURON			English	Article							PAIRED-PULSE FACILITATION; II MUTANT MICE; SYNAPTIC PLASTICITY; ACID RECEPTORS; BINDING-PROTEINS; CA1 REGION; DIFFERENTIAL PATTERN; NEUROTROPHIC FACTOR; MOUSE EMBRYOS; WATER-MAZE	Hippocampal long-term potentiation (LTP) and longterm depression (LTD) are the most widely studied forms of synaptic plasticity thought to underlie spatial learning and memory. We report here that RAR beta deficiency in mice virtually eliminates hippocampal CA1 LTP and LTD. It also results in substantial performance deficits in spatial learning and memory tasks. Surprisingly, RXR gamma null mice exhibit a distinct phenotype in which LTD is lost whereas LTP is normal. Thus, while retinoid receptors contribute to both LTP and LTD, they do so in different ways. These findings not only genetically uncouple LTP and LTD but also reveal a novel and unexpected role for vitamin A in higher cognitive functions.	Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, San Diego, CA 92138 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, San Diego, CA 92138 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; McGill Univ, Dept Biochem, Mol Oncol Grp, Royal Victoria Hosp, Montreal, PQ H3A 181, Canada; McGill Univ, Dept Med, Mol Oncol Grp, Royal Victoria Hosp, Montreal, PQ H3A 181, Canada; McGill Univ, Dept Oncol, Mol Oncol Grp, Royal Victoria Hosp, Montreal, PQ H3A 181, Canada; Univ So Calif, Sch Med, Inst Med Genet, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; University of Southern California	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, San Diego, CA 92138 USA.	evans@salk.edu	Evans, Ronald/AAF-4001-2019; Kempermann, Gerd/F-5416-2010	Evans, Ronald/0000-0002-9986-5965; Kempermann, Gerd/0000-0002-5304-4061; Schikorski, Thomas/0000-0003-3902-2461; Sucov, Henry/0000-0002-3792-3795; Giguere, Vincent/0000-0001-9567-3694	NICHD NIH HHS [HD 21783] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; CHRISTIE BR, 1992, NEURON, V9, P79, DOI 10.1016/0896-6273(92)90222-Y; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DOLLE P, 1990, DEVELOPMENT, V110, P1133; DOLLE P, 1994, MECH DEVELOP, V45, P91, DOI 10.1016/0925-4773(94)90023-X; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Grondona JM, 1996, DEVELOPMENT, V122, P2173; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; Kandel E.R., 1991, PRINC NEUROSCI; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kastner P, 1997, DEVELOPMENT, V124, P313; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; LI E, 1993, P NATL ACAD SCI USA, V90, P1590, DOI 10.1073/pnas.90.4.1590; LINDNER MD, 1988, BEHAV NEUROSCI, V102, P621, DOI 10.1037/0735-7044.102.5.621; Lindner MD, 1997, COGNITIVE BRAIN RES, V5, P329, DOI 10.1016/S0926-6410(97)00006-2; LUO JM, 1995, MECH DEVELOP, V53, P61, DOI 10.1016/0925-4773(95)00424-6; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Mangelsdorf David J., 1994, P319; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1992, RETINOLD RECEPTORS T; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; RUBERTE E, 1991, DEVELOPMENT, V111, P45; RUBERTE E, 1993, DEVELOPMENT, V118, P267; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Sommer A., 1982, NUTR BLINDNESS XEROP; Sporn M.B., 1994, RETINOIDS BIOL CHEM; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; WEXLER EM, 1993, NEUROREPORT, V4, P591, DOI 10.1097/00001756-199305000-00034; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YAMAGATA T, 1994, DEV BRAIN RES, V77, P163, DOI 10.1016/0165-3806(94)90193-7; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	58	266	275	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1353	1361		10.1016/S0896-6273(00)80654-6	http://dx.doi.org/10.1016/S0896-6273(00)80654-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883728	Bronze			2022-12-24	WOS:000077910600017
J	Giger, RJ; Urquhart, ER; Gillespie, SKH; Levengood, DV; Ginty, DD; Kolodkin, AL				Giger, RJ; Urquhart, ER; Gillespie, SKH; Levengood, DV; Ginty, DD; Kolodkin, AL			Neuropilin-2 is a receptor for semaphorin IV: Insight into the structural basis of receptor function and specificity	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; CELL-SURFACE MOLECULE; LUNG-CANCER; AXON GUIDANCE; MAM DOMAIN; REGION; EXPRESSION; FAMILY	Neuropilins bind secreted members of the semaphorin family of proteins. Neuropilin-1 is a receptor for Sema III. Here, we show that neuropilin-2 is a receptor for the secreted semaphorin Sema IV and acts selectively to mediate repulsive guidance events in discrete populations of neurons, neoropilin-2 and semaIV are expressed in strikingly complementary patterns during neurodevelopment. The extracellular complement-binding (CUB) and coagulation factor domains of neuropilin-2 confer specificity to the Sema IV repulsive response, and these domains of neuropilin-1 are necessary and sufficient for binding of the Sema III semaphorin (sema) domain. The coagulation factor domains alone are necessary and sufficient for binding of the Sema III immunoglobulin- (Ig-) basic domain and the unrelated ligand, vascular endothelial growth factor (VEGF). Lastly, neuropilin-1 can homomultimerize and form heteromultimers with neuropilin-2. These results provide insight into how interactions between neuropilins and secreted semaphorins function to coordinate repulsive axon guidance during neurodevelopment.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.				NIMH NIH HHS [R01MH59199] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Bargmann CI, 1997, CELL, V90, P585, DOI 10.1016/S0092-8674(00)80518-8; Chedotal A, 1998, DEVELOPMENT, V125, P4313; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fujisawa H, 1997, CELL TISSUE RES, V290, P465, DOI 10.1007/s004410050954; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; HE S, 1997, CELL, V90, P739; KAWAKAMI A, 1995, J NEUROBIOL, V29, P1; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kolodkin AL, 1997, NEURON, V19, P1159, DOI 10.1016/S0896-6273(00)80408-0; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Koppel AM, 1998, J BIOL CHEM, V273, P15708, DOI 10.1074/jbc.273.25.15708; Lierheimer R, 1997, EUR J BIOCHEM, V243, P502, DOI 10.1111/j.1432-1033.1997.0502a.x; Marchand P, 1996, J BIOL CHEM, V271, P24236, DOI 10.1074/jbc.271.39.24236; Mark MD, 1997, CELL TISSUE RES, V290, P299, DOI 10.1007/s004410050934; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Roche J, 1996, ONCOGENE, V12, P1289; SATODA M, 1995, J NEUROSCI, V15, P942; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Xiang RH, 1996, GENOMICS, V32, P39, DOI 10.1006/geno.1996.0074; ZONDAG GCM, 1995, J BIOL CHEM, V270, P14247, DOI 10.1074/jbc.270.24.14247	31	302	309	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1079	1092		10.1016/S0896-6273(00)80625-X	http://dx.doi.org/10.1016/S0896-6273(00)80625-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856463	hybrid			2022-12-24	WOS:000077386100018
J	Lee, HK; Kameyama, K; Huganir, RL; Bear, MF				Lee, HK; Kameyama, K; Huganir, RL; Bear, MF			NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; AREA CA1; POTENTIATION; INDUCTION; PHOSPHORYLATION; NEURONS; CALCIUM; PLASTICITY	Brief bath application of N-methyl-D-aspartate (NMDA) to hippocampal slices produces long-term synaptic depression (LTD) in CA1 that is (1) sensitive to postnatal age, (2) saturable, (3) induced postsynaptically, (4) reversible, and (5) not associated with a change in paired pulse facilitation. Chemically induced LTD (Chem-LTD) and homosynaptic LTD are mutually occluding, suggesting a common expression mechanism. Using phosphorylation site-specific antibodies, we found that induction of chem-LTD produces a persistent dephosphorylation of the GluR1 subunit of AMPA receptors at serine 845, a cAMP-dependent protein kinase (PKA) substrate, but not at serine 831, a substrate of protein kinase C (PKC) and calcium/calmodulin-dependent protein kinase II (CaMKII). These results suggest that dephosphorylation of AMPA receptors is an expression mechanism for LTD and indicate an unexpected role of PKA in the postsynaptic modulation of excitatory synaptic transmission.	Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Brown University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University	Bear, MF (corresponding author), Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA.			Lee, Hey-Kyoung/0000-0002-5554-983X; Bear, Mark/0000-0002-9903-2541				Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUBER KM, 1995, J NEUROPHYSIOL, V73, P270, DOI 10.1152/jn.1995.73.1.270; ITO I, 1991, NEUROSCI LETT, V121, P1119; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu YM, 1996, J NEUROSCI, V16, P5457; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PETIT D, 1994, SCIENCE, V266, P1881; Pizzi M, 1996, EUR J NEUROSCI, V8, P1516, DOI 10.1111/j.1460-9568.1996.tb01614.x; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SCHURR A, 1995, J NEUROSCI METH, V59, P129, DOI 10.1016/0165-0270(94)00203-S; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Wenthold RJ, 1996, J NEUROSCI, V16, P1982	55	515	523	1	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1151	1162		10.1016/S0896-6273(00)80632-7	http://dx.doi.org/10.1016/S0896-6273(00)80632-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856470	hybrid			2022-12-24	WOS:000077386100025
J	Jiang, YH; Armstrong, D; Albrecht, U; Atkins, CM; Noebels, JL; Eichele, G; Sweatt, JD; Beaudet, AL				Jiang, YH; Armstrong, D; Albrecht, U; Atkins, CM; Noebels, JL; Eichele, G; Sweatt, JD; Beaudet, AL			Mutation of the angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; APLYSIA SENSORY NEURONS; CONJUGATING ENZYME; PERSISTENT ACTIVATION; MAINTENANCE PHASE; E6 ONCOPROTEIN; SYNDROME GENE; PRADER-WILLI; HIPPOCAMPUS; UBE3A	The E6-AP ubiquitin ligase (human/mouse gene UBE3A/Ube3a) promotes the degradation of p53 in association with papilloma E6 protein, and maternal deficiency causes human Angelman syndrome (AS). Ube3a is imprinted with silencing of the paternal allele in hippocampus and cerebellum in mice. We found that the phenotype of mice with maternal deficiency (m-/p+) for Ube3a resembles human AS with motor dysfunction, inducible seizures, and a context-dependent learning deficit. Long-term potentiation (LTP) was severely impaired in m-/p+ mice despite normal base-line synaptic transmission and neuroanatomy, indicating that ubiquitination may play a role in mammalian LTP and that LTP may be abnormal in AS. The cytoplasmic abundance of p53 was increased in postmitotic neurons in m-/p+ mice and in AS, providing a potential biochemical basis for the phenotype through failure to ubiquitinate and degrade various effecters.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	abeaudet@bcm.tmc.edu	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Atkins, Coleen/0000-0003-4718-7493; Sweatt, J. David/0000-0003-3567-485X; Noebels, Jeffrey/0000-0002-2887-0839	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-57014] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BeerRomero P, 1997, ONCOGENE, V14, P595, DOI 10.1038/sj.onc.1200872; BERGOLD PJ, 1992, NEURON, V8, P387, DOI 10.1016/0896-6273(92)90304-V; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; CHAIN DG, 1995, J NEUROSCI, V15, P7592; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Clark HB, 1997, J NEUROSCI, V17, P7385; Daniels PR, 1998, J GEN VIROL, V79, P489, DOI 10.1099/0022-1317-79-3-489; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Glenn CC, 1997, MOL HUM REPROD, V3, P321, DOI 10.1093/molehr/3.4.321; Harbers K, 1996, P NATL ACAD SCI USA, V93, P12412, DOI 10.1073/pnas.93.22.12412; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Horsthemke B, 1997, HUM MUTAT, V10, P329, DOI 10.1002/(SICI)1098-1004(1997)10:5<329::AID-HUMU1>3.3.CO;2-Y; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; KLANN E, 1991, J BIOL CHEM, V266, P24253; KO LJ, 1998, GENE DEV, V10, P1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; McNish KA, 1997, J NEUROSCI, V17, P9353; Minassian BA, 1998, ANN NEUROL, V43, P485, DOI 10.1002/ana.410430412; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; OH CE, 1994, J NEUROSCI, V14, P3166; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Piette J, 1997, ONCOGENE, V15, P1001, DOI 10.1038/sj.onc.1201432; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; POWELL CM, 1994, J BIOL CHEM, V269, P27958; ROBB SA, 1989, ARCH DIS CHILD, V64, P83, DOI 10.1136/adc.64.1.83; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; SAITOH S, 1994, AM J MED GENET, V52, P158, DOI 10.1002/ajmg.1320520207; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SHAULSKY G, 1991, ONCOGENE, V6, P2055; SHAULSKY G, 1990, ONCOGENE, V5, P1707; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Vicari EM, 1951, J PSYCHOL, V32, P79, DOI 10.1080/00223980.1951.9916086; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617; Zhen M, 1996, EMBO J, V15, P3229, DOI 10.1002/j.1460-2075.1996.tb00687.x	69	635	653	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					799	811		10.1016/S0896-6273(00)80596-6	http://dx.doi.org/10.1016/S0896-6273(00)80596-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808466	Bronze			2022-12-24	WOS:000076697300023
J	Futatsugi, A; Kato, K; Ogura, H; Li, ST; Nagata, E; Kuwajima, G; Tanaka, K; Itohara, S; Mikoshiba, K				Futatsugi, A; Kato, K; Ogura, H; Li, ST; Nagata, E; Kuwajima, G; Tanaka, K; Itohara, S; Mikoshiba, K			Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; RAT HIPPOCAMPAL SLICES; GYRUS IN-VITRO; SYNAPTIC PLASTICITY; SKELETAL-MUSCLE; DENTATE GYRUS; CA2+ RELEASE; AUTORADIOGRAPHIC ANALYSIS	To evaluate the role in synaptic plasticity of ryanodine receptor type 3 (RyR3), which is normally enriched in hippocampal area CA1, we generated RyR3-deficient mice. Mutant mice exhibited facilitated CA1 long-term potentiation (LTP) induced by short tetanus (100 Hz, 100 ms) stimulation. Unlike LTP in wild-type mice, this LTP was not blocked by the NMDA receptor antagonist D-APS but was partially dependent on L-type voltage-dependent Ca2+ channels (VDCCs) and metabotropic glutamate receptors (mGluRs). Long-term depression (LTD) was not induced in RyR3-deficient mice. RyR3-deficient mice also exhibited improved spatial learning on a Morris water maze task. These results suggest that in wild-type mice, in contrast to the excitatory role of Ca2+ influx, RyR3-mediated intracellular Ca2+ ([Ca2+]) release from endoplasmic reticulum (ER) may inhibit hippocampal LTP and spatial learning.	Japan Sci & Technol Corp, Mikoshiba Calciosignal Net Project, Exploratory Res Adv Technol, Bunkyo Ku, Tokyo 1130021, Japan; Shionogi & Co Ltd, Shionogi Inst Med Sci, Settsu, Osaka 5660022, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3002635, Japan; Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan; RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	Japan Science & Technology Agency (JST); Shionogi & Company Limited; University of Tokyo; Eisai Co Ltd; Keio University; RIKEN; RIKEN	Kato, K (corresponding author), Japan Sci & Technol Corp, Mikoshiba Calciosignal Net Project, Exploratory Res Adv Technol, Bunkyo Ku, 2-28-8 Honkomagome, Tokyo 1130021, Japan.		Mikoshiba, Katsuhiko/N-7943-2015; Itohara, Shigeyoshi/I-8769-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Li, Sheng Tian/0000-0002-2836-3802				ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bertocchini F, 1997, EMBO J, V16, P6956, DOI 10.1093/emboj/16.23.6956; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; COLLINGRIDGE G, 1987, NATURE, V330, P604, DOI 10.1038/330604a0; Coussens CM, 1996, SYNAPSE, V24, P97, DOI 10.1002/(SICI)1098-2396(199610)24:2<97::AID-SYN1>3.0.CO;2-9; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; CUMMINGS JA, 1994, NEUROSCI LETT, V176, P110, DOI 10.1016/0304-3940(94)90883-4; DIANA G, 1995, BRAIN RES, V686, P107, DOI 10.1016/0006-8993(95)00440-2; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; ELLISMAN MH, 1990, NEURON, V5, P135, DOI 10.1016/0896-6273(90)90304-X; FURUICHI T, 1994, J NEUROSCI, V14, P4794; Gage AT, 1997, HIPPOCAMPUS, V7, P286; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HARVEY J, 1992, NEUROSCI LETT, V139, P197, DOI 10.1016/0304-3940(92)90551-H; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ikemoto T, 1997, J PHYSIOL-LONDON, V501, P305, DOI 10.1111/j.1469-7793.1997.305bn.x; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; KOHDA K, 1995, J NEUROPHYSIOL, V74, P2184, DOI 10.1152/jn.1995.74.5.2184; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murayama T, 1996, J BIOL CHEM, V271, P5079; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; NAKANISHI S, 1992, NEUROSCI RES, V15, P130, DOI 10.1016/0168-0102(92)90026-9; NORI A, 1993, BIOCHEM J, V291, P199, DOI 10.1042/bj2910199; OBENAUS A, 1989, NEUROSCI LETT, V98, P172, DOI 10.1016/0304-3940(89)90505-3; OMARA SM, 1995, NEUROSCIENCE, V68, P621, DOI 10.1016/0306-4522(95)00233-9; OUYANG Y, 1993, BRAIN RES, V620, P269, DOI 10.1016/0006-8993(93)90165-J; PADUA RA, 1991, BRAIN RES, V542, P135, DOI 10.1016/0006-8993(91)91007-N; Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238; REYNES M, 1996, J NEUROSCI, V16, P5951; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; TANAKA K, 1991, J CEREBR BLOOD F MET, V11, P283, DOI 10.1038/jcbfm.1991.60; TANAKA K, 1988, BRAIN RES BULL, V21, P693, DOI 10.1016/0361-9230(88)90210-9; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812; Wang Y, 1996, J PHYSIOL-LONDON, V495, P755, DOI 10.1113/jphysiol.1996.sp021631; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918	57	149	154	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					701	713		10.1016/S0896-6273(00)81123-X	http://dx.doi.org/10.1016/S0896-6273(00)81123-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595520	Bronze			2022-12-24	WOS:000083913000024
J	Wiese, S; Digby, MR; Gunnersen, JM; Gotz, R; Pei, G; Holtmann, B; Lowenthal, J; Sendtner, M				Wiese, S; Digby, MR; Gunnersen, JM; Gotz, R; Pei, G; Holtmann, B; Lowenthal, J; Sendtner, M			The anti-apoptotic protein ITA is essential for NGF-mediated survival of embryonic chick neurons	NATURE NEUROSCIENCE			English	Article							TROPHIC FACTOR DEPRIVATION; SYMPATHETIC NEURONS; CELL-DEATH; CYTOCHROME-C; IAP GENES; CASPASES; FAMILY; BAX; SUFFICIENT; INHIBITORS	The avian ITA is homologous to the baculoviral and mammalian inhibitor of apoptosis (IAP) proteins, which can prevent apoptosis by inhibition of specific caspases. We investigated the role of ITA in embryonic chick sympathetic and dorsal root ganglionic neurons, which depend on nerve growth factor (NGF) for their survival. Within 6 hours, NGF upregulated ITA protein production more than 25-fold in sensory and sympathetic neurons. Overexpression of ITA in primary neurons supported survival of these cells in the absence of NGF, and ita antisense constructs inhibited NGF-mediated survival. Thus the induction of ITA expression seems to be an essential signaling event for survival of sympathetic and dorsal root ganglionic sensory neurons in response to NGF.	Univ Wuerzburg, Dept Neurol, Klin Forschergrp Neuroregenerat, D-97080 Wuerzburg, Germany; CSIRO, Div Anim Hlth, Geelong, Vic 3220, Australia	University of Wurzburg; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sendtner, M (corresponding author), Univ Wuerzburg, Dept Neurol, Klin Forschergrp Neuroregenerat, Josef Schneider Str 11, D-97080 Wuerzburg, Germany.		Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014; lowenthal, john w/G-4459-2010	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; lowenthal, john w/0000-0002-0548-2497; Gunnersen, Jenny/0000-0002-6310-7724				BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Clem RJ, 1997, TRENDS CELL BIOL, V7, P337, DOI 10.1016/S0962-8924(97)01088-X; Crowder RJ, 1998, J NEUROSCI, V18, P2933; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Digby MR, 1996, DNA CELL BIOL, V15, P981, DOI 10.1089/dna.1996.15.981; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Newmeyer DD, 1998, NEURON, V21, P653, DOI 10.1016/S0896-6273(00)80580-2; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; SENDTNER M, 1988, J NEUROSCI, V8, P458; Simons M, 1999, J NEUROCHEM, V72, P292, DOI 10.1046/j.1471-4159.1999.0720292.x; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974	28	59	60	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					978	983		10.1038/14777	http://dx.doi.org/10.1038/14777			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526336				2022-12-24	WOS:000083883300014
J	Neitz, J; Neitz, M; He, JC; Shevell, SK				Neitz, J; Neitz, M; He, JC; Shevell, SK			Trichromatic color vision with only two spectrally distinct photopigments	NATURE NEUROSCIENCE			English	Article							DEUTERANOMALOUS TRICHROMATS; ABSORPTION-SPECTRA; MOLECULAR-GENETICS; CONE PIGMENTS; GENES; RED; GREEN; DISCRIMINATION	Protanomaly is a common, X-linked abnormality of color vision. Like people with normal color vision, protanomalous observers are trichromatic, but their ability to discriminate colors in the red-green part of the spectrum is reduced because the photopigments that mediate discrimination in this range are abnormally similar. Whereas normal subjects have pigments whose wavelengths of peak sensitivity differ by about 30 nm, the peak wavelengths for protanomalous observers are thought to differ by only a few nanometers. We found, however, that although this difference occurred in some protanomalous subjects, others had pigments whose peak wavelengths were identical. Genetic and psychophysical results from the latter class indicated that limited red-green discrimination can be achieved with pigments that have the same peak wavelength sensitivity and that differ only in optical density. A single amino acid substitution was correlated with trichromacy in these subjects, suggesting that differences in pigment sequence may regulate the optical density of the cone.	Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; Univ Chicago, Dept Ophthalmol & Visual Sci, Chicago, IL 60637 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Chicago; University of Chicago	Neitz, J (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.			Neitz, Jay/0000-0003-3877-6712; Neitz, Maureen/0000-0002-5404-3343				ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; HE JC, 1995, VISION RES, V35, P2579, DOI 10.1016/0042-6989(95)00007-M; IBBOTSON RE, 1992, P ROY SOC B-BIOL SCI, V247, P145, DOI 10.1098/rspb.1992.0021; MERBS SL, 1992, SCIENCE, V258, P464, DOI 10.1126/science.1411542; MERBS SL, 1993, PHOTOCHEM PHOTOBIOL, V58, P706, DOI 10.1111/j.1751-1097.1993.tb04956.x; MOLLON JD, 1989, J EXP BIOL, V146, P21; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ J, 1989, NATURE, V342, P679, DOI 10.1038/342679a0; NEITZ J, 1993, VISION RES, V33, P117, DOI 10.1016/0042-6989(93)90064-4; Neitz J, 1996, SCIENCE, V274, P801, DOI 10.1126/science.274.5288.801; NEITZ M, 1995, VISION RES, V35, P2095, DOI 10.1016/0042-6989(94)00306-8; NEITZ M, 1995, SCIENCE, V267, P1013, DOI 10.1126/science.7863325; Neitz M., 1998, COLOR VISION PERSPEC, P101, DOI [10.1515/9783110806984.101, DOI 10.1515/9783110806984.101]; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; SHEVELL S, 1997, COLOUR VISION DEFICI, V13, P45; Shevell SK, 1997, VISION RES, V37, P1115, DOI 10.1016/S0042-6989(96)00270-2; STRUTT JW, 1881, NATURE, V25, P64; VONKRIES J, 1899, Z SINNESPHYSIOL, V19, P63; WILLIAMS AJ, 1992, EMBO J, V11, P2039, DOI 10.1002/j.1460-2075.1992.tb05261.x; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0	22	43	43	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					884	888		10.1038/13185	http://dx.doi.org/10.1038/13185			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491608				2022-12-24	WOS:000083883200013
J	Gaiano, N; Kohtz, JD; Turnbull, DH; Fishell, G				Gaiano, N; Kohtz, JD; Turnbull, DH; Fishell, G			A method for rapid gain-of-function studies in the mouse embryonic nervous system	NATURE NEUROSCIENCE			English	Article							RETROVIRAL VECTORS; SONIC-HEDGEHOG; GENE-TRANSFER; LINEAGE ANALYSIS; NEURONAL CLONES; CEREBRAL-CORTEX; HIGH-TITER; STEM-CELL; EXPRESSION; DIFFERENTIATION	We used ultrasound image-guided injections of high-titer retroviral vectors to obtain widespread introduction of genes into the mouse nervous system in utero as early as embryonic day 8.5 (E8.5). The vectors used included internal promoters that substantially improved proviral gene expression in the ventricular zone of the brain. To demonstrate the utility of this system, we extended our previous work in vitro by infecting the telencephalon in vivo as early as E8.5 with a virus expressing Sonic Hedgehog. Infected embryos showed gross morphological brain defects, as well as ectopic expression of ventral telencephalic markers characteristic of either the medial or lateral ganglionic eminences.	NYU, Sch Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Radiol, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Fishell, G (corresponding author), NYU, Sch Med, Dev Genet Program, 540 1st Ave, New York, NY 10016 USA.	turnbull@saturn.med.nyu.edu		Turnbull, Daniel/0000-0003-0889-5155; Fishell, Gordon/0000-0002-9640-9278	NHLBI NIH HHS [HL62334] Funding Source: Medline; NINDS NIH HHS [NS38461, NS32993] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL062334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038461, R01NS032993] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Altaba ARI, 1997, CELL, V90, P193, DOI 10.1016/S0092-8674(00)80325-6; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Bell EJD, 1997, MOL BIOTECHNOL, V7, P289, DOI 10.1007/BF02740819; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cepko CL, 1998, CURR TOP DEV BIOL, V36, P51; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; EIDELMAN O, 1984, J BIOL CHEM, V259, P4622; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gaiano N, 1996, BBA-REV CANCER, V1288, pO11, DOI 10.1016/0304-419X(96)00017-0; GORMAN CM, 1985, CELL, V42, P519, DOI 10.1016/0092-8674(85)90109-6; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JOHNSON AD, 1994, GENE, V147, P223, DOI 10.1016/0378-1119(94)90070-1; KEMPLER G, 1993, VIROLOGY, V193, P690, DOI 10.1006/viro.1993.1177; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; Lange C, 1997, GENE THER, V4, P303, DOI 10.1038/sj.gt.3300395; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Olsson M, 1997, NEURON, V19, P761, DOI 10.1016/S0896-6273(00)80959-9; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sawicki JA, 1998, EXP CELL RES, V244, P367, DOI 10.1006/excr.1998.4175; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimamura K, 1997, DEVELOPMENT, V124, P2709; SLACK JMW, 1994, CURR BIOL, V4, P116, DOI 10.1016/S0960-9822(94)00027-8; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Takahashi T, 1996, J NEUROSCI, V16, P6183; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Toresson H, 1999, DEVELOPMENT, V126, P1317; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Yan YL, 1998, DEV DYNAM, V213, P370, DOI 10.1002/(SICI)1097-0177(199812)213:4<370::AID-AJA3>3.0.CO;2-O; YEE JK, 1994, METHOD CELL BIOL, V43, P99	50	149	155	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					812	819		10.1038/12186	http://dx.doi.org/10.1038/12186			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461220				2022-12-24	WOS:000083882900012
J	Wong, JTW; Wong, STM; O'Connor, TP				Wong, JTW; Wong, STM; O'Connor, TP			Ectopic semaphorin-1a functions as an attractive guidance cue for developing peripheral neurons	NATURE NEUROSCIENCE			English	Article							GROWTH CONE GUIDANCE; DROSOPHILA-MELANOGASTER; GRASSHOPPER LEGS; PIONEER NEURONS; NERVE PATHWAYS; SPINAL-CORD; TRANSMEMBRANE; FAMILY; EMBRYOGENESIS; RECEPTOR	Transmembrane and secreted glycoproteins of the semaphorin family are typically classified as inhibitory neuronal guidance molecules. However, although chemorepulsive activity has been demonstrated for several semaphorin family members, little is known about the function of the numerous transmembrane semaphorins identified to date. Here we demonstrated that the extracellular semaphorin domain of a transmembrane semaphorin, semaphorin-1a, could actively perturb axon pathfinding in vivo when presented homogenously as a recombinant freely soluble factor. When ectopic overexpression was limited to defined epithelial regions, semaphorin-1a could directly steer axons by acting as an attractive guidance molecule.	Univ British Columbia, Dept Anat, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Wong, JTW (corresponding author), Univ British Columbia, Dept Anat, 2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.							Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Bagnard D, 1998, DEVELOPMENT, V125, P5043; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CAUDY M, 1986, J NEUROSCI, V6, P1781; CAUDY M, 1986, J NEUROSCI, V6, P364; CHANG WS, 1992, DEVELOPMENT, V114, P507; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; CONDIC ML, 1989, J NEUROSCI, V10, P3935; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; HART AC, 1993, NATURE, V361, P732, DOI 10.1038/361732a0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Isbister CM, 1999, DEVELOPMENT, V126, P2007; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KESHISHIAN H, 1983, DEV BIOL, V96, P103, DOI 10.1016/0012-1606(83)90315-9; KESHISHIAN H, 1983, DEV BIOL, V96, P89, DOI 10.1016/0012-1606(83)90314-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KLOSE M, 1989, SCIENCE, V245, P982, DOI 10.1126/science.2772651; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1998, J BIOL CHEM, V273, P15708, DOI 10.1074/jbc.273.25.15708; LUO Y, 1993, CELL, V74, P217; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; Mark MD, 1997, CELL TISSUE RES, V290, P299, DOI 10.1007/s004410050934; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong JTW, 1997, DEVELOPMENT, V124, P3597; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	43	54	56	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					798	803		10.1038/12168	http://dx.doi.org/10.1038/12168			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461218				2022-12-24	WOS:000083882900010
J	Tu, JC; Xiao, B; Naisbitt, S; Yuan, JP; Petralia, RS; Brakeman, P; Doan, A; Aakalu, VK; Lanahan, AA; Sheng, M; Worley, PF				Tu, JC; Xiao, B; Naisbitt, S; Yuan, JP; Petralia, RS; Brakeman, P; Doan, A; Aakalu, VK; Lanahan, AA; Sheng, M; Worley, PF			Coupling of mGluR/Homer and PSD-95 complexes by the shank family of postsynaptic density proteins	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; CEREBELLAR PURKINJE-CELLS; ALDRICH-SYNDROME PROTEIN; DENDRITIC SPINES; ENDOPLASMIC-RETICULUM; SYNAPTIC ACTIVATION; RAT HIPPOCAMPUS; LEUCINE-ZIPPER; INDUCTION	Shank is a recently described family of postsynaptic proteins that function as part of the NMDA receptor-associated PSD-95 complex (Naisbitt et al., 1999 [this issue of Neuron]). Here, we report that Shank proteins also bind to Homer. Homer proteins form multivalent complexes that bind proline-rich motifs in group 1 metabotropic glutamate receptors and inositol trisphosphate receptors, thereby coupling these receptors in a signaling complex. A single Homer-binding site is identified in Shank, and Shank and Homer coimmunoprecipitate from brain and colocalize at postsynaptic densities. Moreover, Shank clusters mGluR5 in heterologous cells in the presence of Homer and mediates the coclustering of Homer with PSD-95/GKAP. Thus, Shank may cross-link Homer and PSD-95 complexes in the PSD and play a role in the signaling mechanisms of both mGluRs and NMDA receptors.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA 02114 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.			Xiao, Bo/0000-0002-6161-9478; Sheng, Morgan/0000-0002-8703-5366	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011742, R37DA010309, R01DA010309] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10309, DA11742] Funding Source: Medline; NIMH NIH HHS [KO2 MH01152] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; ANIKSZTEJN L, 1991, EUR J PHARMACOL, V205, P327, DOI 10.1016/0014-2999(91)90921-C; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Lu YM, 1997, J NEUROSCI, V17, P5196; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Ponting CP, 1997, J MOL MED-JMM, V75, P769, DOI 10.1007/s001090050166; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Sun J, 1998, FEBS LETT, V437, P304, DOI 10.1016/S0014-5793(98)01256-3; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; VILLA A, 1992, NEUROSCIENCE, V49, P467, DOI 10.1016/0306-4522(92)90111-E; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998	45	831	854	0	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					583	592		10.1016/S0896-6273(00)80810-7	http://dx.doi.org/10.1016/S0896-6273(00)80810-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433269	hybrid			2022-12-24	WOS:000081701000021
J	Desmurget, M; Epstein, CM; Turner, RS; Prablanc, C; Alexander, GE; Grafton, ST				Desmurget, M; Epstein, CM; Turner, RS; Prablanc, C; Alexander, GE; Grafton, ST			Role of the posterior parietal cortex in updating reaching movements to a visual target	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MEMORY-GUIDED SACCADES; HAND POSITION; OPTIC ATAXIA; ARM; HUMANS; SUPPRESSION; PERCEPTION; REPRESENTATION; COMPUTATIONS	The exact role of posterior parietal cortex (PPC) in visually directed reaching is unknown. We propose that, by building an internal representation of instantaneous hand location, PPC computes a dynamic motor error used by motor centers to correct the ongoing trajectory. With unseen right hands, five subjects pointed to visual targets that either remained stationary or moved during saccadic eye movements. Transcranial magnetic stimulation (TMS) was applied over the left PPC during target presentation. Stimulation disrupted path corrections that normally occur in response to target jumps, but had no effect on those directed at stationary targets. Furthermore, left-hand movement corrections were not blocked, ruling out visual or oculomotor effects of stimulation.	Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; INSERM, U94, F-69500 Bron, France	Emory University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Grafton, ST (corresponding author), Emory Univ, Sch Med, Dept Neurol, Woodruff Mem Bldg,Suite 6000,PO Drawer V, Atlanta, GA 30322 USA.		Turner, Robert S/A-9695-2008; Desmurget, Michel/L-2401-2017	Turner, Robert S/0000-0002-6074-4365; 	NINDS NIH HHS [NS33504] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033504] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Arbib M. A., 2011, HDB PHYSL NERVOUS SY, P1449, DOI [DOI 10.1016/J.JPHYSPARIS.2008.03.001, 10.1002/cphy.cp010233]; AUERBACH SH, 1981, J NEUROL NEUROSUR PS, V44, P430, DOI 10.1136/jnnp.44.5.430; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Desmurget M, 1997, J NEUROPHYSIOL, V77, P1644, DOI 10.1152/jn.1997.77.3.1644; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262, DOI 10.1139/y95-037; DESMURGET M, IN PRESS Q J EXP PSY; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; Epstein CM, 1996, J CLIN NEUROPHYSIOL, V13, P242, DOI 10.1097/00004691-199605000-00008; FAUGIERGRIMAUD S, 1985, EXP BRAIN RES, V59, P125; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; GRAFTON ST, 1993, EXP BRAIN RES, V95, P172; HINTON G, 1984, J MOTOR BEHAV, V16, P171; Hoff B., 1992, EXP BRAIN RES, V22, P285; HOLLERBACH JM, 1982, TRENDS NEUROSCI, V5, P189, DOI 10.1016/0166-2236(82)90111-4; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Keele S. W., 1981, HDB PHYSL 1, P1391, DOI DOI 10.1002/CPHY.CP010231; Kertzman C, 1997, EXP BRAIN RES, V114, P170, DOI 10.1007/PL00005617; MATIN E, 1974, PSYCHOL BULL, V81, P899, DOI 10.1037/h0037368; MCKAY WA, 1992, J NEUROPHYSIOL, V67, P1335; Muri RM, 1996, J NEUROPHYSIOL, V76, P2102, DOI 10.1152/jn.1996.76.3.2102; OYACHI H, 1995, INVEST OPHTH VIS SCI, V36, P1441; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Rushworth MFS, 1998, J NEUROPHYSIOL, V79, P478, DOI 10.1152/jn.1998.79.1.478; SEAL J, 1982, BRAIN RES, V250, P229, DOI 10.1016/0006-8993(82)90417-6; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; Wang XG, 1998, J VISUAL COMP ANIMAT, V9, P33, DOI 10.1002/(SICI)1099-1778(199801/03)9:1<33::AID-VIS174>3.0.CO;2-Q; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	39	629	632	1	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					563	567		10.1038/9219	http://dx.doi.org/10.1038/9219			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448222				2022-12-24	WOS:000084735900017
J	Gauthier, I; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC				Gauthier, I; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC			Activation of the middle fusiform 'face area' increases with expertise in recognizing novel objects	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUNCTIONAL MRI; RECOGNITION; PROSOPAGNOSIA; MECHANISMS; REGIONS	Part of the ventral temporal robe is thought to be critical for face perception, but what determines this specialization remains unknown. We present evidence that expertise recruits the fusiform gyrus 'face area'. Functional magnetic resonance imaging (fMRI) was used to measure changes associated with increasing expertise in brain areas selected for their face preference. Acquisition of expertise with novel objects (greebles) led to increased activation in the right hemisphere face areas for matching of upright greebles as compared to matching inverted greebles. The same areas were also more activated in experts than in novices during passive viewing of greebles. Expertise seems to be one factor that leads to specialization in the face area.	Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Yale University; Brown University	Gauthier, I (corresponding author), Yale Univ, Sch Med, Dept Diagnost Radiol, 333 Cedar St,Fitkin Basement, New Haven, CT 06510 USA.		Tudusciuc, Oana/C-1339-2011	Gauthier, Isabel/0000-0002-6249-4769				ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; BRUYER R, 1992, B PSYCHONOMIC SOC, V30, P501; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GAUTHIER I, IN PRESS COGNIT NEUR; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, 1998, COGNITION B, V68, P1; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Puce A, 1997, HUM BRAIN MAPP, V5, P298, DOI 10.1002/(SICI)1097-0193(1997)5:4<298::AID-HBM16>3.0.CO;2-A; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; PUCE A, 1996, NEUROPHYSIOLOGY, V74, P1192; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; RHODES G, 1994, VIS COGN, V1, P275, DOI DOI 10.1080/13506289408402303; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SCHWEICH M, 1993, COGN NEUROPSYCHOL, V10, P529, DOI 10.1080/02643299308253472; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tovee MJ, 1998, NEURON, V21, P1239, DOI 10.1016/S0896-6273(00)80644-3; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	35	867	885	2	198	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					568	573		10.1038/9224	http://dx.doi.org/10.1038/9224			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273YA	10448223				2022-12-24	WOS:000084735900018
J	Gleeson, JG; Lin, PT; Flanagan, LA; Walsh, CA				Gleeson, JG; Lin, PT; Flanagan, LA; Walsh, CA			Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons	NEURON			English	Article							PLATELET-ACTIVATING-FACTOR; DIEKER LISSENCEPHALY GENE; LAMINAR ORGANIZATION; ASPERGILLUS-NIDULANS; STABLE MICROTUBULES; NEURITE OUTGROWTH; SIGNALING PROTEIN; NUCLEAR MIGRATION; MAMMALIAN BRAIN; TUBULIN	Doublecortin (DCX) is required for normal migration of neurons into the cerebral cortex, since mutations in the human gene cause a disruption of cortical neuronal migration. To date, little is known about the distribution of DCX protein or its function. Here, we demonstrate that DCX is expressed in migrating neurons throughout the central and peripheral nervous system during embryonic and postnatal development. DCX protein localization overlaps with microtubules in cultured primary cortical neurons, and this overlapping expression is disrupted by microtubule depolymerization. DCX coassembles with brain microtubules, and recombinant DCX stimulates the polymerization of purified tubulin. Finally, overexpression of DCX in heterologous cells leads to a dramatic microtubule phenotype that is resistant to depolymerization. Therefore, DCX likely directs neuronal migration by regulating the organization and stability of microtubules.	Harvard Univ, Dept Neurol, Div Neurogenet, Beth Israel Deaconess Med Ctr,Inst Med, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Walsh, CA (corresponding author), Harvard Univ, Dept Neurol, Div Neurogenet, Beth Israel Deaconess Med Ctr,Inst Med, Boston, MA 02115 USA.	cwalsh@caregroup.harvard.edu		Walsh, Christopher/0000-0002-0156-2238	NINDS NIH HHS [5K12NS01701-04, R01-NS 38097, R01-NS 35129, R01 NS041537] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001701, R01NS038097, R01NS041537, R01NS035129] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anton ES, 1996, J NEUROSCI, V16, P2283; BAAS PW, 1992, J CELL BIOL, V119, P171, DOI 10.1083/jcb.119.1.171; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Berg MJ, 1998, NEUROLOGY, V50, P1143, DOI 10.1212/WNL.50.4.1143; BLACK MM, 1984, BRAIN RES, V295, P255, DOI 10.1016/0006-8993(84)90974-0; Brunati AM, 1996, EUR J BIOCHEM, V240, P400, DOI 10.1111/j.1432-1033.1996.0400h.x; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; des Portes V, 1998, CELL, V92, P51; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Frotscher M, 1997, CELL TISSUE RES, V290, P315, DOI 10.1007/s004410050936; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GLEESON JG, 1997, NORMAL ABNORMAL DEV, P145; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOBAYASHI S, 1993, FEBS LETT, V335, P171, DOI 10.1016/0014-5793(93)80723-8; LIESI P, 1992, EXP NEUROL, V117, P103, DOI 10.1016/0014-4886(92)90119-B; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MARECK A, 1980, NATURE, V284, P353, DOI 10.1038/284353a0; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; Matsuo N, 1998, BIOCHEM BIOPH RES CO, V252, P571, DOI 10.1006/bbrc.1998.9698; MATUS A, 1986, NEUROSCIENCE, V17, P371, DOI 10.1016/0306-4522(86)90253-8; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MORRIS JR, 1982, J CELL BIOL, V92, P192, DOI 10.1083/jcb.92.1.192; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; NORDQUIST DT, 1988, J NEUROSCI, V8, P4780; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; ORourke NA, 1997, DEVELOPMENT, V124, P997; Pearlman AL, 1996, PROG BRAIN RES, V108, P119, DOI 10.1016/S0079-6123(08)62536-4; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 1998, DEVELOPMENT, V125, P3719; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Sapir T, 1997, EMBO J, V16, P6977, DOI 10.1093/emboj/16.23.6977; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sossey-Alaoui K, 1998, HUM MOL GENET, V7, P1327, DOI 10.1093/hmg/7.8.1327; Stottmann RW, 1998, J COMP NEUROL, V395, P121; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tint I, 1998, J NEUROSCI, V18, P8660; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; WEBB BC, 1980, BIOCHEMISTRY-US, V19, P1993, DOI 10.1021/bi00550a041; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Xia ZG, 1996, J NEUROSCI, V16, P5425; XIANG X, 1995, MOL BIOL CELL, V6, P297, DOI 10.1091/mbc.6.3.297; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100	65	1029	1050	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1999	23	2					257	271		10.1016/S0896-6273(00)80778-3	http://dx.doi.org/10.1016/S0896-6273(00)80778-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399933	Bronze			2022-12-24	WOS:000081218600012
J	Hirsch, JC; Agassandian, C; Merchan-Perez, A; Ben-Ari, Y; DeFelipe, J; Esclapez, M; Bernard, C				Hirsch, JC; Agassandian, C; Merchan-Perez, A; Ben-Ari, Y; DeFelipe, J; Esclapez, M; Bernard, C			Deficit of quantal release of GABA in experimental models of temporal lobe epilepsy	NATURE NEUROSCIENCE			English	Article							INHIBITION; HIPPOCAMPUS; SYNAPSES; NEURONS		INSERM, U29, F-75014 Paris, France; Univ Europea Madrid, Dept Ciencias Morfol & Fisiol, Madrid 28670, Spain; CSIC, Inst Cajal, E-28002 Madrid, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); European University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Bernard, C (corresponding author), INSERM, U29, 123 Bld Port Royal, F-75014 Paris, France.		bernard, christophe/S-5937-2016; Esclapez, Monique/O-6509-2016; Merchan-Perez, Angel/D-7417-2014; Merchan-Perez, Angel/AAY-8947-2020; DEFELIPE, JAVIER/D-1195-2014; bernard, christophe/A-4929-2012	bernard, christophe/0000-0003-3014-1966; Esclapez, Monique/0000-0002-8558-1363; Merchan-Perez, Angel/0000-0002-7228-5821; Merchan-Perez, Angel/0000-0002-7228-5821; DEFELIPE, JAVIER/0000-0001-5484-0660; bernard, christophe/0000-0003-3014-1966; Ben-Ari, Yehezkel/0000-0001-6208-8480				Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NADLER JV, 1981, LIFE SCI, V29, P2031; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; RUSAKOV DA, 1991, NEUROSCI LETT, V131, P156, DOI 10.1016/0304-3940(91)90602-P; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Wu MN, 1997, CURR OPIN NEUROBIOL, V7, P624, DOI 10.1016/S0959-4388(97)80081-5	14	98	99	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					499	500		10.1038/9142	http://dx.doi.org/10.1038/9142			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448211				2022-12-24	WOS:000084735900006
J	Murthy, VN; Stevens, CF				Murthy, VN; Stevens, CF			Reversal of synaptic vesicle docking at central synapses	NATURE NEUROSCIENCE			English	Article							SINGLE PRESYNAPTIC BOUTONS; TRANSMITTER RELEASE; EXOCYTOSIS; COMPONENTS; TURNOVER; FUSION; RIBBON; POOLS; CYCLE	We used quantitative fluorescence imaging of vesicles labeled with membrane-soluble dyes to determine rates of undocking and spontaneous exocytosis of vesicles docked to the active zone of hippocampal synapses in culture. Individual vesicles undock about once per two minutes and spontaneously exocytose about once per eight minutes. Thus, not only does undocking occur, but it is over threefold faster than spontaneous fusion.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Murthy, Venkatesh/0000-0003-2443-4252				BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Calakos N, 1996, PHYSIOL REV, V76, P1; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	23	175	178	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					503	507		10.1038/9149	http://dx.doi.org/10.1038/9149			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448213				2022-12-24	WOS:000084735900008
J	Noel, J; Ralph, GS; Pickard, L; Williams, J; Molnar, E; Uney, JB; Collingridge, GL; Henley, JM				Noel, J; Ralph, GS; Pickard, L; Williams, J; Molnar, E; Uney, JB; Collingridge, GL; Henley, JM			Surface expression of AMPA receptors in hippocampal neurons is regulated by an NSF-dependent mechanism	NEURON			English	Article							LONG-TERM POTENTIATION; SILENT SYNAPSES; SUBUNIT; GLUR2; LTP; BINDING; CELLS	Here, we show that disruption of N-ethylmaleimide-sensitive fusion protein-(NSF-) GluR2 interaction by infusion into cultured hippocampal neurons of a blocking peptide (pep2m) caused a rapid decrease in the frequency but no change in the amplitude of AMPA receptor-mediated miniature excitatory postsynaptic currents (mEPSCs). N-methyl-D-aspartate (NMDA) receptor-mediated mEPSCs were not changed. Viral expression of pep2m reduced the surface expression of alpha-amino-3-hydroxy-5-methyl-isoxazolepropionate (AMPA) receptors, whereas NMDA receptor surface expression in the same living cells was unchanged. In permeabilized neurons, the total amount of GluR2 immunoreactivity was unchanged, and a punctate distribution of GluR2 was observed throughout the dendritic tree. These data suggest that the NSF-GluR2 interaction is required for the surface expression of GluR2-containing AMPA receptors and that disruption of the interaction leads to the functional elimination of AMPA receptors at synapses.	Univ Bristol, Dept Anat, MRC, Ctr Synapt Plastic,Sch Med Sci, Bristol BS8 1TD, Avon, England; Univ Bristol, Dept Med, Bristol BS2 8HW, Avon, England; Newcastle Univ, Sch Med, Dept Pharmacol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Bristol; University of Bristol; Newcastle University - UK	Henley, JM (corresponding author), Univ Bristol, Dept Anat, MRC, Ctr Synapt Plastic,Sch Med Sci, Univ Walk, Bristol BS8 1TD, Avon, England.	j.m.henley@bris.ac.uk	Molnár, Elek/D-1427-2019; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020; Henley, Jeremy M/A-2776-2009	Molnár, Elek/0000-0002-3525-4671; Collingridge, Graham L/0000-0002-9572-5359; Henley, Jeremy/0000-0003-3589-8335	Biotechnology and Biological Sciences Research Council [GTH12528] Funding Source: Medline; Medical Research Council [G9629038] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9629038] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allison DW, 1998, J NEUROSCI, V18, P2423; Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Harding TC, 1997, J NEUROCHEM, V69, P2620; Harding TC, 1998, NAT BIOTECHNOL, V16, P553, DOI 10.1038/nbt0698-553; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Rao A, 1998, J NEUROSCI, V18, P1217; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	33	251	254	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1999	23	2					365	376		10.1016/S0896-6273(00)80786-2	http://dx.doi.org/10.1016/S0896-6273(00)80786-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399941	Bronze			2022-12-24	WOS:000081218600020
J	Carroll, RC; Lissin, DV; von Zastrow, M; Nicoll, RA; Malenka, RC				Carroll, RC; Lissin, DV; von Zastrow, M; Nicoll, RA; Malenka, RC			Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures	NATURE NEUROSCIENCE			English	Article							MINIATURE SYNAPTIC CURRENTS; SILENT SYNAPSES; TRANSMITTER RELEASE; PYRAMIDAL CELLS; AMPA RECEPTORS; NMDA RECEPTOR; SPINAL-CORD; AREA CA1; POTENTIATION; EXPRESSION	Synaptic strength can be altered by a variety of pre- or postsynaptic modifications. Here we test the hypothesis that long-term depression (LTD) involves a decrease in the number of glutamate receptors that are clustered at individual synapses in primary cultures of hippocampal neurons. Similar to a prominent form of LTD observed in hippocampal slices, LTD in hippocampal cultures required NMDA receptor activation and was accompanied by a decrease in the amplitude and frequency of miniature excitatory postsynaptic currents. Immunocytochemical analysis revealed that induction of LTD caused a concurrent decrease in the number of AMPA receptors clustered at synapses but had no effect on synaptic NMDA receptor clusters. These results suggest that a subtype-specific redistribution of synaptic glutamate receptors contributes to NMDA receptor-dependent LTD.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Malenka, RC (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.							ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Bardoni R, 1998, J NEUROSCI, V18, P6558; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Halpain S, 1998, J NEUROSCI, V18, P9835; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lissin DV, 1999, J NEUROSCI, V19, P1263; Mainen ZF, 1998, NAT NEUROSCI, V1, P579, DOI 10.1038/2812; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NICOLL RA, IN PRESS ANN NY ACAD; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rumpel S, 1998, J NEUROSCI, V18, P8863; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; XIAO MY, 1995, NEUROSCIENCE, V68, P625, DOI 10.1016/0306-4522(95)00173-G	50	363	375	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					454	460		10.1038/8123	http://dx.doi.org/10.1038/8123			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321250				2022-12-24	WOS:000084609400016
J	Schreiber, M; Yuan, A; Salkoff, L				Schreiber, M; Yuan, A; Salkoff, L			Transplantable sites confer calcium sensitivity to BK channels	NATURE NEUROSCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; CA-2+-ACTIVATED K+ CHANNELS; RAT SKELETAL-MUSCLE; N-BROMOACETAMIDE; HAIR-CELLS; VOLTAGE; DROSOPHILA; VARIANTS; DOMAIN; MSLO	Both intracellular calcium and voltage activate Slo1, a high-conductance potassium channel, linking calcium with electrical excitability. Using molecular techniques, we created a calcium-insensitive variant of this channel gated by voltage alone. Calcium sensitivity was restored by adding back small portions of the carboxyl (C)-terminal 'tail' domain. Two separate regions of the tail independently conferred different degrees of calcium sensitivity; together, they restored essentially wild-type calcium dependence. These results suggest that, in the absence of calcium, the Slo1 tail inhibits voltage-dependent gating, and that calcium removes this inhibition. Slo1 may have evolved from an ancestral voltage-sensitive potassium channel represented by the core; the tail may represent the more recent addition of a calcium-dependent modulatory domain.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.			Yuan, Alex/0000-0003-0191-8035				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CORNEJO M, 1987, J MEMBRANE BIOL, V99, P147, DOI 10.1007/BF01871234; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; Cox DH, 1997, J GEN PHYSIOL, V109, P633, DOI 10.1085/jgp.109.5.633; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dichiara TJ, 1995, J PHYSIOL-LONDON, V489, P403, DOI 10.1113/jphysiol.1995.sp021061; Fuchs P A, 1992, Curr Opin Neurobiol, V2, P457, DOI 10.1016/0959-4388(92)90180-S; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; HILLE B, 1983, IONIC CHANNELS EXCIT; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KUME H, 1990, J PHYSIOL-LONDON, V424, P445, DOI 10.1113/jphysiol.1990.sp018076; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; MCMANUS OB, 1988, J PHYSIOL-LONDON, V402, P79, DOI 10.1113/jphysiol.1988.sp017195; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METHFESSEL C, 1982, BIOPHYS STRUCT MECH, V9, P35, DOI 10.1007/BF00536014; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Moss GWJ, 1996, J GEN PHYSIOL, V108, P473, DOI 10.1085/jgp.108.6.473; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; PALLOTTA BS, 1985, J GEN PHYSIOL, V86, P601, DOI 10.1085/jgp.86.5.601; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TABCHARANI JA, 1989, BIOCHIM BIOPHYS ACTA, V982, P62, DOI 10.1016/0005-2736(89)90174-0; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; WU YC, 1995, PROG BIOPHYS MOL BIO, V63, P131, DOI 10.1016/0079-6107(95)00002-5	43	119	122	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					416	421		10.1038/8077	http://dx.doi.org/10.1038/8077			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321244				2022-12-24	WOS:000084609400010
J	Wes, PD; Xu, XZS; Li, HS; Chien, F; Doberstein, SK; Montell, C				Wes, PD; Xu, XZS; Li, HS; Chien, F; Doberstein, SK; Montell, C			Termination of phototransduction requires binding of the NINAC myosin III and the PDZ protein INAD	NATURE NEUROSCIENCE			English	Article							DROSOPHILA PHOTORECEPTORS; ACTIN-FILAMENTS; SIGNALING COMPLEX; DOMAIN PROTEIN; CA2+ CHANNEL; TRP; GENE; LOCALIZATION; KINASE; CELLS	Many of the proteins that are critical for Drosophila phototransduction assemble into a signaling complex; signalplex, through association with the PDZ-domain protein INAD. Some of these proteins depend on INAD for proper subcellular localization to the phototransducing organelle, the rhabdomere, making it difficult to assess any physiological function of this signaling complex independent of localization. Here we demonstrated that INAD bound directly to the NINAC myosin III, yet the subcellular localization of NINAC was normal in inaD mutants. Nevertheless, the INAD binding site was sufficient to target a heterologous protein to the rhabdomeres. Disruption of the NINAC/INAD interaction delayed termination of the photoreceptor response. Thus one role of this signaling complex is in rapid deactivation of the photoresponse.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.		Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Wes, Paul/0000-0002-8903-3102	NEI NIH HHS [EY08117] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008117] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; ARIKAWA K, 1990, J CELL BIOL, V110, P1993, DOI 10.1083/jcb.110.6.1993; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hicks JL, 1996, CELL MOTIL CYTOSKEL, V35, P367, DOI 10.1002/(SICI)1097-0169(1996)35:4<367::AID-CM8>3.0.CO;2-3; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; MISMER D, 1987, GENETICS, V116, P565; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Niethammer M, 1996, J NEUROSCI, V16, P2157; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Pak WL, 1979, GENETIC APPROACHES N, P67; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; PORTER JA, 1993, J CELL BIOL, V122, P601, DOI 10.1083/jcb.122.3.601; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; WILLIAMS DS, 1991, BIOESSAYS, V13, P171, DOI 10.1002/bies.950130405; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545	39	102	104	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					447	453		10.1038/8116	http://dx.doi.org/10.1038/8116			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321249				2022-12-24	WOS:000084609400015
J	Luquin, MR; Montoro, RJ; Guillen, J; Saldise, L; Insausti, R; Del Rio, J; Lopez-Barneo, J				Luquin, MR; Montoro, RJ; Guillen, J; Saldise, L; Insausti, R; Del Rio, J; Lopez-Barneo, J			Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen	NEURON			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; RAT-BRAIN; 2 PARTS; DISEASE; SURVIVAL; GDNF; TRANSPLANTATION; HYPOXIA	We have studied the effect of unilateral autografts of carotid body cell aggregates into the putamen of MPTP-treated monkeys with chronic parkinsonism. Two to four weeks after transplantation, the monkeys initiated a progressive recovery of mobility with reduction of tremor and bradykinesia and restoration of fine motor abilities on the contralateral side. Apomorphine injections induced rotations toward the side of the transplant. Functional recovery was accompanied by the survival of tyrosine hydroxylase-positive (TH-positive) grafted glomus cells. A high density of TH-immunoreactive fibers was seen reinnervating broad regions of the ipsilateral putamen and caudate nucleus. The nongrafted, contralateral striatum remained deafferented. Intrastriatal autografting of carotid body tissue is a feasible technique with beneficial effects on parkinsonian monkeys; thus, this therapeutic approach could also be applied to treat patients with Parkinson's disease.	Univ Sevilla, Fac Med, Dept Fisiol Med & Biofis, E-41009 Seville, Spain; Univ Navarra, Fac Med, Dept Neurol, E-31080 Pamplona, Spain; Univ Navarra, Fac Med, Dept Farmacol, E-31080 Pamplona, Spain; Univ Castilla La Mancha, Fac Med, Dept Anat, E-02071 Albacete, Spain	University of Sevilla; University of Navarra; University of Navarra; Universidad de Castilla-La Mancha	Lopez-Barneo, J (corresponding author), Univ Sevilla, Fac Med, Dept Fisiol Med & Biofis, E-41009 Seville, Spain.		IBIS, NEUROBIOLOGIA/O-9922-2015; Luquin, M R/T-5546-2017	Luquin, M R/0000-0002-5594-1794; Montoro Laseca, Rafael Jesus/0000-0001-8700-0828				Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BJORKLUND A, 1987, TRENDS NEUROSCI, V10, P509, DOI 10.1016/0166-2236(87)90131-7; Bjorklund A, 1985, NEURAL GRAFTING MAMM, P3; BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034; BOYCE S, 1990, CLIN NEUROPHARMACOL, V13, P448, DOI 10.1097/00002826-199010000-00006; Brownell AL, 1998, NAT MED, V4, P1308, DOI 10.1038/3300; CZYZYKKRZESKA MF, 1992, J NEUROCHEM, V58, P1538, DOI 10.1111/j.1471-4159.1992.tb11376.x; Deacon T, 1997, NAT MED, V3, P350, DOI 10.1038/nm0397-350; Espejo EF, 1998, NEURON, V20, P197, DOI 10.1016/S0896-6273(00)80449-3; Fidone SJ., 1986, HDB PHYSL RESPIRATOR, VII, P247; FISHMAN MC, 1985, P NATL ACAD SCI USA, V82, P1448, DOI 10.1073/pnas.82.5.1448; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Hagan JJ, 1997, TRENDS PHARMACOL SCI, V18, P156, DOI 10.1016/S0165-6147(97)01050-X; HERRERO MT, 1993, NEUROSCIENCE, V56, P965, DOI 10.1016/0306-4522(93)90142-3; Horger BA, 1998, J NEUROSCI, V18, P4929; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; LANGSTON JW, 1984, SCIENCE, V225, P1480, DOI 10.1126/science.6332378; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LopezBarneo J, 1996, TRENDS NEUROSCI, V19, P435; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; LUQUIN MR, 1992, ANN NEUROL, V31, P551, DOI 10.1002/ana.410310514; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; NAKAO N, 1995, ACTA NEUROCHIR, V133, P61, DOI 10.1007/BF01404950; Nosrat CA, 1996, CELL TISSUE RES, V286, P191, DOI 10.1007/s004410050688; PEREZOTANO I, 1991, BRAIN RES, V567, P127, DOI 10.1016/0006-8993(91)91444-6; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; Rosenblad C, 1998, NEUROSCIENCE, V82, P129; Rosenthal A, 1998, NEURON, V20, P169, DOI 10.1016/S0896-6273(00)80445-6; SCHMIDTKASTNER R, 1994, MOL BRAIN RES, V26, P325, DOI 10.1016/0169-328X(94)90106-6; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Senut MC, 1996, NAT BIOTECHNOL, V14, P1650, DOI 10.1038/nbt1296-1650; SLADEK JR, 1988, J NEUROSURG, V68, P337, DOI 10.3171/jns.1988.68.3.0337; STEA A, 1992, P NATL ACAD SCI USA, V89, P9469, DOI 10.1073/pnas.89.20.9469; STEA A, 1995, J NEUROSCI, V15, P2192, DOI 10.1523/JNEUROSCI.15-03-02192.1995; SZABO J, 1984, J COMP NEUROL, V222, P265, DOI 10.1002/cne.902220208; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; YUREK DM, 1990, ANNU REV NEUROSCI, V13, P415, DOI 10.1146/annurev.neuro.13.1.415; ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N	44	88	92	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					743	750		10.1016/S0896-6273(00)80733-3	http://dx.doi.org/10.1016/S0896-6273(00)80733-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230794				2022-12-24	WOS:000079976200017
J	Martinez, A; Anllo-Vento, L; Sereno, MI; Frank, LR; Buxton, RB; Dubowitz, DJ; Wong, EC; Hinrichs, H; Heinze, HJ; Hillyard, SA				Martinez, A; Anllo-Vento, L; Sereno, MI; Frank, LR; Buxton, RB; Dubowitz, DJ; Wong, EC; Hinrichs, H; Heinze, HJ; Hillyard, SA			Involvement of striate and extrastriate visual cortical areas in spatial attention	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; SELECTIVE ATTENTION; NEURAL MECHANISMS; FUNCTIONAL MRI; HUMAN BRAIN; CORTEX; POTENTIALS; DYNAMICS; NETWORKS; MODEL	We investigated the cortical mechanisms of visual-spatial attention while subjects discriminated patterned targets within distracter arrays. Functional magnetic resonance imaging (fMRI) was used to map the boundaries of retinotopic visual areas and to localize attention-related changes in neural activity within several of those areas, including primary visual (striate) cortex. Event-related potentials (ERPs) and modeling of their neural sources, however, indicated that the initial sensory input to striate cortex at 50-55 milliseconds after the stimulus was not modulated by attention. The earliest facilitation of attended signals was observed in extrastriate visual areas, at 70-75 milliseconds. We hypothesize that the striate cortex modulation found with fMRI may represent a delayed, re-entrant feedback from higher visual areas or a sustained biasing of striate cortical neurons during attention. ERP recordings provide critical temporal information for analyzing the functional neuroanatomy of visual attention.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Otto von Guericke Univ, Dept Clin Neurophysiol, Magdeburg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California Institute of Technology; Otto von Guericke University	Hillyard, SA (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Sereno, Martin I/F-7657-2012; Martinez, Antigona/X-2317-2019	Sereno, Martin I/0000-0002-7598-7829; Martinez, Antigona/0000-0003-4806-5199	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH025594, R01MH025594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036722] Funding Source: NIH RePORTER; NIMH NIH HHS [MH25594] Funding Source: Medline; NINDS NIH HHS [NS36722] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aine C J, 1995, Int J Neurosci, V80, P79, DOI 10.3109/00207459508986095; Anllo-Vento L, 1998, HUM BRAIN MAPP, V6, P216, DOI 10.1002/(SICI)1097-0193(1998)6:4<216::AID-HBM3>3.0.CO;2-6; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; COLBY CL, 1991, J CHILD NEUROL, V6, P90; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DUPONT P, 1993, P NATL ACAD SCI USA, V90, P10927, DOI 10.1073/pnas.90.23.10927; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Gratton G, 1997, NEUROREPORT, V8, P1749, DOI 10.1097/00001756-199705060-00036; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LABERGE D, 1995, ATTENTION PROCESSING; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.0.CO;2-Z; Motter BC, 1998, ATTENTIVE BRAIN, P51; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Scherg M, 1990, AUDITORY EVOKED MAGN, P40; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Skinner J. E., 1977, ATTENTION VOLUNTARY, P30; Talairach J., 1988, COPLANAR STEREOTAXIC; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	38	750	762	3	73	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					364	369		10.1038/7274	http://dx.doi.org/10.1038/7274			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204544				2022-12-24	WOS:000080532000016
J	Cai, DM; Shen, YJ; De Bellard, M; Tang, S; Filbin, MT				Cai, DM; Shen, YJ; De Bellard, M; Tang, S; Filbin, MT			Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EMBRYONIC SPINAL-CORD; RAT-BRAIN; NEURITE OUTGROWTH; WHITE-MATTER; GROWTH CONES; PC12 CELLS; GLYCOPROTEIN; NEURONS; ELONGATION	MAG is a potent inhibitor of axonal regeneration. Here, inhibition by MAG, and myelin in general, is blocked if neurons are exposed to neurotrophins before encountering the inhibitor; priming cerebellar neurons with BDNF or GDNF, but not NGF, or priming DRG neurons with any of these neurotrophins blocks inhibition by MAG/myelin. Dibutyryl cAMP also overcomes inhibition by MAG/myelin, and cAMP is elevated by neurotrophins. A PKA inhibitor present during priming abrogates the block of inhibition. Finally, if neurons are exposed to MAG/myelin and neurotrophins simultaneously, but with the G(i) protein inhibitor, inhibition is blocked. We suggest that priming neurons with particular neurotrophins elevates cAMP and activates PKA, which blocks subsequent inhibition of regeneration and that priming is required because MAG/myelin activates a G(i) protein, which blocks increases in cAMP. This is important for encouraging axons to regrow in vivo.	CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Filbin, MT (corresponding author), CUNY Hunter Coll, Dept Biol, New York, NY 10021 USA.		de Bellard, Maria Elena/M-6510-2019; de Bellard, Maria Elena/D-5312-2009	de Bellard, Maria Elena/0000-0001-9881-0447; de Bellard, Maria Elena/0000-0001-9881-0447; Cai, Dongming/0000-0002-0601-6826	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037060, R01NS037060] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 37060] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; Bartsch U, 1995, NEURON, V15, P1375, DOI 10.1016/0896-6273(95)90015-2; BATES CA, 1993, EXP NEUROL, V123, P106, DOI 10.1006/exnr.1993.1144; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; BREGMAN BS, 1998, FRONTIERS NEURAL DEV; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; CRUTCHER KA, 1989, EXP NEUROL, V104, P39, DOI 10.1016/0014-4886(89)90007-1; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; Filbin MT, 1996, MOL CELL NEUROSCI, V8, P84, DOI 10.1006/mcne.1996.0047; FILBIN MT, 1995, CURR OPIN NEUROBIOL, V5, P588, DOI 10.1016/0959-4388(95)80063-8; Grill R, 1997, J NEUROSCI, V17, P5560; HASAN SJ, 1993, J NEUROSCI, V13, P492; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Jelsma Tony N., 1994, Current Opinion in Neurobiology, V4, P717, DOI 10.1016/0959-4388(94)90015-9; JOHNSON AR, 1993, BIOESSAYS, V15, P807, DOI 10.1002/bies.950151206; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; Katoh H, 1996, J BIOL CHEM, V271, P29780, DOI 10.1074/jbc.271.47.29780; KEIRSTEAD HS, 1992, P NATL ACAD SCI USA, V89, P11664, DOI 10.1073/pnas.89.24.11664; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Keynes Roger J., 1995, Current Opinion in Neurobiology, V5, P75, DOI 10.1016/0959-4388(95)80090-5; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; KNIPPER M, 1993, FEBS LETT, V324, P147, DOI 10.1016/0014-5793(93)81382-A; KNIPPER M, 1993, NEUROREPORT, V4, P483, DOI 10.1097/00001756-199305000-00005; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; LI Y, 1993, BRAIN RES, V629, P115, DOI 10.1016/0006-8993(93)90489-A; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 1997, J NEUROSCI, V17, P7860; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SCHWEGLER G, 1995, J NEUROSCI, V15, P2756; Shen YJ, 1998, MOL CELL NEUROSCI, V12, P79, DOI 10.1006/mcne.1998.0700; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Tigyi G, 1996, J NEUROCHEM, V66, P537; Turnley AM, 1998, NEUROREPORT, V9, P1987, DOI 10.1097/00001756-199806220-00013; Tuttle R, 1998, MOL CELL NEUROSCI, V11, P1, DOI 10.1006/mcne.1998.0671; Wang Q, 1998, J NEUROSCI, V18, P4973	58	440	477	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					89	101		10.1016/S0896-6273(00)80681-9	http://dx.doi.org/10.1016/S0896-6273(00)80681-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027292	Bronze			2022-12-24	WOS:000078410300015
J	Nobre, AC; Coull, JT; Frith, CD; Mesulam, MM				Nobre, AC; Coull, JT; Frith, CD; Mesulam, MM			Orbitofrontal cortex is activated during breaches of expectation in tasks of visual attention	NATURE NEUROSCIENCE			English	Article							PET		Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Inst Neurol, Wellcome Dept Cognit Neurol, Funct Imaging Lab, London WC1N 3BG, England; Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA	University of Oxford; University of London; University College London; Northwestern University	Nobre, AC (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.		Coull, Jennifer T/M-4243-2015; Frith, Chris D/A-2171-2009	Coull, Jennifer T/0000-0002-8790-5835; Frith, Chris D/0000-0002-8665-0690; Nobre, Anna Christina/0000-0001-5762-2802	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Craighero L., 1998, ADV PSYCHOL SCI, V2; Damasio AR, 1979, CLIN NEUROPSYCHOLOGY, P360; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Kawashima R, 1996, BRAIN RES, V728, P79, DOI 10.1016/0006-8993(96)00389-7; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124	15	186	187	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					11	12		10.1038/4513	http://dx.doi.org/10.1038/4513			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195173				2022-12-24	WOS:000078409300006
J	Pham, TA; Impey, S; Storm, DR; Stryker, MP				Pham, TA; Impey, S; Storm, DR; Stryker, MP			CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period	NEURON			English	Article							KITTEN VISUAL-CORTEX; MONOCULAR DEPRIVATION; POSTSYNAPTIC ACTIVITY; STRIATE CORTEX; PHOSPHORYLATION; EXPRESSION; PROTEIN; RESPONSES; MOUSE; BRAIN	Neuronal activity-dependent processes are believed to mediate the formation of synaptic connections during neocortical development, but the underlying intracellular mechanisms are not known. In the visual system, altering the pattern of visually driven neuronal activity by monocular deprivation induces cortical synaptic rearrangement during a postnatal developmental window, the critical period. Here, using transgenic mice carrying a CRE-lacZ reporter, we demonstrate that a calcium- and cAMP-regulated signaling pathway is activated following monocular deprivation. We find that monocular deprivation leads to an induction of CRE-mediated lacZ expression in the visual cortex preceding the onset of physiologic plasticity, and this induction is dramatically downregulated following the end of the critical period. These results suggest that CRE-dependent coordinate regulation of a network of genes may control physiologic plasticity during postnatal neocortical development.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Pham, TA (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	tpham@phy.ucsf.edu; stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033, P50NS016033, R01NS020498] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS020498, NS20498, P01 NS016033-180017, NS16033, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLAKEMORE C, 1978, J PHYSIOL-LONDON, V283, P223, DOI 10.1113/jphysiol.1978.sp012498; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DOMENICI L, 1991, P NATL ACAD SCI USA, V88, P8811, DOI 10.1073/pnas.88.19.8811; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gordon JA, 1996, J NEUROSCI, V16, P3274; GU Q, 1993, EUR J NEUROSCI, V5, P475, DOI 10.1111/j.1460-9568.1993.tb00514.x; GU Q, 1995, EUR J NEUROSCI, V7, P1146, DOI 10.1111/j.1460-9568.1995.tb01104.x; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hayashi M, 1997, BRAIN RES, V749, P283, DOI 10.1016/S0006-8993(96)01317-0; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Kaplan IV, 1996, MOL BRAIN RES, V36, P12, DOI 10.1016/0169-328X(95)00228-K; KASAMATSU T, 1976, SCIENCE, V194, P206, DOI 10.1126/science.959850; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MORI Y, 1993, J BIOL CHEM, V268, P26482; MOWER GD, 1994, MOL BRAIN RES, V21, P47, DOI 10.1016/0169-328X(94)90376-X; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; RAUSCHECKER JP, 1979, NATURE, V280, P58, DOI 10.1038/280058a0; RIBAK CE, 1975, BRAIN RES, V92, P341, DOI 10.1016/0006-8993(75)90322-4; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; SAUERWALD A, 1990, J BIOL CHEM, V265, P14932; SENGPIEL F, 1994, NATURE, V368, P847, DOI 10.1038/368847a0; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; SHAW C, 1984, NATURE, V308, P731, DOI 10.1038/308731a0; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SIMMONS PA, 1982, J COMP NEUROL, V211, P295, DOI 10.1002/cne.902110308; Singer W, 1982, Hum Neurobiol, V1, P41; SUN ZM, 1995, MOL CELL BIOL, V15, P561, DOI 10.1128/MCB.15.1.561; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; Walker GA, 1998, J NEUROPHYSIOL, V79, P227, DOI 10.1152/jn.1998.79.1.227; WATKINS DW, 1978, J NEUROPHYSIOL, V41, P322, DOI 10.1152/jn.1978.41.2.322; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WILSON JR, 1977, J NEUROPHYSIOL, V40, P891, DOI 10.1152/jn.1977.40.4.891	60	152	157	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1999	22	1					63	72		10.1016/S0896-6273(00)80679-0	http://dx.doi.org/10.1016/S0896-6273(00)80679-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027290	Bronze			2022-12-24	WOS:000078410300013
J	Cox, GA; Mahaffey, CL; Frankel, WN				Cox, GA; Mahaffey, CL; Frankel, WN			Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele	NEURON			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; DNA-BINDING PROTEIN; SUPEROXIDE-DISMUTASE; HELICASE-A; LINKAGE; LOCUS; TRANSCRIPTION; COMPLEX; HETEROGENEITY	The nmd mouse mutation causes progressive degeneration of spinal motor neurons and muscle atrophy. We identified the mutated gene as the putative transcriptional activator and ATPase/DNA helicase previously described as Smbp2, Rip1, Gf1, or Catf1. Mutations were found in two alleles-a single amino acid deletion in nmd(J) and a splice donor mutation in nmd(2J). The selective vulnerability of motor neurons is striking in view of the widespread expression of this gene, although the pattern of degeneration may reflect a specific threshold since neither allele is null. In addition, the severity of the nmd phenotype is attenuated in a semidominant fashion by a major genetic locus on chromosome (Chr) 13. The identification of the nmd gene and mapping of a major suppressor provide new opportunities for understanding mechanisms of motor neuron degeneration.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Cox, GA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.				NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031348] Funding Source: NIH RePORTER; NCI NIH HHS [CA34196] Funding Source: Medline; NINDS NIH HHS [NS31348] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APPELBAUM JS, 1992, NEUROLOGY, V42, P1488, DOI 10.1212/WNL.42.8.1488; Biswas EE, 1997, BIOCHEMISTRY-US, V36, P13277, DOI 10.1021/bi971292s; Biswas SB, 1997, BIOCHEMISTRY-US, V36, P13270, DOI 10.1021/bi9712910; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; COOK SA, 1995, MAMM GENOME, V6, P187, DOI 10.1007/BF00293010; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 1998, CANCER RES, V58, P89; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FRANKEL WN, 1994, MAMM GENOME, V5, P659, DOI 10.1007/BF00426071; FRANKEL WN, 1995, MAMM GENOME, V6, P830, DOI 10.1007/BF00292431; FUKITA Y, 1993, J BIOL CHEM, V268, P17463; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Iwahashi H, 1997, NATURE, V390, P413, DOI 10.1038/37144; KAUSCH K, 1991, HUM GENET, V86, P317; KAUSHIK N, 1994, MAMM GENOME, V5, P688, DOI 10.1007/BF00426074; KERR D, 1991, J BIOL CHEM, V266, P15876; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lehmann AR, 1998, BIOESSAYS, V20, P146, DOI 10.1002/(SICI)1521-1878(199802)20:2<146::AID-BIES7>3.3.CO;2-5; Letts VA, 1997, GENOMICS, V43, P62, DOI 10.1006/geno.1997.4780; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MCBRIDE K, 1993, MOL CELL BIOL, V13, P600, DOI 10.1128/MCB.13.1.600; MERETTE C, 1994, GENOMICS, V21, P27, DOI 10.1006/geno.1994.1220; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; Mohan WS, 1998, J LIPID RES, V39, P255; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; Schupp IW, 1997, IMMUNOGENETICS, V45, P180, DOI 10.1007/s002510050187; SEBASTIANI G, 1995, MAMM GENOME, V6, P147, DOI 10.1007/BF00303264; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; SHIEH SY, 1995, J BIOL CHEM, V270, P21503, DOI 10.1074/jbc.270.37.21503; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Siddique T, 1996, HUM MOL GENET, V5, P1465, DOI 10.1093/hmg/5.Supplement_1.1465; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; TAYLOR BA, 1993, GENOMICS, V16, P380, DOI 10.1006/geno.1993.1201; THOMPSON TG, 1995, NAT GENET, V9, P56, DOI 10.1038/ng0195-56; TIMMERMAN V, 1992, J NEUROL SCI, V109, P41, DOI 10.1016/0022-510X(92)90091-X; Warbrick E, 1996, CURR BIOL, V6, P1057, DOI 10.1016/S0960-9822(02)70663-5; Zerres K, 1997, NEUROMUSCULAR DISORD, V7, P202, DOI 10.1016/S0960-8966(97)00459-8	46	99	101	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1327	1337		10.1016/S0896-6273(00)80652-2	http://dx.doi.org/10.1016/S0896-6273(00)80652-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883726	Bronze			2022-12-24	WOS:000077910600015
J	Finley, KD; Edeen, PT; Foss, M; Gross, E; Ghbeish, N; Palmer, RH; Taylor, BJ; McKeown, M				Finley, KD; Edeen, PT; Foss, M; Gross, E; Ghbeish, N; Palmer, RH; Taylor, BJ; McKeown, M			dissatisfaction encodes a tailless-like nuclear receptor expressed in a subset of CNS neurons controlling Drosophila sexual behavior	NEURON			English	Article							DOUBLESEX GENE; FRUITLESS GENE; MELANOGASTER; COURTSHIP; ELEMENT; FLIES; DNA; DIFFERENTIATION; DETERMINANTS; ORIENTATION	The dissatisfaction (dsf) gene is necessary for appropriate sexual behavior and sex-specific neural development in both sexes, dsf males are bisexual and mate poorly, while mutant females resist male courtship and fail to lay eggs. Males and females have sex-specific neural abnormalities. We have cloned dsf and rescued both behavioral and neural phenotypes. dsf encodes a nuclear receptor closely related to the vertebrate Tailless proteins and is expressed in both sexes in an extremely limited set of neurons in regions of the brain potentially involved in sexual behavior. Expression of a female transformer cDNA under the control of a dsf enhancer in males leads to dsf-like bisexual behavior.	Salk Inst Biol Studies, Mol Biol & Virol Lab, San Diego, CA 92186 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Salk Institute; Oregon State University	McKeown, M (corresponding author), Salk Inst Biol Studies, Mol Biol & Virol Lab, San Diego, CA 92186 USA.	mckeown@salk.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; BAKER BS, 1998, J NEUROSCI, V18, P4335; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRIZUELA BJ, 1994, GENETICS, V137, P803; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COOLEY L, 1990, P NATL ACAD SCI USA, V87, P3170, DOI 10.1073/pnas.87.8.3170; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; DALBY B, 1995, GENETICS, V139, P757; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; GAILEY DA, 1991, DEVELOPMENT, V113, P879; GAILEY DA, 1989, GENETICS, V121, P773; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jiang W, 1998, BIOTECHNIQUES, V24, P349; KNIPPLE DC, 1985, NATURE, V317, P40, DOI 10.1038/317040a0; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; ODELL KMC, 1995, NEURON, V15, P55, DOI 10.1016/0896-6273(95)90064-0; ODell KMC, 1997, CURR BIOL, V7, pR345, DOI 10.1016/S0960-9822(06)00170-9; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PIGNONI F, 1990, CELL, V62, P151, DOI 10.1016/0092-8674(90)90249-E; QUINN WG, 1984, ANNU REV NEUROSCI, V7, P67, DOI 10.1146/annurev.ne.07.030184.000435; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RIO DC, 1991, TRENDS GENET, V7, P282, DOI 10.1016/0168-9525(91)90176-Q; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RYNER LC, 1991, GENE DEV, V5, P2071, DOI 10.1101/gad.5.11.2071; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SIDENKIAMOS I, 1990, NUCLEIC ACIDS RES, V18, P6261, DOI 10.1093/nar/18.21.6261; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TAYLOR BJ, 1995, DEVELOPMENT, V121, P3079; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; TAYLOR BJ, 1992, GENETICS, V132, P179; TIAN M, 1992, SCIENCE, V256, P237, DOI 10.1126/science.1566072; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; TOROK T, 1993, GENETICS, V135, P71; TOWER J, 1993, GENETICS, V133, P347; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Villella A, 1996, GENETICS, V143, P331; Villella A, 1997, GENETICS, V147, P1107; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; ZHANG P, 1993, GENETICS, V133, P361	61	73	75	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1363	1374		10.1016/S0896-6273(00)80655-8	http://dx.doi.org/10.1016/S0896-6273(00)80655-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883729	Bronze			2022-12-24	WOS:000077910600018
J	Gomperts, SN; Rao, A; Craig, AM; Malenka, RC; Nicoll, RA				Gomperts, SN; Rao, A; Craig, AM; Malenka, RC; Nicoll, RA			Postsynaptically silent synapses in single neuron cultures	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; NMDA RECEPTOR; AMPA; LTP; EXPRESSION; CELLS	We have used the synapses that isolated hippocampal cells in culture form onto themselves (autapses) to determine if some synapses lack functional AMPA receptors (AMPARs). A comparison of the synaptic variability of the AMPAR- and NMDAR-mediated evoked responses, as well as of miniature synaptic responses, indicates that a population of events exists that only contains an NMDAR component. Spillover of glutamate from adjacent synapses cannot explain these results because in single cell cultures all synaptic events mediated by AMPARs should be detected. Immunocytochemical analysis of these cultures clearly reveals a population of synapses with puncta for NR1 (NMDAR) but not for GluR1 (AMPAR). These results provide strong anatomical and physiological evidence for the existence of postsynaptically silent synapses.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Craig, Ann Marie/M-2054-2014; Gomperts, Stephen/AAC-6949-2020		NIGMS NIH HHS [GM07618] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bardoni R, 1998, J NEUROSCI, V18, P6558; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Goslin K., 1998, CULTURING NERVE CELL, P339; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kiyosue K, 1997, DEV BRAIN RES, V99, P201, DOI 10.1016/S0165-3806(97)00008-4; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Niu YP, 1998, BRAIN RES, V800, P253, DOI 10.1016/S0006-8993(98)00526-5; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	23	111	114	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1443	1451		10.1016/S0896-6273(00)80662-5	http://dx.doi.org/10.1016/S0896-6273(00)80662-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883736	Bronze			2022-12-24	WOS:000077910600025
J	Mott, DD; Doherty, JJ; Zhang, SN; Washburn, MS; Fendley, MJ; Lyuboslavsky, P; Traynelis, SF; Dingledine, R				Mott, DD; Doherty, JJ; Zhang, SN; Washburn, MS; Fendley, MJ; Lyuboslavsky, P; Traynelis, SF; Dingledine, R			Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; CEREBELLAR GRANULE NEURONS; CULTURED CORTICAL-NEURONS; ANTI-ISCHEMIC AGENTS; AMINO-ACID; PHARMACOLOGICAL PROPERTIES; GLUTAMATE-RECEPTOR; CEREBRAL-ISCHEMIA; XENOPUS OOCYTES; CA2+ CHANNELS	The phenylethanolamines, ifenprodil and CP-101,606, are NMDA receptor antagonists with promising neuroprotective properties. In recombinant NMDA receptors expressed in Xenopus oocytes, we found that these drugs inhibit NMDA receptors through a unique mechanism, making the receptor more sensitive to inhibition by protons, an endogenous negative modulator. These findings support a critical role for the proton sensor in gating the NMDA receptor and point the way to identifying a context-dependent NMDA receptor antagonist that is inactive at physiological pH, but is a potent inhibitor during the acidic conditions that arise during epilepsy, ischemia and brain trauma.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Mott, DD (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.		dingledine, Ray/F-5173-2011	Dingledine, Ray/0000-0001-7128-4520; Mott, David/0000-0003-0758-8006				Bath CP, 1996, EUR J PHARMACOL, V299, P103, DOI 10.1016/0014-2999(95)00846-2; Biton B, 1997, EUR J PHARMACOL, V323, P277, DOI 10.1016/S0014-2999(97)00141-6; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222; CARTER CJ, 1990, J PHARMACOL EXP THER, V253, P475; CHENARD BL, 1995, J MED CHEM, V38, P3138, DOI 10.1021/jm00016a017; CHENARD BL, 1991, J MED CHEM, V34, P3085, DOI 10.1021/jm00114a018; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; GRAHAM D, 1992, EUR J PHARM-MOLEC PH, V226, P373, DOI 10.1016/0922-4106(92)90056-2; HOCH DB, 1986, DEV BRAIN RES, V25, P53, DOI 10.1016/0165-3806(86)90151-3; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; Kashiwagi K, 1996, MOL PHARMACOL, V49, P1131; Kew JNC, 1996, J PHYSIOL-LONDON, V497, P761, DOI 10.1113/jphysiol.1996.sp021807; Kew JNC, 1998, BRIT J PHARMACOL, V123, P463, DOI 10.1038/sj.bjp.0701634; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lees KR, 1997, NEUROLOGY, V49, pS66, DOI 10.1212/WNL.49.5_Suppl_4.S66; LEGENDRE P, 1991, MOL PHARMACOL, V40, P289; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; MCCOOL BA, 1995, NEUROPHARMACOLOGY, V34, P621, DOI 10.1016/0028-3908(95)00030-A; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Menniti F, 1997, EUR J PHARMACOL, V331, P117, DOI 10.1016/S0014-2999(97)10092-9; Pahk AJ, 1997, NEUROSCI LETT, V225, P29, DOI 10.1016/S0304-3940(97)00176-6; Pasternack M, 1996, NEUROPHARMACOLOGY, V35, P1279, DOI 10.1016/S0028-3908(96)00075-5; REYNOLDS IJ, 1989, MOL PHARMACOL, V36, P758; ROOT MJ, 1994, SCIENCE, V265, P1852, DOI 10.1126/science.7522344; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TAMURA Y, 1993, J PHARMACOL EXP THER, V265, P1017; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; TRAYNELIS SF, 1998, PH BRAIN FUNCTION, P407; VYKLICKY L, 1990, J PHYSIOL-LONDON, V430, P497, DOI 10.1113/jphysiol.1990.sp018304; Williams K, 1995, MOL PHARMACOL, V48, P1087; WILLIAMS K, 1995, NEUROSCI LETT, V184, P181, DOI 10.1016/0304-3940(94)11201-S; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	48	181	190	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					659	667		10.1038/3661	http://dx.doi.org/10.1038/3661			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196581				2022-12-24	WOS:000077323400009
J	Whitmore, D; Foulkes, NS; Strahle, U; Sassone-Corsi, P				Whitmore, D; Foulkes, NS; Strahle, U; Sassone-Corsi, P			Zebrafish Clock rhythmic expression reveals independent peripheral circadian oscillators	NATURE NEUROSCIENCE			English	Article							DROSOPHILA PERIOD GENE; MESSENGER-RNA LEVELS; TRANSCRIPTION; ANTAGONISTS; TIMELESS; BEHAVIOR; CLONING; LESIONS; PROTEIN; RETINA	The only vertebrate clock gene identified by mutagenesis is mouse Clock, which encodes a bHLH-PAS transcription factor. We have cloned Clock in zebrafish and show that, in contrast to its mouse homologue, it is expressed with a pronounced circadian rhythm in the brain and in two defined pacemaker structures, the eye and the pineal gland. Clock oscillation was also found in other tissues, including kidney and heart. In these tissues, expression of Clock continues to oscillate in vitro. This demonstrates that self-sustaining circadian oscillators exist in several vertebrate organs, as was previously reported for invertebrates.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.		Sassone-Corsi, Paolo/H-6182-2011; Straehle, Uwe/K-7054-2013; Foulkes, Nicholas S/K-7003-2013	Foulkes, Nicholas S/0000-0002-1794-9891; Whitmore, David/0000-0003-2420-8220				Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cahill GM, 1996, BRAIN RES, V708, P177, DOI 10.1016/0006-8993(95)01365-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x; Foulkes NS, 1996, BBA-REV CANCER, V1288, pF101, DOI 10.1016/S0304-419X(96)00025-X; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; MELLSTROM B, 1993, NEURON, V10, P655, DOI 10.1016/0896-6273(93)90167-P; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Rajendran RR, 1996, J EXP BIOL, V199, P2775; REPPERT SM, 1995, NEURON, V15, P983, DOI 10.1016/0896-6273(95)90086-1; Reppert SM, 1997, CELL, V89, P487, DOI 10.1016/S0092-8674(00)80229-9; Reppert SM, 1995, CELL, V83, P1059, DOI 10.1016/0092-8674(95)90131-0; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sassone-Corsi P, 1998, NATURE, V392, P871, DOI 10.1038/31821; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SERVILLO G, 1991, BIOCHEM BIOPH RES CO, V175, P104, DOI 10.1016/S0006-291X(05)81206-9; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; ZERR DM, 1990, J NEUROSCI, V10, P2749; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	41	274	280	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					701	707		10.1038/3703	http://dx.doi.org/10.1038/3703			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196586				2022-12-24	WOS:000077323400014
J	Atkins, CM; Selcher, JC; Petraitis, JJ; Trzaskos, JM; Sweatt, JD				Atkins, CM; Selcher, JC; Petraitis, JJ; Trzaskos, JM; Sweatt, JD			The MAPK cascade is required for mammalian associative learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; RABBIT FOLLOWING STIMULATION; II MUTANT MICE; SYNAPTIC TRANSMISSION; LASTING POTENTIATION; RETROGRADE-AMNESIA; CONTEXTUAL FEAR; PERFORANT PATH; DENTATE AREA	Mitogen-activated protein kinase (MAPK) is an integral component of cellular signaling during mitogenesis and differentiation of mitotic cells. Recently MAPK activation in post-mitotic cells has been implicated in hippocampal long-term potentiation (LTP), a potential cellular mechanism of learning and memory Here we investigate the involvement of MAPK in learning and memory in behaving animals. MAPK activation increased in the rat. hippocampus after an associative learning task, contextual fear conditioning. Two other protein kinases known to be activated during hippocampal LTP, protein kinase C and alpha-calcium/calmodulin protein kinase II, also were activated in the hippocampus after learning. Inhibition of the specific upstream activator of MAPK, MAPK kinase (MEK), blocked fear conditioning. Thus, classical conditioning in mammals activates MAPK, which is necessary for consolidation of the resultant learning.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; DuPont Pharmaceut Res Labs, Chem & Phys Sci, Wilmington, DE 19880 USA; DuPont Pharmaceut Res Labs, Inflammatory Dis Res, Wilmington, DE 19880 USA	Baylor College of Medicine; DuPont; DuPont	Sweatt, JD (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	david@ligand.neusc.bcm.tmc.edu		Atkins, Coleen/0000-0003-4718-7493; Sweatt, J. David/0000-0003-3567-485X	NIMH NIH HHS [MH 57014] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bordi F, 1996, NEUROPHARMACOLOGY, V35, P1557, DOI 10.1016/S0028-3908(96)00101-3; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; Brunet A, 1997, ESSAYS BIOCHEM, V32, P1; Crow T, 1998, J NEUROSCI, V18, P3480; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Grunbaum L, 1998, J NEUROSCI, V18, P4384; HARGREAVES EL, 1992, BEHAV BRAIN RES, V47, P23, DOI 10.1016/S0166-4328(05)80249-9; IZQUIERDO I, 1995, NEUROBIOL LEARN MEM, V63, P19, DOI 10.1006/nlme.1995.1002; JERUSALINSKY D, 1994, BEHAV NEURAL BIOL, V61, P107, DOI 10.1016/S0163-1047(05)80063-9; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Nogues X, 1996, BEHAV BRAIN RES, V75, P139, DOI 10.1016/0166-4328(96)00194-5; PAYLOR R, IN PRESS LEARN MEM; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; ROBERTS TM, 1992, NATURE, V360, P534, DOI 10.1038/360534a0; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Tan SE, 1996, BRAIN RES, V711, P234, DOI 10.1016/0006-8993(95)01411-X; Tan SE, 1997, BRAIN RES, V748, P227, DOI 10.1016/S0006-8993(96)01298-X; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; WOLFMAN C, 1994, BEHAV NEURAL BIOL, V61, P203, DOI 10.1016/S0163-1047(05)80001-9; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yasoshima Y, 1997, NEUROREPORT, V8, P1363, DOI 10.1097/00001756-199704140-00009	50	912	928	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					602	609		10.1038/2836	http://dx.doi.org/10.1038/2836			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196568				2022-12-24	WOS:000077437100016
J	Williams, BM; Temburni, MK; Levey, MS; Bertrand, S; Bertrand, D; Jacob, MH				Williams, BM; Temburni, MK; Levey, MS; Bertrand, S; Bertrand, D; Jacob, MH			The long internal loop of the alpha 3 subunit targets nAChRs to subdomains within individual synapses on neurons in vivo	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BUNGAROTOXIN BINDING-SITES; CILIARY GANGLION NEURONS; ANTISENSE OLIGONUCLEOTIDES; SYMPATHETIC NEURONS; MULTIPLE CLASSES; GENE-EXPRESSION; CHICK; LOCALIZATION; INNERVATION	Different types of neurotransmitter receptors coexist within single neurons and must be targeted to discrete synaptic regions for proper function. In chick ciliary ganglion neurons, nicotinic acetylcholine receptors (nAChRs) containing alpha 3 and alpha 5 subunits are concentrated in the postsynaptic membrane, whereas alpha-bungarotoxin receptors composed of alpha 7 subunits are localized perisynaptically and excluded from the synapse. Using retroviral vector-mediated gene transfer in vivo, we show that the long cytoplasmic loop of alpha 3 targets chimeric alpha 7 subunits to the synapse and reduces endogenous nAChR surface levels, whereas the alpha 5 loop does neither. These results show that a particular domain of one subunit targets specific receptor subtypes to the interneuronal synapse in vivo. Moreover, our findings suggest a difference in the mechanisms that govern assembly of interneuronal synapses as compared to the neuromuscular junction in vertebrates.	Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; Univ Geneva, Dept Physiol, CH-1211 Geneva 4, Switzerland	Tufts University; University of Geneva	Jacob, MH (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	mjacob@opal.tufts.edu		Temburni, Murali/0000-0002-8814-9920	PHS HHS [21725] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; BARALD KF, 1989, DEV BIOL, V135, P349, DOI 10.1016/0012-1606(89)90185-1; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Federspiel MJ, 1997, METHOD CELL BIOL, V52, P179, DOI 10.1016/S0091-679X(08)60379-9; Homburger SA, 1996, DEV DYNAM, V206, P112, DOI 10.1002/(SICI)1097-0177(199605)206:1<112::AID-AJA10>3.0.CO;2-7; Horch HLW, 1995, J NEUROSCI, V15, P7778; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; JACOB MH, 1991, J NEUROSCI, V11, P1701; JACOB MH, 1983, J NEUROSCI, V3, P260; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Lena C, 1997, CURR OPIN NEUROBIOL, V7, P674, DOI 10.1016/S0959-4388(97)80088-8; Levey MS, 1996, J NEUROSCI, V16, P6878; LEVEY MS, 1995, NEURON, V14, P153, DOI 10.1016/0896-6273(95)90249-X; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; LORING RH, 1987, J NEUROSCI, V7, P2153; LORING RH, 1985, NEUROSCIENCE, V14, P645, DOI 10.1016/0306-4522(85)90316-1; MAIMONE MM, 1993, NEURON, V11, P53, DOI 10.1016/0896-6273(93)90270-2; MANDELZYS A, 1994, J NEUROSCI, V14, P2357; MARGIOTTA JF, 1989, DEV BIOL, V135, P326, DOI 10.1016/0012-1606(89)90183-8; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; MOSS BL, 1993, J NEUROSCI, V13, P13; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; RATHOUZ MM, 1995, J BIOL CHEM, V270, P14366, DOI 10.1074/jbc.270.24.14366; ROLE LW, 1985, J NEUROSCI, V5, P2197; SALPETER MM, 1993, ANN NY ACAD SCI, V681, P155, DOI 10.1111/j.1749-6632.1993.tb22881.x; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; Ullian EM, 1997, J NEUROSCI, V17, P7210; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; VicenteAgullo F, 1996, FEBS LETT, V399, P83, DOI 10.1016/S0014-5793(96)01291-4; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; YU XM, 1994, J NEUROSCI, V14, P785; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	42	111	113	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					557	562		10.1038/2792	http://dx.doi.org/10.1038/2792			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196562				2022-12-24	WOS:000077437100010
J	Robitaille, R				Robitaille, R			Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction	NEURON			English	Article							PERISYNAPTIC SCHWANN-CELLS; ASTROCYTES IN-SITU; INTRACELLULAR CALCIUM; TRANSMITTER RELEASE; GROWTH-FACTOR; G-PROTEINS; CA2+; CHANNELS; RECEPTORS; MUSCLE	The ability of perisynaptic glial cells to modulate transmitter release and synaptic depression was studied at the frog neuromuscular junction (nmj). Injection of GTP gamma S in perisynaptic Schwann cells (PSCs), glial cells at this synapse, induced a reduction in the amplitude of nerve-evoked synaptic responses but had no effect on the frequency, the amplitude, or the duration of the miniature endplate currents (MEPCs). Also, paired pulse facilitation was not affected. The reduction in transmitter release was mediated by pertussis toxin-(PTX) sensitive and insensitive G proteins. Blockade of G proteins in PSCs with GDP beta S reduced synaptic depression induced by high frequency trains of stimuli, whereas activation of G proteins occluded it. Hence, the activation by endogenous neurotransmitters of G proteins in PSCs induced a profound depression in neurotransmitter release.	Univ Montreal, Ctr Rech Sci Neurol, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Robitaille, R (corresponding author), Univ Montreal, Ctr Rech Sci Neurol, Dept Physiol, Montreal, PQ H3C 3J7, Canada.	robitair@ere.umontreal.ca		Robitaille, Richard/0000-0001-6628-0146				BaliceOrdon RJ, 1996, CURR BIOL, V6, P1054, DOI 10.1016/S0960-9822(02)70662-3; BENNETT MR, 1989, J PHYSIOL-LONDON, V418, P219, DOI 10.1113/jphysiol.1989.sp017836; BEVAN S, 1973, NATURE-NEW BIOL, V241, P85, DOI 10.1038/newbio241085a0; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bourque MJ, 1998, J PHYSIOL-LONDON, V512, P197, DOI 10.1111/j.1469-7793.1998.197bf.x; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; CHIU SY, 1994, GLIA, V11, P191, DOI 10.1002/glia.440110213; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DAN Y, 1992, SCIENCE, V256, P1570, DOI 10.1126/science.1317971; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; David G, 1997, J PHYSIOL-LONDON, V504, P83, DOI 10.1111/j.1469-7793.1997.083bf.x; DENNIS MJ, 1974, J PHYSIOL-LONDON, V237, P431, DOI 10.1113/jphysiol.1974.sp010490; FINKBEINER SM, 1993, GLIA, V9, P83, DOI 10.1002/glia.440090202; GEORGIOU J, 1994, NEURON, V12, P443, DOI 10.1016/0896-6273(94)90284-4; HARISH OE, 1992, NEURON, V9, P1201, DOI 10.1016/0896-6273(92)90077-Q; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; Hoffenberg S, 1996, MOL PHARMACOL, V49, P156; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; KIMELBERG HK, 1995, NEUROCHEM INT, V26, P27, DOI 10.1016/0197-0186(94)00118-E; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; LINDGREN CA, 1994, NEUROREPORT, V5, P2205, DOI 10.1097/00001756-199410270-00054; MA JY, 1994, P NATL ACAD SCI USA, V91, P12351, DOI 10.1073/pnas.91.25.12351; MADDEN KS, 1985, J PHARMACOL EXP THER, V232, P305; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PARPURA V, 1995, J NEUROSCI, V15, P5831; Pasti L, 1997, J NEUROSCI, V17, P7817; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; PORTER JT, 1995, J NEUROCHEM, V65, P1515, DOI 10.1046/j.1471-4159.1995.65041515.x; Reich KM, 1997, ENDOCRINOLOGY, V138, P1014, DOI 10.1210/en.138.3.1014; REIST NE, 1992, P NATL ACAD SCI USA, V86, P5178; Robitaille R, 1997, J PHYSIOL-LONDON, V504, P337, DOI 10.1111/j.1469-7793.1997.337be.x; ROBITAILLE R, 1995, J NEUROSCI, V15, P7121; Robitaille R, 1996, J NEUROSCI, V16, P148; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Ruberti F, 1997, DEV BRAIN RES, V101, P295, DOI 10.1016/S0165-3806(97)00082-5; SALTER MW, 1995, J NEUROSCI, V15, P2961; SASAKI K, 1995, BRAIN RES BULL, V38, P185, DOI 10.1016/0361-9230(95)00092-S; SILINSKY EM, 1989, BRIT J PHARMACOL, V97, P16, DOI 10.1111/j.1476-5381.1989.tb11918.x; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; Vernadakis A, 1996, PROG NEUROBIOL, V49, P185, DOI 10.1016/S0301-0082(96)00012-3; YOSHINO M, 1995, EXP PHYSIOL, V80, P575, DOI 10.1113/expphysiol.1995.sp003868; YU PR, 1995, AM J PHYSIOL-GASTR L, V269, pG659, DOI 10.1152/ajpgi.1995.269.5.G659; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	49	192	195	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					847	855		10.1016/S0896-6273(00)80600-5	http://dx.doi.org/10.1016/S0896-6273(00)80600-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808470	Bronze			2022-12-24	WOS:000076697300027
J	Takahashi, T; Nakamura, F; Jin, Z; Kalb, RG; Strittmatter, SM				Takahashi, T; Nakamura, F; Jin, Z; Kalb, RG; Strittmatter, SM			Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors	NATURE NEUROSCIENCE			English	Article							PERIPHERAL-NERVE PROJECTION; GROWTH CONE COLLAPSE; HERPES-SIMPLEX VIRUS; AXON GUIDANCE; DEVELOPING CHICK; FAMILY; EXPRESSION; PROTEIN; MEMBER; SYSTEM	Neuropilin-1 (NP-1) has been identified as a necessary component of a semaphorin D (SemD) receptor; that repulses dorsal root ganglion (DRG) axons during development. SemA and SemE are related to SemD and bind to NP-1, but do not repulse DRG axons. By expressing NP-1 in retinal neurons and NP-2 in DRG neurons, we demonstrate that neuropilins are sufficient to determine the functional specificity of semaphorin responsiveness. SemA and SemE block SemD binding to NP-1 and abolish SemD repulsion in axons expressing NP-1. SemA and SemE seem to have a newly discovered protein antagonist capacity at NP-1 receptors, whereas they act as agonists at receptors containing NP-2.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, POB 208018,333 Cedar St, New Haven, CT 06520 USA.	stephen_stritmatter@qm.yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; DODD J, 1995, CELL, V81, P471, DOI 10.1016/0092-8674(95)90066-7; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Furuyama T, 1996, J BIOL CHEM, V271, P33376, DOI 10.1074/jbc.271.52.33376; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; INAGAKI S, 1995, FEBS LETT, V370, P269, DOI 10.1016/0014-5793(95)00850-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kikuchi K, 1997, MOL BRAIN RES, V51, P229, DOI 10.1016/S0169-328X(97)00251-9; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kolodkin AL, 1997, NEURON, V19, P1159, DOI 10.1016/S0896-6273(00)80408-0; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Lim F, 1996, BIOTECHNIQUES, V20, P460; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; STRITTMATTER SM, 1994, J NEUROSCI, V14, P5503; TAKAGI S, 1987, DEV BIOL, V122, P90, DOI 10.1016/0012-1606(87)90335-6; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; Takahashi T, 1997, J NEUROSCI, V17, P9183; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713	40	199	203	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					487	493		10.1038/2203	http://dx.doi.org/10.1038/2203			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196546				2022-12-24	WOS:000076406900013
J	Hahn, TM; Breininger, JF; Baskin, DG; Schwartz, MW				Hahn, TM; Breininger, JF; Baskin, DG; Schwartz, MW			Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons	NATURE NEUROSCIENCE			English	Article							NEUROPEPTIDE-Y; MESSENGER-RNA; ARCUATE NUCLEUS; EXPRESSION; LEPTIN; OBESITY; AGOUTI; MICE; RECEPTOR; MOUSE		Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98108 USA; Univ Washington, Harborview Med Ctr, Dept Biol Struct, Seattle, WA 98108 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Schwartz, MW (corresponding author), Univ Washington, Harborview Med Ctr, Dept Med, 1660 S Columbian Way, Seattle, WA 98108 USA.		Schwartz, Michael W/H-9950-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052989, R01DK012829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032273, R29NS032273] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-12829, DK-52989] Funding Source: Medline; NINDS NIH HHS [NS-32273] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1997, NEW ENGL J MED, V336, P1802, DOI 10.1056/NEJM199706193362507; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; STANLEY BG, 1986, PEPTIDES, V7, P1189; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; WHITE J D, 1990, Molecular and Cellular Neuroscience, V1, P41; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939	15	862	884	1	48	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					271	272		10.1038/1082	http://dx.doi.org/10.1038/1082			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195157				2022-12-24	WOS:000076361300007
J	Sun, HJ; Frost, BJ				Sun, HJ; Frost, BJ			Computation of different optical variables of looming objects in pigeon nucleus rotundus neurons	NATURE NEUROSCIENCE			English	Article							ORTHOPTERAN DCMD NEURON; APPROACHING OBJECTS; MOVING-OBJECTS; FLOW-FIELD; TIME; RESPONSES; MOTION; REEVALUATION; COLLISION; EXPANSION	Three types of looming-selective neurons have been found in the nucleus rotundus of pigeons, each computing a different optical variable related to image expansion of objects approaching on a direct collision course with the bird. None of these neurons respond to simulated approach toward stationary objects. A detailed analysis of these neurons' firing pattern to approaching objects of different sizes and velocities shows that one group of neurons signals relative rate of expansion tau (tau), a second group signals absolute rate of expansion rho (rho), and a third group signals yet another optical variable eta (eta). The rho parameter is required for the computation of both tau and eta, whose respective ecological functions probably provide precise 'time-to-collision' information and 'early warning' detection for large approaching objects.	Queens Univ, Dept Psychol, Visual & Audit Neurosci Lab, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Frost, BJ (corresponding author), Queens Univ, Dept Psychol, Visual & Audit Neurosci Lab, Kingston, ON K7L 3N6, Canada.	Frost@pavlov.psyc.queensu.ca						BALL W, 1971, SCIENCE, V171, P818, DOI 10.1126/science.171.3973.818; BOWER TGR, 1970, PERCEPT PSYCHOPHYS, V9, P193; DILL LM, 1974, ANIM BEHAV, V22, P771; Frost B.J., 1994, P248; Frost BJ, 1997, FROM LIVING EYES TO SEEING MACHINES, P80; Gibson JJ, 1979, ECOLOGICAL APPROACH; Gibson JJ., 1966, SENSES CONSIDERED PE; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; HAYES WN, 1967, ANIM BEHAV, V15, P102, DOI 10.1016/S0003-3472(67)80018-6; Ingle DJ, 1985, BRAIN MECH SPATIAL V, P229; Lee D.N., 1985, BRAIN MECH SPATIAL V, P1, DOI 10.1007/978-94-009-5071-9_1; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1982, J EXP PSYCHOL HUMAN, V8, P448; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; LONGUETHIGGINS HC, 1980, P R SOC LOND B, V206, P358; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; REGAN D, 1993, VISION RES, V33, P447, DOI 10.1016/0042-6989(93)90252-R; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; ROBERTSON RM, 1993, NATURWISSENSCHAFTEN, V80, P176, DOI 10.1007/BF01226378; ROY JP, 1990, NATURE, V348, P160, DOI 10.1038/348160a0; SCHIFF W, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093887; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; SIMMONS PJ, 1992, J NEUROPHYSIOL, V68, P1667, DOI 10.1152/jn.1992.68.5.1667; SUN HJ, 1992, EXP BRAIN RES, V91, P171; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TRESILIAN JR, 1993, PERCEPTION, V22, P653, DOI 10.1068/p220653; TRONICK E, 1967, J COMP PHYSIOL PSYCH, V64, P529, DOI 10.1037/h0025206; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; WANG YC, 1993, VISUAL NEUROSCI, V10, P21, DOI 10.1017/S0952523800003199; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0; Wann JP, 1996, J EXP PSYCHOL HUMAN, V22, P1031, DOI 10.1037/0096-1523.22.4.1031; WYLIE DR, 1993, J NEUROPHYSIOL, V70, P2632, DOI 10.1152/jn.1993.70.6.2632	33	278	282	0	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					296	303		10.1038/1110	http://dx.doi.org/10.1038/1110			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195163				2022-12-24	WOS:000076361300013
J	Guo, S; Brush, J; Teraoka, H; Goddard, A; Wilson, SW; Mullins, MC; Rosenthal, A				Guo, S; Brush, J; Teraoka, H; Goddard, A; Wilson, SW; Mullins, MC; Rosenthal, A			Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein soulless/Phox2a	NEURON			English	Article							NEURAL CREST CELLS; BETA-HYDROXYLASE GENE; SEGMENTATION GENE; CHICK-EMBRYO; TRANSCRIPTION; EXPRESSION; PHOX2A; DIFFERENTIATION; NOREPINEPHRINE; PHENOTYPE	We report that the zebrafish mutation soulless, in which the development of locus coeruleus (LC) noradrenergic (NA) neurons failed to occur, disrupts the homeodomain protein Phox2a. Phox2a is not only necessary but also sufficient to induce Phox2b(+) dopamine-beta-hydroxylase(+) and tyrosine hydroxylase(+) NA neurons in ectopic locations. Phox2a is first detected in LC progenitors in the dorsal anterior hindbrain, and its expression there is dependent on FGF8 from the mid/hindbrain boundary and on optimal concentrations of BMP signal from the epidermal ectoderm/future dorsal neural plate junction. These findings suggest that Phox2a coordinates the specification of LC in part through the induction of Phox2b and in response to cooperating signals that operate along the mediolateral and anteroposterior axes of the neural plate.	Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Univ London Univ Coll, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of London; University College London; University of Pennsylvania	Rosenthal, A (corresponding author), Genentech Inc, Dept Neurosci, 1 DNA Way, San Francisco, CA 94080 USA.	ar@gene.com	Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008	Wilson, Stephen W/0000-0002-8557-5940	NIGMS NIH HHS [R01-GM56326] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson D, 1997, MOL CELLULAR APPROAC, P26; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BRIER B, 1998, CATECHOLAMINES BRIDG, P785; CHANPALAY V, 1991, PROG BRAIN RES, V88, P625; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dale L, 1999, SEMIN CELL DEV BIOL, V10, P319, DOI 10.1006/scdb.1999.0308; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Kim HS, 1998, J NEUROSCI, V18, P8247; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; LO LC, 1991, DEV BIOL, V145, P139, DOI 10.1016/0012-1606(91)90220-W; Lo LC, 1998, DEVELOPMENT, V125, P609; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; Martinez S, 1999, DEVELOPMENT, V126, P1189; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Mullins MC, 1996, DEVELOPMENT, V123, P81; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Reifers F, 1998, DEVELOPMENT, V125, P2381; REISSMAN E, 1998, DEVELOPMENT, V122, P2079; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Shamim H, 1999, DEVELOPMENT, V126, P945; Siegel JM, 1999, CELL, V98, P409, DOI 10.1016/S0092-8674(00)81969-8; Smeets W. J. A. J., 1994, PHYLOGENY DEV CATECH; Stanke M, 1999, DEVELOPMENT, V126, P4087; STERN CD, 1991, DEVELOPMENT, V113, P207; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; STRUDEL G, 1977, CR ACAD SCI D NAT, V284, P967; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Tiveron MC, 1996, J NEUROSCI, V16, P7649; VALARCHE I, 1993, DEVELOPMENT, V119, P881; VARLEY JE, 1995, DEV DYNAM, V203, P434, DOI 10.1002/aja.1002030406; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; Wilson PA, 1997, DEVELOPMENT, V124, P3177; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yang CY, 1998, J NEUROCHEM, V71, P1813; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zellmer E, 1995, J NEUROSCI, V15, P8109; ZHANG JM, 1992, BRAIN RES, V570, P251, DOI 10.1016/0006-8993(92)90588-Z; Zhang JM, 1997, J NEUROBIOL, V32, P262, DOI 10.1002/(SICI)1097-4695(199703)32:3<262::AID-NEU2>3.0.CO;2-5; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	51	182	188	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					555	566		10.1016/S0896-6273(00)81112-5	http://dx.doi.org/10.1016/S0896-6273(00)81112-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595509	Bronze			2022-12-24	WOS:000083913000013
J	Schulte, D; Furukawa, T; Peters, MA; Kozak, CA; Cepko, CL				Schulte, D; Furukawa, T; Peters, MA; Kozak, CA; Cepko, CL			Misexpression of the Emx-related homeobox genes cVax and mVax2 ventralizes the retina and perturbs the retinotectal map	NEURON			English	Article							RECEPTOR TYROSINE KINASES; VISUAL-SYSTEM; CHICK-EMBRYO; TRANSCRIPTION FACTORS; COMMISSURAL AXONS; PROJECTION MAP; EPH RECEPTORS; EYE ANLAGE; IN-VITRO; T-BOX	The mechanisms that establish the dorsal-ventral (D-V) axis of the eye are poorly understood. We isolated two homeobox genes from mouse and chicken, mVax2 and cVax, whose expression during early eye development is restricted to the ventral retina. In chick, ectopic expression of either Var leads to ventralization of the early retina, as assayed by expression of the transcription factors Pax2 and Tbx5, and the Eph family members EphB2, EphB3, ephrinB1, and ephrinB2, all of which are normally dorsally or ventrally restricted. Moreover, the projections of dorsal but not ventral ganglion cell axons onto the optic tectum showed profound targeting errors following cVax mis-expression, mVax2/cVax thus specify positional identity along the D-V axis of the retina and influence retinotectal mapping.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			Schulte, Dorothea/0000-0002-7243-6319	NATIONAL EYE INSTITUTE [T32EY007110] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EYO 7110] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Boncinelli E, 1995, CIBA F SYMP, V193, P100; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Brennan C, 1997, DEVELOPMENT, V124, P655; Bruhn SL, 1996, J NEUROSCI, V16, P1430; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Drager UC, 1998, J NUTR, V128, p463S, DOI 10.1093/jn/128.2.463S; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; DUTTING D, 1995, DEV BIOL, V167, P263, DOI 10.1006/dbio.1995.1022; Dutting D, 1995, INT J DEV BIOL, V39, P921; EKKER M, 1992, NEURON, V9, P27, DOI 10.1016/0896-6273(92)90217-2; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; Godbout R, 1996, DEV DYNAM, V205, P319, DOI 10.1002/(SICI)1097-0177(199603)205:3<319::AID-AJA11>3.0.CO;2-#; GOLDBERG S, 1976, DEV BIOL, V53, P126, DOI 10.1016/0012-1606(76)90214-1; Green E., 1981, GENETICS PROBABILITY, DOI 10.1007/978-1-349-04904-2; Hallonet M, 1998, DEVELOPMENT, V125, P2599; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Huh SO, 1999, DEV BIOL, V211, P53, DOI 10.1006/dbio.1999.9303; HYATT GA, 1992, P NATL ACAD SCI USA, V89, P8293, DOI 10.1073/pnas.89.17.8293; Hyatt GA, 1996, DEVELOPMENT, V122, P195; Isaac A, 1998, DEVELOPMENT, V125, P1867; KASTURY K, 1994, GENOMICS, V22, P41, DOI 10.1006/geno.1994.1343; Logan M, 1998, DEVELOPMENT, V125, P2825; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; MARSHARMSTRONG N, 1994, P NATL ACAD SCI USA, V91, P7286, DOI 10.1073/pnas.91.15.7286; MATSUNO T, 1992, NEUROSCI RES, V15, P96, DOI 10.1016/0168-0102(92)90022-5; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; Muramatsu T, 1998, INT J MOL MED, V1, P55; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NOMES HO, 1990, DEVELOPMENT, V109, P797; Ohsaki K, 1999, GENES CELLS, V4, P267, DOI 10.1046/j.1365-2443.1999.00257.x; Ohuchi H, 1998, DEVELOPMENT, V125, P51; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shimamura K, 1995, DEVELOPMENT, V121, P3923; SIMON H, 1995, CURR BIOL, V5, P205, DOI 10.1016/S0960-9822(95)00041-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; SZEL A, 1992, J COMP NEUROL, V325, P327, DOI 10.1002/cne.903250302; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0	55	140	143	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					541	553		10.1016/S0896-6273(00)81111-3	http://dx.doi.org/10.1016/S0896-6273(00)81111-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595508	Bronze			2022-12-24	WOS:000083913000012
J	Petersen, CI; DeFelice, LJ				Petersen, CI; DeFelice, LJ			Ionic interactions in the Drosophila serotonin transporter identify it as a serotonin channel	NATURE NEUROSCIENCE			English	Article							CALCIUM CHANNELS; FROG-MUSCLE; EXPRESSION; CLONING; SELECTIVITY; MEMBRANE; BINDING; 5-HYDROXYTRYPTAMINE; TRANSMISSION; LOCALIZATION	Serotonin transporters (SERTs) are targets for drugs such as Prozac that increase serotonin (5HT) levels by blocking 5HT reuptake. Although SERTs saturate in the micromolar range, synaptic 5HT may exceed 1 mM. To examine SERT's response to high 5HT concentrations, we expressed Drosophila SERT (dSERT) in Xenopus oocytes and found that transport continued to increase with concentration up to 0.3 mM 5HT. As 5HT is a monovalent cation, its entry through an ion channel in SERT might explain uptake at high concentrations. We therefore investigated dSERT using traditional ion channel methods, including mole-fraction experiments under voltage clamp. We propose that SERTs may function as 5HT-permeable channels, and that this mechanism may be important for clearance of the neurotransmitter at high concentrations.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	DeFelice, LJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.			De Felice, Louis/0000-0002-4594-3171	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007390] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-07390] Funding Source: Medline; NINDS NIH HHS [NS-34075] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIDLEY DJ, 1996, ION CHANNELS MOL ACT, P121; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Barker Eric L., 1995, P321; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; BRUNS D, 1993, NEURON, V10, P559, DOI 10.1016/0896-6273(93)90159-O; Bunin MA, 1998, J NEUROSCI, V18, P4854; Cammack JN, 1996, P NATL ACAD SCI USA, V93, P723, DOI 10.1073/pnas.93.2.723; Cao YW, 1997, J NEUROSCI, V17, P2257; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COOL DR, 1990, BIOCHEMISTRY-US, V29, P1818, DOI 10.1021/bi00459a022; COREY JL, 1994, P NATL ACAD SCI USA, V91, P1188, DOI 10.1073/pnas.91.3.1188; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; DEMCHYSHYN LL, 1994, P NATL ACAD SCI USA, V91, P5158, DOI 10.1073/pnas.91.11.5158; DUNCAN GE, 1992, BRAIN RES, V591, P181, DOI 10.1016/0006-8993(92)91699-F; ECCLES JC, 1958, PROC R SOC SER B-BIO, V148, P38, DOI 10.1098/rspb.1958.0003; FULLER RW, 1994, J PHARMACOL EXP THER, V269, P132; Galli A, 1997, J NEUROSCI, V17, P3401; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; GALLI A, 1999, PATCH CLAMP AMPEROME; GU H, 1994, J BIOL CHEM, V269, P7124; GUAN XM, 1988, BRAIN RES BULL, V21, P43, DOI 10.1016/0361-9230(88)90118-9; HAGIWARA S, 1974, J MEMBRANE BIOL, V18, P61, DOI 10.1007/BF01870103; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; Hille B, 1992, IONIC CHANNELS EXCIT, P362; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; HUMPHREYS CJ, 1988, MOL PHARMACOL, V33, P657; KEYES SR, 1982, J BIOL CHEM, V257, P1172; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; NEHER E, 1978, J MEMBRANE BIOL, V40, P97, DOI 10.1007/BF01871143; NELSON PJ, 1979, J BIOL CHEM, V254, P84; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Sonders MS, 1997, J NEUROSCI, V17, P960; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Su A, 1996, BIOPHYS J, V70, P762, DOI 10.1016/S0006-3495(96)79616-9; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X	37	55	55	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					605	610		10.1038/10158	http://dx.doi.org/10.1038/10158			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404179				2022-12-24	WOS:000083882600010
J	Beites, CL; Xie, H; Bowser, R; Trimble, WS				Beites, CL; Xie, H; Bowser, R; Trimble, WS			The septin CDCrel-1 binds syntaxin and inhibits exocytosis	NATURE NEUROSCIENCE			English	Article							CEREVISIAE CELL-CYCLE; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; GENE-PRODUCT; SYNAPTIC VESICLES; BUDDING SITE; BUD NECK; PROTEIN; COMPLEX; LOCALIZATION	Septins are GTPases required for the completion of cytokinesis in diverse organisms, yet their roles in cytokinesis or other cellular processes remain unknown. Here we describe studies of a newly identified septin, CDCrel-1, which is predominantly expressed in the nervous system. This protein was associated with membrane fractions, and a significant fraction of the protein copurified and coprecipitated with synaptic vesicles. In detergent extracts, CDCrel-1 and another septin, Nedd5, immunoprecipitated with the SNARE protein syntaxin by directly binding to syntaxin via the SNARE interaction domain. Transfection of HIT-T15 cells with wild-type CDCrel-1 inhibited secretion, whereas GTPase dominant-negative mutants enhanced secretion. These data suggest that septins may regulate vesicle dynamics through interactions with syntaxin.	Univ Toronto, Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Trimble, WS (corresponding author), Univ Toronto, Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.				NIA NIH HHS [AG13208] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R29AG013208] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BOWSER R, 1992, J CELL BIOL, V118, P1041, DOI 10.1083/jcb.118.5.1041; Burgess RW, 1997, J CELL BIOL, V138, P861, DOI 10.1083/jcb.138.4.861; Byers B, 1981, MOL BIOL YEAST SACCH, P59; BYERS B, 1976, J CELL BIOL, V70, P35; Caltagarone J, 1998, NEUROREPORT, V9, P2907, DOI 10.1097/00001756-199808240-00042; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; FARES H, 1995, MOL BIOL CELL, V6, P1843, DOI 10.1091/mbc.6.12.1843; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Honer WG, 1997, NEUROSCIENCE, V78, P99, DOI 10.1016/S0306-4522(96)00489-7; HONER WG, 1993, BRAIN RES, V609, P9, DOI 10.1016/0006-8993(93)90848-H; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Huang XH, 1998, MOL ENDOCRINOL, V12, P1060, DOI 10.1210/me.12.7.1060; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; McKie JM, 1997, HUM GENET, V101, P6, DOI 10.1007/s004390050576; MONCK JR, 1994, NEURON, V12, P707, DOI 10.1016/0896-6273(94)90325-5; NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SANDERS SL, 1994, CURR BIOL, V4, P907, DOI 10.1016/S0960-9822(00)00201-3; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weis WI, 1998, NATURE, V395, P328, DOI 10.1038/26354; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; XIE H, IN PRESS CELL MOTIL; Zieger B, 1997, J CLIN INVEST, V99, P520, DOI 10.1172/JCI119188	40	305	313	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					434	439		10.1038/8100	http://dx.doi.org/10.1038/8100			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321247				2022-12-24	WOS:000084609400013
J	Bazhenov, M; Timofeev, I; Steriade, M; Sejnowski, TJ				Bazhenov, M; Timofeev, I; Steriade, M; Sejnowski, TJ			Self-sustained rhythmic activity in the thalamic reticular nucleus mediated by depolarizing GABA(A) receptor potentials	NATURE NEUROSCIENCE			English	Article							PIG HIPPOCAMPAL SLICE; IN-VITRO; THALAMOCORTICAL OSCILLATIONS; SPINDLE RHYTHMICITY; IONIC MECHANISMS; AFTER-DISCHARGES; RELAY NEURONS; CURRENTS; MODEL; CAT	Intracellular recordings from reticular thalamic (RE) neurons in vivo revealed inhibitory postsynaptic potentials (IPSPs) between RE cells that reversed and became depolarizing at the hyperpolarized membrane potentials that occur during sleep. These excitatory IPSPs can directly trigger low-threshold spikes (LTSs). The oscillatory mechanisms underlying IPSP-triggered LTSs crowned by spike bursts were investigated in models of isolated RE networks. In a one-dimensional network model, external stimulation evoked waves of excitation propagating at a constant velocity of 25-150 cells per second. In a large-scale, two-dimensional model of the reticular nucleus, the network showed transient or self-sustained oscillations controlled by the maximum conductance of the low-threshold calcium current and the membrane potential. This model predicts that the isolated reticular nucleus could initiate sequences of spindle oscillations in thalamocortical networks in vivo.	Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Univ Laval, Sch Med, Neurophysiol Lab, Quebec City, PQ G1K 7P4, Canada; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; Laval University; University of California System; University of California San Diego	Bazhenov, M (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bazhenov@salk.edu	Timofeev, Igor/E-8828-2012; Timofeev, Igor/AAP-7529-2021; Sejnowski, Terrence/AAV-5558-2021	Timofeev, Igor/0000-0002-1389-5857				Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; Bazhenov M, 1998, J NEUROPHYSIOL, V79, P2730, DOI 10.1152/jn.1998.79.5.2730; BAZHENOV M, 1994, PHYSICA D, V73, P318, DOI 10.1016/0167-2789(94)90103-1; Budde T, 1997, J PHYSIOL-LONDON, V503, P79, DOI 10.1111/j.1469-7793.1997.079bi.x; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; CONTRERAS D, 1995, J NEUROSCI, V15, P604; COULLET P, 1989, PHYS REV LETT, V62, P1619, DOI 10.1103/PhysRevLett.62.1619; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Destexhe A, 1996, J NEUROSCI, V16, P169; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Golomb D, 1998, J NEUROPHYSIOL, V79, P1; GOLOMB D, 1994, J NEUROPHYSIOL, V72, P1109, DOI 10.1152/jn.1994.72.3.1109; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; MICHELSON HB, 1991, SCIENCE, V253, P1420, DOI 10.1126/science.1654594; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; QIAN N, 1990, P NATL ACAD SCI USA, V87, P8145, DOI 10.1073/pnas.87.20.8145; Rinzel J, 1998, SCIENCE, V279, P1351, DOI 10.1126/science.279.5355.1351; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 1997, THALAMUS ORG FUNCTIO; Steriade M., 1990, THALAMIC OSCILLATION; Timofeev I, 1998, J NEUROPHYSIOL, V79, P2716, DOI 10.1152/jn.1998.79.5.2716; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Traub R.D., 1991, NEURONAL NETWORKS HI; TRAUB RD, 1993, J PHYSIOL-LONDON, V472, P267, DOI 10.1113/jphysiol.1993.sp019946; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Ulrich D, 1996, P NATL ACAD SCI USA, V93, P13245, DOI 10.1073/pnas.93.23.13245; Ulrich D, 1997, J NEUROSCI, V17, P2348; Ulrich D, 1997, J NEUROPHYSIOL, V78, P1748, DOI 10.1152/jn.1997.78.3.1748; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WINFREE AT, 1987, WHEN TIME BREAKS DOW, P9103; Zhang SLJ, 1997, J NEUROPHYSIOL, V78, P2280, DOI 10.1152/jn.1997.78.5.2280	43	124	125	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					168	174		10.1038/5729	http://dx.doi.org/10.1038/5729			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195202				2022-12-24	WOS:000078231600017
J	Liao, DH; Zhang, XQ; O'Brien, R; Ehlers, MD; Huganir, RL				Liao, DH; Zhang, XQ; O'Brien, R; Ehlers, MD; Huganir, RL			Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; MOSSY FIBER; SPINAL NEURONS; DENTATE GYRUS; CELL-CULTURE; NMDA; RESPONSES; LIGHT; LTP	Many excitatory synapses are thought to be postsynaptically 'silent', possessing functional NMDA but lacking functional AMPA glutamate receptors. The acquisition of AMPA receptors at silent synapses may be important in synaptic plasticity and neuronal development. Here we characterize a possible morphological correlate of silent synapses in cultured hippocampal neurons. Initially, most excitatory synapses contained NMDA receptors, but only a few contained detectable AMPA receptors. Synapses progressively acquired AMPA receptors as the cultures matured. AMPA receptor blockade increased the number, size and fluorescent intensity of AMPA receptor clusters and rapidly induced the appearance of AMPA receptors at 'silent' synapses. In contrast, NMDA receptor blockade increased the size, intensity and number of NMDA receptor clusters and decreased the number of AMPA receptor clusters, resulting in an increase in the proportion of 'silent' synapses. These results suggest that the number of silent synapses is regulated during development and by changes in synaptic activity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.							AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Goslin K., 1991, CULTURING NERVE CELL, P251; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	38	331	344	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					37	43		10.1038/4540	http://dx.doi.org/10.1038/4540			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195178				2022-12-24	WOS:000078409300011
J	Alder, TB; Rose, GJ				Alder, TB; Rose, GJ			Long-term temporal integration in the anuran auditory system	NATURE NEUROSCIENCE			English	Article							SONG-SPECIFIC NEURONS; ZEBRA FINCH; FOREBRAIN; MIDBRAIN; PLASTICITY; PRINCIPLES; MECHANISMS; DURATION; SIGNALS; CORTEX	Analysis of the temporal structure of acoustic signals is important for the communication and survival of a variety of animals including humans. Recognition and discrimination of particular temporal patterns in sounds may involve integration of auditory information presented over hundreds of milliseconds or seconds. Here we show neural evidence for long-term integration in the anuran auditory system. The responses of one class of auditory neurons in the torus semicircularis (auditory midbrain) of frogs reflect the integration of information, gathered over approximately 45-150 ms, from a series of stimulus pulses, not stimulus energy. This integration process is fundamental to the selective responses of these neurons for particular call types.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Rose, GJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	gary.rose@m.cc.utah.edu						BRENOWITZ EA, 1994, ANIM BEHAV, V47, P633, DOI 10.1006/anbe.1994.1086; BULLOCK TH, 1986, BRAIN BEHAV EVOLUT, V28, P145, DOI 10.1159/000118699; CASSEDAY JH, 1994, SCIENCE, V264, P847, DOI 10.1126/science.8171341; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Gerhardt H.C., 1988, P455; GOOLER DM, 1992, J NEUROPHYSIOL, V67, P1, DOI 10.1152/jn.1992.67.1.1; Green DM, 1966, SIGNAL DETECTION THE; HUBER F, 1985, SCI AM, V253, P60, DOI 10.1038/scientificamerican1285-60; KLUMP GM, 1987, NATURE, V326, P286, DOI 10.1038/326286a0; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; LEE JM, 1994, J ACOUST SOC AM, V96, P2140, DOI 10.1121/1.410156; Lewicki MS, 1996, J NEUROSCI, V16, P5854; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Moss CF, 1995, **NON-TRADITIONAL**, P87; Olive J. P., 1993, ACOUSTICS AM ENGLISH; PIHEIRO AD, 1991, J COMP PHSL, V169, P69; Rauschecker JP, 1997, ACTA OTO-LARYNGOL, P34; ROSE G, 1983, SCIENCE, V219, P1087, DOI 10.1126/science.6600522; ROSE GJ, 1984, J COMP PHYSIOL, V154, P211, DOI 10.1007/BF00604986; Rose GJ, 1997, ANIM BEHAV, V53, P353, DOI 10.1006/anbe.1996.0400; ROSE GJ, 1985, J COMP PHYSIOL A, V157, P763, DOI 10.1007/BF01350073; SUGA N, 1989, J EXP BIOL, V146, P277; SUGA N, 1978, SCIENCE, V200, P778, DOI 10.1126/science.644320; VIEMEISTER NF, 1991, J ACOUST SOC AM, V90, P858, DOI 10.1121/1.401953; Walkowiak W., 1988, P275; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212	30	68	69	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					519	523		10.1038/2237	http://dx.doi.org/10.1038/2237			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196551				2022-12-24	WOS:000076406900018
J	Lin, JHC; Weigel, H; Cotrina, ML; Liu, SJ; Bueno, E; Hansen, AJ; Hansen, TW; Goldman, S; Nedergaard, M				Lin, JHC; Weigel, H; Cotrina, ML; Liu, SJ; Bueno, E; Hansen, AJ; Hansen, TW; Goldman, S; Nedergaard, M			Gap-junction-mediated propagation and amplification of cell injury	NATURE NEUROSCIENCE			English	Article							CEREBRAL BLOOD-FLOW; FOCAL ISCHEMIA; INFARCT VOLUME; CALCIUM; BCL-2; EXPRESSION; BRAIN; COMMUNICATION; DEATH; RAT	Gap junctions are conductive channels that connect the interiors of coupled cells. We determined whether gap junctions propagate transcellular signals during metabolic stress and whether such signaling exacerbates cell injury. Although overexpression of the human proto-oncogene bcl2 in C6 glioma cells normally increased their resistance to injury, the relative resistance of bcl2(+) cells to calcium overload, oxidative stress and metabolic inhibition was compromised when they formed gap junctions with more vulnerable cells. The likelihood of death was in direct proportion to the number and density of gap junctions with their less resistant neighbors. Thus, dying glia killed neighboring cells that would otherwise have escaped injury. This process of glial 'fratricide' may provide a basis for the secondary propagation of brain injury in cerebral ischemia.	New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA; Cornell Univ, Med Ctr, Dept Neurol & Neurosci, New York, NY 10021 USA; Novo Nordisk AS, DK-2750 Malev, Denmark	New York Medical College; New York Medical College; New York Medical College; Cornell University; Novo Nordisk	Lin, JHC (corresponding author), New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA.				PHS HHS [R0130007, R0135011] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Dermietzel R, 1998, GLIA, V24, P1, DOI 10.1002/(SICI)1098-1136(199809)24:1<1::AID-GLIA1>3.0.CO;2-A; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; GINSBERG MD, 1995, NEUROSCIENTIST, V1, P95; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Graham D.I., 1992, GREENFIELDS NEUROPAT, P153; Haugland R., 1996, HDB FLUORESCENT PROB; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; MIRABELLI F, 1988, BIOCHEM PHARMACOL, V37, P3423, DOI 10.1016/0006-2952(88)90691-0; Nadarajah B, 1996, J COMP NEUROL, V376, P326, DOI 10.1002/(SICI)1096-9861(19961209)376:2<326::AID-CNE13>3.0.CO;2-J; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; NEDERGAARD M, 1996, CELLULAR MOL MECH IS, P301; PREHN JHM, 1994, P NATL ACAD SCI USA, V91, P12599, DOI 10.1073/pnas.91.26.12599; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rohlmann A., 1996, GAP JUNCTIONS NERVOU, P175, DOI DOI 10.1007/978-3-662-21935-5_10; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; Saito R, 1997, J CEREBR BLOOD F MET, V17, P857, DOI 10.1097/00004647-199708000-00004; SIESJO BK, 1995, ANN THORAC SURG, V59, P1316, DOI 10.1016/0003-4975(95)00077-X; SULLIVAN R, 1995, J CELL BIOL, V130, P419, DOI 10.1083/jcb.130.2.419; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Venance L, 1997, J NEUROSCI, V17, P1981; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; WARNER DS, 1995, ANESTHESIOLOGY, V82, P1237, DOI 10.1097/00000542-199505000-00019; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	36	395	423	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					494	500		10.1038/2210	http://dx.doi.org/10.1038/2210			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196547				2022-12-24	WOS:000076406900014
J	Rioult-Pedotti, MS; Friedman, D; Hess, G; Donoghue, JP				Rioult-Pedotti, MS; Friedman, D; Hess, G; Donoghue, JP			Strengthening of horizontal cortical connections following skill learning	NATURE NEUROSCIENCE			English	Article							RAT MOTOR CORTEX; LONG-TERM POTENTIATION; LTP INDUCTION; IN-VITRO; PLASTICITY; MAPS; NEURONS; REPRESENTATIONS; DEPENDENCE; CURRENTS	Learning a new motor skill requires an alteration in the spatiotemporal pattern of muscle activation. Motor areas of cerebral neocortex are thought to be involved in this type of learning, possibly by functional reorganization of cortical connections. Here we show that skill learning is accompanied by changes in the strength of connections within adult rat primary motor cortex (M1). Rats were trained for three or five days in a skilled reaching task with one forelimb, after which slices of motor cortex were examined to determine the effect of training on the strength of horizontal intracortical connections in layer II/III. The amplitude of field potentials in the forelimb region contralateral to the trained limb was significantly increased relative to the opposite 'untrained' hemisphere. No differences were seen in the hindlimb region. Moreover, the amount of long-term potentiation (LTP) that could be induced in trained M1 was less than in controls, suggesting that the effect of training was at least partly due to LTP-like mechanisms. These data represent the first direct evidence that plasticity of intracortical connections is associated with learning a new motor skill.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Jagiellonian Univ, Inst Zool, PL-31102 Krakow, Poland	Brown University; Jagiellonian University	Rioult-Pedotti, MS (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	mengia-rioult@brown.edu	Rioult-Pedotti, Mengia-Seraina/AAF-1377-2021; Hess, Grzegorz/HGQ-0966-2022		NINDS NIH HHS [NS22517] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022517] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; ARONIADOU VA, 1995, CEREB CORTEX, V5, P353, DOI 10.1093/cercor/5.4.353; Asanuma H, 1997, NEUROREPORT, V8, pR1; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Cohen L G, 1993, Adv Neurol, V63, P187; DARIAN SC, 1994, NATURE, V368, P737; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1994, J CLIN NEUROPHYSIOL, V11, P382; Donoghue JP, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P363; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Donoghue JP, 1997, CEREB CORTEX, V7, P97, DOI 10.1093/cercor/7.2.97; Garraghty P E, 1992, Curr Opin Neurobiol, V2, P522, DOI 10.1016/0959-4388(92)90191-M; Gilbert C D, 1993, Curr Opin Neurobiol, V3, P100, DOI 10.1016/0959-4388(93)90042-W; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KARNI A, 1995, NATURE, V377, P155; Kleim JA, 1996, J NEUROSCI, V16, P4529; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MERZENICH MM, 1988, NEUROBIOLOGY NEOCORT, P41; Morris RGM, 1991, LONG TERM POTENTIATI, P267; Nudo RJ, 1996, J NEUROSCI, V16, P785; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PRICE AW, 1981, BRAIN RES, V205, P81, DOI 10.1016/0006-8993(81)90721-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; WOODY CD, 1991, BRAIN RES, V539, P76, DOI 10.1016/0006-8993(91)90688-R; YOSHIMURA Y, 1994, J NEUROPHYSIOL, V71, P1638, DOI 10.1152/jn.1994.71.5.1638	33	512	517	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					230	234		10.1038/678	http://dx.doi.org/10.1038/678			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195148				2022-12-24	WOS:000076361200014
J	Stevens, CF; Zador, AM				Stevens, CF; Zador, AM			Input synchrony and the irregular firing of cortical neurons	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; NEOCORTICAL NEURONS; IN-VITRO; VARIABILITY; INTEGRATION; INHIBITION; POTENTIALS; NETWORK; SLICES; CELLS	Cortical neurons in the waking brain fire highly irregular, seemingly random, spike trains in response to constant sensory stimulation, whereas in vitro they fire regularly in response to constant current injection. To test whether, as has been suggested, this high in vivo variability could be due to the postsynaptic currents generated by independent synaptic inputs, we injected synthetic synaptic current into neocortical neurons in brain slices. We report that independent inputs cannot account for this high variability, but this variability can be explained by a simple alternative model of the synaptic drive in which inputs arrive synchronously. Our results suggest that synchrony may be important in the neural code by providing a means for encoding signals with high temporal fidelity over a population of neurons.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Zador, AM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	zador@salk.edu		Zador, Anthony/0000-0002-8431-9136	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BAIR W, 1996, NEURAL COMPUT, V8, P1184; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; Berretta N, 1996, J NEUROPHYSIOL, V76, P1089, DOI 10.1152/jn.1996.76.2.1089; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; BURGARD EC, 1993, J NEUROPHYSIOL, V70, P1841, DOI 10.1152/jn.1993.70.5.1841; BURNS BD, 1976, PROC R SOC SER B-BIO, V194, P211, DOI 10.1098/rspb.1976.0074; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Feller W., 1971, INTRO PROBABILITY TH, V2; GESHON ED, 1998, J NEUROPHYSIOL, V79, P1135; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; HUBBARD JI, 1968, J PHYSIOL-LONDON, V197, P639, DOI 10.1113/jphysiol.1968.sp008579; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; NELSON S, 1994, SCIENCE, V265, P74; NODA H, 1970, BRAIN RES, V18, P513, DOI 10.1016/0006-8993(70)90134-4; Nowak LG, 1997, CEREB CORTEX, V7, P487, DOI 10.1093/cercor/7.6.487; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Rieke F., 1997, SPIKES EXPLORING NEU; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; Softky W R, 1995, Curr Opin Neurobiol, V5, P239, DOI 10.1016/0959-4388(95)80032-8; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Tang AC, 1997, CEREB CORTEX, V7, P502, DOI 10.1093/cercor/7.6.502; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; USHER M, 1994, NEURAL COMPUT, V6, P795, DOI 10.1162/neco.1994.6.5.795; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; ZADOR A, 1998, J NEUROPHYSIOL, V19, P1230; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	43	376	380	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					210	217		10.1038/659	http://dx.doi.org/10.1038/659			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195145				2022-12-24	WOS:000076361200011
J	Choi, YB; Tenneti, L; Le, DA; Ortiz, J; Bai, G; Chen, HSV; Lipton, SA				Choi, YB; Tenneti, L; Le, DA; Ortiz, J; Bai, G; Chen, HSV; Lipton, SA			Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation	NATURE NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; METHYL-D-ASPARTATE; GLUTAMATE-RECEPTOR; REDOX MODULATION; SMOOTH-MUSCLE; INDUCED BLOCKADE; N-GLYCOSYLATION; NEUROTOXICITY; ACTIVATION; RELEASE	Several ion channels are thought to be directly modulated by nitric-oxide (NO), but the molecular basis of this regulation is unclear. Here we show that the NMDA receptor (NMDAR)-associated ion channel was modulated not only by exogenous NO but also by endogenous NO. Site-directed mutagenesis identified a critical cysteine residue (Cys 399) on the NR2A subunit whose S-nitrosylation (NO+ transfer) under physiological conditions underlies this modulation. In cell systems expressing NMDARs with mutant NR2A subunits in which this single cysteine was replaced by an alanine, the effect of endogenous NO was lost. Thus endogenous S-nitrosylation can regulate ion channel activity.	Brigham & Womens Hosp, Cerebrovasc & Neurosci Res Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lipton, SA (corresponding author), Burnham Inst, Del E Webb Ctr Neurosci & Aging Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		le, da/GSI-8607-2022	Lipton, Stuart/0000-0002-3490-1259	NEI NIH HHS [R01 EY09024, R01 EY05477] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477, R01EY009024] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Aizenman E, 1999, BRIT J PHARMACOL, V126, P296, DOI 10.1038/sj.bjp.0702295; Aizenman E, 1998, PROG BRAIN RES, V118, P53; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BOLOTINA VM, 1994, NATURE, V368, P520; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Bredt DS, 1992, NEURON, V8, P3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dawson D. M., 1993, International Journal of Robotics & Automation, V8, P13; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; DINGLEDINE R, 1990, TRENDS PHARMACOL SCI, V11, P334, DOI 10.1016/0165-6147(90)90238-4; FAGNI L, 1995, MOL PHARMACOL, V47, P1239; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GASTON B, 1994, J PHARMACOL EXP THER, V268, P978; HOLLAND A, 1994, ENVIRON VALUE, V3, P1; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HOYT KR, 1992, BRAIN RES, V592, P310, DOI 10.1016/0006-8993(92)91690-G; KENDRICK KM, 1996, EUR J NEUROSCI, V8, P1619; Koh SD, 1995, J PHYSIOL-LONDON, V489, P735, DOI 10.1113/jphysiol.1995.sp021087; KOIVISTO A, 1995, J PHYSIOL-LONDON, V486, P59, DOI 10.1113/jphysiol.1995.sp020790; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; KURENNY DE, 1994, NEURON, V13, P315, DOI 10.1016/0896-6273(94)90349-2; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 1998, PROG BRAIN RES, V118, P73; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MANZONI O, 1993, J NEUROCHEM, V61, P368, DOI 10.1111/j.1471-4159.1993.tb03580.x; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; OMEROVIC A, 1995, J RECEPT SIGNAL TR R, V15, P811, DOI 10.3109/10799899509049859; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1996, METHODS NITRIC OXIDE, P521; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Takeuchi T, 1996, BRIT J PHARMACOL, V117, P1204, DOI 10.1111/j.1476-5381.1996.tb16717.x; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yuan XJ, 1996, P NATL ACAD SCI USA, V93, P10489, DOI 10.1073/pnas.93.19.10489	50	345	358	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					15	21		10.1038/71090	http://dx.doi.org/10.1038/71090			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607390				2022-12-24	WOS:000085810200007
J	Hynes, M; Ye, WL; Wang, K; Stone, D; Murone, M; de Sauvage, F; Rosenthal, A				Hynes, M; Ye, WL; Wang, K; Stone, D; Murone, M; de Sauvage, F; Rosenthal, A			The seven-transmembrane receptor Smoothened cell-autonomously induces multiple ventral cell types	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURON INDUCTION; SONIC-HEDGEHOG; FLOOR PLATE; POLARIZING ACTIVITY; CANDIDATE GENE; PATCHED GENE; SPINAL-CORD; HOMEO BOX; EXPRESSION; PATTERN	Sonic Hedgehog (Shh) is a secreted protein that controls cell fate and mitogenesis in the developing nervous system. Here we show that a constitutively active form of Smoothened (Smo-M2) mimics concentration-dependent actions of Shh in the;developing neural tube, including activation of ventral marker genes (HNF3 beta, patched, Nkx2.2, netrin-1), suppression of dorsal markers (Pax-3, Gli-3, Ephrin A5) and induction of ventral neurons (dopaminergic, serotonergic) and ventrolateral motor neurons (Islet-1+, Islet-2+, HB9+) and interneurons (Engrailed-1+, CHX10+). Furthermore, Smo-M2's patterning activities were cell autonomous, occurring exclusively in cells expressing Smo-M2 These findings suggest that Smo is a key signaling component in the Hh receptor and that Shh patterns the vertebrate nervous system as a morphogen, rather than through secondary relay signals.	Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Hynes, M (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	mah@gene.com; ar@gene.com		Ye, Weilan/0000-0002-6219-3982; Hynes, Mary/0000-0001-6623-6727; Wang, Kevin/0000-0002-9343-6473				Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Johnson RL, 1995, DEVELOPMENT, V121, P4161; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Marigo V, 1996, DEVELOPMENT, V122, P1225; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Struhl G, 1997, DEVELOPMENT, V124, P2155; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Tremblay P, 1996, DEVELOPMENT, V122, P2555; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; Yang Y, 1997, DEVELOPMENT, V124, P4393; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; [No title captured]	49	121	126	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					41	46		10.1038/71114	http://dx.doi.org/10.1038/71114			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607393				2022-12-24	WOS:000085810200010
J	Crowley, JC; Katz, LC				Crowley, JC; Katz, LC			Development of ocular dominance columns in the absence of retinal input	NATURE NEUROSCIENCE			English	Article							DORSAL LATERAL GENICULATE; BINOCULAR IMPULSE BLOCKADE; FERRET VISUAL-CORTEX; STRIATE CORTEX; BILATERAL ENUCLEATION; POSTNATAL-DEVELOPMENT; MAMMALIAN RETINA; GANGLION-CELLS; NUCLEUS; MONKEY	The initial establishment of ocular dominance columns in visual cortex is believed to involve the segregation of overlapping geniculocortical axons into eye-specific patches based on patterns of correlated activity. However, we found that total removal of retinal influence early in visual development did not prevent segregation of geniculocortical axons into alternating stripes with periodicity normal for ocular dominance columns. Because the patterning of geniculocortical afferents resists this dramatic change in the level, source and pattern of spontaneous activity, we propose that formation of ocular dominance columns relies on molecular cues present on thalamic axons, cortical cells or both.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Crowley, JC (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3209, Durham, NC 27710 USA.				NATIONAL EYE INSTITUTE [R01EY007960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012359] Funding Source: NIH RePORTER; NEI NIH HHS [EYO7960] Funding Source: Medline; NIMH NIH HHS [MH12359] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; BRUNSOBECHTOLD JK, 1981, NEUROSCIENCE, V6, P2579, DOI 10.1016/0306-4522(81)90103-2; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dehay C, 1996, J COMP NEUROL, V367, P70, DOI 10.1002/(SICI)1096-9861(19960325)367:1<70::AID-CNE6>3.0.CO;2-G; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Erwin E, 1998, J NEUROSCI, V18, P9870; Finney EM, 1998, J NEUROSCI, V18, P8826; FITZPATRICK D, 1983, J NEUROSCI, V3, P673; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; GUILLERY RW, 1985, J NEUROSCI, V5, P1370; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; Horton JC, 1996, J NEUROSCI, V16, P7228; Horton JC, 1996, J NEUROSCI, V16, P1791; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; JACKSON CA, 1989, J NEUROSCI, V9, P1242; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; KULJIS RO, 1990, P NATL ACAD SCI USA, V87, P5303, DOI 10.1073/pnas.87.14.5303; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCCORMICK DA, 1995, J NEUROSCI, V15, P5739; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; REDIES C, 1990, J NEUROSCI, V10, P2791; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	50	176	179	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1125	1130		10.1038/16051	http://dx.doi.org/10.1038/16051			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570491				2022-12-24	WOS:000085810100018
J	Helmchen, F; Svoboda, K; Denk, W; Tank, DW				Helmchen, F; Svoboda, K; Denk, W; Tank, DW			In vivo dendritic calcium dynamics in deep-layer cortical pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; IN-VIVO; NEOCORTICAL NEURONS; APICAL DENDRITES; SENSORIMOTOR CORTEX; SYNAPTIC RESPONSES; INHIBITORY CONTROL; CA2+ CHANNELS; MOTOR CORTEX; RAT	Dendritic Ca2+ action potentials in neocortical pyramidal neurons have been characterized in brain slices, but their presence and role in the intact neocortex remain unclear. Here we used two-photon microscopy to demonstrate Ca2+ electrogenesis in apical dendrites of deep-layer pyramidal neurons of rat barrel cortex in vive. During whisker stimulation, complex spikes recorded intracellularly from distal dendrites and sharp waves in the electrocorticogram were accompanied by large dendritic [Ca2+] transients; these also occurred during bursts of action potentials recorded from somata of identified layer 5 neurons. The amplitude of the [Ca2+] transients was largest proximal to the main bifurcation, where sodium action potentials produced little Ca2+ influx. In some cases, synaptic stimulation evoked [Ca2+] transients without a concomitant action potential burst, suggesting variable coupling between dendrite and soma.	Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Cold Spring Harbor Laboratory	Helmchen, F (corresponding author), Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA.		denk, winfried/I-6627-2012; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569				AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1850, DOI 10.1152/jn.1993.69.6.1850; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; CAULLER LJ, 1994, J NEUROSCI, V14, P751; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; FRANCESCHETTI S, 1995, BRAIN RES, V696, P127, DOI 10.1016/0006-8993(95)00807-3; FRIEDMAN A, 1989, EUR J NEUROSCI, V1, P374, DOI 10.1111/j.1460-9568.1989.tb00802.x; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; Kandel A, 1997, J NEUROSCI, V17, P6783; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASON A, 1990, J NEUROSCI, V10, P1415; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; NUNEZ A, 1993, J NEUROPHYSIOL, V70, P418, DOI 10.1152/jn.1993.70.1.418; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Pare D, 1998, EUR J NEUROSCI, V10, P3164, DOI 10.1046/j.1460-9568.1998.00323.x; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; REUVENI I, 1993, J NEUROSCI, V13, P4609; RHODES PA, 1994, NEURAL COMPUT, V6, P1086, DOI 10.1162/neco.1994.6.6.1086; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; Seamans JK, 1997, J NEUROSCI, V17, P5936; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TSENG GF, 1993, J COMP NEUROL, V335, P92, DOI 10.1002/cne.903350107; WANG Z, 1993, J NEUROSCI, V13, P219; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	50	287	291	1	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					989	996		10.1038/14788	http://dx.doi.org/10.1038/14788			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526338				2022-12-24	WOS:000083883300016
J	Ishihara, T; Hong, M; Zhang, B; Nakagawa, Y; Lee, MK; Trojanowski, JQ; Lee, VMY				Ishihara, T; Hong, M; Zhang, B; Nakagawa, Y; Lee, MK; Trojanowski, JQ; Lee, VMY			Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform	NEURON			English	Article							PAIRED HELICAL FILAMENTS; AMYOTROPHIC LATERAL SCLEROSIS; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; PARKINSONISM-DEMENTIA; SUPRANUCLEAR PALSY; PROTEIN-TAU; FETAL TAU; PHOSPHORYLATION	Filamentous tau aggregates are hallmarks of tauopathies, e.g., frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and amyotrophic lateral sclerosis/parkinsonism-dementia complex (ALS/PDC). Since FTDP-17 tau gene mutations alter levels/functions of tau, we overexpressed the smallest human tau isoform in the CNS of transgenic (Tg) mice to model tauopathies. These mice acquired age-dependent CNS pathology similar to FTDP-17 and ALS/PDC, including insoluble, hyperphosphorylated tau and argyrophilic intraneuronal inclusions formed by tau-immunoreactive filaments. Inclusions were present in cortical and brainstem neurons but were most abundant in spinal cord neurons, where they were associated with axon degeneration, diminished microtubules (Mis), and reduced axonal transport in ventral roots, as well as spinal cord gliosis and motor weakness. These Tg mice recapitulate key features of tauopathies and provide models for elucidating mechanisms underlying diverse tauopathies, including Alzheimer's disease (AD).	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Neuropathol Lab, Baltimore, MD 21205 USA	University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.		Lee, Michael K/D-9491-2013	Lee, Michael K/0000-0001-5865-9682				ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brion JP, 1999, AM J PATHOL, V154, P255, DOI 10.1016/S0002-9440(10)65272-8; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Clark W, 1998, J AM ETHNIC HIST, V17, P95; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Goedert M., 1997, MOL GENETIC BASIS NE, P613; Goetz Juergen, 1995, EMBO (European Molecular Biology Organization) Journal, V14, P1304; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HIRANO A, 1961, BRAIN, V84, P642, DOI 10.1093/brain/84.4.642; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima M, 1999, NEUROREPORT, V10, P497, DOI 10.1097/00001756-199902250-00010; KATO T, 1986, ACTA NEUROPATHOL, V71, P11, DOI 10.1007/BF00687955; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; MATSUMOTO S, 1990, NEUROLOGY, V40, P975, DOI 10.1212/WNL.40.6.975; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; NAKAZATO Y, 1984, ACTA NEUROPATHOL, V64, P30, DOI 10.1007/BF00695603; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PERRY G, 1985, P NATL ACAD SCI USA, V82, P3916, DOI 10.1073/pnas.82.11.3916; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Reed LA, 1998, J NEUROPATH EXP NEUR, V57, P588, DOI 10.1097/00005072-199806000-00006; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; SCHMIDT ML, 1991, LAB INVEST, V64, P352; SCHMIDT ML, 1990, AM J PATHOL, V136, P1069; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; SHANKAR SK, 1989, ANN NEUROL, V25, P146, DOI 10.1002/ana.410250207; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; TOMONAGA M, 1977, ACTA NEUROPATHOL, V37, P177, DOI 10.1007/BF00692065; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; TU PH, 1995, J CELL BIOL, V129, P1629, DOI 10.1083/jcb.129.6.1629; Tu PH, 1997, LAB INVEST, V76, P441; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	47	453	474	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					751	762		10.1016/S0896-6273(00)81127-7	http://dx.doi.org/10.1016/S0896-6273(00)81127-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595524	Bronze			2022-12-24	WOS:000083913000028
J	Kim, SH; Wang, R; Gordon, DJ; Bass, J; Steiner, DF; Lynn, DG; Thinakaran, G; Meredith, SC; Sisodia, SS				Kim, SH; Wang, R; Gordon, DJ; Bass, J; Steiner, DF; Lynn, DG; Thinakaran, G; Meredith, SC; Sisodia, SS			Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia	NATURE NEUROSCIENCE			English	Article							CONSTITUTIVE SECRETORY PATHWAY; PSEUDOMONAS EXOTOXIN-A; PRECURSOR PROTEINS; SEQUENCE REQUIREMENTS; ENDOPROTEASE; GENE; ANGIOPATHY; EXPRESSION; RESISTANT; VIRUSES	The genetic lesion underlying familial British dementia (FBD), an autosomal dominant neurodegenerative disorder, is a T-A transversion at the termination codon of the BRI gene. The mutant gene encodes BRI-L, the precursor of ABri peptides that accumulate in amyloid deposits in FBD brain. We now report that both BRI-L and its wild-type counterpart, BRI, were constitutively processed by the proprotein convertase, furin, resulting in the secretion of carboxyl-terminal peptides that encompass all or part of ABri. Elevated levels of peptides were generated from the mutant BRI precursor. Electron microscopic studies revealed that synthetic ABri peptides assembled into irregular, short fibrils. Collectively, our results support the view that enhanced furin-mediated processing of mutant BRI generates fibrillogenic peptides that initiate the pathogenesis of FBD.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Med Scientists Training Program, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Rockefeller Univ, Lab Mass Spectrometry, New York, NY 10021 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; Rockefeller University	Sisodia, SS (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Abbott 316,947 E 58th St, Chicago, IL 60637 USA.		Wang, Rong/A-8721-2009	Gordon, David/0000-0003-1830-4371	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER; NIA NIH HHS [AG14248] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07281] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Duguay SJ, 1997, J BIOL CHEM, V272, P6663, DOI 10.1074/jbc.272.10.6663; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GRIFFITHS RA, 1982, J NEUROL NEUROSUR PS, V45, P396, DOI 10.1136/jnnp.45.5.396; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MOEHRING JM, 1983, INFECT IMMUN, V41, P998, DOI 10.1128/IAI.41.3.998-1009.1983; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SPENCE MJ, 1995, SOMAT CELL MOLEC GEN, V21, P1, DOI 10.1007/BF02255818; TAKAHASHI S, 1994, J BIOCHEM-TOKYO, V116, P47, DOI 10.1093/oxfordjournals.jbchem.a124501; Vidal R, 1999, NATURE, V399, P776; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; WATANABE T, 1993, FEBS LETT, V320, P215, DOI 10.1016/0014-5793(93)80589-M; WATANABE T, 1992, J BIOL CHEM, V267, P8270; Worster-Drought C, 1940, BRAIN, V63, P237, DOI 10.1093/brain/63.3.237; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	25	127	131	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					984	988		10.1038/14783	http://dx.doi.org/10.1038/14783			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526337				2022-12-24	WOS:000083883300015
J	Brennan, C; Rivas-Plata, K; Landis, SC				Brennan, C; Rivas-Plata, K; Landis, SC			The p75 neurotrophin receptor influences NT-3 responsiveness of sympathetic neurons in vivo	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; FOREBRAIN CHOLINERGIC NEURONS; AFFINITY NGF RECEPTOR; MICE LACKING; CELL-DEATH; SIGNAL-TRANSDUCTION; SURVIVAL; TRKA; EXPRESSION; ACTIVATION	To determine the role of the p75 neurotrophin receptor (p75(NTR)) in sympathetic neuron development, we crossed transgenic mice with mutations in p75(NTR), nerve growth factor (NGF) and neurotrophin-3 (NT-3). Neuron number is normal in sympathetic ganglia of adult p75(NTR-/-) mice. Mice heterozygous for a NGF deletion (NGF(+/-)) have 50% fewer sympathetic neurons. In the absence of p75(NTR) (P75(NTR-/-) NGF(+/-)), however, neuron number is restored to wild-type levels. When NT-3 levels are reduced (p75(NTR-/-) NGF(+/-) NT3(+/-)), neuron number decreases compared to p75(NTR-/-) NGF(+/-) NT3(+/+). Thus, without p75(NTR), NT3 substitutes for NGF, suggesting that p75 alters the neurotrophin specificity of TrkA in vivo.	NINDS, Neural Dev Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Brennan, C (corresponding author), NINDS, Neural Dev Sect, NIH, 36 Convent Dr,Bldg 36,Rm 2B08, Bethesda, MD 20892 USA.							ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Bergmann I, 1997, EUR J NEUROSCI, V9, P18, DOI 10.1111/j.1460-9568.1997.tb01349.x; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chen KS, 1997, J NEUROSCI, V17, P7288; CLARY DO, 1994, P NATL ACAD SCI USA, V91, P11133, DOI 10.1073/pnas.91.23.11133; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135; EMFORS P, 1994, CELL, V77, P503; Fagan AM, 1996, J NEUROSCI, V16, P6208; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Frade JM, 1996, NATURE, V383, P166; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; Horton A, 1997, MOL CELL NEUROSCI, V10, P162, DOI 10.1006/mcne.1997.0650; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Ladiwala U, 1998, J NEUROSCI, V18, P1297; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LEE KF, 1994, DEVELOPMENT, V120, P1027; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; Majdan M, 1997, J NEUROSCI, V17, P6988; Peterson DA, 1997, SCIENCE, V277, P837, DOI 10.1126/science.277.5327.837; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; WRIGHT LL, 1983, J NEUROCYTOL, V12, P727, DOI 10.1007/BF01258147; Wyatt S, 1997, EMBO J, V16, P3115, DOI 10.1093/emboj/16.11.3115; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Yoon SO, 1998, J NEUROSCI, V18, P3273	50	99	102	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					699	705		10.1038/11158	http://dx.doi.org/10.1038/11158			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412058				2022-12-24	WOS:000083882800008
J	De Weerd, P; Peralta, MR; Desimone, R; Ungerleider, LG				De Weerd, P; Peralta, MR; Desimone, R; Ungerleider, LG			Loss of attentional stimulus selection after extrastriate cortical lesions in macaques	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL CORTEX; AREA V4; INFEROTEMPORAL CORTEX; VISUAL-SEARCH; SHAPE-DISCRIMINATION; NEURAL MECHANISMS; CEREBRAL-CORTEX; NEURONS; MONKEY; COLOR	Many objects in natural visual scenes compete for attention. To identify the neural mechanisms necessary for visual attention, we made restricted lesions, affecting different quadrants of the visual field but leaving one quadrant intact, in extrastriate cortical areas V4 and TEO of two monkeys. Monkeys were trained to discriminate the orientation of a target grating surrounded by distracters. As distracter contrast increased, performance deteriorated in quadrants affected by V4 and TEO lesions, but not in the normal quadrant. Performance in affected quadrants was restored by increasing the contrast of the target relative to distracters. Thus, without V4 and TEO, visual attention is 'captured' by strong stimuli, regardless of their behavioral relevance.	NIMH, Lab Brain Cognit, Bethesda, MD 20892 USA; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	De Weerd, P (corresponding author), Univ Arizona, Coll Social & Behav Sci, Dept Psychol, POB 210068, Tucson, AZ 85721 USA.		Desimone, Robert/G-1121-2018					BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; BRITTEN KH, 1992, EXP BRAIN RES, V88, P292, DOI 10.1007/BF02259104; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; COWEY A, 1970, EXP BRAIN RES, V11, P128; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DEAN P, 1978, EXP BRAIN RES, V32, P445; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DESIMONE R, 1980, BRAIN RES, V184, P41, DOI 10.1016/0006-8993(80)90586-7; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; DeWeerd P, 1996, VISUAL NEUROSCI, V13, P529, DOI 10.1017/S0952523800008208; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; DRIVER J, 1989, J EXP PSYCHOL HUMAN, V15, P448, DOI 10.1037/0096-1523.15.3.448; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GAFFAN D, 1986, Q J EXP PSYCHOL-B, V38, P5; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; GATTASS R, 1988, J NEUROSCI, V8, P1831; Groh JM, 1996, CURR BIOL, V6, P1406, DOI 10.1016/S0960-9822(96)00743-9; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HEYWOOD CA, 1992, J NEUROSCI, V12, P4056; IWAI E, 1969, EXP NEUROL, V25, P585, DOI 10.1016/0014-4886(69)90101-0; JULESZ B, 1986, BIOL CYBERN, V54, P245, DOI 10.1007/BF00318420; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOMATSU H, 1993, J NEUROPHYSIOL, V70, P677, DOI 10.1152/jn.1993.70.2.677; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Merigan WH, 1996, VISUAL NEUROSCI, V13, P51, DOI 10.1017/S0952523800007124; MIYASHITA Y, 1993, NEUROPSYCHOLOGIA, V31, P1119, DOI 10.1016/0028-3932(93)90036-Y; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NAKAMURA H, 1993, J NEUROSCI, V13, P3681; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Reynolds JH, 1999, J NEUROSCI, V19, P1736; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; SCHILLER PH, 1993, VISUAL NEUROSCI, V10, P717, DOI 10.1017/S0952523800005423; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; WALSH V, 1992, BEHAV BRAIN RES, V50, P115, DOI 10.1016/S0166-4328(05)80293-1; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; WILD HM, 1985, NATURE, V313, P133, DOI 10.1038/313133a0; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	50	119	122	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					753	758		10.1038/11234	http://dx.doi.org/10.1038/11234			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FA	10412066				2022-12-24	WOS:000083882800016
J	Elias, CF; Aschkenasi, C; Lee, C; Kelly, J; Ahima, RS; Bjorbaek, C; Flier, JS; Saper, CB; Elmquist, JK				Elias, CF; Aschkenasi, C; Lee, C; Kelly, J; Ahima, RS; Bjorbaek, C; Flier, JS; Saper, CB; Elmquist, JK			Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area	NEURON			English	Article							PROOPIOMELANOCORTIN MESSENGER-RNA; MELANOCYTE-STIMULATING HORMONE; OBESE GENE-PRODUCT; NEUROPEPTIDE-Y; RAT-BRAIN; PARAVENTRICULAR NUCLEUS; MELANOCORTIN RECEPTORS; VENTROMEDIAL NUCLEUS; INSITU HYBRIDIZATION; MOUSE HYPOTHALAMUS	Recent studies have reinforced the view that the lateral hypothalamic area (LHA) regulates food intake and body weight. We identified leptin-sensitive neurons in the arcuate nucleus of the hypothalamus (Arc) that innervate the LHA using retrograde tracing with leptin administration. We found that retrogradely labeled cells in the Are contained neuropeptide Y (NPY) mRNA or proopiomelanocortin (POMC) mRNA. Following leptin administration, NPY cells in the Are did not express Fos but expressed suppressor of cytokine signaling-3 (SOCS-3) mRNA. In contrast, leptin induced both Fos and SOCS-3 expression in POMC neurons, many of which also innervated the LHA. These findings suggest that leptin directly and differentially engages NPY and POMC neurons that project to the LHA, linking circulating leptin and neurons that regulate feeding behavior and body weight homeostasis.	Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Elmquist, JK (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.		Saper, Clifford/L-3815-2019; Flier, jeffrey/AAG-6223-2019; Jansen, Heiko T./A-5770-2008; Bjorbaek, Christian/S-4727-2019; Ahima, Rexford/W-1394-2019	Jansen, Heiko T./0000-0003-0178-396X; Elias, Carol F/0000-0001-9878-9203	NIMH NIH HHS [MH44694, MH56537] Funding Source: Medline; NINDS NIH HHS [NS33987] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044694, R29MH056537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033987] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766; BILLINGTON CJ, 1994, AM J PHYSIOL, V266, pR1765, DOI 10.1152/ajpregu.1994.266.6.R1765; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Broberger C, 1998, J COMP NEUROL, V402, P460; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CANTERAS NS, 1992, J COMP NEUROL, V324, P195, DOI 10.1002/cne.903240205; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; Chan YY, 1996, ENDOCRINOLOGY, V137, P1319, DOI 10.1210/en.137.4.1319; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; CURRIE PJ, 1995, PEPTIDES, V16, P599, DOI 10.1016/0196-9781(95)00020-K; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; FOSTER DO, 1982, CAN J PHYSIOL PHARM, V60, P747, DOI 10.1139/y82-104; Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; GROSSMAN SP, 1978, SCIENCE, V202, P537, DOI 10.1126/science.705344; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kelly AB, 1996, J COMP NEUROL, V370, P231, DOI 10.1002/(SICI)1096-9861(19960624)370:2<231::AID-CNE7>3.0.CO;2-3; KITA H, 1982, BRAIN RES BULL, V8, P63, DOI 10.1016/0361-9230(82)90028-4; Lambert R., 1997, NEUROPEPTIDES, V31, P620; Ludwig DS, 1998, AM J PHYSIOL-ENDOC M, V274, pE627, DOI 10.1152/ajpendo.1998.274.4.E627; MARKS DL, 1992, MOL CELL NEUROSCI, V3, P395, DOI 10.1016/1044-7431(92)90051-3; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Peyron C, 1998, J NEUROSCI, V18, P9996; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Rossi M, 1997, ENDOCRINOLOGY, V138, P351, DOI 10.1210/en.138.1.351; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; SAWCHENKO PE, 1985, J COMP NEUROL, V241, P138, DOI 10.1002/cne.902410203; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; STANLEY BG, 1993, BRAIN RES, V604, P304; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; STRICKER EM, 1978, BRAIN RES, V158, P470, DOI 10.1016/0006-8993(78)90692-3; Stricker EM, 1976, PROGR PSYCHOBIOLOGY, P121; SWANSON LW, 1992, BRAIN MAPS STRUCTURE, V1; TATRO JB, 1987, ENDOCRINOLOGY, V121, P1900, DOI 10.1210/endo-121-5-1900; TATRO JB, 1990, BRAIN RES, V536, P124, DOI 10.1016/0006-8993(90)90016-5; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; TSUJII S, 1989, BRAIN RES BULL, V23, P165, DOI 10.1016/0361-9230(89)90142-1; UNGERSTEDT U, 1970, Acta Physiologica Scandinavica, V80, p35A, DOI 10.1111/j.1748-1716.1970.tb04858.x; van den Pol AN, 1999, J NEUROSCI, V19, P3171; vanDijk G, 1996, AM J PHYSIOL-REG I, V271, pR1096, DOI 10.1152/ajpregu.1996.271.4.R1096; VEENING JG, 1982, J COMP NEUROL, V206, P82, DOI 10.1002/cne.902060107; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; WISON BD, 1999, ENDOCRINOLOGY, V140, P2387; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	78	705	730	0	29	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					775	786		10.1016/S0896-6273(01)80035-0	http://dx.doi.org/10.1016/S0896-6273(01)80035-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482243	Bronze			2022-12-24	WOS:000082280900020
J	Banin, E; Cideciyan, AV; Aleman, TS; Petters, RM; Wong, F; Milam, AH; Jacobson, SG				Banin, E; Cideciyan, AV; Aleman, TS; Petters, RM; Wong, F; Milam, AH; Jacobson, SG			Retinal rod photoreceptor-specific gene mutation perturbs cone pathway development	NEURON			English	Article							RETINITIS-PIGMENTOSA; B-WAVE; TRANSGENIC MICE; RHODOPSIN MUTATIONS; MAMMALIAN RETINA; DEGENERATION; MODEL; ELECTRORETINOGRAM; PHOTOTRANSDUCTION; CELLS	Rod-specific photoreceptor dystrophies are complicated by the delayed death of genetically normal neighboring cones. In transgenic (Tg) swine with a rod-specific (rhodopsin) gene mutation, cone photoreceptor physiology was normal for months but later declined, consistent with delayed cone cell death. Surprisingly, cone postreceptoral function was markedly abnormal when cone photoreceptor physiology was still normal. The defect was localized to hyperpolarizing cells postsynaptic to the middle wavelength-sensitive cones. Recordings throughout postnatal development indicated a failure of cone circuitry maturation, a novel mechanism of secondary cone abnormality in rod dystrophy. The results have implications for therapy for human retinal dystrophies and raise the possibility that rod afferent activity plays a role in the postnatal maturation of cone retinal circuitry.	Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA; Duke Univ, Dept Neurobiol, Durham, NC 27710 USA	University of Pennsylvania; University of North Carolina; North Carolina State University; Duke University; Duke University	Jacobson, SG (corresponding author), Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA.	jacobsos@mail.med.upenn.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X	NEI NIH HHS [EY-05627, EY-09047, EY-11498] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011498, R01EY009047, R55EY009047] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ACLAND GM, 1987, EXP EYE RES, V44, P491, DOI 10.1016/S0014-4835(87)80160-4; Adler R, 1996, ARCH OPHTHALMOL-CHIC, V114, P79, DOI 10.1001/archopht.1996.01100130075012; BIRCH DG, 1987, VISION RES, V27, P1105, DOI 10.1016/0042-6989(87)90025-3; BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; Bisti S, 1998, J NEUROSCI, V18, P5019; BLANKS JC, 1974, J COMP NEUROL, V156, P95, DOI 10.1002/cne.901560108; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; Bush RA, 1996, J OPT SOC AM A, V13, P557, DOI 10.1364/JOSAA.13.000557; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 1996, VISION RES, V36, P2609, DOI 10.1016/0042-6989(95)00327-4; CIDECIYAN AV, 1993, INVEST OPHTH VIS SCI, V34, P3253; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; FALSINI B, 1994, INVEST OPHTH VIS SCI, V35, P4282; Farber DB, 1997, CURR OPIN NEUROBIOL, V7, P666, DOI 10.1016/S0959-4388(97)80087-6; Fletcher EL, 1997, J COMP NEUROL, V388, P1; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; GUREVICH L, 1993, VISION RES, V33, P2431, DOI 10.1016/0042-6989(93)90122-D; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; HOOD DC, 1990, VISION RES, V30, P51, DOI 10.1016/0042-6989(90)90127-7; Hood DC, 1996, J OPT SOC AM A, V13, P623, DOI 10.1364/JOSAA.13.000623; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Hood DC, 1996, VISION RES, V36, P1699, DOI 10.1016/0042-6989(95)00246-4; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; JACOBSON SG, 1987, DOC OPHTHALMOL, V65, P7, DOI 10.1007/BF00162715; JACOBSON SG, 1994, INVEST OPHTH VIS SCI, V35, P2521; JANSEN HG, 1992, J COMP NEUROL, V316, P117, DOI 10.1002/cne.903160110; Kedzierski W, 1998, J NEUROSCI, V18, P4076; KOMMONEN B, 1990, VISION RES, V30, P207, DOI 10.1016/0042-6989(90)90036-K; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Li ZY, 1998, INVEST OPHTH VIS SCI, V39, P808; MASLIM J, 1986, BRAIN RES, V373, P35, DOI 10.1016/0006-8993(86)90313-6; McCall MA, 1996, EXP EYE RES, V63, P35, DOI 10.1006/exer.1996.0089; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; Moon S. J., 1998, IOVS, V39, pS880; MURPHY CJ, 1987, VISION RES, V27, P599, DOI 10.1016/0042-6989(87)90045-9; NEITZ J, 1989, VISUAL NEUROSCI, V2, P97, DOI 10.1017/S0952523800011949; PAPERMASTER DS, 1995, INVEST OPHTH VIS SCI, V36, P977; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Redburn DA, 1996, INVEST OPHTH VIS SCI, V37, P1479; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; SIEVING PA, 1994, VISUAL NEUROSCI, V11, P519, DOI 10.1017/S0952523800002431; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; Tso M O, 1997, Trans Am Ophthalmol Soc, V95, P467; USUKURA J, 1994, CELL TISSUE RES, V275, P79, DOI 10.1007/BF00305377; Vaney DI, 1997, INVEST OPHTH VIS SCI, V38, P267; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wong F, 1997, PROG RETIN EYE RES, V16, P353, DOI 10.1016/S1350-9462(96)00032-8	53	65	69	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1999	23	3					549	557		10.1016/S0896-6273(00)80807-7	http://dx.doi.org/10.1016/S0896-6273(00)80807-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433266	hybrid			2022-12-24	WOS:000081701000018
J	Cesare, P; Dekker, LV; Sardini, A; Parker, PJ; McNaughton, PA				Cesare, P; Dekker, LV; Sardini, A; Parker, PJ; McNaughton, PA			Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat	NEURON			English	Article							PROTEIN-KINASE-C; ROOT GANGLION NEURONS; SENSORY NEURONS; NOCICEPTIVE NEURONS; ACTIVATED CURRENT; DOWN-REGULATION; BRADYKININ; RAT; TRANSDUCTION; MUTAGENESIS	Pain is unique among sensations in that the perceived intensity increases, or sensitizes, during exposure to a strong stimulus. One important mediator of sensitization is bradykinin (BK), a peptide released as a consequence of tissue damage. BK enhances the membrane ionic current activated by heat in nociceptive neurons, using a pathway that involves activation of protein kinase C (PKC). We find that five PKC isoforms are present in sensory neurons but that only PKC-epsilon is translocated to the cell membrane by BK. The heat response is sensitized when constitutively active PKC-epsilon is incorporated into nociceptive neurons. Conversely, BK-induced sensitization is suppressed by a specific peptide inhibitor of PKC-epsilon. We conclude that PKC-epsilon is principally responsible for sensitization of the heat response in nociceptors by bradykinin.	Univ London Kings Coll, Sch Biomed Sci, Neurosci Res Ctr, London WC2R 2LS, England; Imperial Canc Res Fund, Lincolns Inn Fields, London WC2A 3PX, England	University of London; King's College London; Cancer Research UK	McNaughton, PA (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.		Dekker, Lodewijk/J-6934-2013; Parker, Peter j/D-5192-2013	Dekker, Lodewijk/0000-0001-5247-3297; parker, peter/0000-0002-6218-2933; Cesare, Paolo/0000-0003-1324-5974; McNaughton, Peter/0000-0003-1946-9610				Ahlgren SC, 1997, NEUROSCIENCE, V76, P285; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1997, CURR OPIN NEUROBIOL, V7, P493, DOI 10.1016/S0959-4388(97)80028-1; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DEKKER LV, 1993, J BIOL CHEM, V268, P19498; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Gilabert R, 1997, J NEUROSCI METH, V71, P191, DOI 10.1016/S0165-0270(96)00144-6; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; Hurley JH, 1997, PROTEIN SCI, V6, P477; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Kirschstein T, 1997, NEUROSCI LETT, V231, P33, DOI 10.1016/S0304-3940(97)00533-8; KOLTZENBURG M, 1992, NEUROSCIENCE, V46, P465, DOI 10.1016/0306-4522(92)90066-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGNADO L, 1992, J PHYSIOL-LONDON, V455, P111, DOI 10.1113/jphysiol.1992.sp019293; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MEYER RA, 1994, TXB PAIN, P13; Mizumura K, 1996, PROG BRAIN RES, V113, P115, DOI 10.1016/S0079-6123(08)61084-5; Mizumura K, 1997, NEUROSCI LETT, V237, P29, DOI 10.1016/S0304-3940(97)00793-3; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; OLIVIER AR, 1991, EUR J BIOCHEM, V200, P805, DOI 10.1111/j.1432-1033.1991.tb16248.x; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; STERANKA LR, 1988, P NATL ACAD SCI USA, V85, P3245, DOI 10.1073/pnas.85.9.3245; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAYS DK, 1992, J BIOL CHEM, V267, P4799; YOUNG S, 1988, EUR J BIOCHEM, V173, P247, DOI 10.1111/j.1432-1033.1988.tb13991.x	36	328	339	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					617	624		10.1016/S0896-6273(00)80813-2	http://dx.doi.org/10.1016/S0896-6273(00)80813-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433272	Bronze			2022-12-24	WOS:000081701000024
J	Chapin, JK; Moxon, KA; Markowitz, RS; Nicolelis, MAL				Chapin, JK; Moxon, KA; Markowitz, RS; Nicolelis, MAL			Real-time control of a robot arm using simultaneously recorded neurons in the motor cortex	NATURE NEUROSCIENCE			English	Article							SOMATIC SENSORY TRANSMISSION; MOVEMENT; RAT; PATTERNS; RESTORATION; MODULATION; ENSEMBLES; THALAMUS	To determine whether simultaneously recorded motor cortex neurons can be used for real-time device control, rats were trained to position a robot arm to obtain water by pressing a lever. Mathematical transformations, including neural networks, converted multineuron signals into 'neuronal population functions' that accurately predicted lever trajectory. Next, these functions were electronically converted into real-time signals for robot arm control. After switching to this 'neurorobotic' mode, 4 of 6 animals (those with >25 task-related neurons) routinely used these brain-derived signals to position the robot arm and obtain water. With continued training in neurorobotic mode, the animals' lever movement diminished or stopped. These results suggest a possible means for movement restoration in paralysis patients.	MCP Hahnemann Sch Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Drexel University; Duke University	Chapin, JK (corresponding author), MCP Hahnemann Sch Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA.	chapinj@mcphu.edu	Moxon, Karen/K-7407-2012	Moxon, Karen/0000-0002-5790-097X	NINDS NIH HHS [NS26722, NS62352] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026722] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bhadra N, 1997, J CLIN NEUROPHYSIOL, V14, P378, DOI 10.1097/00004691-199709000-00004; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; CHAPIN JK, 1986, EXP NEUROL, V91, P502, DOI 10.1016/0014-4886(86)90048-8; Chapin JK, 1996, EEG CL N SU, P113; CHAPIN JK, 1982, EXP NEUROL, V78, P670, DOI 10.1016/0014-4886(82)90083-8; CHAPIN JK, 1998, NEURONAL POPULATION, P193; CHAPIN JK, 1987, NEURAL BEHAV APPROAC, P201; Deadwyler SA, 1997, ANNU REV NEUROSCI, V20, P217, DOI 10.1146/annurev.neuro.20.1.217; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1985, BRAIN RES, V333, P173, DOI 10.1016/0006-8993(85)90141-6; DORMONT JF, 1982, EXP BRAIN RES, V48, P315; ERICKSON RP, 1968, PSYCHOL REV, V75, P447, DOI 10.1037/h0026752; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FETZ E, 1972, BRAIN RES, V40, P19, DOI 10.1016/0006-8993(72)90100-X; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; FETZ EE, 1975, EXP BRAIN RES, V23, P217; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghez C, 1982, Electroencephalogr Clin Neurophysiol Suppl, V36, P409; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Lukashin AV, 1996, NEUROREPORT, V7, P2597, DOI 10.1097/00001756-199611040-00038; MOORE GP, 1966, ANNU REV PHYSIOL, V28, P493, DOI 10.1146/annurev.ph.28.030166.002425; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1993, P NATL ACAD SCI USA, V90, P2212, DOI 10.1073/pnas.90.6.2212; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Nicolelis MAL, 1997, J NEUROPHYSIOL, V78, P1691, DOI 10.1152/jn.1997.78.3.1691; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; SCHMIDT EM, 1980, ANN BIOMED ENG, V8, P339, DOI 10.1007/BF02363437; SCHMIDT EM, 1975, BRAIN RES, V83, P213, DOI 10.1016/0006-8993(75)90931-2; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHIN HC, 1990, EXP BRAIN RES, V81, P515, DOI 10.1007/BF02423500; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462	36	720	775	5	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					664	670		10.1038/10223	http://dx.doi.org/10.1038/10223			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404201				2022-12-24	WOS:000083882600019
J	Thompson-Schill, SL; D'Esposito, M; Kan, IP				Thompson-Schill, SL; D'Esposito, M; Kan, IP			Effects of repetition and competition on activity in left prefrontal cortex during word generation	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; BOLD FMRI STATISTICS; SHORT-TERM-MEMORY; ELECTRICAL-STIMULATION; ALZHEIMERS-DISEASE; SEMANTIC KNOWLEDGE; EMPIRICAL ANALYSES; CATEGORY FLUENCY; FIELD POTENTIALS; NULL-HYPOTHESIS	Neuroimaging studies have revealed an association between word generation and activity in the left inferior frontal gyrus (IFG) that is attentuated with item repetition. The experiment reported here examined the effects of repeated word generation, under conditions in which completion was either decreased or increased, on activity measured during whole-brain echoplanar functional magnetic resonance imaging. Activity in left IFG decreased during repetition conditions that reduced competition but increased during repetition conditions that increased competition; this pattern was contrasted to repetition effects observed in other cortical areas, specifically regions of left temporal cortex. The increase in left IFG activity, which is not predicted by a simple semantic retrieval account of prefrontal function, is consistent with the hypothesis that left IFG subserves the selection of semantic knowledge among competing alternatives.	Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thompson-Schill, SL (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	thompson@psych.upenn.edu	Thompson-Schill, Sharon/M-1788-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013483] Funding Source: NIH RePORTER; NIA NIH HHS [AG05743, AG13483] Funding Source: Medline; NINDS NIH HHS [NS01762] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Aguirre GK, 1997, NEUROIMAGE, V5, P199, DOI 10.1006/nimg.1997.0264; ALEXANDER MP, 1989, ARCH NEUROL-CHICAGO, V46, P885, DOI 10.1001/archneur.1989.00520440075023; ALEXANDER MP, 1997, BEHAV NEUROLOGY NEUR, P133; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; BOGEN JE, 1976, ANN NY ACAD SCI, V280, P834, DOI 10.1111/j.1749-6632.1976.tb25546.x; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; BURNSTINE TH, 1990, NEUROLOGY, V40, P966, DOI 10.1212/WNL.40.6.966; CHERTKOW H, 1990, BRAIN, V113, P397, DOI 10.1093/brain/113.2.397; COSLETT HB, 1991, ARCH NEUROL-CHICAGO, V48, P949, DOI 10.1001/archneur.1991.00530210075027; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; Dronkers N. F., 1998, HDB NEUROLINGUISTICS, DOI DOI 10.1016/B978-012666055-5/50015-0; Farah M.J., 1990, VISUAL AGNOSIA DISOR; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; GOLDENBERG G, 1994, BRAIN LANG, V47, P684, DOI 10.1006/brln.1994.1063; Goodglass H., 1983, ASSESSMENT APHASIA R, V2; HODGES JR, 1994, COGNITIVE NEUROPSYCH, V11, P505, DOI 10.1080/02643299408251984; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P1089, DOI 10.1136/jnnp.53.12.1089; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; KLEIN D, 1995, P NATL ACAD SCI USA, V92, P2899, DOI 10.1073/pnas.92.7.2899; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; LUDERS H, 1986, NEUROLOGY, V36, P505, DOI 10.1212/WNL.36.4.505; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; MARTIN A, 1999, IN PRESS COGNITIVE N; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; MILLER EK, 1993, J NEUROSCI, V13, P1460; MILLER EK, 1994, SCIENCE, V263, P520, DOI 10.1126/science.8290960; Milner B., 1964, FRONTAL GRANULAR COR, P313; MOSCOVITCH M, 1992, NEUROPSYCHOLOGY MEMO, P5; Mummery CJ, 1996, P ROY SOC B-BIOL SCI, V263, P989, DOI 10.1098/rspb.1996.0146; Newcombe F, 1969, MISSLE WOUNDS BRAIN; NOBRE AC, 1995, J NEUROSCI, V15, P1090; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Randolph C., 1993, NEUROPSYCHOLOGY, V7, P82, DOI [10.1037/0894-4105.7.1.82, DOI 10.1037/0894-4105.7.1.82]; RICHES IP, 1991, J NEUROSCI, V11, P1763; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; ROSSER A, 1994, J NEUROL NEUROSUR PS, V57, P1389, DOI 10.1136/jnnp.57.11.1389; SCARBOROUGH DL, 1979, MEM COGNITION, V7, P3, DOI 10.3758/BF03196928; SEGER CA, 1999, IN PRESS BRAIN COGN; SRINIVAS K, 1990, J MEM LANG, V29, P389, DOI 10.1016/0749-596X(90)90063-6; Swaab TY, 1998, NEUROPSYCHOLOGIA, V36, P737, DOI 10.1016/S0028-3932(97)00174-7; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1999, J EXP PSYCHOL LEARN, V25, P41, DOI 10.1037/0278-7393.25.1.41; Thompson-Schill SL, 1999, NEUROPSYCHOLOGIA, V37, P671, DOI 10.1016/S0028-3932(98)00126-2; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WELDON MS, 1991, J EXP PSYCHOL LEARN, V17, P526, DOI 10.1037/0278-7393.17.3.526; WERNICKE K, 1968, P BOST C PHIL SCI, V4, P34; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	60	401	403	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1999	23	3					513	522		10.1016/S0896-6273(00)80804-1	http://dx.doi.org/10.1016/S0896-6273(00)80804-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	221AA	10433263	Green Submitted, hybrid			2022-12-24	WOS:000081701000015
J	Liu, KS; Fetcho, JR				Liu, KS; Fetcho, JR			Laser ablations reveal functional relationships of segmental hindbrain neurons in zebrafish	NEURON			English	Article							RETICULOSPINAL COMMAND NEURON; CAENORHABDITIS-ELEGANS; MAUTHNER CELL; SPINAL-CORD; GOLDFISH; BEHAVIOR; ESCAPE; RESPONSES; PATHWAYS; CIRCUIT	Segmentation of the vertebrate brain is most obvious in the hindbrain, where successive segments contain repeated neuronal types. One such set of three repeated reticulospinal neurons - the Mauthner cell, MiD2cm, and MiD3cm - is thought to produce different forms of the escape response that fish use to avoid predators. We used laser ablations in larval zebrafish to test the hypothesis that these segmental hindbrain cells form a functional group. Killing all three cells eliminated short-latency, high-performance escape responses to both head- and tail-directed stimuli. Killing just the Mauthner cell affected escapes from tail-directed but not from head-directed stimuli. These results reveal the contributions of one set of reticulospinal neurons to behavior and support the idea that serially repeated hindbrain neurons form functional groups.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fetcho, JR (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.				NINDS NIH HHS [NS26539, R01 NS026539-25, R01 NS026539] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026539, R29NS026539, R37NS026539] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1991, NEURON, V7, P792; CHALFIE M, 1985, J NEUROSCI, V5, P956; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; DIDOMENICO R, 1988, BRAIN RES, V473, P15, DOI 10.1016/0006-8993(88)90310-1; EATON RC, 1985, BRAIN BEHAV EVOLUT, V27, P132, DOI 10.1159/000118726; EATON RC, 1991, J EXP BIOL, V161, P469; EATON RC, 1980, J COMP PHYSIOL, V140, P337, DOI 10.1007/BF00606273; EATON RC, 1982, J COMP PHYSIOL, V145, P485, DOI 10.1007/BF00612814; EATON RC, 1984, J COMP PHYSIOL, V155, P813, DOI 10.1007/BF00611598; EATON RC, 1981, J COMP PHYSIOL, V144, P521, DOI 10.1007/BF01326837; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; FETCHO JR, 1992, BRAIN BEHAV EVOLUT, V40, P82, DOI 10.1159/000113905; Fetcho JR, 1998, ANN NY ACAD SCI, V860, P333, DOI 10.1111/j.1749-6632.1998.tb09060.x; Fetcho JR, 1998, HISTOCHEM J, V30, P153, DOI 10.1023/A:1003243302777; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; Foreman M.B., 1993, J NEUROSCI, V13, P4104; Granato M, 1996, DEVELOPMENT, V123, P399; KIMMEL CB, 1982, J COMP NEUROL, V205, P112, DOI 10.1002/cne.902050203; KIMMEL CB, 1980, J COMP PHYSIOL, V140, P343, DOI 10.1007/BF00606274; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; METCALFE WK, 1986, J COMP NEUROL, V251, P147, DOI 10.1002/cne.902510202; NISSANOV J, 1990, BRAIN RES, V517, P88, DOI 10.1016/0006-8993(90)91012-6; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; SELVERSTON AI, 1980, J NEUROPHYSIOL, V44, P1102, DOI 10.1152/jn.1980.44.6.1102; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; Svoboda KR, 1996, J NEUROSCI, V16, P843; ZOTTOLI SJ, 1977, J EXP BIOL, V66, P243	27	293	299	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					325	335		10.1016/S0896-6273(00)80783-7	http://dx.doi.org/10.1016/S0896-6273(00)80783-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399938	Bronze, Green Submitted			2022-12-24	WOS:000081218600017
J	Garrity, PA; Lee, CH; Salecker, I; Robertson, HC; Desai, CJ; Zinn, K; Zipursky, SL				Garrity, PA; Lee, CH; Salecker, I; Robertson, HC; Desai, CJ; Zinn, K; Zipursky, SL			Retinal axon target selection in Drosophila is regulated by a receptor protein tyrosine phosphatase	NEURON			English	Article							GROWTH CONE GUIDANCE; 1ST OPTIC GANGLION; GLIAL-CELLS; PTP-SIGMA; MELANOGASTER; LAR; DIMERIZATION; INHIBITION; EXPRESSION; ELEGANS	Different Drosophila photoreceptors (R cells) connect to neurons in different optic lobe layers. R1-R6 axons project to the lamina; R7 and R8 axons project to separate layers of the medulla. We show a receptor tyrosine phosphatase, PTP69D, is required for lamina target specificity. In Ptp69D mutants, R1-R6 project through the lamina, terminating in the medulla. Genetic mosaics, transgene rescue, and immunolocalization indicate PTP69D functions in R1-R6 growth cones. PTP69D overexpression in R7 and R8 does not respecify their connections, suggesting PTP69D acts in combination with other factors to determine target specificity. Structure-function analysis indicates the extracellular fibronectin type III domains and intracellular phosphatase activity are required for targeting. We propose PTP69D promotes R1-R6 targeting in response to extracellular signals by dephosphorylating substrate(s) in R1-R6 growth cones.	Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Dept Biol Chem,Howard Hughes Med Inst, Los Angeles, CA 90095 USA; MIT, Dept Biol, Cambridge, MA 02138 USA; Vanderbilt Univ, Med Ctr, Ctr Molec Neurosci, Nashville, TN 37232 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Massachusetts Institute of Technology (MIT); Vanderbilt University; California Institute of Technology	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Dept Biol Chem,Howard Hughes Med Inst, Los Angeles, CA 90095 USA.		Lee, Chi-Hon/G-9190-2012; Salecker, Iris/V-1228-2018	Garrity, Paul/0000-0002-8274-6564; Zipursky, Stephen/0000-0001-5630-7181; Salecker, Iris/0000-0003-3775-7763; Lee, Chi-Hon/0000-0002-6138-711X	NIGMS NIH HHS [5 T32 GM07287-24] Funding Source: Medline; NINDS NIH HHS [R01 NS28128] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Bolz J, 1996, PROG BRAIN RES, V108, P41, DOI 10.1016/S0079-6123(08)62531-5; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chien CB, 1996, NEURON, V16, P1065, DOI 10.1016/S0896-6273(00)80131-2; DESAI CJ, 1994, J NEUROSCI, V14, P7272; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; HEBERLEIN U, 1990, P NATL ACAD SCI USA, V87, P5916, DOI 10.1073/pnas.87.15.5916; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Kashio N, 1998, J BIOL CHEM, V273, P33856, DOI 10.1074/jbc.273.50.33856; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; Meinertzhagen Ian A., 1993, P1363; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; MISMER D, 1987, GENETICS, V116, P565; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; STOKER AW, 1995, DEVELOPMENT, V121, P1833; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; WINBERG ML, 1992, DEVELOPMENT, V115, P903; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	39	126	126	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					707	717		10.1016/S0896-6273(00)80730-8	http://dx.doi.org/10.1016/S0896-6273(00)80730-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230791	Bronze			2022-12-24	WOS:000079976200014
J	Gould, E; Beylin, A; Tanapat, P; Reeves, A; Shors, TJ				Gould, E; Beylin, A; Tanapat, P; Reeves, A; Shors, TJ			Learning enhances adult neurogenesis in the hippocampal formation	NATURE NEUROSCIENCE			English	Article							NICTITATING-MEMBRANE RESPONSE; DENTATE GRANULE CELLS; RECEPTOR ACTIVATION; PSYCHOSOCIAL STRESS; BRAIN SYSTEMS; TOTAL NUMBER; GYRUS; RAT; NEURONS; MEMORY	Thousands of hippocampal neurons are born in adulthood, suggesting that new cells could be important for hippocampal function. To determine whether hippocampus-dependent learning affects adult-generated neurons, we examined the fate of new cells labeled with the thymidine analog bromodeoxyuridine following specific behavioral tasks. Here we report that the number of adult-generated neurons doubles in the rat dentate gyrus in response to training on associative learning tasks that require the hippocampus. In contrast, training on associative learning tasks that do not require the hippocampus did not alter the number of new cells. These findings indicate that adult-generated hippocampal neurons are specifically affected by, and potentially involved in, associative memory formation.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Neurosci, Piscataway, NJ 08854 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.				NIMH NIH HHS [MH52423, MH59970] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052423, R01MH059970] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BAYER SA, 1982, EXP BRAIN RES, V46, P315; Beylin AV, 1998, BEHAV NEUROSCI, V112, P1327, DOI 10.1037/0735-7044.112.6.1327; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Krugers HJ, 1997, HIPPOCAMPUS, V7, P427, DOI 10.1002/(SICI)1098-1063(1997)7:4<427::AID-HIPO8>3.3.CO;2-L; Kuhn HG, 1996, J NEUROSCI, V16, P2027; MARKOWSKA AL, 1993, BEHAV NEUROSCI, V107, P627; McCormick CM, 1997, BEHAV NEUROSCI, V111, P518; Milner B, 1972, Clin Neurosurg, V19, P421; MINTURN JE, 1995, J COMP NEUROL, V355, P369, DOI 10.1002/cne.903550304; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; SCHMALTZ LW, 1972, J COMP PHYSIOL PSYCH, V79, P328, DOI 10.1037/h0032531; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Shors TJ, 1998, LEARN MEMORY, V5, P220; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P241, DOI 10.1146/annurev.ne.05.030182.001325; Squire LR, 1997, PHILOS T R SOC B, V352, P1663, DOI 10.1098/rstb.1997.0148; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WEISS C, IN PRESS BEHAV BRAIN; WEISZ DJ, 1984, BEHAV BRAIN RES, V12, P145, DOI 10.1016/0166-4328(84)90037-8; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	34	1603	1675	1	129	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					260	265		10.1038/6365	http://dx.doi.org/10.1038/6365			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195219				2022-12-24	WOS:000081684500014
J	Hamann, SB; Ely, TD; Grafton, ST; Kilts, CD				Hamann, SB; Ely, TD; Grafton, ST; Kilts, CD			Amygdala activity related to enhanced memory for pleasant and aversive stimuli	NATURE NEUROSCIENCE			English	Article							AUTOMATED IMAGE REGISTRATION; DECLARATIVE MEMORY; LONG-TERM; FREE-RECALL; HUMANS; HIPPOCAMPAL; INFORMATION; MECHANISMS; VALIDATION; AROUSAL	Pleasant or aversive events are better remembered than neutral events. Emotional enhancement of episodic memory has been linked to the amygdala in animal and neuropsychological studies. Using positron emission tomography, we show that bilateral amygdala activity during memory encoding is correlated with enhanced episodic recognition memory for both pleasant and aversive visual stimuli relative to neutral stimuli, and that this relationship is specific to emotional stimuli. Furthermore, data suggest that the amygdala enhances episodic memory in part through modulation of hippocampal activity The human amygdala seems to modulate the strength of conscious memory for events according to emotional importance, regardless of whether the emotion is pleasant or aversive.	Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Ctr PET, Atlanta, GA 30322 USA	Emory University; Emory University	Hamann, SB (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.			Ely, Timothy/0000-0002-5690-5234				Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1990, BEHAV NEUROSCI, V104, P532, DOI 10.1037/0735-7044.104.4.532; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Center for the Study of Emotion and Attention National Institute of Mental Health, 1999, INT AFF PICT SYST; DAVIS M, 1992, P255; EICHENBAUM H, 1992, J COGNITIVE NEUROSCI, V4, P217, DOI 10.1162/jocn.1992.4.3.217; GAFFAN D, 1992, P471; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Ikemoto S, 1997, J NEUROSCI, V17, P8580; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Macmillan N. A., 1991, DETECTION THEORY USE; MAZZIOTTA JC, 1985, J CEREBR BLOOD F MET, V5, P70, DOI 10.1038/jcbfm.1985.10; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Merali Z, 1998, J NEUROSCI, V18, P4758; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Talairach I., 1988, COPLANAR STEREOTACTI; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	28	700	716	1	67	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					289	293		10.1038/6404	http://dx.doi.org/10.1038/6404			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	220TX	10195224				2022-12-24	WOS:000081684500019
J	Ito, M; Gilbert, CD				Ito, M; Gilbert, CD			Attention modulates contextual influences in the primary visual cortex of alert monkeys	NEURON			English	Article							CLASSICAL RECEPTIVE-FIELD; STATE DEPENDENT ACTIVITY; CAT STRIATE CORTEX; SELECTIVE ATTENTION; NEURONAL RESPONSES; NEURAL MECHANISMS; MACAQUE MONKEY; AREAS V1; ORIENTATION; STIMULI	The response properties of cells in the primary visual cortex (V1) were measured while the animals directed their attention either to the position of the neuron's receptive field (RF), to a position away from the RF (focal attention), or to four locations in the visual field (distributed attention). Over the population, varying attentional state had no significant effect on the response to an isolated stimulus within the RF but had a large influence on the facilitatory effects of contextual lines. We propose that the attentional modulation of contextual effects represents a gating of long range horizontal connections within area V1 by feedback connections to V1 and that this gating provides a mechanism for shaping responses under attention to stimulus configuration.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	gilbert@rookvax.rockefeller.edu						AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GULYAS B, 1987, J NEUROPHYSIOL, V57, P1767, DOI 10.1152/jn.1987.57.6.1767; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hillyard Steven A., 1995, P665; Ito M, 1998, NEURON, V20, P1191, DOI 10.1016/S0896-6273(00)80499-7; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kastner S, 1997, VISION RES, V37, P371, DOI 10.1016/S0042-6989(96)00184-8; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; NOTHDURFT HC, 1985, VISION RES, V25, P99, DOI 10.1016/0042-6989(85)90084-7; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TANAKA K, 1986, J NEUROSCI, V6, P134; TREISMAN A, 1992, AM J PSYCHOL, V105, P341, DOI 10.2307/1423032; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; ULLMAN S, 1990, COLD SH Q B, V55, P889; *US DHHS, 1985, US DHHS PUBL, V8623; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI 10.1037/11496-005; WOLBARSHT ML, 1960, SCIENCE, V132, P1309, DOI 10.1126/science.132.3436.1309; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Zipser K, 1996, J NEUROSCI, V16, P7376	49	322	326	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					593	604		10.1016/S0896-6273(00)80713-8	http://dx.doi.org/10.1016/S0896-6273(00)80713-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197538	Bronze, Green Published			2022-12-24	WOS:000079483900022
J	Sugita, S; Khvochtev, M; Sudhof, TC				Sugita, S; Khvochtev, M; Sudhof, TC			Neurexins are functional alpha-latrotoxin receptors	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; CELL-SURFACE PROTEINS; WIDOW SPIDER VENOM; BETA-NEUREXINS; I-ALPHA; EXOCYTOSIS; BINDING; ADHESION; RELEASE; SIGNAL	alpha-Latrotoxin is a potent neurotoxin that triggers synaptic exocytosis. Surprisingly, two distinct neuronal receptors for alpha-latrotoxin have been described: CIRL/latrophilin 1 (CL1) and neurexin-1 alpha, alpha-latrotoxin is thought to trigger exocytosis by binding to CL1,while the role of neurexin 1 alpha is uncertain. Using PC12 cells, we now demonstrate that neurexins indeed function as alpha-latrotoxin receptors that are at least as potent as CL1. Both alpha- and beta-neurexins represent autonomous alpha latrotoxin receptors that are regulated by alternative splicing. Similar to CL1, truncated neurexins without intracellular sequences are fully active; therefore, neurexins and CL1 recruit alpha-latrotoxin but are not themselves involved in exocytosis. Thus, alpha-latrotoxin is unique among neurotoxins, because it utilizes two unrelated receptors, probably to amplify recruitment of alpha-latrotoxin to active sites.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75235 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		; Khvotchev, Mikhail/G-5411-2013	Sugita, Shuzo/0000-0002-9182-873X; Khvotchev, Mikhail/0000-0001-9328-8549	NATIONAL INSTITUTE OF MENTAL HEALTH [S15MH050824] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50824] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bittner MA, 1998, J NEUROSCI, V18, P2914; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; DAVLETOV BA, 1995, J BIOL CHEM, V270, P23903, DOI 10.1074/jbc.270.41.23903; Geppert M, 1998, J BIOL CHEM, V273, P1705, DOI 10.1074/jbc.273.3.1705; Hata Y, 1996, J NEUROSCI, V16, P2488; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ichtchenko K, 1998, EMBO J, V17, P6188, DOI 10.1093/emboj/17.21.6188; KIYATKIN NI, 1990, FEBS LETT, V270, P127, DOI 10.1016/0014-5793(90)81250-R; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MELDOLESI J, 1983, NEUROSCIENCE, V10, P997, DOI 10.1016/0306-4522(83)90238-5; MISLER S, 1979, P NATL ACAD SCI USA, V76, P991, DOI 10.1073/pnas.76.2.991; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; VALTORTA F, 1984, J CELL BIOL, V99, P124, DOI 10.1083/jcb.99.1.124	22	78	84	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					489	496		10.1016/S0896-6273(00)80704-7	http://dx.doi.org/10.1016/S0896-6273(00)80704-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197529	Bronze			2022-12-24	WOS:000079483900013
J	Hata, Y; Tsumoto, T; Stryker, MP				Hata, Y; Tsumoto, T; Stryker, MP			Selective pruning of more active afferents when cat visual cortex is pharmacologically inhibited	NEURON			English	Article							GROWTH-FACTOR NGF; OCULAR DOMINANCE; HIPPOCAMPAL-NEURONS; PLASTICITY; NEUROTROPHINS; SITES; LOCALIZATION; DEPRESSION; BLOCKADE; RELEASE	Activity-dependent competition is thought to guide the normal development of specific patterns of neural connections. Such competition generally favors more active inputs, making them larger and stronger, while less active inputs become smaller and weaker. We pharmacologically inhibited the activity of visual cortical cells and measured the three-dimensional structure of inputs serving the two eyes when one eye was occluded. The more active inputs serving the open eye actually became smaller than the deprived inputs from the occluded eye, which were similar to those in normal animals. These findings demonstrate in vivo that it is not the amount of afferent activity but the correlation between cortical and afferent activity that regulates the growth or retraction of these inputs.	Osaka Univ, Sch Med, Biomed Res Ctr, Dept Neurophysiol, Osaka 5650871, Japan; Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA	Osaka University; University of California System; University of California San Francisco	Hata, Y (corresponding author), Osaka Univ, Sch Med, Biomed Res Ctr, Dept Neurophysiol, Osaka 5650871, Japan.			Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R01 EY002874, EY02874, R37 EY002874-20] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002874, R37EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONINI A, 1993, J NEUROSCI, V13, P3549; Antonini A, 1996, J COMP NEUROL, V369, P64; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; HILL DR, 1981, NATURE, V290, P149, DOI 10.1038/290149a0; KATO N, 1993, NEUROPHARMACOLOGY, V32, P511; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; NEEDLER MC, 1984, BRAIN RES, V308, P347, DOI 10.1016/0006-8993(84)91076-X; Pizzorusso T, 1996, CURR OPIN NEUROL, V9, P122, DOI 10.1097/00019052-199604000-00012; REITER HO, 1986, EXP BRAIN RES, V65, P182; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; TAMURA H, 1992, J NEUROPHYSIOL, V68, P1603, DOI 10.1152/jn.1992.68.5.1603; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	26	69	71	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					375	381		10.1016/S0896-6273(00)81097-1	http://dx.doi.org/10.1016/S0896-6273(00)81097-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069342	Bronze			2022-12-24	WOS:000078875200021
J	Eskandar, EN; Assad, JA				Eskandar, EN; Assad, JA			Dissociation of visual, motor and predictive signals in parietal cortex during visual guidance	NATURE NEUROSCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; PURSUIT; SYSTEM	The role of the posterior parietal cortex (PPC) in the visual guidance of movements was studied in monkeys trained to use a joystick to guide a spot to a target. Visual and motor influences were dissociated by transiently occluding the spot and by varying the relationship between the direction of joystick and spot movements. We found a strong segregation of function in PPC during visual guidance. Neurons in area MST were selectively modulated by the direction of visible moving stimuli, whereas neurons in area MIP were selectively modulated by the direction of hand movement. In contrast, the selectivity of cells in the lateral intraparietal area (LIP) did not directly depend on either visual input or motor output, but rather seemed to encode a predictive representation of stimulus movement. These predictive signals may be an important link in visuomotor transformations.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Assad, JA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jassad@hms.harvard.edu						ABRAMSON N, 1963, INFORMATION THEORY C; Andersen RA, 1987, HDB PHYSL 1, VV, P483; ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; BECKER W, 1985, EXP BRAIN RES, V57, P562; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Critchley M., 1953, PARIETAL LOBES; DALLOS PJ, 1963, IEEE T AUTOMAT CONTR, P218; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0	17	135	136	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					88	93		10.1038/4594	http://dx.doi.org/10.1038/4594			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195185				2022-12-24	WOS:000078409300018
J	Asaad, WF; Rainer, G; Miller, EK				Asaad, WF; Rainer, G; Miller, EK			Neural activity in the primate prefrontal cortex during associative learning	NEURON			English	Article							INFERIOR TEMPORAL CORTEX; CONDITIONAL OCULOMOTOR ASSOCIATIONS; SUPPLEMENTARY EYE FIELD; INFEROTEMPORAL-FRONTAL DISCONNECTION; NEURONAL-ACTIVITY; DELAYED-RESPONSE; RHESUS-MONKEYS; UNIT-ACTIVITY; PERIARCUATE LESIONS; PREMOTOR CORTEX	The prefrontal (PF) cortex has been implicated in the remarkable ability of primates to form and rearrange arbitrary associations rapidly. This ability was studied in two monkeys, using a task that required them to learn to make specific saccades in response to particular cues and then repeatedly reverse these responses. We found that the activity of individual PF neurons represented both the cues and the associated responses, perhaps providing a neural substrate for their association. Furthermore, during learning, neural activity conveyed the direction of the animals' impending responses progressively earlier within each successive trial. The final level of activity just before the response, however, was unaffected by learning. These results suggest a role for the PF cortex in learning arbitrary cue-response associations, an ability critical for complex behavior.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ekm@ai.mit.edu	Asaad, Wael/I-8485-2012; Miller, Earl K./AAE-8187-2019; Rainer, Gregor/B-5876-2012	Asaad, Wael/0000-0003-4406-9096; Miller, Earl K./0000-0002-0582-6958; Rainer, Gregor/0000-0002-5805-2220	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145, R29NS035145] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35145-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARBAS H, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P35; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P28; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Deadwyler SA, 1996, J NEUROSCI, V16, P354; DIPELLEGRINO G, 1991, BRAIN, V114, P951; EACOTT MJ, 1992, EUR J NEUROSCI, V4, P1320, DOI 10.1111/j.1460-9568.1992.tb00157.x; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Fuster JM, 1995, MEMORY CEREBRAL CORT; GAFFAN D, 1988, BEHAV BRAIN RES, V31, P149, DOI 10.1016/0166-4328(88)90018-6; HALSBAND U, 1985, BEHAV BRAIN RES, V18, P269, DOI 10.1016/0166-4328(85)90035-X; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MILLER EK, 1991, VISUAL NEUROSCI, V7, P357, DOI 10.1017/S0952523800004843; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MITZ AR, 1991, J NEUROSCI, V11, P1855; Murray EA, 1996, BEHAV NEUROSCI, V110, P1261; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; PANDYA DN, 1990, PROG BRAIN RES, V85, P63; Parker A, 1998, NEUROPSYCHOLOGIA, V36, P259, DOI 10.1016/S0028-3932(97)00112-7; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Perecman E., 1987, FRONTAL LOBES REVISI, P41; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; PETRIDES M, 1982, BEHAV BRAIN RES, V5, P407, DOI 10.1016/0166-4328(82)90044-4; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; PETRIDES M, 1986, J NEUROSCI, V6, P2054; PETRIDES M, 1990, NEUROPSYCHOLOGIA, V28, P137, DOI 10.1016/0028-3932(90)90096-7; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; RAINER G, 1998, IN PRESS P NATL ACAD; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RUPNIAK NMJ, 1987, J NEUROSCI, V7, P2331; Rushworth MFS, 1997, J NEUROSCI, V17, P4829; SAKAGAMI M, 1994, EXP BRAIN RES, V100, P165; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHWARTZ ML, 1984, J COMP NEUROL, V226, P403, DOI 10.1002/cne.902260309; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; SPITZER H, 1991, EXP BRAIN RES, V83, P340; WATANABE M, 1992, EXP BRAIN RES, V89, P233; WATANABE M, 1986, BRAIN RES, V382, P15, DOI 10.1016/0006-8993(86)90105-8; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; YOUNG BJ, 1994, J NEUROSCI, V14, P6553	59	392	393	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1399	1407		10.1016/S0896-6273(00)80658-3	http://dx.doi.org/10.1016/S0896-6273(00)80658-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883732	Bronze			2022-12-24	WOS:000077910600021
J	Mainen, ZF; Jia, ZP; Roder, J; Malinow, R				Mainen, ZF; Jia, ZP; Roder, J; Malinow, R			Use-dependent AMPA receptor block in mice lacking GluR2 suggests postsynaptic site for LTP expression	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; TRANSMITTER RELEASE; SYNAPTIC CURRENTS; PYRAMIDAL CELLS; SILENT SYNAPSES; PROTEIN-KINASE; CA1 NEURONS; HIPPOCAMPUS; PROBABILITY; RAT	The mechanisms responsible for enhanced transmission during long-term potentiation (LTP) at CA1 hippocampal synapses remain elusive. Several popular models for LTP expression propose an increase in 'use' of existing synaptic elements, such as increased probability of transmitter release or increased opening of postsynaptic receptors. To test these models directly, we studied a GluR2 knockout mouse in which AMPA receptor transmission is rendered sensitive to a use-dependent block by polyamine compounds. This method can detect increases during manipulations affecting transmitter release or AMPA receptor channel open time and probability, but shows no such changes during LTP. Our results indicate that the recruitment of new AMPA receptors and/or an increase in the conductance of these receptors is responsible for the expression of CA1 LTP.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mt Sinai Hosp, Res Inst, Toronto, ON M5G 1X5, Canada	Cold Spring Harbor Laboratory; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Mainen, ZF (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	mainen@cshl.org	Jia, zhengping/AAZ-4190-2021; Roder, John/G-6468-2013	Mainen, Zachary/0000-0001-7913-9109				AMBROSINGERSON J, 1993, P NATL ACAD SCI USA, V90, P7903, DOI 10.1073/pnas.90.16.7903; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BAHRING R, IN PRESS J PHYSL LON; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huang EP, 1997, J NEUROPHYSIOL, V78, P2870, DOI 10.1152/jn.1997.78.6.2870; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1992, NATURE, V360, P70, DOI 10.1038/360070a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Stricker C, 1996, J PHYSIOL-LONDON, V490, P443, DOI 10.1113/jphysiol.1996.sp021156; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Washburn MS, 1997, J NEUROSCI, V17, P9393; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	47	42	43	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					579	586		10.1038/2812	http://dx.doi.org/10.1038/2812			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196565				2022-12-24	WOS:000077437100013
J	Qian, XZ; Riccio, A; Zhang, Y; Ginty, DD				Qian, XZ; Riccio, A; Zhang, Y; Ginty, DD			Identification and characterization of novel substrates of TrK receptors in developing neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; SYMPATHETIC NEURONS; SIGNAL-TRANSDUCTION; NEURITE OUTGROWTH; SH2 DOMAINS; PC12 CELLS; NEUROTROPHIC FACTOR; KINASE-ACTIVITY; MAP KINASE	Neurotrophins influence growth and survival of specific populations of neurons through activation of Trks, members of the receptor tyrosine kinase (RTK) family. In this report, we describe the identification and characterization of two substrates of Trk kinases, rAPS and SH2-B, which are closely related Src homolog 2 (SH2) domain-containing signaling molecules, rAPS and SH2-B are substrates of TrkB and TrkC in cortical neurons and SH2-B is a substrate of TrkA in sympathetic neurons. Moreover, rAPS and SH2-B bind to Grb2, and both are sufficient to mediate NGF induction of Pas, MAP kinase (MAPK), and morphological differentiation of PC12 cells. Lastly, antibody perturbation and transient transfection experiments indicate that SH2-B, or a closely related molecule, is necessary for NGF-dependent signaling in neonatal sympathetic neurons. Together, these observations indicate that rAPS and SH2-B mediate Trk signaling in developing neurons.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	david_ginty@qmail.bs.jhu.edu			PHS HHS [N534814] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BARKER P, 1998, NEUROTROPHINS NEURAL, P59; BORASIO GD, 1989, NEURON, V2, P1087; BORASIO GD, 1993, J CELL BIOL, V121, P665, DOI 10.1083/jcb.121.3.665; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; CARTER BD, 1995, J BIOL CHEM, V270, P21751, DOI 10.1074/jbc.270.37.21751; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOLEMIS EA, 1994, CURRENT PROTOCOLS MO; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1995, CURR OPIN NEUROBIOL, V5, P579, DOI 10.1016/0959-4388(95)80062-X; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUANG X, 1992, P NATL ACAD SCI USA, V92, P11618; INAGAKI N, 1995, EUR J NEUROSCI, V7, P1125, DOI 10.1111/j.1460-9568.1995.tb01102.x; Iwasaki Y, 1997, J NEUROCHEM, V68, P927; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; LOEB DM, 1994, J BIOL CHEM, V269, P8901; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MAINS RE, 1973, J CELL BIOL, V59, P329, DOI 10.1083/jcb.59.2.329; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; OSBORNE MA, 1995, BIO-TECHNOL, V13, P1474, DOI 10.1038/nbt1295-1474; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; Riedel H, 1997, J BIOCHEM-TOKYO, V122, P1105; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SAMBROOK J, 1989, EXTRACTS MAMMALIAN C, V2; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; SHU HKG, 1994, MOL CELL BIOL, V14, P6868, DOI 10.1128/MCB.14.10.6868; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163	50	183	192	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1017	1029		10.1016/S0896-6273(00)80620-0	http://dx.doi.org/10.1016/S0896-6273(00)80620-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856458	hybrid			2022-12-24	WOS:000077386100013
J	Laughlin, SB; van Steveninck, RRD; Anderson, JC				Laughlin, SB; van Steveninck, RRD; Anderson, JC			The metabolic cost of neural information	NATURE NEUROSCIENCE			English	Article							EXPENSIVE-TISSUE HYPOTHESIS; COMPOUND EYE; DROSOPHILA PHOTORECEPTORS; BLOWFLY PHOTORECEPTORS; SODIUM-PUMP; CHANNELS; HISTAMINE; SYNAPSE; KINESIN; BRAIN	We derive experimentally based estimates of the energy used by neural mechanisms to code known quantities of information. Biophysical measurements from cells in the blowfly retina yield estimates of the ATP required to generate graded (analog) electrical signals that transmit known amounts of information. Energy consumption is several orders of magnitude greater than the thermodynamic minimum. It costs 10(4) ATP molecules to transmit a bit at a chemical synapse, and 10(6) - 10(7) ATP for graded signals in an interneuron or a photoreceptor, or for spike coding. Therefore, in noise-limited signaling systems, a weak pathway of low capacity transmits information more economically, which promotes the distribution of information among multiple pathways.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; NEC Res Inst, Princeton, NJ 08540 USA; Univ Sussex, Sussex Ctr Neurosci, Brighton BN1 9QG, E Sussex, England	University of Cambridge; NEC Corporation; University of Sussex	Laughlin, SB (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Aiello LC, 1997, BRAZ J GENET, V20, P141, DOI 10.1590/S0100-84551997000100023; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; Ames Adelbert Iii, 1997, P17; BEERSMA DGM, 1977, J COMP PHYSIOL, V119, P207, DOI 10.1007/BF00656634; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BRAY D, 1998, IN PRESS ANN REV BIO; Diamond JM, 1996, NATURE, V382, P756, DOI 10.1038/382756a0; FROHLICH A, 1985, J COMP NEUROL, V241, P311, DOI 10.1002/cne.902410306; Gerster U, 1997, J COMP PHYSIOL A, V180, P113, DOI 10.1007/s003590050032; HALL ZW, 1992, INTRO MOL NEUROBIOLO, V555; HAMDORF K, 1988, J COMP PHYSIOL A, V162, P285, DOI 10.1007/BF00606117; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; Hille B., 1992, IONIC CHANNELS EXCIT; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; JANSONIUS NM, 1990, J COMP PHYSIOL A, V167, P461, DOI 10.1007/BF00190816; KEISTER M, 1974, PHYSL INSECTA, V6; Kety S.S., 1957, METABOLISM NERVOUS S, P221; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; LEFF HS, 1990, MAXWELLS DEMON ENTRO, V349; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Martin RD, 1996, NEWS PHYSIOL SCI, V11, P149, DOI 10.1152/physiologyonline.1996.11.4.149; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; NICOL D, 1982, J COMP NEUROL, V207, P29, DOI 10.1002/cne.902070104; RIEKE F, 1997, SPIKES EXPLORING NEU, V395; SARPESHKAR R, 1998, IN PRESS NEURAL COMP; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; SKINGSLEY DR, 1995, J COMP PHYSIOL A, V176, P611, DOI 10.1007/BF01021581; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Stuart AE, 1996, J NEUROSCI, V16, P3178; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; TSACOPOULOS M, 1994, J NEUROSCI, V14, P1339, DOI 10.1523/JNEUROSCI.14-03-01339.1994; UUSITALO RO, 1994, J NEUROPHYSIOL, V71, P1381, DOI 10.1152/jn.1994.71.4.1381; VANHATEREN JH, 1990, J COMP PHYSIOL A, V166, P437, DOI 10.1007/BF00192015; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; WECKSTROM M, 1992, PFLUG ARCH EUR J PHY, V421, P469, DOI 10.1007/BF00370258; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729	43	707	716	11	106	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					36	41		10.1038/236	http://dx.doi.org/10.1038/236			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195106				2022-12-24	WOS:000076361000015
J	Lewohl, JM; Wilson, WR; Mayfield, RD; Brozowski, SJ; Morrisett, RA; Harris, RA				Lewohl, JM; Wilson, WR; Mayfield, RD; Brozowski, SJ; Morrisett, RA; Harris, RA			G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; LONG-CHAIN ALCOHOLS; GATED K+ CHANNEL; G-BETA-GAMMA; GLUTAMATE RECEPTORS; GENERAL-ANESTHESIA; CHLORIDE CURRENTS; XENOPUS OOCYTES; NEURONAL SODIUM; RAT-BRAIN	C-protein-coupled inwardly rectifying potassium channels (GIRKs) are important for regulation of synaptic transmission and neuronal firing rates. Because of their key role in brain function, we asked if these potassium channels are targets of alcohol action. Ethanol enhanced function of cerebellar granule cell GIRKs coupled to GABA(B) receptors. Enhancement of GIRK function by ethanol was studied in detail using Xenopus oocytes expressing homomeric or heteromeric channels. Function of all GIRK channels was enhanced by intoxicating concentrations of ethanol, but other, related inwardly rectifying potassium channels were not affected. GIRK2/IRK1 chimeras and GIRK2 truncation mutants were used to identify a region of 43 amino acids in the carboxyl (C) terminus that is critical for the action of ethanol on these channels.	Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; Univ Texas, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas, Coll Pharm, Dept Pharmacol & Toxicol, Austin, TX 78712 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Lewohl, JM (corresponding author), Univ Texas, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	lewohlj@mail.utexas.edu	Lewohl, Joanne/D-6163-2011		NIAAA NIH HHS [AA03527, AA06399] Funding Source: Medline; NIGMS NIH HHS [GM47818] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA003527, R37AA006399, R01AA006399] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALIFIMOFF JK, 1989, BRIT J PHARMACOL, V96, P9, DOI 10.1111/j.1476-5381.1989.tb11777.x; ANANTHARAM V, 1992, MOL PHARMACOL, V42, P499; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Coe IR, 1996, J BIOL CHEM, V271, P29468, DOI 10.1074/jbc.271.46.29468; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; DildyMayfield JE, 1996, BRIT J PHARMACOL, V118, P378, DOI 10.1111/j.1476-5381.1996.tb15413.x; DILDYMAYFIELD JE, 1992, J PHARMACOL EXP THER, V262, P487; Dopico AM, 1996, MOL PHARMACOL, V49, P40; ELLIOTT JR, 1992, GEN PHARMACOL, V23, P1005, DOI 10.1016/0306-3623(92)90278-R; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Herlitze X, 1999, J PHYSIOL-LONDON, V517, P341, DOI 10.1111/j.1469-7793.1999.0341t.x; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hille B., 1992, IONIC CHANNELS EXCIT, V2 ed, P115; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Karschin C, 1996, J NEUROSCI, V16, P3559; KIM JY, 1994, J BIOL CHEM, V269, P28724; Korn SJ., 1991, J NEUROSCI METH, V4, P264; KOVOOR A, 1995, J BIOL CHEM, V270, P589, DOI 10.1074/jbc.270.2.589; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Leonoudakis D, 1998, J NEUROSCI, V18, P868; LEVIN LR, 1995, J BIOL CHEM, V270, P7573, DOI 10.1074/jbc.270.13.7573; LI CY, 1994, P NATL ACAD SCI USA, V91, P8200, DOI 10.1073/pnas.91.17.8200; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mascia MP, 1996, BRIT J PHARMACOL, V119, P1331, DOI 10.1111/j.1476-5381.1996.tb16042.x; MIHIC SJ, 1994, MOL PHARMACOL, V46, P851; Minami K, 1998, MOL PHARMACOL, V53, P148, DOI 10.1124/mol.53.1.148; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Plapp B V, 1993, Adv Exp Med Biol, V328, P391; Ponce A, 1996, J NEUROSCI, V16, P1990; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Sonders MS, 1997, J NEUROSCI, V17, P960; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; URBAN BW, 1993, BRIT J ANAESTH, V71, P25, DOI 10.1093/bja/71.1.25; WAFFORD KA, 1989, BRAIN RES, V505, P215, DOI 10.1016/0006-8993(89)91445-5; WANN KT, 1993, BRIT J ANAESTH, V71, P2, DOI 10.1093/bja/71.1.2; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Yost CS, 1999, ANESTHESIOLOGY, V90, P1186, DOI 10.1097/00000542-199904000-00035	46	189	196	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1084	1090		10.1038/16012	http://dx.doi.org/10.1038/16012			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570485				2022-12-24	WOS:000085810100012
J	Romanski, LM; Tian, B; Fritz, J; Mishkin, M; Goldman-Rakic, PS; Rauschecker, JP				Romanski, LM; Tian, B; Fritz, J; Mishkin, M; Goldman-Rakic, PS; Rauschecker, JP			Dual streams of auditory afferents target multiple domains in the primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SUPERIOR TEMPORAL SULCUS; RHESUS-MONKEY; MACAQUE MONKEYS; FRONTAL-CORTEX; TONOTOPIC ORGANIZATION; CORTICAL CONNECTIONS; FUNCTIONAL MRI; COMPLEX SOUNDS; MEMORY	'What' and 'where' visual streams define ventrolateral object and dorsolateral spatial processing domains in the prefrontal cortex of nonhuman primates. We looked for similar streams for auditory-prefrontal connections in rhesus macaques by combining microelectrode recording with anatomical tract-tracing. Injection of multiple tracers into physiologically mapped regions AL, ML and CL of the auditory belt cortex revealed that anterior belt cortex was reciprocally connected with the frontal pole (area 10), rostral principal sulcus (area 46) and ventral prefrontal regions (areas 12 and 45), whereas the caudal belt was mainly connected with the caudal principal sulcus (area 46) and frontal eye fields (area 8a). Thus separate auditory streams originate in caudal and rostral auditory cortex and target spatial and non-spatial domains of the frontal lobe, respectively.	Yale Univ, Sch Med, New Haven, CT 06510 USA; Georgetown Univ, Med Ctr, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	Yale University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Romanski, LM (corresponding author), Yale Univ, Sch Med, B 413 SHM,333 Cedar St, New Haven, CT 06510 USA.		Rauschecker, Josef P/A-4120-2013; Fritz, Jonathan/AAK-4863-2020	Rauschecker, Josef P./0000-0003-4353-9084; Fritz, Jonathan/0000-0002-0625-172X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004845] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004845, R01 DC004845-01] Funding Source: Medline; NIMH NIH HHS [R01 MH038546-21] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; AZUMA M, 1984, BRAIN RES, V298, P343, DOI 10.1016/0006-8993(84)91434-3; BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CHAVIS DA, 1976, BRAIN RES, V117, P369, DOI 10.1016/0006-8993(76)90089-5; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; DEMB JB, 1995, J NEUROSCI, V15, P5870; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fuster J.M., 1989, PREFRONTAL CORTEX; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; GOLDMAN PS, 1970, EXP NEUROL, V27, P291, DOI 10.1016/0014-4886(70)90222-0; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; GROSS CG, 1962, EXP NEUROL, V5, P453, DOI 10.1016/0014-4886(62)90057-2; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Kosaki H, 1997, J COMP NEUROL, V386, P304; LAWICKA W, 1966, P C POLISH PHYSIOL S, V10, P178; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PANDYA DN, 1969, BRAIN RES, V13, P13, DOI 10.1016/0006-8993(69)90141-3; PETRIDES M, 1986, J NEUROSCI, V6, P2054; PETRIDES M, 1988, J COMP NEUROL, V273, P52, DOI 10.1002/cne.902730106; PREUSS TM, 1991, J COMP NEUROL, V310, P429, DOI 10.1002/cne.903100402; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; SELTZER B, 1989, J COMP NEUROL, V281, P97, DOI 10.1002/cne.902810108; Stevens AA, 1998, ARCH GEN PSYCHIAT, V55, P1097, DOI 10.1001/archpsyc.55.12.1097; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; TANILA H, 1993, BEHAV BRAIN RES, V53, P3; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; VAADIA E, 1986, J NEUROPHYSIOL, V56, P934, DOI 10.1152/jn.1986.56.4.934; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	50	809	820	0	43	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1131	1136		10.1038/16056	http://dx.doi.org/10.1038/16056			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570492	Green Accepted			2022-12-24	WOS:000085810100019
J	Gonzalez, M; Ruggiero, FP; Chang, Q; Shi, YJ; Rich, MM; Kraner, S; Balice-Gordon, RJ				Gonzalez, M; Ruggiero, FP; Chang, Q; Shi, YJ; Rich, MM; Kraner, S; Balice-Gordon, RJ			Disruption of TrkB-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions	NEURON			English	Article							SCHWANN-CELL PROCESSES; NERVOUS-SYSTEM; MOTOR-NEURONS; SYNAPSE ELIMINATION; INVIVO OBSERVATIONS; NEUROTROPHIC FACTOR; DENDRITIC GROWTH; AXON WITHDRAWAL; MESSENGER-RNAS; TROPHIC FACTOR	Neurotrophins and tyrosine receptor kinase (Trk) receptors are expressed in skeletal muscle, but it is unclear what functional role Trk-mediated signaling plays during postnatal life. Full-length TrkB (trkB.FL) as well as truncated TrkB (trkB.t1) were found to be localized primarily to the postsynaptic acetylcholine receptor- (AChR-) rich membrane at neuromuscular junctions. In vivo, dominant-negative manipulation of TrkB signaling using adenovirus to overexpress trkB.t1 in mouse sternomastoid muscle fibers resulted in the disassembly of postsynaptic AChR clusters at neuromuscular junctions, similar to that observed in mutant trkB(+/-) mice. When TrkB-mediated signaling was disrupted in cultured myotubes in the absence of motor nerve terminals and Schwann cells, agrin-induced AChR clusters were also disassembled. These results demonstrate a novel role for neurotrophin signaling through TrkB receptors on muscle fibers in the ongoing maintenance of postsynaptic AChR regions.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Balice-Gordon, RJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.	rballceg@mail.med.upenn.edu		Balice-Gordon, Rita/0000-0002-9950-7965	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013329] Funding Source: NIH RePORTER; NIA NIH HHS [AG13329] Funding Source: Medline; NINDS NIH HHS [NS34373, NS10745] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; BaliceGordon RJ, 1997, METHOD CELL BIOL, V52, P323, DOI 10.1016/S0091-679X(08)60386-6; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; Culican SM, 1998, J NEUROSCI, V18, P4953; Eide FF, 1996, J NEUROSCI, V16, P3123; FRIEDMAN B, 1995, J NEUROSCI, V15, P1044; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; Horch HW, 1999, NEURON, V23, P353; Huang EJ, 1999, DEVELOPMENT, V126, P2191; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; KASSEISLER A, 1994, GENE THER, V1, P395; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KOLIATSOS VE, 1994, P NATL ACAD SCI USA, V91, P3304, DOI 10.1073/pnas.91.8.3304; LE GLS, 1993, SCIENCE, V259, P988; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; OFFENHAUSER N, 1995, EUR J NEUROSCI, V7, P917, DOI 10.1111/j.1460-9568.1995.tb01079.x; OMalley JP, 1997, J CELL BIOL, V138, P159, DOI 10.1083/jcb.138.1.159; Oppenheim RW, 1996, NEURON, V17, P195, DOI 10.1016/S0896-6273(00)80151-8; PATI UK, 1992, GENE, V114, P285, DOI 10.1016/0378-1119(92)90589-H; Precious B., 1985, VIROLOGY PRACTICAL A, P193; RICH MM, 1994, NEUROLOGY, V44, P2138, DOI 10.1212/WNL.44.11.2138; RICH MM, 1989, J NEUROSCI, V9, P1781, DOI 10.1523/jneurosci.09-05-01781.1989; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5; Tomanin R, 1997, GENE, V193, P129, DOI 10.1016/S0378-1119(97)00074-7; Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0; WANG T, 1995, J NEUROSCI, V15, P4796; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Wells DG, 1999, P NATL ACAD SCI USA, V96, P1112, DOI 10.1073/pnas.96.3.1112; Woo YJ, 1997, CIRCULATION, V96, P3561; Xie KW, 1997, J NEUROSCI, V17, P2947; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343; Yan Q, 1997, J COMP NEUROL, V378, P135	58	190	194	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					567	583		10.1016/S0896-6273(00)81113-7	http://dx.doi.org/10.1016/S0896-6273(00)81113-7			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595510	hybrid			2022-12-24	WOS:000083913000014
J	Usdin, TB; Hoare, SRJ; Wang, T; Mezey, E; Kowalak, JA				Usdin, TB; Hoare, SRJ; Wang, T; Mezey, E; Kowalak, JA			TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus	NATURE NEUROSCIENCE			English	Article							MESSENGER-RIBONUCLEIC-ACID; RENIN-RELEASING FACTOR; RAT SENSORY NEURONS; PARATHYROID-HORMONE; PTH2 RECEPTOR		NIMH, Cell Biol Unit, Genet Lab, Bethesda, MD 20892 USA; NINDS, Basic Neurosci Program, Bethesda, MD 20892 USA; NIMH, Lab Neurotoxicol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Usdin, TB (corresponding author), NIMH, Cell Biol Unit, Genet Lab, Bldg 36,Room 3D06,36 Convent Dr MSC4094, Bethesda, MD 20892 USA.		Hoare, Sam/J-9018-2019; Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002685, Z01MH002685] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Behar V, 1996, ENDOCRINOLOGY, V137, P2748, DOI 10.1210/en.137.7.2748; BENNETT HPJ, 1978, BIOCHEM J, V175, P1139, DOI 10.1042/bj1751139; CUI M, 1995, NEUROSCIENCE, V66, P459, DOI 10.1016/0306-4522(94)00567-O; FRASER RA, 1990, ENDOCRINOLOGY, V127, P2517, DOI 10.1210/endo-127-5-2517; Gardella TJ, 1996, J BIOL CHEM, V271, P19888, DOI 10.1074/jbc.271.33.19888; HINGTGEN CM, 1995, J NEUROSCI, V15, P5411; HOARE SRJ, IN PRESS ENDOCRINOLO; PANG PKT, 1988, AM J PHYSIOL, V255, pR643, DOI 10.1152/ajpregu.1988.255.4.R643; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; URBAN JH, 1992, NEUROENDOCRINOLOGY, V55, P574, DOI 10.1159/000126170; Usdin TB, 1999, ENDOCRINOLOGY, V140, P3363, DOI 10.1210/en.140.7.3363; Usdin TB, 1997, ENDOCRINOLOGY, V138, P831, DOI 10.1210/en.138.2.831; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; Usdin TB, 1996, ENDOCRINOLOGY, V137, P4285, DOI 10.1210/en.137.10.4285; VANDEKAR LD, 1987, HYPERTENSION, V9, P598, DOI 10.1161/01.HYP.9.6.598	15	142	153	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					941	943		10.1038/14724	http://dx.doi.org/10.1038/14724			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526330				2022-12-24	WOS:000083883300008
J	Shammat, IM; Gordon, SE				Shammat, IM; Gordon, SE			Stoichiometry and arrangement of subunits in rod cyclic nucleotide-gated channels	NEURON			English	Article							RETINAL RODS; ACTIVATED CHANNELS; CATION CHANNEL; ION CHANNELS; MOLECULAR MECHANISM; MEMBRANE PATCHES; PROTEIN; PHOSPHORYLATION; RESOLUTION; MODULATION	Cyclic nucleotide-gated (CNG) ion channels mediate the response to light in retinal rods. They are tetramers of two homologous subunits (alpha and beta), each of which is essential for the function of the channels in vivo. We have investigated the stoichiometry and arrangement of these two subunits to determine how they come together within an individual channel complex. We exploited the very specific geometric and spatial requirements for forming a high-affinity Ni(2+)-binding site to examine the number and relative positions of the subunits. We found that only an order of alpha/alpha/beta/beta could account qualitatively and quantitatively for the observed intersubunit coordination of Ni(2+) in wild-type and mutant alpha/beta channels. Furthermore, our results suggest a structural dimerization among like subunits, at least at the level of the Ni(2+)-binding site.	Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75235 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gordon, SE (corresponding author), Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA.	seg@u.washington.edu		Shammat, Iman/0000-0003-2679-7735				CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Gavazzo P, 1996, NATO ADV SCI I A-LIF, V289, P75; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GORDON SE, 1995, BIOPHYS J, V69, P409, DOI 10.1016/S0006-3495(95)79913-1; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; ILDEFONSE M, 1992, J MEMBRANE BIOL, V130, P91; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Molokanova E, 1997, J NEUROSCI, V17, P9068; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Picco C, 1996, J GEN PHYSIOL, V108, P265, DOI 10.1085/jgp.108.4.265; Shapiro MS, 1998, P NATL ACAD SCI USA, V95, P14546, DOI 10.1073/pnas.95.24.14546; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243	32	53	54	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					809	819		10.1016/S0896-6273(01)80038-6	http://dx.doi.org/10.1016/S0896-6273(01)80038-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482246	Bronze			2022-12-24	WOS:000082280900023
J	Cacciatore, TW; Brodfuehrer, PD; Gonzalez, JE; Jiang, T; Adams, SR; Tsien, RY; Kristan, WB; Kleinfeld, D				Cacciatore, TW; Brodfuehrer, PD; Gonzalez, JE; Jiang, T; Adams, SR; Tsien, RY; Kristan, WB; Kleinfeld, D			Identification of neural circuits by imaging coherent electrical activity with FRET-based dyes	NEURON			English	Article							RESONANCE ENERGY-TRANSFER; MEDICINAL LEECH; NEURONAL CONTROL; NERVOUS-SYSTEM; MOTOR NEURONS; MEMBRANE; FLUORESCENCE; GENERATION; PATTERNS; NETWORK	We show that neurons that underlie rhythmic patterns of electrical output may be identified by optical imaging and frequency-domain analysis. Our contrast agent is a two-component dye system in which changes in membrane potential modulate the relative emission between a pair of fluorophores. We demonstrate our methods with the circuit responsible for fictive swimming in the isolated leech nerve cord. The output of a motor neuron provides a reference signal for the phase-sensitive detection of changes in fluorescence from individual neurons in a ganglion. We identify known and possibly novel neurons that participate in the swim rhythm and determine their phases within a cycle. A variant of this approach is used to identify the postsynaptic followers of intracellularly stimulated neurons.	Univ Calif San Diego, Neurosci Grp, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; Aurora Biosci, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Bryn Mawr College	Kleinfeld, D (corresponding author), Univ Calif San Diego, Neurosci Grp, La Jolla, CA 92093 USA.	dk@physics.ucsd.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051	NIGMS NIH HHS [GM08107] Funding Source: Medline; NIMH NIH HHS [MH43396] Funding Source: Medline; NINDS NIH HHS [NS10479-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F33NS010479] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Borst A, 1997, NEUROSCI LETT, V238, P29, DOI 10.1016/S0304-3940(97)00836-7; BRODFUEHRER PD, 1995, J NEUROBIOL, V27, P403, DOI 10.1002/neu.480270312; CALABRESE RL, 1995, J NEUROBIOL, V27, P390, DOI 10.1002/neu.480270311; Canepari M, 1996, EUR BIOPHYS J BIOPHY, V24, P359, DOI 10.1007/BF00576708; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FRIESEN WO, 1976, P NATL ACAD SCI USA, V73, P3734, DOI 10.1073/pnas.73.10.3734; FROMHERZ P, 1991, BIOCHIM BIOPHYS ACTA, V1068, P149, DOI 10.1016/0005-2736(91)90203-K; Getting P. A., 1989, NETWORK OSCILLATOR U, P215; Gonzalez JE, 1997, CHEM BIOL, V4, P269, DOI 10.1016/S1074-5521(97)90070-3; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; GRANZOW B, 1985, J NEUROSCI, V5, P2035; GRILLNER S, 1991, ANNU REV NEUROSCI, V14, P169, DOI 10.1146/annurev.neuro.14.1.169; KLEINFELD D, 1988, BIOPHYS J, V54, P1039, DOI 10.1016/S0006-3495(88)83041-8; KRISTAN WB, 1974, J COMP PHYSIOL, V94, P155, DOI 10.1007/BF00617839; LOEW LM, 1979, NATURE, V281, P497, DOI 10.1038/281497a0; MANN ME, 1994, J GEOPHYS RES-ATMOS, V99, P25819, DOI 10.1029/94JD02396; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MULLER KJ, 1981, NEUROBIOLOGY LEECH; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Obaid AL, 1999, J NEUROSCI, V19, P3073; ORT CA, 1974, J COMP PHYSIOL, V94, P121, DOI 10.1007/BF00617838; PAWLEY JB, 1995, HDB BIOL CONFOCAL MI; PERCIVAL DB, 1993, SPECTRAL ANAL PHYSIC; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; SATTERLIE RA, 1985, SCIENCE, V229, P402, DOI 10.1126/science.229.4711.402; Selverston A.I., 1987, CRUSTACEAN STOMATOGA; SLEPIAN D, 1961, BELL SYST TECH J, V40, P43, DOI 10.1002/j.1538-7305.1961.tb03976.x; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; Thomson D. J, 1991, ADV SPECTRUM ANAL AR, VI, P58; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; TSIEN RY, 1976, THESIS CAMBRIDGE U C; WEEKS JC, 1978, J EXP BIOL, V77, P71; YOUNGENTOB SL, 1995, J NEUROPHYSIOL, V73, P387, DOI 10.1152/jn.1995.73.1.387; ZECEVIC D, 1989, J NEUROSCI, V9, P3681	40	70	78	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1999	23	3					449	459		10.1016/S0896-6273(00)80799-0	http://dx.doi.org/10.1016/S0896-6273(00)80799-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433258	Bronze			2022-12-24	WOS:000081701000010
J	Takumi, Y; Ramirez-Leon, V; Laake, P; Rinvik, E; Ottersen, OP				Takumi, Y; Ramirez-Leon, V; Laake, P; Rinvik, E; Ottersen, OP			Different modes of expression of AMPA and NMDA receptors in hippocampal synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; EXCITATORY SYNAPSES; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; SILENT SYNAPSES; PYRAMIDAL CELLS; SUBUNITS; LTP	Postembedding immunogold labeling was used to determine the relationship between AMPA and NMDA receptor density and size of Schaffer collateral-commissural (SCC) synapses of the adult rat. All SCC synapses expressed NMDA receptors. AMPA and NMDA receptors were colocalized in at least 75% of SCC synapses; the ratio of AMPA to NMDA receptors was a linear function of postsynaptic density (PSD) diameter, with AMPA receptor number dropping to zero at a PSD diameter of similar to 180 nm. These findings indicate that 'silent' SCC synapses are smaller than the majority of SCC synapses at which AMPA and NMDA receptors are colocalized. Thus synapse size may determine important properties of SCC synapses.	Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0317 Oslo, Norway; Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 0368562, Japan; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Univ Oslo, Sect Med Stat, N-0317 Oslo, Norway	University of Oslo; Hirosaki University; Karolinska Institutet; University of Oslo	Ottersen, OP (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, POB 1105 Blindern, N-0317 Oslo, Norway.							Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BRAMHAM CR, 1990, NEUROSCIENCE, V39, P405, DOI 10.1016/0306-4522(90)90277-B; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DESMOND NL, 1988, BRAIN RES, V453, P308, DOI 10.1016/0006-8993(88)90171-0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; HARRIS KM, 1992, J NEUROSCI, V12, P2685; He Y, 1998, J NEUROSCI RES, V54, P444, DOI 10.1002/(SICI)1097-4547(19981115)54:4<444::AID-JNR2>3.0.CO;2-3; HJELLE OP, 1994, EUR J NEUROSCI, V6, P793, DOI 10.1111/j.1460-9568.1994.tb00990.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KELLENBERGER E, 1987, J HISTOCHEM CYTOCHEM, V35, P959, DOI 10.1177/35.9.3302020; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; KHARAZIA VN, IN PRESS J COMP NEUR; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; Matsubara A, 1996, J NEUROSCI, V16, P4457; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Popratiloff A, 1996, J NEUROSCI, V16, P3363; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wang YX, 1998, J NEUROSCI, V18, P1148; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	48	518	531	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					618	624		10.1038/10172	http://dx.doi.org/10.1038/10172			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10409387				2022-12-24	WOS:000083882600012
J	Ming, GI; Song, HJ; Berninger, B; Inagaki, N; Tessier-Lavigne, M; Poo, MM				Ming, GI; Song, HJ; Berninger, B; Inagaki, N; Tessier-Lavigne, M; Poo, MM			Phospholipase C-gamma and phosphoinositide 3-kinase mediate cytoplasmic signaling in nerve growth cone guidance	NEURON			English	Article							PROTEIN-KINASE; PC12 CELLS; NEUROTROPHIC FACTORS; NEURITE OUTGROWTH; TRK RECEPTORS; NEURONS; TRANSDUCTION; INHIBITOR; RESPONSES; SHC	Expression of rat TrkA in Xenopus spinal neurons confers responsiveness of these neurons to nerve growth factor (NGF) in assays of neuronal survival and growth cone chemotropism. Mutational analysis indicates that coactivation of phospholipase C-gamma (PLC-gamma) and phosphoinositide 3-kinase (PI3-kinase) by specific cytoplasmic domains of TrkA is essential for triggering chemoattraction of the growth cone in an NGF gradient. Uniform exposure of TrkA-expressing neurons to NGF resulted in a cross-desensitization of turning responses induced by a gradient of netrin-1, brain-derived neurotrophic factor (BDNF), or myelin-associated glycoprotein (MAG) but not by a gradient of collapsin-1/semaphorin III/D or neurotrophin-3 (NT-3). These results, together with the effects of pharmacological inhibitors, support the notion that there are common cytosolic signaling pathways for two separate groups of guidance cues, one of which requires coactivation of PLC-gamma and PI3-kinase pathways.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Nara Inst Sci & Technol, Div Signal Transduct, Ikoma 6300101, Japan; Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Diego; Nara Institute of Science & Technology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Poo, MM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782; Ming, Guo-li/0000-0002-2517-6075	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 22764] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aibel L, 1998, J NEUROSCI RES, V54, P424, DOI 10.1002/(SICI)1097-4547(19981101)54:3<424::AID-JNR13>3.0.CO;2-6; ALDER J, 1995, J NEUROSCI, V15, P511; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BAXTER RM, 1995, EUR J BIOCHEM, V234, P84, DOI 10.1111/j.1432-1033.1995.084_c.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gallo G, 1997, J NEUROSCI, V17, P5445; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Ganju P, 1998, EUR J NEUROSCI, V10, P1995, DOI 10.1046/j.1460-9568.1998.00209.x; GUNDERSEN RW, 1980, J CELL BIOL, V87, P546, DOI 10.1083/jcb.87.3.546; INAGAKI N, 1995, EUR J NEUROSCI, V7, P1125, DOI 10.1111/j.1460-9568.1995.tb01102.x; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LOEB DM, 1994, J BIOL CHEM, V269, P8901; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 1997, J NEUROSCI, V17, P7860; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Obermeier A, 1995, ANN NY ACAD SCI, V766, P1, DOI 10.1111/j.1749-6632.1995.tb26643.x; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Tabti N, 1998, CULTURING NERVE CELL, P237; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang Q, 1998, J NEUROSCI, V18, P4973; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	38	235	237	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					139	148		10.1016/S0896-6273(00)80760-6	http://dx.doi.org/10.1016/S0896-6273(00)80760-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402200	Bronze			2022-12-24	WOS:000080681200017
J	Kuan, CY; Yang, DD; Roy, DRS; Davis, RJ; Rakic, P; Flavell, RA				Kuan, CY; Yang, DD; Roy, DRS; Davis, RJ; Rakic, P; Flavell, RA			The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development	NEURON			English	Article							N-TERMINAL KINASE; SIGNAL-TRANSDUCTION PATHWAY; PROGRAMMED CELL-DEATH; C-JUN; MICE LACKING; SKELETAL-MUSCLE; MAP KINASES; IN-VIVO; ACTIVATION; NEURULATION	The c-Jun NH2-terminal kinase (Jnk) family is implicated in apoptosis, but its function in brain development is unclear. Here, we address this issue using mutant mice lacking different members of the family (Jnk1, Jnk2, and Jnk3). Mice deficient in Jnk1, Jnk2, Jnk3, and Jnk1/Jnk3 or Jnk2/Jnk3 double mutants all survived normally. Compound mutants lacking Jnk1 and Jnk2 genes were embryonic lethal and had severe dysregulation of apoptosis in brain. Specifically, there was a reduction of cell death in the lateral edges of hindbrain prior to neural tube closure. In contrast, increased apoptosis and caspase activation were found in the mutant forebrain, leading to precocious degeneration. These results suggest that Jnk1 and Jnk2 regulate region-specific apoptosis during early brain development.	Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University; Yale University	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA.							Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Hogan B, 1994, MANIPULATING MOUSE E; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KALLEN B, 1955, J ANAT, V89, P153; KAUFMAN M, 1979, AM J ANAT, V155, P425, DOI 10.1002/aja.1001550403; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; MartinezAnaya MA, 1996, FOOD SCI TECHNOL INT, V2, P35, DOI 10.1177/108201329600200105; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Smith JL, 1997, TRENDS NEUROSCI, V20, P510, DOI 10.1016/S0166-2236(97)01121-1; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; WAHLE P, 1992, J NEUROSCI METH, V41, P153, DOI 10.1016/0165-0270(92)90057-K; Weil M, 1997, CURR BIOL, V7, P281, DOI 10.1016/S0960-9822(06)00125-4; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; YANG XM, 1991, TERATOLOGY, V43, P643, DOI 10.1002/tera.1420430620; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	42	733	758	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					667	676		10.1016/S0896-6273(00)80727-8	http://dx.doi.org/10.1016/S0896-6273(00)80727-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230788	Bronze			2022-12-24	WOS:000079976200011
J	Bruckner, K; Labrador, JP; Scheiffele, P; Herb, A; Seeburg, PH; Klein, R				Bruckner, K; Labrador, JP; Scheiffele, P; Herb, A; Seeburg, PH; Klein, R			EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains	NEURON			English	Article							GPI-ANCHORED PROTEINS; RECEPTOR TYROSINE KINASES; EPH RECEPTORS; SIGNALING COMPLEXES; TRANSMEMBRANE LIGANDS; DOMAIN PROTEINS; BINDING-PROTEIN; CELL-SURFACE; LIVING CELLS; ATTACHMENT	Transmembrane ephrinB proteins have important functions during embryonic patterning as ligands for Eph receptor tyrosine kinases and presumably as signal-transducing receptor-like molecules. Consistent with "reverse" signaling, ephrinB1 is localized in sphingo-lipid/cholesterol-enriched raft microdomains, platforms for the localized concentration and activation of signaling molecules. Glutamate receptor-interacting protein (GRIP) and a highly related protein, which we have termed GRIP2, are recruited into these rafts through association with the c-terminal PDZ target site of ephrinB1. Stimulation of ephrinB1 with soluble EphB2 receptor ectodomain causes the formation of large raft patches that also contain GRIP proteins. Moreover, a GRIP-associated serine/threonine kinase activity is recruited into ephrinB1-GRIP complexes. Our findings suggest that GRIP proteins provide a scaffold for the assembly of a multiprotein signaling complex downstream of ephrinB ligands.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Programme, D-69117 Heidelberg, Germany; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Max Planck Society	Klein, R (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	klein@embl-heidelberg.de	Labrador, Juan Pablo/C-3018-2014; Klein, Ruediger/C-6147-2008	Labrador, Juan Pablo/0000-0003-3671-848X; Klein, Ruediger/0000-0002-3109-0163				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Allison DW, 1998, J NEUROSCI, V18, P2423; Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; BROWN D, 1993, CURR OPIN IMMUNOL, V5, P349, DOI 10.1016/0952-7915(93)90052-T; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gale NW, 1996, ONCOGENE, V13, P1343; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Holowka D, 1996, ANNU REV BIOPH BIOM, V25, P79; KAMPS MP, 1991, METHOD ENZYMOL, V201, P21; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Labrador JP, 1997, EMBO J, V16, P3889, DOI 10.1093/emboj/16.13.3889; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Stauffer TP, 1997, J CELL BIOL, V139, P1447, DOI 10.1083/jcb.139.6.1447; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; VANDENBERG CW, 1995, J CELL BIOL, V131, P669, DOI 10.1083/jcb.131.3.669; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9	51	290	301	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					511	524		10.1016/S0896-6273(00)80706-0	http://dx.doi.org/10.1016/S0896-6273(00)80706-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197531	Bronze			2022-12-24	WOS:000079483900015
J	Chen, H; He, ZG; Bagri, A; Tessier-Lavigne, M				Chen, H; He, ZG; Bagri, A; Tessier-Lavigne, M			Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; GROWTH CONE GUIDANCE; FAMILY; RECEPTOR; COLLAPSIN; DOMAIN; CHEMOREPELLENT; MOLECULES; MEMBER; IV	Neuropilin-1 and neuropilin-2 show specificity in binding to different class III semaphorins, including Sema III, Sema E, and Sema IV, suggesting that the specificity of action of these semaphorins is dictated by the complement of neuropilins expressed by responsive neurons. In support of this, we show that sympathetic axons coexpress neuropilin-1 and -2, that their responses to Sema III, Sema E, and Sema IV are affected in predicted ways by antibodies to neuropilin-1, and that neuropilin-1 and -2 can form homo- and heterooligomers through an interaction involving at least partly the neuropilin MAM (meprin, A5, mu) domain. These results support the idea that in sympathetic axons, the Sema III signal is mediated predominantly by neuropilin-1 oligomers, the Sema IV signal by neuropilin-2 oligomers, and the Sema E signal by neuropilin-1 and -2, either as homo- or heterooligomers.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu						Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodkin AL, 1997, NEURON, V19, P1159, DOI 10.1016/S0896-6273(00)80408-0; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Koppel AM, 1998, J BIOL CHEM, V273, P15708, DOI 10.1074/jbc.273.25.15708; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; ZONDAG GCM, 1995, J BIOL CHEM, V270, P14247, DOI 10.1074/jbc.270.24.14247	26	241	248	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1283	1290		10.1016/S0896-6273(00)80648-0	http://dx.doi.org/10.1016/S0896-6273(00)80648-0			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883722	Bronze			2022-12-24	WOS:000077910600011
J	Grundemann, D; Schechinger, B; Rappold, GA; Schomig, E				Grundemann, D; Schechinger, B; Rappold, GA; Schomig, E			Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter	NATURE NEUROSCIENCE			English	Article							NORADRENALINE; CELLS; EXPRESSION; GENE; RAT		Univ Heidelberg, Dept Pharmacol, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Human Genet, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schomig, E (corresponding author), Univ Heidelberg, Dept Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.		Gründemann, Dirk/AAD-2217-2022					Borowsky B, 1995, INT REV NEUROBIOL, V38, P139, DOI 10.1016/S0074-7742(08)60526-7; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Eisenhofer G, 1996, N-S ARCH PHARMACOL, V354, P287; Grundemann D, 1997, J BIOL CHEM, V272, P10408; IVERSEN LL, 1965, BRIT J PHARM CHEMOTH, V25, P18, DOI 10.1111/j.1476-5381.1965.tb01753.x; IVERSEN LL, 1965, BRIT J PHARM CHEMOTH, V24, P387, DOI 10.1111/j.1476-5381.1965.tb01726.x; KARHUNEN T, 1994, J HISTOCHEM CYTOCHEM, V42, P1079, DOI 10.1177/42.8.8027527; LUO DF, 1995, AM J HUM GENET, V57, P911; MARK A, 1996, J HYPERTENS, V14, P159; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Russ H, 1996, EUR J NEUROSCI, V8, P1256, DOI 10.1111/j.1460-9568.1996.tb01294.x; Schomig E, 1998, FEBS LETT, V425, P79, DOI 10.1016/S0014-5793(98)00203-8; SCHOMIG E, 1990, N-S ARCH PHARMACOL, V341, P404; SCHULTEIS G, 1994, NATURE, V371, P108, DOI 10.1038/371108a0; Trendelenburg U, 1988, HDB EXP PHARM, P279	15	307	313	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					349	351		10.1038/1557	http://dx.doi.org/10.1038/1557			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196521				2022-12-24	WOS:000076361400009
J	Studer, L; Tabar, V; McKay, RDG				Studer, L; Tabar, V; McKay, RDG			Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; MIDBRAIN DOPAMINERGIC-NEURONS; FETAL VENTRAL MESENCEPHALON; LONG-TERM SURVIVAL; STEM-CELLS; NEURAL PROGENITORS; SONIC HEDGEHOG; GRAFT-SURVIVAL; GENE-THERAPY; IN-VIVO	In vitro expansion of central nervous system (CNS) precursors might overcome the limited availability of dopaminergic neurons in transplantation for Parkinson's disease, but generating dopaminergic neurons from in vitro dividing precursors has proven difficult. Here a three-dimensional cell differentiation system was used to convert precursor cells derived from E12 rat ventral mesencephalon into dopaminergic neurons. We demonstrate that CNS precursor cell populations expanded in vitro can efficiently differentiate into dopaminergic neurons, survive intrastriatal transplantation and induce functional recovery in hemiparkinsonian rats. The numerical expansion of primary CNS precursor cells is a new approach that could improve both the ethical and the technical outlook for the use of human fetal tissue in clinical transplantation.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Massachusetts, Div Neurosurg, Worcester, MA 01655 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Massachusetts System; University of Massachusetts Worcester	McKay, RDG (corresponding author), NINDS, Mol Biol Lab, NIH, 36 Convent Dr,Bldg 36,Room 5A29, Bethesda, MD 20892 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987				BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BRUNDIN P, 1988, DEV BRAIN RES, V39, P233, DOI 10.1016/0165-3806(88)90027-2; BRUSTIE O, 1997, CURRENT PROTOCOLS NE; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Deacon T, 1997, NAT MED, V3, P350, DOI 10.1038/nm0397-350; FISHELL G, 1995, DEVELOPMENT, V121, P803; FISHER LJ, 1991, NEURON, V6, P371, DOI 10.1016/0896-6273(91)90246-V; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUYENET PG, 1981, BRAIN RES, V213, P291, DOI 10.1016/0006-8993(81)90235-3; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; JIAO SS, 1993, NATURE, V362, P450, DOI 10.1038/362450a0; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; MARTINEZSERRANO A, 1995, NEURON, V15, P473, DOI 10.1016/0896-6273(95)90051-9; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rosenthal A, 1998, NEURON, V20, P169, DOI 10.1016/S0896-6273(00)80445-6; SABATE O, 1995, NAT GENET, V9, P256, DOI 10.1038/ng0395-256; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; Spenger C, 1996, EXP BRAIN RES, V112, P47; Studer L, 1996, BRAIN RES BULL, V41, P143, DOI 10.1016/0361-9230(96)00114-1; STUDER L, 1997, CURRENT PROTOCOLS NE; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; TAKAYAMA H, 1995, NAT MED, V1, P53, DOI 10.1038/nm0195-53; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; VICARIOABEJON C, 1995, J NEUROSCI, V15, P6351; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; Wenning GK, 1997, ANN NEUROL, V42, P95, DOI 10.1002/ana.410420115; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	45	455	514	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					290	295		10.1038/1105	http://dx.doi.org/10.1038/1105			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195162				2022-12-24	WOS:000076361300012
J	Oram, MW; Richmon, BJ				Oram, MW; Richmon, BJ			I see a face - a happy face	NATURE NEUROSCIENCE			English	News Item							INFERIOR TEMPORAL CORTEX; STRIATE CORTEX; MACAQUE MONKEY; MECHANISMS; LATENCY; CAT	Information analysis shows that face-selective neurons in inferior temporal cortex encode different stimulus attributes early and late in their response to the same image.	Univ St Andrews, Sch Psychol, St Andrews KY16 9JU, Fife, Scotland; NIMH, NIH, Bethesda, MD 20892 USA	University of St Andrews; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Oram, MW (corresponding author), Univ St Andrews, Sch Psychol, St Andrews KY16 9JU, Fife, Scotland.		Oram, Michael/A-2558-2010	Oram, Mike W/0000-0001-5005-4208				BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; McClelland J. L., 1988, EXPLORATIONS PARALLE; OPTICAN LM, 1987, J NEUROPHYSIOL, V57, P162, DOI 10.1152/jn.1987.57.1.162; ORAM MW, 1992, J NEUROPHYSIOL, V68, P70, DOI 10.1152/jn.1992.68.1.70; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SUGASE Y, IN PRESS NATURE, V401; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Worgotter F, 1996, NEUROREPORT, V7, P741	14	9	9	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					856	858		10.1038/13149	http://dx.doi.org/10.1038/13149			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491600				2022-12-24	WOS:000083883200005
J	Parmantier, E; Lynn, B; Lawson, D; Turmaine, M; Namini, SS; Chakrabarti, L; McMahon, AP; Jessen, KR; Mirsky, R				Parmantier, E; Lynn, B; Lawson, D; Turmaine, M; Namini, SS; Chakrabarti, L; McMahon, AP; Jessen, KR; Mirsky, R			Schwann cell-derived desert hedgehog controls the development of peripheral nerve sheaths	NEURON			English	Article							TIGHT JUNCTION; CARTILAGE DIFFERENTIATION; EMBRYONIC NERVES; FREEZE-FRACTURE; SCIATIC-NERVE; GAP-JUNCTIONS; PATCHED GENE; E-CADHERIN; PERINEURIUM; OCCLUDIN	We show that Schwann cell-derived Desert hedgehog (Dhh) signals the formation of the connective tissue sheath around peripheral nerves, mRNAs for dhh and its receptor patched (ptc) are expressed in Schwann cells and perineural mesenchyme, respectively. In dhh(-/-) mice, epineurial collagen is reduced, while the perineurium is thin and disorganized, has patchy basal lamina, and fails to express connexin 43. Perineurial tight junctions are abnormal and allow the passage of proteins and neutrophils. In nerve fibroblasts, Dhh upregulates ptc and hedgehog-interacting protein (hip). These experiments reveal a novel developmental signaling pathway between glia and mesenchymal connective tissue and demonstrate its molecular identity in peripheral nerve. They also show that Schwann cell-derived signals can act as important regulators of nerve development.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England; UCL, Dept Mol Pathol, London WC1E 6BT, England; Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA	University of London; University College London; University of London; University College London; University of London; University College London; Harvard University	Mirsky, R (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	r.mirsky@ucl.ac.uk	Chakrabarti, Lisa/G-4236-2011; McMahon, Andrew P/ABE-7520-2020	Chakrabarti, Lisa/0000-0001-7213-6837	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AHMED AM, 1979, NEUROPATH APPL NEURO, V5, P469, DOI 10.1111/j.1365-2990.1979.tb00644.x; Akiyama H, 1997, BIOCHEM BIOPH RES CO, V235, P142, DOI 10.1006/bbrc.1997.6750; BARANOWSKI R, 1986, BRIT J PHARMACOL, V89, P267, DOI 10.1111/j.1476-5381.1986.tb10256.x; BEAMISH NG, 1992, J NEUROCYTOL, V21, P67, DOI 10.1007/BF01206898; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Bradley JL, 1998, J ANAT, V192, P529, DOI 10.1046/j.1469-7580.1998.19240529.x; BUNGE MB, 1989, SCIENCE, V243, P229, DOI 10.1126/science.2492115; Chandross KJ, 1996, MOL CELL NEUROSCI, V7, P501, DOI 10.1006/mcne.1996.0036; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; CURTIS R, 1992, J CELL BIOL, V117, P225; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Dong ZP, 1999, J NEUROSCI RES, V56, P334, DOI 10.1002/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#; ELIAS PM, 1976, J CELL BIOL, V68, P173, DOI 10.1083/jcb.68.2.173; Fujimoto K, 1997, J CELL SCI, V110, P311; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gold R, 1999, BRAIN PATHOL, V9, P343; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Greening J, 1998, MANUAL THERAPY, V3, P187; HALL SM, 1989, NEUROPATH APPL NEURO, V15, P513, DOI 10.1111/j.1365-2990.1989.tb01251.x; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; JESSEN KR, 1999, IN PRESS TRENDS NEUR; Kojima T, 1996, EXP CELL RES, V223, P314, DOI 10.1006/excr.1996.0087; KRISTENSSON K, 1971, ACTA NEUROPATHOL, V17, P127, DOI 10.1007/BF00687488; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; LAWSON D, 1984, J CELL BIOL, V99, P1451, DOI 10.1083/jcb.99.4.1451; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; McCarthy KM, 1996, J CELL SCI, V109, P2287; OLSSON Y, 1990, CRIT REV NEUROBIOL, V5, P265; OWENS GC, 1991, DEVELOPMENT, V112, P639; REX M, 1994, BIOCHEMICA, V3, P24; ROSENBAUM T, 1995, DEVELOPMENT, V121, P3583; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SCHIAVINATO A, 1991, J NEUROCYTOL, V20, P459, DOI 10.1007/BF01252274; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; Takabatake T, 1997, FEBS LETT, V410, P485, DOI 10.1016/S0014-5793(97)00645-5; THOMAS PK, 1978, ACTA NEUROPATHOL, V43, P135; THOMAS PK, 1984, PERIPHERAL NEUROPATH, V1, P97; THOMAS PK, 1965, J ANAT, V101, P45; THOMAS PK, 1990, GREENFIELDS NEUROPAT, P409; Vanderburg CR, 1996, ACTA ANAT, V157, P87; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399	52	236	240	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					713	724		10.1016/S0896-6273(01)80030-1	http://dx.doi.org/10.1016/S0896-6273(01)80030-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482238	Bronze			2022-12-24	WOS:000082280900015
J	Thaler, J; Harrison, K; Sharma, K; Lettieri, K; Kehrl, J; Pfaff, SL				Thaler, J; Harrison, K; Sharma, K; Lettieri, K; Kehrl, J; Pfaff, SL			Active suppression of interneuron programs within developing motor neurons revealed by analysis of homeodomain factor HB9	NEURON			English	Article							IN-SITU HYBRIDIZATION; SPINAL-CORD; HOMEOBOX GENE; SONIC HEDGEHOG; TAIL MUTATION; FLOOR PLATE; EXPRESSION; ZEBRAFISH; IDENTITY; CELLS	Sonic hedgehog (Shh) specifies the identity of both motor neurons (MNs) and interneurons with morphogen-like activity. Here, we present evidence that the homeodomain factor HB9 is critical for distinguishing MN and interneuron identity in the mouse. Presumptive MN progenitors and postmitotic MNs express HB9, whereas interneurons never express this factor. This pattern resembles a composite of the avian homologs MNR2 and HB9. In mice lacking Hb9, the genetic profile of MNs is significantly altered, particularly by upregulation of Chx10, a gene normally restricted to a class of ventral interneurons. This aberrant gene expression is accompanied by topological disorganization of motor columns, loss of the phrenic and abducens nerves, and intercostal nerve pathfinding defects. Thus, MNs actively suppress interneuron genetic programs to establish their identity.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	Salk Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037116, R01NS037116] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37116] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arendt D, 1999, DEVELOPMENT, V126, P2309; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Brown, 1981, ORG SPINAL CORD ANAT; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Duboule D, 1998, TRENDS GENET, V14, P54, DOI 10.1016/S0168-9525(97)01358-9; Eizinger A, 1999, TRENDS GENET, V15, P197, DOI 10.1016/S0168-9525(99)01728-X; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fedtsova N, 1997, DEV BIOL, V190, P18, DOI 10.1006/dbio.1997.8691; Greer JJ, 1999, J APPL PHYSIOL, V86, P779, DOI 10.1152/jappl.1999.86.3.779; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Halpern ME, 1995, DEVELOPMENT, V121, P4257; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; HARRISON KA, 1999, IN PRESS NAT GENET; Hemavathy K, 1997, DEVELOPMENT, V124, P3683; HOBERT O, 1999, IN PRESS TRENDS GENE; Hogan B, 1994, MANIPULATING MOUSE E; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; LEBER SM, 1990, J NEUROSCI, V10, P2451; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Maatman R, 1997, DEVELOPMENT, V124, P4019; Nomes H. O., 1978, BRAIN RES, V159, P1; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SHARMA K, 1994, DEVELOPMENT, V120, P1315; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Siegler MVS, 1999, NEURON, V22, P265, DOI 10.1016/S0896-6273(00)81088-0; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Tiret L, 1998, DEVELOPMENT, V125, P279; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; WETTS R, 1994, NEUROSCIENCE, V63, P1117, DOI 10.1016/0306-4522(94)90577-0; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085	53	277	288	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					675	687		10.1016/S0896-6273(01)80027-1	http://dx.doi.org/10.1016/S0896-6273(01)80027-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482235	Bronze			2022-12-24	WOS:000082280900012
J	Zhu, Y; Li, HS; Zhou, LJ; Wu, JY; Rao, Y				Zhu, Y; Li, HS; Zhou, LJ; Wu, JY; Rao, Y			Cellular and molecular guidance of GABAergic neuronal migration from an extracortical origin to the neocortex	NEURON			English	Article							DEVELOPING CEREBRAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; CLONALLY RELATED CELLS; ADULT MAMMALIAN BRAIN; REELER-LIKE PHENOTYPE; PRENATAL DEVELOPMENT; DROSOPHILA-MELANOGASTER; TANGENTIAL MIGRATION; INTERMEDIATE ZONE; CORTICAL-CELLS	Formation of the normal mammalian cerebral cortex requires the migration of GABAergic inhibitory interneurons from an extracortical origin, the lateral ganglionic eminence (LGE). Mechanisms guiding the migratory direction of these neurons, or other neurons in the neocortex, are not well understood. We have used an explant assay to study GABAergic neuronal migration and found that the ventricular zone (VZ) of the LGE is repulsive to GABAergic neurons. Furthermore, the secreted protein Slit is a chemorepellent guiding the migratory direction of GABAergic neurons, and blockade of endogenous Slit signaling inhibits the repulsive activity in the VZ. These results have revealed a cellular source of guidance for GABAergic neurons, demonstrated a molecular cue important for cortical development, and suggested a guidance mechanism for the migration of extracortical neurons into the neocortex.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Rao, Y (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	raoyi@thalamus.wustl.edu			NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114197-01A2] Funding Source: Medline; NEI NIH HHS [R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Battye R, 1999, DEVELOPMENT, V126, P2475; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; COBAS A, 1991, NEUROSCIENCE, V40, P375, DOI 10.1016/0306-4522(91)90127-A; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DEDIEGO I, 1994, EUR J NEUROSCI, V6, P983, DOI 10.1111/j.1460-9568.1994.tb00593.x; DELRIO JA, 1992, J COMP NEUROL, V326, P501, DOI 10.1002/cne.903260403; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; Goldman SA, 1998, TRENDS NEUROSCI, V21, P107, DOI 10.1016/S0166-2236(97)01191-0; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GUTHRIE S, 1994, NEUROPROTOCOLS, V4, P116; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; Hatten M E, 1993, Curr Opin Neurobiol, V3, P38, DOI 10.1016/0959-4388(93)90033-U; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1984, J CELL BIOL, V98, P193, DOI 10.1083/jcb.98.1.193; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; LAUDER JM, 1986, NEUROSCIENCE, V19, P465, DOI 10.1016/0306-4522(86)90275-7; LEWIS JO, 1994, MECH DEVELOP, V48, P81, DOI 10.1016/0925-4773(94)90018-3; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lumsden A, 1997, SCIENCE, V278, P402, DOI 10.1126/science.278.5337.402; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Luskin MB, 1998, J NEUROBIOL, V36, P221; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; MASON CA, 1988, J NEUROSCI, V8, P3124; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Montell DJ, 1999, DEVELOPMENT, V126, P3035; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; ORourke NA, 1997, DEVELOPMENT, V124, P997; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1995, P NATL ACAD SCI USA, V92, P11323, DOI 10.1073/pnas.92.25.11323; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Rice DS, 1998, DEVELOPMENT, V125, P3719; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; SORIANO E, 1995, P NATL ACAD SCI USA, V92, P11676, DOI 10.1073/pnas.92.25.11676; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1995, DEVELOPMENT, V121, P1029; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; VANEDEN CG, 1989, J COMP NEUROL, V289, P213, DOI 10.1002/cne.902890204; WALSH C, 1990, EXPERIENTIA, V46, P940, DOI 10.1007/BF01939387; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; YAN XX, 1992, DEV BRAIN RES, V65, P191, DOI 10.1016/0165-3806(92)90179-Z; Yoneshima H, 1997, NEUROSCI RES, V29, P217, DOI 10.1016/S0168-0102(97)00088-6; YUAN W, 1999, IN PRESS DEV BIOL; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417; Zhou L, 1997, MECH DEVELOP, V67, P59, DOI 10.1016/S0925-4773(97)00107-X	81	199	210	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1999	23	3					473	485		10.1016/S0896-6273(00)80801-6	http://dx.doi.org/10.1016/S0896-6273(00)80801-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433260	Bronze			2022-12-24	WOS:000081701000012
J	Bargmann, CI				Bargmann, CI			A complex sensory map for pheromones	NEURON			English	Article							MULTIGENE FAMILY; ODORANT RECEPTORS; MAMMALS		Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RODRIGUEZ I, 1999, IN PRESS CELL, V97; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; TAKAMI S, 1991, J COMP NEUROL, V311, P65, DOI 10.1002/cne.903110106; Vickers NJ, 1998, J COMP NEUROL, V400, P35; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9	12	4	4	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					640	642		10.1016/S0896-6273(00)80720-5	http://dx.doi.org/10.1016/S0896-6273(00)80720-5			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230781	Bronze			2022-12-24	WOS:000079976200004
J	Ba-Charvet, KTN; Brose, K; Marillat, V; Kidd, T; Goodman, CS; Tessier-Lavigne, M; Sotelo, C; Chedotal, A				Ba-Charvet, KTN; Brose, K; Marillat, V; Kidd, T; Goodman, CS; Tessier-Lavigne, M; Sotelo, C; Chedotal, A			Slit2-mediated chemorepulsion and collapse of developing forebrain axons	NEURON			English	Article							GROWTH CONE GUIDANCE; RAT OLFACTORY-BULB; SEMAPHORIN-III; NERVOUS-SYSTEM; OPTIC CHIASM; SPINAL-CORD; FLOOR PLATE; CONNECTIONS; PROJECTIONS; MIDLINE	Diffusible chemorepellents play a major role in guiding developing axons toward their correct targets by preventing them from entering or steering them away from certain regions. Genetic studies in Drosophila revealed a novel repulsive guidance system that prevents inappropriate axons from crossing the CNS midline; this repulsive system is mediated by the Roundabout (Robo) receptor and its secreted ligand Slit. In rodents, Robe and Slit are expressed in the spinal cord and Slit can repel spinal motor axons in vitro. Here, we extend these findings into higher brain centers by showing that Robo1 and Robo2, as well as Slit1 and Slit2, are often expressed in complementary patterns in the developing forebrain. Furthermore, we show that human Slit2 can repel olfactory and hippocampal axons and collapse their growth cones.	Hop La Pitie Salpetriere, INSERM, U106, F-75013 Paris, France; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Chedotal, A (corresponding author), Hop La Pitie Salpetriere, INSERM, U106, Batiment Pediat,47 Blvd Hop, F-75013 Paris, France.	chedotal@infobiogen.fr	Chedotal, Alain/F-2750-2017; Sotelo, Constantino/AAS-5475-2021; Nguyen-Ba-Charvet, Kim/J-3507-2017; Kidd, Thomas/AAT-9993-2020	Chedotal, Alain/0000-0001-7577-3794; Sotelo, Constantino/0000-0001-8051-2492; Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872; Kidd, Thomas/0000-0001-7190-4208				Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Amaral David G., 1995, P443; Ba-Charvet KTN, 1998, DEVELOPMENT, V125, P4273; Bagnard D, 1998, DEVELOPMENT, V125, P5043; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BROSE K, 1999, IN PRESS CELL, V96; Chedotal A, 1998, DEVELOPMENT, V125, P4313; COLOMARINO SA, 1995, CELL, V81, P621; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Grove EA, 1998, DEVELOPMENT, V125, P2315; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KIDD T, 1999, IN PRESS CELL, V96; Kobayashi H, 1997, J NEUROSCI, V17, P8339; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LopezMascaraque L, 1996, NEUROSCIENCE, V70, P255, DOI 10.1016/0306-4522(95)00360-U; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Metin C, 1997, DEVELOPMENT, V124, P5063; MOODY SA, 1989, J COMP NEUROL, V346, P97; OAKLEY RA, 1993, J NEUROSCI, V13, P3773; PINI A, 1993, SCIENCE, V261, P34; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; Richards LJ, 1997, J NEUROSCI, V17, P2445; Sato Y, 1998, J NEUROSCI, V18, P7800; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Super H, 1998, J NEUROSCI, V18, P4616; TAMADA A, 1995, NEURON, V14, P1083, DOI 10.1016/0896-6273(95)90347-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tuttle R, 1998, DEVELOPMENT, V125, P791; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; WANG KH, 1999, IN PRESS CELL, V96; Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	47	241	245	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					463	473		10.1016/S0896-6273(00)80702-3	http://dx.doi.org/10.1016/S0896-6273(00)80702-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197527	Bronze			2022-12-24	WOS:000079483900011
J	Davenport, RW; Thies, E; Cohen, ML				Davenport, RW; Thies, E; Cohen, ML			Neuronal growth cone collapse triggers lateral extensions along trailing axons	NATURE NEUROSCIENCE			English	Article							RETINAL AXONS; RETINOTECTAL PROJECTION; TOPOGRAPHIC ORDER; CELLULAR-LOCALIZATION; TARGET RECOGNITION; DIRECTIONAL CUES; GUIDANCE CUES; IN-VITRO; GRADIENTS; MOLECULES	Axonal outgrowth is generally thought to be controlled by direct interaction of the lead growth cone with guidance cues, and, in trailing axons, by fasciculation with pioneer fibers. Responses of axons and growth cones were examined as cultured retinal ganglion cell (RCC) axons encountered repellent cues. Either contact with cells expressing ephrins or mechanical probing increased the probability of lead growth cone retraction. Lateral extension of filopodia and lamellipodia hundreds of microns behind the lead growth cone was correlated with its collapse. Transmission electron microscopy showed that some of the lateral extensions originate from the pioneer axon, whereas others represent growth cones of defasciculating trailing axons.	NICHHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Davenport, RW (corresponding author), Univ Maryland, Dept Biol, 1210 Zool Psychol Bldg, College Pk, MD 20742 USA.							BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; BODICK N, 1980, P NATL ACAD SCI-BIOL, V77, P4374, DOI 10.1073/pnas.77.7.4374; BONHOEFFER F, 1984, TRENDS NEUROSCI, V7, P378, DOI 10.1016/S0166-2236(84)80060-0; BURMEISTER DW, 1991, CELL MOTIL CYTOSKEL, V19, P255, DOI 10.1002/cm.970190404; BURRILL JD, 1995, J NEUROSCI, V15, P2935; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Davenport RW, 1998, J NEUROSCI, V18, P975; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Davenport RW, 1996, J NEUROSCI, V16, P2074; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; GIERER A, 1987, DEVELOPMENT, V101, P479; GOLDBERG DJ, 1991, NERVE GROWTH CONE, P79; GOLDBERG S, 1974, DEV BIOL, V36, P24, DOI 10.1016/0012-1606(74)90188-2; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HARRIS WA, 1995, NEURON, V15, P241, DOI 10.1016/0896-6273(95)90000-4; MCCAIG CD, 1990, J CELL SCI, V95, P605; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; NEALE EA, 1978, BRAIN RES, V152, P265, DOI 10.1016/0006-8993(78)90255-X; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OLEARY DDM, 1985, BRAIN RES, V336, P326, DOI 10.1016/0006-8993(85)90661-4; ROSKIES A, 1995, PERSPECT DEV NEUROBI, V3, P63; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; Sanes J R, 1993, Curr Opin Neurobiol, V3, P67, DOI 10.1016/0959-4388(93)90037-Y; SIMOES AMP, 1990, J ELECTROCHEM SOC, V137, P1; SIMON DK, 1994, DEV BIOL, V162, P384, DOI 10.1006/dbio.1994.1095; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, COLD SPRING HARB SYM, V55, P351; Szebenyi G, 1998, J NEUROSCI, V18, P7930; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; THANOS S, 1983, J COMP NEUROL, V219, P420, DOI 10.1002/cne.902190404; THANOS S, 1984, P NATL ACAD SCI-BIOL, V81, P1906, DOI 10.1073/pnas.81.6.1906; THANOS S, 1987, J COMP NEUROL, V261, P155, DOI 10.1002/cne.902610114; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; Vanegas H, 1984, COMP NEUROLOGY OPTIC; WILLIAMS CV, 1995, J NEUROBIOL, V27, P127, DOI 10.1002/neu.480270202	42	57	58	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					254	259		10.1038/6360	http://dx.doi.org/10.1038/6360			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195218				2022-12-24	WOS:000081684500013
J	Schuller, AGP; King, MA; Zhang, JW; Bolan, E; Pan, YX; Morgan, DJ; Chang, A; Czick, ME; Unterwald, EM; Pasternak, GW; Pintar, JE				Schuller, AGP; King, MA; Zhang, JW; Bolan, E; Pan, YX; Morgan, DJ; Chang, A; Czick, ME; Unterwald, EM; Pasternak, GW; Pintar, JE			Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1	NATURE NEUROSCIENCE			English	Article							MORPHINE-INDUCED ANALGESIA; PROTEIN ALPHA-SUBUNITS; NITRIC-OXIDE SYNTHASE; OPIOID-RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDES; DIFFERENTIAL BLOCKADE; MOLECULAR-BIOLOGY; MU-RECEPTOR; EXPRESSION; BINDING	Morphine produces analgesia by activating mu opioid receptors encoded by the MOR-1 gene. Although morphine-6 beta-glucuronide (M6G), heroin and 6-acetylmorphine also are considered mu opioids, recent evidence suggests that they act through a distinct receptor mechanism. We examined this question in knockout mice containing disruptions of either the first or second coding exon of MOR-1. Mice homozygous for either MOR-1 mutation were insensitive to morphine. Heroin, 6-acetylmorphine and M6G still elicited analgesia in the exon-l MOR-1 mutant, which also showed specific M6G binding, whereas M6G and 6-acetylmorphine were inactive in the exon-2 MOR-1 mutant. These results provide genetic evidence for a unique receptor site for M6G and heroin analgesia.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, CABM, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Mem Sloan Kettering Canc Ctr, Cotzias Lab Neurooncol, New York, NY 10021 USA; NYU, Med Ctr, Dept Psychiat, New York, NY 10016 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Memorial Sloan Kettering Cancer Center; New York University	Pintar, JE (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, CABM, Dept Neurosci & Cell Biol, RM 326,675 Hoes Lane, Piscataway, NJ 08854 USA.	pintar@mbcl.rutgers.edu		Morgan, Daniel/0000-0002-9467-4019	NIDA NIH HHS [DA-08622, DA-09040, R56 DA002615, DA-00296, R01 DA007242] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008622, R01DA007242, R56DA002615, R01DA009040] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brown GP, 1997, J PHARMACOL EXP THER, V282, P1291; Brown GP, 1997, FEBS LETT, V412, P35, DOI 10.1016/S0014-5793(97)00710-2; CHEN XH, 1995, EUR J PHARMACOL, V275, P105, DOI 10.1016/0014-2999(95)00012-A; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; INTURRISI CE, 1984, NEW ENGL J MED, V310, P1213, DOI 10.1056/NEJM198405103101902; INTURRISI CE, 1983, LIFE SCI, V33, P773, DOI 10.1016/0024-3205(83)90616-1; Joyner AL, 1993, GENE TARGETING PRACT; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MOSKOWITZ AS, 1985, BRAIN RES, V360, P117, DOI 10.1016/0006-8993(85)91227-2; OLDENDORF WH, 1972, SCIENCE, V178, P984, DOI 10.1126/science.178.4064.984; PASTERNAK GW, 1995, TRENDS PHARMACOL SCI, V16, P344, DOI 10.1016/S0165-6147(00)89068-9; PASTERNAK GW, 1993, CLIN NEUROPHARMACOL, V16, P1, DOI 10.1097/00002826-199302000-00001; PAUL D, 1989, J PHARMACOL EXP THER, V251, P477; PICK CG, 1993, J PHARMACOL EXP THER, V265, P166; REISINE T, 1993, TRENDS NEUROSCI, V16, P506, DOI 10.1016/0166-2236(93)90194-Q; ROSSI G, 1994, LIFE SCI, V54, pPL375, DOI 10.1016/0024-3205(94)90038-8; ROSSI GC, 1995, NEUROSCI LETT, V198, P99, DOI 10.1016/0304-3940(95)11977-5; ROSSI GC, 1995, FEBS LETT, V369, P192, DOI 10.1016/0014-5793(95)00757-Z; Rossi GC, 1996, NEUROSCI LETT, V216, P1; Rossi GC, 1997, J PHARMACOL EXP THER, V281, P109; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Standifer KM, 1996, MOL PHARMACOL, V50, P293; Tian MT, 1997, J EXP MED, V185, P1517, DOI 10.1084/jem.185.8.1517; UHL GR, 1994, TRENDS NEUROSCI, V17, P89, DOI 10.1016/0166-2236(94)90110-4; WAY EL, 1960, J PHARMACOL EXP THER, V129, P144; WAY EL, 1965, B NARCOTICS, V17, P25; ZIMPRICH A, 1995, FEBS LETT, V359, P142, DOI 10.1016/0014-5793(95)00028-8	30	258	264	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					151	156		10.1038/5706	http://dx.doi.org/10.1038/5706			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195199				2022-12-24	WOS:000078231600014
J	Bulfone, A; Wang, F; Hevner, R; Anderson, S; Cutforth, T; Chen, S; Meneses, J; Pedersen, R; Axel, R; Rubenstein, JLR				Bulfone, A; Wang, F; Hevner, R; Anderson, S; Cutforth, T; Chen, S; Meneses, J; Pedersen, R; Axel, R; Rubenstein, JLR			An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons	NEURON			English	Article							ODORANT RECEPTOR EXPRESSION; MOUSE FOREBRAIN; GENE-EXPRESSION; SYNAPSE FORMATION; HOMEOBOX GENES; DLX GENES; BULB; ORGANIZATION; EPITHELIUM; SYSTEM	Olfactory sensory neurons expressing a given odorant receptor project to two topographically fixed glomeruli in the olfactory bulb. We have examined the contribution of different cell types in the olfactory bulb to the establishment of this topographic map. Mice with a homozygous deficiency in Tbr-1 lack most projection neurons, whereas mice with a homozygous deficiency in Dlx-1 and Dlx-2 lack most GABAergic interneurons. Mice bearing a P2-IRES-tau-lacZ allele and deficient in either Tbr-1 or Dlx-1/Dlx-2 reveal the convergence of axons to one medial and one lateral site at positions analogous to those observed in wild-type mice. These observations suggest that the establishment of a topographic map is not dependent upon cues provided by, or synapse formation with, the major neuronal cell types in the olfactory bulb.	Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, Ctr Neurobiol & Psychiat, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol & Biomed Sci, San Francisco, CA 94143 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University; Howard Hughes Medical Institute	Bulfone, A (corresponding author), Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, Ctr Neurobiol & Psychiat, Dept Psychiat, San Francisco, CA 94143 USA.	jlrr@cgl.ucsf.edu		Axel, Richard/0000-0002-3141-4076	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001973, R01NS034661] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH01046-01] Funding Source: Medline; NINDS NIH HHS [NS01973-02, NS34661-01A1] Funding Source: Medline; Telethon [TGM97000, TGM06S01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BULFONE A, 1993, MECH DEVELOP, V40, P129, DOI 10.1016/0925-4773(93)90071-5; BULFONE A, 1993, J NEUROSCI, V13, P3155; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Davenport RW, 1996, J NEUROSCI, V16, P2074; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HINDS JW, 1976, J COMP NEUROL, V169, P15, DOI 10.1002/cne.901690103; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIYAMA H, 1991, NEUROSCI LETT, V128, P85, DOI 10.1016/0304-3940(91)90765-L; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; Liu JK, 1997, DEV DYNAM, V210, P498, DOI 10.1002/(SICI)1097-0177(199712)210:4<498::AID-AJA12>3.0.CO;2-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; Oland LA, 1996, J NEUROBIOL, V30, P92; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; ROYET JP, 1989, J COMP NEUROL, V289, P586, DOI 10.1002/cne.902890405; SALINAS PC, 1992, MECH DEVELOP, V39, P151, DOI 10.1016/0925-4773(92)90042-I; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Shipley MT, 1996, J NEUROBIOL, V30, P123; SULLIVAN SL, 1995, NEURON, V15, P779, DOI 10.1016/0896-6273(95)90170-1; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; VANSELOW J, 1989, DEV BRAIN RES, V45, P15, DOI 10.1016/0165-3806(89)90003-5; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WU DY, 1995, J COMP NEUROL, V358, P206, DOI 10.1002/cne.903580204; ZHU WJ, 1995, MOL BRAIN RES, V30, P312, DOI 10.1016/0169-328X(95)00017-M	43	265	272	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1273	1282		10.1016/S0896-6273(00)80647-9	http://dx.doi.org/10.1016/S0896-6273(00)80647-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883721	hybrid			2022-12-24	WOS:000077910600010
J	Impey, S; Smith, DM; Obrietan, K; Donahue, R; Wade, C; Storm, DR				Impey, S; Smith, DM; Obrietan, K; Donahue, R; Wade, C; Storm, DR			Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; HIPPOCAMPAL-LESIONS; MUTANT MICE; LATE-PHASE; BASOLATERAL AMYGDALA; ADENYLATE-CYCLASE; GENE-EXPRESSION; FEAR; POTENTIATION; CREB	Recent studies suggest that the CREB-CRE transcriptional pathway is pivotal in the formation of some types of long-term memory. However, it has not been demonstrated that stimuli that induce learning and memory activate CRE-mediated gene expression. To address this issue, we used a mouse strain transgenic for a CRE-lac Z reporter to examine the effects of hippocampus-dependent learning on CRE-mediated gene expression in the brain. Training for contextual conditioning or passive avoidance led to significant increases in CRE-dependent gene expression in areas CA1 and CA3 of the hippocampus. Auditory cue fear-conditioning, which is amygdala dependent, was associated with increased CRE-mediated gene expression in the amygdala, but not the hippocampus. These data demonstrate that learning in response to behavioral conditioning activates the CRE transcriptional pathway in specific areas of brain.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Mail Box 357280,Hlth Sci Bldg, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BARONDES SH, 1968, P NATL ACAD SCI USA, V61, P923, DOI 10.1073/pnas.61.3.923; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; CAMPEAU S, 1996, NEURON, V16, P237; Chen C, 1996, BEHAV NEUROSCI, V110, P1177; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; IMPEY S, IN PRESS NEURON; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; LUBOW RE, 1973, PSYCHOL BULL, V79, P398, DOI 10.1037/h0034425; Maren S, 1996, BEHAV NEUROSCI, V110, P718, DOI 10.1037/0735-7044.110.4.718; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Nguyen PV, 1996, J NEUROSCI, V16, P3189; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PHILLIPS RG, 1995, J NEUROSCI, V15, P5308; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YECKEL MF, 1995, HIPPOCAMPUS, V5, P108, DOI 10.1002/hipo.450050204; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; YOVELL Y, 1987, P NATL ACAD SCI USA, V84, P9285, DOI 10.1073/pnas.84.24.9285	50	425	439	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					595	601		10.1038/2830	http://dx.doi.org/10.1038/2830			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196567				2022-12-24	WOS:000077437100015
J	Nakamura, F; Tanaka, M; Takahashi, T; Kalb, RG; Strittmatter, SM				Nakamura, F; Tanaka, M; Takahashi, T; Kalb, RG; Strittmatter, SM			Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; RECEPTOR; PROTEIN; FAMILY; HEDGEHOG; GUIDANCE; EXPRESSION; MOLECULES; SYSTEM; CHICK	Somatosensory axon outgrowth is repulsed when soluble semaphorin D (semD) binds to growth cone neuropilin-1 (Npn-1). Here, semD ligand binding studies of Npn-1 mutants demonstrate that the sema domain binds to the amino-terminal quarter, or complement-binding (CUB) domain, of Npn-1. By herpes simplex virus- (HSV-) mediated expression of Npn-1 mutants in chick retinal ganglion cells, we show that semD-induced growth cone collapse requires two segments of the ectodomain of Npn-1, the CUB domain and the juxtamembrane portion, or MAM (meprin, A5, mu) domain. In contrast, the transmembrane segment and cytoplasmic tail of Npn-1 are not required for biologic activity. These data imply that the CUB and MAM ectodomains of Npn-1 interact with another transmembrane growth cone protein that in turn transduces a semD signal into axon repulsion.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	stephen_strittmatter@qm.yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; Jin Z, 1997, J NEUROSCI, V17, P6256; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kolodkin AL, 1997, NEURON, V19, P1159, DOI 10.1016/S0896-6273(00)80408-0; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Koppel AM, 1998, J BIOL CHEM, V273, P15708, DOI 10.1074/jbc.273.25.15708; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; NAKAMURA F, 1997, CELL TECHNOL JPN, V16, P1116; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Puschel AW, 1996, EUR J NEUROSCI, V8, P1317, DOI 10.1111/j.1460-9568.1996.tb01593.x; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Takahashi T, 1997, J NEUROSCI, V17, P9183; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang LH, 1996, J NEUROSCI, V16, P6197	32	233	237	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1093	1100		10.1016/S0896-6273(00)80626-1	http://dx.doi.org/10.1016/S0896-6273(00)80626-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856464	hybrid			2022-12-24	WOS:000077386100019
J	Sangoram, AM; Saez, L; Antoch, MP; Gekakis, N; Staknis, D; Whiteley, A; Fruechte, EM; Vitaterna, MH; Shimomura, K; King, DP; Young, MW; Weitz, CJ; Takahashi, JS				Sangoram, AM; Saez, L; Antoch, MP; Gekakis, N; Staknis, D; Whiteley, A; Fruechte, EM; Vitaterna, MH; Shimomura, K; King, DP; Young, MW; Weitz, CJ; Takahashi, JS			Mammalian circadian autoregulatory loop: A timeless ortholog and mPer1 interact and negatively regulate CLOCK-BMAL1-induced transcription	NEURON			English	Article							DROSOPHILA PERIOD GENE; MOLECULAR ANALYSIS; CLOCK GENE; PROTEIN; RHYTHMS; EXPRESSION; MECHANISM; MUTANT; LIGHT; MELANOGASTER	We report the cloning and mapping of mouse (mTim) and human (hTIM) orthologs of the Drosophila timeless (dtim) gene. The mammalian Tim genes are widely expressed in a variety of tissues; however, unlike Drosophila, mTim mRNA levels do not oscillate in the suprachiasmatic nucleus (SCN) or retina. Importantly, hTIM interacts with the Drosophila PERIOD (dPER) protein as well as the mouse PER1 and PER2 proteins in vitro. In Drosophila (S2) cells, hTIM and dPER interact and translocate into the nucleus. Finally, hTIM and mPER1 specifically inhibit CLOCK-BMAL1-induced transactivation of the mPer1 promoter. Taken together, these results demonstrate that mTim and hTIM are mammalian orthologs of timeless and provide a framework for a basic circadian autoregulatory loop in mammals.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Natl Sci Fdn Ctr Biol Timing, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Rockefeller Univ, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Natl Sci Fdn Ctr Biol Timing, New York, NY 10021 USA	Northwestern University; National Science Foundation (NSF); NSF - Center for Biological Timing; Northwestern University; Howard Hughes Medical Institute; Northwestern University; Harvard University; Harvard Medical School; Rockefeller University; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.		, 机智的马小跳和机智的羊不愁/ABC-5169-2020; Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Whiteley, Andrew/0000-0002-8159-6381; Antoch, mantoch/0000-0003-3001-8511	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dembinska ME, 1997, J BIOL RHYTHM, V12, P157, DOI 10.1177/074873049701200207; Dunlap J, 1998, SCIENCE, V280, P1548, DOI 10.1126/science.280.5369.1548; Dunlap JC, 1996, ANNU REV GENET, V30, P579, DOI 10.1146/annurev.genet.30.1.579; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Myers MP, 1997, NUCLEIC ACIDS RES, V25, P4710, DOI 10.1093/nar/25.23.4710; Ousley A, 1998, GENETICS, V148, P815; Pittendrigh C, 1993, ANNU REV PHYSIOL, V55, P17; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; Rosato E, 1997, BIOESSAYS, V19, P1075, DOI 10.1002/bies.950191206; Rutila JE, 1996, NEURON, V17, P921, DOI 10.1016/S0896-6273(00)80223-8; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	49	288	299	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1101	1113		10.1016/S0896-6273(00)80627-3	http://dx.doi.org/10.1016/S0896-6273(00)80627-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856465	Bronze			2022-12-24	WOS:000077386100020
J	Antonov, SM; Gmiro, VE; Johnson, JW				Antonov, SM; Gmiro, VE; Johnson, JW			Binding sites for permeant ions in the channel of NMDA receptors and their effects on channel block	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; VOLTAGE-DEPENDENT BLOCK; MOUSE CENTRAL NEURONS; ACTIVATED CHANNELS; CORTICAL-NEURONS; STRUCTURAL BASIS; GLUTAMATE; KINETICS; SUBUNITS; CURRENTS	We report the presence of binding sites for permeant monovalent cations at the internal and external entrances to the channel of NMDA receptors. We measured the effects of changing internal cesium (Cs+) and external sodium (Na+) concentrations on the channel-blocking kinetics of the adamantane derivatives IEM-1754 and IEM-1857. Binding of Na+, or of Cs+ after it permeates the channel, to sites at the external channel entrance prevents blockers from entering the channel. Binding of Na+ to a blocked channel prevents blocker unbinding. Cs+ binding to a site at the internal channel entrance prevents IEM-1754 from occupying the deeper of its two sites of block. The results show the critical effects of permeant ions on the kinetics, affinity and voltage-dependence of channel blockers.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; Russian Acad Med Sci, Inst Expt Med, St Petersburg 197022, Russia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Institute of Experimental Medicine; Russian Academy of Medical Sciences	Johnson, JW (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	Johnson@bns.pitt.edu	Antonov, Sergei M/B-5192-2014	Antonov, Sergei M/0000-0002-0644-9330; Gmiro, Valery/0000-0002-2093-8552	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH045156, R29MH045817, K02MH000944, R01MH045817] Funding Source: NIH RePORTER; NIMH NIH HHS [MH45817, MH45156, MH00944] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTONOV SM, 1995, MOL PHARMACOL, V47, P558; Antonov SM, 1996, J PHYSIOL-LONDON, V493, P425, DOI 10.1113/jphysiol.1996.sp021394; ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; Colquhoun David, 1995, P483; Dang TX, 1998, J GEN PHYSIOL, V111, P185, DOI 10.1085/jgp.111.2.185; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; ISHII T, 1993, J BIOL CHEM, V268, P2836; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; Kiss L, 1998, J GEN PHYSIOL, V111, P195, DOI 10.1085/jgp.111.2.195; KLECKNER NW, 1995, J PHYSIOL-LONDON, V486, P411, DOI 10.1113/jphysiol.1995.sp020822; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuner T, 1996, J NEUROSCI, V16, P3549; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LiSmerin YY, 1996, J PHYSIOL-LONDON, V491, P121, DOI 10.1113/jphysiol.1996.sp021201; LYNCH DR, 1995, J NEUROCHEM, V64, P1462; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Premkumar LS, 1996, NEURON, V16, P869, DOI 10.1016/S0896-6273(00)80107-5; Raditsch M, 1996, EUR J BIOCHEM, V240, P416, DOI 10.1111/j.1432-1033.1996.0416h.x; RADITSCH M, 1993, FEBS LETT, V324, P63, DOI 10.1016/0014-5793(93)81533-6; RUPPERSBERG JP, 1994, SEMIN NEUROSCI, V6, P87; Sharma G, 1996, P NATL ACAD SCI USA, V93, P14170, DOI 10.1073/pnas.93.24.14170; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sobolevsky A, 1998, BIOPHYS J, V74, P1305, DOI 10.1016/S0006-3495(98)77844-0; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; SUBRAMANIAM S, 1994, MOL PHARMACOL, V45, P117; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; WEAST RC, 1996, CRC HDB CHEM PHYSICS; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Wyllie D, 1996, J PHYSIOL-LONDON, V491P, pP135; YAMAKURA T, 1993, NEUROREPORT, V4, P687, DOI 10.1097/00001756-199306000-00021; ZAREI MM, 1994, J GEN PHYSIOL, V103, P231, DOI 10.1085/jgp.103.2.231; ZAREI MM, 1995, J NEUROSCI, V15, P1446; ZHONG J, 1994, MOL PHARMACOL, V45, P846; ZORUMSKI CF, 1993, PHARMACOL THERAPEUT, V39, P145	50	64	68	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					451	461		10.1038/2167	http://dx.doi.org/10.1038/2167			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196542				2022-12-24	WOS:000076406900009
J	Han, ZS; Zhang, ET; Craig, AD				Han, ZS; Zhang, ET; Craig, AD			Nociceptive and thermoreceptive lamina I neurons are anatomically distinct	NATURE NEUROSCIENCE			English	Article							SUPERFICIAL DORSAL HORN; RAT SPINAL-CORD; TRIGEMINAL-NUCLEUS-CAUDALIS; SPINOTHALAMIC TRACT NEURONS; MARGINAL ZONE; SUBSTANCE-P; MORPHOLOGICAL CHARACTERIZATION; AXONAL CONTACTS; RAPHE MAGNUS; CAT	Pain and temperature stimuli activate neurons of lamina I within the dorsal horn of the spinal cord, and although these neurons can be classified into three basic morphological types and three major physiological classes, earlier studies did not establish a structure/function correlation between their morphology and their physiological responses. We recorded and intracellularly labeled 38 cat lamina I neurons. All 12 fusiform cells were nociceptive-specific, responsive only to pinch and/or heat. All 11 pyramidal cells were thermoreceptive-specific, responsive only to innocuous cooling. Of ten multipolar cells, six were polymodal, responsive to heat, pinch and cold, and four were nociceptive-specific. Five unclassified cells had features consistent with this pattern. These results support the view that central pain and temperature pathways contain anatomically discrete sets of modality-selective neurons.	Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; Barrow Neurol Inst, Div Neurosurg, Phoenix, AZ 85013 USA	Barrow Neurological Institute; Barrow Neurological Institute	Craig, AD (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.				NIDA NIH HHS [DA 07402] Funding Source: Medline; NINDS NIH HHS [NS 25616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007402] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BENNETT GJ, 1981, BRAIN RES, V209, P421, DOI 10.1016/0006-8993(81)90164-5; BROWN JL, 1995, J COMP NEUROL, V356, P327, DOI 10.1002/cne.903560302; CERVERO F, 1987, J PHYSL, V383, P383; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Craig A. D, 1996, SOMESTHESIS NEUROBIO, P27; CRAIG AD, 1993, J COMP NEUROL, V331, P517, DOI 10.1002/cne.903310407; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; CRAIG AD, 1985, J PHYSIOL-LONDON, V365, P197, DOI 10.1113/jphysiol.1985.sp015767; CRAIG AD, 1994, BRAIN RES, V636, P233, DOI 10.1016/0006-8993(94)91022-7; CRAIG AD, 1991, BRAIN RES, V558, P93, DOI 10.1016/0006-8993(91)90719-C; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; DE KONINCK Y, 1991, P NATL ACAD SCI USA, V88, P11344, DOI 10.1073/pnas.88.24.11344; DOSTROVSKY JO, 1983, J NEUROPHYSIOL, V49, P948, DOI 10.1152/jn.1983.49.4.948; Dostrovsky JO, 1996, J NEUROPHYSIOL, V76, P3656, DOI 10.1152/jn.1996.76.6.3656; FERRINGTON DG, 1987, J PHYSIOL-LONDON, V388, P681, DOI 10.1113/jphysiol.1987.sp016638; GOBEL S, 1978, J COMP NEUROL, V180, P375, DOI 10.1002/cne.901800212; HOFFERT MJ, 1983, BRAIN RES, V267, P361, DOI 10.1016/0006-8993(83)90890-9; HYLDEN JLK, 1986, J COMP NEUROL, V247, P505, DOI 10.1002/cne.902470410; LIGHT AR, 1993, SOMATOSENS MOT RES, V10, P309, DOI 10.3109/08990229309028840; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; LIMA D, 1986, J COMP NEUROL, V244, P53, DOI 10.1002/cne.902440105; LIMA D, 1993, J CHEM NEUROANAT, V6, P43, DOI 10.1016/0891-0618(93)90006-P; LOPEZGARCIA JA, 1994, EUR J NEUROSCI, V6, P998, DOI 10.1111/j.1460-9568.1994.tb00594.x; MACIVER MB, 1992, ANESTHESIOLOGY, V76, P617; Marshall GE, 1996, NEUROSCIENCE, V72, P255, DOI 10.1016/0306-4522(95)00558-7; Menendez L, 1996, J NEUROPHYSIOL, V75, P2099, DOI 10.1152/jn.1996.75.5.2099; MILETIC V, 1984, J COMP NEUROL, V228, P129, DOI 10.1002/cne.902280112; MOKHA SS, 1987, EXP BRAIN RES, V65, P427; MOLONY V, 1981, Q J EXP PHYSIOL CMS, V66, P211, DOI 10.1113/expphysiol.1981.sp002551; MOSCHOVAKIS AK, 1991, J COMP NEUROL, V311, P531, DOI 10.1002/cne.903110408; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; PICKAR JG, 1994, J NEUROPHYSIOL, V71, P753, DOI 10.1152/jn.1994.71.2.753; PRICE DD, 1978, J NEUROPHYSIOL, V41, P933, DOI 10.1152/jn.1978.41.4.933; Schmelz M, 1997, J NEUROSCI, V17, P8003; STEEDMAN WM, 1985, EXP BRAIN RES, V58, P171; SUN MK, 1991, J PHYSIOL-LONDON, V436, P685, DOI 10.1113/jphysiol.1991.sp018573; TAMAMAKI N, 1995, J COMP NEUROL, V354, P583, DOI 10.1002/cne.903540408; WALL PD, 1995, PAIN, V62, P389, DOI 10.1016/0304-3959(95)00130-K; Willis William D., 1985, PAIN SYSTEM; WOOLF CJ, 1994, PAIN, V58, P141, DOI 10.1016/0304-3959(94)90195-3; WOOLF CJ, 1983, J COMP NEUROL, V221, P313, DOI 10.1002/cne.902210307; Zhang ET, 1996, J COMP NEUROL, V367, P537; Zhang ET, 1997, J NEUROSCI, V17, P3274	46	182	187	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					218	225		10.1038/665	http://dx.doi.org/10.1038/665			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195146				2022-12-24	WOS:000076361200012
J	Staley, KJ; Longacher, M; Bains, JS; Yee, A				Staley, KJ; Longacher, M; Bains, JS; Yee, A			Presynaptic modulation of CA3 network activity	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PYRAMIDAL CELLS; SYNCHRONIZED AFTERDISCHARGES; SYNAPTIC TRANSMISSION; EPILEPTIFORM ACTIVITY; HIPPOCAMPAL SYNAPSES; GRANULE CELLS; IN-VITRO; RAT; INHIBITION	The simultaneous discharge of hippocampal CA3 pyramidal cells is a widely studied in vitro model of physiological and pathological network synchronization. This network is rapidly activated because of extensive positive feedback mediated by recurrent axon collaterals. Here we show that population-burst duration is limited by depletion of the releasable glutamate pool at these recurrent synapses. Postsynaptic inhibitory conductances further limit burst duration but are not necessary for burst termination. The interval between bursts in vitro depends on the rate of replenishment of releasable glutamate vesicles and the probability of release of those vesicles at recurrent synapses. Therefore presynaptic factors controlling glutamate release at recurrent synapses regulate the probability and duration of synchronous discharges of the CA3 network.	Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Staley, KJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol, Box B182,4200 E 9th Ave, Denver, CO 80262 USA.	Kevin.Staley@UCHSC.edu		Bains, Jaideep/0000-0002-3634-6463				Anderson Caroline M., 1997, Epilepsia, V38, P16; Barbarosie M, 1997, J NEUROSCI, V17, P9308; BUSH PC, 1994, J NEUROPHYSIOL, V71, P2183, DOI 10.1152/jn.1994.71.6.2183; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Capogna M, 1996, J NEUROPHYSIOL, V75, P2017, DOI 10.1152/jn.1996.75.5.2017; CHAMBERLIN NL, 1990, J NEUROPHYSIOL, V64, P1000, DOI 10.1152/jn.1990.64.3.1000; Chambon A., 1989, J STRAT SYST THER, V8, P3, DOI [https://doi.org/10.1521/jsst.1989.8.bonus.3, DOI 10.1521/JSST.1989.8.BONUS.3]; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUNWIDDIE TV, 1980, EPILEPSIA, V21, P541, DOI 10.1111/j.1528-1157.1980.tb04305.x; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; JEFFERYS JGR, 1993, EPILEPSIES, P241; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; MACVICAR BA, 1982, BRAIN RES, V242, P341; MADISON DV, 1996, NEURON S, V10, P55; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Mayr O., 1970, ORIGINS FEEDBACK CON; MILES R, 1984, NEUROSCIENCE, V12, P1179, DOI 10.1016/0306-4522(84)90012-5; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MUELLER AL, 1983, EPILEPSIA, V24, P57, DOI 10.1111/j.1528-1157.1983.tb04866.x; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Otis T, 1996, J NEUROSCI, V16, P7496; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; RAFIQ A, 1993, J NEUROPHYSIOL, V70, P1962, DOI 10.1152/jn.1993.70.5.1962; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RUTECKI PA, 1990, J NEUROPHYSIOL, V64, P1077, DOI 10.1152/jn.1990.64.4.1077; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SCHARFMAN HE, 1994, J NEUROSCI, V14, P6041; Schikorski T, 1997, J NEUROSCI, V17, P5858; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; SWARTZWELDER HS, 1987, BRAIN RES, V410, P362; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Taylor RT, 1995, BIOREMED SER, V3, P15; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525, DOI 10.1113/jphysiol.1993.sp019527; Traub RD, 1996, EPILEPSIA, V37, P879, DOI 10.1111/j.1528-1157.1996.tb00042.x; TRAUB RD, 1984, NEUROSCIENCE, V12, P1191, DOI 10.1016/0306-4522(84)90013-7; TRAUB RD, 1991, NEURONAL NETWORKS HI, pCH6; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; WHITTINGTON MA, 1994, J PHYSIOL-LONDON, V481, P593, DOI 10.1113/jphysiol.1994.sp020466; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	49	155	157	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					201	209		10.1038/651	http://dx.doi.org/10.1038/651			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195144				2022-12-24	WOS:000076361200010
J	Buchman, VL; Adu, J; Pinon, LGP; Ninkina, NN; Davies, AM				Buchman, VL; Adu, J; Pinon, LGP; Ninkina, NN; Davies, AM			Persyn, a member of the synuclein family, influences neurofilament network integrity	NATURE NEUROSCIENCE			English	Article							A-BETA COMPONENT; PRECURSOR PROTEIN; ALPHA-SYNUCLEIN; DISEASE; DEGRADATION		Univ St Andrews, Sch Biol & Med Sci, St Andrews KY16 9AJ, Fife, Scotland; Russian Acad Sci, Inst Gene Biol, Moscow, Russia; Neuropa Ltd, Glasgow G11 6NU, Lanark, Scotland	University of St Andrews; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Buchman, VL (corresponding author), Univ St Andrews, Sch Biol & Med Sci, Bute Med Bldg, St Andrews KY16 9AJ, Fife, Scotland.		Davies, Alun M/A-4334-2010; Ninkina, Natalia N/A-1732-2011; Adu, Jimi/R-8434-2019; Buchman, Vladimir L/A-4814-2010	Davies, Alun M/0000-0001-5841-8176; Buchman, Vladimir L/0000-0002-7631-8352	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Banik NL, 1997, BRAIN RES, V748, P205, DOI 10.1016/S0006-8993(96)01302-9; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; GILBERT DS, 1975, NATURE, V256, P586, DOI 10.1038/256586a0; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Krieglstein J, 1997, CLIN NEUROSCI, V4, P184; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; WANG S, 1994, J NEUROCHEM, V62, P739; WONG PC, 1990, J CELL BIOL, V111, P1987, DOI 10.1083/jcb.111.5.1987; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141	13	91	95	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					101	103		10.1038/349	http://dx.doi.org/10.1038/349			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195122				2022-12-24	WOS:000076361100008
J	Redmond, L; Oh, SR; Hicks, C; Weinmaster, G; Ghosh, A				Redmond, L; Oh, SR; Hicks, C; Weinmaster, G; Ghosh, A			Nuclear Notch1 signaling and the regulation of dendritic development	NATURE NEUROSCIENCE			English	Article							NEURON-SPECIFIC ENOLASE; DROSOPHILA-NOTCH; CELL-DIFFERENTIATION; INTRACELLULAR DOMAIN; XENOPUS-EMBRYOS; MAMMALIAN NOTCH; EXPRESSION; RECEPTOR; HOMOLOG; GENE	To understand the function of Notch in the mammalian brain, we examined Notch1 signaling and its cellular consequences in developing cortical neurons. We found that the cytoplasmic domain of endogenous Notch1 translocated to the nucleus during neuronal differentiation. Notch1 cytoplasmic-domain constructs transfected into cortical neurons were present in multiple phosphorylated forms, localized to the nucleus and could induce CBF1-mediated transactivation. Molecular perturbation experiments suggested that Notch1 signaling in cortical neurons promoted dendritic branching and inhibited dendritic growth. These observations show that Notch1 signaling to the nucleus exerts an important regulatory influence on the specification of dendritic morphology in neurons.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	aghosh@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036176] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36176] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; CONLON RA, 1995, DEVELOPMENT, V121, P1533; DELAMO FF, 1992, DEVELOPMENT, V115, P737; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GINIGER E, 1993, DEVELOPMENT, V117, P431; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; GONATAS JO, 1985, J NEUROCHEM, V45, P497, DOI 10.1111/j.1471-4159.1985.tb04016.x; GREENWALD I, 1992, CELL, V68, P271, DOI 10.1016/0092-8674(92)90470-W; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lardelli M, 1996, MECH DEVELOP, V59, P177, DOI 10.1016/0925-4773(96)00589-8; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; SCHMECHEL DE, 1980, BRAIN RES, V190, P195, DOI 10.1016/0006-8993(80)91169-5; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shawber C, 1996, DEVELOPMENT, V122, P3765; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; THORMODSSON FR, 1995, J NEUROCHEM, V64, P1919; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931	50	265	272	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					30	40		10.1038/71104	http://dx.doi.org/10.1038/71104			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607392				2022-12-24	WOS:000085810200009
J	Kobayashi, T; Ikeda, K; Kojima, H; Niki, H; Yano, R; Yoshioka, T; Kumanishi, T				Kobayashi, T; Ikeda, K; Kojima, H; Niki, H; Yano, R; Yoshioka, T; Kumanishi, T			Ethanol opens G-protein-activated inwardly rectifying K+ channels	NATURE NEUROSCIENCE			English	Article							GAMMA-AMINOBUTYRIC-ACID; KAPPA-OPIOID RECEPTORS; POTASSIUM CHANNEL; FUNCTIONAL COUPLINGS; ALCOHOL-INTOXICATION; GLYCINE RECEPTORS; XENOPUS-OOCYTES; MESSENGER-RNAS; BETA-SUBUNIT; MICE LACKING	Ethanol affects many functions of the brain and peripheral organs. Here we show that ethanol opens G-protein-activated, inwardly rectifying K+ (GIRK) channels, which has important implications for inhibitory regulation of neuronal excitability and heart rate. At pharmacologically relevant concentrations, ethanol activated both brain-type GIRK1/2 and cardiac-type GIRK1/4 channels without interaction with G proteins or second messengers. Moreover, weaver mutant mice, which have a missense mutation in the GIRK2 channel, showed a loss of ethanol-induced analgesia. These results suggest that the GIRK channels in the brain and heart are important target sites for ethanol.	Niigata Univ, Inst Brain Res, Dept Mol Neuropathol, Niigata 9518585, Japan; Niigata Univ, Sch Med, Dept Psychiat, Niigata 9518510, Japan; RIKEN, Brain Sci Inst, Lab Neurobiol Emot, Wako, Saitama 3510198, Japan; RIKEN, Brain Sci Inst, Lab Cellular Informat Proc, Wako, Saitama 3510198, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Tokyo 1698555, Japan; Waseda Univ, Sch Human Sci, Dept Mol Neurobiol, Tokorozawa, Saitama 3591164, Japan	Niigata University; Niigata University; RIKEN; RIKEN; Waseda University; Waseda University	Kobayashi, T (corresponding author), Niigata Univ, Inst Brain Res, Dept Mol Neuropathol, 1-757 Asahimachi, Niigata 9518585, Japan.		Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278				BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CARLEN PL, 1982, SCIENCE, V215, P306, DOI 10.1126/science.7053581; COVARRUBIAS M, 1993, P NATL ACAD SCI USA, V90, P6957, DOI 10.1073/pnas.90.15.6957; Covernton PJO, 1997, BRIT J PHARMACOL, V122, P1661, DOI 10.1038/sj.bjp.0701568; Devic E, 1996, MECH DEVELOP, V59, P141, DOI 10.1016/0925-4773(96)00588-6; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; HOBBS WR, 1996, GOODMAN GILMANS PHAR, P361; Ikeda K, 1999, NEUROSCI RES, V34, P149, DOI 10.1016/S0168-0102(99)00047-4; IKEDA K, 1995, MOL BRAIN RES, V33, P61, DOI 10.1016/0169-328X(95)00107-4; Ikeda K, 1996, ANN NY ACAD SCI, V801, P95, DOI 10.1111/j.1749-6632.1996.tb17434.x; IKEDA K, 1995, BIOCHEM BIOPH RES CO, V208, P302, DOI 10.1006/bbrc.1995.1338; Ikeda K, 1997, MOL BRAIN RES, V45, P117, DOI 10.1016/S0169-328X(96)00252-5; Karschin C, 1996, J NEUROSCI, V16, P3559; Kobayashi T, 1998, BRIT J PHARMACOL, V123, P421, DOI 10.1038/sj.bjp.0701621; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LI CY, 1994, P NATL ACAD SCI USA, V91, P8200, DOI 10.1073/pnas.91.17.8200; Liao YJ, 1996, J NEUROSCI, V16, P7137; LOVINGER DM, 1991, MOL PHARMACOL, V40, P263; LYON RC, 1981, J PHARMACOL EXP THER, V218, P669; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; OSMANOVIC SS, 1994, J PHARMACOL EXP THER, V271, P334; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PENNA M, 1985, ALCOHOL, V2, P603, DOI 10.1016/0741-8329(85)90087-4; PEOPLES RW, 1995, P NATL ACAD SCI USA, V92, P2825, DOI 10.1073/pnas.92.7.2825; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SHEFNER SA, 1985, ALCOHOL, V2, P239, DOI 10.1016/0741-8329(85)90052-7; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; TREISTMAN SN, 1991, ANN NY ACAD SCI, V625, P249, DOI 10.1111/j.1749-6632.1991.tb33844.x; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Wickman K, 1997, GENOMICS, V40, P395, DOI 10.1006/geno.1997.4599; Yan K, 1996, J BIOL CHEM, V271, P17597, DOI 10.1074/jbc.271.30.17597	40	187	200	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1091	1097		10.1038/16019	http://dx.doi.org/10.1038/16019			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570486				2022-12-24	WOS:000085810100013
J	Tokumaru, H; Augustine, GJ				Tokumaru, H; Augustine, GJ			UNC-13 and neurotransmitter release	NATURE NEUROSCIENCE			English	News Item							SECRETION; MUNC13-1; MEMBRANE; FUSION	Genetic studies in mice, worms and flies indicate that the synaptic protein UNC-13 plays a central role in the regulation of vesicle fusion.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Duke University; Marine Biological Laboratory - Woods Hole	Tokumaru, H (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.		Augustine, George James/J-9228-2013					Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BRENNER S, 1974, GENETICS, V77, P71; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Katz B., 1969, RELEASE NEURAL TRANS; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; QUASTEL DMJ, 1971, SCIENCE, V172, P1034, DOI 10.1126/science.172.3987.1034; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Sassa T, 1999, J NEUROSCI, V19, P4772; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9	17	16	17	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					929	930		10.1038/14710	http://dx.doi.org/10.1038/14710			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526324				2022-12-24	WOS:000083883300003
J	Yamashita, T; Tucker, KL; Barde, YA				Yamashita, T; Tucker, KL; Barde, YA			Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth	NEURON			English	Article							NERVE GROWTH-FACTOR; AFFINITY NGF RECEPTOR; ACTIN STRESS FIBERS; SENSORY NEURONS; ADP-RIBOSYLTRANSFERASE; MESSENGER-RNA; EXPRESSION; DEATH; APOPTOSIS; PROTEIN	While the neurotrophin receptor p75(NTR) is expressed by many developing neurons, its function in cells escaping elimination by programmed cell death remains unclear. The lack of intrinsic enzymatic activity of p75(NTR) prompted a search for protein interactors expressed in the developing retina, which resulted in the identification of the GTPase RhoA. In transfected cells, p75(NTR) activated RhoA, and neurotrophin binding abolished RhoA activation. In cultured neurons, inactivation of Rho proteins mimicked the effect of neurotrophins by increasing the rate of neurite elongation. In vivo, axonal outgrowth was retarded in mice carrying a mutation in the p75(NTR) gene. These results indicate that p75(NTR) modulates in a ligand-dependent fashion the activity of intracellular proteins known to regulate actin assembly.	Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Martinsried, Germany	Max Planck Society	Barde, YA (corresponding author), Max Planck Inst Neurobiol, Dept Neurobiochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X; Yamashita, Toshihide/0000-0003-4559-7018				AKTORIES K, 1987, FEBS LETT, V212, P109, DOI 10.1016/0014-5793(87)81566-1; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BORASIO GD, 1989, NEURON, V2, P1087; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; COLLINS F, 1983, P NATL ACAD SCI-BIOL, V80, P2091, DOI 10.1073/pnas.80.7.2091; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Davey F, 1998, CURR BIOL, V8, P915, DOI 10.1016/S0960-9822(07)00371-5; DAVIES AM, 1993, J NEUROSCI, V13, P4961; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ERNFORS P, 1988, NEURON, V1, P983, DOI 10.1016/0896-6273(88)90155-9; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FEINSTEIN DL, 1990, FEBS LETT, V272, P7, DOI 10.1016/0014-5793(90)80437-N; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1996, NATURE, V383, P166; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; Gomez J, 1998, IMMUNOL CELL BIOL, V76, P125, DOI 10.1046/j.1440-1711.1998.00723.x; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P12655; Hotchin NA, 1996, CANCER SURV, V27, P311; Jin Z, 1997, J NEUROSCI, V17, P6256; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; KOCH G, 1991, FEBS LETT, V291, P336, DOI 10.1016/0014-5793(91)81315-Y; KOCH G, 1992, BIOCHEM BIOPH RES CO, V186, P448, DOI 10.1016/S0006-291X(05)80828-9; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LEE HJ, 1990, J NEUROSCI, V10, P1779; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Liu JP, 1998, DEVELOPMENT, V125, P5055; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MOODY SA, 1989, J COMP NEUROL, V279, P567, DOI 10.1002/cne.902790406; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NARUMIYA S, 1988, J BIOL CHEM, V263, P17255; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schropel A, 1995, MOL CELL NEUROSCI, V6, P544, DOI 10.1006/mcne.1995.0006; Stucky CL, 1997, J NEUROSCI, V17, P4398; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; VONBARTHELD CS, 1991, J COMP NEUROL, V310, P103, DOI 10.1002/cne.903100110; YAN Q, 1988, J NEUROSCI, V8, P3481	54	415	421	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					585	593		10.1016/S0896-6273(00)81114-9	http://dx.doi.org/10.1016/S0896-6273(00)81114-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595511	Bronze			2022-12-24	WOS:000083913000015
J	Kirov, SA; Harris, KM				Kirov, SA; Harris, KM			Dendrites are more spiny on mature hippocampal neurons when synapses are inactivated	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; PYRAMIDAL CELLS; SLICE CULTURES; NERVOUS-SYSTEM; AREA CA1; DENSITY; ACTIN; PLASTICITY; STABILITY	Dendrites of CA1 pyramidal neurons in mature rat hippocampal slices were exposed to different levels of synaptic activation. In some slices, synaptic transmission was blocked with glutamate receptor antagonists, sodium and calcium channel blockers and/or a nominally calcium-free medium with high magnesium. In other slices, synapses were activated with low-frequency control stimulation or repeated tetanic stimulation. In slices with blocked synaptic transmission, dendrites were spinier than in either of the activated states. Thus, mature neurons can increase their numbers of spines, possibly compensating for lost synaptic activity.	Childrens Hosp, Dept Neurol, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Harris, KM (corresponding author), Childrens Hosp, Dept Neurol, Div Neurosci, Enders 260,300 Longwood Ave, Boston, MA 02115 USA.	harrisk@hub.tch.harvard.edu		Harris, Kristen/0000-0002-1943-4744	NIMH NIH HHS [MH/DA57351] Funding Source: Medline; NINDS NIH HHS [NS21184, NS33574] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021184, R01NS021184, R23NS021184, R01NS033574] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; ANNIS CM, 1994, J NEUROBIOL, V25, P1483, DOI 10.1002/neu.480251202; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; CHANG FLF, 1982, BRAIN RES, V232, P283, DOI 10.1016/0006-8993(82)90274-8; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Dailey ME, 1996, J NEUROSCI, V16, P2983; DALVA MB, 1994, J NEUROSCI, V14, P3588; Drakew A, 1996, NEUROSCIENCE, V70, P31, DOI 10.1016/0306-4522(95)00379-W; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1985, BRAIN RES REV, V9, P187, DOI 10.1016/0165-0173(85)90012-8; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; GOULD E, 1990, J NEUROSCI, V10, P1286; GRAY EG, 1959, J ANAT, V93, P420; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; HAAS HL, 1984, J PHYSIOL-LONDON, V354, P185, DOI 10.1113/jphysiol.1984.sp015371; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HORNER CH, 1993, PROG NEUROBIOL, V41, P281, DOI 10.1016/0301-0082(93)90002-A; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENSEN FE, 1989, J NEUROSCI METH, V29, P217, DOI 10.1016/0165-0270(89)90146-5; Jiang MH, 1998, J NEUROSCI, V18, P8356; Kirov SA, 1999, J NEUROSCI, V19, P2876; Kossel AH, 1997, J NEUROSCI, V17, P9634; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PAPA M, 1995, J NEUROSCI, V15, P1; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Paul L A, 1986, Adv Neurol, V44, P775; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; ROCHA M, 1995, P NATL ACAD SCI USA, V92, P8026, DOI 10.1073/pnas.92.17.8026; RUSAKOV DA, 1995, J NEUROSCI METH, V60, P11, DOI 10.1016/0165-0270(94)00215-3; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sorra KE, 1998, J NEUROSCI, V18, P658; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990	50	158	160	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					878	883		10.1038/13178	http://dx.doi.org/10.1038/13178			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491607				2022-12-24	WOS:000083883200012
J	Muhr, J; Graziano, E; Wilson, S; Jessell, TM; Edlund, T				Muhr, J; Graziano, E; Wilson, S; Jessell, TM; Edlund, T			Convergent inductive signals specify midbrain, hindbrain, and spinal cord identity in gastrula stage chick embryos	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; FIBROBLAST GROWTH-FACTOR; FLOOR PLATE DIFFERENTIATION; ANTERIOR-POSTERIOR AXIS; NEURAL INDUCTION; AVIAN GASTRULATION; PARAXIAL MESODERM; SONIC HEDGEHOG; EXPRESSION PATTERNS; SUBTYPE IDENTITY	In the chick embryo, neural cells acquire midbrain, hindbrain, and spinal cord character over a similar to 6 hr period during gastrulation. The convergent actions of four signals appear to specify caudal neural character. Fibroblast growth factors (FGFs) and a paraxial mesoderm-caudalizing (PMC) activity are involved, but neither signal is sufficient to induce any single region. FGFs act indirectly by inducing mesoderm that expresses PMC and retinoid activity and also directly on prospective neural cells, in combination with PMC activity and a rostralizing signal, to induce midbrain character. Hindbrain character emerges from cells that possess the potential to acquire midbrain character upon exposure to higher levels of PMC activity. Induction of spinal cord character appears to involve PMC and retinoid activities.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.							Alvarez IS, 1998, DEV BIOL, V199, P42, DOI 10.1006/dbio.1998.8903; Ang HL, 1997, DEV DYNAM, V208, P536; Bang AG, 1997, DEVELOPMENT, V124, P2075; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; Blumberg B, 1997, DEVELOPMENT, V124, P373; Burdsal CA, 1998, DEV BIOL, V198, P231, DOI 10.1016/S0012-1606(98)80001-8; CICCODICOLA A, 1989, EMBO J, V8, P1987, DOI 10.1002/j.1460-2075.1989.tb03605.x; Cox WG, 1995, DEVELOPMENT, V121, P4349; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; DONIACH T, 1993, J NEUROBIOL, V24, P1256, DOI 10.1002/neu.480241003; Doniach T, 1995, CELL, V83, P1067, DOI 10.1016/0092-8674(95)90133-7; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Foley AC, 1997, DEVELOPMENT, V124, P2983; Fukushima M, 1996, DEVELOPMENT, V122, P905; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Grapin-Botton A, 1998, DEVELOPMENT, V125, P1173; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamburger V, 1988, HERITAGE EXPT EMBRYO; HATADA Y, 1994, DEVELOPMENT, V120, P2879; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; KENGAKU M, 1995, DEVELOPMENT, V121, P3121; KINTNER CR, 1991, DEVELOPMENT, V113, P1495; Knezevic V, 1997, DEVELOPMENT, V124, P411; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; Kolm PJ, 1997, COLD SPRING HARB SYM, V62, P511; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lee SMK, 1997, DEVELOPMENT, V124, P959; Lemaire L, 1997, MECH DEVELOP, V67, P3, DOI 10.1016/S0925-4773(97)00102-0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maden M, 1998, DEVELOPMENT, V125, P4133; MAHMOOD R, 1995, DEVELOPMENT, V121, P1399; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; PLACZEK M, 1993, DEVELOPMENT, V117, P205; Popperl H, 1997, DEVELOPMENT, V124, P2997; Rao Bantwal Ramanath, 1968, Wilhelm Roux Arch Entwickl Mech Org, V160, P187, DOI 10.1007/BF00572650; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; RIESE J, 1995, MECH DEVELOP, V49, P13, DOI 10.1016/0925-4773(94)00296-Y; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHOENWOLF GC, 1992, DEV DYNAM, V193, P235, DOI 10.1002/aja.1001930304; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Shamim H, 1999, DEVELOPMENT, V126, P945; SLACK JMW, 1994, BIOCHEM SOC T, V22, P585, DOI 10.1042/bst0220585; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Stern CD, 1998, CELL, V94, P143, DOI 10.1016/S0092-8674(00)81412-9; Storey KG, 1998, DEVELOPMENT, V125, P473; STOREY KG, 1992, DEVELOPMENT, V114, P29; Streit A, 1997, DEVELOPMENT, V124, P1191; Studer M, 1998, DEVELOPMENT, V125, P1025; Sun BI, 1999, DEVELOPMENT, V126, P1467; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Woo K, 1998, DEV BIOL, V197, P283, DOI 10.1006/dbio.1998.8870; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254; Xu CH, 1999, DEVELOPMENT, V126, P483; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V	76	116	120	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					689	702		10.1016/S0896-6273(01)80028-3	http://dx.doi.org/10.1016/S0896-6273(01)80028-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482236	Bronze			2022-12-24	WOS:000082280900013
J	Wong, ST; Athos, J; Figueroa, XA; Pineda, VV; Schaefer, ML; Chavkin, CC; Muglia, LJ; Storm, DR				Wong, ST; Athos, J; Figueroa, XA; Pineda, VV; Schaefer, ML; Chavkin, CC; Muglia, LJ; Storm, DR			Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP	NEURON			English	Article							II MUTANT MICE; SYNAPTIC PLASTICITY; CONTEXTUAL FEAR; PROTEIN-KINASE; AREA CA1; DROSOPHILA; POTENTIATION; CREB; EXPRESSION; INDUCTION	It is hypothesized that Ca2+ stimulation of calmodulin (CaM)-activated adenylyl cyclases (AC1 or AC8) generates cAMP signals critical for late phase LTP (L-LTP) and long-term memory (LTM). However, mice lacking either AC1 or AC8 exhibit normal L-LTP and LTM. Here, we report that mice lacking both enzymes (DKO) do not exhibit L-LTP or LTM. To determine if these defects are due to a loss of cAMP increases in the hippocampus, DKO mice were unilaterally cannulated to deliver forskolin. Administration of forskolin to area CA1 before training restored normal LTM. We conclude that Ca2+-stimulated adenylyl cyclase activity is essential for L-LTP and LTM and that AC1 or AC8 can produce the necessary cAMP signal.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63130 USA	University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL)	Storm, DR (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NIGMS NIH HHS [T32 GM07270] Funding Source: Medline; NINDS NIH HHS [NS 20498, NS 37056] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037056, R01NS020498] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baker LP, 1999, J NEUROSCI, V19, P180, DOI 10.1523/JNEUROSCI.19-01-00180.1999; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CHEN CN, 1986, P NATL ACAD SCI USA, V83, P9313, DOI 10.1073/pnas.83.24.9313; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; CHOI EJ, 1993, BIOCHEMISTRY-US, V32, P1891, DOI 10.1021/bi00059a001; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DOUGLAS RJ, 1975, HIPPOCAMPUS; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEREAU RW, 1994, J NEUROSCI, V14, P3310; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; HOLM IE, 1991, J COMP NEUROL, V308, P409, DOI 10.1002/cne.903080308; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; JACOBOWITZ O, 1993, J BIOL CHEM, V268, P3829; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Muglia LM, 1999, J NEUROSCI, V19, P2051; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PHILLIPS RG, 1995, J NEUROSCI, V15, P5308; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SARA SJ, 1992, EXP BRAIN RES, V89, P125; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; SPRUIJT B, 1990, BRAIN RES, V527, P192, DOI 10.1016/0006-8993(90)91137-6; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Villacres EC, 1998, J NEUROSCI, V18, P3186; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; WEATHERLY LS, 1996, BRAIN RES, V716, P1; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WESTCOTT KR, 1979, P NATL ACAD SCI USA, V76, P204, DOI 10.1073/pnas.76.1.204; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1993, J NEUROCHEM, V60, P305, DOI 10.1111/j.1471-4159.1993.tb05852.x; Xia ZG, 1997, CURR OPIN NEUROBIOL, V7, P391, DOI 10.1016/S0959-4388(97)80068-2; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	61	387	399	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1999	23	4					787	798		10.1016/S0896-6273(01)80036-2	http://dx.doi.org/10.1016/S0896-6273(01)80036-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482244	Bronze			2022-12-24	WOS:000082280900021
J	Grailhe, R; Waeber, C; Dulawa, SC; Hornung, JP; Zhuang, XX; Brunner, D; Geyer, MA; Hen, R				Grailhe, R; Waeber, C; Dulawa, SC; Hornung, JP; Zhuang, XX; Brunner, D; Geyer, MA; Hen, R			Increased exploratory activity and altered response to LSD in mice lacking the 5-HT5A receptor	NEURON			English	Article							ELEVATED PLUS-MAZE; SEROTONIN RECEPTOR; RAT-BRAIN; ANXIETY; BEHAVIOR; CLONING; EXPRESSION; KNOCKOUT; FAMILY	In order to determine the distribution and function of the 5-HT5A serotonin receptor subtype, we generated knockout mice lacking the 5-HT5A gene. Comparative autoradiography studies of brains of wild-type (wt) and 5-HT5A knockout (5A-KO) mice revealed the existence of binding sites with high affinity for [I-125]LSD that correspond to 5-HT5A receptors and that are concentrated in the olfactory bulb, neocortex, and medial habenula. When exposed to novel environments, the 5A-KO mice displayed increased exploratory activity but no change in anxiety-related behaviors. In addition, the stimulatory effect of LSD on exploratory activity was attenuated in 5A-KO mice. These results suggest that 5-HT5A receptors modulate the activity of neural circuits involved specifically in exploratory behavior and suggest that some of the psychotropic effects of LSD may be mediated by 5-HT5A receptors.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Massachusetts Gen Hosp, Dept Surg, Harvard Med Sch, Charlestown, MA 02129 USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; CUNY Hunter Coll, Dept Psychol, New York, NY 10032 USA; Columbia Univ, Dept Dev Psychobiol, New York, NY 10032 USA	Columbia University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; University of Lausanne; City University of New York (CUNY) System; Hunter College (CUNY); Columbia University	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	rh95@columbia.edu	Hornung, Jean-Pierre/O-7505-2015; Dulawa, Stephanie/M-8070-2016; Waeber, Christian/A-8333-2009; Waeber, Christian/B-3171-2016	Hornung, Jean-Pierre/0000-0002-9229-7520; Dulawa, Stephanie/0000-0003-1281-782X; Waeber, Christian/0000-0001-6078-0027; Waeber, Christian/0000-0001-6078-0027	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009862] Funding Source: NIH RePORTER; NIDA NIH HHS [DA09862] Funding Source: Medline; NIMH NIH HHS [MH48126] Funding Source: Medline; NINDS NIH HHS [NS35611-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; BERLYNE DE, 1955, J COMP PHYSIOL PSYCH, V48, P238, DOI 10.1037/h0042968; BRUNNER D, 1999, IN PRESS BEHAV NEURO; BUHOT MC, 1995, HIPPOCAMPUS, V5, P198, DOI 10.1002/hipo.450050306; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Carson MJ, 1996, GLIA, V17, P317, DOI 10.1002/(SICI)1098-1136(199608)17:4<317::AID-GLIA6>3.0.CO;2-W; CONTESTABILE A, 1981, J COMP NEUROL, V196, P253; Davis M., 1984, P287; Dulawa SC, 1997, PSYCHOPHARMACOLOGY, V132, P125, DOI 10.1007/s002130050328; ERLANDER MG, 1993, P NATL ACAD SCI USA, V90, P3452, DOI 10.1073/pnas.90.8.3452; EVANS JAC, 1983, IRCS MED SCI-BIOCHEM, V11, P779; FILE SE, 1992, BIOL COUN S, P25; Geyer MA, 1996, BEHAV BRAIN RES, V73, P31; GEYER MA, 1994, HALLUCINOGENS UPDATE, P124; GRAILHE R, 1997, SEROTONIN RECEPTORS, P311; Heymann JAW, 1997, P NATL ACAD SCI USA, V94, P4966, DOI 10.1073/pnas.94.10.4966; HOYER D, 1994, PHARMACOL REV, V46, P157; JACOBS BL, 1991, J CLIN PSYCHIAT, V52, P17; LUCAS JJ, 1995, TRENDS PHARMACOL SCI, V16, P246, DOI 10.1016/S0165-6147(00)89034-3; MATTHES H, 1993, MOL PHARMACOL, V43, P313; MITTMAN SM, 1991, PSYCHOPHARMACOLOGY, V105, P69, DOI 10.1007/BF02316866; Netter P, 1996, NEUROPSYCHOBIOLOGY, V34, P155, DOI 10.1159/000119318; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PINEL JPJ, 1978, J COMP PHYSIOL PSYCH, V92, P708, DOI 10.1037/h0077494; PLASSAT JL, 1992, EMBO J, V11, P4779, DOI 10.1002/j.1460-2075.1992.tb05583.x; PLASSAT JL, 1993, MOL PHARMACOL, V44, P229; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; REES S, 1994, FEBS LETT, V355, P242, DOI 10.1016/0014-5793(94)01209-1; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Taylor DP, 1990, ANN N Y ACAD SCI, V600, P545; WAEBER C, 1995, EUR J PHARMACOL, V283, P31, DOI 10.1016/0014-2999(95)00275-P; Wilkinson LO, 1991, SEROTONIN RECEPTOR S, P147; WISDEN W, 1993, FEBS LETT, V333, P25, DOI 10.1016/0014-5793(93)80368-5	36	154	159	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					581	591		10.1016/S0896-6273(00)80712-6	http://dx.doi.org/10.1016/S0896-6273(00)80712-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197537	hybrid			2022-12-24	WOS:000079483900021
J	Stowell, JN; Craig, AM				Stowell, JN; Craig, AM			Axon/dendrite targeting of metabotropic glutamate receptors by their cytoplasmic carboxy-terminal domains	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; MONOCLONAL-ANTIBODY; EPITHELIAL-CELLS; SORTING SIGNALS; RAT-BRAIN; INTERNALIZATION SIGNAL; PHOSPHOLIPASE-C; BETA-ARRESTIN	The subcellular targeting of neurotransmitter receptors is vital in controlling polarized information flow in the brain. We show here that metabotropic glutamate receptors are differentially targeted when expressed from defective viral vectors in cultured hippocampal neurons; mGluR1a and mGluR2 are targeted to dendrites and excluded from axons, whereas mGluR7 is targeted to axons and dendrites. Chimeras and deletions revealed that axon exclusion of mGluR2 versus axon targeting of mGluR7 is mediated by their 60 amino acid C-terminal cytoplasmic domains. Addition of the mGluR7 C-terminal sequence to mGluR2! or to the unrelated somatodendritic protein telencephalin (tln) induced axon targeting, indicating dominance of the axonal signal. These mGluR sorting signals represent novel plasma membrane axon/dendrite targeting signals.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Craig, AM (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.		Craig, Ann Marie/M-2054-2014		NINDS NIH HHS [NS33184] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033184] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Balazs R, 1997, J NEUROCHEM, V69, P151; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Benson DL, 1998, J NEUROSCI RES, V52, P43, DOI 10.1002/(SICI)1097-4547(19980401)52:1<43::AID-JNR5>3.3.CO;2-A; Bradley SR, 1996, J NEUROSCI, V16, P2044; Bradley SR, 1998, J NEUROCHEM, V71, P636; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1995, NATURE, V375, P592, DOI 10.1038/375592a0; DEHOOP M, 1995, J CELL BIOL, V130, P1447, DOI 10.1083/jcb.130.6.1447; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; FAIVRESARRAILH C, 1992, J NEUROSCI, V12, P257; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goslin K., 1998, CULTURING NERVE CELL, P339; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; KABA H, 1994, SCIENCE, V265, P262, DOI 10.1126/science.8023145; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Keller P, 1997, J CELL SCI, V110, P3001; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Kinzie JM, 1997, J COMP NEUROL, V385, P372; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Lewin DA, 1998, BBA-MOL CELL RES, V1401, P129, DOI 10.1016/S0167-4889(97)00130-4; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MARTIN LJ, 1992, NEURON, V9, P259, DOI 10.1016/0896-6273(92)90165-A; Mary S, 1998, J BIOL CHEM, V273, P425, DOI 10.1074/jbc.273.1.425; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATLIN K S, 1992, Current Opinion in Cell Biology, V4, P623; MORI K, 1987, P NATL ACAD SCI USA, V84, P3921, DOI 10.1073/pnas.84.11.3921; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Neki A, 1996, NEUROSCI LETT, V202, P197, DOI 10.1016/0304-3940(95)12248-6; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Ohishi H, 1998, NEUROSCI RES, V30, P65, DOI 10.1016/S0168-0102(97)00120-X; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; West AE, 1997, J CELL BIOL, V139, P917, DOI 10.1083/jcb.139.4.917; West AE, 1997, J NEUROSCI, V17, P6038; Wozniak M, 1998, BRAIN RES, V780, P311, DOI 10.1016/S0006-8993(97)01216-X; YOSHIHARA Y, 1994, NEURON, V12, P541, DOI 10.1016/0896-6273(94)90211-9	56	124	142	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					525	536		10.1016/S0896-6273(00)80707-2	http://dx.doi.org/10.1016/S0896-6273(00)80707-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197532	Bronze			2022-12-24	WOS:000079483900016
J	Emptage, N; Bliss, TVP; Fine, A				Emptage, N; Bliss, TVP; Fine, A			Single synaptic events evoke NMDA receptor-mediated release of calcium from internal stores in hippocampal dendritic spines	NEURON			English	Article							LONG-TERM POTENTIATION; CYCLOPIAZONIC ACID; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; PRESYNAPTIC CALCIUM; PYRAMIDAL NEURONS; CA2+ RELEASE; TIME-COURSE; AREA CA1; RAT	We have used confocal microscopy to monitor synaptically evoked Ca2+ transients in the dendritic spines of hippocampal pyramidal cells. Individual spines respond to single afferent stimuli (<0.1 Hz) with Ca2+ transients or failures, reflecting the probability of transmitter release at the activated synapse. Both AMPA and NMDA glutamate receptor antagonists block the synaptically evoked Ca2+ transients; the block by AMPA antagonists is relieved by low Mg2+. The Ca2+ transients are mainly due to the release of calcium from internal stores, since they are abolished by antagonists of calcium-induced calcium release (CICR); CICR antagonists, however, do not depress spine Ca2+ transients generated by backpropagating action potentials. These results have implications for synaptic plasticity, since they show that synaptic stimulation can activate NMDA receptors, evoking substantial Ca2+ release from the internal stores in spines without inducing long-term potentiation (LTP) or depression (LTD).	Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	MRC National Institute for Medical Research; Dalhousie University	Fine, A (corresponding author), Natl Inst Med Res, Div Neurophysiol, Mill Hill, London NW7 1AA, England.		Fine, Alan/P-5936-2014	Fine, Alan/0000-0002-4960-6973				ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BASHIR ZI, 1993, EUR J PHARMACOL, V239, P265, DOI 10.1016/0014-2999(93)91009-C; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P301; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; HARVEY J, 1992, NEUROSCI LETT, V139, P197, DOI 10.1016/0304-3940(92)90551-H; JAFFE DB, 1994, J NEUROBIOL, V25, P220, DOI 10.1002/neu.480250303; Katz B, 1969, SHERRINGTON LECT, VX; Kirischuk S, 1996, CELL CALCIUM, V19, P59, DOI 10.1016/S0143-4160(96)90013-5; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Miller LDP, 1996, J NEUROPHYSIOL, V76, P554, DOI 10.1152/jn.1996.76.1.554; MILLER RJ, 1992, TRENDS NEUROSCI, V15, P317, DOI 10.1016/0166-2236(92)90045-A; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; NELSON EJ, 1994, BIOCHEM J, V302, P147, DOI 10.1042/bj3020147; Neuman RS, 1995, BEHAV BRAIN RES, V73, P273; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Nomura Y, 1996, J PHARMACOL EXP THER, V279, P830; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OBENAUS A, 1989, NEUROSCI LETT, V98, P172, DOI 10.1016/0304-3940(89)90505-3; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Rahman S, 1996, BRIT J PHARMACOL, V119, P877, DOI 10.1111/j.1476-5381.1996.tb15754.x; Reyes M, 1996, J NEUROSCI, V16, P5951; SAYER RJ, 1990, J NEUROSCI, V10, P826; SCHIEGG A, 1995, J NEUROPHYSIOL, V74, P1046, DOI 10.1152/jn.1995.74.3.1046; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; SHARP AH, 1993, J NEUROSCI, V13, P3051; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; TARRANT SB, 1979, NEUROSCI LETT, V11, P289, DOI 10.1016/0304-3940(79)90010-7; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Wang Y, 1996, J PHYSIOL-LONDON, V495, P755, DOI 10.1113/jphysiol.1996.sp021631; WU LG, 1994, J NEUROSCI, V14, P645; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167	58	357	363	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					115	124		10.1016/S0896-6273(00)80683-2	http://dx.doi.org/10.1016/S0896-6273(00)80683-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027294	Bronze			2022-12-24	WOS:000078410300017
J	Koizumi, S; Bootman, MD; Bobanovic, LK; Schell, MJ; Berridge, MJ; Lipp, P				Koizumi, S; Bootman, MD; Bobanovic, LK; Schell, MJ; Berridge, MJ; Lipp, P			Characterization of elementary Ca2+ release signals in NGF-differentiated PC12 cells and hippocampal neurons	NEURON			English	Article							ROOT GANGLION-CELLS; ACTION-POTENTIAL PROPAGATION; CEREBELLAR PURKINJE NEURONS; DENDRITIC SPINES; INTRACELLULAR STORES; INOSITOL TRISPHOSPHATE; SYMPATHETIC NEURONS; PYRAMIDAL NEURONS; CALCIUM WAVES; CA1 DENDRITES	Elementary Ca2+ release signals in nerve growth factor- (NGF-) differentiated PC12 cells and hippocampal neurons, functionally analogous to the "Ca2+ sparks" and "Ca2+ puffs" identified in other cell types, were characterized by confocal microscopy. They either occurred spontaneously or could be activated by caffeine and metabotropic agonists. The release events were dissimilar to the sparks and puffs described so far, as many arose from clusters of both ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate receptors (InsP(3)Rs). Increasing either the stimulus strength or loading of the intracellular stores enhanced the frequency of and coupling between elementary release sites and evoked global Ca2+ signals. In the PC12 cells, the elementary Ca2+ release preferentially occurred around the branch points. Spatio-temporal recruitment of such elementary release events may regulate neuronal activities.	Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Cambridge	Bootman, MD (corresponding author), Babraham Inst, Mol Signalling Lab, Cambridge CB2 4AT, England.	martin.bootman@bbsrc.ac.uk	Bootman, Martin/AAB-3330-2019; Koizumi, Schuichi/E-8568-2010	Bootman, Martin/0000-0002-6447-3451; Koizumi, Schuichi/0000-0001-6184-3106; Schell, Michael/0000-0003-1553-3582	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDREASEN M, 1995, BRAIN RES, V698, P193, DOI 10.1016/0006-8993(95)00910-I; Bennett DL, 1998, BIOCHEM J, V329, P349; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; Boittin FX, 1998, CELL CALCIUM, V23, P303, DOI 10.1016/S0143-4160(98)90026-4; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; BRORSON JR, 1991, J NEUROSCI, V11, P4024; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; CHEEK TR, 1994, BIOCHEM J, V301, P879, DOI 10.1042/bj3010879; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; CLEMENTI E, 1992, J BIOL CHEM, V267, P2164; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Eilers J, 1996, CELL CALCIUM, V20, P215, DOI 10.1016/S0143-4160(96)90108-6; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; HernandezCruz A, 1997, J GEN PHYSIOL, V109, P147, DOI 10.1085/jgp.109.2.147; JAFFE DB, 1994, J NEUROPHYSIOL, V72, P471, DOI 10.1152/jn.1994.72.1.471; Keizer J, 1998, BIOPHYS J, V75, P595, DOI 10.1016/S0006-3495(98)77550-2; Koizumi S, 1998, BIOCHEM BIOPH RES CO, V244, P293, DOI 10.1006/bbrc.1998.8251; KOIZUMI S, 1998, BRIT J PHARMACOL, V115, P1502; Lipp P, 1996, PROG BIOPHYS MOL BIO, V65, P265, DOI 10.1016/S0079-6107(96)00014-4; LIPP P, 1994, CIRC RES, V74, P979, DOI 10.1161/01.RES.74.5.979; LOPEZLOPEZ JR, 1995, SCIENCE, V268, P1042, DOI 10.1126/science.7754383; LORENZON P, 1995, J CELL BIOL, V129, P797, DOI 10.1083/jcb.129.3.797; LUSCHER C, 1994, J NEUROPHYSIOL, V72, P634, DOI 10.1152/jn.1994.72.2.634; Luscher C, 1996, J PHYSIOL-LONDON, V490, P319; MARRION NV, 1992, J PHYSIOL-LONDON, V445, P515, DOI 10.1113/jphysiol.1992.sp018937; MATHERS DA, 1984, BRAIN RES, V293, P35, DOI 10.1016/0006-8993(84)91450-1; Miller LDP, 1996, J NEUROPHYSIOL, V76, P554, DOI 10.1152/jn.1996.76.1.554; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; PETERSEN OH, 1994, ANNU REV PHYSIOL, V56, P297, DOI 10.1146/annurev.ph.56.030194.001501; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Porter VA, 1998, AM J PHYSIOL-CELL PH, V274, pC1346; Reber BFX, 1996, PFLUG ARCH EUR J PHY, V432, P893, DOI 10.1007/s004240050213; SATIN LS, 1987, BRAIN RES, V401, P331, DOI 10.1016/0006-8993(87)91417-X; SHMIGOL A, 1994, PFLUG ARCH EUR J PHY, V426, P174, DOI 10.1007/BF00374686; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Thomas D, 1998, J BIOL CHEM, V273, P27130, DOI 10.1074/jbc.273.42.27130; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Usachev YM, 1997, J NEUROSCI, V17, P7404; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	54	130	131	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1999	22	1					125	137		10.1016/S0896-6273(00)80684-4	http://dx.doi.org/10.1016/S0896-6273(00)80684-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027295	Bronze			2022-12-24	WOS:000078410300018
J	Wechsler-Reya, RJ; Scott, MP				Wechsler-Reya, RJ; Scott, MP			Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog	NEURON			English	Article							FIBROBLAST GROWTH-FACTOR; ACTIVATING POLYPEPTIDE PACAP; TERMINAL CLEAVAGE PRODUCT; DROSOPHILA PATCHED GENE; CELL CARCINOMA SYNDROME; VENTRAL MIDLINE CELLS; I IGF-I; HUMAN HOMOLOG; SIGNALING PATHWAY; PURKINJE-CELLS	Cerebellar granule cells are the most abundant type of neuron in the brain, but the molecular mechanisms that control their generation are incompletely understood. We show that Sonic hedgehog (Shh), which is made by Purkinje cells, regulates the division of granule cell precursors (GCPs). Treatment of GCPs with Shh prevents differentiation and induces a potent, long-lasting proliferative response. This response can be inhibited by basic fibroblast growth factor or by activation of protein kinase A. Blocking Shh function in vivo dramatically reduces GCP proliferation. These findings provide insight into the mechanisms of normal growth and tumorigenesis in the cerebellum.	Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Scott, MP (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ABO T, 1981, J IMMUNOL, V127, P1024; ALTMAN J, 1997, RELATIN ITS EVOLUTIO; ARIMURA A, 1995, FRONT NEUROENDOCRIN, V16, P53, DOI 10.1006/frne.1995.1003; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BASILLE M, 1994, DEV BRAIN RES, V82, P81, DOI 10.1016/0165-3806(94)90150-3; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Borycki AG, 1998, DEVELOPMENT, V125, P777; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chidambaram A, 1996, CANCER RES, V56, P4599; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; Ding Q, 1998, DEVELOPMENT, V125, P2533; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Duprez D, 1998, DEVELOPMENT, V125, P495; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; Gonzalez BJ, 1997, NEUROSCIENCE, V78, P419, DOI 10.1016/S0306-4522(96)00617-3; Gonzalez BJ, 1996, ANN NY ACAD SCI, V805, P302; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hamre KM, 1997, DEVELOPMENT, V124, P4201; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Helms AW, 1998, DEVELOPMENT, V125, P919; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jensen AM, 1997, DEVELOPMENT, V124, P363; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; JOHNSON RL, 1997, COLD SPRING HARB SYM, V62, P555; Kenigsberg RL, 1997, AM J PATHOL, V151, P867; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; KUHAR SG, 1993, DEVELOPMENT, V117, P97; LEVI G, 1987, J NEUROSCI RES, V18, P407, DOI 10.1002/jnr.490180305; Lin X, 1996, NEUROSCI LETT, V220, P81, DOI 10.1016/S0304-3940(96)13214-6; Lin X, 1997, DEV BRAIN RES, V99, P234, DOI 10.1016/S0165-3806(97)00015-1; Liu SQJ, 1998, J NEUROSCI, V18, P2881; Marinovich M, 1996, ENVIRON TOXICOL PHAR, V1, P13, DOI 10.1016/1382-6689(95)00004-6; MATSUDA S, 1994, NEUROSCIENCE, V59, P651, DOI 10.1016/0306-4522(94)90184-8; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; Mullen RJ, 1997, PERSPECT DEV NEUROBI, V5, P43; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pietsch T, 1997, CANCER RES, V57, P2085; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; Raffel C, 1997, CANCER RES, V57, P842; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; SCHMECHEL DE, 1980, BRAIN RES, V190, P195, DOI 10.1016/0006-8993(80)91169-5; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Sonmez E, 1984, Brain Res, V314, P271; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; Teillet MA, 1998, DEVELOPMENT, V125, P2019; Traiffort E, 1998, J NEUROCHEM, V70, P1327; Vaudry D, 1998, NEUROSCIENCE, V84, P801, DOI 10.1016/S0306-4522(97)00545-9; VOGEL MW, 1989, J NEUROSCI, V9, P3454; Vorechovsky I, 1997, ONCOGENE, V15, P361, DOI 10.1038/sj.onc.1201340; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; WERNECKE H, 1985, J NEUROIMMUNOL, V9, P115, DOI 10.1016/S0165-5728(85)80012-6; Ye Ping, 1996, Developmental Brain Research, V95, P44, DOI 10.1016/0165-3806(96)00492-0; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	82	996	1012	2	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					103	114		10.1016/S0896-6273(00)80682-0	http://dx.doi.org/10.1016/S0896-6273(00)80682-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027293	Bronze			2022-12-24	WOS:000078410300016
J	Fox, JW; Lamperti, ED; Eksioglu, YZ; Hong, SE; Feng, YY; Graham, DA; Scheffer, IE; Dobyns, WB; Hirsch, BA; Radtke, RA; Berkovic, SF; Huttenlocher, PR; Walsh, CA				Fox, JW; Lamperti, ED; Eksioglu, YZ; Hong, SE; Feng, YY; Graham, DA; Scheffer, IE; Dobyns, WB; Hirsch, BA; Radtke, RA; Berkovic, SF; Huttenlocher, PR; Walsh, CA			Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia	NEURON			English	Article							ACTIN-BINDING PROTEIN; GENE; KINASE; IDENTIFICATION; MACROPHAGES; ABP-280; REGION; LOCUS; MICE; XQ28	Long-range, directed migration is particularly dramatic in the cerebral cortex, where postmitotic neurons generated deep in the brain migrate to form layers with distinct form and function. In the X-linked dominant human disorder periventricular heterotopia (PH), many neurons fail to migrate and persist as nodules lining the ventricular surface. Females with PH present with epilepsy and other signs, including patent ductus arteriosus and coagulopathy, while hemizygous males die embryonically. We have identified the PH gene as filamin I (FLN1), which encodes an actin-cross-linking phosphoprotein that transduces ligand-receptor binding into actin reorganization, and which is required for locomotion of many cell types. FLN1 shows previously unrecognized, high-level expression in the developing cortex, is required for neuronal migration to the cortex, and is essential for embryogenesis.	Harvard Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; Univ Melbourne, Dept Neurol, Austin & Repatriat Med Ctr, Heidelberg, Vic 3084, Australia; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Duke University; University of Chicago	Walsh, CA (corresponding author), Harvard Inst Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurogenet, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	jiang, yu/HGU-0029-2022; Scheffer, Ingrid E/G-1668-2013; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Scheffer, Ingrid E/0000-0002-2311-2174; Dobyns, William/0000-0002-7681-2844; Berkovic, Samuel/0000-0003-4580-841X; Walsh, Christopher/0000-0002-0156-2238	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS35129] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bellanger Jean-Michel, 1998, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V192, P367; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CONDEELIS J, 1984, J CELL BIOL, V99, pS119, DOI 10.1083/jcb.99.1.119s; Cox D, 1996, MOL BIOL CELL, V7, P803, DOI 10.1091/mbc.7.5.803; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; des Portes V, 1998, CELL, V92, P51; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Fink JM, 1997, AM J HUM GENET, V61, P379, DOI 10.1086/514863; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HARTWIG J, 1992, J CELL BIOL, V106, P1525; HARTWIG JH, 1980, J CELL BIOL, V87, P841, DOI 10.1083/jcb.87.3.841; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; HUTTENLOCHER PR, 1994, NEUROLOGY, V44, P51, DOI 10.1212/WNL.44.1.51; JUST W, 1994, HUM MOL GENET, V3, P2268, DOI 10.1093/hmg/3.12.2268; Kopp P, 1997, MOL CELL PROBE, V11, P217, DOI 10.1006/mcpr.1997.0099; LETOURNEAU PC, 1989, DEVELOPMENT, V105, P505; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; MAESTRINI E, 1993, HUM MOL GENET, V2, P761, DOI 10.1093/hmg/2.6.761; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Meyer SC, 1997, J BIOL CHEM, V272, P2914, DOI 10.1074/jbc.272.5.2914; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; MURRAY JG, 1997, MAYO CLIN CARDIOLOGY; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OKITA JR, 1985, J CELL BIOL, V100, P317, DOI 10.1083/jcb.100.1.317; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; PATROSSO MC, 1994, GENOMICS, V21, P71, DOI 10.1006/geno.1994.1226; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rice DS, 1998, DEVELOPMENT, V125, P3719; Rogner UC, 1996, GENOME RES, V6, P922, DOI 10.1101/gr.6.10.922; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Small K, 1998, HUM MOL GENET, V7, P135, DOI 10.1093/hmg/7.1.135; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; STENDAHL OI, 1980, J CELL BIOL, V84, P215, DOI 10.1083/jcb.84.2.215; WANG K, 1975, P NATL ACAD SCI USA, V72, P4483, DOI 10.1073/pnas.72.11.4483; Wang Q, 1996, J CELL BIOCHEM, V62, P383, DOI 10.1002/(SICI)1097-4644(199609)62:3<383::AID-JCB8>3.0.CO;2-N; WARE J, 1990, P NATL ACAD SCI USA, V87, P2026, DOI 10.1073/pnas.87.5.2026; YASUTAKA O, 1995, BIOCHEMISTRY-US, V34, P6745, DOI 10.1021/bi00020a020; Zhang WJ, 1998, J NEUROSCI, V18, P914; ZHOU SY, 1995, TRENDS BIOCHEM SCI, V20, P470	56	620	635	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1315	1325		10.1016/S0896-6273(00)80651-0	http://dx.doi.org/10.1016/S0896-6273(00)80651-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883725	Bronze			2022-12-24	WOS:000077910600014
J	Blakemore, SJ; Wolpert, DM; Frith, CD				Blakemore, SJ; Wolpert, DM; Frith, CD			Central cancellation of self-produced tickle sensation	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; MOTOR CONTROL; CEREBELLUM; TRANSMISSION; ACQUISITION; MOVEMENT; NEURONS; TOUCH; AREAS; CAT	A self-produced tactile stimulus is perceived as less ticklish than the same stimulus generated externally. We used fMRI to examine neural responses when subjects experienced a tactile stimulus that was either self-produced or externally produced. More activity was found in somatosensory cortex when the stimulus was externally produced. In the cerebellum, less activity was associated with a movement that generated a tactile stimulus than with a movement that did not. This difference suggests that the cerebellum is involved in predicting the specific sensory consequences of movements, providing the signal that is used to cancel the sensory response to self-generated stimulation.	Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Inst Neurol, Sobell Dept, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Blakemore, SJ (corresponding author), Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	s.blakemore@ucl.ac.uk	Frith, Chris D/A-2171-2009; Hoogkamer, Wouter/G-4498-2010; Blakemore, Sarah-Jayne/A-1792-2010; Galantucci, Bruno/E-5770-2010	Frith, Chris D/0000-0002-8665-0690; Blakemore, Sarah-Jayne/0000-0002-1690-2805; Wolpert, Daniel/0000-0003-2011-2790	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSSON G, 1987, J PHYSIOL-LONDON, V385, P107, DOI 10.1113/jphysiol.1987.sp016487; ANDERSSON G, 1985, NEUROSCI LETT S, V22, pS27; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Bower JM, 1997, PROG BRAIN RES, V114, P463; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; CLAXTON G, 1975, PERCEPT MOTOR SKILL, V41, P335, DOI 10.2466/pms.1975.41.1.335; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Decety J, 1996, REV NEUROSCIENCE, V7, P285; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; FRISTON KJ, 1997, HUMAN BRAIN FUNCTION, P107; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; ITO M, 1970, INT J NEUROL, V7, P162; Jansma JM, 1998, NEUROREPORT, V9, P501; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; JIANG W, 1991, EXP BRAIN RES, V84, P342; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; LEINER HC, 1995, HUMAN BRAIN MAPPING, V2, P244; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Morissette J, 1996, EXP BRAIN RES, V109, P240; Oscarsson O., 1980, INFERIOR OLIVARY NUC, P279; Paulesu E., 1997, HUMAN BRAIN FUNCTION, P183; PAULIN MG, 1989, DYNAMIC INTERACTIONS, P241; PORRINO LJ, 1993, PSYCHOPHARMACOLOGY, V112, P343, DOI 10.1007/BF02244931; SIMPSON JL, 1995, BRAIN BEHAV SCI, V19, P368; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Talairach J., 1988, COPLANAR STEREOTAXIC; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 1993, NEUROBIOLOGY CINGULA; VONHOLST E, 1902, BRIT J ANIM BEHAV, V289, P54; WEISKRANTZ L, 1971, NATURE, V230, P598, DOI 10.1038/230598a0; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	41	880	888	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					635	640		10.1038/2870	http://dx.doi.org/10.1038/2870			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196573				2022-12-24	WOS:000077437100021
J	Naruse, S; Thinakaran, G; Luo, JJ; Kusiak, JW; Tomita, T; Iwatsubo, T; Qian, XZ; Ginty, DD; Price, DL; Borchelt, DR; Wong, PC; Sisodia, SS				Naruse, S; Thinakaran, G; Luo, JJ; Kusiak, JW; Tomita, T; Iwatsubo, T; Qian, XZ; Ginty, DD; Price, DL; Borchelt, DR; Wong, PC; Sisodia, SS			Effects of PS1 deficiency on membrane protein trafficking in neurons	NEURON			English	Article							AMYLOID-BETA-PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; COPII-COATED VESICLES; PRECURSOR PROTEIN; HIPPOCAMPAL-NEURONS; IN-VIVO; ENDOPLASMIC-RETICULUM; GOLGI TRANSPORT; MAMMALIAN-CELLS; NERVOUS-SYSTEM	We have examined the trafficking and metabolism of the beta-amyloid precursor protein (APP), an APP homolog (APLP1), and TrkB in neurons that lack PS1. We report that PS1-deficient neurons fail to secrete A beta, and that the rate of appearance of soluble APP derivatives in the conditioned medium is increased. Remarkably, carboxyl-terminal fragments (CTFs) derived from APP and APLP1 accumulate in PS1-deficient neurons. Hence, PS1 plays a role in promoting intramembrane cleavage and/or degradation of membrane-bound CTFs. Moreover, the maturation of TrkB and BDNF-inducible TrkB autophosphorylation is severely compromised in neurons lacking PS1. We conclude that PS1 plays an essential role in modulating trafficking and metabolism of a selected set of membrane and secretory proteins in neurons.	Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA; NIA, Baltimore, MD 21224 USA; Univ Tokyo, Fac Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 113, Japan	University of Chicago; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Tokyo	Sisodia, SS (corresponding author), Univ Chicago, Dept Pharmacol & Physiol Sci, 947 E 58Th St, Chicago, IL 60637 USA.	ssisodia@drugs.bsd.uchicago.edu	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	NIA NIH HHS [1PO1 AG14248, AG05146] Funding Source: Medline; NINDS NIH HHS [NS 20471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DESTROOPER B, 1995, EMBO J, V14, P4932, DOI 10.1002/j.1460-2075.1995.tb00176.x; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haass C, 1998, NATURE, V391, P339, DOI 10.1038/34800; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Lah JJ, 1997, J NEUROSCI, V17, P1971; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; SELKOE DJ, 1997, MOL GENETIC BASIS NE, P601; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Simons M, 1996, J NEUROSCI, V16, P899; SISODIA SS, 1993, J NEUROSCI, V13, P3136; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; VANNOSTRAND WE, 1989, NATURE, V341, P546; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; YAVIN Z, 1980, DEV BIOL, V75, P454, DOI 10.1016/0012-1606(80)90176-1; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	45	336	342	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1213	1221		10.1016/S0896-6273(00)80637-6	http://dx.doi.org/10.1016/S0896-6273(00)80637-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856475	hybrid			2022-12-24	WOS:000077386100030
J	Corbetta, M; Akbudak, E; Conturo, TE; Snyder, AZ; Ollinger, JM; Drury, HA; Linenweber, MR; Petersen, SE; Raichle, ME; Van Essen, DC; Shulman, GL				Corbetta, M; Akbudak, E; Conturo, TE; Snyder, AZ; Ollinger, JM; Drury, HA; Linenweber, MR; Petersen, SE; Raichle, ME; Van Essen, DC; Shulman, GL			A common network of functional areas for attention and eye movements	NEURON			English	Review							POSITRON EMISSION TOMOGRAPHY; POSTERIOR PARIETAL CORTEX; VISUAL-SPATIAL ATTENTION; SUPERIOR TEMPORAL SULCUS; SACCADE-RELATED ACTIVITY; MONKEY CEREBRAL-CORTEX; NIGRA PARS RETICULATA; NEURONAL-ACTIVITY; MACAQUE MONKEY; RHESUS-MONKEY	Functional magnetic resonance imaging (fMRI) and surface-based representations of brain activity were used to compare the functional anatomy of two tasks, one involving covert shifts of attention to peripheral visual stimuli, the other involving both attentional and saccadic shifts to the same stimuli. Overlapping regional networks in parietal, frontal, and temporal lobes were active in both tasks. This anatomical overlap is consistent with the hypothesis that attentional and oculomotor processes are tightly integrated at the neural level.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, McDonnell Ctr Higher Brain Funct, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Petersen, Steve/ABF-1368-2020	CORBETTA, MAURIZIO/0000-0001-8295-3304	NEI NIH HHS [EY00379] Funding Source: Medline; NINDS NIH HHS [NS32979, NS06833] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032979, P50NS006833, P01NS006833] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN RA, 1987, EXP BRAIN RES, V67, P316; ANDERSEN RA, 1989, ANNU REV NEUROSCI, V12, P377, DOI 10.1146/annurev.neuro.12.1.377; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; BIZZI E, 1968, EXP BRAIN RES, V6, P69; BOCH RA, 1989, J NEUROPHYSIOL, V61, P1064, DOI 10.1152/jn.1989.61.5.1064; BodisWollner I, 1997, NEUROLOGY, V49, P416, DOI 10.1212/WNL.49.2.416; BON L, 1992, EXP BRAIN RES, V89, P571, DOI 10.1007/BF00229882; Bon L, 1997, EXP BRAIN RES, V113, P180, DOI 10.1007/BF02454156; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chelazzi L, 1995, BEHAV BRAIN RES, V71, P81, DOI 10.1016/0166-4328(95)00134-4; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CORBETTA M, 1997, NEUROIMAGE S, V5, P85; Darby DG, 1996, NEUROIMAGE, V3, P53, DOI 10.1006/nimg.1996.0006; De Renzi E., 1982, DISORDERS SPACE EXPL; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; Drury HA, 1996, J COGNITIVE NEUROSCI, V8, P1, DOI 10.1162/jocn.1996.8.1.1; EPSTEIN FH, 1994, MAGN RESON MED, V31, P164, DOI 10.1002/mrm.1910310210; ERIKSEN CW, 1972, PERCEPT PSYCHOPHYS, V12, P201, DOI 10.3758/BF03212870; FOX PT, 1985, J NEUROPHYSIOL, V54, P348, DOI 10.1152/jn.1985.54.2.348; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; GEIGER B, 1993, 2105 I NAT RECH INF; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; HAWKINS HL, 1988, PERCEPT PSYCHOPHYS, V44, P484, DOI 10.3758/BF03210434; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hunton DL, 1996, HUM BRAIN MAPP, V4, P122, DOI 10.1002/(SICI)1097-0193(1996)4:2<122::AID-HBM4>3.0.CO;2-5; James W., 1890, PRINCIPLES PSYCHOL, V2; Klein R. M., 1980, ATTENTION PERFORM, P259, DOI DOI 10.1037/E665402011-424; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kodaka Y, 1997, NEUROSCI RES, V28, P291, DOI 10.1016/S0168-0102(97)00055-2; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LANG W, 1994, NEUROREPORT, V5, P921, DOI 10.1097/00001756-199404000-00017; Law I, 1997, ACTA PHYSIOL SCAND, V161, P419, DOI 10.1046/j.1365-201X.1997.00207.x; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; MOTTER BC, 1987, J NEUROSCI, V7, P154; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Muri RM, 1996, J NEUROL NEUROSUR PS, V60, P445, DOI 10.1136/jnnp.60.4.445; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OLLINGER JM, 1997, INT SOC MAGN RESON M, V2, P1672; OLSEN CR, 1993, NEUROBIOLOGY CINGULA, P366; PAUS T, 1995, J NEUROPHYSIOL, V74, P2179, DOI 10.1152/jn.1995.74.5.2179; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; PETIT L, 1995, EUR J NEUROSCI, V7, P169, DOI 10.1111/j.1460-9568.1995.tb01031.x; Petit L, 1996, J NEUROSCI, V16, P3714; PETIT L, 1993, J NEUROPHYSIOL, V69, P1009, DOI 10.1152/jn.1993.69.4.1009; Petit L, 1997, J NEUROPHYSIOL, V77, P3386, DOI 10.1152/jn.1997.77.6.3386; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; REMINGTON RW, 1980, J EXP PSYCHOL HUMAN, V6, P726, DOI 10.1037/0096-1523.6.4.726; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P713, DOI 10.1152/jn.1995.74.2.713; Scalaidhe SPO, 1997, BEHAV BRAIN RES, V84, P31; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; SCHLAG J, 1992, EXP BRAIN RES, V90, P302; SELEMON LD, 1988, J NEUROSCI, V8, P4049; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; SNYDER AZ, 1995, QUANTIFICATION BRAIN, P131; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STEINMETZ MA, 1994, J NEUROPHYSIOL, V72, P1020, DOI 10.1152/jn.1994.72.2.1020; SUZUKI H, 1977, BRAIN RES, V126, P497, DOI 10.1016/0006-8993(77)90600-X; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Talairach J., 1988, COPLANAR STEREOTAXIC; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ullman S., 1996, HIGH LEVEL VISION OB; Vallar G., 1987, NEUROPHYSIOLOGICAL N, V45, P235; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; VanEssen DC, 1997, J NEUROSCI, V17, P7079; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121	104	1215	1226	5	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					761	773		10.1016/S0896-6273(00)80593-0	http://dx.doi.org/10.1016/S0896-6273(00)80593-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	133QM	9808463	Bronze			2022-12-24	WOS:000076697300020
J	Dan, Y; Alonso, JM; Usrey, WM; Reid, RC				Dan, Y; Alonso, JM; Usrey, WM; Reid, RC			Coding of visual information by precisely correlated spikes in the lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							RETINAL GANGLION-CELLS; CROSS-CORRELATION ANALYSIS; BEHAVING MONKEYS; CAT RETINA; X-CELL; Y-CELL; CORTEX; NEURONS; SYNCHRONIZATION; OSCILLATIONS	Correlated firing among neurons is widespread in the nervous system. Precisely correlated spiking, occurring on a millisecond time scale, has recently been observed among neurons in the lateral geniculate nucleus with overlapping receptive fields. We have used an information-theoretic analysis to examine the role of these correlations in visual coding. Considerably more information can be extracted from two cells if temporal correlations between them are considered. The percentage increase in information depends on the degree of correlation; the average increase is approximately 20% for strongly correlated pairs. Thus, precise temporal correlation could be used as an additional information channel from thalamus to visual cortex.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA	Harvard University; Harvard Medical School; Rockefeller University	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu		Dan, Yang/0000-0002-3818-877X	NATIONAL EYE INSTITUTE [R01EY010115, R37EY005253, R01EY005253] Funding Source: NIH RePORTER; NEI NIH HHS [EY10115, EY06604, EY05253] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Adrian E.D., 1928, BASIS SENSATION; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; CLELAND BG, 1986, VISUAL NEUROSCI, P111; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; GHOSE GM, 1994, J NEUROPHYSIOL, V71, P330, DOI 10.1152/jn.1994.71.1.330; GUIDO W, 1995, VISUAL NEUROSCI, V12, P723, DOI 10.1017/S0952523800008993; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; KAPLAN E, 1987, J PHYSIOL-LONDON, V391, P267, DOI 10.1113/jphysiol.1987.sp016737; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; Shannon C.E., 1963, MATH THEORY COMMUNIC; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sutter E.E., 1987, ADV METHODS PHYSIOLO, V1, P303; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; TSO DY, 1986, J NEUROSCI, V6, P1160; USREY WM, IN PRESS NATURE; USREY WM, IN PRESS ANN REV PHY, V61	36	192	195	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					501	507		10.1038/2217	http://dx.doi.org/10.1038/2217			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196548				2022-12-24	WOS:000076406900015
J	Stevens, CF; Sullivan, JM				Stevens, CF; Sullivan, JM			Regulation of the readily releasable vesicle pool by protein kinase C	NEURON			English	Article							ISOLATED HIPPOCAMPAL-NEURONS; SYNAPTIC TRANSMISSION; PHORBOL ESTERS; PRESYNAPTIC ENHANCEMENT; TRANSMITTER RELEASE; RAT HIPPOCAMPUS; INITIAL RATE; SYNAPSES; SIZE; EXOCYTOSIS	Modulation of the size of the readily releasable vesicle pool has recently come under scrutiny as a candidate for the regulation of synaptic strength. Using electro-physiological and optical measurement techniques, we show that phorbol esters increase the size of the readily releasable pool at glutamatergic hippocampal synapses in culture through a protein kinase C (PKC)-dependent mechanism. Phorbol ester activation of PKC also increases the rate at which the pool refills. These results identify two powerful ways that activation of the PKC pathway may regulate synaptic strength by modulating the readily releasable pool of vesicles.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Sullivan, JM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	janes@axp2.salk.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 12961] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BARABAN JM, 1985, P NATL ACAD SCI USA, V82, P2538, DOI 10.1073/pnas.82.8.2538; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; Brodin L, 1997, EUR J NEUROSCI, V9, P2503, DOI 10.1111/j.1460-9568.1997.tb01679.x; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DOERNER D, 1988, J NEUROSCI, V8, P4069; FINCH DM, 1990, BRAIN RES, V518, P269, DOI 10.1016/0006-8993(90)90979-L; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Goda Y, 1998, P NATL ACAD SCI USA, V95, P1283, DOI 10.1073/pnas.95.3.1283; Goda Y, 1996, LEARN MEMORY, V3, P182, DOI 10.1101/lm.3.2-3.182; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; LEVISON SW, 1991, CULTURING NERVE CELL, P309; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; MURTHY VN, 1997, NEURON, V18, P559; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEGAL M, 1989, NEUROSCI LETT, V101, P169, DOI 10.1016/0304-3940(89)90525-9; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; STORM JF, 1987, NEUROSCI LETT, V75, P71, DOI 10.1016/0304-3940(87)90077-2; SWARTZ KJ, 1993, NATURE, V361, P165, DOI 10.1038/361165a0; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VITALE ML, 1992, NEUROSCIENCE, V51, P463, DOI 10.1016/0306-4522(92)90330-5; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645	48	213	217	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					885	893		10.1016/S0896-6273(00)80603-0	http://dx.doi.org/10.1016/S0896-6273(00)80603-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808473	Bronze			2022-12-24	WOS:000076697300030
J	Xiong, WH; Solessio, EC; Yau, KW				Xiong, WH; Solessio, EC; Yau, KW			An unusual cGMP pathway underlying depolarizing light response of the vertebrate parietal-eye photoreceptor	NATURE NEUROSCIENCE			English	Article							GUANYLYL CYCLASE RECEPTORS; SIGNAL-TRANSDUCTION; INVERTEBRATE PHOTORECEPTORS; DROSOPHILA PHOTORECEPTORS; G-PROTEINS; ACTIVATION; PHOTOTRANSDUCTION; CURRENTS; CASCADE; CA2+	All cellular signaling pathways currently known to elevate cGMP involve the activation of a guanylyl cyclase to synthesize cGMP. Here we describe an exception to this rule. In the vertebrate parietal eye, the photoreceptors depolarize to light under dark-adapted conditions, unlike rods and cones but like most invertebrate photoreceptors. WE! report that the signaling pathway for this response involves a rise in intracellular cGMP resulting from an inhibition of the phosphodiesterase that hydrolyzes cGMP. Furthermore, this phosphodiesterase is driven by an active G protein in darkness. These results indicate an antagonistic control of the phosphodiesterase by two G proteins, analogous to the G(s)/G(i) control of adenylyl cyclase. Our findings demonstrate an unusual phototransduction mechanism and at the same time indicate that signaling involving cyclic nucleotides is more elaborate than previously known.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Univ Utah, Ctr Hlth Sci, John A Moran Eye Ct, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Utah System of Higher Education; University of Utah	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	kwyau@welchlink.welch.jhu.edu						BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; EAKIN RM, 1973, 3 EYE; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOMEZ MD, 1995, NEURON, V15, P607, DOI 10.1016/0896-6273(95)90149-3; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KOCH KW, 1985, J BIOL CHEM, V260, P6788; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LI YX, 1994, J GEN PHYSIOL, V104, P941, DOI 10.1085/jgp.104.5.941; NICOL GD, 1987, J GEN PHYSIOL, V90, P651, DOI 10.1085/jgp.90.5.651; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; PUGH EN, 1993, NATURE, V364, P389, DOI 10.1038/364389a0; RANGANATHAN R, 1995, ANNU REV NEUROSCI, V18, P283; SHIN JH, 1993, NEURON, V11, P845, DOI 10.1016/0896-6273(93)90114-7; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; UI M, 1990, ADV SEC MESS PHOSPH, V24, P63; Wedel BJ, 1997, FEBS LETT, V410, P29, DOI 10.1016/S0014-5793(97)00358-X; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213; ZONG XG, 1994, J NEUROSCI, V14, P4847	30	33	35	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					359	365		10.1038/nn0998_359	http://dx.doi.org/10.1038/nn0998_359			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196524				2022-12-24	WOS:000076361400012
J	Rajan, R				Rajan, R			Receptor organ damage causes loss of cortical surround inhibition without topographic map plasticity	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; PRIMARY AUDITORY-CORTEX; ADULT FLYING-FOX; STRIATE CORTEX; INFERIOR COLLICULUS; RESPONSE PROPERTIES; GABAERGIC NEURONS; DIGIT AMPUTATION; FIELD PROPERTIES; FUNCTIONAL-ROLE	Following restricted peripheral damage, reorganization of adult sensory or motor cortex is believed to depend on loss of surround inhibition, which unmasks latent inputs to the deprived cortex. Here I demonstrate that limited damage to auditory receptors causes loss of functional surround inhibition in the cortex, unmasking of latent inputs and significantly altered neural coding. However, these changes do not lead to plasticity of the cortical map, defined by the most sensitive input from the receptor surface to each cortical location. Thus, in sensory cortex, loss of surround inhibition as a consequence of receptor organ damage does not necessarily result in cortical map plasticity.	Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.		rajan, ramesh/L-4842-2019; Rajan, Ramesh/A-5945-2008	Rajan, Ramesh/0000-0001-9862-0520				ALLOWAY KD, 1989, EXP BRAIN RES, V78, P514; BATUEV AS, 1989, EXP BRAIN RES, V76, P198; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CALFORD MB, 1991, J NEUROPHYSIOL, V65, P178, DOI 10.1152/jn.1991.65.2.178; CALFORD MB, 1991, P ROY SOC B-BIOL SCI, V243, P269, DOI 10.1098/rspb.1991.0041; DAmelio F, 1996, J NEUROSCI RES, V44, P532; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; DYKES RW, 1984, J NEUROPHYSIOL, V52, P1066, DOI 10.1152/jn.1984.52.6.1066; EVANS EF, 1980, EXP BRAIN RES, V40, P115; GARRAGHTY PE, 1991, SOMATOSENS MOT RES, V8, P347, DOI 10.3109/08990229109144757; HENDRY SHC, 1986, P NATL ACAD SCI USA, V83, P1536, DOI 10.1073/pnas.83.5.1536; HENDRY SHC, 1990, J NEUROSCI, V10, P2438; HENDRY SHC, 1986, NATURE, V320, P750, DOI 10.1038/320750a0; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kiang NYS, 1965, DISCHARGE PATTERNS S; LIBERMAN MC, 1988, HEARING RES, V34, P179, DOI 10.1016/0378-5955(88)90105-0; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; MANLEY GA, 1976, J PHYSIOL-LONDON, V258, P323, DOI 10.1113/jphysiol.1976.sp011422; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; POLLAK GD, 1993, HEARING RES, V65, P99, DOI 10.1016/0378-5955(93)90205-F; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; RAJAN R, 1991, HEARING RES, V53, P153, DOI 10.1016/0378-5955(91)90222-U; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; RASMUSSON DD, 1992, SOMATOSENS MOT RES, V9, P279, DOI 10.3109/08990229209144777; RASMUSSON DD, 1993, SOMATOSENS MOT RES, V10, P69, DOI 10.3109/08990229309028825; RAUSELL E, 1992, P NATL ACAD SCI USA, V89, P2571, DOI 10.1073/pnas.89.7.2571; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; SANES JN, 1990, EXP BRAIN RES, V79, P479; SCHMIEDT RA, 1989, HEARING RES, V42, P23, DOI 10.1016/0378-5955(89)90115-9; SCHREINER CE, 1990, J NEUROPHYSIOL, V64, P1442, DOI 10.1152/jn.1990.64.5.1442; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; VATER M, 1992, J COMP PHYSIOL A, V171, P541; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; WALL JT, 1988, TRENDS NEUROSCI, V11, P549, DOI 10.1016/0166-2236(88)90184-1; WARREN R, 1989, J COMP NEUROL, V288, P583, DOI 10.1002/cne.902880405; WELKER E, 1989, EXP BRAIN RES, V74, P441, DOI 10.1007/BF00247346; YANG LC, 1992, J NEUROPHYSIOL, V68, P1760, DOI 10.1152/jn.1992.68.5.1760	41	139	139	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					138	143		10.1038/388	http://dx.doi.org/10.1038/388			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195129				2022-12-24	WOS:000076361100015
J	Kim, WK; Choi, YB; Rayudu, PV; Das, P; Asaad, W; Arnelle, DR; Stamler, JS; Lipton, SA				Kim, WK; Choi, YB; Rayudu, PV; Das, P; Asaad, W; Arnelle, DR; Stamler, JS; Lipton, SA			Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; METHYL-D-ASPARTATE; S-NITROSYLATION; GLUTAMATE NEUROTOXICITY; SUPEROXIDE-DISMUTASE; INDUCED BLOCKADE; L-ARGININE; OXIDATION; APOPTOSIS; RELEASE	Recent evidence indicates that the NO-related species, nitroxyl anion (NO-), is produced in physiological systems by several redox metal-containing proteins, including hemoglobin, nitric oxide synthase (NOS), superoxide dismutase, and S-nitrosothiols (SNOs), which have recently been identified in brain. However, the chemical biology of NO- remains largely unknown. Here, we show that NO--unlike NO., but reminiscent of NO+ transfer (or S-nitrosylation) - reacts mainly with Cys-399 in the NR2A subunit of the N-methyl-D-aspartate (NMDA) receptor to curtail excessive Ca2+ influx and thus provide neuroprotection from excitotoxic insults. This effect of NO- closely resembles that of NOS, which also downregulates NMDA receptor activity under similar conditions in culture.	Brigham & Womens Hosp, Cerebrovasc & Neurosci Res Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Howard Hughes Medical Institute; Duke University	Lipton, SA (corresponding author), Burnham Inst, Del E Webb Ctr Neurosci & Aging Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Asaad, Wael/I-8485-2012	Asaad, Wael/0000-0003-4406-9096; Posina, Venkata Rayudu/0000-0002-3040-9224; Stamler, Jonathan/0000-0002-6866-1572; Lipton, Stuart/0000-0002-3490-1259	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477, R01EY009024] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY05477, R01 EY09024] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; AMELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bonner F.T., 2010, CHEMINFORM, V28, DOI [10.1002/chin.199715245, DOI 10.1002/CHIN.199715245]; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BUTLER AR, 1995, TRENDS PHARMACOL SCI, V16, P18, DOI 10.1016/S0165-6147(00)88968-3; Chazotte-Aubert L, 1999, J BIOL CHEM, V274, P20909, DOI 10.1074/jbc.274.30.20909; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; DOYLE MP, 1988, J AM CHEM SOC, V110, P593, DOI 10.1021/ja00210a047; FAGNI L, 1995, MOL PHARMACOL, V47, P1239; Feelisch M., 1996, METHODS NITRIC OXIDE, P71; FUKUTO JM, 1992, BIOCHEM PHARMACOL, V43, P607, DOI 10.1016/0006-2952(92)90584-6; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HOBBS AJ, 1994, P NATL ACAD SCI USA, V91, P10992, DOI 10.1073/pnas.91.23.10992; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; Hughes MN, 1999, BBA-BIOENERGETICS, V1411, P263, DOI 10.1016/S0005-2728(99)00019-5; KENDRICK KM, 1996, EUR J NEUROSCI, V8, P1619; KIM WK, 1996, BIOL NITRIC OXIDE 5, P26; Kluge I, 1997, J NEUROCHEM, V69, P2599; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LIPTON SA, 1994, NEUROPHARMACOLOGY, V33, P1229, DOI 10.1016/0028-3908(94)90021-3; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lipton SA, 1999, METH MOL B, V128, P121; Lipton SA, 1996, TRENDS PHARMACOL SCI, V17, P186, DOI 10.1016/0165-6147(96)20028-8; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MANZONI O, 1993, J NEUROCHEM, V61, P368, DOI 10.1111/j.1471-4159.1993.tb03580.x; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; MURPHY ME, 1991, P NATL ACAD SCI USA, V88, P10860, DOI 10.1073/pnas.88.23.10860; NAGASAWA HT, 1995, J MED CHEM, V38, P1865, DOI 10.1021/jm00011a005; Ogura T, 1997, BIOCHEM BIOPH RES CO, V236, P365, DOI 10.1006/bbrc.1997.6948; PUFAHL RA, 1995, BIOCHEMISTRY-US, V34, P1930, DOI 10.1021/bi00006a014; RADI R, 1991, J BIOL CHEM, V266, P4244; Schmidt HHHW, 1996, P NATL ACAD SCI USA, V93, P14492, DOI 10.1073/pnas.93.25.14492; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Tenneti L, 1997, NEUROSCI LETT, V236, P139, DOI 10.1016/S0304-3940(97)00780-5; WINK DA, 1996, METHODS NITRIC OXIDE, P403; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; ZAMORA R, 1995, BIOCHEM J, V312, P333, DOI 10.1042/bj3120333; ZHAO XJ, 1995, BIOCHEM BIOPH RES CO, V212, P1054, DOI 10.1006/bbrc.1995.2076	60	170	181	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					461	469		10.1016/S0896-6273(00)80859-4	http://dx.doi.org/10.1016/S0896-6273(00)80859-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571239	Bronze			2022-12-24	WOS:000083423700020
J	Voisin, DL; Chakfe, Y; Bourque, CW				Voisin, DL; Chakfe, Y; Bourque, CW			Coincident detection of CSFNa+ and osmotic pressure in osmoregulatory neurons of the supraoptic nucleus	NEURON			English	Article							LAMINAE TERMINALIS INVITRO; IN-VITRO; RAT; SODIUM; CHANNELS; RESPONSES; OSMORECEPTOR; OXYTOCIN; RELEASE; THIRST	Behavioral and neuroendocrine responses underlying systemic osmoregulation are under the concerted control of centrally located osmoreceptors and cerebrospinal fluid (CSF) Na+ concentration ([Na+]) detectors. Although the process underlying osmoreception is understood, the mechanism by which [Na+] is detected and integrated with cellular information derived from osmoreceptors is unknown. Here, we show that shifts in extracellular [Na+] ([Na+](o)) cause proportional changes in the relative Na+ permeability of mechanosensitive cation channels responsible for signal transduction in the osmosensory neurons of the supraoptic nucleus. This effect causes the generation of Na+-specific receptor potentials under isotonic conditions and modulates osmoreceptor potentials and electrical responsiveness during osmotic perturbation. These results provide a cellular basis for Na+-sensing and for the coordinated detection of CSF [Na+] and osmolality in central osmoregulatory neurons.	Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Bourque, CW (corresponding author), Montreal Gen Hosp, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.			Bourque, Charles/0000-0002-1594-742X				ANDERSSON B, 1971, AM SCI, V59, P408; ARMSTRONG WE, 1994, J PHYSIOL-LONDON, V475, P115, DOI 10.1113/jphysiol.1994.sp020053; BLACKBURN RE, 1993, P NATL ACAD SCI USA, V90, P10380, DOI 10.1073/pnas.90.21.10380; Bourque CW, 1997, ANNU REV PHYSIOL, V59, P601, DOI 10.1146/annurev.physiol.59.1.601; Bourque CW, 1998, PROG BRAIN RES, V119, P59; BOURQUE CW, 1990, FRONT NEUROENDOCRIN, V11, P183; Bourque CW, 1998, CELL MOL NEUROBIOL, V18, P3, DOI 10.1023/A:1022566924921; Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; ELINDER F, 1994, BIOPHYS J, V67, P71, DOI 10.1016/S0006-3495(94)80456-4; HALTER JB, 1977, J CLIN ENDOCR METAB, V44, P609, DOI 10.1210/jcem-44-4-609; HILLE B, 1979, BRAIN RES BULL, V4, P159, DOI 10.1016/0361-9230(79)90079-0; JANDHYALA BS, 1986, CLIN SCI, V70, P103, DOI 10.1042/cs0700103; LENG G, 1989, J NEUROENDOCRINOL, V1, P35, DOI 10.1111/j.1365-2826.1989.tb00074.x; LENG G, 1992, HORM RES, V37, P1; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; MCKINLEY MJ, 1987, CAN J PHYSIOL PHARM, V65, P1724, DOI 10.1139/y87-271; MCKINLEY MJ, 1978, BRAIN RES, V141, P89, DOI 10.1016/0006-8993(78)90619-4; McKinley MJ, 1985, VASOPRESSIN, P299; OLIET SHR, 1992, J PHYSIOL-LONDON, V455, P291, DOI 10.1113/jphysiol.1992.sp019302; OLIET SHR, 1993, NATURE, V364, P341, DOI 10.1038/364341a0; OLIET SHR, 1996, NEURON, V16, P75; OLLET SHR, 1993, AM J PHYSIOL, V265, pR1475; OLSSON K, 1974, ACTA PHYSIOL SCAND, V91, P286, DOI 10.1111/j.1748-1716.1974.tb05684.x; PEREZCORNEJO P, 1994, BIOPHYS J, V66, P1929, DOI 10.1016/S0006-3495(94)80986-5; Richard D, 1995, J PHYSIOL-LONDON, V489, P567, DOI 10.1113/jphysiol.1995.sp021073; SAYER RJ, 1984, AM J PHYSIOL, V247, pR374, DOI 10.1152/ajpregu.1984.247.2.R374; SIBBALD JR, 1988, BRAIN RES, V461, P205, DOI 10.1016/0006-8993(88)90251-X; THORNTON SN, 1985, Q J EXP PHYSIOL CMS, V70, P549, DOI 10.1113/expphysiol.1985.sp002941; THRASHER TN, 1980, AM J PHYSIOL, V238, pR338; VERBALIS JG, 1992, TRENDS ENDOCRIN MET, V3, P1, DOI 10.1016/1043-2760(92)90084-E; VERNEY EB, 1947, P ROY SOC LOND B BIO, V135, P26; VIVAS L, 1990, BRAIN RES, V519, P294, DOI 10.1016/0006-8993(90)90091-O; Yool AJ, 1996, BIOPHYS J, V71, P2467, DOI 10.1016/S0006-3495(96)79440-7	33	43	44	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					453	460		10.1016/S0896-6273(00)80858-2	http://dx.doi.org/10.1016/S0896-6273(00)80858-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571238	Bronze			2022-12-24	WOS:000083423700019
J	Hutchison, WD; Davis, KD; Lozano, AM; Tasker, RR; Dostrovsky, JO				Hutchison, WD; Davis, KD; Lozano, AM; Tasker, RR; Dostrovsky, JO			Pain-related neurons in the human cingulate cortex	NATURE NEUROSCIENCE			English	Article							HUMAN ANTERIOR CINGULATE; REGIONS		Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON M5S 2S8, Canada; Toronto Hosp, Res Inst, Toronto, ON M5S 2S8, Canada; Toronto Hosp, Western Div, Playfair Neurosci Unit, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Hutchison, WD (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, 399 Bathurst St,EW6-528, Toronto, ON M5S 2S8, Canada.	whutch@playfair.utoronto.ca	Lozano, Andres M/A-5058-2012; Tudusciuc, Oana/C-1339-2011	Lozano, Andres M./0000-0001-8257-3694; Hutchison, William/0000-0002-3866-4940	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036824] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36824] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Lozano AM, 1995, ADV STER F, V11, P30; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Talairach I., 1988, COPLANAR STEREOTACTI; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x	13	446	474	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					403	405		10.1038/8065	http://dx.doi.org/10.1038/8065			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321241				2022-12-24	WOS:000084609400007
J	Neumann, S; Woolf, CJ				Neumann, S; Woolf, CJ			Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury	NEURON			English	Article							ROOT GANGLION NEURONS; PERIPHERAL-NERVE AUTOGRAFTS; NEURITE GROWTH-INHIBITORS; MESSENGER-RNA EXPRESSION; PRIMARY SENSORY NEURONS; AXONAL REGENERATION; CORTICOSPINAL TRACT; GAP-43 EXPRESSION; SCHWANN-CELLS; RAT	Regeneration is abortive following adult mammalian CNS injury. We have investigated whether increasing the intrinsic growth state of primary sensory neurons by a conditioning peripheral nerve lesion increases regrowth of their central axons. After dorsal column lesions, ail fibers stop at the injury site. Animals with a peripheral axotomy concomitant with the central lesion show axonal growth into the lesion but not into the spinal cord above the lesion. A preconditioning lesion 1 or 2 weeks prior to the dorsal column injury results in growth into the spinal cord above the lesion. In vitro, the growth capacity of DRG neurite is also increased following preconditioning lesions. The intrinsic growth state of injured neurons is, therefore, a key determinant for central regeneration.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.		Woolf, Clifford/A-9784-2010					AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; BENFEY M, 1985, J NEUROCYTOL, V14, P279, DOI 10.1007/BF01258453; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Cajal S., 1991, DEGENERATION REGENER; CAMPBELL G, 1992, J NEUROCYTOL, V21, P755, DOI 10.1007/BF01237903; Chong MS, 1996, J COMP NEUROL, V370, P97, DOI 10.1002/(SICI)1096-9861(19960617)370:1<97::AID-CNE9>3.0.CO;2-G; CHONG MS, 1994, J NEUROSCI, V14, P4375; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DAVIES SJA, 1994, J NEUROSCI, V14, P1596, DOI 10.1523/JNEUROSCI.14-03-01596.1994; Edstrom A, 1996, NEUROSCIENCE, V75, P1165, DOI 10.1016/0306-4522(96)00324-7; HUTSAI M, 1994, J NEUROSCI RES, V39, P634, DOI 10.1002/jnr.490390603; IWASHITA Y, 1994, NATURE, V367, P167, DOI 10.1038/367167a0; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; KLEITMAN N, 1988, EXP NEUROL, V102, P298, DOI 10.1016/0014-4886(88)90223-3; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; LI Y, 1994, J NEUROSCI, V14, P4050; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; PINDZOLA RR, 1993, DEV BIOL, V156, P34, DOI 10.1006/dbio.1993.1057; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7; RICHARDSON PM, 1987, BRAIN RES, V411, P406, DOI 10.1016/0006-8993(87)91096-1; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SCHREYER DJ, 1991, J NEUROSCI, V11, P3738; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SMITH DS, 1997, J NEUROSCI, V17, P343; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; WOOLF CJ, 1995, J COMP NEUROL, V360, P121, DOI 10.1002/cne.903600109; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202	39	501	517	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					83	91		10.1016/S0896-6273(00)80755-2	http://dx.doi.org/10.1016/S0896-6273(00)80755-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402195	Bronze			2022-12-24	WOS:000080681200012
J	Patel, AJ; Honore, E; Lesage, F; Fink, M; Romey, G; Lazdunski, M				Patel, AJ; Honore, E; Lesage, F; Fink, M; Romey, G; Lazdunski, M			Inhalational anesthetics activate two-pore-domain background K+ channels	NATURE NEUROSCIENCE			English	Article							GENERAL-ANESTHETICS; ION CHANNELS; VOLATILE ANESTHETICS; ARACHIDONIC-ACID; NEURONS; MEMBRANE; MECHANISMS; TWIK-1; YEAST; RAT	Volatile anesthetics produce safe, reversible unconsciousness, amnesia and analgesia via hyperpolarization of mammalian neurons. In molluscan pacemaker neurons, they activate an inhibitory synaptic K+ current (I-KAn), proposed to be important in general anesthesia. Here we show that TASK and TREK-1, two recently cloned mammalian two-P-domain K+ channels similar to I-KAn in biophysical properties, are activated by volatile general anesthetics. Chloroform, diethyl ether, halothane and isoflurane activated TREK-1, whereas only halothane and isoflurane activated TASK. Carboxy (C)-terminal regions were critical for anesthetic activation in both channels. Thus both TREK-1 and TASK are possibly important target sites for these agents.	CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lazdunski, M (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, 660 Route Lucioles, F-06560 Valbonne, France.		Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; HONORE, Eric/0000-0002-8007-0919				BERGJOHNSEN J, 1987, ACTA PHYSIOL SCAND, V130, P679, DOI 10.1111/j.1748-1716.1987.tb08192.x; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Felisberti F, 1997, BRAIN RES, V766, P56, DOI 10.1016/S0006-8993(97)00554-4; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; FRANKS NP, 1991, SCIENCE, V254, P427, DOI 10.1126/science.1925602; FRANKS NP, 1988, NATURE, V333, P662, DOI 10.1038/333662a0; Gray AT, 1998, ANESTHESIOLOGY, V88, P1076, DOI 10.1097/00000542-199804000-00029; HARRIS RA, 1995, FASEB J, V9, P1454, DOI 10.1096/fasebj.9.14.7589987; KETCHUM KA, 1995, NATURE, V376, P69; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lesage F, 1996, J BIOL CHEM, V271, P4183; Lopes CMB, 1998, BRIT J PHARMACOL, V125, P309, DOI 10.1038/sj.bjp.0702069; MACIVER MB, 1991, ANESTHESIOLOGY, V74, P83; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; NICOLL RA, 1982, SCIENCE, V217, P1055, DOI 10.1126/science.7112112; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Reid JD, 1996, RECEPTOR CHANNEL, V4, P51; Sirois JE, 1998, J PHYSIOL-LONDON, V512, P851, DOI 10.1111/j.1469-7793.1998.851bd.x; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D	24	516	545	1	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					422	426		10.1038/8084	http://dx.doi.org/10.1038/8084			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321245				2022-12-24	WOS:000084609400011
J	Ma, L; Zablow, L; Kandel, ER; Siegelbaum, SA				Ma, L; Zablow, L; Kandel, ER; Siegelbaum, SA			Cyclic AMP induces functional presynaptic boutons in hippocampal CA3-CA1 neuronal cultures	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CA1 PYRAMIDAL CELLS; LATE-PHASE; NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; AXOSPINOUS SYNAPSES; BINDING PROTEIN; SILENT SYNAPSES; LTP	Long-term forms of synaptic plasticity that may underlie learning and memory have been suggested to depend on changes in the number of synapses between presynaptic and postsynaptic neurons. Here we have investigated a form of synaptic plasticity in cultures of hippocampal CA3 and CA1 neurons related to the late phase of long-term potentiation, which depends on cAMP and protein synthesis. Using the fluorescent dye FM 1-43 to label active presynaptic terminals, we find that a membrane permeable analog of cAMP enhances the number of active presynaptic terminals and that this effect requires protein synthesis.	Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Dept Physiol Psychiat & Biochem, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Dept Pharmacol, 722 W 168 St, New York, NY 10032 USA.	sas8@columbia.edu						Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Geinisman Y, 1996, J COMP NEUROL, V368, P413; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; HUANG LLH, 1996, BIOMED ENG-APP BAS C, V8, P3; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MALGAROLI A, 1995, NATURE, V268, P1624; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; Rusakov DA, 1997, NEUROSCIENCE, V80, P69, DOI 10.1016/S0306-4522(97)00125-5; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sorra KE, 1998, J NEUROSCI, V18, P658; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; WOJTOWICZ JM, 1989, CAN J PHYSIOL PHARM, V67, P167, DOI 10.1139/y89-028; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972	46	130	131	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					24	30		10.1038/4525	http://dx.doi.org/10.1038/4525			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195176				2022-12-24	WOS:000078409300009
J	Stern-Bach, Y; Russo, S; Neuman, M; Rosenmund, C				Stern-Bach, Y; Russo, S; Neuman, M; Rosenmund, C			A point mutation in the glutamate binding site blocks desensitization of AMPA receptors	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; NEURONAL NICOTINIC RECEPTOR; AMINO-ACID RECEPTORS; METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION; KAINATE RECEPTORS; HIPPOCAMPAL-NEURONS; CHANNEL DOMAIN; CYCLOTHIAZIDE; ACTIVATION	Desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptors is thought to shape the synaptic response and act as a neuroprotective mechanism at central synapses, but the molecular mechanism underlying desensitization is poorly understood. We found that replacing the glutamate binding domain S1 of GluR3 (an AMPA receptor) with S1 of GluR6 (a kainate receptor) resulted in a fully active but completely nondesensitizing receptor. Smaller substitutions within S1 identified, besides two additional modulatory regions, a single exchange, L507Y, as is required and sufficient for the block, of desensitization. This phenotype was specific for AMPA receptors and required an aromatic residue at this position. L507 lies between two residues (T504 and R509) that form part of the glutamate binding site. The physical proximity of these residues, which are involved in binding and gating, suggests they may form part of the link between these two events.	Max Planck Inst Biophys Chem, Workgrp Cellular Neurobiol, D-37070 Gottingen, Germany; Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Anat & Cell Biol, IL-91120 Jerusalem, Israel; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37070 Gottingen, Germany	Max Planck Society; Hebrew University of Jerusalem; Max Planck Society	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Workgrp Cellular Neurobiol, Fassberg, D-37070 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Green T, 1998, NEURON, V20, P427, DOI 10.1016/S0896-6273(00)80986-1; Heckmann M, 1996, BIOPHYS J, V71, P1743, DOI 10.1016/S0006-3495(96)79375-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUGHES TE, 1995, J MOL NEUROSCI, V5, P211; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kessler M, 1996, MOL PHARMACOL, V49, P123; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; Paas Y, 1996, NEURON, V17, P979, DOI 10.1016/S0896-6273(00)80228-7; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STEMBACH Y, 1994, NEURON, V13, P1345; Sutcliffe MJ, 1996, BIOPHYS J, V70, P1575, DOI 10.1016/S0006-3495(96)79724-2; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; TRUSSELL LO, 1994, SEMIN NEUROSCI, V6, P71; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; YAMADA KA, 1993, J NEUROSCI, V13, P3904	53	203	209	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					907	918		10.1016/S0896-6273(00)80605-4	http://dx.doi.org/10.1016/S0896-6273(00)80605-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808475	Bronze, Green Published			2022-12-24	WOS:000076697300032
J	Steward, O; Wallace, CS; Lyford, GL; Worley, PF				Steward, O; Wallace, CS; Lyford, GL; Worley, PF			Synaptic activation causes the mRNA for the IEG Arc to localise selectively near activated postsynaptic sites on dendrites	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; MESSENGER-RNA; DENTATE GYRUS; HIPPOCAMPAL-FORMATION; GROWTH-FACTOR; LATE-PHASE; LOCALIZATION; GENE; POLYRIBOSOMES	Polyribosomal complexes beneath postsynaptic sites on dendrites provide a substrate for local translation of particular mRNAs, but the signals that target mRNAs to synapses remain to be defined. Here, we report that high frequency activation of the perforant path projections to the dentate gyrus causes newly synthesized mRNA for the immediate-early gene (IEG) Are to localize selectively in activated dendritic segments. Newly synthesized Are protein also accumulates in the portion of the dendrite that had been synaptically activated. The targeting of Are mRNA was not disrupted by locally inhibiting protein synthesis, indicating that the signals for mRNA localization reside in the mRNA itself. This novel mechanism through which newly synthesized mRNA is precisely targeted to activated synapses is well suited to play a role in the enduring forms of activity-dependent synaptic modification that require protein synthesis.	Univ Virginia, Hlth Sci Ctr, Dept Neurosci, Charlottesville, VA 22908 USA; Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Virginia; Johns Hopkins University; Johns Hopkins Medicine	Steward, O (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Neurosci, Charlottesville, VA 22908 USA.			Steward, Oswald/0000-0001-7069-8756	NIMH NIH HHS [MH53603] Funding Source: Medline; NINDS NIH HHS [NS0973, NS12333] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS000973] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Knowles RB, 1997, P NATL ACAD SCI USA, V94, P14804, DOI 10.1073/pnas.94.26.14804; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Nguyen PV, 1996, J NEUROSCI, V16, P3189; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Paradies MA, 1997, J NEUROBIOL, V33, P473, DOI 10.1002/(SICI)1097-4695(199710)33:4<473::AID-NEU10>3.0.CO;2-D; REID IM, 1970, LAB INVEST, V23, P119; STEWARD O, 1990, BRAIN RES, V516, P292, DOI 10.1016/0006-8993(90)90930-A; STEWARD O, 1983, COLD SPRING HARB SYM, V48, P745, DOI 10.1101/SQB.1983.048.01.077; STEWARD O, 1983, PROG BRAIN RES, V58, P131, DOI 10.1016/S0079-6123(08)60013-8; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; STEWARD O, 1997, MRNA METABOLISM POST, P127; Wallace CS, 1998, J NEUROSCI, V18, P26; WHITE G, 1990, J NEUROPHYSIOL, V64, P1186, DOI 10.1152/jn.1990.64.4.1186; YISRAELI JK, 1990, DEVELOPMENT, V108, P289	29	629	640	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					741	751		10.1016/S0896-6273(00)80591-7	http://dx.doi.org/10.1016/S0896-6273(00)80591-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808461	hybrid			2022-12-24	WOS:000076697300018
J	Cheour, M; Ceponiene, R; Lehtokoski, A; Luuk, A; Allik, J; Alho, K; Naatanen, R				Cheour, M; Ceponiene, R; Lehtokoski, A; Luuk, A; Allik, J; Alho, K; Naatanen, R			Development of language-specific phoneme representations in the infant brain	NATURE NEUROSCIENCE			English	Article							PERCEPTION; DISCRIMINATION; CONTRASTS; RESPONSES; CHILDREN; ENGLISH; ADULTS		Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland; Tartu State Univ, Dept Psychol, EE-202400 Tartu, Estonia	University of Helsinki; University of Tartu	Cheour, M (corresponding author), Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland.	Marie.Cheour@Helsinki.fi	Alho, Kimmo/G-2997-2013; Allik, Jüri/N-3038-2019; Allik, Jüri/D-5609-2009	Alho, Kimmo/0000-0001-8563-2792; Allik, Jüri/0000-0002-8358-4747; Allik, Jüri/0000-0002-8358-4747				BEST CT, 1988, J EXP PSYCHOL HUMAN, V14, P345, DOI 10.1037/0096-1523.14.3.345; Cheour M, 1997, NEUROREPORT, V8, P1785, DOI 10.1097/00001756-199705060-00043; CheourLuhtanen M, 1996, PSYCHOPHYSIOLOGY, V33, P478, DOI 10.1111/j.1469-8986.1996.tb01074.x; IIVONEN A, 1995, PHONETICA, V52, P221, DOI 10.1159/000262174; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R., 2018, ATTENTION BRAIN FUNC; POLKA L, 1994, J EXP PSYCHOL HUMAN, V20, P421, DOI 10.1037/0096-1523.20.2.421; STRANGE W, 1984, PERCEPT PSYCHOPHYS, V36, P131, DOI 10.3758/BF03202673; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Werker J. F., 1994, DEV SPEECH PERCEPTIO; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672	14	393	397	2	79	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					351	353		10.1038/1561	http://dx.doi.org/10.1038/1561			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	127QE	10196522				2022-12-24	WOS:000076361400010
J	Jaramillo, F; Wiesenfeld, K				Jaramillo, F; Wiesenfeld, K			Mechanoelectrical transduction assisted by Brownian motion: a role for noise in the auditory system	NATURE NEUROSCIENCE			English	Article							SACCULAR HAIR-CELLS; STOCHASTIC RESONANCE; INFORMATION-TRANSFER; BUNDLES; MECHANORECEPTORS; ENHANCEMENT; ADAPTATION; RESPONSES; CHANNELS; CRAYFISH	The organs of the vestibular, auditory and lateral line systems rely on a common strategy for the stimulation of their primary receptors, the hair cells: stimuli induce shear between hair cell epithelia and accessory structures to which hair bundles, the hair cells' mechanosensitive organelles, are attached. The inner hair cells of the cochlea, whose hair bundles are not attached to the overlying tectorial membrane, are a notable exception. Because their hair bundles are not restrained, they undergo significant Brownian motion, a characteristic traditionally thought to blunt the sensitivity of hearing. Contrary to this view, the work reported here indicates that Brownian motion of the hair bundle serves to enhance the sensitivity of mechanoelectrical transduction.	Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Jaramillo, F (corresponding author), Emory Univ, Sch Med, Dept Physiol, 1648 Pierce Dr, Atlanta, GA 30322 USA.	fjaram@physio.emory.edu						ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ATKINS PW, 1978, PHYSICAL CHEM; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; COREY DP, 1983, J NEUROSCI, V3, P962; DALLOS P, 1985, J NEUROSCI, V5, P1591; DALLOS P, 1972, SCIENCE, V177, P356, DOI 10.1126/science.177.4046.356; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; DEVRIES HL, 1948, PHYSICA, V14, P48, DOI 10.1016/0031-8914(48)90060-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS GG, 1968, J ACOUST SOC AM, V44, P176, DOI 10.1121/1.1911052; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1986, HEARING RES, V23, P93, DOI 10.1016/0378-5955(86)90178-4; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; LINDEMAN HH, 1972, ACTA OTOLARYNGOL, V72, P229; MCNAMARA B, 1989, PHYS REV A, V39, P4854, DOI 10.1103/PhysRevA.39.4854; Narins PM, 1997, AUDIT NEUROSCI, V3, P389; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V250, P217, DOI 10.1098/rspb.1992.0152; RUSSELL IJ, 1986, NATURE, V321, P517, DOI 10.1038/321517a0; SVRCEKSEILER WA, IN PRESS J THEOR BIO	27	157	158	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					384	388		10.1038/1597	http://dx.doi.org/10.1038/1597			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196528				2022-12-24	WOS:000076361400016
J	Xu, T; Binz, T; Niemann, H; Neher, E				Xu, T; Binz, T; Niemann, H; Neher, E			Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity	NATURE NEUROSCIENCE			English	Article							ADRENAL CHROMAFFIN CELLS; READILY RELEASABLE POOL; MEMBRANE-FUSION COMPLEX; PROTEIN-KINASE-C; TETANUS TOXIN; NEUROTRANSMITTER RELEASE; CLOSTRIDIAL NEUROTOXINS; CA2+-ACTIVATED SECRETION; CATECHOLAMINE RELEASE; BOTULINUM NEUROTOXINS	The secretion of synaptic and other vesicles is a complex process involving multiple steps. Many molecular components of the secretory apparatus have been identified, but how they relate to the different stages of vesicle release is not clear. We examined this issue in adrenal chromaffin cells, where capacitance measurements and amperometry allow us to measure vesicle fusion and hormone release simultaneously. Using flash photolysis of caged intracellular calcium to induce exocytosis, we observed three distinct kinetic components to vesicle fusion, of which only two are related to catecholamine release. Intracellular dialysis with botulinum neurotoxin E, D or C1 or tetanus-toxin light chains abolishes the catecholamine-related components, but leaves the third component untouched. Botulinum neurotoxin A, which removes nine amino acids from the carboxy(C)-terminal end of SNAP-25, does not eliminate catecholamine release completely, but slows down both catecholamine-related components. Thus we assign a dual role to SNAP-25 and suggest that its nine C-terminal amino acids are directly involved in coupling the calcium sensor to the final step in exocytosis.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Med Hsch Hannover, Dept Biochem, D-30625 Hannover, Germany	Max Planck Society; Hannover Medical School	Xu, T (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Fassberg 11, D-37077 Gottingen, Germany.		Neher, Erwin/A-2109-2013					Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; BINZ T, 1994, J BIOL CHEM, V269, P1617; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BITTNER MA, 1993, CELL MOL NEUROBIOL, V13, P649, DOI 10.1007/BF00711564; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Capogna M, 1997, J NEUROSCI, V17, P7190; Colombo MI, 1996, J BIOL CHEM, V271, P18810, DOI 10.1074/jbc.271.31.18810; DREYER F, 1987, N-S ARCH PHARMACOL, V335, P1, DOI 10.1007/BF00165027; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; FORAN P, 1995, BIOCHEMISTRY-US, V34, P5494, DOI 10.1021/bi00016a021; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gillis Kevin D., 1995, P155; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HohneZell B, 1996, FEBS LETT, V394, P109, DOI 10.1016/0014-5793(96)00931-3; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Lawrence GW, 1997, BIOCHEMISTRY-US, V36, P3061, DOI 10.1021/bi9622478; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; MCMAHON HT, 1992, J BIOL CHEM, V267, P21338; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Moser T, 1997, J NEUROSCI, V17, P2314; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; OTTO H, 1995, BIOCHEM BIOPH RES CO, V212, P945, DOI 10.1006/bbrc.1995.2061; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Poulain B, 1996, NEUROSCIENCE, V70, P567, DOI 10.1016/0306-4522(95)00336-3; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Weimbs T, 1997, TRENDS CELL BIOL, V7, P393, DOI 10.1016/S0962-8924(97)01130-6; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3	50	284	292	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					192	200		10.1038/642	http://dx.doi.org/10.1038/642			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195143	Green Published			2022-12-24	WOS:000076361200009
J	Egger, V; Feldmeyer, D; Sakmann, B				Egger, V; Feldmeyer, D; Sakmann, B			Coincidence detection and changes of synaptic efficacy in spiny stellate neurons in vat barrel cortex	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE RECEPTORS; VISUAL-CORTEX; ACTION-POTENTIALS; CALCIUM CURRENTS; AREA CA1; HIPPOCAMPUS; INDUCTION; PLASTICITY; LTD	Paired whole-cell voltage recordings were made from synaptically connected spiny stellate neurons in layer 4 of the barrel field in young (P14) rat somatosensory cortex. When postsynaptic action potentials (APs) followed each of 5 presynaptic APs in a 10- or 20-Hz train by less than 25 ms, subsequent unitary EPSP amplitudes were persistently reduced. Induction of long-term depression (LTD) depended on activation of group II metabotropic glutamate receptors, but not on NMDA or AMPA receptors. Reducing postsynaptic increases in intracellular calcium ([Ca2+](i)) by intracellular loading with a fast- (BAPTA) or a slow- (EGTA) acting Ca2+ buffer blocked synaptic depression. Analysis of EPSP failures suggested mediation of LTD by a reduction in release probability. We propose a mechanism by which coincident activity results in long-lasting reduction of synaptic efficacy between synaptically connected neurons.	Max Planck Inst Med Forsch, Abt Zellphysiol, D-69120 Heidelberg, Germany	Max Planck Society	Feldmeyer, D (corresponding author), Max Planck Inst Med Forsch, Abt Zellphysiol, Jahnstr 29, D-69120 Heidelberg, Germany.		Feldmeyer, Dirk/H-5940-2013	Feldmeyer, Dirk/0000-0002-1716-8972				AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; Bear MF, 1996, J PHYSIOL-PARIS, V90, P223, DOI 10.1016/S0928-4257(97)81428-3; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bevington PR, 1969, DATA REDUCTION ERROR; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BROCHER S, 1992, P NATL ACAD SCI USA, V89, P123, DOI 10.1073/pnas.89.1.123; Choi SK, 1997, J NEUROSCI, V17, P8613; CHRISTIE BR, 1997, NEUROPHYSIOLOGY, V225, P189; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Domenici MR, 1998, P NATL ACAD SCI USA, V95, P8310, DOI 10.1073/pnas.95.14.8310; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dudek SM, 1996, NEURON, V16, P1097, DOI 10.1016/S0896-6273(00)80136-1; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Hebb Donald O., 1949, ORG BEHAV; Huang LQ, 1999, NEUROPHARMACOLOGY, V38, P73, DOI 10.1016/S0028-3908(98)00168-3; JANE DE, 1994, BRIT J PHARMACOL, V112, P809; Jane DE, 1996, NEUROPHARMACOLOGY, V35, P1029, DOI 10.1016/S0028-3908(96)00048-2; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; LUND JS, 1984, CEREB CORTEX, V1, P255; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; ROTHE T, 1994, PFLUG ARCH EUR J PHY, V426, P161, DOI 10.1007/BF00374684; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; Snedecor GW, 1980, STAT METHODS, V7th; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STAUBLI U, 1990, BRAIN RES, V513, P113, DOI 10.1016/0006-8993(90)91096-Y; Stefani A, 1996, MOL NEUROBIOL, V13, P81, DOI 10.1007/BF02740753; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Torii N, 1997, NEUROSCIENCE, V79, P317; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812	50	217	219	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1098	1105		10.1038/16026	http://dx.doi.org/10.1038/16026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570487				2022-12-24	WOS:000085810100014
J	Janz, R; Sudhof, TC; Hammer, RE; Unni, V; Siegelbaum, SA; Bolshakov, VY				Janz, R; Sudhof, TC; Hammer, RE; Unni, V; Siegelbaum, SA; Bolshakov, VY			Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I	NEURON			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; TYROSINE KINASE INHIBITORS; MOSSY FIBER LTP; VESICLE PROTEIN; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; SYNAPSIN-I; SUBUNIT 2B; HIPPOCAMPUS	We have generated mice lacking synaptogyrin I and synaptophysin I to explore the functions of these abundant tyrosine-phosphorylated proteins of synaptic vesicles. Single and double knockout mice were alive and fertile without significant morphological or biochemical changes. Electrophysiological recordings in the hippocampal CA1 region revealed that shortterm and long-term synaptic plasticity were severely reduced in the synaptophysin/synaptogyrin double knockout mice. LTP was decreased independent of the induction protocol, suggesting that the defect in LTP was not caused by insufficient induction. Our data show that synaptogyrin I and synaptophysin I perform redundant and essential functions in synaptic plasticity without being required for neurotransmitter release itself.	Univ Texas, Howard Hughes Med Inst, SW Med Sch, Dallas, TX 75235 USA; Univ Texas, Ctr Basic Neurosci, SW Med Sch, Dallas, TX 75235 USA; Univ Texas, Dept Mol Genet, SW Med Sch, Dallas, TX 75235 USA; Univ Texas, Dept Biochem, SW Med Sch, Dallas, TX 75235 USA; Columbia Univ, Ctr Neurobiol & Behav, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, Dept Pharmacol, New York, NY 10032 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Columbia University; Howard Hughes Medical Institute; Columbia University	Sudhof, TC (corresponding author), Univ Texas, Howard Hughes Med Inst, SW Med Sch, Dallas, TX 75235 USA.			Janz, Roger/0000-0002-9872-0596; Hammer, Robert E./0000-0001-5487-7551				ABE K, 1993, BRAIN RES, V621, P167, DOI 10.1016/0006-8993(93)90315-E; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; BARNEKOW A, 1990, ONCOGENE, V5, P1019; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; FYKSE EM, 1993, J NEUROSCI, V13, P4997; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Haass NK, 1996, J CELL BIOL, V134, P731, DOI 10.1083/jcb.134.3.731; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kedra D, 1998, HUM GENET, V103, P131, DOI 10.1007/s004390050795; KNAUS P, 1990, NEURON, V5, P453, DOI 10.1016/0896-6273(90)90084-S; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINSTEDT AD, 1992, J CELL BIOL, V117, P1077, DOI 10.1083/jcb.117.5.1077; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; LUPICA CR, 1992, J NEUROSCI, V12, P3753; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; MARQUEZE-POUEY B, 1991, J NEUROSCI, V11, P3388; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Sambrook J., 2002, MOL CLONING LAB MANU; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stenius K, 1995, J CELL BIOL, V131, P1801, DOI 10.1083/jcb.131.6.1801; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; Sugita S, 1999, J BIOL CHEM, V274, P18893, DOI 10.1074/jbc.274.27.18893; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	60	252	264	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					687	700		10.1016/S0896-6273(00)81122-8	http://dx.doi.org/10.1016/S0896-6273(00)81122-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595519	Bronze			2022-12-24	WOS:000083913000023
J	Kay, LM; Laurent, G				Kay, LM; Laurent, G			Odor- and context-dependent modulation of mitral cell activity in behaving rats	NATURE NEUROSCIENCE			English	Article							RABBIT OLFACTORY-BULB; TUFTED CELLS; HORSERADISH-PEROXIDASE; UNIT-ACTIVITY; CONNECTIONS; RESPONSES; MOLECULES; SYSTEM; DISCRIMINATION; HIPPOCAMPUS	The projections and odor responses of mammalian olfactory receptor neurons, as well as the physiology of the bulb's principal neurons-the mitral cells (MCs)-are known from studies in slices and anesthetized animals. In behaving rats trained to discriminate between two odors associated with different reinforcers, we examined MC responses following alternated odor-reinforcer pairings. Whereas only 11% of the recorded MCs showed changes in odor-selective firing rate during the odor-sampling phase, 94% of MCs modulated activity during specific behaviors surrounding odor sampling. These cell- and odor-selective responses were not primary sensory responses; rather, they depended (reversibly) on the predictive value of each odor. MC activity thus depends critically on efferent influences linked to the animal's experience and behavior.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.		Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Kay, Leslie/0000-0003-3049-477X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NCRR NIH HHS [P41-RR09754] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUONVISO N, 1990, J NEUROPHYSIOL, V63, P447, DOI 10.1152/jn.1990.63.3.447; CARMICHAEL ST, 1994, J COMP NEUROL, V346, P403, DOI 10.1002/cne.903460306; CHAPUT MA, 1985, PHYSIOL BEHAV, V34, P249, DOI 10.1016/0031-9384(85)90113-1; DARLING FMC, 1994, PHYSIOL BEHAV, V55, P817, DOI 10.1016/0031-9384(94)90065-5; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; DIPRISCO GV, 1985, BEHAV NEUROSCI, V99, P964; FREEMAN WJ, 1983, J COMP PSYCHOL, V97, P12, DOI 10.1037/0735-7036.97.1.12; GRAY CM, 1988, EXP BRAIN RES, V73, P189, DOI 10.1007/BF00279672; GRAY CM, 1988, EXP BRAIN RES, V69, P378; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Jansen HT, 1998, BRAIN RES BULL, V45, P27, DOI 10.1016/S0361-9230(97)00279-7; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; Kay LM, 1996, INT J NEURAL SYST, V7, P489, DOI 10.1142/S0129065796000476; KLINGBERG F, 1965, ACTA BIOL MED GER, V14, P593; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; MILLER SD, 1966, PHYSIOL BEHAV, V1, P145, DOI 10.1016/0031-9384(66)90059-X; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Motokizawa F, 1996, EXP BRAIN RES, V112, P24; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; PAGER J, 1983, BRAIN RES, V289, P87, DOI 10.1016/0006-8993(83)90009-4; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; RHINEHARTDOTY JA, 1994, CHEM SENSES, V19, P425, DOI 10.1093/chemse/19.5.425; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	35	269	273	2	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					1003	1009		10.1038/14801	http://dx.doi.org/10.1038/14801			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526340				2022-12-24	WOS:000083883300018
J	Leon, MI; Shadlen, MN				Leon, MI; Shadlen, MN			Effect of expected reward magnitude on the response of neurons in the dorsolateral prefrontal cortex of the macaque	NEURON			English	Article							FRONTAL EYE FIELDS; RHESUS-MONKEY; DOPAMINERGIC INNERVATION; UNIT-ACTIVITY; PRIMATE; BEHAVIOR; TASK; EXPECTATION; PROJECTIONS; ANTAGONISTS	The dorsolateral prefrontal cortex plays a critical role in guiding actions that ensue seconds after an instruction. We recorded from neurons in area 46 and the frontal eye field (FEF) while monkeys performed a memory-guided eye movement task. A visual cue signaled whether a small or large liquid reward would accompany a correct response. Many neurons in area 46 responded more when the monkey expected a larger reward. Reward-related enhancement was evident throughout the memory period and was most pronounced when the remembered target appeared in the neuron's response field. Enhancement was not present in the FEF. The mixture of neural signals representing spatial working memory and reward expectation appears to be a distinct feature of area 46.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.		Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210	NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline; NINDS NIH HHS [5T32NS07395] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007395] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; BERGER B, 1991, TRENDS NEUROSCI, V14, P21, DOI 10.1016/0166-2236(91)90179-X; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Draper NR., 1998, APPL REGRESSION ANAL, DOI [10.1002/9781118625590, DOI 10.1002/9781118625590]; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J.M., 1989, PREFRONTAL CORTEX; Fuster JM, 1995, MEMORY CEREBRAL CORT; FUSTER JM, 1985, CEREB CORTEX, P151; GAFFAN D, 1990, J NEUROSCI, V10, P3479; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; GOLDMANRAKIC PS, 1987, HDB PHYSL NERVOUS SY, P373; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; HIKOSAKA O, 1989, NEUROBIOLOGY SACCADI, P257; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; ILINSKY IA, 1985, J COMP NEUROL, V236, P315, DOI 10.1002/cne.902360304; INOUE M, 1985, BRAIN RES, V326, P307, DOI 10.1016/0006-8993(85)90040-X; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Jacobsen CF, 1935, ARCH NEURO PSYCHIATR, V33, P558, DOI 10.1001/archneurpsyc.1935.02250150108009; JACOBSON S, 1975, BRAIN RES, V100, P132, DOI 10.1016/0006-8993(75)90248-6; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAMURA K, 1984, Neuroscience Research, V1, P89, DOI 10.1016/S0168-0102(84)80007-3; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; Leon MI, 1998, J EXP PSYCHOL ANIM B, V24, P265, DOI 10.1037/0097-7403.24.3.265; Levy R, 1999, J NEUROSCI, V19, P5149; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; PANDYA DN, 1971, BRAIN RES, V31, P35, DOI 10.1016/0006-8993(71)90632-9; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rainer G, 1999, J NEUROSCI, V19, P5493; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; ROBERTSON A, 1989, NEUROSCI BIOBEHAV R, V13, P163, DOI 10.1016/S0149-7634(89)80026-0; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Rosner B., 2011, FUNDAMENTALS BIOSTAT; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; WATANABE M, 1992, EXP BRAIN RES, V89, P233; WATANABE M, 1990, EXP BRAIN RES, V80, P296; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199	55	350	354	1	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					415	425		10.1016/S0896-6273(00)80854-5	http://dx.doi.org/10.1016/S0896-6273(00)80854-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	251BA	10571234	Bronze			2022-12-24	WOS:000083423700015
J	Ahn, S; Ginty, DD; Linden, DJ				Ahn, S; Ginty, DD; Linden, DJ			A late phase of cerebellar long-term depression requires activation of CaMKIV and CREB	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; ELEMENT-BINDING PROTEIN; CAMP-RESPONSIVE ELEMENT; DEVELOPING RAT-BRAIN; GENE-EXPRESSION; CA2+/CALMODULIN KINASE; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; PURKINJE-CELLS; MUTANT MICE	Recently, it has been shown that cerebellar LTD has a late phase that may be blocked by protein synthesis inhibitors. To understand the mechanisms underlying the late phase, we interfered with the activation of transcription factors that might couple synaptic activation to protein synthesis. Particle-mediated transfection of cultured Purkinje neurons with an expression vector encoding a dominant inhibitory form of CREB resulted in a nearly complete blockade of the late phase. Kinases that activate CREB were inhibited, and LTD was assessed. Inhibition of PKA or the MAPK/RSK cascades were without effect on the late phase, while constructs designed to interfere with CaMKIV function attenuated the late phase. These results indicate that the activation of CaMKIV and ORES are necessary to establish a late phase of cerebellar LTD.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.				NIMH NIH HHS [MH01590, MH51106] Funding Source: Medline; NINDS NIH HHS [NS34815] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R29MH051106, R01MH051106] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham W.C., 1991, KINDLING SYNAPTIC PL, P92; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAY RN, 1989, J BIOL CHEM, V264, P431; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; ENYEART JJ, 1987, AM J PHYSIOL, V253, pC162, DOI 10.1152/ajpcell.1987.253.1.C162; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GINTY DD, 1991, J BIOL CHEM, V266, P15325; Ginty DD, 1997, NEURON, V18, P183, DOI 10.1016/S0896-6273(00)80258-5; GLASS DB, 1989, J BIOL CHEM, V264, P8802; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Heist EK, 1998, CELL CALCIUM, V23, P103; Ho N, 1996, J EXP MED, V184, P101, DOI 10.1084/jem.184.1.101; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Huang Y Y, 1994, Learn Mem, V1, P74; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; KURINO M, 1995, J NEUROCHEM, V65, P1282; Lamprecht R, 1997, J NEUROSCI, V17, P8443; LI GD, 1992, MOL PHARMACOL, V42, P489; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Matthies H, 1990, Adv Exp Med Biol, V268, P359; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Narasimhan K, 1998, J NEUROPHYSIOL, V80, P2963, DOI 10.1152/jn.1998.80.6.2963; Narasimhan K, 1996, NEURON, V17, P333, DOI 10.1016/S0896-6273(00)80164-6; NGHIEM P, 1994, NATURE, V371, P347, DOI 10.1038/371347a0; Peavy RD, 1998, J NEUROCHEM, V71, P603; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; SAKAGAMI H, 1993, MOL BRAIN RES, V20, P51, DOI 10.1016/0169-328X(93)90109-3; SAKAGAMI H, 1992, MOL BRAIN RES, V16, P20, DOI 10.1016/0169-328X(92)90189-I; SAKAGAMI H, 1993, MOL BRAIN RES, V19, P215, DOI 10.1016/0169-328X(93)90029-O; Sawamura Y, 1996, BRAIN RES, V706, P259, DOI 10.1016/0006-8993(95)01161-7; SEGER R, 1994, J BIOL CHEM, V269, P25699; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SIRHA TS, 1995, NEUROPHARMACOLOGY, V34, P731; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vincent SR, 1998, SYNAPSE, V29, P29, DOI 10.1002/(SICI)1098-2396(199805)29:1<29::AID-SYN3>3.3.CO;2-T; WALAAS SI, 1988, MOL BRAIN RES, V4, P233, DOI 10.1016/0169-328X(88)90029-0; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	76	144	147	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					559	568		10.1016/S0896-6273(00)80808-9	http://dx.doi.org/10.1016/S0896-6273(00)80808-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433267	hybrid			2022-12-24	WOS:000081701000019
J	Bourinet, E; Soong, TW; Sutton, K; Slaymaker, S; Mathews, E; Monteil, A; Zamponi, GW; Nargeot, J; Snutch, TP				Bourinet, E; Soong, TW; Sutton, K; Slaymaker, S; Mathews, E; Monteil, A; Zamponi, GW; Nargeot, J; Snutch, TP			Splicing of alpha(1A) subunit gene generates phenotypic variants of P- and Q-type calcium channels	NATURE NEUROSCIENCE			English	Article							OMEGA-AGA-IVA; CA2+ CHANNELS; MOLECULAR DETERMINANTS; FUNCTIONAL EXPRESSION; SYNAPTIC TRANSMISSION; GATING MODIFIER; SCORPION TOXIN; K+ CHANNELS; NEURONS; ACTIVATION	P-type and Q-type calcium channels mediate neurotransmitter release at many synapses in the mammalian nervous system. The or,, calcium channel has been implicated in the etiologies of conditions such as episodic ataxia, epilepsy and familial migraine, and shares several properties with native P- and Q-type channels. However, the exact relationship between alpha(1A) and P- and Q-type channels is unknown. Here we report that alternative splicing of the alpha(1A) subunit gene results in channels with distinct kinetic, pharmacological and modulatory properties. Overall, the results indicate that alternative splicing of the alpha(1A) gene generates P-type and Q-type channels as well as multiple phenotypic variants.	Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1W5, Canada; CNRS, UPR 1142, IGH, Montpellier, France; Univ Calgary, Dept Pharmacol, Calgary, AB, Canada	University of British Columbia; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Calgary	Snutch, TP (corresponding author), Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1W5, Canada.		Snutch, Terrance P/L-3464-2019; Monteil, Arnaud/G-3113-2012	Snutch, Terrance P/0000-0001-5182-1296; Monteil, Arnaud/0000-0003-1632-7318; Zamponi, Gerald W./0000-0002-0644-9066; Soong, Tuck Wah/0000-0002-0876-0325; Nargeot, Joel/0000-0003-2893-5636; bourinet, emmanuel/0000-0001-8021-0419				BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Berrow NS, 1997, EUR J NEUROSCI, V9, P739, DOI 10.1111/j.1460-9568.1997.tb01422.x; Bourinet E, 1996, J NEUROSCI, V16, P4983; Brody DL, 1997, J PHYSIOL-LONDON, V499, P637, DOI 10.1113/jphysiol.1997.sp021956; BULLER AL, 1990, J MEMBRANE BIOL, V115, P179, DOI 10.1007/BF01869456; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Herlitze S, 1997, P NATL ACAD SCI USA, V94, P1512, DOI 10.1073/pnas.94.4.1512; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Lee JH, 1999, J NEUROSCI, V19, P1912; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Ligon B, 1998, J BIOL CHEM, V273, P13905, DOI 10.1074/jbc.273.22.13905; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MCCLESKEY EW, 1991, CURR TOP MEMBR, V39, P295; McDonough SI, 1997, BIOPHYS J, V72, P2117, DOI 10.1016/S0006-3495(97)78854-4; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PRAGNELL M, 1994, NATURE, V368, P68; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; STEA A, 1995, NEURON, V15, P929, DOI 10.1016/0896-6273(95)90183-3; STEA A, 1995, HDB RECEPTORS CHANNE, P113; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TANAKA I, 1990, J VAC SCI TECHNOL A, V8, P567, DOI 10.1116/1.576389; Tottene A, 1996, J NEUROSCI, V16, P6353; TURNER TJ, 1992, SCIENCE, V258, P310, DOI 10.1126/science.1357749; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YU ASL, 1992, P NATL ACAD SCI USA, V89, P10494, DOI 10.1073/pnas.89.21.10494; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	50	337	355	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					407	415		10.1038/8070	http://dx.doi.org/10.1038/8070			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321243				2022-12-24	WOS:000084609400009
J	Choi-Lundberg, D; Rosenthal, A				Choi-Lundberg, D; Rosenthal, A			Autotransplantation for Parkinson's disease goes a step further	NEURON			English	Article							2 PARTS; TRANSPLANTATION; RECOVERY; THERAPY		Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Choi-Lundberg, D (corresponding author), Genentech Inc, Dept Neurosci, 1 DNA Way, S San Francisco, CA 94080 USA.		Choi-Lundberg, Derek L/J-7670-2014	Choi-Lundberg, Derek L/0000-0002-3594-8585				BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034; Espejo EF, 1998, NEURON, V20, P197, DOI 10.1016/S0896-6273(00)80449-3; FIDONE SJ, 1987, ENCY NEUROSCIENCE, P189; Gage FH, 1998, NATURE, V392, P18; HONDA Y, 1992, J APPL PHYSIOL, V73, P1; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Luquin MR, 1999, NEURON, V22, P743, DOI 10.1016/S0896-6273(00)80733-3; Nosrat CA, 1996, CELL TISSUE RES, V286, P191, DOI 10.1007/s004410050688; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; Rosenthal A, 1998, NEURON, V20, P169, DOI 10.1016/S0896-6273(00)80445-6	11	3	3	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					635	636		10.1016/S0896-6273(00)80717-5	http://dx.doi.org/10.1016/S0896-6273(00)80717-5			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230778	Bronze			2022-12-24	WOS:000079976200001
J	Kammermeier, PJ; Ikeda, SR				Kammermeier, PJ; Ikeda, SR			Expression of RGS2 alters the coupling of metabotropic glutamate receptor 1a to M-type K+ and N-type Ca2+ channels	NEURON			English	Article							RAT SYMPATHETIC NEURONS; PUTATIVE PHEROMONE RECEPTORS; GTPASE-ACTIVATING PROTEINS; G-BETA-GAMMA; SIGNAL-TRANSDUCTION; CALCIUM CHANNELS; HIPPOCAMPAL-NEURONS; PERTUSSIS TOXIN; ALPHA-SUBUNITS; ION CHANNELS	Group I mGluRs heterologously expressed in sympathetic neurons inhibited calcium (I-Ca) and M-type potassium (I-M) currents. Treatment with pertussis toxin (PTX) revealed a voltage-dependent (VD), PTX-sensitive component of I-Ca inhibition and a voltage-independent (VI), PTX-insensitive component. Coexpression of RGS2 occluded mGluR1a inhibition of I-M and made I-Ca inhibition VD in PTX-treated cells, presumably by blocking the effects of G alpha(q/11)-GTP. These data indicate that mGluR1a can couple to G(i/o) as well as G(q/11). In addition, VI I-Ca inhibition proceeds through a G alpha(q/11)-GTP-mediated pathway, which can be occluded by expressing RGS2, leaving the VD, G beta gamma-mediated inhibition active. These data may reveal a functional role for the upregulation of RGS2 expression in in vivo systems.	Guthrie Res Inst, Lab Molec Physiol, Sayre, PA 18840 USA		Ikeda, SR (corresponding author), Guthrie Res Inst, Lab Molec Physiol, Sayre, PA 18840 USA.	sikeda@inet.guthrie.org		Ikeda, Stephen/0000-0002-4088-9508				ABE T, 1992, J BIOL CHEM, V267, P13361; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; BEECH DJ, 1992, NEURON, V8, P97, DOI 10.1016/0896-6273(92)90111-P; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Burchett SA, 1998, J NEUROCHEM, V70, P2216; CHARPAK S, 1990, NATURE, V347, P765, DOI 10.1038/347765a0; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Choi S, 1996, J NEUROSCI, V16, P36; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; Delmas P, 1998, EUR J NEUROSCI, V10, P1654, DOI 10.1046/j.1460-9568.1998.00170.x; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Filippov AK, 1998, J NEUROSCI, V18, P5170, DOI 10.1523/JNEUROSCI.18-14-05170.1998; Haley JE, 1998, J NEUROSCI, V18, P4521; HAY M, 1994, J NEUROPHYSIOL, V72, P421, DOI 10.1152/jn.1994.72.1.421; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Ikeda S R, 1997, Methods Mol Biol, V83, P191; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1995, NEURON, V14, P1029, DOI 10.1016/0896-6273(95)90341-0; INGL T, 1998, J NEUROSCI, V18, P7178; Jeong SW, 1998, NEURON, V21, P1201, DOI 10.1016/S0896-6273(00)80636-4; JOLY C, 1995, J NEUROSCI, V15, P3970; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; LESTER RAJ, 1990, NEURON, V4, P741, DOI 10.1016/0896-6273(90)90200-Y; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McCool BA, 1998, J NEUROPHYSIOL, V79, P379, DOI 10.1152/jn.1998.79.1.379; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Paulssen RH, 1996, J BIOL CHEM, V271, P26622, DOI 10.1074/jbc.271.43.26622; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; PLUMMER MR, 1991, J NEUROSCI, V11, P2339; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Saugstad JA, 1998, J NEUROSCI, V18, P905; SCHOFIELD GG, 1991, EUR J PHARM-MOLEC PH, V207, P195, DOI 10.1016/0922-4106(91)90031-C; SCHOFIELD GG, 1990, EUR J PHARMACOL, V180, P37, DOI 10.1016/0014-2999(90)90590-3; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; SIDEROVSKI DP, 1994, DNA CELL BIOL, V13, P125, DOI 10.1089/dna.1994.13.125; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; Toby G, 1998, BIOTECHNIQUES, V24, P637, DOI 10.2144/98244st05; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WITTINGHOFER A, 1994, CELL, V76, P201, DOI 10.1016/0092-8674(94)90327-1; WOMBLE MD, 1994, SYNAPSE, V17, P69, DOI 10.1002/syn.890170202; WU DQ, 1993, J BIOL CHEM, V268, P3704; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; ZHU Y, 1994, NEURON, V13, P657, DOI 10.1016/0896-6273(94)90033-7	58	103	106	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					819	829		10.1016/S0896-6273(00)80740-0	http://dx.doi.org/10.1016/S0896-6273(00)80740-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230801	Bronze			2022-12-24	WOS:000079976200024
J	Shou, J; Rim, PC; Calof, AL				Shou, J; Rim, PC; Calof, AL			BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor	NATURE NEUROSCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; MOUSE OLFACTORY EPITHELIUM; ACHAETE-SCUTE HOMOLOG-1; TGF-BETA SUPERFAMILY; NEURAL CREST CELLS; NEURONAL DIFFERENTIATION; IN-VITRO; OSTEOGENIC PROTEIN-1; PROGENITOR CELLS	Bone morphogenetic proteins (BMPs), negative regulators of neural determination in the early embryo, were found to be potent inhibitors of neurogenesis in olfactory epithelium (OE) cultures. BMPs 2, 4 or 7 decreased the number of proliferating progenitor cells and blocked production of olfactory receptor neurons (ORNs). Experiments suggested that this effect was due to an action of BMPs on an early-stage progenitor in the ORN lineage. Further analysis revealed that progenitors exposed to BMPs rapidly (< 2 h) lost MASH1, a transcription factor known to be required for the production of ORNs. This disappearance was due to proteolysis of existing MASH1 protein, but new gene expression was required to trigger it. The data suggest a novel mechanism of BMP action, whereby the induced degradation of an essential transcription factor results in premature termination of a neuronal lineage.	Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Ctr Dev Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Calof, AL (corresponding author), Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, 364 Med Surge 2, Irvine, CA 92697 USA.	alcalof@uci.edu	Calof, Anne/A-8644-2013	Calof, Anne/0000-0003-3676-2499; Shou, Jianyong/0000-0002-3752-7215	NIDCD NIH HHS [DC03583] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003583] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Arkell R, 1997, DEVELOPMENT, V124, P1; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Calof AL, 1998, J NEUROBIOL, V36, P190, DOI 10.1002/(SICI)1097-4695(199808)36:2<190::AID-NEU7>3.0.CO;2-X; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Calof AL, 1998, ANN NY ACAD SCI, V855, P226, DOI 10.1111/j.1749-6632.1998.tb10571.x; CALOF AL, 1999, IBRO HB S M, V18, P23; Cau E, 1997, DEVELOPMENT, V124, P1611; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CLARK MS, 1995, J NEUROSCI, V15, P6167; DEHAMER MK, 1994, NEURON, V13, P1083, DOI 10.1016/0896-6273(94)90047-7; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Furuta Y, 1997, DEVELOPMENT, V124, P2203; GORDON MK, 1995, MOL CELL NEUROSCI, V6, P363, DOI 10.1006/mcne.1995.1028; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; HELDER MN, 1995, J HISTOCHEM CYTOCHEM, V43, P1035, DOI 10.1177/43.10.7560881; HOLCOMB JD, 1995, DEV BIOL, V172, P307, DOI 10.1006/dbio.1995.0025; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KIM S, 1987, J CELL BIOL, V104, P51, DOI 10.1083/jcb.104.1.51; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEVEY MS, 1991, J NEUROSCI, V11, P3556; Li WW, 1998, J NEUROSCI, V18, P8853; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; MAGAE J, ONCOGENE; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Mumm JS, 1996, P NATL ACAD SCI USA, V93, P11167, DOI 10.1073/pnas.93.20.11167; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Strom A, 1997, GENE DEV, V11, P3168, DOI 10.1101/gad.11.23.3168; TEMPLE S, 1995, NEURON, V15, P249, DOI 10.1016/0896-6273(95)90030-6; VARLEY JE, 1995, DEV DYNAM, V203, P434, DOI 10.1002/aja.1002030406; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wu DK, 1996, J NEUROSCI, V16, P6454; Zhang DM, 1998, J NEUROSCI, V18, P3314; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	49	122	130	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					339	345		10.1038/7251	http://dx.doi.org/10.1038/7251			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204540	Green Published			2022-12-24	WOS:000080532000012
J	Beck, C; Wollmuth, LP; Seeburg, PH; Sakmann, B; Kuner, T				Beck, C; Wollmuth, LP; Seeburg, PH; Sakmann, B; Kuner, T			NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR CHANNEL; GLUTAMATE-RECEPTOR; BINDING-SITE; M2 SEGMENT; N-GLYCOSYLATION; ALPHA-SUBUNIT; TOPOLOGY; CALCIUM; DESENSITIZATION; IDENTIFICATION	In NMDA receptor channels, the M2 loop forms the narrow constriction and the cytoplasmic vestibule. The identity of an extracellular vestibule leading toward the constriction remained unresolved. Using the substituted cysteine accessibility method (SCAM), we identified channel-lining residues of the NR1 subunit in the region preceding M1 (preM1), the C-terminal part of M3 (M3(C)), and the N-terminal part of M4 (M4,). These residues are located on the extracellular side of the constriction and, with one exception, are exposed to the pore independently of channel activation, suggesting that the gate is at the constriction or further cytoplasmic to it. Permeation of Ca2+ ions was decreased by mutations in M3(C) and M4(N), but not by mutations in preM1, suggesting a functionally distinct contribution of the segments to the extracellular vestibule of the NMDA receptor channel.	Max Planck Inst Med Res, Abt Mol Neurobiol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society	Kuner, T (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	kuner@neuro.duke.edu						AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; FERRERMONTIEL AV, 1995, P NATL ACAD SCI USA, V92, P8021, DOI 10.1073/pnas.92.17.8021; GASIC GP, 1992, ANNU REV PHYSIOL, V54, P507, DOI 10.1146/annurev.physiol.54.1.507; Hille B., 1992, IONIC CHANNELS EXCIT, V2; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; HOLLMANN M, 1996, IONOTROPIC GLUTAMATE; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kashiwagi K, 1997, MOL PHARMACOL, V52, P701, DOI 10.1124/mol.52.4.701; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuner T, 1996, J NEUROSCI, V16, P3549; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; Premkumar LS, 1996, NEURON, V16, P869, DOI 10.1016/S0896-6273(00)80107-5; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; SPRENGEL R, 1995, LIGAND VOLTAGE GATED, P213; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; WATKINS JC, 1984, TRENDS PHARMACOL SCI, V5, P373, DOI 10.1016/0165-6147(84)90474-7; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; ZAREI MM, 1995, J NEUROSCI, V15, P1446; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	42	112	115	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					559	570		10.1016/S0896-6273(00)80710-2	http://dx.doi.org/10.1016/S0896-6273(00)80710-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197535	Bronze			2022-12-24	WOS:000079483900019
J	Bates, B; Rios, M; Trumpp, A; Chen, C; Fan, GP; Bishop, JM; Jaenisch, R				Bates, B; Rios, M; Trumpp, A; Chen, C; Fan, GP; Bishop, JM; Jaenisch, R			Neurotrophin-3 is required for proper cerebellar development	NATURE NEUROSCIENCE			English	Article							CELLS; MICE; REVEALS; SYSTEM; GROWTH; GENE; NT-3; BDNF		Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Calif San Francisco, George Williams Hooper Fdn, San Francisco, CA 94143 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California San Francisco	Bates, B (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466				Conover JC, 1997, REV NEUROSCIENCE, V8, P13; EMFORS P, 1994, CELL, V77, P503; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KRUEGER BK, 1995, J NEUROSCI, V15, P3366; LEINGARTNER A, 1994, EUR J NEUROSCI, V6, P1149, DOI 10.1111/j.1460-9568.1994.tb00613.x; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Neveu I, 1996, J CELL BIOL, V133, P631, DOI 10.1083/jcb.133.3.631; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2	14	115	116	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					115	117		10.1038/5669	http://dx.doi.org/10.1038/5669			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195193				2022-12-24	WOS:000078231600008
J	Zhang, B; Koh, YH; Beckstead, RB; Budnik, V; Ganetzky, B; Bellen, HJ				Zhang, B; Koh, YH; Beckstead, RB; Budnik, V; Ganetzky, B; Bellen, HJ			Synaptic vesicle size and number are regulated by a clathrin adaptor protein required for endocytosis	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; COATED VESICLES; ASSEMBLY PROTEIN; TRANSMITTER RELEASE; BOVINE BRAIN; NEUROTRANSMITTER RELEASE; DROSOPHILA-MELANOGASTER; ALPHA-ADAPTIN; F1-20 PROTEIN; BINDING-SITE	Clathrin-mediated endocytosis is thought to involve the activity of the clathrin adaptor protein AP180. However, the role of this protein in endocytosis in vivo remains unknown. Here, we show that a mutation that eliminates an AP180 homolog (LAP) in Drosophila severely impairs the efficiency of synaptic vesicle endocytosis and alters the normal localization of clathrin in nerve terminals. Most importantly, the size of both synaptic vesicles and quanta is significantly increased in lap mutants. These results provide novel insights into the molecular mechanism of endocytosis and reveal a role for AP180 in regulating vesicle size through a clathrin-dependent reassembly process.	Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Div Neurosci,Dept Cell Biol,Program Dev Biol, Houston, TX 77030 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Massachusetts, Dept Biol, Amherst, MA 01009 USA	Baylor College of Medicine; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst	Zhang, B (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Div Neurosci,Dept Cell Biol,Program Dev Biol, Houston, TX 77030 USA.			Bellen, Hugo/0000-0001-5992-5989				AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; Artalejo CR, 1998, CURR BIOL, V8, pR62, DOI 10.1016/S0960-9822(98)70036-3; BAZINET C, 1993, GENETICS, V134, P1119; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CECCARELLI B, 1979, J CELL BIOL, V81, P178, DOI 10.1083/jcb.81.1.178; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Estes PS, 1996, J NEUROSCI, V16, P5443; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; IKEDA K, 1976, NATURE, V259, P489, DOI 10.1038/259489a0; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Katz B., 1969, RELEASE NEURAL TRANS; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; KLENE ML, 1987, EMBO J, V6, P2209; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1993, J NEUROSCI, V13, P2313, DOI 10.1523/JNEUROSCI.13-06-02313.1993; KOENIG JH, 1989, J NEUROSCI, V9, P1937; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOHTZ DS, 1988, J BIOL CHEM, V263, P7418; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LINDNER R, 1992, J BIOL CHEM, V267, P16567; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MORRIS SA, 1990, J BIOL CHEM, V265, P3354; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; MURPHY JE, 1991, J BIOL CHEM, V266, P4401; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; ROBINSON MS, 1989, J CELL BIOL, V108, P833, DOI 10.1083/jcb.108.3.833; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; Sambrook J., 2002, MOL CLONING LAB MANU; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; SOUSA R, 1992, J NEUROSCI, V12, P2130; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; TORRITARELLI F, 1987, J NEUROCYTOL, V16, P205, DOI 10.1007/BF01795304; VALTORTA F, 1988, J CELL BIOL, V107, P2717, DOI 10.1083/jcb.107.6.2717; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; YE WL, 1995, J BIOL CHEM, V270, P10933, DOI 10.1074/jbc.270.18.10933; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; ZHOU SB, 1992, J NEUROSCI, V12, P2144	71	333	341	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1465	1475		10.1016/S0896-6273(00)80664-9	http://dx.doi.org/10.1016/S0896-6273(00)80664-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883738	Bronze			2022-12-24	WOS:000077910600027
J	ElShamy, WM; Fridvall, LK; Ernfors, P				ElShamy, WM; Fridvall, LK; Ernfors, P			Growth arrest failure, G1 restriction point override, and S phase death of sensory precursor cells in the absence of neurotrophin-3	NEURON			English	Article							CYCLIN-DEPENDENT KINASES; MYC-INDUCED APOPTOSIS; MOUSE CORTICAL NEUROGENESIS; C-MYC; N-MYC; ORNITHINE DECARBOXYLASE; DIFFERENTIAL EXPRESSION; NUCLEAR-LOCALIZATION; NEUROBLASTOMA-CELLS; TARGET INNERVATION	More than half of the dorsal root ganglion (DRG) neurons are lost by excessive cell death coinciding with precursor proliferation and cell cycle exit in neurotrophin-3 null mutant (NT-3(-/-)) mice. We find that in the absence of NT-3, sensory precursor cells fail to arrest the cell cycle, override the G1 phase restriction point, and die by apoptosis in S phase, which can be prevented in vivo by a cell cycle blocker. Uncoordinated cell cycle reentry is preceded by a failure of nuclear N-myc downregulation and is paralleled by the activation of the full repertoire of G1 and S phase cell cycle proteins required for cell cycle entry. Our results provide evidence for novel activity of neurotrophins in cell cycle control and point toward an N-myc sensitization to cell death in the nervous system that is under the control of NT-3.	Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden	Karolinska Institutet	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Doktorsringen 12A, S-17177 Stockholm, Sweden.	patrik@cajal.mbb.ki.se	ElShamy, Wael/AAF-2867-2019	Ernfors, Patrik/0000-0002-1140-3986				Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Albers KM, 1996, J CELL BIOL, V134, P487, DOI 10.1083/jcb.134.2.487; AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; Carter BD, 1997, NEURON, V18, P187, DOI 10.1016/S0896-6273(00)80259-7; CASACCIA BP, 1996, NATURE, V383, P716; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Coleman A., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P439; DAKSIS JI, 1994, ONCOGENE, V9, P3635; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DEGREGORI J, 1995, GENE DEV, V9, P2873, DOI 10.1101/gad.9.23.2873; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1; ElShamy WM, 1996, DEVELOPMENT, V122, P2405; ElShamy WM, 1997, J NEUROSCI, V17, P8667; EMFORS P, 1994, CELL, V77, P503; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; EVAN GI, 1993, CURR OPIN GENET DEV, V3, P44, DOI 10.1016/S0959-437X(05)80339-9; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; Frade JM, 1996, NATURE, V383, P166; FREYTAG SO, 1990, CELL GROWTH DIFFER, V1, P339; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; Green DR, 1997, SCIENCE, V278, P1246, DOI 10.1126/science.278.5341.1246; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; Guy CT, 1996, MOL CELL BIOL, V16, P685; HARPER JW, 1993, CELL, V75, P805; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; IKADA MA, 1996, P NATL ACAD SCI USA, V93, P3215; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; JOHNSON AF, 1993, ECOSYSTEMS WORLD, V2, P365; Kerr J.F.R., 1987, P93; KERR JFR, 1991, APOPTOSIS MOL BASIS, P5; KLEFSTROM J, 1994, EMBO J, V13, P5442, DOI 10.1002/j.1460-2075.1994.tb06879.x; LAROCCA SA, 1994, ONCOGENE, V9, P3499; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; LEE MJ, 1992, J BIOL CHEM, V267, P21773; Lee TC, 1997, P NATL ACAD SCI USA, V94, P12886, DOI 10.1073/pnas.94.24.12886; Lewin GR, 1996, PHILOS T ROY SOC B, V351, P405, DOI 10.1098/rstb.1996.0035; LEWIN GR, 1996, ANNU REV NEUROSCI, V19, P19; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lukas J, 1996, MOL CELL BIOL, V16, P6917; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Lutz W, 1996, ONCOGENE, V13, P803; MATSUSHIMA H, 1993, MOL CELL BIOL, V13, P7447, DOI 10.1128/MCB.13.12.7447; MEICHLE A, 1992, BIOCHIM BIOPHYS ACTA, V1114, P129, DOI 10.1016/0304-419X(92)90011-M; Ockel M, 1996, DEVELOPMENT, V122, P301; Packham G, 1996, ONCOGENE, V13, P461; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; PENN L, 1990, MOL CELL BIOL, V11, P4177; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; POLUHA W, 1995, ONCOGENE, V10, P185; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; REED SI, 1991, TRENDS GENET, V7, P95, DOI 10.1016/0168-9525(91)90064-W; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; Rudolph B, 1996, EMBO J, V15, P3065, DOI 10.1002/j.1460-2075.1996.tb00669.x; SAWAI S, 1993, DEVELOPMENT, V117, P1445; SAWAI S, 1990, MOL CELL BIOL, V10, P2017, DOI 10.1128/MCB.10.5.2017; SCHWARZ JK, 1995, P NATL ACAD SCI USA, V92, P483, DOI 10.1073/pnas.92.2.483; SLAMON DJ, 1986, SCIENCE, V232, P768, DOI 10.1126/science.3008339; SMITH RK, 1992, MOL CELL BIOL, V12, P1578, DOI 10.1128/MCB.12.4.1578; SoferLevi Y, 1996, ONCOGENE, V13, P2431; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; TAM SW, 1994, ONCOGENE, V9, P2663; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TROY CM, 1990, NEUROSCIENCE, V36, P217, DOI 10.1016/0306-4522(90)90364-A; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; WAGNER AJ, 1993, CELL GROWTH DIFFER, V4, P879; WAKAMATSU Y, 1993, NEURON, V10, P1, DOI 10.1016/0896-6273(93)90236-K; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Wallach D, 1997, NATURE, V388, P123, DOI 10.1038/40516; WANG E, 1985, J CELL BIOL, V110, P1695; ZHANG DM, 1994, J NEUROBIOL, V25, P1517, DOI 10.1002/neu.480251205; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	96	55	55	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1998	21	5					1003	1015		10.1016/S0896-6273(00)80619-4	http://dx.doi.org/10.1016/S0896-6273(00)80619-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856457	Bronze			2022-12-24	WOS:000077386100012
J	Galarreta, M; Hestrin, S				Galarreta, M; Hestrin, S			Frequency-dependent synaptic depression and the balance of excitation and inhibition in the neocortex	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; PYRAMIDAL NEURONS; RELEASE PROBABILITY; STRIATE CORTEX; RAT NEOCORTEX; CELL SYNAPSES; GAIN-CONTROL; INTERNEURONS; TRANSMISSION; CONNECTIONS	The stability of cortical neuron activity in vivo suggests that the firing rates of both excitatory and inhibitory neurons are dynamically adjusted. Using dual recordings from excitatory pyramidal neurons and inhibitory fast-spiking neurons in neocortical slices, we report that sustained activation by trains of several hundred presynaptic spikes resulted in much stronger depression of synaptic currents at excitatory synapses than at inhibitory ones. The steady-state synaptic depression was frequency dependent and reflected presynaptic function. These results suggest that inhibitory terminals of fast-spiking cells are better equipped to support prolonged transmitter release at a high frequency compared with excitatory ones. This difference in frequency-dependent depression could produce a relative increase in the impact of inhibition during periods of high global activity and promote the stability of cortical circuits.	Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Hestrin, S (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA.		Hestrin, Shaul/F-4410-2010					Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ABELES M, 1991, CORTICONICS NEUROL C; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chance FS, 1998, J NEUROSCI, V18, P4785; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Douglas RJ, 1996, J NEUROCYTOL, V25, P893, DOI 10.1007/BF02284849; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Katz B., 1966, NERVE MUSCLE SYNAPSE; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MOSHON JA, 1978, J PHYSIOL-LONDON, V283, P101; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PORTER JT, IN PRESS EUR J NEURO; Pouzat C, 1997, J NEUROSCI, V17, P9104; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tarczy-Hornoch K, 1998, J PHYSIOL-LONDON, V508, P351, DOI 10.1111/j.1469-7793.1998.351bq.x; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; White E.L., 1989, CORTICAL CIRCUITS, DOI [10.1007/978-1-4684-8721-3, DOI 10.1007/978-1-4684-8721-3]; Wu LG, 1998, BIOPHYS J, V74, P3003, DOI 10.1016/S0006-3495(98)78007-5; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	50	329	337	2	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					587	594		10.1038/2822	http://dx.doi.org/10.1038/2822			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196566				2022-12-24	WOS:000077437100014
J	Rubin, BD; Katz, LC				Rubin, BD; Katz, LC			Optical imaging of odorant representations in the mammalian olfactory bulb	NEURON			English	Article							OSCILLATING NEURAL ASSEMBLIES; RECEPTOR GENE-EXPRESSION; PROPIONIC-ACID VAPOR; MITRAL TUFTED CELLS; FUNCTIONAL-ORGANIZATION; VISUAL-CORTEX; 2-DEOXYGLUCOSE UPTAKE; INTRINSIC SIGNALS; NEURONAL-ACTIVITY; 2-DG UPTAKE	We adapted the technique of intrinsic signal imaging to visualize how odorant concentration and structure are represented spatially in the rat olfactory bulb. Most odorants activated one or more glomeruli in the imaged region of the bulb; these optically imaged responses reflected the excitation of underlying neurons. Odorant-evoked patterns were similar across animals and symmetrical in the two bulbs of the same animal. The variable sensitivity of individual glomeruli produced distinct maps for different odorant concentrations. Using a series of homologous aldehydes, we found that glomeruli were tuned to detect particular molecular features and that maps of similar molecules were highly correlated. These characteristics suggest that odorants and their concentrations can be encoded by distinct spatial patterns of glomerular activation.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Rubin, BD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				ADRIAN ED, 1950, BRIT MED BULL, V6, P330, DOI 10.1093/oxfordjournals.bmb.a073625; BELL GA, 1987, BRAIN RES, V426, P8, DOI 10.1016/0006-8993(87)90419-7; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; BRAUN JJ, 1969, PHYSIOL BEHAV, V4, P245; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Chapman B, 1996, J NEUROSCI, V16, P6443; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; COOPERSMITH R, 1984, SCIENCE, V225, P849, DOI 10.1126/science.6474157; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Galizia CG, 1999, CELL TISSUE RES, V295, P383, DOI 10.1007/s004410051245; GESTELAND RC, 1965, J PHYSIOL-LONDON, V181, P525, DOI 10.1113/jphysiol.1965.sp007781; GREER CA, 1982, J NEUROSCI, V2, P1744; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; GUTHRIE KM, 1995, BRAIN RES BULL, V38, P129, DOI 10.1016/0361-9230(95)00078-S; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HOLLEY A, 1991, SMELL TASTE HLTH DIS, P329; HUDSON R, 1987, BRAIN RES, V421, P85, DOI 10.1016/0006-8993(87)91278-9; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; JOURDAN F, 1980, BRAIN RES, V188, P139, DOI 10.1016/0006-8993(80)90563-6; KAITZ M, 1987, DEV PSYCHOBIOL, V20, P587, DOI 10.1002/dev.420200604; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; LEON M, 1992, J NEUROBIOL, V23, P1557, DOI 10.1002/neu.480231012; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; LU XCM, 1994, BRAIN RES, V639, P26, DOI 10.1016/0006-8993(94)91760-4; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Masino SA, 1996, P NATL ACAD SCI USA, V93, P4942, DOI 10.1073/pnas.93.10.4942; MEISAMI E, 1993, DEV BRAIN RES, V71, P253, DOI 10.1016/0165-3806(93)90177-C; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; MORI K, 1995, PROG NEUROBIOL, V46, P1995; OHLOFF G, 1986, EXPERIENTIA, V42, P271, DOI 10.1007/BF01942507; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RISSER JM, 1987, PHYSIOL BEHAV, V40, P545, DOI 10.1016/0031-9384(87)90042-4; SALLAZ M, 1993, NEUROREPORT, V4, P55, DOI 10.1097/00001756-199301000-00014; SATO T, 1994, J NEUROPHYSIOL, V72, P2980, DOI 10.1152/jn.1994.72.6.2980; SCOTT JW, 1993, MICROSC RES TECHNIQ, V24, P142, DOI 10.1002/jemt.1070240206; SHARP FR, 1975, BRAIN RES, V98, P596, DOI 10.1016/0006-8993(75)90377-7; SHARP FR, 1977, J NEUROPHYSIOL, V40, P800, DOI 10.1152/jn.1977.40.4.800; Shepherd G M, 1985, Prog Clin Biol Res, V176, P99; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; SKEEN LC, 1977, BRAIN RES, V124, P147, DOI 10.1016/0006-8993(77)90871-X; Slotnick B.M., 1990, COMP PERCEPT, V1, P155; Slotnick BM, 1997, BRAIN RES, V762, P89, DOI 10.1016/S0006-8993(97)00357-0; SLOTNICK BM, 1989, BRAIN RES, V500, P161, DOI 10.1016/0006-8993(89)90310-7; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vroon P., 1994, SMELL SECRET SEDUCER; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WILSON DA, 1988, J NEUROPHYSIOL, V59, P1770, DOI 10.1152/jn.1988.59.6.1770; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	73	519	525	0	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					499	511		10.1016/S0896-6273(00)80803-X	http://dx.doi.org/10.1016/S0896-6273(00)80803-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433262	Bronze			2022-12-24	WOS:000081701000014
J	Alder, J; Lee, KJ; Jessell, TM; Hatten, ME				Alder, J; Lee, KJ; Jessell, TM; Hatten, ME			Generation of cerebellar granule neurons in vivo by transplantation of BMP-treated neural progenitor cells	NATURE NEUROSCIENCE			English	Article							CREST CELLS; COMMISSURAL INTERNEURONS; PATTERN-FORMATION; PURKINJE-CELLS; MOUSE EMBRYOS; CHICK-EMBRYO; SPINAL-CORD; PLATE CELLS; EXPRESSION; HINDBRAIN	Cerebellar granule neurons, the most abundant class of CNS neurons, have a critical role in cerebellar function. Granule neurons are generated at the dorsal border of the mesencephalon and metencephalon, the rhombic lip. In the mouse embryo, rhombic lip cells express a number of granule neuron markers, notably the bHLH transcription factor Math1. Dorsal midline cells adjacent to the rhombic lip express Bmp6, Bmp7 and Gdf7, three genes encoding peptide growth factors of the bone morphogenetic protein (BMP) family. These BMPs induced the expression of granule neuron markers in cultured neural tissue. Moreover, BMP-treated neural cells formed mature granule neurons after transplantation into the early postnatal cerebellum, suggesting that BMPs initiate the program of granule cell specification.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA; Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Rockefeller University; Columbia University; Howard Hughes Medical Institute	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	hatten@rockvax.rockefeller.edu		Lee, Kevin/0000-0001-9823-0952; Alder, Janet/0000-0002-5694-4946	NINDS NIH HHS [NS0532-05] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Altman J, 1997, DEV CEREBELLAR SYSTE; Arkell R, 1997, DEVELOPMENT, V124, P1; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; ARUGA J, 1994, J NEUROCHEM, V63, P1880; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; BenArie N, 1996, HUM MOL GENET, V5, P1207, DOI 10.1093/hmg/5.9.1207; CHAN WY, 1988, DEVELOPMENT, V102, P427; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; DAVIS CA, 1991, DEVELOPMENT, V111, P287; Eccles JC, 1967, CEREBELLUM NEURONAL; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; GAO WQ, 1994, DEVELOPMENT, V120, P1059; GAO WQ, 1993, SCIENCE, V260, P367, DOI 10.1126/science.8469990; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HALLONET MER, 1993, EUR J NEUROSCI, V5, P1145, DOI 10.1111/j.1460-9568.1993.tb00969.x; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Helms AW, 1998, DEVELOPMENT, V125, P919; Ito M, 1984, CEREBELLUM NEURAL CO; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MARTINEZ S, 1989, EUR J NEUROSCI, V1, P549, DOI 10.1111/j.1460-9568.1989.tb00362.x; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; PARR BA, 1993, DEVELOPMENT, V119, P247; Peringa A, 1995, CURR OPIN NEUROL, V8, P437, DOI 10.1097/00019052-199512000-00006; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; RYDER EF, 1994, NEURON, V12, P1011, DOI 10.1016/0896-6273(94)90310-7; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; TAN SS, 1985, CELL TISSUE RES, V240, P403; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	50	160	162	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					535	540		10.1038/9189	http://dx.doi.org/10.1038/9189			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448218				2022-12-24	WOS:000084735900013
J	Chee, MWL; Caplan, D; Soon, CS; Sriram, N; Tan, EWL; Thiel, T; Weekes, B				Chee, MWL; Caplan, D; Soon, CS; Sriram, N; Tan, EWL; Thiel, T; Weekes, B			Processing of visually presented sentences in mandarin and English studied with fMRI	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; 2ND LANGUAGE; HEMISPHERIC-SPECIALIZATION; CORTICAL REPRESENTATION; PREFRONTAL CORTEX; WORD RECOGNITION; BILINGUAL BRAIN; FUNCTIONAL MRI; TEMPORAL-LOBE; PET	Comprehension of visually presented sentences in fluent bilinguals was studied with functional magnetic resonance imaging (fMRI) using a set of conceptually similar sentences in two orthographically and phonologically distinct languages, Mandarin and English. Responses were monitored during scanning. Sentence comprehension in each language was compared to fixation in nine subjects and Tamil-like pseudo-word strings in five subjects. Spatially congruent activations in the prefrontal, temporal, and superior parietal regions and in the anterior supplementary motor area were observed for both languages and in both experiments at the individual and group levels of analysis. Proficient bilinguals exposed to both languages early in life utilize common neuroanatomical regions during the conceptual and syntactic processing of written language irrespective of their differences in surface features.	Singapore Gen Hosp, Cognit Neurosci Lab, Singapore 169856, Singapore; Natl Univ Singapore, Dept Social Work & Psychol, Singapore 119260, Singapore; Massachusetts Gen Hosp, Dept Neurol, Neuropsychol Lab, Boston, MA 02114 USA; Univ Freiburg, Dept Radiol, D-79106 Freiburg, Germany; Univ Kent, Dept Psychol, Canterbury CT2 7LZ, Kent, England	Singapore General Hospital; National University of Singapore; Harvard University; Massachusetts General Hospital; University of Freiburg; University of Kent	Chee, MWL (corresponding author), Singapore Gen Hosp, Cognit Neurosci Lab, Singapore 169856, Singapore.		Soon, Chun Siong/O-8409-2017; Weekes, Brendan Stuart/E-9897-2010	Soon, Chun Siong/0000-0003-2073-4557; Chee, Michael/0000-0002-6087-0548	NIDCD NIH HHS [DC02146] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002146] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Albert M.L., 1978, BILINGUAL BRAIN NEUR; Bavelier D, 1998, NEURON, V21, P275, DOI 10.1016/S0896-6273(00)80536-X; Bavelier D, 1997, J COGNITIVE NEUROSCI, V9, P664, DOI 10.1162/jocn.1997.9.5.664; Bavelier D, 1998, NEUROREPORT, V9, P1537, DOI 10.1097/00001756-199805110-00054; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Binder JR, 1996, NEUROLOGY, V46, P978, DOI 10.1212/WNL.46.4.978; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Buonocore MH, 1997, MAGNET RESON MED, V38, P89, DOI 10.1002/mrm.1910380114; Caplan D, 1996, BRAIN, V119, P933, DOI 10.1093/brain/119.3.933; Chee MWL, 1999, J NEUROSCI, V19, P3050; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; FLEZ JA, 1996, J NEUROSCI, V16, P808; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GREEN DW, 1986, BRAIN LANG, V27, P210, DOI 10.1016/0093-934X(86)90016-7; Hennel F, 1998, J MAGN RESON, V134, P206, DOI 10.1006/jmre.1998.1502; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; KLEIN D, 1995, P NATL ACAD SCI USA, V92, P2899, DOI 10.1073/pnas.92.7.2899; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; Koyama S, 1998, NEUROPSYCHOLOGIA, V36, P83, DOI 10.1016/S0028-3932(97)00097-3; Kroll J. F., 1997, TUTORIALS BILINGUALI, P169; Li P, 1996, J MEM LANG, V35, P757, DOI 10.1006/jmla.1996.0039; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; McClelland J.L., 1989, LANG COGNITIVE PROC, V4, P287; Muller RA, 1997, NEUROREPORT, V8, P3767; Neville HJ, 1998, CURR OPIN NEUROBIOL, V8, P254, DOI 10.1016/S0959-4388(98)80148-7; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; OJEMANN GA, 1978, ARCH NEUROL-CHICAGO, V35, P409, DOI 10.1001/archneur.1978.00500310011002; Osterhout L, 1997, TRENDS COGN SCI, V1, P203, DOI 10.1016/S1364-6613(97)01073-5; PARADIS M, 1982, BRAIN LANG, V15, P55, DOI 10.1016/0093-934X(82)90046-3; Paradis M., 1998, HDB NEUROLINGUISTICS, P417, DOI [10.1016/B978-012666055-5/50033-2, DOI 10.1016/B978-012666055-5/50033-2]; Paradis Michel, 1995, ASPECTS BILINGUAL AP; PENFIELD W, 1959, SPEECH BRAIN MECHANI, P253; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Poeppel D, 1996, BRAIN LANG, V55, P317, DOI 10.1006/brln.1996.0108; Price CJ, 1996, NEUROIMAGE, V3, P40, DOI 10.1006/nimg.1996.0005; RAPPORT RL, 1983, BRAIN LANG, V18, P342, DOI 10.1016/0093-934X(83)90024-X; SASANUMA S, 1995, ASPECTS BILINGUAL AP, P111; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; SMITH MC, 1982, Q J EXP PSYCHOL-A, V34, P153, DOI 10.1080/14640748208400864; Smith MC., 1997, TUTORIALS BILINGUALI, P145; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; SUGISHITA M, 1992, BRAIN, V115, P1563, DOI 10.1093/brain/115.5.1563; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Weber-Fox C., 1997, J COGNITIVE NEUROSCI, V8, P231; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	51	168	178	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					127	137		10.1016/S0896-6273(00)80759-X	http://dx.doi.org/10.1016/S0896-6273(00)80759-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402199	Bronze			2022-12-24	WOS:000080681200016
J	Dobrunz, LE; Stevens, CF				Dobrunz, LE; Stevens, CF			Response of hippocampal synapses to natural stimulation patterns	NEURON			English	Article							LONG-TERM POTENTIATION; NEOCORTICAL PYRAMIDAL NEURONS; NONLINEAR-SYSTEMS ANALYSIS; PATH-DENTATE PROJECTION; TRANSMITTER RELEASE; QUANTITATIVE DESCRIPTION; NEUROMUSCULAR JUNCTION; SYNAPTIC TRANSMISSION; EXCITATORY SYNAPSES; VISUAL-CORTEX	We have studied the synaptic responses in hippocampal slices to stimulus patterns derived from in vivo recordings of place cell firing in a behaving rodent. We find that synaptic strength is strongly modulated during the presentation of these natural stimulus trains, varying 2-fold or more because of short-term plasticity. This modulation of synaptic strength is precise and deterministic, because the pattern of synaptic response amplitudes is nearly identical from one presentation of the train to the next. The mechanism of synaptic modulation is primarily a change in release probability rather than a change in the size of the elementary postsynaptic response. In addition, natural stimulus trains are effective in inducing long-term potentiation (LTP). We conclude that short-term synaptic plasticity-facilitation, augmentation, and depression-plays a prominent role in normal synaptic function.	Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Dobrunz, LE (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	dobrunz@axpl.salk.edu		Dobrunz, Lynn E./0000-0002-3317-554X				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BEAM KG, 1983, J GEN PHYSIOL, V81, P485, DOI 10.1085/jgp.81.4.485; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BERGER TW, 1988, J NEUROPHYSIOL, V60, P1077, DOI 10.1152/jn.1988.60.3.1077; BERGER TW, 1988, J NEUROPHYSIOL, V60, P1095, DOI 10.1152/jn.1988.60.3.1095; Best PJ, 1998, P NATL ACAD SCI USA, V95, P2717, DOI 10.1073/pnas.95.6.2717; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CastroAlamancos MA, 1996, J NEUROSCI, V16, P2767; Chance FS, 1998, J NEUROSCI, V18, P4785; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Dobrunz L. E., 1996, Progress in Biophysics and Molecular Biology, V65, P187; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; FRANKENHAEUSER B, 1963, J PHYSIOL-LONDON, V169, P431, DOI 10.1113/jphysiol.1963.sp007269; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Katz B., 1969, RELEASE NEURAL TRANS; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; MAGLEBY KL, 1987, SYNAPTIC FUNCTION, P21; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; RAASTAD M, 1995, EUR J NEUROSCI, V7, P1882, DOI 10.1111/j.1460-9568.1995.tb00709.x; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SCLABASSI RJ, 1988, J NEUROPHYSIOL, V60, P1066, DOI 10.1152/jn.1988.60.3.1066; Sen K, 1996, J NEUROSCI, V16, P6307; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; THOMSON AM, 1993, NEUROSCIENCE, V54, P329, DOI 10.1016/0306-4522(93)90256-F; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Varela JA, 1997, J NEUROSCI, V17, P7926; Zador AM, 1997, NEURON, V19, P1, DOI 10.1016/S0896-6273(00)80341-4; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	49	154	156	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1999	22	1					157	166		10.1016/S0896-6273(00)80687-X	http://dx.doi.org/10.1016/S0896-6273(00)80687-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027298	Bronze			2022-12-24	WOS:000078410300021
J	Chiesa, R; Piccardo, P; Ghetti, B; Harris, DA				Chiesa, R; Piccardo, P; Ghetti, B; Harris, DA			Neurological illness in transgenic mice expressing a prion protein with an insertional mutation	NEURON			English	Article							CREUTZFELDT-JAKOB-DISEASE; CENTRAL-NERVOUS-SYSTEM; CULTURED-CELLS; WILD-TYPE; BIOCHEMICAL-PROPERTIES; SCRAPIE ISOFORM; PHOSPHOLIPASE-C; MUTANT; GENE; PRP	Familial prion diseases are caused by mutations in the gene encoding the prion protein (PrP). We have produced transgenic mice that express the mouse homolog of a mutant human PrP containing a nine octapeptide insertion associated with prion dementia. These mice exhibit a slowly progressive neurological disorder characterized clinically by ataxia and neuropathologically by cerebellar atrophy and granule cell loss, gliosis, and PrP deposition that is most prominent in the cerebellum and hippocampus. Mutant PrP molecules expressed in the brains of these mice are resistant to digestion by low concentrations of proteinase K and display several other biochemical properties reminiscent of PrPSc, the pathogenic isoform of PrP. These results establish a new transgenic animal model of an inherited human prion disorder.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Indiana Univ, Sch Med, Div Neuropathol, Indianapolis, IN 46202 USA	Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis	Harris, DA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	dharris@cellbio.wustl.edu	Chiesa, Roberto/G-1561-2017	Chiesa, Roberto/0000-0002-3842-3733; Harris, David/0000-0002-6985-5790	NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG10133] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BOLTON DC, 1991, J VIROL, V65, P3667, DOI 10.1128/JVI.65.7.3667-3675.1991; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Capellari S, 1997, NEUROLOGY, V49, P133, DOI 10.1212/WNL.49.1.133; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chen SG, 1997, NAT MED, V3, P1009, DOI 10.1038/nm0997-1009; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CHIESA R, 1998, NEUROBIOL AGING, V19, pS300; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; COLLINGE J, 1992, BRAIN, V115, P687, DOI 10.1093/brain/115.3.687; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; DUCHEN LW, 1993, BRAIN, V116, P555, DOI 10.1093/brain/116.3.555; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; KITAMOTO T, 1992, AM J PATHOL, V140, P1285; KRASEMANN S, 1995, MOL BRAIN RES, V34, P173, DOI 10.1016/0169-328X(95)00175-R; Lehmann S, 1997, MOL BRAIN RES, V52, P139, DOI 10.1016/S0169-328X(97)00231-3; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; MANSON J, 1992, DEVELOPMENT, V115, P117; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OWEN F, 1992, MOL BRAIN RES, V13, P155, DOI 10.1016/0169-328X(92)90056-H; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; PARCHI P, 1995, CURR OPIN NEUROL, V8, P286, DOI 10.1097/00019052-199508000-00007; Parchi P., 1998, PROGR PATHOLOGY, P39; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; Piccardo P, 1998, AM J PATHOL, V152, P1415; Priola SA, 1998, J BIOL CHEM, V273, P11980, DOI 10.1074/jbc.273.19.11980; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; ROSENBERRY TL, 1991, CELL BIOL INT REP, V15, P1133, DOI 10.1016/0309-1651(91)90060-V; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wozniak DF, 1996, BRAIN RES, V707, P165, DOI 10.1016/0006-8993(95)01230-3; Young Katherine, 1999, P139	54	262	266	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1339	1351		10.1016/S0896-6273(00)80653-4	http://dx.doi.org/10.1016/S0896-6273(00)80653-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883727	Bronze			2022-12-24	WOS:000077910600016
J	Crowell, JA; Banks, MS; Shenoy, KV; Andersen, RA				Crowell, JA; Banks, MS; Shenoy, KV; Andersen, RA			Visual self-motion perception during head turns	NATURE NEUROSCIENCE			English	Article							EYE-MOVEMENTS; OPTICAL-FLOW; PURSUIT; NEURONS; CORTEX; MONKEY; MST	Extra-retinal information is critical in the interpretation of visual input during self-motion. Turning our eyes and head to track objects displaces the retinal image but does not affect our ability to navigate because we use extra-retinal information to compensate for these displacements. We showed observers animated displays depicting their forward motion through a scene. They perceived the simulated self-motion accurately while smoothly shifting the gaze by turning the head, but not when the same gaze shift was simulated in the display; this indicates that the visual system also uses extra-retinal information during head turns. Additional experiments compared self-motion judgments during active and passive head turns, passive rotations of the body and rotations of the body with head fixed in space. We found that accurate perception during active head turns is mediated by contributions from three extra-retinal cues: vestibular canal stimulation, neck proprioception and an efference copy of the motor command to turn the head.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	California Institute of Technology; University of California System; University of California Berkeley	Crowell, JA (corresponding author), CALTECH, Div Biol, Mail Code 21676,1200 E Calif Blvd, Pasadena, CA 91125 USA.							Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; GIBSON J J, 1955, Am J Psychol, V68, P372, DOI 10.2307/1418521; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; KAWANO K, 1980, NEUROSCI LETT, V17, P55, DOI 10.1016/0304-3940(80)90061-0; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; ROYDEN CS, 1994, VISION RES, V34, P3215, DOI 10.1016/0042-6989(94)90085-X; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; vandenBerg AV, 1996, VISION RES, V36, P2337, DOI 10.1016/0042-6989(95)00247-2; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1991, J EXP PSYCHOL HUMAN, V17, P28, DOI 10.1037/0096-1523.17.1.28	17	114	115	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					732	737		10.1038/3732	http://dx.doi.org/10.1038/3732			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	144PR	10196591				2022-12-24	WOS:000077323400019
J	Obrietan, K; Impey, S; Storm, DR				Obrietan, K; Impey, S; Storm, DR			Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei	NATURE NEUROSCIENCE			English	Article							NMDA RECEPTOR ANTAGONISTS; EPIDERMAL GROWTH-FACTOR; DROSOPHILA PERIOD GENE; BIOLOGICAL CLOCK; C-FOS; RETINOHYPOTHALAMIC TRACT; CREB PHOSPHORYLATION; PROTEIN-KINASE; MESSENGER-RNA; PC12 CELLS	Although the circadian time-keeping properties of the suprachiasmatic nuclei (SCN) require gene expression, little is known about the signal transduction pathways that initiate transcription. Here we report that a brief exposure to light during the subjective night, but not during the subjective day, activates the p44/42 mitogen-activated protein kinase (MAPK) signaling cascade in the SCN. In addition, MAPK stimulation activates CREB (cAMP response element binding protein), indicating that potential downstream transcription factors are stimulated by the MAPK pathway in the SCN. We also observed striking circadian variations in MAPK activity within the SCN, suggesting that the MAPK cascade is involved in crock rhythmicity.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Mail Box 357280,Hlth Sci Bldg, Seattle, WA 98195 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [NS 20498] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; ARONIN N, 1990, P NATL ACAD SCI USA, V87, P5959, DOI 10.1073/pnas.87.15.5959; Cagampang FRA, 1998, MOL BRAIN RES, V53, P277, DOI 10.1016/S0169-328X(97)00309-4; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; COLWELL CS, 1991, BRAIN RES, V554, P105, DOI 10.1016/0006-8993(91)90177-W; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Ding JM, 1997, J NEUROSCI, V17, P667; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Ghosh PK, 1997, DEV BRAIN RES, V102, P1, DOI 10.1016/S0165-3806(97)00066-7; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Glaser B.G., 1965, AM BEHAV SCI, V8, P5, DOI DOI 10.1177/000276426500800602; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guido ME, 1996, NEUROSCI LETT, V217, P9; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; KALSBEEK A, 1995, BRAIN RES, V682, P75, DOI 10.1016/0006-8993(95)00324-J; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Miller JD, 1996, SLEEP, V19, P641, DOI 10.1093/sleep/19.8.641; MOFFETT JR, 1990, P NATL ACAD SCI USA, V87, P8065, DOI 10.1073/pnas.87.20.8065; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; PROSSER RA, 1994, MOL BRAIN RES, V25, P151, DOI 10.1016/0169-328X(94)90292-5; RAJU U, 1991, SCIENCE, V253, P673, DOI 10.1126/science.1871602; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WOLLNIK F, 1995, EUR J NEUROSCI, V7, P388, DOI 10.1111/j.1460-9568.1995.tb00334.x; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; YANG J, 1994, MOL CELL NEUROSCI, V5, P97, DOI 10.1006/mcne.1994.1011; Yoshitomi H, 1997, AM J PHYSIOL-ENDOC M, V272, pE769, DOI 10.1152/ajpendo.1997.272.5.E769; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	50	306	311	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					693	700		10.1038/3695	http://dx.doi.org/10.1038/3695			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196585				2022-12-24	WOS:000077323400013
J	MacEvoy, SP; Kim, W; Paradiso, MA				MacEvoy, SP; Kim, W; Paradiso, MA			Integration of surface information in primary visual cortex	NATURE NEUROSCIENCE			English	Article							CLASSICAL RECEPTIVE-FIELD; ALERT MACAQUE; FILLING-IN; RESPONSES; NEURONS; CAT; SUPPRESSION; MECHANISMS; DEPENDENCE; LIGHTNESS	Ample evidence suggests that primary visual cortex is involved in the perception of form, and there is increasing evidence that it may also be important in the perception of surfaces. Perceptual qualities of surfaces, such as brightness, are based on extensive integration of information throughout the visual field. In primary visual cortex, we found that the responses of neurons to surfaces were also influenced by the intensity and organization of light in large portions of the visual field. Interactions with surrounding stimuli typically extended 10 to 20 degrees beyond a cell's receptive field, the same spatial scale as perceptual interactions. Moreover, there were both facilitatory and inhibitory influences, just as there are additive and subtractive perceptual interactions. Surprisingly, influences from outside the receptive field obtained with surface stimuli did not reliably correlate with influences recorded with gratings. These properties suggest that the underlying neuronal interactions may serve as the fundamental building blocks of surface perception.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Paradiso, MA (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.							ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEYOE EA, 1980, EXP BRAIN RES, V39, P125; FISKEN RA, 1975, PHILOS T ROY SOC B, V272, P487, DOI 10.1098/rstb.1975.0099; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HEINEMANN EG, 1972, HDB SENSORY PHYSL, P146; HELSON H, 1963, J OPT SOC AM, V53, P179, DOI 10.1364/JOSA.53.000179; Hess C, 1894, ARCH OPHTHALMOL-CHIC, V40, P1, DOI [DOI 10.1007/BF01693963, 10.1007/BF01693963]; KAYAMA Y, 1979, J NEUROPHYSIOL, V42, P1495, DOI 10.1152/jn.1979.42.6.1495; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Komatsu H, 1996, COGNITIVE BRAIN RES, V5, P97, DOI 10.1016/S0926-6410(96)00045-6; LAMME VAF, 1995, J NEUROSCI, V15, P1605; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; LAND EH, 1959, P NATL ACAD SCI USA, V45, P115, DOI 10.1073/pnas.45.1.115; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; PARADISO MA, 1991, VISION RES, V31, P1221, DOI 10.1016/0042-6989(91)90047-9; Paradiso MA, 1996, VISION RES, V36, P2657, DOI 10.1016/0042-6989(96)00033-8; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Reid R. C., 1989, SEEING CONTOUR COLOU, P324; REID RC, 1988, VISION RES, V28, P115, DOI 10.1016/0042-6989(88)90013-2; ROSSI AF, 1996, SCIENCE, V273, P1391; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SQUATRITO S, 1990, BRAIN RES, V536, P261, DOI 10.1016/0006-8993(90)90034-9; Toth LJ, 1996, P NATL ACAD SCI USA, V93, P9869, DOI 10.1073/pnas.93.18.9869; WALLACH H, 1948, J EXP PSYCHOL, V38, P310, DOI 10.1037/h0053804; WHITE M, 1979, PERCEPTION, V8, P413, DOI 10.1068/p080413; YUND EW, 1975, VISION RES, V15, P917, DOI 10.1016/0042-6989(75)90231-X; ZIPSER K, 1996, J NEUROSCI, V16, P260	30	61	64	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					616	620		10.1038/2849	http://dx.doi.org/10.1038/2849			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196570				2022-12-24	WOS:000077437100018
J	Krimer, LS; Muly, EC; Williams, GV; Goldman-Rakic, PS				Krimer, LS; Muly, EC; Williams, GV; Goldman-Rakic, PS			Dopaminergic regulation of cerebral cortical microcirculation	NATURE NEUROSCIENCE			English	Article							BLOOD-FLOW; PREFRONTAL CORTEX; VASOMOTOR RESPONSES; BETA-HYDROXYLASE; NEURONS PROJECT; BASAL FOREBRAIN; BRAIN-SLICES; NITRIC-OXIDE; RAT-BRAIN; MICROVESSELS	Functional variations in cerebral cortical activity are accompanied by local changes in blood flow, but the mechanisms underlying this physiological coupling are not well understood. Here we report that dopamine, a neurotransmitter normally associated with neuromodulatory actions, may directly affect local cortical blood flow. Using light and electron-microscopic immunocytochemistry, we show that dopaminergic axons innervate the intraparenchymal microvessels. We also provide evidence in an in vitro slice preparation that dopamine produces vasomotor responses in the cortical vasculature. These anatomical and physiological observations reveal a previously unknown source of regulation of the microvasculature by dopamine. The findings may be relevant to the mechanisms underlying changes in blood flow observed in circulatory and neuropsychiatric disorders.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University; Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.	patricia.goldman-rakic@yale.edu			NIMH NIH HHS [MH44866] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH044866] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CEPEDA C, 1992, SYNAPSE, V11, P330, DOI 10.1002/syn.890110408; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; COHEN Z, 1995, NEUROSCIENCE, V66, P555, DOI 10.1016/0306-4522(94)00625-F; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; DACEY RG, 1988, J CEREBR BLOOD F MET, V8, P254, DOI 10.1038/jcbfm.1988.56; EDVINSSON L, 1985, BRIT J PHARMACOL, V85, P403, DOI 10.1111/j.1476-5381.1985.tb08875.x; Farber NE, 1997, ANESTHESIOLOGY, V87, P1191, DOI 10.1097/00000542-199711000-00024; FAVARD C, 1990, BRAIN RES, V523, P127, DOI 10.1016/0006-8993(90)91645-W; GEIJOBARRIENTOS E, 1995, EUR J NEUROSCI, V7, P358, DOI 10.1111/j.1460-9568.1995.tb00331.x; GOLDBERG LI, 1984, AM J MED, V77, P37, DOI 10.1016/S0002-9343(84)80036-4; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; HAEFLIGER IO, 1994, INVEST OPHTH VIS SCI, V35, P991; HARTMAN BK, 1972, P NATL ACAD SCI USA, V69, P2722, DOI 10.1073/pnas.69.9.2722; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; LOU HC, 1987, ANN NEUROL, V22, P289, DOI 10.1002/ana.410220302; MACKENZIE ET, 1987, CRC CR REV CL NEUROB, V2, P357; Magistretti PJ, 1997, NEUROSCIENTIST, V3, P361, DOI 10.1177/107385849700300608; MORRISON JH, 1982, BRAIN RES BULL, V9, P309, DOI 10.1016/0361-9230(82)90144-7; RAICHLE ME, 1975, P NATL ACAD SCI USA, V72, P3726, DOI 10.1073/pnas.72.9.3726; REINHARD JF, 1979, SCIENCE, V206, P85, DOI 10.1126/science.482930; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; SATO A, 1992, NEUROSCI RES, V14, P242, DOI 10.1016/0168-0102(92)90071-J; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; VAUCHER E, 1995, J NEUROSCI, V15, P7427; WAHL M, 1993, ACTA NEUROCHIR, P3; WEILFUGAZZA J, 1993, NEUROCHEM RES, V18, P965, DOI 10.1007/BF00966754; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199	29	263	267	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					286	289		10.1038/1099	http://dx.doi.org/10.1038/1099			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195161				2022-12-24	WOS:000076361300011
J	Kandler, K; Katz, LC; Kauer, JA				Kandler, K; Katz, LC; Kauer, JA			Focal photolysis of caged glutamate produces long-term depression of hippocampal glutamate receptors	NATURE NEUROSCIENCE			English	Article							MINIATURE SYNAPTIC CURRENTS; BLOCKS INDUCTION; PROTEIN-KINASE; AMPA RESPONSES; AREA CA1; POTENTIATION; PLASTICITY; MECHANISMS; NEURONS; LTP	Separating contributions of pre- and postsynaptic factors to the maintenance of long-term potentiation (LIP) and long-term depression (LTD) has been confounded by their experimental interdependence. To isolate the postsynaptic contribution, glutamate-receptor-mediated currents were elicited by localized photolysis of caged glutamate in small spots along the dendrites of CA1 hippocampal pyramidal cells. With synaptic transmission blocked, pairing depolarization of pyramidal cells with repeated photolysis of caged glutamate at one site markedly and persistently depressed subsequent responses to glutamate; responses at a second, unpaired site were unchanged. Like synaptically induced LTD at the CA3-CA1 synapse, this depression was site specific, NMDA-receptor dependent and blocked by protein-phosphatase inhibitors. Thus, robust, persistent alterations of postsynaptic glutamate receptor efficacy can occur without presynaptic neurotransmitter release.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Kandler, K (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.			Kandler, Karl/0000-0002-6053-6400; Kauer, Julie/0000-0002-3362-1642	NEI NIH HHS [EY06730-02, F32 EY006730] Funding Source: Medline; NINDS NIH HHS [NS30500-06A1] Funding Source: Medline; NATIONAL EYE INSTITUTE [U10EY006730, U01EY006730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS030500, R01NS030500] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CORMIER RJ, 1993, NEURON, V10, P907, DOI 10.1016/0896-6273(93)90206-7; Coussens CM, 1996, SYNAPSE, V24, P97, DOI 10.1002/(SICI)1098-2396(199610)24:2<97::AID-SYN1>3.0.CO;2-9; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Givens R S, 1998, Methods Enzymol, V291, P1; Givens RS, 1997, J AM CHEM SOC, V119, P8369, DOI 10.1021/ja971331n; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; KANDLER K, IMAGING LIVING CELLS; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; ROSENKRANZ ER, 1993, CURR OPIN CARDIOL, V8, P262, DOI 10.1097/00001573-199303000-00012; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Vickery RM, 1997, SYNAPSE, V25, P103, DOI 10.1002/(SICI)1098-2396(199701)25:1<103::AID-SYN12>3.0.CO;2-0; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9	43	84	88	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					119	123		10.1038/368	http://dx.doi.org/10.1038/368			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195126				2022-12-24	WOS:000076361100012
J	Macknik, SL; Livingstone, MS				Macknik, SL; Livingstone, MS			Neuronal correlates of visibility and invisibility in the primate visual system	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; MONKEY SUPERIOR COLLICULUS; STRIATE CORTEX; INFORMATION; MASKING; VISION; METACONTRAST; RESPONSES	A brief visual target stimulus may be rendered invisible if it is immediately preceded or followed by another stimulus. This class of illusions, known as visual masking, may allow insights into the neural mechanisms that underlie visual perception. We have therefore explored the temporal characteristics of masking illusions in humans, and compared them with corresponding neuronal responses in the primary visual cortex of awake and anesthetized monkeys. Stimulus parameters that in humans produce forward masking (in which the mask precedes the target) suppress the transient on-response to the target in monkey visual cortex. Those that produce backward masking (in which the mask comes after the target) inhibit the transient after-discharge, the excitatory response that occurs just after the disappearance of the target. These results suggest that, for targets that can be masked (those of short duration), the transient neuronal responses associated with onset and turning off of the target may be important in its visibility.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Macknik, SL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Macknik, Stephen L./H-7704-2019	Macknik, Stephen L./0000-0002-3143-9230; Livingstone, Margaret/0000-0002-1950-0123				ALPERN M, 1952, Am J Optom Arch Am Acad Optom, V29, P631; ALPERN M, 1953, J OPT SOC AM, V43, P648, DOI 10.1364/JOSA.43.000648; BREITMEYER B, 1984, VISUAL MASKING INTEG, P1; BREITMEYER BG, 1978, B PSYCHONOMIC SOC, V12, P50; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; BRIDGEMAN B, 1975, VISION RES, V15, P91, DOI 10.1016/0042-6989(75)90065-6; BRIDGEMAN B, 1971, PSYCHOL REV, V78, P528, DOI 10.1037/h0031782; BRIDGEMAN B, 1980, BRAIN RES, V196, P347, DOI 10.1016/0006-8993(80)90400-X; Coppola D, 1996, P NATL ACAD SCI USA, V93, P8001, DOI 10.1073/pnas.93.15.8001; Day EC, 1915, AM J PHYSIOL, V38, P369, DOI 10.1152/ajplegacy.1915.38.3.369; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; EXNER S, 1868, WIENER SITZUNGBERICH, P601; FRANCIS G, 1995, ONLINE P 1996 MIDWES; HELMHOLTZ H, 1985, HELMHOLTZS TREATISE, P1; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; KOLERS PA, 1960, AM J PSYCHOL, V73, P2, DOI 10.2307/1419113; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; MATIN E, 1975, PSYCHOL REV, V82, P451; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MCFADDEN, 1973, VISION RES, V13, P185; OLSON CX, 1984, PERCEPT PSYCHOPHYS, V35, P295, DOI 10.3758/BF03206331; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; RIGGS LA, 1952, J OPT SOC AM, V42, P872; SCHILLER PH, 1968, VISION RES, V8, P855, DOI 10.1016/0042-6989(68)90135-1; Schiller PH, 1969, INFORMATION PROCESSI, P141; SMITH MC, 1966, CAN J PSYCHOLOGY, V20, P191, DOI 10.1037/h0082933; SPERLING G, 1965, J OPT SOC AM, V55, P541, DOI 10.1364/JOSA.55.000541; STIGLER R, 1913, 9 C INT PHYS, P78; Stigler R, 1926, HDB BIOL ARBEITSMETH, P949; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; WEISSTEIN N, 1971, PERCEPT PSYCHOPHYS, V9, P275, DOI 10.3758/BF03212647; WEISSTEIN N, 1965, PSYCHON SCI, V2, P75, DOI 10.3758/BF03343337; Werner H, 1935, AM J PSYCHOL, V47, P40, DOI 10.2307/1416707; WURTZ RH, 1980, J NEUROPHYSIOL, V43, P1168, DOI 10.1152/jn.1980.43.4.1168; YARBUS AL, 1967, EYE MOVEMENTS VISON	39	296	303	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					144	149		10.1038/393	http://dx.doi.org/10.1038/393			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QB	10195130				2022-12-24	WOS:000076361100016
J	Lupien, SJ; de Leon, M; de Santi, S; Convit, A; Tarshish, C; Thakur, M; McEwen, BS; Hauger, RL; Meaney, MJ				Lupien, SJ; de Leon, M; de Santi, S; Convit, A; Tarshish, C; Thakur, M; McEwen, BS; Hauger, RL; Meaney, MJ			Cortisol levels during human aging predict hippocampal atrophy and memory deficits	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; RAT-BRAIN; STRESS; CORTICOSTERONE; MODULATION; HYPOTHESIS; BASAL	Elevated glucocorticoid levels produce hippocampal dysfunction and correlate with individual deficits in spatial learning in aged rats. Previously we related persistent cortisol increases to memory impairments in elderly humans studied over five years. Here we demonstrate that aged humans with significant prolonged cortisol elevations showed reduced hippocampal volume and deficits in hippocampus-dependent memory tasks compared to normal-cortisol controls. Moreover, the degree of hippocampal atrophy correlated strongly with both the degree of cortisol elevation over time and current basal cortisol levels. Therefore, basal cortisol elevation may cause hippocampal damage and impair hippocampus-dependent learning and memory in humans.	McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Aging Res Program, Verdun, PQ H4H 1R3, Canada; Geriatr Inst Montreal, Human Psychoneuroendocrine Res Lab, Montreal, PQ H3W 1W5, Canada; NYU, Med Ctr, Aging & Dementia Res Ctr, New York, NY 10016 USA; Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92161 USA; VA Med Ctr, San Diego, CA 92161 USA	McGill University; Universite de Montreal; New York University; Rockefeller University; University of California System; University of California San Diego	Lupien, SJ (corresponding author), McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Aging Res Program, 6875 Blvd Lasalle, Verdun, PQ H4H 1R3, Canada.	lupiens@magellan.umontreal.ca	de Leon, Mony/AAP-7890-2021; McEwen, Bruce/Z-1630-2019	de Leon, Mony/0000-0003-2245-4380; Convit, Antonio/0000-0003-2201-2689	NIA NIH HHS [AG12101, AG13616, AG09488] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009488, R01AG012101, R01AG013616] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8; DELEON MJ, 1988, LANCET, V2, P391; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; FISCHETTE CT, 1980, BRAIN RES, V195, P373, DOI 10.1016/0006-8993(80)90073-6; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; ISSA AM, 1990, J NEUROSCI, V10, P3247; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; JOELS M, 1989, SCIENCE, V245, P1502, DOI 10.1126/science.2781292; JOELS M, 1997, FRONT NEUROENDOCRIN, V18, P495; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; LANDFIELD PW, 1994, NEUROBIOL AGING, V15, P579, DOI 10.1016/0197-4580(94)90101-5; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994; Lupien S, 1996, NEUROBIOL AGING, V17, P95, DOI 10.1016/0197-4580(95)02005-5; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Magarinos AM, 1996, J NEUROSCI, V16, P3534; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sapolsky RM, 1992, STRESS AGING BRAIN M; SCOLVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Wolkowitz OM, 1997, ANN NY ACAD SCI, V823, P81, DOI 10.1111/j.1749-6632.1997.tb48381.x	30	1134	1189	2	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					69	73		10.1038/271	http://dx.doi.org/10.1038/271			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195112				2022-12-24	WOS:000076361000021
J	Riesenhuber, M; Poggio, T				Riesenhuber, M; Poggio, T			Hierarchical models of object recognition in cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; VISUAL-SYSTEM; 3-DIMENSIONAL OBJECTS; NEURAL CIRCUITRY; FACE DETECTION; MACAQUE; VIEW; RESPONSES; SHAPE; ATTENTION	Visual processing in cortex is classically modeled as a hierarchy of increasingly sophisticated representations, naturally extending the model of simple to complex cells of Hubel and Wiesel. Surprisingly, little quantitative modeling has been done to explore the biological feasibility of this class of models to explain aspects of higher-level visual processing such as object recognition. We describe a new hierarchical model consistent with physiological data from inferotemporal cortex that accounts for this complex visual task and makes testable predictions. The model is based on a MAX-like operation applied to inputs to certain cortical neurons that may have a general role in cortical function.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02142 USA; MIT, Ctr Biol & Computat Learning, Cambridge, MA 02142 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Poggio, T (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02142 USA.	tp@ai.mit.edu		Riesenhuber, Maximilian/0000-0002-5744-0408				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Conner CE, 1997, J NEUROSCI, V17, P3201; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Missal M, 1997, CEREB CORTEX, V7, P758, DOI 10.1093/cercor/7.8.758; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; REICHARDT W, 1983, BIOL CYBERN, V46, P1, DOI 10.1007/BF00595226; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Riesenhuber M, 1997, ADV NEUR IN, V9, P17; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; Riesenhuber M, 1998, ADV NEUR IN, V10, P215; ROLLS ET, 1995, EXP BRAIN RES, V103, P409; Rowley HA, 1998, IEEE T PATTERN ANAL, V20, P23, DOI 10.1109/34.655647; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; SATO T, 1989, EXP BRAIN RES, V77, P23; Sung KK, 1998, IEEE T PATTERN ANAL, V20, P39, DOI 10.1109/34.655648; TARR MJ, 1995, PSYCHON B REV, V2, P55, DOI 10.3758/BF03214412; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5	47	1983	2085	6	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					1019	1025		10.1038/14819	http://dx.doi.org/10.1038/14819			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526343				2022-12-24	WOS:000083883300021
J	Chichilnisky, EJ; Baylor, DA				Chichilnisky, EJ; Baylor, DA			Receptive-field microstructure of blue-yellow ganglion cells in primate retina	NATURE NEUROSCIENCE			English	Article							MONKEY RETINA; BIPOLAR CELLS; MACAQUE RETINA; CONES; PHOTORECEPTORS; SENSITIVITY; MORPHOLOGY; MODULATION; MECHANISM; MIDGET	We examined the functional microcircuitry of cone inputs to blue-ON/yellow-OFF (BY) ganglion cells in the macaque retina using multielectrode recording. BY cells were identified by their ON responses to blue light and OFF responses to red or green light. Cone-isolating stimulation indicated that ON responses originated in short (S) wavelength-sensitive cones, whereas OFF responses originated in both long (L) and middle (M) wavelength-sensitive cones. Stimulation with fine spatial patterns revealed locations of individual S cones in BY cell receptive fields. Neighboring BY cells received common but unequal inputs from one or more S cones. Inputs from individual S cones differed in strength, indicating different synaptic weights, and summed approximately linearly to control BY cell firing.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Chichilnisky, EJ (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Chichilnisky, E.J./0000-0002-5613-0248	NEI NIH HHS [EY05750] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRINDLEY GS, 1966, J PHYSIOL-LONDON, V183, P497, DOI 10.1113/jphysiol.1966.sp007879; Calkins DJ, 1998, J NEUROSCI, V18, P3373; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P197, DOI 10.1113/jphysiol.1975.sp011087; DEVALOIS RL, 1965, COLD SPRING HARB SYM, V30, P567, DOI 10.1101/SQB.1965.030.01.055; ENROTHCUGELL C, 1970, NATURE, V226, P458, DOI 10.1038/226458a0; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; KIER CK, 1995, J NEUROSCI, V15, P7673; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; MARIANI AP, 1984, NATURE, V308, P184, DOI 10.1038/308184a0; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SCHNEEWEISS A, 1988, GERIATR CARDIOVASC, V1, P255; SMITH VC, 1992, J PHYSIOL-LONDON, V458, P191, DOI 10.1113/jphysiol.1992.sp019413; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; STOCKMAN A, 1991, VISION RES, V31, P189, DOI 10.1016/0042-6989(91)90111-H; STOCKMAN A, 1993, J OPT SOC AM A, V10, P1396, DOI 10.1364/JOSAA.10.001396; Wandell B.A., 1995, FDN VISION; WASSLE H, 1994, VISION RES, V34, P561, DOI 10.1016/0042-6989(94)90013-2; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; WILLIAMS DR, 1981, VISION RES, V21, P1357, DOI 10.1016/0042-6989(81)90242-X; WISOWATY JJ, 1980, VISION RES, V20, P895, DOI 10.1016/0042-6989(80)90071-1; YEH T, 1995, J OPT SOC AM A, V12, P456, DOI 10.1364/JOSAA.12.000456	27	104	105	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					889	893		10.1038/13189	http://dx.doi.org/10.1038/13189			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491609				2022-12-24	WOS:000083883200014
J	Nieder, A; Wagner, H				Nieder, A; Wagner, H			Perception and neuronal coding of subjective contours in the owl	NATURE NEUROSCIENCE			English	Article							ORIENTATION DISCRIMINATION; ILLUSORY CONTOURS; VISUAL-CORTEX; COLUMBA-LIVIA; WULST; TELENCEPHALON; ORGANIZATION; MONKEY	Robust form perception and underlying neuronal mechanisms require generalized representation of object boundaries, independent of how they are defined. One visual ability essential for form perception is reconstruction of contours absent from the retinal image. Here we show that barn owls perceive subjective contours defined by grating gaps and phase-shifted abutting gratings. Moreover, single-neuron recordings from visual forebrain (visual Wulst) of awake, behaving birds revealed a high proportion of neurons signaling such subjective contours, independent of local stimulus attributes. These data suggest that the visual Wulst is important in contour-based form perception and exhibits a functional complexity analogous to mammalian extrastriate cortex.	Rhein Westfal TH Aachen, Inst Biol 2, Lehrstuhl Zool Tierphysiol, D-52074 Aachen, Germany	RWTH Aachen University	Nieder, A (corresponding author), Rhein Westfal TH Aachen, Inst Biol 2, Lehrstuhl Zool Tierphysiol, Kopernikusstr 16, D-52074 Aachen, Germany.		Wagner, Hermann/G-5454-2012	Wagner, Hermann/0000-0002-8191-7595				BRAVO M, 1988, VISION RES, V28, P861, DOI 10.1016/0042-6989(88)90095-8; Casini G., 1993, P159; DEWEERD P, 1990, BEHAV BRAIN RES, V39, P1, DOI 10.1016/0166-4328(90)90117-W; DeWeerd P, 1996, VISUAL NEUROSCI, V13, P529, DOI 10.1017/S0952523800008208; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GREGORY RL, 1972, NATURE, V238, P51, DOI 10.1038/238051a0; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; Grossberg S., 1987, PERCEPTION ILLUSORY, P116, DOI [10.1007/978-1-4612-4760-9_12, DOI 10.1007/978-1-4612-4760-9_12]; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; KANIZSA G, 1979, ORG VISION ESSAYS GE; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Nieder A, 1999, HEARING RES, V127, P41, DOI 10.1016/S0378-5955(98)00179-8; PARADISO MA, 1989, VISION RES, V29, P1205, DOI 10.1016/0042-6989(89)90066-7; Peterhans E, 1997, CEREBR CORT, V12, P335; Petry S., 1987, PERCEPTION ILLUSORY; Pettigrew J.D., 1986, P208; PETTIGREW JD, 1979, PROC R SOC SER B-BIO, V204, P435, DOI 10.1098/rspb.1979.0038; PETTIGREW JD, 1976, SCIENCE, V193, P675, DOI 10.1126/science.948741; Ramachandran V. S., 1987, PERCEPTION ILLUSORY, P93, DOI 10.1007/978-1-4612-4760-9_10; ROCK I, 1979, PERCEPTION, V8, P665, DOI 10.1068/p080665; SCHUMANN F, 1990, Z PSYCHOL PHYSL SINN, V23, P1; Sheth BR, 1996, SCIENCE, V274, P2110, DOI 10.1126/science.274.5295.2110; SHIMIZU T, 1995, J COMP NEUROL, V359, P551, DOI 10.1002/cne.903590404; Shimizu Toru, 1993, P103; Spillmann L, 1996, TRENDS NEUROSCI, V19, P428; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; van der Willigen RF, 1998, NEUROREPORT, V9, P1233, DOI 10.1097/00001756-199804200-00050; Van Essen David C., 1995, P383; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; Von Der Heydt Ruediger, 1995, P365; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731	33	86	87	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					660	663		10.1038/10217	http://dx.doi.org/10.1038/10217			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404200				2022-12-24	WOS:000083882600018
J	Logothetis, NK; Guggenberger, H; Peled, S; Pauls, J				Logothetis, NK; Guggenberger, H; Peled, S; Pauls, J			Functional imaging of the monkey brain	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; SOMATOSENSORY STIMULATION; SENSORY STIMULATION; ELECTRICAL-ACTIVITY; INTRINSIC SIGNALS; MRI; ACTIVATION; CONTRAST; FMRI; RAT	Functional magnetic resonance imaging (fMRI) has become an essential tool for studying human brain function. Here we describe the application of this technique to anesthetized monkeys. We present spatially resolved functional images of the monkey cortex based on blood oxygenation level dependent (BOLD) contrast. Checkerboard patterns or pictures of primates were used to study stimulus-induced activation of the visual cortex, in a 4.7-Tesla magnetic field, using optimized multi-slice, gradient-recalled, echo-planar imaging (EPI) sequences to image the entire brain. Under our anesthesia protocol, visual stimulation yielded robust, reproducible, focal activation of the lateral geniculate nucleus (LGN), the primary visual area (V1) and a number of extrastriate visual areas, including areas in the superior temporal sulcus. Similar responses were obtained in alert, behaving monkeys performing a discrimination task.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Tubingen Hosp, Dept Anesthesiol, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	nikos.logothetis@tuebingen.mpg.de	Peled, Sharon/F-8590-2015; Peled, Sharon/ABD-7732-2021; Logothetis, Nikos/U-9282-2019					BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BINDER JR, 1995, INT J IMAG SYST TECH, V6, P280, DOI 10.1002/ima.1850060219; Bock C, 1998, MAGNET RESON MED, V39, P457, DOI 10.1002/mrm.1910390316; Buckner RL, 1996, SEMIN NEUROSCI, V8, P47, DOI 10.1006/smns.1996.0007; Courtney SM, 1997, CURR OPIN NEUROBIOL, V7, P554, DOI 10.1016/S0959-4388(97)80036-0; CRYER PE, 1980, NEW ENGL J MED, V303, P436; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; FRAHM J, 1993, MAGNET RESON MED, V29, P139, DOI 10.1002/mrm.1910290126; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gyngell ML, 1996, MAGNET RESON MED, V36, P13, DOI 10.1002/mrm.1910360104; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; HOCHMANN J, 1980, J MAGN RESON, V38, P23, DOI 10.1016/0022-2364(80)90174-2; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; Huang W, 1996, P NATL ACAD SCI USA, V93, P6037, DOI 10.1073/pnas.93.12.6037; Jezzard P, 1997, MAGNET RESON MED, V38, P699, DOI 10.1002/mrm.1910380504; Kindermann SS, 1997, SCHIZOPHR RES, V27, P143, DOI 10.1016/S0920-9964(97)00063-7; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MENON RS, 1992, INVEST RADIOL, V27, pS47, DOI 10.1097/00004424-199212002-00009; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Posner MI, 1998, P NATL ACAD SCI USA, V95, P763, DOI 10.1073/pnas.95.3.763; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yang XJ, 1997, MAGNET RESON MED, V38, P874, DOI 10.1002/mrm.1910380604	44	406	416	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					555	562		10.1038/9210	http://dx.doi.org/10.1038/9210			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448221				2022-12-24	WOS:000084735900016
J	Bellingham, MC; Walmsley, B				Bellingham, MC; Walmsley, B			A novel presynaptic inhibitory mechanism underlies paired pulse depression at a fast central synapse	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; ANTEROVENTRAL COCHLEAR NUCLEUS; READILY RELEASABLE POOL; TRANSMITTER RELEASE; TIME-COURSE; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; RECEPTOR DESENSITIZATION; GLUTAMATE RECEPTORS; CLIMBING FIBER	Several distinct mechanisms may cause synaptic depression, a common form of short-term synaptic plasticity. These include postsynaptic receptor desensitization, presynaptic depletion of releasable vesicles, or other presynaptic mechanisms depressing vesicle release. At the endbulb of Held, a fast central calyceal synapse in the auditory pathway, cyclothiazide (CTZ) abolished marked paired pulse depression (PPD) by acting presynaptically to enhance transmitter release, rather than by blocking postsynaptic receptor desensitization. PPD and its response to CTZ were not altered by prior depletion of the releasable vesicle pool but were blocked by lowering external calcium concentration, while raising external calcium enhanced PPD. We conclude that a major component of PPD at the endbulb is due to a novel, transient depression of release, which is dependent on the level of presynaptic calcium entry and is CTZ sensitive.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Synapt Struct & Funct Grp, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Bellingham, MC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Synapt Struct & Funct Grp, Canberra, ACT 0200, Australia.	mark.bellingham@anu.edu.au	Bellingham, Mark/G-1697-2011; Oka, Yoshitaka/C-9670-2010	Bellingham, Mark/0000-0001-9189-4430; Oka, Yoshitaka/0000-0002-3482-3051				AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HOYT KR, 1995, J NEUROCHEM, V64, P2049; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; ISAACSON JS, 1995, J NEUROPHYSIOL, V73, P964, DOI 10.1152/jn.1995.73.3.964; Isaacson JS, 1996, J NEUROPHYSIOL, V76, P1566, DOI 10.1152/jn.1996.76.3.1566; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Katz B., 1969, RELEASE NEURAL TRANS; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MENNERICK S, 1995, J NEUROSCI, V15, P3178; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; ODonovan MJ, 1997, TRENDS NEUROSCI, V20, P431, DOI 10.1016/S0166-2236(97)01124-7; Oertel D, 1997, NEURON, V19, P959, DOI 10.1016/S0896-6273(00)80388-8; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Reist NE, 1998, J NEUROSCI, V18, P7662; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; THIES RE, 1965, J NEUROPHYSIOL, V28, P427, DOI 10.1152/jn.1965.28.3.427; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Varela JA, 1997, J NEUROSCI, V17, P7926; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; VYKLICKY L, 1991, NEURON, V7, P971, DOI 10.1016/0896-6273(91)90342-W; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WINSLOW JL, 1994, J NEUROPHYSIOL, V72, P1769, DOI 10.1152/jn.1994.72.4.1769; Wu MN, 1997, CURR OPIN NEUROBIOL, V7, P624, DOI 10.1016/S0959-4388(97)80081-5; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	64	135	135	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1999	23	1					159	170		10.1016/S0896-6273(00)80762-X	http://dx.doi.org/10.1016/S0896-6273(00)80762-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402202	Bronze			2022-12-24	WOS:000080681200019
J	Jo, YH; Schlichter, R				Jo, YH; Schlichter, R			Synaptic corelease of ATP and GABA in cultured spinal neurons	NATURE NEUROSCIENCE			English	Article							DORSAL HORN NEURONS; INTERMEDIATE LOBE CELLS; NERVOUS-SYSTEM; SUBSTANTIA-GELATINOSA; GLUTAMATE RELEASE; RECEPTORS; TRANSMISSION; CORD; LOCALIZATION; ADENOSINE	In the spinal dorsal horn (DH), transmission and modulation of peripheral nociceptive (pain-inducing) messages involve classical neurotransmitters and neuropeptides. We show that approximately half of DH neurons use ATP as a fast excitatory neurotransmitter acting at ionotropic P2X postsynaptic receptors. ATP was not codetected with glutamate but was coreleased with the inhibitory neurotransmitter GABA. Moreover, adenosine, probably generated by extracellular metabolism of ATP, finely tuned GABAergic inhibitory postsynaptic currents. Differential modulation of excitatory versus inhibitory components of this mixed cotransmission may help to explain changes in sensory message processing in the DH during mechanical hyperalgesia and neuropathic pain.	Univ Strasbourg, CNRS, Lab Neurophysiol Cellulaire & Integree, UMR 7519, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schlichter, R (corresponding author), Univ Strasbourg, CNRS, Lab Neurophysiol Cellulaire & Integree, UMR 7519, 21 Rue Descartes, Strasbourg, France.	schlichter@neurochem.u-strasbg.fr		Jo, Young-Hwan/0000-0001-6939-8000				Bardoni R, 1997, J NEUROSCI, V17, P5297; BURNSTOCK G, 1972, BRIT J PHARMACOL, V44, P451, DOI 10.1111/j.1476-5381.1972.tb07283.x; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Burnstock G, 1996, CURR OPIN NEUROBIOL, V6, P526, DOI 10.1016/S0959-4388(96)80060-2; Coggeshall RE, 1997, BRAIN RES REV, V24, P28, DOI 10.1016/S0165-0173(97)00010-6; Collo G, 1996, J NEUROSCI, V16, P2495; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; Feoktistov I, 1997, PHARMACOL REV, V49, P381; FYFFE REW, 1984, P NATL ACAD SCI-BIOL, V81, P6890, DOI 10.1073/pnas.81.21.6890; GALLIGAN JJ, 1994, J NEUROSCI, V14, P7563; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hu ZH, 1997, J PHYSIOL-LONDON, V501, P67, DOI 10.1111/j.1469-7793.1997.067bo.x; JAHR CE, 1983, NATURE, V304, P730, DOI 10.1038/304730a0; Jo YH, 1998, J NEUROSCI, V18, P2377; Jo YH, 1998, J NEUROPHYSIOL, V79, P1583, DOI 10.1152/jn.1998.79.3.1583; JOHNSON MD, 1994, NEURON, V12, P433, DOI 10.1016/0896-6273(94)90283-6; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; LI J, 1995, J NEUROSCI, V15, P3357; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; North RA, 1997, CURR OPIN NEUROBIOL, V7, P346, DOI 10.1016/S0959-4388(97)80062-1; OLSEN RW, 1990, FASEB J, V4, P1469, DOI 10.1096/fasebj.4.5.2155149; Poisbeau P, 1996, J NEUROSCI, V16, P4835; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ralevic V, 1998, PHARMACOL REV, V50, P413; SALTER MW, 1993, PROG NEUROBIOL, V41, P125, DOI 10.1016/0301-0082(93)90006-E; SAWYNOK J, 1993, BRAIN RES, V610, P32, DOI 10.1016/0006-8993(93)91213-C; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; TODD AJ, 1993, PROG NEUROBIOL, V41, P609, DOI 10.1016/0301-0082(93)90045-T; Todorov LD, 1997, NATURE, V387, P76, DOI 10.1038/387076a0; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; YOSHIMURA M, 1989, J NEUROPHYSIOL, V62, P96, DOI 10.1152/jn.1989.62.1.96; ZHANG ZW, 1991, BRIT J PHARMACOL, V102, P19, DOI 10.1111/j.1476-5381.1991.tb12125.x; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	40	286	297	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					241	245		10.1038/6344	http://dx.doi.org/10.1038/6344			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195216				2022-12-24	WOS:000081684500011
J	Thompson, KG; Schall, JD				Thompson, KG; Schall, JD			The detection of visual signals by macaque frontal eye field during masking	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL NEURONS; CEREBRAL-CORTEX; STRIATE CORTEX; RESPONSES; REPRESENTATION; ENHANCEMENT; INITIATION; CORRELATE; SYSTEM; AREAS	The neural link between a sensory signal and its behavioral report was investigated in macaques trained to locate an intermittently detectable visual target. Neurons in the frontal eye field, an area involved in converting the outcome of visual processing into motor commands, responded at short latencies to the target stimulus whether or not the monkey reported its presence. Neural activity immediately preceding the visual response to the mask was significantly greater on hits than on misses, and was significantly greater on false alarms than on correct rejections. The results show that visual signals masked by light are not filtered out at early stages of visual processing; furthermore, the magnitude of early visual responses in prefrontal cortex predicts the behavioral report.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University	Thompson, KG (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Wilson Hall, Nashville, TN 37240 USA.	kirk.g.thompson@vanderbilt.edu			NATIONAL EYE INSTITUTE [R01EY008890, P30EY008126] Funding Source: NIH RePORTER; NEI NIH HHS [P30-EY08126, R01-EY08890] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; COENEN AML, 1972, EXP BRAIN RES, V15, P441; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; FEHMI LG, 1969, EXP BRAIN RES, V7, P299; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; Green DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANES DP, 1995, EXP BRAIN RES, V103, P85; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; Koch C, 1996, CURR OPIN NEUROBIOL, V6, P158, DOI 10.1016/S0959-4388(96)80068-7; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; NOWAL K, 1997, CEREB CORTEX, V12, P205; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 1997, CEREBR CORT, V12, P527; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SCHILLER PH, 1968, VISION RES, V8, P855, DOI 10.1016/0042-6989(68)90135-1; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766	31	112	115	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					283	288		10.1038/6398	http://dx.doi.org/10.1038/6398			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195223				2022-12-24	WOS:000081684500018
J	Rao, RPN; Ballard, DH				Rao, RPN; Ballard, DH			Predictive coding in the visual cortex: a functional interpretation of some extra-classical receptive-field effects	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RESPONSE PROPERTIES; NATURAL SCENES; RECOGNITION; GENERATION; NEURONS; MECHANISMS; INHIBITION; NEOCORTEX; MACAQUE	We describe a model of visual processing in which feedback connections from a higher- to a lower-order visual cortical area carry predictions of lower-level neural activities, whereas the feedforward connections carry the residual errors between the predictions and the actual lower-level activities. When exposed to natural images, a hierarchical network of model neurons implementing such a model developed simple-cell-like receptive fields. A subset of neurons responsible for carrying the residual errors showed endstopping and other extra-classical receptive-field effects. These results suggest that rather than being exclusively feedforward phenomena, nonclassical surround effects in the visual cortex may also result from cortico-cortical feedback as a consequence of the visual system using an efficient hierarchical strategy for encoding natural images.	Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Univ Rochester, Dept Comp Sci, Rochester, NY 14627 USA	Salk Institute; Salk Institute; University of Rochester	Rao, RPN (corresponding author), Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Rao, Rajesh P. N./0000-0003-0682-8952				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; BOLZ J, 1989, TRENDS NEUROSCI, V12, P292, DOI 10.1016/0166-2236(89)90009-X; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; Dan Y, 1996, J NEUROSCI, V16, P3351; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Gross C G, 1992, Curr Opin Neurobiol, V2, P156, DOI 10.1016/0959-4388(92)90004-5; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Lee DD, 1997, ADV NEUR IN, V9, P515; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LUETTGEN MR, 1995, IEEE T IMAGE PROCESS, V4, P194, DOI 10.1109/83.342185; MacKay D. M., 1956, ANN MATH STUD, V34, P235, DOI DOI 10.1515/9781400882618-012; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PECE AEC, 1992, ARTIFICIAL NEURAL NE, V2, P865; PETERHANS E, 1991, TRENDS NEUROSCI, V14, P112, DOI 10.1016/0166-2236(91)90072-3; Peterhans E., 1991, REPRESENTATIONS VISI, P111; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rao RPN, 1997, NEURAL COMPUT, V9, P721, DOI 10.1162/neco.1997.9.4.721; RAO RPN, IN PRESS VISION RES; Rissanen J., 1989, STOCHASTIC COMPLEXIT; SANDELL JH, 1982, J NEUROPHYSIOL, V48, P38, DOI 10.1152/jn.1982.48.1.38; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Softky WR, 1996, ADV NEUR IN, V8, P809; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; ULLMAN S, 1994, LARGE SCALE THEORIES, P257; Zipser K, 1996, J NEUROSCI, V16, P7376; [No title captured]	50	2538	2575	8	183	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					79	87		10.1038/4580	http://dx.doi.org/10.1038/4580			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195184				2022-12-24	WOS:000078409300017
J	Xia, J; Zhang, XQ; Staudinger, J; Huganir, RL				Xia, J; Zhang, XQ; Staudinger, J; Huganir, RL			Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1	NEURON			English	Article							LONG-TERM POTENTIATION; SILENT SYNAPSES; FASCICLIN-II; GLUTAMATE; SYSTEM; PSD-95; YEAST; LTP; RECOGNITION; HIPPOCAMPUS	Synaptic clustering of neurotransmitter receptors is crucial for efficient signal transduction and integration in neurons. PDZ domain-containing proteins such as PSD-95/SAP90 interact with the intracellular C termini of a variety of receptors and are thought to be important in the targeting and anchoring of receptors to specific synapses. Here, we show that PICK1 (protein interacting with C kinase), a PDZ domain-containing protein, interacts with the C termini of alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) receptors in vitro and in vivo. In neurons, PICK1 specifically colocalizes with AMPA receptors at excitatory synapses. Furthermore, PICK1 induces clustering of AMPA receptors in heterologous expression systems. These results suggest that PICK1 may play an important role in the modulation of synaptic transmission by regulating the synaptic targeting of AMPA receptors.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Glaxo Wellcome Inc, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA	Howard Hughes Medical Institute; Johns Hopkins University; GlaxoSmithKline	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.		Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188				Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLACKSTONE CD, 1992, ANN NEUROL, V31, P680, DOI 10.1002/ana.410310620; BLAKE DJ, 1995, TRENDS BIOCHEM SCI, V20, P133, DOI 10.1016/S0968-0004(00)88986-0; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; James P, 1996, GENETICS, V144, P1425; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	40	468	496	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					179	187		10.1016/S0896-6273(00)80689-3	http://dx.doi.org/10.1016/S0896-6273(00)80689-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027300	Bronze			2022-12-24	WOS:000078410300023
J	Koleske, AJ; Gifford, AM; Scott, ML; Nee, M; Bronson, RT; Miczek, KA; Baltimore, D				Koleske, AJ; Gifford, AM; Scott, ML; Nee, M; Bronson, RT; Miczek, KA; Baltimore, D			Essential roles for the Abl and Arg tyrosine kinases in neurulation	NEURON			English	Article							C-ABL; DNA-DAMAGE; SUBCELLULAR-LOCALIZATION; ATAXIA-TELANGIECTASIA; HUMAN LEUKEMIA; CELL-GROWTH; PROTEIN; GENE; MICE; BINDING	The Abl and Arg tyrosine kinases play fundamental roles in the development and function of the central nervous system. Arg is most abundant in adult mouse brain, especially in synapse-rich regions. arg(-/-) mice develop normally but exhibit multiple behavioral abnormalities, suggesting that arg(-/-) brains suffer from defects in neuronal function. Embryos deficient in both Abl and Arg suffer from defects in neurulation and die before 11 days postcoitum (dpc). Although they divide normally, abl(-/-)arg(-/-) neuroepithelial cells display gross alterations in their actin cytoskeleton. We find that Abl and Arg colocalize with each other and with actin microfilaments at the apical surface of the developing neuroepithelium. Thus, Abl and Arg play essential roles in neurulation and can regulate the structure of the actin cytoskeleton.	MIT, Dept Biol, Cambridge, MA 02139 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Dept Vet Med, Dept Pathol, Boston, MA 02111 USA; CALTECH, Pasadena, CA 91125 USA; Tufts Univ, Dept Psychol Pharmacol & Psychiat, Medford, MA 02155 USA	Massachusetts Institute of Technology (MIT); Tufts University; Tufts University; California Institute of Technology; Tufts University	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	anthony.koleske@yale.edu			NCI NIH HHS [CA51462] Funding Source: Medline; NIAAA NIH HHS [AA5122] Funding Source: Medline; NIDA NIH HHS [DA02632] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA005122, R01AA005122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BURNSIDE B, 1973, AM ZOOL, V13, P989; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DALEY GQ, 1991, ADV CANCER RES, V57, P151; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; GOGA A, 1995, ONCOGENE, V11, P791; GOLDOWITZ D, 1992, TECHNIQUES GENETIC A; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Hardin JD, 1996, ONCOGENE, V12, P2669; HARDIN JD, 1995, CELL IMMUNOL, V165, P44, DOI 10.1006/cimm.1995.1185; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; HUBER G, 1984, J NEUROSCI, V4, P151; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; KARFUNKEL P, 1972, J EXP ZOOL, V181, P289, DOI 10.1002/jez.1401810302; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; KRUH GD, 1986, SCIENCE, V234, P1545, DOI 10.1126/science.3787260; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; MATTIONI T, 1995, ONCOGENE, V10, P1325; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; MCWHIRTER JR, 1991, MOL CELL BIOL, V11, P1553, DOI 10.1128/MCB.11.3.1553; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; MICZEK KA, 1978, PSYCHOPHARMACOLOGY, V57, P47, DOI 10.1007/BF00426957; Mysliwiec T, 1996, ONCOGENE, V12, P631; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; ROSENBERG N, 1988, ADV VIRUS RES, V35, P39; Salgia R, 1997, J CLIN INVEST, V100, P46, DOI 10.1172/JCI119520; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Smith JL, 1997, TRENDS NEUROSCI, V20, P510, DOI 10.1016/S0166-2236(97)01121-1; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Wang BL, 1996, ONCOGENE, V13, P193; Wang BL, 1996, ONCOGENE, V12, P1921; WANG JYJ, 1984, CELL, V36, P349; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0	53	327	335	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1259	1272		10.1016/S0896-6273(00)80646-7	http://dx.doi.org/10.1016/S0896-6273(00)80646-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883720	hybrid			2022-12-24	WOS:000077910600009
J	Wall, MJ; Usowicz, MM				Wall, MJ; Usowicz, MM			Development of the quantal properties of evoked and spontaneous synaptic currents at a brain synapse	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; NEUROMUSCULAR-JUNCTION; TEMPERATURE-DEPENDENCE; HIPPOCAMPAL SLICES; RECEPTOR CHANNELS; RAT HIPPOCAMPUS; TRANSMISSION; MINIATURE; NEURONS	In many studies of central synaptic transmission, the quantal properties of miniature synaptic events do not match those derived from synaptic events evoked by action potentials. Here we show that at mossy fiber-granule cell (MF-gc) synapses of mature cerebellum, evoked excitatory postsynaptic currents (EPSCs) are multiquantal, and their amplitudes vary in discrete steps, whereas miniature (m)EPSCs are monoquantal or multiquantal with quantal parameters identical to those of the EPSCs. in contrast, at immature MF-gc synapses, EPSCs are multiquantal, but their amplitudes do not vary in discrete steps, whereas most mEPSCs seem to be monoquantal with a broad and skewed amplitude distribution. The results demonstrate that quantal variance decreases during synaptic development. They also directly confirm the quantal hypothesis of neurotransmission at a mature brain synapse.	Univ Bristol, Dept Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Usowicz, MM (corresponding author), Univ Bristol, Dept Pharmacol, Univ Walk, Bristol BS8 1TD, Avon, England.	m.m.usowicz@bris.ac.uk	wall, mark/A-7470-2010	wall, mark/0000-0002-7014-1867; Usowicz, Maria/0000-0002-4844-4546	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABDULGHANI MA, 1996, J PHYSIOL-LONDON, V495, P112; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P665, DOI 10.1113/jphysiol.1972.sp010053; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bekkers John M., 1994, Current Opinion in Neurobiology, V4, P360, DOI 10.1016/0959-4388(94)90097-3; BENNETT MR, 1995, PROG NEUROBIOL, V46, P331, DOI 10.1016/0301-0082(94)00061-L; BLACKMAN JG, 1963, J PHYSIOL-LONDON, V167, P389, DOI 10.1113/jphysiol.1963.sp007157; BORNSTEIN JC, 1978, J PHYSIOL-LONDON, V282, P375, DOI 10.1113/jphysiol.1978.sp012470; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; COHEN IS, 1983, J PHYSIOL-LONDON, V336, P335, DOI 10.1113/jphysiol.1983.sp014584; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DENNIS MJ, 1971, PROC R SOC SER B-BIO, V177, P509, DOI 10.1098/rspb.1971.0045; DILGER JP, 1991, BIOCHIM BIOPHYS ACTA, V1063, P253, DOI 10.1016/0005-2736(91)90379-M; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FELDMEYER D, 1993, J PHYSIOL-LONDON, V459, pP284; FOX CA, 1967, PROG BRAIN RES, V25, P172; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Katz B., 1966, NERVE MUSCLE SYNAPSE; KORN H, 1993, J NEUROPHYSIOL, V70, P1249, DOI 10.1152/jn.1993.70.3.1249; KRASZEWSKI K, 1992, NEUROSCIENCE, V47, P555, DOI 10.1016/0306-4522(92)90165-X; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LIU GS, 1992, J NEUROPHYSIOL, V68, P1468, DOI 10.1152/jn.1992.68.4.1468; MARTIN AR, 1964, J PHYSIOL-LONDON, V175, P1; MASON CA, 1984, J NEUROSCI, V4, P1715; MEIRI U, 1971, J PHYSIOL-LONDON, V215, P709, DOI 10.1113/jphysiol.1971.sp009493; Min MY, 1996, J PHYSIOL-LONDON, V494, P171, DOI 10.1113/jphysiol.1996.sp021483; Palay SL, 1974, CEREBELLAR CORTEX CY, P142; Paulsen O, 1996, J PHYSIOL-LONDON, V496, P759, DOI 10.1113/jphysiol.1996.sp021725; PAULSEN O, 1994, J PHYSIOL-LONDON, V480, P505, DOI 10.1113/jphysiol.1994.sp020379; Peters A., 1991, FINE STRUCTURE NERVO; ROPERT N, 1990, J PHYSIOL-LONDON, V428, P707, DOI 10.1113/jphysiol.1990.sp018236; SILVER RA, 1992, NATURE, V355, P163, DOI 10.1038/355163a0; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Tia S, 1996, J NEUROSCI, V16, P3630; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; ULRICH D, 1993, J NEUROPHYSIOL, V69, P1769, DOI 10.1152/jn.1993.69.5.1769; VANDERKLOOT W, 1984, J NEUROSCI, V9, P2200; VONKITZING E, 1994, MOL CELLULAR MECH NE, P235; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; WALMSLEY B, 1995, P ROY SOC B-BIOL SCI, V261, P245, DOI 10.1098/rspb.1995.0144	50	70	70	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					675	682		10.1038/3677	http://dx.doi.org/10.1038/3677			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196583				2022-12-24	WOS:000077323400011
J	Impey, S; Obrietan, K; Wong, ST; Poser, S; Yano, S; Wayman, G; Deloulme, JC; Chan, G; Storm, DR				Impey, S; Obrietan, K; Wong, ST; Poser, S; Yano, S; Wayman, G; Deloulme, JC; Chan, G; Storm, DR			Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL GROWTH-FACTOR; LONG-TERM POTENTIATION; C-FOS TRANSCRIPTION; GENE-EXPRESSION; MAP KINASE; SIGNALING PATHWAY; PC12 CELLS; MEMBRANE DEPOLARIZATION; CALCIUM REGULATION	Although Ca2+-stimulated cAMP response element binding protein- (CREB-) dependent transcription has been implicated in growth, differentiation, and neuroplasticity, mechanisms for Ca2+-activated transcription have not been defined. Here, we report that extracellular signal-related protein kinase (ERK) signaling is obligatory for Ca2+-stimulated transcription in PC12 cells and hippocampal neurons. The sequential activation of ERK and Rsk2 by Ca2+ leads to the phosphorylation and transactivation of CREB. Interestingly, the Ca2+-induced nuclear translocation of ERK and Rsk2 to the nucleus requires protein kinase A (PKA) activation. This may explain why PKA activity is required for Ca2+-stimulated CREB-dependent transcription. Furthermore, the full expression of the late phase of long-term potentiation (L-LTP) and L-LTP-associated CRE-mediated transcription requires ERK activation, suggesting that the activation of CREB by ERK plays a critical role in the formation of long lasting neuronal plasticity.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; Oregon Health & Science University	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.		Deloulme, Jean Christophe/P-6858-2017; Chan, Guy/B-1862-2009	Deloulme, Jean Christophe/0000-0002-2234-5865; 	NINDS NIH HHS [NS 20498] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHN NG, 1991, J BIOL CHEM, V266, P4220; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Chan GCK, 1998, J NEUROSCI, V18, P5322, DOI 10.1523/JNEUROSCI.18-14-05322.1998; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Ginty DD, 1997, NEURON, V18, P183, DOI 10.1016/S0896-6273(00)80258-5; GINTY DD, 1991, J BIOL CHEM, V266, P17454; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Gringhuis SI, 1997, J BIOL CHEM, V272, P31809, DOI 10.1074/jbc.272.50.31809; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; IMPEY S, 1994, MOL CELL BIOL, V14, P8272, DOI 10.1128/MCB.14.12.8272; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Johnson CM, 1997, J NEUROSCI, V17, P6189; JOHNSON JA, 1994, J BIOL CHEM, V269, P18856; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; MARK MD, 1995, J CELL BIOL, V130, P701, DOI 10.1083/jcb.130.3.701; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEGER R, 1994, J BIOL CHEM, V269, P25699; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	62	747	766	1	29	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					869	883		10.1016/S0896-6273(00)80602-9	http://dx.doi.org/10.1016/S0896-6273(00)80602-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808472	Bronze			2022-12-24	WOS:000076697300029
J	Saberi, K; Takahashi, Y; Konishi, M; Albeck, Y; Arthur, BJ; Farahbod, H				Saberi, K; Takahashi, Y; Konishi, M; Albeck, Y; Arthur, BJ; Farahbod, H			Effects of interaural decorrelation on neural and behavioral detection of spatial cues	NEURON			English	Article							AUDITORY-NERVE DATA; COMPLEX BINAURAL STIMULI; BARN OWL; CROSS-CORRELATION; TIME DIFFERENCE; OPTIC TECTUM; COINCIDENCE DETECTION; SOUND LOCALIZATION; LOW-FREQUENCY; SPACE MAP	The detection of interaural time differences (ITDs) for sound localization critically depends on the similarity between the left and right ear signals (interaural correlation). We show that, like humans, owls can localize phantom sound sources well until the correlation declines to a very low value, below which their performance rapidly deteriorates. Decreasing interaural correlation also causes the response of the owl's tectal auditory neurons to decline nonlinearly, with a rapid drop followed by a more gradual reduction. A detection-theoretic analysis of the statistical properties of neuronal responses could account for the variance of behavioral responses as interaural correlation is decreased. Finally, cross-correlation analysis suggests that low interaural correlations cause misalignment of cross-correlation peaks across different frequencies, contributing heavily to the nonlinear decline in neural and ultimately behavioral performance.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Saberi, K (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	kourosh@caltech.edu	Saberi, Kourosh/GXG-0944-2022	Albeck, Yehuda/0000-0003-1021-0178	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000134, R29DC003648] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00134-19A1, DC03648-01] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALBECK Y, 1995, J NEUROPHYSIOL, V74, P1689, DOI 10.1152/jn.1995.74.4.1689; Batra R, 1997, J NEUROPHYSIOL, V78, P1237, DOI 10.1152/jn.1997.78.3.1237; BLAUERT J, 1978, ACUSTICA, V39, P96; BLAUERT J, 1986, J ACOUST SOC AM, V79, P806, DOI 10.1121/1.393471; Blauert J, 1996, SPATIAL HEARING PSYC; CARR CE, 1990, J NEUROSCI, V10, P3227; COLBURN HS, 1973, J ACOUST SOC AM, V54, P1458, DOI 10.1121/1.1914445; COLBURN HS, 1977, J ACOUST SOC AM, V61, P525, DOI 10.1121/1.381294; COLBURN HS, 1978, J ACOUST SOC AM, V64, P96; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; Dyson ML, 1998, J COMP PHYSIOL A, V182, P695, DOI 10.1007/s003590050214; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; FUJITA I, 1991, J NEUROSCI, V11, P722; GRANTHAM DW, 1979, J ACOUST SOC AM, V65, P1509, DOI 10.1121/1.382915; Green DM, 1966, SIGNAL DETECTION THE; HOLDSWORTH J, 1988, 2341 U CAMBR APPL PS; JEFFRESS LA, 1962, J ACOUST SOC AM, V34, P1658, DOI 10.1121/1.1909077; JEFFRESS LA, 1962, J ACOUST SOC AM, V32, P1122; Keller CH, 1996, J NEUROSCI, V16, P4300; Keller CH, 1996, J COMP PHYSIOL A, V178, P499; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1984, J NEUROPHYSIOL, V52, P709, DOI 10.1152/jn.1984.52.4.709; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Konishi M., 1988, AUDITORY FUNCTION NE, P721; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; Litovsky RY, 1997, J NEUROPHYSIOL, V77, P2223, DOI 10.1152/jn.1997.77.4.2223; McAlpine D, 1998, J NEUROSCI, V18, P6026; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P637, DOI 10.1007/BF00614506; Mori K, 1997, HEARING RES, V111, P22, DOI 10.1016/S0378-5955(97)00090-7; Pena JL, 1996, J NEUROSCI, V16, P7046; POLLACK I, 1959, J ACOUST SOC AM, V31, P1250, DOI 10.1121/1.1907852; ROBINSON DE, 1963, J ACOUST SOC AM, V35, P1947, DOI 10.1121/1.1918864; Saberi K, 1996, PSYCHOL REV, V103, P137, DOI 10.1037/0033-295X.103.1.137; Saberi K, 1998, J ACOUST SOC AM, V103, P2551, DOI 10.1121/1.422776; Saberi K, 1995, J ACOUST SOC AM, V98, P3146, DOI 10.1121/1.413804; SAYERS BM, 1957, J ACOUST SOC AM, V29, P973, DOI 10.1121/1.1914990; SHACKLETON TM, 1992, J ACOUST SOC AM, V91, P2276, DOI 10.1121/1.403663; Siebert WM., 1968, RECOGNIZING PATTERNS, V104, P602; STERN RM, 1978, J ACOUST SOC AM, V64, P127, DOI 10.1121/1.381978; STERN RM, 1988, J ACOUST SOC AM, V84, P156, DOI 10.1121/1.396982; STERN RM, 1997, BINAURAL SPATIAL HEA, P499; Swets JA, 1964, SIGNAL DETECTION REC; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; TAKAHASHI TT, 1989, ANN NY ACAD SCI, V563, P101, DOI 10.1111/j.1749-6632.1989.tb42193.x; TAKAHASHI TT, 1989, J EXP BIOL, V146, P307; TRAHIOTIS C, 1994, J ACOUST SOC AM, V96, P3804, DOI 10.1121/1.410570; Van Trees H. L., 1968, DETECTION ESTIMATI 1; YIN TCT, 1987, J NEUROPHYSIOL, V58, P562, DOI 10.1152/jn.1987.58.3.562; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	50	62	64	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					789	798		10.1016/S0896-6273(00)80595-4	http://dx.doi.org/10.1016/S0896-6273(00)80595-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808465	Bronze			2022-12-24	WOS:000076697300022
J	Fairman, WA; Sonders, MS; Murdoch, GH; Amara, SG				Fairman, WA; Sonders, MS; Murdoch, GH; Amara, SG			Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4	NATURE NEUROSCIENCE			English	Article							PURKINJE-CELL SYNAPSES; PROTEIN-KINASE-C; LIPOXYGENASE METABOLITES; CHLORIDE CONDUCTANCE; CLIMBING FIBER; ION CHANNELS; GLIAL-CELLS; FATTY-ACIDS; MODULATION; PERMEATION	Arachidonic acid modulates both electrical and biochemical properties of membrane proteins involved in cellular signaling. In Xenopus laevis oocytes expressing the excitatory amino acid transporter EAAT4, physiologically relevant concentrations of arachidonic acid increase the amplitude of the substrate-activated current by roughly twofold at -60 mV. This stimulation is not attributable to the modulation of either substrate/ion cotransport or the ligand-gated chloride current, the major conductance associated with this carrier. ion-substitution experiments reveal that arachidonic: acid stimulates a proton-selective conductance. The effect does not require metabolism of arachidonic acid and is not blocked by inhibitors of endogenous oocyte ion-exchangers. This proton conductance expands the complex repertoire of the ligand-gated channel properties associated with EAAT4.	Oregon Hlth Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst Adv Biomed Res, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Pathol, Portland, OR 97201 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Amara, SG (corresponding author), Oregon Hlth Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA.	amaras@ohsu.edu		Amara, Susan/0000-0001-8914-1106	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033273] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33273] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; ATTWELL D, 1993, SEMIN NEUROSCI, V5, P159, DOI 10.1016/S1044-5765(05)80049-1; BARBOUR B, 1989, NATURE, V342, P918, DOI 10.1038/342918a0; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; CASADO M, 1993, J BIOL CHEM, V268, P27313; CHAN PH, 1983, J NEUROCHEM, V40, P309, DOI 10.1111/j.1471-4159.1983.tb11284.x; Conradt M, 1997, J NEUROCHEM, V68, P1244, DOI 10.1046/j.1471-4159.1997.68031244.x; COSTA PF, 1989, J PHYSIOL-LONDON, V413, P199, DOI 10.1113/jphysiol.1989.sp017649; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DEAMER DW, 1989, J MEMBRANE BIOL, V107, P91, DOI 10.1007/BF01871715; DEAMER DW, 1987, J BIOENERG BIOMEMBR, V19, P457; DeCoursey TE, 1997, J GEN PHYSIOL, V109, P415, DOI 10.1085/jgp.109.4.415; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fersht AR., 1977, ENZYME STRUCTURE MEC; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Kanai Y, 1997, CURR OPIN CELL BIOL, V9, P565, DOI 10.1016/S0955-0674(97)80035-X; Kataoka Y, 1997, J NEUROSCI, V17, P7017; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; Lester HA, 1996, NEURON, V17, P807, DOI 10.1016/S0896-6273(00)80213-5; Linden DJ, 1995, NEURON, V15, P1393, DOI 10.1016/0896-6273(95)90017-9; ORDWAY RW, 1991, TRENDS NEUROSCI, V14, P96, DOI 10.1016/0166-2236(91)90069-7; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Pellerin L, 1997, J NEUROCHEM, V69, P2132; PETROU S, 1993, TRENDS BIOCHEM SCI, V18, P41, DOI 10.1016/0968-0004(93)90050-W; PIOMELLI D, 1990, TRENDS PHARMACOL SCI, V11, P367, DOI 10.1016/0165-6147(90)90182-8; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; POTTOSIN II, 1993, J MEMBRANE BIOL, V136, P113, DOI 10.1007/BF02505756; QUICK MW, 1994, METHODS NEUROSCI, V14, P261; SESAKI S, 1992, BIOCHIM BIOPHYS ACTA, V1137, P45; SHEARMAN MS, 1989, FEBS LETT, V243, P177, DOI 10.1016/0014-5793(89)80125-5; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Takahashi KI, 1996, NEUROSCI RES, V24, P109, DOI 10.1016/0168-0102(95)00989-2; Takahashi M, 1997, J EXP BIOL, V200, P401; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tanaka J, 1997, NEUROREPORT, V8, P2461, DOI 10.1097/00001756-199707280-00010; TOLNER B, 1995, MOL MICROBIOL, V18, P123, DOI 10.1111/j.1365-2958.1995.mmi_18010123.x; TROTTI D, 1995, J BIOL CHEM, V270, P9890, DOI 10.1074/jbc.270.17.9890; VOLTERRA A, 1992, J NEUROCHEM, V59, P600, DOI 10.1111/j.1471-4159.1992.tb09411.x; VOLTERRA A, 1992, ADV EXP MED BIOL, V318, P147; VOLTERRA A, 1994, MOL PHARMACOL, V46, P986; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yamada K, 1996, NEUROREPORT, V7, P2013, DOI 10.1097/00001756-199608120-00032; ZERANGUE N, 1995, J BIOL CHEM, V270, P6433, DOI 10.1074/jbc.270.12.6433; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	50	53	56	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					105	113		10.1038/355	http://dx.doi.org/10.1038/355			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195124				2022-12-24	WOS:000076361100010
J	Mareschal, I; Baker, CL				Mareschal, I; Baker, CL			A cortical locus for the processing of contrast-defined contours	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; CATS STRIATE CORTEX; VISUAL-CORTEX; MOTION PERCEPTION; SIMPLE-CELL; SPATIAL SUMMATION; ILLUSORY CONTOURS; RECEPTIVE-FIELDS; 2ND-ORDER MOTION; MACAQUE MONKEY	Object boundaries in the natural environment are often defined by changes in luminance; in other cases, however, there may be no difference in average luminance across the boundary, which is instead defined by more subtle 'second-order' cues, such as changes in the contrast of a fine-grained texture. The detection of luminance boundaries may be readily explained in terms of visual cortical neurons, which compute the linear sum of the excitatory and inhibitory inputs to different parts of their receptive field. The detection of second-order stimuli is less well understood, but is thought to involve a separate nonlinear processing stream, in which boundary detectors would receive inputs from many smaller subunits. To address this, we have examined the properties of cortical neurons which respond to both first- and second-order stimuli. We show that the inputs to these neurons are also oriented, but with no fixed orientational relationship to the neurons they subserve. Our results suggest a flexible mechanism by which the visual cortex can detect object boundaries regardless of whether they are defined by luminance or texture.	Dept Ophthalmol, McGill Vis Res Unit, Montreal, PQ H3A 1A1, Canada	McGill University	Mareschal, I (corresponding author), Dept Ophthalmol, McGill Vis Res Unit, 687 Pine Ave W H4-14, Montreal, PQ H3A 1A1, Canada.	Isabelle@astra.vision.mcgill.ca		Mareschal, Isabelle/0000-0003-4378-600X				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; BADCOCK DR, 1989, VISION RES, V29, P731, DOI 10.1016/0042-6989(89)90035-7; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; DAUGMAN JG, 1995, J OPT SOC AM A, V12, P641, DOI 10.1364/JOSAA.12.000641; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DERRINGTON AM, 1993, CURR BIOL, V3, P800, DOI 10.1016/0960-9822(93)90037-O; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; GRAHAM N, 1992, VISION RES, V32, P719, DOI 10.1016/0042-6989(92)90188-O; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Langley K, 1996, CURR BIOL, V6, P891, DOI 10.1016/S0960-9822(02)00613-9; LEDGEWAY T, 1994, VISION RES, V34, P2727, DOI 10.1016/0042-6989(94)90229-1; LEVAY S, 1981, J NEUROSCI, V1, P956; Mareschal I., 1997, Investigative Ophthalmology and Visual Science, V38, pS624; MARIDA KV, 1972, STAT DIRECTIONAL DAT; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; OLAVARRIA JF, 1992, J NEUROPHYSIOL, V68, P164, DOI 10.1152/jn.1992.68.1.164; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; SHOU T, 1989, J NEUROSCI, V9, P4287; SOLOMON JA, 1994, VISION RES, V34, P2239, DOI 10.1016/0042-6989(94)90105-8; SOODAK RE, 1987, J NEUROPHYSIOL, V58, P267, DOI 10.1152/jn.1987.58.2.267; SPITZER H, 1985, J NEUROPHYSIOL, V53, P1244, DOI 10.1152/jn.1985.53.5.1244; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; VIDYASAGAR TR, 1982, EXP BRAIN RES, V46, P157; VIDYASAGAR TR, 1984, EXP BRAIN RES, V57, P196; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WATSON AB, 1985, J OPT SOC AM A, V2, P322, DOI 10.1364/JOSAA.2.000322; WERKHOVEN P, 1994, VISION RES, V34, P2741, DOI 10.1016/0042-6989(94)90230-5; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; ZHOU YX, 1993, SCIENCE, V261, P98, DOI 10.1126/science.8316862; ZHOU YX, 1994, J NEUROPHYSIOL, V72, P2134, DOI 10.1152/jn.1994.72.5.2134	35	116	117	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					150	154		10.1038/401	http://dx.doi.org/10.1038/401			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195131				2022-12-24	WOS:000076361100017
J	Viaud-Delmon, I; Ivanenko, YP; Berthoz, A; Jouvent, R				Viaud-Delmon, I; Ivanenko, YP; Berthoz, A; Jouvent, R			Sex, lies and virtual reality	NATURE NEUROSCIENCE			English	Article									Coll France, CNRS, LPPA, F-75005 Paris, France; Hop La Pitie Salpetriere, CNRS UMR 7593, F-75013 Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Viaud-Delmon, I (corresponding author), Coll France, CNRS, LPPA, 11 Pl Marcelin Berthelot, F-75005 Paris, France.		Ivanenko, Yury/L-1599-2018	Ivanenko, Yury/0000-0001-9363-9548; Viaud-Delmon, Isabelle/0000-0002-8664-3941				EALS M, 1994, ETHOL SOCIOBIOL, V15, P95, DOI 10.1016/0162-3095(94)90020-5; HALPERN DF, 1986, SEX DIFFERENCE COGNI; Ivanenko YP, 1998, NEUROSCI LETT, V241, P167; LAWTHER A, 1988, AVIAT SPACE ENVIR MD, V59, P399; McBurney DH, 1997, EVOL HUM BEHAV, V18, P165, DOI 10.1016/S1090-5138(97)00001-9; MCGLONE J, 1980, BEHAV BRAIN SCI, V3, P215, DOI 10.1017/S0140525X00004398; SCHOLAN K, 1990, PERCEPT MOTOR SKILL, V71, P763, DOI 10.2466/PMS.71.7.763-768; STUMPF H, 1993, MEM COGNITION, V21, P828, DOI 10.3758/BF03202750; WITTELSON SF, 1995, J NEUROSCI, V15, P3418	9	43	44	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					15	16		10.1038/215	http://dx.doi.org/10.1038/215			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195102				2022-12-24	WOS:000076361000011
J	Schoppa, NE; Westbrook, GL				Schoppa, NE; Westbrook, GL			Regulation of synaptic timing in the olfactory bulb by an A-type potassium current	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL NEURONS; NMDA RECEPTORS; DENDRODENDRITIC INHIBITION; HIPPOCAMPAL-NEURONS; ODOR STIMULATION; SODIUM-CHANNELS; GANGLION-CELLS; GRANULE CELLS; K+ CHANNELS; RAT	Although rapid synaptic transmission confers signal fidelity, the activity of some neuronal circuits depends on prolonged excitation or inhibition. Here we demonstrate that GABAergic granule cells in the rat olfactory bulb produce prolonged inhibition of mitral cells through a precise kinetic matching between transmitter-gated and voltage-gated channels in their dendritic membrane. A transient A-type potassium current (I-A) specifically attenuated dendrodendritic inputs mediated by fast-acting AMPA receptors such that the excitation and subsequent inhibitory output of granule cells followed the prolonged kinetics of their NMDA receptors. Altering the weights of the AMPA and NMDA receptor-mediated inputs by modulating I-A provides a mechanism to regulate the timing of inhibition according to the demands on the bulb network.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Schoppa, NE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026494, R01NS026494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000270] Funding Source: NIH RePORTER; NIDCD NIH HHS [5F32 DC00270] Funding Source: Medline; NINDS NIH HHS [NS26494] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; BARDONI R, 1993, J NEUROPHYSIOL, V69, P2222, DOI 10.1152/jn.1993.69.6.2222; BUZSAKI G, 1997, CAN J PHYSL PHARM, V75, P505; CASSELL JF, 1986, J PHYSIOL-LONDON, V374, P273, DOI 10.1113/jphysiol.1986.sp016079; CHEN QX, 1991, J NEUROSCI, V11, P337; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DICKENSON AH, 1990, BRAIN RES, V506, P31, DOI 10.1016/0006-8993(90)91195-M; GAGE PW, 1992, TRENDS NEUROSCI, V15, P46, DOI 10.1016/0166-2236(92)90025-4; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; HARRISON TA, 1986, J NEUROPHYSIOL, V56, P1571, DOI 10.1152/jn.1986.56.6.1571; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1304, DOI 10.1152/jn.1991.66.4.1304; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1982, J PHYSIOL-LONDON, V326, P213, DOI 10.1113/jphysiol.1982.sp014187; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LUNDH H, 1978, BRAIN RES, V153, P307, DOI 10.1016/0006-8993(78)90409-2; Magee JC, 1998, J NEUROSCI, V18, P7613; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MOLGO J, 1977, J PHARMACOL EXP THER, V203, P653; MORI K, 1978, J PHYSIOL-LONDON, V279, P569, DOI 10.1113/jphysiol.1978.sp012362; MULLER D, 1986, J PHYSIOL-LONDON, V379, P479, DOI 10.1113/jphysiol.1986.sp016265; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; SALT TE, 1986, NATURE, V322, P263, DOI 10.1038/322263a0; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SEGAL M, 1984, J NEUROSCI, V4, P604; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; TANK DW, 1994, SCIENCE, V265, P1819, DOI 10.1126/science.265.5180.1819; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	47	166	171	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1106	1113		10.1038/16033	http://dx.doi.org/10.1038/16033			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570488				2022-12-24	WOS:000085810100015
J	Fenstemaker, SB; Zup, SL; Frank, LG; Glickman, SE; Forger, NG				Fenstemaker, SB; Zup, SL; Frank, LG; Glickman, SE; Forger, NG			A sex difference in the hypothalamus of the spotted hyena	NATURE NEUROSCIENCE			English	Article							PREOPTIC AREA; MALE FERRETS; LESIONS; DIFFERENTIATION		Univ Massachusetts, Ctr Neuroendocrine Studies, Amherst, MA 01003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of Massachusetts System; University of Massachusetts Amherst; New York University; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Berkeley	Forger, NG (corresponding author), Univ Massachusetts, Ctr Neuroendocrine Studies, Tobin Hall, Amherst, MA 01003 USA.	nforger@psych.umass.edu			NICHD NIH HHS [HD33044, HD01188] Funding Source: Medline; NIMH NIH HHS [MH-39914] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033044, R29HD033044, K02HD001188] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		COMMINS D, 1984, BRAIN RES BULL, V13, P185, DOI 10.1016/0361-9230(84)90020-0; DEJONGE FH, 1989, BRAIN RES BULL, V23, P483, DOI 10.1016/0361-9230(89)90194-9; FRANK LG, 1991, SCIENCE, V252, P702, DOI 10.1126/science.2024122; GLICKMAN SE, 1992, ANN NY ACAD SCI, V662, P135, DOI 10.1111/j.1749-6632.1992.tb22858.x; GLICKMAN SE, 1992, J REPROD FERTIL, V95, P451; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; Holekamp KE, 1998, BIOSCIENCE, V48, P997, DOI 10.2307/1313456; KRUUK H, 1972, SPOTTED HYENA; MATTHEWS L. HARRISON, 1939, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P1; PAREDES RG, 1995, J NEUROSCI, V15, P6619; Sachs BD, 1988, PHYSL REPROD; TOBET SA, 1986, NEUROENDOCRINOLOGY, V44, P299, DOI 10.1159/000124660; TOBET SA, 1992, HDB BEHAVIORAL NEURO, V11, P41; Watson M., 1877, P ZOOL SOC LOND, V45, P369; YALCINKAYA TM, 1993, SCIENCE, V260, P1929, DOI 10.1126/science.8391165	15	13	15	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					943	945		10.1038/14728	http://dx.doi.org/10.1038/14728			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526331				2022-12-24	WOS:000083883300009
J	Hodge, CW; Mehmert, KK; Kelley, SP; McMahon, T; Haywood, A; Olive, MF; Wang, D; Sanchez-Perez, AM; Messing, RO				Hodge, CW; Mehmert, KK; Kelley, SP; McMahon, T; Haywood, A; Olive, MF; Wang, D; Sanchez-Perez, AM; Messing, RO			Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKC epsilon	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; WHOLE-CELL CURRENTS; A RECEPTOR; ETHANOL SENSITIVITY; RAT-BRAIN; GABAERGIC TRANSMISSION; CHLORIDE CHANNELS; NEURONS; PHOSPHORYLATION; ENHANCEMENT	Several of the actions of ethanol are mediated by gamma-aminobutyrate type A (GABA(A)) receptors. Here we demonstrated that mutant mice lacking protein kinase C epsilon (PKC epsilon) were more sensitive than wildtype littermates to the acute behavioral effects of ethanol and other drugs that allosterically activate GABA(A) receptors. GABA(A) receptors in membranes isolated from the frontal cortex of PKC epsilon null mice were also supersensitive to allosteric activation by ethanol and flunitrazepam. In addition, these mutant mice showed markedly reduced ethanol self-administration. These findings indicate that inhibition of PKC epsilon increases sensitivity of GABA(A) receptors to ethanol and allosteric modulators. Pharmacological agents that inhibit PKC epsilon may be useful for treatment of alcoholism and may provide a non-sedating alternative for enhancing GABA(A) receptor function to treat other disorders such as anxiety and epilepsy.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Hodge, CW (corresponding author), Univ Calif San Francisco, Dept Neurol, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.		Messing, Robert/D-3642-2015; Sánchez-Pérez, Ana María/AAB-4454-2019; Sánchez-Pérez, Ana María M/N-2731-2017	Messing, Robert/0000-0002-5345-4431; Sánchez-Pérez, Ana María M/0000-0002-5811-0005; Hodge, Clyde/0000-0002-6860-7955; Olive, Foster/0000-0002-2517-0351				ALLAN AM, 1987, PHARMACOL BIOCHEM BE, V27, P665, DOI 10.1016/0091-3057(87)90192-4; Coe IR, 1996, J BIOL CHEM, V271, P29468, DOI 10.1074/jbc.271.46.29468; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; DEITRICH RA, 1989, PHARMACOL REV, V41, P489; DIETRICH RA, 1989, PHARMACOL REV, V41, P489; FINN DA, 1994, ALCOHOL CLIN EXP RES, V18, P382, DOI 10.1111/j.1530-0277.1994.tb00029.x; FRYE GD, 1981, PSYCHOPHARMACOLOGY, V75, P372, DOI 10.1007/BF00435856; GIVENS BS, 1990, J PHARMACOL EXP THER, V254, P528; Gordon AS, 1997, MOL PHARMACOL, V52, P554, DOI 10.1124/mol.52.4.554; GUIDOTTI A, 1983, NEUROPHARMACOLOGY, V22, P1471, DOI 10.1016/0028-3908(83)90115-6; HARRIS RA, 1995, P NATL ACAD SCI USA, V92, P3658, DOI 10.1073/pnas.92.9.3658; HODGE C, 1996, ALCOHOL CLIN EXP RES, V21, P250; Hodge CW, 1995, ALCOHOL CLIN EXP RES, V19, P1486, DOI 10.1111/j.1530-0277.1995.tb01012.x; Hodge CW, 1998, PSYCHOPHARMACOLOGY, V139, P95, DOI 10.1007/s002130050694; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Hundle B, 1997, J BIOL CHEM, V272, P15028, DOI 10.1074/jbc.272.23.15028; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; KELLENBERGER S, 1992, J BIOL CHEM, V267, P25660; KHASAR S, IN PRESS NEURON; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; LEIDENHEIMER NJ, 1992, ADV BIOCHEM PSYCHOPH, V47, P269; LEIDENHEIMER NJ, 1992, MOL PHARMACOL, V41, P1116; LIN YF, 1994, NEURON, V13, P1421, DOI 10.1016/0896-6273(94)90427-8; Lin YF, 1996, MOL PHARMACOL, V50, P185; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; MARSZALEC W, 1994, J PHARMACOL EXP THER, V269, P157; MEHTA AK, 1988, J PHARMACOL EXP THER, V246, P558; MESSING RO, 1991, J BIOL CHEM, V266, P23428; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Mochly-Rosen D, 1998, FASEB J, V12, P35; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; OLSEN RW, 1982, ANNU REV PHARMACOL, V22, P245, DOI 10.1146/annurev.pa.22.040182.001333; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Poisbeau P, 1999, J NEUROSCI, V19, P674; PROCTOR WR, 1992, BRAIN RES, V595, P220, DOI 10.1016/0006-8993(92)91053-H; SAITO N, 1993, BRAIN RES, V607, P241, DOI 10.1016/0006-8993(93)91512-Q; Sapp DW, 1998, J PHARMACOL EXP THER, V284, P768; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SIGEL E, 1993, FEBS LETT, V324, P140, DOI 10.1016/0014-5793(93)81380-I; SIGGINS GR, 1987, BRAIN RES, V414, P22, DOI 10.1016/0006-8993(87)91323-0; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; WEINER JL, 1994, J PHARMACOL EXP THER, V268, P1388; Weiner JL, 1997, J NEUROCHEM, V68, P1949	46	259	270	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					997	1002		10.1038/14795	http://dx.doi.org/10.1038/14795			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526339				2022-12-24	WOS:000083883300017
J	Ruan, WJ; Pang, P; Rao, Y				Ruan, WJ; Pang, P; Rao, Y			The SH2/SH3 adaptor protein dock interacts with the Ste20-like kinase misshapen in controlling growth cone motility	NEURON			English	Article							TYROSINE PHOSPHORYLATION; AXON GUIDANCE; SH3 DOMAIN; STE20-RELATED KINASE; DROSOPHILA HOMOLOG; 2-HYBRID SYSTEM; NCK; CELL; FAMILY; PAK	Recent studies suggest that the SH2/SH3 adaptor Dock/Nck transduces tyrosine phosphorylation signals to the actin cytoskeleton in regulating growth cone motility. The signaling cascade linking the action of Dock/Nck to the reorganization of cytoskeleton is poorly understood. We now demonstrate that Dock interacts with the Ste20-like kinase Misshapen (Msn) in the Drosophila photoreceptor (R cell) growth cones. Loss of msn causes a failure of growth cones to stop at the target, a phenotype similar to loss of dock, whereas overexpression of msn induces pretarget growth cone termination. Physical and genetic interactions between Msn and Dock indicate a role for Msn in the Dock signaling pathway. We propose that Msn functions as a key controller of growth cone cytoskeleton in response to Dock-mediated signals.	McGill Univ, Ctr Res Neurosci, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Rao, Y (corresponding author), McGill Univ, Ctr Res Neurosci, Dept Neurol & Neurosurg, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	ezdz@musica.mgill.ca						BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; BIGGS WH, 1992, P NATL ACAD SCI USA, V89, P6295, DOI 10.1073/pnas.89.14.6295; BIXBY JL, 1992, J NEUROBIOL, V23, P468, DOI 10.1002/neu.480230503; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; BRAND AH, 1993, DEVELOPMENT, V118, P401; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; Eichinger L, 1998, J BIOL CHEM, V273, P12952, DOI 10.1074/jbc.273.21.12952; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Harden N, 1996, MOL CELL BIOL, V16, P1896; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Kochhar KS, 1996, CANCER LETT, V104, P163, DOI 10.1016/0304-3835(96)04244-9; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MISMER D, 1987, GENETICS, V116, P565; Quilliam LA, 1996, J BIOL CHEM, V271, P28772, DOI 10.1074/jbc.271.46.28772; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Rorth P, 1998, DEVELOPMENT, V125, P1049; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Smith Donald B., 1993, Methods in Molecular and Cellular Biology, V4, P220; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Treisman JE, 1997, GENE, V186, P119, DOI 10.1016/S0378-1119(96)00694-4; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; XU T, 1993, DEVELOPMENT, V117, P1223; YAMAMOTO K, 1982, J CELL BIOL, V95, P711, DOI 10.1083/jcb.95.3.711	51	64	64	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					595	605		10.1016/S0896-6273(00)81115-0	http://dx.doi.org/10.1016/S0896-6273(00)81115-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595512	Green Submitted, Bronze			2022-12-24	WOS:000083913000016
J	Huang, YF; Myers, SJ; Dingledine, R				Huang, YF; Myers, SJ; Dingledine, R			Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes	NATURE NEUROSCIENCE			English	Article							RESTRICTIVE SILENCER FACTOR; SODIUM-CHANNEL GENE; TARGET GENES; IN-VIVO; EXPRESSION; ACETYLATION; COMPLEX; CHROMATIN; GLUTAMATE; NUCLEOSOME	Many genes whose expression is restricted to neurons in the brain contain a silencer element (RE1/NRSE) that limits transcription in nonneuronal cells by binding the transcription factor REST (also named NRSF or XBR). Although two independent domains of REST are known to confer repression, the mechanisms of transcriptional repression by REST remain obscure. We provide multiple lines of evidence that the N-terminal domain of REST represses transcription of the GluR2 and type II sodium-channel genes by recruiting the corepressor Sin3A and histone deacetylase (HDAC) to the promoter region in nonneuronal cells. These results identify a general mechanism for controlling the neuronal expression pattern of a specific set of genes via the RE1 silencer element.	Emory Univ, Sch Med, Dept Pharmacol & Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA	Emory University	Dingledine, R (corresponding author), Emory Univ, Sch Med, Dept Pharmacol & Biochem, Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA.		dingledine, Ray/F-5173-2011	Dingledine, Ray/0000-0001-7128-4520	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036604] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36604] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ashraf SI, 1998, CURR BIOL, V8, pR683, DOI 10.1016/S0960-9822(98)70435-X; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Gray SG, 1998, BIOCHEM BIOPH RES CO, V245, P423, DOI 10.1006/bbrc.1998.8449; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Leichter M, 1999, EUR J NEUROSCI, V11, P1937, DOI 10.1046/j.1460-9568.1999.00617.x; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Myers SJ, 1998, J NEUROSCI, V18, P6723; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Palm K, 1998, J NEUROSCI, V18, P1280; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; POLLARD H, 1993, NEUROSCIENCE, V57, P545, DOI 10.1016/0306-4522(93)90004-Y; PRINCE HK, 1995, J NEUROCHEM, V64, P462; SATO K, 1993, NEUROSCIENCE, V52, P515, DOI 10.1016/0306-4522(93)90403-3; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; Timmusk T, 1999, J BIOL CHEM, V274, P1078; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VanLint C, 1996, GENE EXPRESSION, V5, P245; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	50	328	334	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					867	872		10.1038/13165	http://dx.doi.org/10.1038/13165			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491605				2022-12-24	WOS:000083883200010
J	Anderson, JC; Binzegger, T; Kahana, O; Martin, KAC; Segev, I				Anderson, JC; Binzegger, T; Kahana, O; Martin, KAC; Segev, I			Dendritic asymmetry cannot account for directional responses of neurons in visual cortex	NATURE NEUROSCIENCE			English	Article							MEYNERT CELLS; CAT; SELECTIVITY; MICROCIRCUIT	A simple model was proposed to account for the direction selectivity of neurons in the primary visual cortex, area V1. In this model, the temporal asymmetries in the summation of inhibition and excitation that produce directionality were generated by structural asymmetries in the tangential organization of the basal dendritic tree of cortical neurons. We reconstructed dendritic trees of neurons with known direction preferences and found no correlation between the small biases of a neuron's dendritic morphology and its direction preference. Detailed simulations indicated that even when the electrotonic asymmetries in the dendrites were extreme, as in cortical Meynert cells, the biophysical properties of single neurons could contribute only partially to the directionality of cortical neurons.	Univ Zurich, ETHZ, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, Jerusalem, Israel	ETH Zurich; University of Zurich; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Martin, KAC (corresponding author), Univ Zurich, ETHZ, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Segev, Idan/0000-0001-7279-9630				ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; AGMONSNIR H, 1993, J NEUROPHYSIOL, V70, P2066, DOI 10.1152/jn.1993.70.5.2066; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; CAJAL SRY, 1999, EV TRIMESTRAL ICORGR, V4, P1; CHANPALAY V, 1974, J NEUROCYTOL, V3, P631, DOI 10.1007/BF01097628; CLARK L, 1942, J ANAT, V76, P369; COLE KS, 1968, MEMBRANES IONS IMPUL; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Galarreta M, 1997, J NEUROSCI, V17, P7220; Hassenstein B., 1956, P 1 INT C CYB, P797; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Maex R, 1996, J NEUROPHYSIOL, V75, P1515, DOI 10.1152/jn.1996.75.4.1515; MARTIN KAC, 1984, J PHYSIOL-LONDON, V356, P291, DOI 10.1113/jphysiol.1984.sp015465; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; ORBAN GA, 1981, J NEUROPHYSIOL, V45, P1043, DOI 10.1152/jn.1981.45.6.1043; Rall W, 1964, NEURAL THEORY MODELI, P73; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; SUAREZ H, 1995, J NEUROSCI, V15, P6700; WINFIELD DA, 1981, PROC R SOC SER B-BIO, V213, P27, DOI 10.1098/rspb.1981.0051; WINFIELD DA, 1983, P R SOC LOND B BIOL, V217, P27	26	42	43	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					820	824		10.1038/12194	http://dx.doi.org/10.1038/12194			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461221				2022-12-24	WOS:000083882900013
J	Luthi, A; McCormick, DA				Luthi, A; McCormick, DA			Modulation of a pacemaker current through Ca2+-induced stimulation of cAMP production	NATURE NEUROSCIENCE			English	Article							ACTIVATED CATION CURRENT; NUCLEOTIDE-GATED CHANNELS; THALAMIC RELAY NEURONS; I-H; SYNCHRONIZED OSCILLATIONS; HIPPOCAMPAL-NEURONS; CALCIUM CURRENTS; ADENYLYL-CYCLASE; GENE-EXPRESSION; LIGAND EFFICACY	Brief increases in [Ca2+](i) can result in prolonged changes in neuronal properties. A Ca2+-dependent modulation of the hyperpolarization-activated cation current (I-h) controls the slow recurrence of synchronized thalamocortical activity. Here we show that the persistent activation of I-h is initiated by rapidly increased [Ca2+](i) and subsequent production of cAMP. The modulation is maintained via a facilitated interaction of cAMP with open (voltage-gated) h-channels, inducing prolonged activation of I-h that may outlast the presence of increased free [Ca2+](i) and [cAMP](i). This persistent I-h activation may control the presence and periodicity of both normal and abnormal synchronized thalamocortical rhythms.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.		Luthi, Anita/ABE-1411-2021; Kobelt, Liza/F-5926-2011; McCormick, David A/J-2649-2015	McCormick, David A/0000-0002-9803-8335; Luthi, Anita/0000-0002-4954-4143				ADAMS SR, 1989, J AM CHEM SOC, V111, P7957, DOI 10.1021/ja00202a042; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bal T, 1997, J NEUROPHYSIOL, V77, P3145, DOI 10.1152/jn.1997.77.6.3145; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; BARAJASLOPEZ C, 1993, PFLUG ARCH EUR J PHY, V424, P410, DOI 10.1007/BF00374902; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Budde T, 1997, J PHYSIOL-LONDON, V503, P79, DOI 10.1111/j.1469-7793.1997.079bi.x; Cooper Dermot M.F., 1998, Advances in Second Messenger and Phosphoprotein Research, V32, P23; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; GUELLAEN G, 1977, BIOCHIM BIOPHYS ACTA, V484, P465, DOI 10.1016/0005-2744(77)90102-4; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Jonas EA, 1996, CURR OPIN NEUROBIOL, V6, P318, DOI 10.1016/S0959-4388(96)80114-0; LANCASTER B, 1994, J PHYSIOL-LONDON, V475, P229, DOI 10.1113/jphysiol.1994.sp020064; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Magee JC, 1998, J NEUROSCI, V18, P7613; Matsuoka I, 1997, J NEUROCHEM, V68, P498; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Onyike CU, 1998, J NEUROCHEM, V71, P1298; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SCHULMAN H, 1995, CURR OPIN NEUROBIOL, V5, P375, DOI 10.1016/0959-4388(95)80051-4; Sodickson DL, 1998, J NEUROSCI, V18, P8153; STERIADE M, 1990, GENERALIZED EPILEPSY, P161; Strata F, 1997, J NEUROSCI, V17, P1435; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750	40	101	101	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					634	641		10.1038/10189	http://dx.doi.org/10.1038/10189			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404196				2022-12-24	WOS:000083882600014
J	Wakamatsu, Y; Maynard, TM; Jones, SU; Weston, JA				Wakamatsu, Y; Maynard, TM; Jones, SU; Weston, JA			NUMB localizes in the basal cortex of mitotic avian neuroepithelial cells and modulates neuronal differentiation by binding to NOTCH-1	NEURON			English	Article							MOUSE CORTICAL NEUROGENESIS; DEVELOPING DROSOPHILA EYE; ASYMMETRIC LOCALIZATION; FATE DETERMINATION; XENOPUS-EMBRYOS; CEREBRAL-CORTEX; MAMMALIAN NUMB; GENE-DELTA; IN-VIVO; EXPRESSION	The importance of lateral inhibition mediated by NOTCH signaling is well demonstrated to control neurogenesis both in invertebrates and vertebrates. We have identified the chicken homolog of Drosophila numb, which suppresses NOTCH signaling. We show that chicken NUMB (c-NUMB) protein is localized to the basal cortex of mitotic neuroepithelial cells, suggesting that c-NUMB regulates neurogenesis by the modification of NOTCH signaling through asymmetrical cell division. Consistent with this suggestion, we show (1) that c-NUMB interferes with the nuclear translocation of activated c-NOTCH-1 through direct binding to the PEST sequence in the cytoplasmic domain of c-NOTCH-1 and (2) that c-NUMB interferes with c-NOTCH-l-mediated inhibition of neuronal differentiation.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Weston, JA (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.		Maynard, Thomas/I-9039-2012	Maynard, Thomas/0000-0001-6976-3936	NINDS NIH HHS [NS-29438] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029438] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Appel B, 1998, DEVELOPMENT, V125, P371; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Baker NE, 1997, CURR BIOL, V7, P122, DOI 10.1016/S0960-9822(06)00056-X; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOE CQ, 1995, NEURON, V15, P991, DOI 10.1016/0896-6273(95)90088-8; Dornseifer P, 1997, MECH DEVELOP, V63, P159, DOI 10.1016/S0925-4773(97)00037-3; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; FRISE E, 1996, P NATL ACAD SCI USA, V93, P1; Fuerstenberg S, 1998, INT J DEV BIOL, V42, P379; FUNAHASHI J, 1993, DEVELOPMENT, V119, P443; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Haddon C, 1998, DEVELOPMENT, V125, P359; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; LIEBER T, 1993, GENE DEV, V7, P949; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Parks AL, 1997, MECH DEVELOP, V63, P61, DOI 10.1016/S0925-4773(97)00675-8; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Vervoort M, 1997, CURR OPIN NEUROBIOL, V7, P21, DOI 10.1016/S0959-4388(97)80116-X; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	49	208	214	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					71	81		10.1016/S0896-6273(00)80754-0	http://dx.doi.org/10.1016/S0896-6273(00)80754-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402194	Bronze			2022-12-24	WOS:000080681200011
J	Ranganath, C; Paller, KA				Ranganath, C; Paller, KA			Frontal brain potentials during recognition are modulated by requirements to retrieve perceptual detail	NEURON			English	Article							EVENT-RELATED POTENTIALS; POSITRON EMISSION TOMOGRAPHY; MEMORY RETRIEVAL; PREFRONTAL CORTEX; TEMPORAL-ORDER; LOBE LESIONS; CONSCIOUS RECOLLECTION; EXPLICIT MEMORY; EPISODIC MEMORY; PICTURES	To assess the role of prefrontal cortex in retrieval and address the controversy about whether prefrontal retrieval operations are engaged only following successful retrieval, we recorded event-related brain potentials during two recognition tests with differing demands on retrieval effort. Both tests included object drawings that were (1) identical to those studied, (2) the same but with altered aspect ratios, and (3) previously unseen. Instructions were to respond "old" only if drawings were not modified (specific test) or regardless of modifications (general test). Frontal potentials were enhanced during the specific relative to the general test for all three types of drawings. We conclude that these potentials reflected differential engagement of strategic retrieval, that this function relied on left prefrontal cortex, and that it was not contingent on successful retrieval.	Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA	Northwestern University	Paller, KA (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	kap@nwu.edu	Paller, Ken/M-2676-2019	Paller, Ken/0000-0003-4415-4143	NINDS NIH HHS [NS34639] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034639, R01NS034639] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan K, 1997, NEUROPSYCHOLOGIA, V35, P387, DOI 10.1016/S0028-3932(96)00094-2; [Anonymous], 1983, CANADIAN PSYCHOL; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Butters M.A., 1994, NEUROPSYCHOLOGY, V8, P343, DOI DOI 10.1037/0894-4105.8.3.343; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; DELLAROCCHETTA AI, 1993, NEUROPSYCHOLOGIA, V31, P503; DESPOSITO M, 1999, IN PRESS COGN BRAIN; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Fuster J.M., 1989, PREFRONTAL CORTEX; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; Johnson Jr R., 1995, HDB NEUROPSYCHOLOGY, V10, P135; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Johnson MK, 1997, PSYCHOL SCI, V8, P250, DOI 10.1111/j.1467-9280.1997.tb00421.x; Johnson MK, 1996, NEUROREPORT, V7, P2929, DOI 10.1097/00001756-199611250-00025; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Kazmerski VA, 1997, COGNITIVE BRAIN RES, V5, P255, DOI 10.1016/S0926-6410(97)00004-9; Knight Robert T., 1995, P1357; Kutas M, 1997, STUD COGNIT, P197; LURIA A R, 1973, P3; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; Mark RE, 1998, BRAIN, V121, P861, DOI 10.1093/brain/121.5.861; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Nolde SF, 1998, TRENDS COGN SCI, V2, P399, DOI 10.1016/S1364-6613(98)01233-9; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; PALLER KA, 1995, PSYCHOL SCI, V6, P107, DOI 10.1111/j.1467-9280.1995.tb00315.x; PALLER KA, 1993, EEG-EMG-Z ELEK ELEKT, V24, P24; Paller KA, 1999, COGNITIVE BRAIN RES, V7, P519, DOI 10.1016/S0926-6410(98)00050-0; PALLER KA, 1992, J COGNITIVE NEUROSCI, V4, P375, DOI 10.1162/jocn.1992.4.4.375; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; POSNER MI, 1995, BEHAV BRAIN SCI, V18, P327, DOI 10.1017/S0140525X0003870X; PRIBRAM K H, 1973, P293; RANGANATH C, 1999, IN PRESS J COGN NEUR; ROSKIES AL, 1994, P NATL ACAD SCI USA, V91, P1989, DOI 10.1073/pnas.91.6.1989; Rugg M.D., 1995, OX PSYCH S, P133; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 1998, HUM BRAIN MAPP, V6, P394, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<394::AID-HBM12>3.3.CO;2-G; Schloerscheidt AM, 1997, NEUROREPORT, V8, P3281, DOI 10.1097/00001756-199710200-00018; Senkfor AJ, 1998, J EXP PSYCHOL LEARN, V24, P1005, DOI 10.1037/0278-7393.24.4.1005; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shimamura A. P., 1996, IMPLICIT MEMORY META, P259; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; SMITH ME, 1993, J COGNITIVE NEUROSCI, V5, P1, DOI 10.1162/jocn.1993.5.1.1; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355, https://doi.org/10.1037/0894-4105.8.3.355]; Trott CT, 1997, NEUROREPORT, V8, P3373, DOI 10.1097/00001756-199710200-00036; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525; WILDING EL, 1995, NEUROPSYCHOLOGIA, V33, P743, DOI 10.1016/0028-3932(95)00017-W; Wilding EL, 1997, NEUROPSYCHOLOGIA, V35, P119, DOI 10.1016/S0028-3932(96)00076-0; Wilding EL, 1997, NEUROPSYCHOLOGIA, V35, P1185, DOI 10.1016/S0028-3932(97)00048-1; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; WILDING EL, 1999, IN PRESS NEUROPSYCHO	66	114	116	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					605	613		10.1016/S0896-6273(00)80714-X	http://dx.doi.org/10.1016/S0896-6273(00)80714-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	182DU	10197539	Bronze			2022-12-24	WOS:000079483900023
J	Zerangue, N; Schwappach, B; Jan, YN; Jan, LY				Zerangue, N; Schwappach, B; Jan, YN; Jan, LY			A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K-ATP channels	NEURON			English	Article							SENSITIVE POTASSIUM CHANNELS; PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM; SULFONYLUREA RECEPTOR; FUNCTIONAL EXPRESSION; QUALITY-CONTROL; PROTEINS; BRAIN; ASSOCIATION; KIR6.2	Proper ion channel function often requires specific combinations of pore-forming alpha and regulatory beta subunits, but little is known about the mechanisms that regulate the surface expression of different channel combinations. Our studies of ATP-sensitive K+ channel (K-ATP) trafficking reveal an essential quality control function for a trafficking motif present in each of the alpha (Kir6.1/2) and beta (SUR1) subunits of the KATP complex. We show that this novel motif for endoplasmic reticulum (ER) retention/retrieval is required at multiple stages of K-ATP assembly to restrict surface expression to fully assembled and correctly regulated octameric channels. We conclude that exposure of a three amino acid motif (RKR) can explain how assembly of an ion channel complex is coupled to intracellular trafficking.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, Program Neurosci, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA.			Schwappach, Blanche/0000-0003-0225-6432				ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; BLOUNT P, 1990, J CELL BIOL, V111, P2601, DOI 10.1083/jcb.111.6.2601; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Bryan J, 1997, CURR OPIN CELL BIOL, V9, P553, DOI 10.1016/S0955-0674(97)80033-6; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; DUNNE MJ, 1986, FEBS LETT, V208, P59, DOI 10.1016/0014-5793(86)81532-0; Fink M, 1996, J BIOL CHEM, V271, P26341, DOI 10.1074/jbc.271.42.26341; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Hille B., 1992, IONIC CHANNELS EXCIT; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; John SA, 1998, J PHYSIOL-LONDON, V510, P333, DOI 10.1111/j.1469-7793.1998.333bk.x; Kast C, 1998, BIOCHEMISTRY-US, V37, P2305, DOI 10.1021/bi972332v; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Makhina EN, 1998, J BIOL CHEM, V273, P3369, DOI 10.1074/jbc.273.6.3369; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; NICHOLS CG, 1991, AM J PHYSIOL, V261, pH1675, DOI 10.1152/ajpheart.1991.261.6.H1675; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; RORSMAN P, 1985, PFLUG ARCH EUR J PHY, V405, P305, DOI 10.1007/BF00595682; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHENG M, 1994, J NEUROSCI, V14, P2408; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Trimmer JS, 1998, CURR OPIN NEUROBIOL, V8, P370, DOI 10.1016/S0959-4388(98)80063-9; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; TSUCHIYA K, 1992, P NATL ACAD SCI USA, V89, P6418, DOI 10.1073/pnas.89.14.6418; Tucker SJ, 1996, J BIOL CHEM, V271, P5866, DOI 10.1074/jbc.271.10.5866; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; UOZUMI N, 1995, J BIOL CHEM, V270, P24276, DOI 10.1074/jbc.270.41.24276; WANG H, 1994, J NEUROSCI, V14, P4588; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wilson GF, 1998, J BIOL CHEM, V273, P6389, DOI 10.1074/jbc.273.11.6389	57	866	887	2	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					537	548		10.1016/S0896-6273(00)80708-4	http://dx.doi.org/10.1016/S0896-6273(00)80708-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197533	Bronze			2022-12-24	WOS:000079483900017
J	Grosche, J; Matyash, V; Moller, T; Verkhratsky, A; Reichenbach, A; Kettenmann, H				Grosche, J; Matyash, V; Moller, T; Verkhratsky, A; Reichenbach, A; Kettenmann, H			Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; CURRENTS; SPINES; RAT	Astrocytes are considered a reticulate network of cells, through which calcium signals can spread easily. In Bergmann glia, astrocytic cells of the cerebellum, we identified subcellular compartments termed 'glial microdomains'. These elements have a complex surface consisting of thin membrane sheets, contain few mitochondria and wrap around synapses. To test for neuronal interaction with these structures, we electrically stimulated parallel fibers. This stimulation increased intracellular calcium concentration ([Ca2+](i)) in small compartments within Bergmann glial cell processes similar in size to glial microdomains. Thus, a Bergmann glial cell may consist of hundreds of independent compartments capable of autonomous interactions with the particular group of synapses that they ensheath.	Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leipzig University	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13122 Berlin, Germany.	hk@nero.glia.mdc-berlin.de	Reichenbach, Andreas/B-2510-2017; Kettenmann, Helmut/AAJ-5142-2021; Verkhratsky, Alexei/J-4527-2013; Möller, Thomas/W-8974-2019	Verkhratsky, Alexei/0000-0003-2592-9898; Kettenmann, Helmut/0000-0001-8208-0291				Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V137, P125, DOI 10.1007/BF00538787; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; KIRISCHUK S, 1996, J PHYSIOL-LONDON, V490, P46; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; Muller T, 1996, GLIA, V17, P274, DOI 10.1002/(SICI)1098-1136(199608)17:4<274::AID-GLIA2>3.0.CO;2-#; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; RALL W, 1992, PHYSIOL REV, V72, P159; Reichenbach A, 1992, Neuroimage, V1, P69, DOI 10.1016/1053-8119(92)90008-B; ROSENTHAL M, 1992, CAN J PHYSIOL PHARM, V70, P165; SARANTIS M, 1990, BRAIN RES, V516, P322, DOI 10.1016/0006-8993(90)90935-5; Sweadner Kathleen J., 1995, P259; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; VERKHRATSKY A, 1998, PHYSIOL REV, V78, P1	19	511	528	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					139	143		10.1038/5692	http://dx.doi.org/10.1038/5692			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195197				2022-12-24	WOS:000078231600012
J	Wills, Z; Marr, L; Zinn, K; Goodman, CS; Van Vactor, D				Wills, Z; Marr, L; Zinn, K; Goodman, CS; Van Vactor, D			Profilin and the Abl tyrosine kinase are required for motor axon outgrowth in the Drosophila embryo	NEURON			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ACTIN-BINDING PROTEINS; LISTERIA-MONOCYTOGENES; ACANTHAMOEBA PROFILIN; SUBCELLULAR-LOCALIZATION; MICROFILAMENT DYNAMICS; CYTOSKELETAL DYNAMICS; PHOSPHOLIPASE-C; HUMAN PLATELET; GROWTH CONES	The ability of neuronal growth cones to be guided by extracellular cues requires intimate communication between signal transduction systems and the dynamic actin-based cytoskeleton at the leading edge. Profilin, a small, actin-binding protein, has been proposed to be a regulator of the cell motility machinery at leading edge membranes. However, its requirement in the developing nervous system has been unknown. Profilin associates with members of the Enabled family of proteins, suggesting that Profilin might link Abl function to the cytoskeleton. Here, genetic analysis in Drosophila is used to demonstrate that mutations in Profilin (chickadee) and Abl (abl) display an identical growth cone arrest phenotype for axons of intersegmental nerve b (ISNb). Moreover, the phenotype of a double mutant suggests that these components function together to control axonal outgrowth.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; CALTECH, Dept Biol, Pasadena, CA 91125 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; California Institute of Technology	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	davie@hms.harvard.edu	Marr, Linsey/C-9698-2010	Marr, Linsey/0000-0003-3628-6891; Wills, Zachary/0000-0001-9822-6742; Van Vactor, Jr., David L./0000-0001-8156-9482	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35909] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BATE M, 1990, DEVELOPMENT, V110, P791; BENNETT RL, 1992, DEVELOPMENT, V116, P953; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BROADIE K, 1993, DEVELOPMENT, P227; BUB F, 1992, CELL MOTIL CYTOSKEL, V22, P51; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAO LG, 1992, J CELL BIOL, V117, P1023, DOI 10.1083/jcb.117.5.1023; Comer AR, 1998, MOL CELL BIOL, V18, P152, DOI 10.1128/MCB.18.1.152; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; HAARER BK, 1990, J CELL BIOL, V110, P105, DOI 10.1083/jcb.110.1.105; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; HILL KK, 1995, GENETICS, V141, P595; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; KARPEN GH, 1992, GENETICS, V132, P737; Kaufmann N, 1998, DEVELOPMENT, V125, P453; KNIPPLE DC, 1991, MOL GEN GENET, V226, P241, DOI 10.1007/BF00273609; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KOTARSKI MA, 1983, GENETICS, V105, P371; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; MACHESKY LM, 1990, CELL REGUL, V1, P937, DOI 10.1091/mbc.1.12.937; Machesky LM, 1997, BIOCHEM J, V328, P105; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; Manseau L, 1996, DEVELOPMENT, V122, P2109; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Mullins RD, 1998, MOL BIOL CELL, V9, P841, DOI 10.1091/mbc.9.4.841; Neely MD, 1997, P ROY SOC B-BIOL SCI, V264, P1701, DOI 10.1098/rspb.1997.0236; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SINK H, 1991, DEVELOPMENT, V112, P307; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; TSENG PCH, 1984, J CELL BIOL, V98, P214, DOI 10.1083/jcb.98.1.214; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0	63	175	176	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					291	299		10.1016/S0896-6273(00)81090-9	http://dx.doi.org/10.1016/S0896-6273(00)81090-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069335	Bronze			2022-12-24	WOS:000078875200014
J	Szczypka, MS; Mandel, RJ; Donahue, BA; Snyder, RO; Leff, SE; Palmiter, RD				Szczypka, MS; Mandel, RJ; Donahue, BA; Snyder, RO; Leff, SE; Palmiter, RD			Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice	NEURON			English	Article							EXPRESSING TYROSINE-HYDROXYLASE; RAT NUCLEUS-ACCUMBENS; RECEPTOR MUTANT MICE; TETRAHYDROBIOPTERIN BIOSYNTHESIS; EXTRACELLULAR DOPAMINE; BEHAVIORAL-RESPONSES; PARKINSONS-DISEASE; SYSTEM ACTIVITY; D2 RECEPTORS; BRAIN	Dopamine-deficient mice (DA(-/-)), lacking tyrosine hydroxylase (TH) in dopaminergic neurons, become hypoactive and aphagic and die by 4 weeks of age. They are rescued by daily treatment with LB, Q-dihydroxyphenylalanine (L-DOPA); each dose restores dopamine (DA) and feeding for less than 24 hr. Recombinant adeno-associated viruses expressing human TH or GTP cyclohydrolase 1 (GTPCH1) were injected into the striatum of DA(-/-) mice. Bilateral coinjection of both viruses restored feeding behavior for several months. However, locomotor activity and coordination were partially improved. A virus expressing only TH was less effective, and one expressing GTPCH1 alone was ineffective. TH immunoreactivity and DA were detected in the ventral striatum and adjacent posterior regions of rescued mice, suggesting that these regions mediate a critical DA-dependent aspect of feeding behavior.	Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA; Cell Genesys Inc, Dept Preclin Biol, Foster City, CA 94404 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Cell Genesys Inc	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA.	palmiter@u.washington.edu			NICHD NIH HHS [HD-09172, HD-08121-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009172, R01HD009172] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Aubert A, 1997, BRAIN BEHAV IMMUN, V11, P107, DOI 10.1006/brbi.1997.0485; BALK JH, 1995, NATURE, V377, P424; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Davidson JR, 1993, WALTHAM INT FOCUS, V3, P9; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; DURING MJ, 1994, SCIENCE, V266, P1399, DOI 10.1126/science.266.5189.1399; FERNANDEZRUIZ J, 1993, BEHAV NEURAL BIOL, V60, P189, DOI 10.1016/0163-1047(93)90314-8; FIBIGER HC, 1973, BRAIN RES, V55, P135, DOI 10.1016/0006-8993(73)90493-9; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Hajnal A, 1997, NEUROREPORT, V8, P2817, DOI 10.1097/00001756-199708180-00033; HEFFNER TG, 1980, SCIENCE, V208, P1168, DOI 10.1126/science.7375926; Hoebel B G, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p704A; HOEBEL BG, 1989, ANN NY ACAD SCI, V575, P171; HORELLOU P, 1994, NEUROREPORT, V6, P49, DOI 10.1097/00001756-199412300-00014; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; HURD YL, 1989, BRAIN RES, V498, P199, DOI 10.1016/0006-8993(89)90422-8; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P81; KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.neuro.11.1.81; LANGSTON JW, 1984, NEUROSCI LETT, V48, P87, DOI 10.1016/0304-3940(84)90293-3; LEIBOWITZ SF, 1980, BRAIN RES, V201, P315, DOI 10.1016/0006-8993(80)91038-0; Lentz SI, 1996, NEUROCHEM INT, V28, P569, DOI 10.1016/0197-0186(95)00124-7; LEVINE RA, 1990, J NEUROCHEM, V54, P1218, DOI 10.1111/j.1471-4159.1990.tb01951.x; Li JA, 1997, J VIROL, V71, P5236, DOI 10.1128/JVI.71.7.5236-5243.1997; LINDVALL O, 1983, CHEM NEUROANATOMY, P229; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; MALDONADOIRIZAR.CA, 1995, J NEUROSCI, V15, P6770; Mandel RJ, 1998, J NEUROSCI, V18, P4271; Martel P, 1996, PHARMACOL BIOCHEM BE, V53, P221, DOI 10.1016/0091-3057(95)00187-5; Martel P, 1996, PHARMACOL BIOCHEM BE, V55, P297, DOI 10.1016/S0091-3057(96)00087-1; Miao CH, 1998, NAT GENET, V19, P13, DOI 10.1038/ng0598-13; MOGENSON GJ, 1982, BRAIN RES BULL, V8, P685, DOI 10.1016/0361-9230(82)90096-X; NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.biochem.54.1.729; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; SALAMONE JD, 1990, NEUROSCIENCE, V39, P17, DOI 10.1016/0306-4522(90)90218-S; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; Sherwin CM, 1997, LAB ANIM, V31, P125, DOI 10.1258/002367797780600134; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; Taber MT, 1997, NEUROSCIENCE, V76, P1105, DOI 10.1016/S0306-4522(96)00450-2; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P49; WILSON C, 1995, J NEUROSCI, V15, P5169; WINN P, 1982, PSYCHOPHARMACOLOGIA, V78, P386; WISE RA, 1992, SYNAPSE, V10, P247, DOI 10.1002/syn.890100307; Xu M, 1997, NEURON, V19, P837, DOI 10.1016/S0896-6273(00)80965-4; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yang ZJ, 1997, PHARMACOL BIOCHEM BE, V58, P631, DOI 10.1016/S0091-3057(97)00022-1; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	55	106	109	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					167	178		10.1016/S0896-6273(00)80688-1	http://dx.doi.org/10.1016/S0896-6273(00)80688-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027299	Bronze			2022-12-24	WOS:000078410300022
J	Herzog, ED; Takahashi, JS; Block, GD				Herzog, ED; Takahashi, JS; Block, GD			Clock controls circadian period in isolated suprachiasmatic nucleus neurons	NATURE NEUROSCIENCE			English	Article							BIOLOGICAL CLOCK; IN-VITRO; RAT; PACEMAKER; RHYTHMS; GENE; TIMELESS; MUTATION; BEHAVIOR; PROTEIN	The suprachiasmatic nucleus (SCN) is the master circadian pacemaker in mammals, and one molecular regulator of circadian rhythms is the Clock gene. Here we studied the discharge patterns of SCN neurons isolated from Clock mutant mice. Long-term, multielectrode recordings showed that heterozygous Clock mutant neurons have,lengthened periods and that homozygous Clock neurons are arrhythmic, paralleling the effects on locomotor activity in the animal. In addition, cells in dispersals expressed a wider range of periods and phase relationships than cells in explants. These results suggest that the Clock gene is required for circadian rhythmicity in individual SCN cells and that a mechanism within the SCN synchronizes neurons and restricts the range of expressed circadian periods.	Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; Northwestern Univ, Dept Neurobiol & Physiol, Howard Hughes Med Inst, Evanston, IL 60208 USA	University of Virginia; Howard Hughes Medical Institute; Northwestern University			Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Herzog, Erik/0000-0001-7209-5174				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BLOCK GD, 1984, J COMP PHYSIOL, V155, P365, DOI 10.1007/BF00610590; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dunlap J, 1998, SCIENCE, V280, P1548, DOI 10.1126/science.280.5369.1548; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; GROSS GW, 1994, J NEUROSCI METH, V52, P73, DOI 10.1016/0165-0270(94)90059-0; GROSS GW, 1982, J NEUROSCI METH, V5, P13, DOI 10.1016/0165-0270(82)90046-2; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; JACKLET JW, 1983, J NEUROCYTOL, V12, P673, DOI 10.1007/BF01181530; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LeSauter J, 1996, J BIOL RHYTHM, V11, P163, DOI 10.1177/074873049601100208; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; LOUDON ASI, 1994, ENDOCRINOLOGY, V135, P712, DOI 10.1210/en.135.2.712; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; MURAKAMI N, 1991, BRAIN RES, V545, P347, DOI 10.1016/0006-8993(91)91312-O; NIEOULLON A, 1977, NATURE, V266, P375, DOI 10.1038/266375a0; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; PROSSER RA, 1994, BRAIN RES, V643, P296, DOI 10.1016/0006-8993(94)90036-1; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REPPERT SM, 1984, J NEUROSCI, V4, P1677; REPPERT SM, 1983, SCIENCE, V220, P969, DOI 10.1126/science.6844923; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SCHWARTZ WJ, 1991, J BIOL RHYTHM, V6, P149, DOI 10.1177/074873049100600205; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; SIMON JL, 1995, RESAMPLING NEW STAT; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; VANDENPOL AN, 1993, NEUROSCIENCE, V56, P793, DOI 10.1016/0306-4522(93)90128-3; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WATANABE A, 1994, BRAIN RES, V646, P161, DOI 10.1016/0006-8993(94)90071-X; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; YAMAZAKI S, IN PRESS J NEUROSCI	43	300	307	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					708	713		10.1038/3708	http://dx.doi.org/10.1038/3708			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196587				2022-12-24	WOS:000077323400015
J	Rodriguez-Moreno, A; Sistiaga, A; Lerma, J; Sanchez-Prieto, J				Rodriguez-Moreno, A; Sistiaga, A; Lerma, J; Sanchez-Prieto, J			Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-KINASE-C; LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; NERVE-TERMINALS; BRAIN; ACTIVATION; AGONIST; RELEASE; SLICES	We have explored whether the desensitization of metabotropic glutamate receptors (mGluRs) coupled to phosphoinositide hydrolysis affects the role that they play in modulating glutamate release. In hippocampal nerve terminals, the agonist 3,5-dihydroxyphenylglycine (DHPG) facilitated evoked glutamate release, but a second stimulation 5 min later reduced rather than facilitated release. After a 30 min interval between stimulations, DHPG again facilitated glutamate release. In hippocampal slices, DHPG caused an inhibition of excitatory postsynaptic currents (EPSCs) recorded from CA1 neurons. However, when the effects of ambient glutamate were prevented, mGluR activation initially induced a facilitation of synaptic transmission, followed by an inhibition. We conclude that group I mGluRs have a dual action on glutamate release, switching from facilitatory to inhibitory upon receptor desensitization triggered by low concentrations of glutamate.	Univ Complutense Madrid, Dept Bioquim, Fac Vet, E-28040 Madrid, Spain; CSIC, Inst Cajal, E-28002 Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Sanchez-Prieto, J (corresponding author), Univ Complutense Madrid, Dept Bioquim, Fac Vet, E-28040 Madrid, Spain.		Lerma, Juan/G-7907-2015; Rodriguez-Moreno, Antonio/I-5225-2015	Lerma, Juan/0000-0001-7838-5199; Rodriguez-Moreno, Antonio/0000-0002-8078-6175; Sanchez-Prieto, Jose/0000-0002-8513-3501				ALALUF S, 1995, FEBS LETT, V367, P301, DOI 10.1016/0014-5793(95)00575-T; ANIKSZTEJN L, 1991, EUR J PHARMACOL, V205, P327, DOI 10.1016/0014-2999(91)90921-C; ARONICA E, 1993, MOL PHARMACOL, V44, P981; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Bradley SR, 1996, J NEUROSCI, V16, P2044; CATANIA MV, 1991, J NEUROCHEM, V56, P1329, DOI 10.1111/j.1471-4159.1991.tb11429.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Fitzjohn SM, 1996, NEUROSCI LETT, V203, P211, DOI 10.1016/0304-3940(96)12301-6; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; HAYASHI Y, 1994, J NEUROSCI, V14, P3370; HERRERO I, 1994, EUR J NEUROSCI, V6, P115, DOI 10.1111/j.1460-9568.1994.tb00253.x; HERRERO I, 1991, NEUROSCI LETT, V126, P41, DOI 10.1016/0304-3940(91)90366-2; Herrero I, 1998, J BIOL CHEM, V273, P1951, DOI 10.1074/jbc.273.4.1951; HERRERO I, 1992, NATURE, V360, P163, DOI 10.1038/360163a0; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HUGANIR RL, 1990, NEURON, V5, P555, DOI 10.1016/0896-6273(90)90211-W; KANNER BI, 1983, BIOCHIM BIOPHYS ACTA, V726, P293, DOI 10.1016/0304-4173(83)90013-7; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Manzoni O, 1995, EUR J NEUROSCI, V7, P2518, DOI 10.1111/j.1460-9568.1995.tb01051.x; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Peretz T, 1996, FEBS LETT, V381, P71, DOI 10.1016/0014-5793(96)00085-3; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; SCHOEPP DD, 1994, J NEUROCHEM, V63, P769; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Siegelbaum S A, 1991, Curr Opin Neurobiol, V1, P113, DOI 10.1016/0959-4388(91)90018-3; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SWARTZ KJ, 1993, NEURON, V11, P305, DOI 10.1016/0896-6273(93)90186-U; THOMSON AM, 1995, EXCITATORY AMINO ACI, P145; TIBBS GR, 1989, J NEUROCHEM, V53, P1693, DOI 10.1111/j.1471-4159.1989.tb09232.x; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3	39	111	113	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1477	1486		10.1016/S0896-6273(00)80665-0	http://dx.doi.org/10.1016/S0896-6273(00)80665-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883739	Bronze			2022-12-24	WOS:000077910600028
J	Griffiths, TD; Buchel, C; Frackowiak, RSJ; Patterson, RD				Griffiths, TD; Buchel, C; Frackowiak, RSJ; Patterson, RD			Analysis of temporal structure in sound by the human brain	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; ITERATED RIPPLED NOISE; PERCEPTION; PITCH; REPRESENTATION; MECHANISMS; COMPONENTS; STRENGTH	For over a century, models of pitch perception have been based on the frequency composition of the sound. Pitch phenomena can also be explained, however in terms of the time structure, or temporal regularity of sounds. To locate the mechanism for the detection of temporal regularity in humans, we used functional imaging and a 'delay-and-add' noise, which activates all frequency regions uniformly, like noise, but which nevertheless produces strong pitch perceptions and tuneful melodies. This stimulus has temporal regularity that can be systematically altered. We found that the activity of primary auditory cortex increased with the regularity of the sound. Moreover, a melody composed of delay-and-add 'notes' produced a distinct pattern of activation in two areas of the temporal lobe distinct from primary auditory cortex. These results suggest a hierarchical analysis of time structure in the human brain.	Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Cambridge CB2 3EG, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Newcastle Univ, Sch Med, Dept Physiol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Cambridge; University of London; University College London; Newcastle University - UK	Griffiths, TD (corresponding author), Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Downing St, Cambridge CB2 3EG, England.	t.griffiths@fil.ion.ucl.ac.uk	Frackowiak, Richard S/I-1809-2013; Frackowiak, Richard/H-4383-2011	Frackowiak, Richard/0000-0002-3151-822X; Griffiths, Timothy/0000-0001-8066-4381	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		COHEN FS, 1995, IEEE T IMAGE PROCESS, V4, P1, DOI 10.1109/83.350818; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1997, HUM BRAIN MAPP, V5, P133, DOI 10.1002/(SICI)1097-0193(1997)5:2<133::AID-HBM7>3.0.CO;2-4; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; Langner G, 1997, J COMP PHYSIOL A, V181, P665, DOI 10.1007/s003590050148; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; MERZENICH MM, 1973, J NEUROPHYSIOL, V24, P193; PANDYA DN, 1995, REV NEUROL, V151, P486; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; PHILLIPS DP, 1990, BEHAV BRAIN RES, V40, P85, DOI 10.1016/0166-4328(90)90001-U; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; ROUILLY E, 1979, HEARING RES, P213; Talairach P., 1988, STEREOTACTIC COPLANA; TALAVAGE TM, 1997, NEUROIMAGE, V5, pS8; Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1993, NEUROPSYCHOLOGIA, V31, P221, DOI 10.1016/0028-3932(93)90086-F	29	248	251	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					422	427		10.1038/1637	http://dx.doi.org/10.1038/1637			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196534				2022-12-24	WOS:000076361400022
J	Stout, AK; Raphael, HM; Kanterewicz, BI; Klann, E; Reynolds, IJ				Stout, AK; Raphael, HM; Kanterewicz, BI; Klann, E; Reynolds, IJ			Glutamate-induced neuron death requires mitochondrial calcium uptake	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; NMDA RECEPTOR ACTIVATION; CEREBELLAR GRANULE CELLS; NITRIC-OXIDE FORMATION; METHYL-D-ASPARTATE; CYTOCHROME-C; INTRACELLULAR ACIDIFICATION; SUPEROXIDE PRODUCTION; CORTICAL CULTURES; PREVENT GLUTAMATE	We have investigated the role of mitochondrial calcium buffering in excitotoxic cell death. Glutamate acts at NMDA receptors in cultured rat forebrain neurons to increase the intracellular free calcium concentration. Although concurrent inhibition of mitochondrial calcium uptake substantially enhanced this cytoplasmic calcium increase, it significantly reduced glutamate-stimulated neuronal cell death. Mitochondrial inhibition did not affect nitric oxide production or MAP kinase phosphorylation, which have been proposed to mediate excitotoxicity. These results indicate that very high levels of cytoplasmic calcium are not necessarily toxic to forebrain neurons, and that potential-driven uptake of calcium into mitochondria is required to trigger NMDA-receptor-stimulated neuronal death.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, IJ (corresponding author), Univ Pittsburgh, Dept Pharmacol, E1354 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	ijr@prophet.pharm.pitt.edu	Reynolds, Ian Jeffery/ABH-3197-2020	Reynolds, Ian/0000-0003-3028-5070	NINDS NIH HHS [NS 09998, NS 34007, NS 34138] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034007, R01NS034007, R01NS034138] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; ARKLES B, 1975, J BIOL CHEM, V250, P8856; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BREDT DS, 1989, BIOCHEM BIOPH RES CO, V159, P976, DOI 10.1016/0006-291X(89)92204-3; BROCKMANN HJ, 1993, TRENDS ECOL EVOL, V8, P2, DOI 10.1016/0169-5347(93)90120-E; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Budd SL, 1996, J NEUROCHEM, V67, P2282; CHOI DW, 1987, J NEUROSCI, V7, P369; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dawson VL, 1996, J NEUROSCI, V16, P2479; DEMERLEPALLARDY C, 1991, BIOCHEM BIOPH RES CO, V181, P456, DOI 10.1016/S0006-291X(05)81441-X; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DYKENS JA, 1987, J NEUROCHEM, V49, P1222, DOI 10.1111/j.1471-4159.1987.tb10014.x; DYKENS JA, 1994, J NEUROCHEM, V63, P584; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; HEWETT SJ, 1993, BRAIN RES, V625, P337, DOI 10.1016/0006-8993(93)91078-7; Hoyt KR, 1998, J PHYSIOL-LONDON, V509, P103, DOI 10.1111/j.1469-7793.1998.103bo.x; HOYT KR, IN PRESS J NEUROCHEM; Hyrc K, 1997, J NEUROSCI, V17, P6669; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kim CN, 1997, CANCER RES, V57, P3115; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; NICHOLLS DG, 1985, MOL MECH ISCHEMIC BR, P97; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; PAUWELS PJ, 1992, NEUROSCI LETT, V143, P27, DOI 10.1016/0304-3940(92)90225-V; RAJDEV S, 1993, NEUROSCI LETT, V162, P149, DOI 10.1016/0304-3940(93)90582-6; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Schinder AF, 1996, J NEUROSCI, V16, P6125; SIMAN R, 1989, J NEUROSCI, V9, P1579; STOUT AK, IN PRESS NEUROSCIENC; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; WANG GJ, 1995, NEUROSCI LETT, V186, P139, DOI 10.1016/0304-3940(95)11305-G; WANG GJ, 1994, J NEUROPHYSIOL, V72, P2563, DOI 10.1152/jn.1994.72.6.2563; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; WHITE RJ, 1995, J NEUROSCI, V15, P1318; White RJ, 1996, J NEUROSCI, V16, P5688; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	49	504	519	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					366	373		10.1038/1577	http://dx.doi.org/10.1038/1577			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196525				2022-12-24	WOS:000076361400013
J	Bulthoff, I; Bulthoff, H; Sinha, P				Bulthoff, I; Bulthoff, H; Sinha, P			Top-down influences on stereoscopic depth-perception	NATURE NEUROSCIENCE			English	Article							BIOLOGICAL MOTION; GAIT PERCEPTION; OBJECTS; CORTEX; MODEL	The interaction between depth perception and object recognition has important implications for the nature of mental object representations and models of hierarchical organization of visual processing. It is often believed that the computation of depth influences subsequent high-level object recognition processes, and that depth processing is an early vision task that is largely immune to 'top-down' object-specific influences, such as object recognition. Here we present experimental evidence that challenges both these assumptions in the specific context of stereoscopic depth-perception. We have found that observers' recognition of familiar dynamic three-dimensional (3D) objects is unaffected even when the objects' depth structure is scrambled, as long as their two-dimensional (2D) projections are unchanged. Furthermore, the observers seem perceptually unaware of the depth anomalies introduced by scrambling. We attribute the latter result to a top-down recognition-based influence whereby expectations about a familiar object's 3D structure override the true stereoscopic information.	Max Planck Inst Biol Kybernet, D-72076 Tubingen, Germany; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	Max Planck Society; University of Wisconsin System; University of Wisconsin Madison	Bulthoff, I (corresponding author), Max Planck Inst Biol Kybernet, D-72076 Tubingen, Germany.		Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012	Bülthoff, Heinrich H/0000-0003-2568-0607				BORING EG, 1930, AM J PSYCHOL, V42, P444, DOI DOI 10.2307/1415447; CUTTING JE, 1981, J EXP PSYCHOL HUMAN, V7, P71, DOI 10.1037/0096-1523.7.1.71; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Gregory R.L., 1973, ILLUSION NATURE RAT, P49; HOFFMAN DD, 1982, BIOL CYBERN, V42, P195; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; JULESZ B, 1991, REV MOD PHYS, V63, P735, DOI 10.1103/RevModPhys.63.735; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Shibata T., 1985, Transactions of the Institute of Electronics and Communication Engineers of Japan, Part D, VJ68D, P1689; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1; WEBB JA, 1982, ARTIF INTELL, V19, P107, DOI 10.1016/0004-3702(82)90023-6	15	111	117	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					254	257		10.1038/699	http://dx.doi.org/10.1038/699			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QC	10195152				2022-12-24	WOS:000076361200018
J	Schiller, PH; Chou, IH				Schiller, PH; Chou, IH			The effects of frontal eye field and dorsomedial frontal cortex lesions on visually guided eye movements	NATURE NEUROSCIENCE			English	Article							SUPPLEMENTARY MOTOR AREA; SUPERIOR COLLICULUS; RHESUS-MONKEY; NEURONAL-ACTIVITY; STIMULATION; SACCADES; INACTIVATION; INITIATION; RESPONSES	In the frontal lobe of primates, two areas play a role in visually guided eye movements: the frontal eye fields (FEF) and the medial eye fields (MEF) in dorsomedial frontal cortex. Previously, FEF lesions have revealed only mild deficits in saccadic eye movements that recovered rapidly. Deficits in eye movements after MEF ablation have not been shown. We report the effects of ablating these areas singly or in combination, using tests in which animals were trained to make saccadic eye movements to paired or multiple targets presented at various temporal asynchronies. FEF lesions produced large and long-lasting deficits on both tasks. Sequences of eye movements made to successively presented targets were also impaired. Much smaller deficits were observed after MEF lesions. Our findings indicate a major, long-lasting loss in temporal ordering and processing speed for visually guided saccadic eye movement generation after FEF lesions and a significant but smaller and shorter-lasting loss after MEF lesions.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schiller, PH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.							Bisiach E, 1988, HDB NEUROPSYCHOLOGY, V1, P195; BIZZI E, 1967, SCIENCE, V157, P1588, DOI 10.1126/science.157.3796.1588; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; Deng S.-Y., 1986, ADAPTIVE PROCESSES V, P201; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744, DOI 10.1152/jn.1995.74.6.2744; GAYMARD B, 1990, ANN NEUROL, V28, P622, DOI 10.1002/ana.410280504; GOTTLIEB JP, 1993, J NEUROPHYSIOL, V69, P786, DOI 10.1152/jn.1993.69.3.786; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; KEATING EG, 1983, BRAIN RES, V269, P145, DOI 10.1016/0006-8993(83)90971-X; KEATING EG, 1993, BEHAV BRAIN RES, V53, P91; LATTO R, 1971, BRAIN RES, V30, P1, DOI 10.1016/0006-8993(71)90002-3; LYNCH JC, 1992, J NEUROPHYSIOL, V68, P1913, DOI 10.1152/jn.1992.68.5.1913; MANN SE, 1988, EXP BRAIN RES, V69, P460; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; OTTES FP, 1984, VISION RES, V24, P1169, DOI 10.1016/0042-6989(84)90172-X; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; Russo GS, 1996, J NEUROPHYSIOL, V76, P825, DOI 10.1152/jn.1996.76.2.825; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P530, DOI 10.1152/jn.1991.66.2.530; SCHILLER PH, 1977, BRAIN RES, V122, P154, DOI 10.1016/0006-8993(77)90672-2; Schiller PH, 1998, COGNITIVE NEUROSCIENCE OF ATTENTION, P3; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; SCHILLER PH, 1979, BRAIN RES, V179, P162, DOI 10.1016/0006-8993(79)90500-6; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179, DOI 10.1152/jn.1987.57.1.179; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; SHOOK BL, 1990, J COMP NEUROL, V301, P618, DOI 10.1002/cne.903010410; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; TEHOVNIK EJ, 1993, EXP BRAIN RES, V96, P430; TEHOVNIK EJ, 1994, EXP BRAIN RES, V98, P179; TEHOVNIK EJ, 1995, BEHAV BRAIN RES, V67, P147, DOI 10.1016/0166-4328(94)00151-5	33	105	105	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					248	253		10.1038/693	http://dx.doi.org/10.1038/693			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195151				2022-12-24	WOS:000076361200017
J	Alais, D; Blake, R; Lee, SH				Alais, D; Blake, R; Lee, SH			Visual features that vary together over time group together over space	NATURE NEUROSCIENCE			English	Article							INTEGRATION; SEGMENTATION; INFORMATION; COHERENCE; BINDING; MOTION; CAT	The visual system perceives objects as coherent even when some parts are hidden or discontinuous. How this representation is constructed from local features of many nearby objects is termed the 'binding problem.' Here we manipulate contrast in several drifting gratings that can be perceived as either independent objects or parts of a single object. Contrast modulations that are correlated in time enhance perceptual coherence, whereas uncorrelated modulations impair coherence. Presumably, correlated contrast modulations produce correlated responses in cortical neurons. Therefore, our results are consistent with the hypothesis that temporal correlation of neural activity is important for feature binding.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University	Blake, R (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA.		Lee, Sang-Hun/B-9898-2008					ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALAIS D, IN PRESS VISION RES; Blake R, 1997, P NATL ACAD SCI USA, V94, P7115, DOI 10.1073/pnas.94.13.7115; Bodis-Wollner I, 1972, Perception, V1, P341, DOI 10.1068/p010341; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Damasio AR, 1989, NEURAL COMPUT, V1, P123, DOI 10.1162/neco.1989.1.1.123; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FAHLE M, 1995, VISION RES, V35, P491, DOI 10.1016/0042-6989(94)00126-7; FAHLE M, 1993, P ROY SOC B-BIOL SCI, V254, P199, DOI 10.1098/rspb.1993.0146; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; HAMILTON DB, 1989, VISION RES, V29, P1285, DOI 10.1016/0042-6989(89)90186-7; Hardcasde V. G., 1994, J CONSCIOUSNESS STUD, V1, P66; Kiper DC, 1996, VISION RES, V36, P539, DOI 10.1016/0042-6989(95)00135-2; KOJIMA H, IN PRESS VISION RES; Ku┬hler W., 1947, GESTALT PSYCHOL; Leonards U, 1996, VISION RES, V36, P2689, DOI 10.1016/0042-6989(96)86829-5; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; MILNER PM, 1974, PSYCHOL REV, V81, P521, DOI 10.1037/h0037149; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SINGER W, 1990, CONCEPTS NEUROSCI, V1, P1; Smith AT, 1998, VISION RES, V38, P403, DOI 10.1016/S0042-6989(97)00134-X; TROY JB, 1993, EXP BRAIN RES, V93, P383; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; von der Malsburg C., 1986, BRAIN THEORY, P161; Zeki S., 1993, VISION BRAIN	29	107	107	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					160	164		10.1038/414	http://dx.doi.org/10.1038/414			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QB	10195133				2022-12-24	WOS:000076361100019
J	Ji, RR; Baba, H; Brenner, GJ; Woolf, CJ				Ji, RR; Baba, H; Brenner, GJ; Woolf, CJ			Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity	NATURE NEUROSCIENCE			English	Article							DORSAL HORN NEURONS; FORMALIN-INDUCED ACTIVITY; LONG-TERM POTENTIATION; RECEPTOR MESSENGER-RNA; PROTEIN-KINASE; CENTRAL SENSITIZATION; TISSUE-INJURY; IN-VIVO; RAT; STIMULATION	We investigated the involvement of extracellular signal-regulated protein kinases (ERK) within spinal neurons in producing pain hypersensitivity. Within a minute of an intense noxious peripheral or C-fiber electrical stimulus, many phosphoERK-positive neurons were observed, most predominantly in lamina I and IIo of the ipsilateral dorsal horn. This staining was intensity and NMDA receptor dependent. Low-intensity stimuli or A-fiber input had no effect. Inhibition of ERK phosphorylation by a MEK inhibitor reduced the second phase of formalin-induced pain behavior, a measure of spinal neuron sensitization. ERK signaling within the spinal cord is therefore involved in generating pain hypersensitivity. Because of its rapid activation, this effect probably involves regulation of neuronal excitability without changes in transcription.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ji, RR (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, 149 13th St,Rm 4309, Boston, MA 02129 USA.	ji@helix.mgh.harvard.edu	Ji, Ru-Rong/L-7070-2017; Woolf, Clifford/A-9784-2010; Brenner, Gary/AAI-1293-2019	Ji, Ru-Rong/0000-0002-9355-3688; Brenner, Gary/0000-0002-4586-1723	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 38253-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baba H, 1999, J NEUROSCI, V19, P859; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BARABAN JM, 1993, J NEUROCHEM, V60, P330, DOI 10.1111/j.1471-4159.1993.tb05855.x; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; DICKENSON AH, 1987, PAIN, V30, P349, DOI 10.1016/0304-3959(87)90023-6; DICKENSON AH, 1987, NEUROSCI LETT, V83, P207, DOI 10.1016/0304-3940(87)90242-4; DUBNER R, 1992, TRENDS NEUROSCI, V15, P96, DOI 10.1016/0166-2236(92)90019-5; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Henry JL, 1999, J NEUROSCI, V19, P6588; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; JI RR, 1995, NEUROSCIENCE, V68, P563, DOI 10.1016/0306-4522(95)94333-T; JI RR, 1994, J NEUROSCI, V14, P6423; Ji RR, 1997, J NEUROSCI, V17, P1776; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McCall WD, 1996, NEUROSCI LETT, V208, P45, DOI 10.1016/0304-3940(96)12552-0; MCCARSON KE, 1994, J NEUROSCI, V14, P712; Messersmith DJ, 1998, MOL BRAIN RES, V53, P259, DOI 10.1016/S0169-328X(97)00308-2; Michael GJ, 1997, J NEUROSCI, V17, P8476; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sgambato V, 1998, J NEUROSCI, V18, P8814; SIMONE DA, 1989, BRAIN RES, V486, P185, DOI 10.1016/0006-8993(89)91293-6; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Woolf CJ, 1998, NEURON, V20, P1063, DOI 10.1016/S0896-6273(00)80487-0; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO T, 1992, ANESTHESIOLOGY, V77, P757, DOI 10.1097/00000542-199210000-00021; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	50	615	668	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1114	1119		10.1038/16040	http://dx.doi.org/10.1038/16040			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570489				2022-12-24	WOS:000085810100016
J	Aravamudan, B; Fergestad, T; Davis, WS; Rodesch, CK; Broadie, K				Aravamudan, B; Fergestad, T; Davis, WS; Rodesch, CK; Broadie, K			Drosophila Unc-13 is essential for synaptic transmission	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; EXPRESSION; GENE; SYNAPTOBREVIN; SYNAPTOTAGMIN; MELANOGASTER; CA2+	The UNC-13 protein family has been suggested to be critical for synaptic vesicle dynamics based on its interactions with Syntaxin, Munc-18 and Doc 2 alpha. We cloned the Drosophila homolog (Dunc-13) and characterized its function using a combination of electrophysiology and ultrastructural analyses. Dunc-13 contained a C1 lipid-binding motif and two C2 calcium-binding domains, and its expression was restricted to neurons. Elimination of dune-13 expression abolished synaptic transmission, an effect comparable only to removal of the core complex proteins Syntaxin and Synaptobrevin. Transmitter release remained impaired under elevated calcium influx or application of hyperosmotic saline. Ultrastructurally, mutant terminals accumulated docked vesicles at presynaptic release sites. We conclude that Dunc-13 is essential for a stage of neurotransmission following vesicle docking and before fusion.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Broadie, K (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.				NICHD NIH HHS [5T32 HD07491] Funding Source: Medline; NIGMS NIH HHS [GM54544] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON WB, 1985, CURR TOP CELL REGUL, V27, P455; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bennett MK, 1997, CURR OPIN NEUROBIOL, V7, P316, DOI 10.1016/S0959-4388(97)80058-X; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BRENNER S, 1974, GENETICS, V77, P71; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, DEVELOPMENT, V119, P533; BROADIE KS, 1995, J PHYSIOLOGY-PARIS, V89, P59, DOI 10.1016/0928-4257(96)80552-3; BROADIE KS, 1993, J NEUROSCI, V13, P167; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; CHIN AC, 1993, GENE, V131, P175, DOI 10.1016/0378-1119(93)90291-A; CURRIE DA, 1995, DEV DYNAM, V203, P311, DOI 10.1002/aja.1002030303; Deitcher DL, 1998, J NEUROSCI, V18, P2028; EGEA G, 1991, J NEUROCHEM, V57, P1593, DOI 10.1111/j.1471-4159.1991.tb06356.x; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Mochida S, 1998, P NATL ACAD SCI USA, V95, P11418, DOI 10.1073/pnas.95.19.11418; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaguchi G, 1998, BIOCHEM BIOPH RES CO, V248, P846, DOI 10.1006/bbrc.1998.9067; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Valtorta Flavia, 1994, Seminars in Cell Biology, V5, P211, DOI 10.1006/scel.1994.1027; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Yoshihara M, 1999, J NEUROSCI, V19, P2432	40	232	237	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					965	971		10.1038/14764	http://dx.doi.org/10.1038/14764			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526334				2022-12-24	WOS:000083883300012
J	Awh, E; Gehring, WJ				Awh, E; Gehring, WJ			The anterior cingulate cortex lends a hand in response selection	NATURE NEUROSCIENCE			English	News Item							OBSESSIVE-COMPULSIVE DISORDER; POSITRON EMISSION TOMOGRAPHY; ERROR-DETECTION; NEURAL SYSTEM; COMPENSATION; PET	The anterior cingulate cortex is involved in decisions between conflicting response tendencies. This exective function seems to involve separate pathways for manual and verbal responses.	Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA; Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Oregon; University of Michigan System; University of Michigan	Awh, E (corresponding author), Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA.			Awh, Edward/0000-0002-5211-5278				BAER L, 1995, ARCH GEN PSYCHIAT, V52, P384; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Cabeza R, 1997, J COGNITIVE NEUROSCI, V9, P1, DOI 10.1162/jocn.1997.9.1.1; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVNISKY O, 1995, BRAIN, V118, P279; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEHRING WJ, IN PRESS PSYCHOL SCI; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Posner MI, 1998, ATTENTIVE BRAIN, P401; TAMMINGA CA, 1992, ARCH GEN PSYCHIAT, V49, P522; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224	13	39	39	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					853	854		10.1038/13145	http://dx.doi.org/10.1038/13145			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FE	10491598				2022-12-24	WOS:000083883200003
J	Dapretto, M; Bookheimer, SY				Dapretto, M; Bookheimer, SY			Form and content: Dissociating syntax and semantics in sentence comprehension	NEURON			English	Article							INFERIOR PREFRONTAL CORTEX; CEREBRAL BLOOD-FLOW; FUNCTIONAL MRI; LANGUAGE; ACTIVATION; APHASIA; SPEECH; PET; RETRIEVAL; KNOWLEDGE	The distinction between syntax (sentence form) and semantics (sentence meaning) is fundamental to our thinking about language. Whether and where this distinction is represented at the neural level is still a matter of considerable debate. In the present fMRI study, we examined the neural correlates of syntactic and semantic functions using an innovative activation paradigm specifically designed to unequivocally disentangle syntactic from lexicosemantic aspects of sentence processing. Our findings strongly indicate that a part of Broca's area (BA 44, pars opercularis) is critically implicated in processing syntactic information, whereas the lower portion of the left inferior frontal gyrus (BA 47, pars orbitalis) is selectively involved in processing the semantic aspects of a sentence.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Ahmnson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Dapretto, M (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Ahmnson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.			Bookheimer, Susan/0000-0002-3417-5891				Bavelier D, 1997, J COGNITIVE NEUROSCI, V9, P664, DOI 10.1162/jocn.1997.9.5.664; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BLUMSTEIN SE, 1982, BRAIN LANG, V17, P301, DOI 10.1016/0093-934X(82)90023-2; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; BOTTINI G, 1994, BRAIN, V117, P1241, DOI 10.1093/brain/117.6.1241; BUCKNER RL, 1995, HDB NEUROPSYCHOLOGY, V10, P439; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; CARAMAZZA A, 1978, PSYCHOL BULL, V85, P898, DOI 10.1037/0033-2909.85.4.898; DEMB JB, 1995, J NEUROSCI, V15, P5870; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goodglass H., 1993, UNDERSTANDING APHASI; HAGOORT P, 1993, BRAIN LANG, V45, P189, DOI 10.1006/brln.1993.1043; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; Iacoboni M, 1998, BRAIN, V121, P2135, DOI 10.1093/brain/121.11.2135; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; Muller RA, 1997, NEUROREPORT, V8, P3767; MUNTE TF, 1993, J COGNITIVE NEUROSCI, V5, P335, DOI 10.1162/jocn.1993.5.3.335; NEVILLE HJ, 1992, CEREB CORTEX, V2, P244, DOI 10.1093/cercor/2.3.244; Ojemann G, 1992, Adv Neurol, V57, P361; ROSLER F, 1993, J COGNITIVE NEUROSCI, V5, P345, DOI 10.1162/jocn.1993.5.3.345; Rueckert L, 1994, J Neuroimaging, V4, P67; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; SHAYWITZ BA, 1995, HUM BRAIN MAPP, V2, P149, DOI DOI 10.1002/HBM.460020304; STOMSWOLD K, 1996, BRAIN LANG, V52, P452; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Woods R.P., 1998, J COMPUT ASSIST TOMO, V22, P141; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21; Zurif E., 1990, NEUROPSYCHOLOGY NEUR, P123	35	475	484	0	43	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					427	432		10.1016/S0896-6273(00)80855-7	http://dx.doi.org/10.1016/S0896-6273(00)80855-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	251BA	10571235	Bronze			2022-12-24	WOS:000083423700016
J	Aldrich, MS; Reynolds, PR				Aldrich, MS; Reynolds, PR			Narcolepsy and the hypocretin receptor 2 gene	NEURON			English	Editorial Material							CANINE NARCOLEPSY; BRAIN		Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Sleep Disorders Ctr, Ann Arbor, MI 48109 USA; Univ Rochester, Sch Med, Dept Orthopaed, Rochester, NY 14642 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Rochester	Aldrich, MS (corresponding author), Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA.							ALDRICH MS, 1994, SLEEP, V17, P598; Bassetti C, 1996, NEUROL CLIN, V14, P545, DOI 10.1016/S0733-8619(05)70273-5; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; GUILLEMINAULT C, 1989, LANCET, V2, P1376; KISH SJ, 1992, NEUROLOGY, V42, P229, DOI 10.1212/WNL.42.1.229; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; MIGNOT E, 1991, P NATL ACAD SCI USA, V88, P3475, DOI 10.1073/pnas.88.8.3475; Nishino S, 1997, PROG NEUROBIOL, V52, P27, DOI 10.1016/S0301-0082(96)00070-6; RINNE JO, 1995, NEUROLOGY, V45, P1735, DOI 10.1212/WNL.45.9.1735; Siegel JM, 1999, J NEUROSCI, V19, P248, DOI 10.1523/JNEUROSCI.19-01-00248.1999	10	9	11	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					625	626		10.1016/S0896-6273(01)80019-2	http://dx.doi.org/10.1016/S0896-6273(01)80019-2			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482224	Bronze			2022-12-24	WOS:000082280900001
J	Lotze, M; Grodd, W; Birbaumer, N; Erb, M; Huse, E; Flor, H				Lotze, M; Grodd, W; Birbaumer, N; Erb, M; Huse, E; Flor, H			Does use of a myoelectric prosthesis prevent cortical reorganization and phantom limb pain?	NATURE NEUROSCIENCE			English	Article							OWL MONKEYS; REPRESENTATION; STIMULATION; AMPUTATION; HAND		Univ Tubingen, Dept Neuroradiol, Sect Expt NMR CNS, D-72076 Tubingen, Germany; Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany; Univ Padua, Dipartimento Psicol, I-35100 Padua, Italy; Humboldt Univ, Dept Psychol, Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Padua; Humboldt University of Berlin	Lotze, M (corresponding author), Univ Tubingen, Dept Neuroradiol, Sect Expt NMR CNS, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.		Lotze, Martin/D-2964-2012	Lotze, Martin/0000-0003-4519-4956; Erb, Michael/0000-0002-9311-4693; Flor, Herta/0000-0003-4809-5398; Birbaumer, Niels/0000-0002-6786-5127				Birbaumer N, 1997, J NEUROSCI, V17, P5503; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Sherman RA, 1997, PHANTOM PAIN	9	256	261	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					501	502		10.1038/9145	http://dx.doi.org/10.1038/9145			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448212				2022-12-24	WOS:000084735900007
J	Trotti, D; Rolfs, A; Danbolt, NC; Brown, RH; Hediger, MA				Trotti, D; Rolfs, A; Danbolt, NC; Brown, RH; Hediger, MA			SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter	NATURE NEUROSCIENCE			English	Article							CU,ZN-SUPEROXIDE DISMUTASE MUTANT; CU,ZN SUPEROXIDE-DISMUTASE; OXYGEN RADICALS; PROTEIN DAMAGE; HYDROGEN-PEROXIDE; SPINAL-CORD; MOTOR CORTEX; RAT-BRAIN; K-M; DEGRADATION	The mechanism by which Cu2+/Zn2+ superoxide dismutase (SOD1) mutants lead to motor neuron degeneration in familial amyotrophic lateral sclerosis (FALS) is unknown. We show that oxidative reactions triggered by hydrogen peroxide and catalyzed by A4V and I113T mutant but not wild-type SOD1 inactivated the glutamate transporter human GLT1. Chelation of the copper ion of the prosthetic group of A4V prevented GLT1 inhibition. GLT1 was a selective target of oxidation mediated by SOD1 mutants, and its reactivity was confined to the intracellular carboxyl-terminal domain. The antioxidant Mn(III)TBAP rescued GLT1 from inhibition. Because inactivation of GLT1 results in neuronal degeneration, we propose that toxic properties of SOD1 mutants lead to neuronal death via an excitotoxic mechanism in SOD1-linked FALS.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Membrane Biol Program, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0317 Oslo, Norway; Harvard Univ, Massachusetts Gen Hosp E, Sch Med, Day Neuromuscular Res Lab, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; Harvard University	Hediger, MA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med, Membrane Biol Program, HIM Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	dtrotti@rics.bwh.harvard.edu; mhediger@rics.bwh.harvard.edu	Danbolt, Niels Christian/A-1907-2014	Danbolt, Niels Christian/0000-0003-4227-4520; Hediger, Matthias/0000-0003-1946-027X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032001, P01NS031248] Funding Source: NIH RePORTER; AHRQ HHS [5F32HS10064] Funding Source: Medline; NINDS NIH HHS [NS32001, 1PO1NS31248-05] Funding Source: Medline; Telethon [754] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Aoki M, 1998, ANN NEUROL, V43, P645, DOI 10.1002/ana.410430514; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BatinicHaberle I, 1997, ARCH BIOCHEM BIOPHYS, V343, P225, DOI 10.1006/abbi.1997.0157; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bogdanov MB, 1998, J NEUROCHEM, V71, P1321; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; BROWN RH, 1995, CELL, V80, P687, DOI 10.1016/0092-8674(95)90346-1; BROWN RH, 1995, CURR OPIN NEUROL, V8, P373, DOI 10.1097/00019052-199510000-00009; Bruijn LI, 1997, P NATL ACAD SCI USA, V94, P7606, DOI 10.1073/pnas.94.14.7606; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Canton T, 1998, NEUROREPORT, V9, P775, DOI 10.1097/00001756-199803300-00001; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; DAVIES KJA, 1987, J BIOL CHEM, V262, P9914; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; EISEN A, 1995, MUSCLE NERVE, V18, P741, DOI 10.1002/mus.880180711; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Gillis Kevin D., 1995, P155; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Mu XJ, 1996, ANN NEUROL, V40, P379, DOI 10.1002/ana.410400307; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Siddique T, 1996, HUM MOL GENET, V5, P1465, DOI 10.1093/hmg/5.Supplement_1.1465; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Taylor PM, 1996, J EXP BIOL, V199, P923; Trotti D, 1996, J BIOL CHEM, V271, P5976, DOI 10.1074/jbc.271.11.5976; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Trotti D, 1997, EUR J NEUROSCI, V9, P2207, DOI 10.1111/j.1460-9568.1997.tb01388.x; Tu PH, 1997, LAB INVEST, V76, P441; VANIWAARDEN PR, 1992, BIOCHIM BIOPHYS ACTA, V1113, P161, DOI 10.1016/0304-4157(92)90037-B; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	48	222	229	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					427	433		10.1038/8091	http://dx.doi.org/10.1038/8091			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321246				2022-12-24	WOS:000084609400012
J	Miyata, M; Okada, D; Hashimoto, K; Kano, M; Ito, M				Miyata, M; Okada, D; Hashimoto, K; Kano, M; Ito, M			Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression	NEURON			English	Article							CENTRAL NERVOUS-SYSTEM; PROTEIN-KINASE-C; INFERIOR OLIVARY NEURONS; MESSENGER-RNA EXPRESSION; PURKINJE-CELL SYNAPSES; NITRIC-OXIDE SYNTHASE; CLIMBING FIBER; RAT-BRAIN; GLUTAMATE RECEPTORS; CALCIUM TRANSIENTS	This study of rat cerebellar slices yielded two lines of evidence indicating that the corticotropin-releasing factor (CRF) found in climbing fibers (CFs) is critical for the induction of long-term depression (LTD) at the parallel fiber (PF) synapses of Purkinje cells (PCs) by their conjunctive activation with either stimulation of CFs or depolarization of PCs, First, LTD induction was effectively blocked by specific CRF receptor antagonists, alpha-helical CRF-(9-41) (alpha-h CRF) and astressin; and second, LTD was no longer observed in CF-deprived cerebella but was restored by CRF replenishment, The data obtained in this study suggest that these effects are mediated by protein kinase C (PKC) and not by Ca2+ signaling or cyclic GMP (cGMP) production.	Inst Phys & Chem Res, RIKEN, Brain Sci Inst, Lab Memory & Learning, Wako, Saitama 3510198, Japan; Inst Phys & Chem Res, RIKEN, Brain Sci Inst, Lab Cellular Neurophysiol, Wako, Saitama 3510198, Japan; Inst Phys & Chem Res, RIKEN, Brain Sci Inst, Lab Cellular Informat Proc, Wako, Saitama 3510198, Japan; Jichi Med Sch, Dept Physiol, Minami Kawachi, Tochigi 32904, Japan	RIKEN; RIKEN; RIKEN; Jichi Medical University	Miyata, M (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan.	mmiyata@research.twmu.ac.jp		Kano, Masanobu/0000-0002-0725-3292; Hashimoto, Kouichi/0000-0002-3884-8213				AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; ARIANO MA, 1982, P NATL ACAD SCI-BIOL, V79, P1316, DOI 10.1073/pnas.79.4.1316; BARMACK NH, 1990, J NEUROSCI, V10, P631; BARMACK NH, 1993, J NEUROSCI, V13, P4647; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BATTAGLIA G, 1987, SYNAPSE, V1, P572, DOI 10.1002/syn.890010610; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BISHOP GA, 1990, NEUROSCIENCE, V39, P251, DOI 10.1016/0306-4522(90)90238-Y; BISHOP GA, 1992, NEUROPEPTIDES, V22, P167, DOI 10.1016/0143-4179(92)90159-T; BISHOP GA, 1992, PROG NEUROBIOL, V39, P475, DOI 10.1016/0301-0082(92)90002-V; Blond O, 1997, NEUROSCIENCE, V77, P945, DOI 10.1016/S0306-4522(96)00524-6; Boxall AR, 1996, NEURON, V16, P805, DOI 10.1016/S0896-6273(00)80100-2; Boxall AR, 1998, EUR J NEUROSCI, V10, P2; CALOGERO AE, 1988, NEUROENDOCRINOLOGY, V47, P303, DOI 10.1159/000124929; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CRATTY MS, 1994, NEUROPEPTIDES, V26, P113, DOI 10.1016/0143-4179(94)90102-3; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; Crepel F, 1990, Neuroreport, V1, P133, DOI 10.1097/00001756-199010000-00013; CREPEL F, 1988, BRAIN RES, V86, P402; CUMMINGS S, 1994, BRAIN RES, V660, P199, DOI 10.1016/0006-8993(94)91290-4; CUMMINGS SL, 1994, J COMP NEUROL, V350, P534, DOI 10.1002/cne.903500403; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DESOUZA EB, 1987, J NEUROSCI, V7, P88; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; FOX EA, 1993, NEUROSCI LETT, V149, P103, DOI 10.1016/0304-3940(93)90358-R; Freeman JH, 1998, NEUROREPORT, V9, P2237, DOI 10.1097/00001756-199807130-00016; GABR RW, 1994, NEUROSCI LETT, V169, P63, DOI 10.1016/0304-3940(94)90357-3; GUERINEAU N, 1991, ENDOCRINOLOGY, V129, P409, DOI 10.1210/endo-129-1-409; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; HARTELL NA, 1994, NEUROREPORT, V5, P913, DOI 10.1097/00001756-199404000-00015; Hartell NA, 1996, J NEUROSCI, V16, P2881; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; HEMART N, 1995, EUR J NEUROSCI, V7, P45, DOI 10.1111/j.1460-9568.1995.tb01019.x; HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Ishizuka T, 1996, METABOLISM, V45, P206, DOI 10.1016/S0026-0495(96)90055-4; ITO M, 1992, NEUROSCI RES, V14, P27, DOI 10.1016/S0168-0102(05)80004-5; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Kano M, 1995, NEUROSCI RES, V24, P87, DOI 10.1016/0168-0102(95)00978-7; KANO M, 1988, NEUROSCI RES, V5, P544, DOI 10.1016/0168-0102(88)90041-7; KARACHOT L, 1994, NEUROSCI RES, V21, P161, DOI 10.1016/0168-0102(94)90158-9; Kiang J G, 1994, Chin J Physiol, V37, P105; KNOPFEL T, 1991, EUR J NEUROSCI, V3, P343, DOI 10.1111/j.1460-9568.1991.tb00821.x; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LevRam V, 1997, LEARN MEMORY, V4, P169, DOI 10.1101/lm.4.1.169; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LEVRAM V, 1995, NEURON, V15, P407, DOI 10.1016/0896-6273(95)90044-6; Linden DJ, 1995, NEURON, V15, P1393, DOI 10.1016/0896-6273(95)90017-9; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; LLIANO I, 1991, JPHYSL LOND, V434, P183; LLINAS R, 1975, SCIENCE, V190, P1230, DOI 10.1126/science.128123; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Martinez V, 1997, J PHARMACOL EXP THER, V280, P754; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; NAGAO S, 1983, EXP BRAIN RES, V53, P36; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; OHEARN E, 1993, NEUROSCIENCE, V55, P303, DOI 10.1016/0306-4522(93)90500-F; Okada D, 1996, J CHEM NEUROANAT, V10, P213, DOI 10.1016/0891-0618(96)00138-X; OKADA D, 1992, J NEUROCHEM, V59, P1203, DOI 10.1111/j.1471-4159.1992.tb08429.x; OKADA D, 1998, BIOL NITRIC OXIDE 6, P103; PARKOVITS M, 1987, P NATL ACAD SCI USA, V84, P3911; POTTER E, 1994, P NATL ACAD SCI USA, V91, P8777, DOI 10.1073/pnas.91.19.8777; ROSSI F, 1991, J COMP NEUROL, V308, P536, DOI 10.1002/cne.903080404; SAKANAKA M, 1987, J COMP NEUROL, V260, P256, DOI 10.1002/cne.902600209; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SAWCHENKO O, 1989, CORTICOTROPIN RELEAS, P29; Shibuki K, 1997, J PHYSIOL-LONDON, V498, P443, DOI 10.1113/jphysiol.1997.sp021870; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Tempia F, 1996, J NEUROSCI, V16, P456; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Umemori H, 1997, SCIENCE, V276, P1878, DOI 10.1126/science.276.5320.1878; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; XIONG YT, 1995, ENDOCRINOLOGY, V136, P1828, DOI 10.1210/en.136.5.1828	91	95	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					763	775		10.1016/S0896-6273(00)80735-7	http://dx.doi.org/10.1016/S0896-6273(00)80735-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230796	Bronze			2022-12-24	WOS:000079976200019
J	Heuckeroth, RO; Enomoto, H; Grider, JR; Golden, JP; Hanke, JA; Jackman, A; Molliver, DC; Bardgett, ME; Snider, WD; Johnson, EM; Milbrandt, J				Heuckeroth, RO; Enomoto, H; Grider, JR; Golden, JP; Hanke, JA; Jackman, A; Molliver, DC; Bardgett, ME; Snider, WD; Johnson, EM; Milbrandt, J			Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons	NEURON			English	Article							MICE LACKING GDNF; NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; TYROSINE KINASE; DRG NEURONS; RECEPTOR; RET; DEFECTS; ABNORMALITIES; ACTIVATION	Neurturin (NTN) is a neuronal survival factor that activates the Ret tyrosine kinase in the presence of a GPI-linked coreceptor (either GFR alpha 1 or GFR alpha 2). Neurturin-deficient (NTN-/-) mice generated by homologous recombination are viable and fertile but have defects in the enteric nervous system, including reduced myenteric plexus innervation density and reduced gastrointestinal motility. Parasympathetic innervation of the lacrimal and submandibular salivary gland is dramatically reduced in NTN-/- mice, indicating that Neurturin is a neurotrophic factor for parasympathetic neurons, GFR alpha 2-expressing cells in the trigeminal and dorsal root ganglia are also depleted in NTN-/- mice. The loss of GFR alpha 2-expressing neurons, in conjunction with earlier studies, provides strong support for GFR alpha 2/Ret receptor complexes as the critical mediators of NTN function in vivo.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Physiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23298 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Virginia Commonwealth University; Virginia Commonwealth University	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	jeff@milbrandt.wustl.edu		Bardgett, Mark/0000-0001-7028-2603; Heuckeroth, Robert/0000-0002-3282-1765; Molliver, Derek/0000-0002-4406-7384; Golden, Judith/0000-0002-5168-8525; Milbrandt, Jeffrey/0000-0002-5477-7689	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG13729, R01 AG13730] Funding Source: Medline; NICHD NIH HHS [KO8 HD01166-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK034153] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGGARWAL A, 1994, GASTROENTEROLOGY, V106, P945, DOI 10.1016/0016-5085(94)90753-6; ALBERTS JR, 1971, PHYSIOL BEHAV, V6, P619, DOI 10.1016/0031-9384(71)90218-6; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Bardgett ME, 1997, BEHAV BRAIN RES, V84, P47, DOI 10.1016/S0166-4328(96)00132-5; Bardgett ME, 1998, PSYCHOPHARMACOLOGY, V135, P270, DOI 10.1007/s002130050509; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CAMILLERI M, 1990, DIGEST DIS SCI, V35, P609, DOI 10.1007/BF01540409; Chalazonitis A., 1997, NEUROSCIENCE, V23, P1430; COSTA M, 1994, AM J GASTROENTEROL, V89, pS129; Denislic M, 1998, J NEUROL NEUROSUR PS, V65, P138, DOI 10.1136/jnnp.65.1.138; Enokido Y, 1998, CURR BIOL, V8, P1019, DOI 10.1016/S0960-9822(07)00422-8; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; GERSHON MD, 1993, J NEUROBIOL, V24, P199, DOI 10.1002/neu.480240207; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; GRIDER JR, 1989, AM J PHYSIOL, V257, pG709, DOI 10.1152/ajpgi.1989.257.5.G709; GRIDER JR, 1986, AM J PHYSIOL, V251, pG40, DOI 10.1152/ajpgi.1986.251.1.G40; Hearn CJ, 1998, DEV BIOL, V197, P93, DOI 10.1006/dbio.1998.8876; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Horger BA, 1998, J NEUROSCI, V18, P4929; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Karaosmanoglu T, 1996, ANAT RECORD, V244, P470, DOI 10.1002/(SICI)1097-0185(199604)244:4<470::AID-AR5>3.0.CO;2-Z; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Nomoto S, 1998, BIOCHEM BIOPH RES CO, V244, P849, DOI 10.1006/bbrc.1998.8361; NOSRAT C, 1997, CELL TISSUE RES, V286, P191; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Raethjen J, 1997, J AUTONOM NERV SYST, V66, P46, DOI 10.1016/S0165-1838(97)00043-X; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sang Q, 1997, J ANAT, V190, P209, DOI 10.1046/j.1469-7580.1997.19020209.x; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SILOSSANTIAGO I, 1995, J NEUROSCI, V15, P5929; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Thompson J, 1998, MOL CELL NEUROSCI, V11, P117, DOI 10.1006/mcne.1998.0682; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; Yu T, 1998, J NEUROSCI, V18, P4684	55	251	253	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					253	263		10.1016/S0896-6273(00)81087-9	http://dx.doi.org/10.1016/S0896-6273(00)81087-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069332	Bronze			2022-12-24	WOS:000078875200011
J	Iadecola, C; Zhang, FY; Niwa, K; Eckman, C; Turner, SK; Fischer, E; Younkin, S; Borchelt, DR; Hsiao, KK; Carlson, GA				Iadecola, C; Zhang, FY; Niwa, K; Eckman, C; Turner, SK; Fischer, E; Younkin, S; Borchelt, DR; Hsiao, KK; Carlson, GA			SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; CHRONIC HYPERTENSION; BLOOD-FLOW; SUPEROXIDE-DISMUTASE; CALCIUM IONOPHORE; BASILAR ARTERY; MOUSE-BRAIN; ARTERIOLES; RESPONSES	Peptides derived from proteolytic processing of the beta-amyloid precursor protein (APP), including the amyloid-beta peptide, are important for the pathogenesis of Alzheimer's dementia. We found that transgenic mice overexpressing APP have a profound and selective impairment in endothelium-dependent regulation of the neocortical microcirculation. Such endothelial dysfunction was not found in transgenic mice expressing both APP and superoxide dismutase-1 (SOD1) or in APP transgenics in which SOD was topically applied to the cerebral cortex. These cerebrovascular effects of peptides derived from APP processing may contribute to the alterations in cerebral blood flow and to neuronal dysfunction in Alzheimer's dementia.	Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA; NIAID, Rocky Mt Lab, Hamilton, MT 59840 USA; Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; McLaughlin Research Institute for Biomedical Sciences, Inc.; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University	Iadecola, C (corresponding author), Univ Minnesota, Dept Neurol, 420 Delaware St SE, Minneapolis, MN 55455 USA.	iadec001@tc.umn.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034179, R01NS034179, R01NS037853, R01NS035806] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35806, NS37853, NS34179] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Blanc EM, 1997, J NEUROCHEM, V68, P1870; Carlson GA, 1997, HUM MOL GENET, V6, P1951, DOI 10.1093/hmg/6.11.1951; Crawford F, 1998, EXP NEUROL, V150, P159, DOI 10.1006/exnr.1997.6743; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FARACI FM, 1989, STROKE, V20, P242, DOI 10.1161/01.STR.20.2.242; HARRIS ED, 1992, J NUTR, V122, P636, DOI 10.1093/jn/122.suppl_3.636; HATAKE K, 1990, STROKE, V21, P1039, DOI 10.1161/01.STR.21.7.1039; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; IADECOLA C, 1990, J CEREBR BLOOD F MET, V10, P608, DOI 10.1038/jcbfm.1990.112; Jagust WJ, 1997, ANN NY ACAD SCI, V826, P254, DOI 10.1111/j.1749-6632.1997.tb48477.x; Johnson KA, 1998, NEUROLOGY, V50, P1563, DOI 10.1212/WNL.50.6.1563; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; MAYHAN WG, 1990, AM J PHYSIOL, V259, pH1455, DOI 10.1152/ajpheart.1990.259.5.H1455; Mayhan WG, 1996, BRAIN RES, V738, P337, DOI 10.1016/S0006-8993(96)01000-1; MAYHAN WG, 1990, AM J PHYSIOL, V258, pH1138, DOI 10.1152/ajpheart.1990.258.4.H1138; MAYHAN WG, 1988, HYPERTENSION, V12, P556, DOI 10.1161/01.HYP.12.6.556; Mentis MJ, 1996, AM J PSYCHIAT, V153, P32; MOHAZZABH KM, 1994, AM J PHYSIOL, V266, pH2568, DOI 10.1152/ajpheart.1994.266.6.H2568; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; NEBOT C, 1993, ANAL BIOCHEM, V214, P442, DOI 10.1006/abio.1993.1521; ROSENBLUM WI, 1986, STROKE, V17, P494, DOI 10.1161/01.STR.17.3.494; ROSENBLUM WI, 1989, STROKE, V20, P1391, DOI 10.1161/01.STR.20.10.1391; ROSENBLUM WI, 1988, STROKE, V19, P1379, DOI 10.1161/01.STR.19.11.1379; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; Sobey CG, 1997, STROKE, V28, P837, DOI 10.1161/01.STR.28.4.837; Sobey CG, 1996, STROKE, V27, P927, DOI 10.1161/01.STR.27.5.927; Stamler JS, 1996, NATURE, V380, P108; Thomas T, 1997, NEUROREPORT, V8, P1387, DOI 10.1097/00001756-199704140-00014; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; WANG Q, 1994, J CEREBR BLOOD F MET, V14, P944, DOI 10.1038/jcbfm.1994.126; Warkentin S, 1997, DEMENT GERIATR COGN, V8, P105, DOI 10.1159/000106614; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; YANG ST, 1991, HYPERTENSION, V17, P612, DOI 10.1161/01.HYP.17.5.612; Zhang FY, 1998, AM J PHYSIOL-REG I, V274, pR1704, DOI 10.1152/ajpregu.1998.274.6.R1704; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997	46	333	346	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					157	161		10.1038/5715	http://dx.doi.org/10.1038/5715			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195200				2022-12-24	WOS:000078231600015
J	Kawai, F; Kurahashi, T; Kaneko, A				Kawai, F; Kurahashi, T; Kaneko, A			Adrenaline enhances odorant contrast by modulating signal encoding in olfactory receptor cells	NATURE NEUROSCIENCE			English	Article							T-TYPE; NEWT; TRANSDUCTION; CHANNELS; CURRENTS; NEURONS; MUCOSA; CONDUCTANCES; SUPPRESSION; MEMBRANE	Olfactory perception is influenced by hormones. Here we report that adrenaline can directly affect the signal encoding of olfactory receptor cells. Application of adrenaline suppressed action potentials near threshold and increased their frequency in response to strong stimuli, resulting in a narrower dynamic range. Under voltage-clamp conditions, adrenaline enhanced sodium current and reduced T-type calcium current. Because sodium current is the major component of spike generation and T-type calcium current lowers the threshold in olfactory receptor cells, the effects of adrenaline on these currents are consistent with the results obtained under current-clamp conditions. Both effects involved a common cytoplasmic pathway, cAMP-dependent phosphorylation. We suggest that adrenaline may enhance contrast in olfactory perception by this mechanism.	Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 4448585, Japan; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Pennsylvania	Kurahashi, T (corresponding author), Osaka Univ, Dept Biol, Toyonaka, Osaka 5600043, Japan.	kurahasi@bio.sci.osaka-u.ac.jp		KAWAI, Fusao/0000-0001-8847-9906				ARECHIGA C, 1969, EXP MED SURG, V27, P384; Bakalyar H A, 1991, Curr Opin Neurobiol, V1, P204, DOI 10.1016/0959-4388(91)90079-M; Breer H, 1992, Curr Opin Neurobiol, V2, P439, DOI 10.1016/0959-4388(92)90177-M; CHEN Y, 1993, J COMP NEUROL, V334, P104, DOI 10.1002/cne.903340109; DUBIN AE, 1994, J GEN PHYSIOL, V103, P181, DOI 10.1085/jgp.103.2.181; FIRESTEIN S, 1987, P NATL ACAD SCI USA, V84, P6292, DOI 10.1073/pnas.84.17.6292; Firestein S, 1992, Curr Opin Neurobiol, V2, P444, DOI 10.1016/0959-4388(92)90178-N; GETCHELL ML, 1984, J COMP PHYSIOL, V155, P435, DOI 10.1007/BF00611909; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; GOLD GH, 1987, TRENDS PHARMACOL SCI, V8, P312, DOI 10.1016/0165-6147(87)90126-X; HALL LJ, 1968, ANN OTO RHINOL LARYN, V77, P1120, DOI 10.1177/000348946807700610; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; HILLE B, 1992, IONIC CHANNELS EXCIT, P170; Kawai F, 1997, J GEN PHYSIOL, V109, P265, DOI 10.1085/jgp.109.2.265; Kawai F, 1996, J GEN PHYSIOL, V108, P525, DOI 10.1085/jgp.108.6.525; Kawai F, 1997, JPN J PHYSIOL, V47, P367, DOI 10.2170/jjphysiol.47.367; KURAHASHI T, 1993, J PHYSIOL-LONDON, V466, P287; KURAHASHI T, 1991, NEUROREPORT, V2, P5, DOI 10.1097/00001756-199101000-00001; KURAHASHI T, 1990, J PHYSIOL-LONDON, V430, P355, DOI 10.1113/jphysiol.1990.sp018295; KURAHASHI T, 1990, BRAIN RES, V515, P261, DOI 10.1016/0006-8993(90)90605-B; KURAHASHI T, 1989, J PHYSIOL-LONDON, V419, P177, DOI 10.1113/jphysiol.1989.sp017868; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; KURAHASHI T, 1994, CURR BIOL, V4, P256, DOI 10.1016/S0960-9822(00)00058-0; KURAHASHI T, 1994, SCIENCE, V265, P118, DOI 10.1126/science.8016645; LAMB TD, 1992, TRENDS NEUROSCI, V15, P291, DOI 10.1016/0166-2236(92)90079-N; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; MATSUDA JJ, 1992, CIRC RES, V70, P199, DOI 10.1161/01.RES.70.1.199; MIYAMOTO T, 1992, J GEN PHYSIOL, V99, P505, DOI 10.1085/jgp.99.4.505; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; ONO K, 1993, CIRC RES, V72, P807, DOI 10.1161/01.RES.72.4.807; PFEIFFERLINN C, 1993, J GEN PHYSIOL, V102, P277, DOI 10.1085/jgp.102.2.277; PUN RYK, 1994, J MEMBRANE BIOL, V142, P103; Restrepo D, 1996, J NEUROBIOL, V30, P37; RONNETT GV, 1992, TRENDS NEUROSCI, V15, P508, DOI 10.1016/0166-2236(92)90104-G; Rosenblith W.A, 1961, SENS COMMUN, P143; SCHILD D, 1989, EXP BRAIN RES, V78, P223; SEELIG TL, 1982, BRAIN RES, V245, P144, DOI 10.1016/0006-8993(82)90349-3; Takagi SF, 1989, HUMAN OLFACTION, P1; WOODHEAD CJ, 1991, J LARYNGOL OTOL, V105, P632, DOI 10.1017/S0022215100116871; ZIELINSKI BS, 1989, ANAT RECORD, V225, P232, DOI 10.1002/ar.1092250309	41	91	94	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					133	138		10.1038/5686	http://dx.doi.org/10.1038/5686			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195196				2022-12-24	WOS:000078231600011
J	Lampl, I; Reichova, I; Ferster, D				Lampl, I; Reichova, I; Ferster, D			Synchronous membrane potential fluctuations in neurons of the cat visual cortex	NEURON			English	Article							CROSS-CORRELATION ANALYSIS; LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELD PROPERTIES; NEOCORTICAL NEURONS; STRIATE CORTEX; SPINY NEURONS; CORTICOTHALAMIC NETWORKS; HORIZONTAL INTERACTIONS; INTRACELLULAR ANALYSIS; ONGOING ACTIVITY	We have recorded intracellularly from pairs of neurons less than 500 mu m distant from one another in V1 of anesthetized cats. Cross-correlation of spontaneous fluctuations in membrane potential revealed significant correlations between the cells in each pair. This synchronization was not dependent on the occurrence of action potentials, indicating that it was not caused by mutual interconnections. The cells were synchronized continuously rather than for brief epochs. Much weaker correlations were found between the EEG and intracellular potentials, suggesting local, rather than global, synchrony. The highest correlation occurred among cells with similar connectivity from the LGN and similar receptive fields. During visual stimulation, correlations increased when both cells responded to the stimulus and decreased when neither cell responded.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Lampl, I (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.			Lampl, Ilan/0000-0002-9380-0730	NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER; NEI NIH HHS [EY04726] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; AMZICA F, 1995, J NEUROSCI, V15, P4658; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BorgGraham L, 1996, J PHYSIOLOGY-PARIS, V90, P185, DOI 10.1016/S0928-4257(97)81421-0; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; Contreras D, 1997, NEUROSCIENCE, V76, P25; CONTRERAS D, 1995, J NEUROSCI, V15, P604; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; ECKHORN R, 1993, BIOL CYBERN, V69, P37, DOI 10.1007/BF00201407; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Ferster D., 1996, Society for Neuroscience Abstracts, V22, P490; Freiwald WA, 1995, NEUROREPORT, V6, P2348, DOI 10.1097/00001756-199511270-00018; GHOSE GM, 1994, J NEUROPHYSIOL, V71, P330, DOI 10.1152/jn.1994.71.1.330; GHOSE GM, 1992, J NEUROPHYSIOL, V68, P1558, DOI 10.1152/jn.1992.68.5.1558; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GILBERT CD, 1975, J COMP NEUROL, V163, P81, DOI 10.1002/cne.901630106; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; HATA Y, 1991, J PHYSIOL-LONDON, V441, P593, DOI 10.1113/jphysiol.1991.sp018769; Hirsch JA, 1998, J NEUROSCI, V18, P9517; KRUGER J, 1988, J NEUROPHYSIOL, V60, P798, DOI 10.1152/jn.1988.60.2.798; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Lee D, 1998, J NEUROSCI, V18, P1161; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MARTIN KAC, 1984, J PHYSIOL-LONDON, V356, P291, DOI 10.1113/jphysiol.1984.sp015465; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Plenz D, 1998, J NEUROSCI, V18, P266; REYES AD, 1993, J NEUROPHYSIOL, V69, P1661, DOI 10.1152/jn.1993.69.5.1661; REYES AD, 1993, J NEUROPHYSIOL, V69, P1673, DOI 10.1152/jn.1993.69.5.1673; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; TSO DY, 1986, J NEUROSCI, V6, P1160; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; WILSON CJ, 1983, EXP BRAIN RES, V51, P227; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; Wilson CJ, 1996, J NEUROSCI, V16, P2397; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	63	313	315	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					361	374		10.1016/S0896-6273(00)81096-X	http://dx.doi.org/10.1016/S0896-6273(00)81096-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069341	Green Published, Bronze			2022-12-24	WOS:000078875200020
J	Tresch, MC; Saltiel, P; Bizzi, E				Tresch, MC; Saltiel, P; Bizzi, E			The construction of movement by the spinal cord	NATURE NEUROSCIENCE			English	Article							MOTOR CONTROL; REFLEXES; ORGANIZATION; HINDLIMB; MUSCLES	We used a computational analysis to identify the basic elements with which the vertebrate spinal cord constructs one complex behavior. This analysis extracted a small set of muscle synergies from the range of muscle activations generated by cutaneous stimulation of the frog hindlimb. The flexible combination of these synergies was able to account for the large number of different motor patterns produced by different animals. These results therefore demonstrate one strategy used by the vertebrate nervous system to produce movement in a computationally simple manner.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Bizzi, E (corresponding author), MIT, Dept Brain & Cognit Sci, E25-526, Cambridge, MA 02139 USA.	emilio@ai.mit.edu	Tresch, Matthew C/B-7634-2009		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009343] Funding Source: NIH RePORTER; NINDS NIH HHS [NS09343] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERKINBLIT MB, 1986, BEHAV BRAIN SCI, V9, P585, DOI 10.1017/S0140525X00051268; Bernstein N.A., 1967, COORDINATION REGULAT; Bishop C. M., 1995, NEURAL NETWORKS PATT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; FLESHMAN JW, 1984, EXP BRAIN RES, V54, P133; GISZTER SF, 1993, J NEUROSCI, V13, P467; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Harman H.H., 1976, MODERN FACTOR ANAL; Hertz JA, 2018, INTRO THEORY NEURAL; Jacobs R, 1996, J NEUROPHYSIOL, V76, P2402, DOI 10.1152/jn.1996.76.4.2402; Lawson CL, 1974, SOLVING LEAST SQUARE; LEE WA, 1984, J MOTOR BEHAV, V16, P135; MACPHERSON JM, 1991, LIFE SCI R, V50, P33; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PRATT CA, 1991, EXP BRAIN RES, V85, P281, DOI 10.1007/BF00229407; SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67; SCHOUENBORG J, 1994, EXP BRAIN RES, V100, P170; SCHOUENBORG J, 1994, NEWS PHYSIOL SCI, V9, P261; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Stein P.S.G., 1997, NEURONS NETWORKS MOT, P61	22	422	426	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					162	167		10.1038/5721	http://dx.doi.org/10.1038/5721			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195201				2022-12-24	WOS:000078231600016
J	Wills, Z; Bateman, J; Korey, CA; Comer, A; Van Vactor, D				Wills, Z; Bateman, J; Korey, CA; Comer, A; Van Vactor, D			The tyrosine kinase Abl and its substrate Enabled collaborate with the receptor phosphatase Dlar to control motor axon guidance	NEURON			English	Article							NEURONAL GROWTH CONES; ACTIN-BASED MOTILITY; DROSOPHILA-ABL; LISTERIA-MONOCYTOGENES; PATHWAY SELECTION; ADHESION MOLECULE; COMMISSURAL AXONS; PROTEIN; FILOPODIA; PHOSPHORYLATION	Genetic analysis of growth cone guidance choice points in Drosophila identified neuronal receptor protein tyrosine phosphatases (RPTPs) as key determinants of axon pathfinding behavior. We now demonstrate that the Drosophila Abl tyrosine kinase functions in the intersegmental nerve b (ISNb) motor choice point pathway as an antagonist of the RPTP Dlar. The function of Abl in this pathway is dependent on an intact catalytic domain. We also show that the Abl phosphoprotein substrate Enabled (Ena) is required for choice point navigation. Both Abl and Ena proteins associate with the Dlar cytoplasmic domain and serve as substrates for Dlar in vitro, suggesting that they play a direct role in the Dlar pathway. These data suggest that Dlar, Abl, and Ena define a phosphorylation state-dependent switch that controls growth cone behavior by transmitting signals at the cell surface to the actin cytoskeleton.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Univ Wisconsin, Mcardle Lab Canc Res, Madison, WI 53706 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	davie@hms.harvard.edu		Van Vactor, Jr., David L./0000-0001-8156-9482; Wills, Zachary/0000-0001-9822-6742	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035909] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35909] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BENTLEY D, 1983, NATURE, V304, P62, DOI 10.1038/304062a0; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BIXBY JL, 1992, J NEUROBIOL, V23, P468, DOI 10.1002/neu.480230503; BRAND AH, 1993, DEVELOPMENT, V118, P401; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Comer AR, 1998, MOL CELL BIOL, V18, P152, DOI 10.1128/MCB.18.1.152; Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Fashena SJ, 1997, MOL CELL BIOL, V17, P6859, DOI 10.1128/MCB.17.12.6859; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; GOLDBERG DJ, 1995, J NEUROBIOL, V27, P553, DOI 10.1002/neu.480270409; Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; HILL KK, 1995, GENETICS, V141, P595; HOFFMANN FM, 1991, TRENDS GENET, V7, P351, DOI 10.1016/0168-9525(91)90254-F; Kaufmann N, 1998, DEVELOPMENT, V125, P453; KLINZ SG, 1995, J NEUROCHEM, V65, P84; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; KUWADA JY, 1986, SCIENCE, V233, P740, DOI 10.1126/science.3738507; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P19, DOI 10.1098/rspb.1981.0080; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Menon KP, 1998, DEVELOPMENT, V125, P4121; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PISTOR S, 1995, CURR BIOL, V5, P517, DOI 10.1016/S0960-9822(95)00104-7; POLLARD TD, 1995, CURR BIOL, V5, P837, DOI 10.1016/S0960-9822(95)00167-9; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; Stoker A, 1998, BIOESSAYS, V20, P463, DOI 10.1002/(SICI)1521-1878(199806)20:6<463::AID-BIES4>3.0.CO;2-N; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; TIAN SS, 1994, J BIOL CHEM, V269, P28478; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Van Vactor D, 1998, CURR OPIN GENET DEV, V8, P112, DOI 10.1016/S0959-437X(98)80070-1; Van Vactor D, 1998, CURR OPIN NEUROBIOL, V8, P80, DOI 10.1016/S0959-4388(98)80011-1; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X	69	251	252	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					301	312		10.1016/S0896-6273(00)81091-0	http://dx.doi.org/10.1016/S0896-6273(00)81091-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069336	Bronze			2022-12-24	WOS:000078875200015
J	Seal, RP; Amara, SG				Seal, RP; Amara, SG			A reentrant loop domain in the glutamate carrier EAAT1 participates in substrate binding and translocation	NEURON			English	Article							RAT-BRAIN; MEMBRANE TOPOLOGY; RHIZOBIUM-MELILOTI; CHANNEL STRUCTURE; TIGER SALAMANDER; ACID TRANSPORTER; N-GLYCOSYLATION; ION FLUXES; RECEPTOR; PORE	To investigate the structural determinants underlying transport by the glutamate transporter EAAT1, we mutated each of 24 highly conserved residues (P392 to Q415) to cysteine. A majority of these substituted cysteines react with the sulfhydryl-modifying reagent MTSEA, suggesting that they reside in an aqueous environment. The impermeant reagents MTSES and MTSET react with residues at each end of the domain (A395C and A414C), supporting a model that places these residues near the extracellular surface. Substrates and inhibitors block the reaction between MTS derivatives and A395C, and the cosubstrate, sodium, slows reaction of MTSEA with Y405C and E406C. From these results, we propose that this domain forms a reentrant membrane loop at the cell surface and may comprise part of the translocation pore for substrates and cotransported ions.	Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Program Neurosci, Vollum Inst, Portland, OR 97201 USA	Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Amara, SG (corresponding author), Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Vollum Inst, Portland, OR 97201 USA.	amaras@ohsu.edu		Seal, Rebecca/0000-0003-4955-703X; Amara, Susan/0000-0001-8914-1106	NIMH NIH HHS [F31 MH011673, MH11673] Funding Source: Medline; NINDS NIH HHS [NS33273] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033273] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; BOLTON E, 1986, ARCH MICROBIOL, V144, P142, DOI 10.1007/BF00414724; Cammack JN, 1996, P NATL ACAD SCI USA, V93, P723, DOI 10.1073/pnas.93.2.723; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; Diamond JS, 1997, J NEUROSCI, V17, P4672; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELIASOF S, 1993, J NEUROSCI, V13, P402; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Javitch JA, 1998, METHOD ENZYMOL, V296, P331; JORDING D, 1993, MOL GEN GENET, V241, P106, DOI 10.1007/BF00280207; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Sather William A., 1994, Current Opinion in Neurobiology, V4, P313, DOI 10.1016/0959-4388(94)90091-4; Seal RP, 1998, RECEPTOR CHANNEL, V6, P51; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Slotboom DJ, 1996, J BIOL CHEM, V271, P31317, DOI 10.1074/jbc.271.49.31317; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; STALLCUP WB, 1979, J NEUROCHEM, V32, P57, DOI 10.1111/j.1471-4159.1979.tb04509.x; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Su A, 1996, BIOPHYS J, V70, P762, DOI 10.1016/S0006-3495(96)79616-9; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; TOLNER B, 1992, J BACTERIOL, V174, P2391, DOI 10.1128/JB.174.7.2391-2393.1992; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	55	99	103	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1487	1498		10.1016/S0896-6273(00)80666-2	http://dx.doi.org/10.1016/S0896-6273(00)80666-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883740	Bronze			2022-12-24	WOS:000077910600029
J	Toth, K; McBain, CJ				Toth, K; McBain, CJ			Afferent-specific innervation of two distinct AMPA receptor subtypes on single hippocampal interneurons	NATURE NEUROSCIENCE			English	Article							GUINEA-PIG HIPPOCAMPUS; MOSSY FIBER SYNAPSES; GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; CA2+ PERMEABILITY; SUBUNIT COMPOSITION; KAINATE RECEPTORS; SYNAPTIC TRANSMISSION; INWARD RECTIFICATION; SELECTIVE ANTAGONISM	Using the polyamine toxin philanthotoxin, which selectively blocks calcium-permeable AMPA receptors, we show that synaptic transmission onto single hippocampal interneurons occurs by afferent-specific activation of philanthotoxin-sensitive and -insensitive AMPA receptors, Calcium-permeable AMPA receptors are found exclusively at synapses from mossy fibers. In contrast, synaptic responses evoked by stimulation of CA3 pyramidal neurons are mediated by calcium-impermeable AMPA receptors. Both pathways converge onto single interneurons and can be discriminated with Group II mGluR agonists. Thus, single interneurons target AMPA receptors of different subunit composition to specific postsynaptic sites, providing a mechanism to increase the synapse-specific computational properties of hippocampal interneurons.	NICHD, Lab Cellular & Mol Neurophysiol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	McBain, CJ (corresponding author), NICHD, Lab Cellular & Mol Neurophysiol, Rm 5A72,Bldg 49,49 Convent Dr, Bethesda, MD 20892 USA.							Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Angulo MC, 1997, J NEUROSCI, V17, P6685; Bahring R, 1998, J PHYSIOL-LONDON, V509, P635, DOI 10.1111/j.1469-7793.1998.635bm.x; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BRACKLEY PTH, 1993, J PHARMACOL EXP THER, V266, P1573; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; FROTSCHER M, 1985, J NEUROCYTOL, V14, P245, DOI 10.1007/BF01258450; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GU YP, 1991, NEURON, V6, P777, DOI 10.1016/0896-6273(91)90174-X; GULYAS AI, 1992, NEUROSCIENCE, V48, P1, DOI 10.1016/0306-4522(92)90334-X; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Howe JR, 1996, J NEUROPHYSIOL, V76, P510, DOI 10.1152/jn.1996.76.1.510; HSU M, 1993, J NEUROSCI, V13, P3964; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Iino M, 1996, J PHYSIOL-LONDON, V496, P431, DOI 10.1113/jphysiol.1996.sp021696; Isa T, 1996, J PHYSIOL-LONDON, V491, P719, DOI 10.1113/jphysiol.1996.sp021252; Isa T, 1996, NEUROREPORT, V7, P689, DOI 10.1097/00001756-199602290-00002; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MAGLOCZKY Z, 1995, NEUROSCIENCE, V66, P847, DOI 10.1016/0306-4522(94)00613-A; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; OTIS TS, 1995, J PHYSIOL-LONDON, V482, P309, DOI 10.1113/jphysiol.1995.sp020519; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Racca C, 1996, EUR J NEUROSCI, V8, P1580, DOI 10.1111/j.1460-9568.1996.tb01303.x; Rozov A, 1998, J PHYSIOL-LONDON, V511, P361, DOI 10.1111/j.1469-7793.1998.361bh.x; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Spruston N, 1997, J COMP NEUROL, V385, P427; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Vissavajjhala P, 1996, EXP NEUROL, V142, P296, DOI 10.1006/exnr.1996.0199; Washburn MS, 1997, J NEUROSCI, V17, P9393; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669	50	206	208	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					572	578		10.1038/2807	http://dx.doi.org/10.1038/2807			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196564				2022-12-24	WOS:000077437100012
J	Hilfiker, S; Schweizer, FE; Kao, HT; Czernik, AJ; Greengard, P; Augustine, GJ				Hilfiker, S; Schweizer, FE; Kao, HT; Czernik, AJ; Greengard, P; Augustine, GJ			Two sites of action for synapsin domain E in regulating neurotransmitter release	NATURE NEUROSCIENCE			English	Article							SQUID GIANT SYNAPSE; PROTEIN-KINASE-II; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; VESICLE PHOSPHOPROTEINS; EXOCYTOSIS; CALCIUM; FUSION; TRANSMISSION; DEPRESSION	Synapsins, a family of synaptic vesicle proteins, have been shown to regulate neurotransmitter release; the mechanism(s) by which they act are not fully understood. Here we have studied the role of domain E of synapsins in neurotransmitter release at the squid giant synapse. Two squid synapsin isoforms were cloned and found to contain a carboxy (C)-terminal domain homologous to domain E of the vertebrate a-type synapsin isoforms. Presynaptic injection of a peptide fragment of domain E greatly reduced the number of synaptic vesicles in the periphery of the active zone, and increased the rate and extent of synaptic depression, suggesting that domain E is essential for synapsins to regulate a reserve pool of synaptic vesicles. Domain E peptide had no effect on the number of docked synaptic vesicles, yet reversibly inhibited and slowed the kinetics of neurotransmitter release, indicating a second role for synapsins that is more intimately associated with the release process itself. Thus, synapsin domain E is involved in at least two distinct reactions that are crucial for exocytosis in presynaptic terminals.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Rockefeller University; Duke University; Marine Biological Laboratory - Woods Hole	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.		Hilfiker, Sabine N/L-6369-2014; Augustine, George James/J-9228-2013	Hilfiker, Sabine N/0000-0002-5167-7682; 				Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; CHARLTON MP, 1978, J GEN PHYSIOL, V72, P471, DOI 10.1085/jgp.72.4.471; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HONG RM, 1994, FEBS LETT, V350, P253, DOI 10.1016/0014-5793(94)00778-0; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Klagges BRE, 1996, J NEUROSCI, V16, P3154; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; OConnor V, 1997, P NATL ACAD SCI USA, V94, P12186, DOI 10.1073/pnas.94.22.12186; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; SANCHEZ ME, 1990, J EXP BIOL, V152, P369; SCHELLER RH, 1995, NEURON, V14, P894; Schikorski T, 1997, J NEUROSCI, V17, P5858; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; TORRITARELLI F, 1990, J CELL BIOL, V110, P449, DOI 10.1083/jcb.110.2.449; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3; Vogel SS, 1996, J CELL BIOL, V134, P329, DOI 10.1083/jcb.134.2.329; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	47	125	125	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					29	35		10.1038/229	http://dx.doi.org/10.1038/229			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195105				2022-12-24	WOS:000076361000014
J	Tarr, MJ				Tarr, MJ			News on views: Pandemonium revisited	NATURE NEUROSCIENCE			English	News Item							OBJECT RECOGNITION; MONKEY; CORTEX; FACES	How do we recognize objects from different viewpoints? A new model, based on the known properties of cortical neurons, may help resolve this long-standing debate.	Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Brown University	Tarr, MJ (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Box 1978, Providence, RI 02912 USA.							BIEDERMAN I, 1995, J EXP PSYCHOL HUMAN, V21, P1506, DOI 10.1037/0096-1523.21.6.1506; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Bienenstock E, 1997, ADV NEUR IN, V9, P838; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Perrett DI, 1998, COGNITION, V67, P111, DOI 10.1016/S0010-0277(98)00015-8; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Selfridge O. G., 1959, S MECH THOUGHT PROC, P513; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TARR MJ, 1995, J EXP PSYCHOL HUMAN, V21, P1494, DOI 10.1037/0096-1523.21.6.1494; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; ULLMAN S, 1989, COGNITION, V32, P193, DOI 10.1016/0010-0277(89)90036-X	15	13	14	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					932	935		10.1038/14714	http://dx.doi.org/10.1038/14714			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FF	10526326				2022-12-24	WOS:000083883300005
J	Zhong, HJ; Yokoyama, CT; Scheuer, T; Catterall, WA				Zhong, HJ; Yokoyama, CT; Scheuer, T; Catterall, WA			Reciprocal regulation of P/Q-type Ca2+ channels by SNAP-25, syntaxin and synaptotagmin	NATURE NEUROSCIENCE			English	Article							CALCIUM-CHANNEL; ALPHA(1A) SUBUNITS; N-TYPE; BRAIN; ISOFORMS; PROTEINS		Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER; NINDS NIH HHS [NS22625] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; MARTINMOUTOT N, 1995, FEBS LETT, V366, P21, DOI 10.1016/0014-5793(95)00467-N; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x	14	122	126	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					939	941		10.1038/14721	http://dx.doi.org/10.1038/14721			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526329				2022-12-24	WOS:000083883300007
J	Sceniak, MP; Ringach, DL; Hawken, MJ; Shapley, R				Sceniak, MP; Ringach, DL; Hawken, MJ; Shapley, R			Contrast's effect on spatial summation by macaque V1 neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELD STRUCTURE; CAT STRIATE CORTEX; SYNAPTIC INTEGRATION; LOCAL CIRCUITS; IN-VITRO; INHIBITION; CELLS; ORGANIZATION; SENSITIVITY	Stimulation outside the receptive field of a primary visual cortical (V1) neuron reveals intracortical neural interactions(1-6). However, previous investigators implicitly or explicitly considered the extent of cortical spatial summation and, therefore, the size of the classical receptive field to be fixed and independent of stimulus characteristics or of surrounding context. On the contrary, we found that the extent of spatial summation in macaque V1 neurons depended on contrast, and was on average 2.3-fold greater at low contrast. This adaptive increase in spatial summation at low contrast was seen in cells throughout V1 and was independent of surround inhibition.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	New York University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sceniak, MP (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.			Sceniak, Michael/0000-0003-2415-5800	NATIONAL EYE INSTITUTE [R01EY001472, R01EY008300] Funding Source: NIH RePORTER; NEI NIH HHS [EY08300, EY01472] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEANGELIS GC, 1995, P NATL ACAD SCI USA, V92, P9682, DOI 10.1073/pnas.92.21.9682; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; Hirsch JA, 1998, J NEUROSCI, V18, P9517; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LUND JS, 1981, J COMP NEUROL, V202, P19, DOI 10.1002/cne.902020104; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Markram H, 1996, J PHYSIOLOGY-PARIS, V90, P229, DOI 10.1016/S0928-4257(97)81429-5; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Zipser K, 1996, J NEUROSCI, V16, P7376	30	460	464	2	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					733	739		10.1038/11197	http://dx.doi.org/10.1038/11197			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412063				2022-12-24	WOS:000083882800013
J	Bush, TG; Puvanachandra, N; Horner, CH; Polito, A; Ostenfeld, T; Svendsen, CN; Mucke, L; Johnson, MH; Sofroniew, MV				Bush, TG; Puvanachandra, N; Horner, CH; Polito, A; Ostenfeld, T; Svendsen, CN; Mucke, L; Johnson, MH; Sofroniew, MV			Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN-BARRIER; RAT-BRAIN; MICROGLIAL RESPONSE; ENDOTHELIAL-CELLS; SPINAL-CORD; BLOOD; REGENERATION; MACROPHAGES; INJURY	Reactive astrocytes adjacent to a forebrain stab injury were selectively ablated in adult mice expressing HSV-TK from the Gfap promoter by treatment with ganciclovir. Injured tissue that was depleted of GFAP-positive astrocytes exhibited (1) a prolonged 25-fold increase in infiltration of CD45-positive leukocytes, including ultrastructurally identified monocytes, macrophages, neutrophils, and lymphocytes, (2) failure of blood-brain barrier (BBB) repair, (3) substantial neuronal degeneration that could be attenuated by chronic glutamate receptor blockade, and (4) a pronounced increase in local neurite outgrowth. These findings show that genetic targeting can be used to ablate scar-forming astrocytes and demonstrate roles for astrocytes in regulating leukocyte trafficking, repairing the BBB, protecting neurons, and restricting nerve fiber growth after injury in the adult central nervous system.	MRC, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; Univ Cambridge, Dept Anat, Cambridge CB2 2PY, England; Univ Calif San Francisco, Gladstone Mol Neurobiol Program, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94141 USA	University of Cambridge; University of Cambridge; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Sofroniew, MV (corresponding author), MRC, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England.	mvs10@cam.ac.uk	Sofroniew, Michael/ABE-8857-2020	johnson, martin/0000-0002-5906-5883; Mucke, Lennart/0000-0001-6256-9559	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Acarin L, 1996, J COMP NEUROL, V367, P361; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BLAKEMORE WF, 1989, J NEUROCYTOL, V18, P519, DOI 10.1007/BF01474547; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; BREWSTER ME, 1994, ANTIMICROB AGENTS CH, V38, P817, DOI 10.1128/AAC.38.4.817; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; Budd SL, 1998, NAT NEUROSCI, V1, P431, DOI 10.1038/2147; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Carson MJ, 1999, J NEUROSCI RES, V55, P1; CHENG YC, 1983, P NATL ACAD SCI-BIOL, V80, P2767, DOI 10.1073/pnas.80.9.2767; Choi DW, 1997, TRENDS NEUROSCI, V20, P499; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Delaney CL, 1996, J NEUROSCI, V16, P6908; DOWDING AJ, 1993, P NATL ACAD SCI USA, V90, P10183, DOI 10.1073/pnas.90.21.10183; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0; FRANK KB, 1984, J BIOL CHEM, V259, P1566; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HEYMAN RA, 1989, P NATL ACAD SCI USA, V86, P2698, DOI 10.1073/pnas.86.8.2698; HIRSCHBERG DL, 1995, J NEUROIMMUNOL, V61, P89, DOI 10.1016/0165-5728(95)00087-I; HOLASH JA, 1993, DEV DYNAM, V197, P14, DOI 10.1002/aja.1001970103; Hurst RD, 1996, J CELL PHYSIOL, V167, P81, DOI 10.1002/(SICI)1097-4652(199604)167:1<81::AID-JCP9>3.3.CO;2-F; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Kettenmann H., 1995, NEUROGLIA; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Krum JM, 1996, EXP NEUROL, V142, P29, DOI 10.1006/exnr.1996.0176; Largo C, 1996, J NEUROSCI, V16, P1219; LARNER AJ, 1995, BIOL REV, V70, P597, DOI 10.1111/j.1469-185X.1995.tb01653.x; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Raivich G, 1998, J NEUROSCI, V18, P5804; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; REIER PJ, 1983, SPINAL CORD RECONSTR, P163; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; RUDGE JS, 1990, J NEUROSCI, V10, P3594; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Toggas SM, 1996, BRAIN RES, V706, P303, DOI 10.1016/0006-8993(95)01197-8; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Veronesi B, 1996, NEUROTOXICOLOGY, V17, P433; WALLACE H, 1991, ENDOCRINOLOGY, V129, P3217, DOI 10.1210/endo-129-6-3217; YCAJAL SR, 1928, DEGENERATION REGENER	56	780	812	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1999	23	2					297	308		10.1016/S0896-6273(00)80781-3	http://dx.doi.org/10.1016/S0896-6273(00)80781-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399936	Bronze			2022-12-24	WOS:000081218600015
J	George, N; Dolan, RJ; Fink, GR; Baylis, GC; Russell, C; Driver, J				George, N; Dolan, RJ; Fink, GR; Baylis, GC; Russell, C; Driver, J			Contrast polarity and face recognition in the human fusiform gyrus	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUNCTIONAL-ORGANIZATION; FACIAL RECOGNITION; RECOGNIZING FACES; TEMPORAL CORTEX; HUMAN BRAIN; MEMORY; PERCEPTION; PROSOPAGNOSIA; NEURONS	Functional imaging has revealed face-responsive visual areas in the human fusiform gyrus, but their role in recognizing familiar individuals remains controversial. Face recognition is particularly impaired by reversing contrast polarity of the image, even though this preserves all edges and spatial frequencies. Here, combined influences of familiarity and priming on face processing were examined as contrast polarity was manipulated. Our fMRI results show that bilateral posterior areas in fusiform gyrus responded more strongly for faces with positive than with negative contrast polarity. An anterior, right-lateralized fusiform region is activated when a given face stimulus becomes recognizable as a well-known individual.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Univ Dusseldorf, Neurol Klin, D-40001 Dusseldorf, Germany; Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; Heinrich Heine University Dusseldorf; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of London; University College London	Dolan, RJ (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	r.dolan@fil.ion.ucl.ac.uk	Fink, Gereon R./E-1616-2012; Fink, Gereon R./AFW-9377-2022; Driver, Jon/A-4779-2010	Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Russell, Charlotte/0000-0002-8194-8033; BAYLIS, Gordon/0000-0002-4223-9074; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andreasen NC, 1996, J NEUROPSYCH CLIN N, V8, P139; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; BRUCE V, 1994, PERCEPTION, V23, P803, DOI 10.1068/p230803; Bruce V., 1994, VIS COGN, V1, P141, DOI [DOI 10.1080/13506289408402299, 10.1080/13506289408402299]; BRUNASWAGSTAFF J, 1992, Q J EXP PSYCHOL-A, V44, P423, DOI 10.1080/14640749208401293; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; CAVANAGH P, 1989, J EXP PSYCHOL HUMAN, V15, P3, DOI 10.1037/0096-1523.15.1.3; Clark VP, 1998, J NEUROPHYSIOL, V79, P3257, DOI 10.1152/jn.1998.79.6.3257; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; DAVIES G, 1978, J APPL PSYCHOL, V63, P180, DOI 10.1037/0021-9010.63.2.180; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DERENZI E, 1989, HDB RES FACE PROCESS, P27; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; ELLIS AW, 1990, Q J EXP PSYCHOL-A, V42, P495, DOI 10.1080/14640749008401234; ETTLIN TM, 1992, CORTEX, V28, P129, DOI 10.1016/S0010-9452(13)80171-2; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; HARRIES MH, 1991, J COGNITIVE NEUROSCI, V3, P9, DOI 10.1162/jocn.1991.3.1.9; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; JOHNSTON A, 1992, PERCEPTION, V21, P365, DOI 10.1068/p210365; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, IN PRESS COGNITION; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; Puce A, 1996, J NEUROSCI, V16, P5205; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RIZZO M, 1987, ANN NEUROL, V22, P41, DOI 10.1002/ana.410220111; ROLLS ET, 1986, EXP BRAIN RES, V65, P38; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SERGENT J, 1989, HDB RES FACE PROCESS, P77; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; SUBRAMANIAM S, 1997, INVEST OPHTHALMOL, V38, P998; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; Warrington E.K., 1967, CORTEX, V3, P317; Wiskott L, 1996, NEUROIMAGE, V4, pS14, DOI 10.1006/nimg.1996.0043; YOUNG AW, 1994, BRIT J PSYCHOL, V85, P393, DOI 10.1111/j.2044-8295.1994.tb02531.x	50	204	209	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					574	580		10.1038/9230	http://dx.doi.org/10.1038/9230			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273YA	10448224				2022-12-24	WOS:000084735900019
J	Epstein, R; Harris, A; Stanley, D; Kanwisher, N				Epstein, R; Harris, A; Stanley, D; Kanwisher, N			The parahippocampal place area: Recognition, navigation, or encoding?	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; HIPPOCAMPAL-FORMATION; BRAIN ACTIVITY; MEMORY; REPRESENTATION; FAMILIARITY; EXPERIENCE; PERCEPTION	The parahippocampal place area (PPA) has been demonstrated to respond more strongly in fMRI to scenes depicting places than to other kinds of visual stimuli. Here, we test several hypotheses about the function of the PPA. We find that PPA activity (1) is not affected by the subjects' familiarity with the place depicted, (2) does not increase when subjects experience a sense of motion through the scene, and (3) is greater when viewing novel versus repeated scenes but not novel versus repeated faces. Thus, we find no evidence that the PPA is involved in matching perceptual information to stored representations in memory, in planning routes, or in monitoring locomotion through the local or distal environment but some evidence that it is involved in encoding new perceptual information about the appearance and layout of scenes.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Epstein, R (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.		Epstein, Russell/G-4517-2013	Harris, Alison/0000-0002-0559-2821	NIMH NIH HHS [MH11459] Funding Source: Medline; PHS HHS [56037] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH011459] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aguirre GK, 1998, P NATL ACAD SCI USA, V95, P839, DOI 10.1073/pnas.95.3.839; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Aguirre GK, 1998, MAGNET RESON MED, V39, P500, DOI 10.1002/mrm.1910390322; AGUIRRE GK, 1999, IN PRESS BRAIN; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Clark VP, 1998, J NEUROPHYSIOL, V79, P3257, DOI 10.1152/jn.1998.79.6.3257; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; HABIB M, 1987, CORTEX, V23, P73, DOI 10.1016/S0010-9452(87)80020-5; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; LANDIS T, 1986, ARCH NEUROL-CHICAGO, V43, P132, DOI 10.1001/archneur.1986.00520020026011; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Maguire EA, 1998, J NEUROL NEUROSUR PS, V65, P903, DOI 10.1136/jnnp.65.6.903; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 1997, J NEUROSCI, V17, P7103; Martin A, 1997, HIPPOCAMPUS, V7, P587, DOI 10.1002/(SICI)1098-1063(1997)7:6<587::AID-HIPO1>3.0.CO;2-C; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy RA, 1996, J NEUROL NEUROSUR PS, V60, P318, DOI 10.1136/jnnp.60.3.318; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; ROSS ED, 1980, ARCH NEUROL-CHICAGO, V37, P193, DOI 10.1001/archneur.1980.00500530031001; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WHITELEY AM, 1978, J NEUROL NEUROSUR PS, V41, P575, DOI 10.1136/jnnp.41.6.575	35	594	601	1	45	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					115	125		10.1016/S0896-6273(00)80758-8	http://dx.doi.org/10.1016/S0896-6273(00)80758-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402198	Bronze			2022-12-24	WOS:000080681200015
J	Craven, SE; El-Husseini, AE; Bredt, DS				Craven, SE; El-Husseini, AE; Bredt, DS			Synaptic targeting of the postsynaptic density protein PSD-95 mediated by lipid and protein motifs	NEURON			English	Article							TUMOR-SUPPRESSOR PROTEIN; NITRIC-OXIDE SYNTHASE; HIPPOCAMPAL-NEURONS; SIGNAL-TRANSDUCTION; CELL-MEMBRANES; FASCICLIN-II; K+ CHANNELS; PDZ DOMAIN; GENE DLG; IN-VIVO	During synaptic development, proteins aggregate at specialized pre- and postsynaptic structures. Mechanisms that mediate protein clustering at these sites remain unknown. To investigate this process, we analyzed synaptic targeting of a postsynaptic density protein, PSD-95, by expressing green fluorescent protein- (GFP-) tagged PSD-95 in cultured hippocampal neurons. We find that postsynaptic clustering relies on three elements of PSD-95: N-terminal palmitoylation, the first two PDZ domains, and a C-terminal targeting motif. In contrast, disruptions of PDZ3, SH3, or guanylate kinase (GK) domains do not affect synaptic targeting. Palmitoylation is sufficient to target the diffusely expressed SAP-97 to synapses, and palmitoylation cannot be replaced with alternative membrane association motifs, suggesting that a specialized synaptic lipid environment mediates postsynaptic clustering. The requirements for PDZ domains and a C-terminal domain of PSD-95 indicate that protein-protein interactions cooperate with lipid interactions in synaptic targeting.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bredt, DS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.							ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; BRENMAN JE, 1998, J NEUROSCI; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CARLIN RK, 1981, J CELL BIOL, V89, P449, DOI 10.1083/jcb.89.3.449; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; delaCruz RR, 1996, REV NEUROSCIENCE, V7, P115; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7; Kaech S, 1997, J NEUROSCI, V17, P9565; Kaech S, 1996, MOL BRAIN RES, V35, P344, DOI 10.1016/0169-328X(95)00238-N; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; LISANTI MP, 1995, MOL MEMBR BIOL, V12, P121, DOI 10.3109/09687689509038506; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Rao A, 1998, J NEUROSCI, V18, P1217; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; WALTERS BB, 1975, BIOCHEM SOC T, V3, P109, DOI 10.1042/bst0030109; Winckler B, 1996, NATURE, V379, P213, DOI 10.1038/379213a0; Wu HJ, 1998, J CELL SCI, V111, P2365; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	60	272	276	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					497	509		10.1016/S0896-6273(00)80705-9	http://dx.doi.org/10.1016/S0896-6273(00)80705-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197530	Bronze			2022-12-24	WOS:000079483900014
J	Clyne, PJ; Warr, CG; Freeman, MR; Lessing, D; Kim, JH; Carlson, JR				Clyne, PJ; Warr, CG; Freeman, MR; Lessing, D; Kim, JH; Carlson, JR			A novel family of divergent seven-transmembrane proteins: Candidate odorant receptors in Drosophila	NEURON			English	Article							MELANOGASTER MEIGEN DIPTERA; OLFACTORY SENSE-ORGANS; PHOSPHOLIPASE-C; INSECT ANTENNAE; MAXILLARY PALP; WILD-TYPE; EXPRESSION; GENE; SYSTEM; INFORMATION	Although insects have proven to be valuable models for exploring the function, organization, and development of the olfactory system, the receptor molecules that bind odors have not been identified in any insect. We have developed a novel search algorithm, used it to search the Drosophila genomic sequence database, and identified a large multigene family encoding seven transmembrane domain proteins that are expressed in olfactory organs. We show that expression is restricted to subsets of olfactory receptor neurons (ORNs) for a number of these genes. Different members of the family initiate expression at different times during antennal development. Some of the genes are not expressed in a mutant of the Acj6 POU-domain transcription factor, a mutant in which a subset of ORNs show abnormal odorant specificities.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06520 USA	Yale University; Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.			Warr, Coral/0000-0002-5289-3950	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M., 1989, DROSOPHILA LAB HDB; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Barth AL, 1997, NEURON, V19, P359, DOI 10.1016/S0896-6273(00)80945-9; Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; BAUMANN A, 1994, EMBO J, V13, P5040, DOI 10.1002/j.1460-2075.1994.tb06833.x; BOEKHOFF I, 1990, CELL SIGNAL, V2, P49, DOI 10.1016/0898-6568(90)90032-6; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Brown T. A., 1991, MOL BIOL LABFAX; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHADWICK R, 1987, EMBO J, V6, P779, DOI 10.1002/j.1460-2075.1987.tb04820.x; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; HAENLIN M, 1987, EMBO J, V6, P801, DOI 10.1002/j.1460-2075.1987.tb04822.x; HAFEN E, 1986, DROSOPHILA PRACTICAL, P139; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; KAISSLING KE, 1987, RH WHITE LECT INSECT; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAISSUE P, 1999, IN PRESS J COMP NEUR, V405; LIENHARD MC, 1991, DEVELOPMENT, V112, P1063; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Reddy GV, 1997, DEVELOPMENT, V124, P703; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RIESGOESCOVAR J, 1995, P NATL ACAD SCI USA, V92, P2864, DOI 10.1073/pnas.92.7.2864; RiesgoEscovar JR, 1997, J COMP PHYSIOL A, V180, P151, DOI 10.1007/s003590050036; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; SIDDIQI O, 1991, CHEM SENS, P79; SINGH RN, 1985, INT J INSECT MORPHOL, V14, P291; STOCKER RF, 1995, ROUX ARCH DEV BIOL, V205, P62, DOI 10.1007/BF00188844; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; VENKATESH S, 1984, INT J INSECT MORPHOL, V13, P51, DOI 10.1016/0020-7322(84)90032-1; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WEGENER JW, 1993, J INSECT PHYSIOL, V39, P153, DOI 10.1016/0022-1910(93)90107-3; White SH., 1994, MEMBRANE PROTEIN STR, P97, DOI [10.1007/978-1-4614-7515-6_4, DOI 10.1007/978-1-4614-7515-6_4]; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	54	829	915	11	109	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					327	338		10.1016/S0896-6273(00)81093-4	http://dx.doi.org/10.1016/S0896-6273(00)81093-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069338	hybrid			2022-12-24	WOS:000078875200017
J	Rossi, J; Luukko, K; Poteryaev, D; Laurikainen, A; Sun, YF; Laakso, T; Eerikainen, S; Tuominen, R; Lakso, M; Rauvala, H; Arumae, U; Pasternack, M; Saarma, M; Airaksinen, MS				Rossi, J; Luukko, K; Poteryaev, D; Laurikainen, A; Sun, YF; Laakso, T; Eerikainen, S; Tuominen, R; Lakso, M; Rauvala, H; Arumae, U; Pasternack, M; Saarma, M; Airaksinen, MS			Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha 2, a functional neurturin receptor	NEURON			English	Article							C-RET PROTOONCOGENE; NEUROTROPHIC FACTOR GDNF; TYROSINE KINASE; SURVIVAL FACTOR; MESSENGER-RNA; EXPRESSION; NEURONS; ALPHA; RAT; MOUSE	Glial cell line-derived neurotrophic factor (GDNF) and a related protein, neurturin (NTN), require a GPI-linked coreceptor, either GFR alpha 1 or GFR alpha 2, for signaling via the transmembrane Ret tyrosine kinase. We show that mice lacking functional GFR alpha 2 coreceptor (Gfra2(-/-)) are viable and fertile but have dry eyes and grow poorly after weaning, presumably due to malnutrition. While the sympathetic innervation appeared normal, the parasympathetic cholinergic innervation was almost absent in the lacrimal and salivary glands and severely reduced in the small bowel. Neurite outgrowth and trophic effects of NTN at low concentrations were lacking in Gfra2(-/-) trigeminal neurons in vitro, whereas responses to GDNF were similar between the genotypes. Thus, GFRa2 is a physiological NTN receptor, essential for the development of specific postganglionic parasympathetic neurons.	Univ Helsinki, Inst Biotechnol, Program Mol Neurobiol, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Program Dev Biol, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biotechnol, Transgene Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Pharm, Div Pharmacol & Toxicol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Biosci, Vikki Bioctr, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Airaksinen, MS (corresponding author), Univ Helsinki, Inst Biotechnol, Program Mol Neurobiol, FIN-00014 Helsinki, Finland.		Arumäe, Urmas/E-8290-2016	Arumäe, Urmas/0000-0003-3658-6464; Airaksinen, Matti/0000-0002-7199-4984; Rauvala, Heikki/0000-0001-7809-9811; Rossi, Jari/0000-0002-3728-9800; Poteryaev, Dmitry/0000-0003-2695-8869				ARUMAE U, 1993, J CELL BIOL, V122, P1053, DOI 10.1083/jcb.122.5.1053; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; Davies A. M., 1995, NEURAL CELL CULTURE, P153; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Durbec PL, 1996, DEVELOPMENT, V122, P349; EBENDAL T, 1989, NERVE GROWTH FACTORS, P81; Enokido Y, 1998, CURR BIOL, V8, P1019, DOI 10.1016/S0960-9822(07)00422-8; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; HEINICKE EA, 1987, J NEUROSCI METH, V21, P45, DOI 10.1016/0165-0270(87)90101-4; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Horger BA, 1998, J NEUROSCI, V18, P4929; HUMPHREYSBEHER MG, 1994, ADV EXP MED BIOL, V350, P631; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Luukko K, 1998, DEV DYNAM, V213, P207, DOI 10.1002/(SICI)1097-0177(199810)213:2<207::AID-AJA6>3.3.CO;2-7; Luukko K, 1997, DEV DYNAM, V210, P463, DOI 10.1002/(SICI)1097-0177(199712)210:4<463::AID-AJA9>3.0.CO;2-E; Masure S, 1998, EUR J BIOCHEM, V251, P622, DOI 10.1046/j.1432-1327.1998.2510622.x; MAYER E, 1992, BAILLIERE CLIN ENDOC, V6, P645, DOI 10.1016/S0950-351X(05)80117-X; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; Nomoto S, 1998, BIOCHEM BIOPH RES CO, V244, P849, DOI 10.1006/bbrc.1998.8361; Nosrat CA, 1997, EXP BRAIN RES, V115, P410, DOI 10.1007/PL00005711; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Reeben M, 1998, NEUROSCIENCE, V83, P151, DOI 10.1016/S0306-4522(97)00361-8; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sang Q, 1998, ANAT REC, V251, P185; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; Suvanto P, 1996, EUR J NEUROSCI, V8, P816, DOI 10.1111/j.1460-9568.1996.tb01267.x; TAGO H, 1986, J HISTOCHEM CYTOCHEM, V34, P1431, DOI 10.1177/34.11.2430009; Thompson J, 1998, MOL CELL NEUROSCI, V11, P117, DOI 10.1006/mcne.1998.0682; Thomsen L, 1998, NAT MED, V4, P848, DOI 10.1038/nm0798-848; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; Vannucchi MG, 1996, NEUROSCI LETT, V206, P105, DOI 10.1016/S0304-3940(96)12440-X; VINCENT SR, 1992, EXPT NEUROANATOMY PR, P162; WEEMS WA, 1981, AM J PHYSIOL, V240, pG147, DOI 10.1152/ajpgi.1981.240.2.G147; Widenfalk J, 1997, J NEUROSCI, V17, P8506; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; Yu T, 1998, J NEUROSCI, V18, P4684	60	219	224	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					243	252		10.1016/S0896-6273(00)81086-7	http://dx.doi.org/10.1016/S0896-6273(00)81086-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069331	Bronze			2022-12-24	WOS:000078875200010
J	Stuart, G				Stuart, G			Voltage-activated sodium channels amplify inhibition in neocortical pyramidal neurons	NATURE NEUROSCIENCE			English	Article							LAYER-V NEURONS; POSTSYNAPTIC POTENTIALS; EXCITABLE DENDRITES; HIPPOCAMPUS; CELLS; EPSPS; INVITRO; CORTEX; SLICES; BACKPROPAGATION	Inhibitory postsynaptic potentials (IPSPs) in neocortical pyramidal neurons are increased in duration and amplitude at depolarized membrane potentials. This effect was not due to changes in the time course of the underlying synaptic current. The role of postsynaptic voltage-activated channels was investigated by mimicking the voltage change that occurs during an IPSP with current injections. The peak and integral of these 'simulated' IPSPs increased during depolarization of the membrane potential in a tetrodotoxin-sensitive manner. This amplification presumably occurs as the hyperpolarization associated with IPSPs turns off sodium channels that are tonically active at depolarized membrane potentials. IPSP amplification increased the ability of IPSPs to inhibit action potential firing and promoted IPSP-induced action potential synchronization.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Stuart, G (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia.	Greg.Stuart@anu.edu.au	stuart, greg j/F-7328-2011	stuart, greg/0000-0001-9395-2219				ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; DEISZ RA, 1991, J NEUROPHYSIOL, V65, P371, DOI 10.1152/jn.1991.65.2.371; HILLE B, 1994, ION CHANNELS EXCITAB; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Johnston D., 1995, FDN CELLULAR NEUROPH; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; MASUKAWA LM, 1984, J NEUROSCI, V4, P217; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Owens DF, 1996, J NEUROSCI, V16, P6414; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; STAFSTROM CE, 1985, J NEUROPHYSIOL, V53, P153, DOI 10.1152/jn.1985.53.1.153; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SUTOR B, 1989, J NEUROPHYSIOL, V61, P607, DOI 10.1152/jn.1989.61.3.607; SUTOR B, 1989, J NEUROPHYSIOL, V61, P621, DOI 10.1152/jn.1989.61.3.621; THOMSON AM, 1988, J NEUROPHYSIOL, V60, P1896, DOI 10.1152/jn.1988.60.6.1896; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Urban NN, 1998, J NEUROPHYSIOL, V80, P1558, DOI 10.1152/jn.1998.80.3.1558; VANBREDERODE JFM, 1995, J NEUROPHYSIOL, V74, P1149, DOI 10.1152/jn.1995.74.3.1149; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x	33	55	57	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					144	150		10.1038/5698	http://dx.doi.org/10.1038/5698			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195198				2022-12-24	WOS:000078231600013
J	Petralia, RS; Esteban, JA; Wang, YX; Partridge, JG; Zhao, HM; Wenthold, RJ; Malinow, R				Petralia, RS; Esteban, JA; Wang, YX; Partridge, JG; Zhao, HM; Wenthold, RJ; Malinow, R			Selective acquisition of AMPA receptors over postnatal development suggests a molecular basis for silent synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; HIPPOCAMPAL SLICES; RAT-BRAIN; NEURONS; SUBUNITS; LIGHT; LTP; LOCALIZATION; EXPRESSION	Early in postnatal development, glutamatergic synapses transmit primarily through NMDA receptors. As development progresses, synapses acquire AMPA receptor function. The molecular basis of these physiological observations is not known. Here we examined single excitatory synapses with immunogold electron-microscopic analysis of AMPA and NMDA receptors along with electrophysiological measurements. Early in postnatal development, a significant fraction of excitatory synapses had NMDA receptors and lacked AMPA receptors. As development progressed, synapses acquired AMPA receptors with little change in NMDA receptor number. Thus, synapses with NMDA receptors but no AMPA receptors can account for the electrophysiologically observed 'silent synapse'.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Vanderbilt University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Esteban, Jose/L-4944-2014	Esteban, Jose/0000-0002-3759-3300	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003, ZIADC000003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Desmond NL, 1998, NEUROREPORT, V9, P857, DOI 10.1097/00001756-199803300-00017; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FOX K, 1995, NEURON, V15, P485, DOI 10.1016/0896-6273(95)90136-1; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JOHNSON ML, 1992, METHOD ENZYMOL, V210, P1; KATZ LC, 1996, SCIENCE, V274, P1132; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Matsubara A, 1996, J NEUROSCI, V16, P4457; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; STRAUME M, 1992, METHOD ENZYMOL, V210, P117; WANG BL, 1985, HISTOCHEMISTRY, V83, P47, DOI 10.1007/BF00495299; Wang YX, 1998, J NEUROSCI, V18, P1148; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998	32	391	406	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					31	36		10.1038/4532	http://dx.doi.org/10.1038/4532			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195177				2022-12-24	WOS:000078409300010
J	Feldheim, DA; Vanderhaeghen, P; Hansen, MJ; Frisen, J; Lu, Q; Barbacid, M; Flanagan, JG				Feldheim, DA; Vanderhaeghen, P; Hansen, MJ; Frisen, J; Lu, Q; Barbacid, M; Flanagan, JG			Topographic guidance labels in a sensory projection to the forebrain	NEURON			English	Article							RECEPTOR TYROSINE KINASES; LATERAL GENICULATE-NUCLEUS; RETINAL AXON GUIDANCE; EPH-FAMILY; OLFACTORY-BULB; VISUAL-SYSTEM; IN-VITRO; LIGANDS; ORGANIZATION; MOUSE	Visual connections to the mammalian forebrain are known to be patterned by neural activity, but it remains unknown whether the map topography of such higher sensory projections depends on axon guidance labels. Here, we show complementary expression and binding for the receptor EphA5 in mouse retina and its ligands ephrin-A2 and ephrin-A5 in multiple retinal targets, including the major forebrain target, the dorsal lateral geniculate nucleus (dLGN). These ligands can act in vitro as topographically specific repellents for mammalian retinal axons and are necessary for normal dLGN mapping in vivo. The results suggest a general and economic modular mechanism for brain mapping whereby a projecting field is mapped onto multiple targets by repeated use of the same labels. They also indicate the nature of a coordinate system for the mapping of sensory connections to the forebrain.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Inst Salud Carlos III, Ctr Nacl Invest Oncol Carlos 3, Madrid 28220, Spain	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Karolinska Institutet; Instituto de Salud Carlos III	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Flanagan, John/AAM-2995-2020	Vanderhaeghen, Pierre/0000-0001-7899-5720	NEI NIH HHS [EY11559] Funding Source: Medline; NICHD NIH HHS [HD29417] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417, R01HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CIOSSEK T, 1995, ONCOGENE, V10, P97; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; Donoghue MJ, 1996, MOL CELL NEUROSCI, V8, P185, DOI 10.1006/mcne.1996.0056; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; FROST DO, 1985, NATURE, V317, P162, DOI 10.1038/317162a0; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Garraghty P E, 1995, Int J Neurosci, V80, P31, DOI 10.3109/00207459508986092; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GODEMENT P, 1989, DEVELOPMENT, V106, P313; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Jacobson M., 1991, DEV NEUROBIOLOGY; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LUND RD, 1974, J COMP NEUROL, V158, P383, DOI 10.1002/cne.901580403; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; MONTERO MM, 1967, J NEUROPHYSIOL, V31, P221; NAGATA T, 1984, J COMP NEUROL, V227, P582, DOI 10.1002/cne.902270409; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROSKIES A, 1995, PERSPECT DEV NEUROBI, V3, P63; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; RUGH R, 1991, MOUSE; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; SAJJADI FG, 1991, NEW BIOL, V3, P769; SCALIA F, 1979, J COMP NEUROL, V186, P271, DOI 10.1002/cne.901860210; Sefton M, 1997, DEV BIOL, V188, P363, DOI 10.1006/dbio.1997.8638; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, NEURON, V9, P977, DOI 10.1016/0896-6273(92)90249-D; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SRETAVAN DW, 1987, J COMP NEUROL, V255, P386, DOI 10.1002/cne.902550306; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; WALSH C, 1983, NATURE, V302, P611, DOI 10.1038/302611a0; WALTER J, 1987, DEVELOPMENT, V101, P909; WALTER J, 1990, TRENDS NEUROSCI, V13, P447, DOI 10.1016/0166-2236(90)90097-T; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6; Zhang JH, 1996, J NEUROSCI, V16, P7182; ZHOU R, 1994, J NEUROSCI RES, V37, P129, DOI 10.1002/jnr.490370117	51	225	232	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1303	1313		10.1016/S0896-6273(00)80650-9	http://dx.doi.org/10.1016/S0896-6273(00)80650-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883724	Bronze			2022-12-24	WOS:000077910600013
J	Gotz, M; Stoykova, A; Gruss, P				Gotz, M; Stoykova, A; Gruss, P			Pax6 controls radial glia differentiation in the cerebral cortex	NEURON			English	Article							GUIDED NEURONAL MIGRATION; MONOCLONAL-ANTIBODY; VENTRICULAR ZONE; PRECURSOR CELLS; NERVOUS-SYSTEM; FETAL MONKEY; ASTROCYTES; MOUSE; EXPRESSION; BRAIN	Radial glia cells perform a dual function in the developing nervous system as precursor cells and guides for migrating neurons. We show here that during forebrain neurogenesis, the transcription factor Pax6 is specifically localized in radial glia cells of the cortex but not of the basal telencephalon. In Pax6-deficient mice, cortical radial glia cells were altered in their morphology, number, tenascin-C (TN-C) expression, and cell cycle. We show that some of these alterations are cell-autonomous, whereas others were rescued by coculturing with wild-type cortical cells. Our results suggest that Pax6 plays an essential role in the differentiation of cortical radial glia. Thus, despite their widespread distribution, radial glia cells are regionally specified in the developing CNS.	Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Max Planck Society	Gruss, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany.	pgruss@gwdg.de		Gotz, Magdalena/0000-0003-1551-9203				Anton ES, 1997, DEVELOPMENT, V124, P3501; BARTSCH S, 1992, J NEUROSCI, V12, P736; BIGNAMI A, 1974, NATURE, V252, P55, DOI 10.1038/252055a0; Cajal S. Ry, 1890, ANAT ANZEIGER, V5, P111; Caric D, 1997, DEVELOPMENT, V124, P5087; CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7; CULICAN SM, 1990, J NEUROSCI, V10, P684; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; FRITSCH R, 1996, THESIS G AUGUST U GO; GADISSEUX JF, 1990, DEV BRAIN RES, V52, P39, DOI 10.1016/0165-3806(90)90220-S; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Gotz M, 1997, EUR J NEUROSCI, V9, P496, DOI 10.1111/j.1460-9568.1997.tb01627.x; GOTZ M, 1995, EUR J NEUROSCI, V7, P889, DOI 10.1111/j.1460-9568.1995.tb01076.x; GRACHEVA N D, 1969, Tsitologiya, V11, P1521; GRAY GE, 1992, DEVELOPMENT, V114, P271; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; GROVE EA, 1993, DEVELOPMENT, V117, P553; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; HEYMAN I, 1995, DEV DYNAM, V204, P301, DOI 10.1002/aja.1002040308; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; His W., 1889, ABH MATH PHYS KSGW, V15, P313; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; KURTZ A, 1994, DEVELOPMENT, V120, P2637; LEVITT P, 1983, DEV BIOL, V96, P472, DOI 10.1016/0012-1606(83)90184-7; LEVITT P, 1981, J NEUROSCI, V1, P27, DOI 10.1523/JNEUROSCI.01-01-00027.1981; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; Mastick GS, 1997, DEVELOPMENT, V124, P1985; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MITROVIC N, 1994, J NEUROCYTOL, V23, P364, DOI 10.1007/BF01666526; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Ramon y Cajal S, 1890, ANAT ANZEIGER, V5, P85; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; Shibata T, 1997, J NEUROSCI, V17, P9212; Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6; STEINDLER DA, 1990, EXP NEUROL, V109, P35, DOI 10.1016/S0014-4886(05)80007-X; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warren N, 1997, DEVELOPMENT, V124, P1573	55	498	504	1	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1031	1044		10.1016/S0896-6273(00)80621-2	http://dx.doi.org/10.1016/S0896-6273(00)80621-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856459	Green Published, Bronze			2022-12-24	WOS:000077386100014
J	Aizenman, CD; Manis, PB; Linden, DJ				Aizenman, CD; Manis, PB; Linden, DJ			Polarity of long-term synaptic gain change is related to postsynaptic spike firing at a cerebellar inhibitory synapse	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; GATED CA2+ CHANNELS; RAT HIPPOCAMPUS; REBOUND POTENTIATION; NEOCORTICAL NEURONS; GABAERGIC SYNAPSES; CALCIUM TRANSIENTS; PYRAMIDAL NEURONS; VISUAL-CORTEX; DEPRESSION	Long-term potentiation and depression (LTP and LTD) in excitatory synapses can coexist, the former being triggered by stimuli that produce strong postsynaptic excitation and the latter by stimuli that produce weaker postsynaptic excitation. It has not been determined whether these properties also apply to LTP and LTD in the inhibitory synapses between Purkinje neurons and the neurons of the deep cerebellar nuclei (DCN), a site that has been implicated in certain types of motor learning. DCN cells exhibit a prominent rebound depolarization (RD) and associated spike burst upon release from hyperpolarization. In these cells, LTP can be elicited by short, high-frequency trains of inhibitory postsynaptic potentials (IPSPs), which reliably evoke an RD. LTD is induced if the same protocol is applied with conditions where the amount of postsynaptic excitation is reduced. The polarity of the change in synaptic strength is correlated with the amount of RD-evoked spike firing during the induction protocol. Thus, some important computational principles that govern the induction of use-dependent change in excitatory synaptic efficacy also apply to inhibitory synapses.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.			Manis, Paul/0000-0003-0131-8961	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000425] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC00425, R01 DC000425] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; KANO M, 1995, NEUROSCI RES, V21, P177, DOI 10.1016/0168-0102(94)00860-I; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu XB, 1997, NEUROREPORT, V8, P1475, DOI 10.1097/00001756-199704140-00030; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MARTY A, 1995, CURR OPIN NEUROBIOL, V5, P335, DOI 10.1016/0959-4388(95)80046-8; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; MOUGINOT D, 1995, NEUROSCIENCE, V64, P699, DOI 10.1016/0306-4522(94)00456-F; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8	44	179	180	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					827	835		10.1016/S0896-6273(00)80598-X	http://dx.doi.org/10.1016/S0896-6273(00)80598-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808468	Bronze			2022-12-24	WOS:000076697300025
J	Alonso, JM; Martinez, LM				Alonso, JM; Martinez, LM			Functional connectivity between simple cells and complex cells in cat striate cortex	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; LATERAL GENICULATE-NUCLEUS; CROSS-CORRELATION ANALYSIS; PRIMARY VISUAL-CORTEX; ORIENTATION SELECTIVITY; PYRAMIDAL NEURONS; RAT NEOCORTEX; AREA 17; ORGANIZATION; PROJECTIONS	In the cat primary visual cortex, neurons are classified into the two main categories of simple cells and complex cells based on their response properties. According to the hierarchical model, complex receptive fields derive from convergent inputs of simple cells with similar orientation preferences. This model received strong support from anatomical studies showing that many complex cells lie within the range of layer IV simple-cell axons but outside the range of most thalamic axons. Physiological evidence for the model, however, has remained elusive. Here we demonstrate that layer IV simple cells and layer II and III complex cells show correlated firing consistent with monosynaptic connections. As expected from the hierarchical model, all connections were in the direction from the simple cell to the complex cell, most frequently between cells with similar orientation preferences.	Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA	Rockefeller University	Alonso, JM (corresponding author), Rockefeller Univ, Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.	alonsoj@rockvax.rockefeller.edu						ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1271, DOI 10.1152/jn.1979.42.5.1271; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FERSTER D, 1985, J PHYSIOL-LONDON, V367, P233, DOI 10.1113/jphysiol.1985.sp015822; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; GHOSE GM, 1994, J NEUROPHYSIOL, V72, P1290, DOI 10.1152/jn.1994.72.3.1290; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; HAMMOND P, 1977, EXP BRAIN RES, V30, P275; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEGGELUND P, 1981, EXP BRAIN RES, V42, P99; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; HOFFMANN KP, 1971, BRAIN RES, V32, P460, DOI 10.1016/0006-8993(71)90340-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KIRKWOOD PA, 1979, J NEUROSCI METH, V1, P107, DOI 10.1016/0165-0270(79)90009-8; LUND JS, 1979, J COMP NEUROL, V184, P599, DOI 10.1002/cne.901840402; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MASON A, 1991, J NEUROSCI, V11, P72; Matsumura M, 1996, J NEUROSCI, V16, P7757; Mel BW, 1998, J NEUROSCI, V18, P4325; MOORE GP, 1970, BIOPHYS J, V10, P876, DOI 10.1016/S0006-3495(70)86341-X; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Orban GA, 1984, STUDIES BRAIN FUNCTI; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SURMEIER DJ, 1985, BRAIN RES, V331, P180, DOI 10.1016/0006-8993(85)90732-2; Sutter E.E., 1987, ADV METHODS PHYSIOLO, V1, P303; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P202, DOI 10.1152/jn.1981.46.2.202; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; TSO DY, 1986, J NEUROSCI, V6, P1160	50	179	184	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					395	403		10.1038/1609	http://dx.doi.org/10.1038/1609			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196530				2022-12-24	WOS:000076361400018
J	Heckers, S; Rauch, SL; Goff, D; Savage, CR; Schacter, DL; Fischman, AJ; Alpert, NM				Heckers, S; Rauch, SL; Goff, D; Savage, CR; Schacter, DL; Fischman, AJ; Alpert, NM			Impaired recruitment of the hippocampus during conscious recollection in schizophrenia	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION TOMOGRAPHY; CEREBRAL BLOOD-FLOW; EPISODIC MEMORY; FUNCTIONAL NEUROANATOMY; RECOGNITION MEMORY; TEMPORAL-LOBE; DYSFUNCTION; BRAIN; MEDICATION; ACTIVATION	Poor attention and impaired memory are enduring and core features of schizophrenia. These impairments have been attributed either to global cortical dysfunction or to perturbations of specific components associated with the dorsolateral prefrontal cortex (DLPFC), hippocampus and cerebellum. Here, we used positron emission tomography (PET) to dissociate activations in DLPFC and hippocampus during verbal episodic memory retrieval. We found reduced hippocampal activation during conscious recollection of studied words, but robust activation of the DLPFC during the effort to retrieve poorly encoded material in schizophrenic patients. This finding provides the first evidence of hippocampal dysfunction during episodic memory retrieval in schizophrenia.	Massachusetts Gen Hosp, Dept Psychiat, Psychot Disorders Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Psychiat, Psychiat Neuroimaging Res Grp, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med, Positron Emiss Tomog Lab, Boston, MA 02114 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Heckers, S (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Psychot Disorders Unit, Boston, MA 02114 USA.		Heckers, Stephan/F-3051-2010	Heckers, Stephan/0000-0003-3601-9910; Schacter, Daniel/0000-0002-2460-6061	NIMH NIH HHS [MH01215, R01MH57915] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057915] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alpert NM, 1996, NEUROIMAGE, V3, P10, DOI 10.1006/nimg.1996.0002; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P273; Andreasen NC, 1996, NEURON, V16, P697, DOI 10.1016/S0896-6273(00)80090-2; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Andreasen NC, 1997, SCIENCE, V275, P1586, DOI 10.1126/science.275.5306.1586; Arnold SE, 1997, J NEUROPSYCH CLIN N, V9, P460; Beauregard M, 1996, CAN J PSYCHIAT, V41, P446, DOI 10.1177/070674379604100710; BERMAN KF, 1986, ARCH GEN PSYCHIAT, V43, P126; BUCKNER RL, 1995, J NEUROSCI, V15, P12; DELISI LE, 1989, BIOL PSYCHIAT, V25, P835, DOI 10.1016/0006-3223(89)90263-1; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; DWORK AJ, 1997, SCHIZOPHR B, V23, P403; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; FRISTON KJ, 1992, BRAIN, V115, P367, DOI 10.1093/brain/115.2.367; FRITH CD, 1995, BRIT J PSYCHIAT, V167, P343, DOI 10.1192/bjp.167.3.343; Gilbertson MW, 1997, BIOL PSYCHIAT, V42, P585, DOI 10.1016/S0006-3223(96)00435-0; Goldberg T. E., 1995, P146; Goldberg TE, 1996, J CLIN PSYCHIAT, V57, P62; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Green MF, 1996, AM J PSYCHIAT, V153, P321; HEATON R, 1994, ARCH GEN PSYCHIAT, V51, P469; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; HURON C, 1995, AM J PSYCHIAT, V152, P1737; Kawasaki Y, 1996, PSYCHIAT RES-NEUROIM, V67, P49, DOI 10.1016/0925-4927(96)02685-6; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kraepelin E., 1919, CUTTING SHEPHERD; KRIECKHAUS EE, 1992, BIOL PSYCHIAT, V31, P560, DOI 10.1016/0006-3223(92)90242-R; LIDDLE PF, 1992, BRIT J PSYCHIAT, V160, P179, DOI 10.1192/bjp.160.2.179; Miller DD, 1997, BIOL PSYCHIAT, V41, P550, DOI 10.1016/S0006-3223(96)00110-2; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; SPITZER M, 1993, BIOL PSYCHIAT, V34, P864, DOI 10.1016/0006-3223(93)90054-H; SPITZER RL, 1991, STRUCTURED CLIN INTE; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; TAMMINGA CA, 1992, ARCH GEN PSYCHIAT, V49, P522; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; VENABLES PH, 1992, ANN NY ACAD SCI, V658, P111, DOI 10.1111/j.1749-6632.1992.tb22841.x; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; Woods RP, 1996, NEUROIMAGE, V4, pS84, DOI 10.1006/nimg.1996.0058	44	473	482	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					318	323		10.1038/1137	http://dx.doi.org/10.1038/1137			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195166				2022-12-24	WOS:000076361300016
J	Muller, CM; Griesinger, CB				Muller, CM; Griesinger, CB			Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HEPATOCYTE GROWTH-FACTOR; MONOCULAR DEPRIVATION; OCULAR DOMINANCE; BINOCULAR COMPETITION; NEURONAL DEGENERATION; EXTRACELLULAR-MATRIX; CORTICAL PLASTICITY; LATE-PHASE; RAT-BRAIN	Preventing visual input to one eye (monocular deprivation) in early postnatal development reduces cortical responses to stimulation of the deprived eye, with a significant loss of thalamocortical connections. These effects are reversible by opening the deprived eye and closing the previously open eye (reverse occlusion). We show that intracortical blockade of tissue plasminogen activator or plasmin selectively prevents recovery of cortical function and thalamic neuron size during reverse occlusion, without affecting the monocular deprivation response. Therefore, a proteolytic cascade consisting of plasmin generated by tissue plasminogen activator may selectively mediate reverse-occlusion-induced cortical plasticity, perhaps via structural remodeling of axons.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Univ London Univ Coll, Dept Physiol, London WC1E 6BT, England	Max Planck Society; University of London; University College London	Muller, CM (corresponding author), Max Planck Inst Dev Biol, Spemannstr 35-1, D-72076 Tubingen, Germany.							Antonini A, 1996, J COMP NEUROL, V369, P64; BEAR MF, 1990, J NEUROSCI, V10, P909; BEAR MF, 1990, P NATL ACAD SCI USA, V87, P9246, DOI 10.1073/pnas.87.23.9246; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; DENNY JB, 1990, BRAIN RES, V534, P317, DOI 10.1016/0006-8993(90)90148-5; DURSTELER MR, 1976, J PHYSIOL-LONDON, V261, P189; EDWARDS FA, 1995, TRENDS NEUROSCI, V18, P250, DOI 10.1016/0166-2236(95)80003-K; Geinisman Y, 1996, J COMP NEUROL, V368, P413; GU Q, 1989, DEV BRAIN RES, V47, P281, DOI 10.1016/0165-3806(89)90183-1; Gualandris A, 1996, J NEUROSCI, V16, P2220; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; KASAMATSU T, 1981, J PHARMACOL EXP THER, V217, P841; KASAMATSU T, 1976, SCIENCE, V267, P1658; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; MARS WM, 1993, AM J PATHOL, V143, P949; Mataga N, 1996, NEUROSCI LETT, V218, P149, DOI 10.1016/S0304-3940(96)13139-6; MCGUIRE PG, 1990, NEURON, V4, P633, DOI 10.1016/0896-6273(90)90121-U; MOVSHON JA, 1977, J NEUROPHYSIOL, V40, P1255, DOI 10.1152/jn.1977.40.6.1255; MOVSHON JA, 1976, J PHYSIOL-LONDON, V261, P125, DOI 10.1113/jphysiol.1976.sp011551; MULLER CM, 1993, J CHEM NEUROANAT, V6, P215, DOI 10.1016/0891-0618(93)90043-4; NAKAJIMA K, 1992, FEBS LETT, V308, P179, DOI 10.1016/0014-5793(92)81270-V; PITTMAN RN, 1995, J NEUROCHEM, V64, P566; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STURZEBECHER J, 1992, PROTEIN SCI, V1, P1007; SWINDALE NV, 1981, PROC R SOC SER B-BIO, V213, P435, DOI 10.1098/rspb.1981.0074; Thewke DP, 1996, J NEUROSCI, V16, P6933; TIAN LM, 1995, BRAIN RES, V680, P164, DOI 10.1016/0006-8993(95)00258-R; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1997, J NEUROSCI, V17, P543; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	42	103	110	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					47	53		10.1038/248	http://dx.doi.org/10.1038/248			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195108				2022-12-24	WOS:000076361000017
J	Huang, LQ; Shanker, YG; Dubauskaite, J; Zheng, JZ; Yan, WT; Rosenzweig, S; Spielman, AI; Max, M; Margolskee, RF				Huang, LQ; Shanker, YG; Dubauskaite, J; Zheng, JZ; Yan, WT; Rosenzweig, S; Spielman, AI; Max, M; Margolskee, RF			G gamma 13 colocalizes with gustducin in taste receptor cells and mediates IP3 responses to bitter denatonium	NATURE NEUROSCIENCE			English	Article							BETA-GAMMA-SUBUNITS; G-PROTEIN; CHROMOSOME LOCALIZATION; GENE STRUCTURE; ALPHA-SUBUNIT; TRANSDUCTION; RAT; KINASE; CDNA; BUDS	Gustducin is a transducin-like G protein selectively expressed in taste receptor cells. The alpha subunit of gustducin (alpha-gustducin) is critical for transduction of responses to bitter or sweet compounds. We identified a G-protein gamma subunit (G gamma 13) that colocalized with alpha-gustducin in taste receptor cells. Of 19 alpha-gustducin/Gy13-positive taste receptor cells profiled, all expressed the G protein beta 3 subunit (G beta 3); similar to 80% also expressed G beta 1. Gustducin heterotrimers (alpha-gustducin/G beta 1/G gamma 13) were activated by taste cell membranes plus bitter denatonium. Antibodies against G gamma 13 blocked the denatonium-induced increase of inositol trisphosphate (IP3) in taste tissue. We conclude that gustducin heterotrimers transduce responses to bitter and sweet compounds via alpha-gustducin's regulation of phosphodiesterase (PDE) and G beta gamma's activation of phospholipase C (PLC).	NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; NYU, Coll Dent, Div Basic Sci, New York, NY 10010 USA	Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; New York University	Margolskee, RF (corresponding author), NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, Box 1677,1 Gustave L Levy Pl, New York, NY 10029 USA.	margolskee@msvax.mssm.edu	Spielman, Andrew I./ABG-1150-2021	Spielman, Andrew I./0000-0002-7052-3689; Huang, Liquan/0000-0003-3400-0685; Margolskee, Robert/0000-0002-9572-2887	NIDCD NIH HHS [DC03155] Funding Source: Medline; NIDCR NIH HHS [DE10754] Funding Source: Medline; NIMH NIH HHS [MH57241] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE010754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH057241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABE K, 1993, J BIOL CHEM, V268, P12033; AKABAS MH, 1988, SCIENCE, V242, P1047, DOI 10.1126/science.3194756; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; Boughter JD, 1997, J NEUROSCI, V17, P2852; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Chaudhari N, 1996, J NEUROSCI, V16, P3817; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FISHER KJ, 1992, MOL CELL BIOL, V12, P1585, DOI 10.1128/MCB.12.4.1585; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HAGA K, 1994, J BIOL CHEM, V269, P12594; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; HWANG PM, 1990, P NATL ACAD SCI USA, V87, P7395, DOI 10.1073/pnas.87.19.7395; Kalyanaraman S, 1998, GENOMICS, V49, P147, DOI 10.1006/geno.1998.5223; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; MORISHITA R, 1995, J BIOL CHEM, V270, P29469, DOI 10.1074/jbc.270.49.29469; Ong OC, 1997, GENOMICS, V44, P101, DOI 10.1006/geno.1997.4814; PALMER S, 1990, METHODS INOSITIDE RE, P127; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; RAHMATULLAH M, 1994, J BIOL CHEM, V269, P3574; RAHMATULLAH M, 1995, J BIOL CHEM, V270, P2946, DOI 10.1074/jbc.270.7.2946; RAY K, 1995, J BIOL CHEM, V270, P21765, DOI 10.1074/jbc.270.37.21765; ROPER SD, 1989, ANNU REV NEUROSCI, V12, P329, DOI 10.1146/annurev.ne.12.030189.001553; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Ruiz C, 1995, EXPT CELL BIOL TASTE, P79; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; Scherer SW, 1996, GENOMICS, V35, P241, DOI 10.1006/geno.1996.0346; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; Spielman AI, 1996, AM J PHYSIOL-CELL PH, V270, pC926, DOI 10.1152/ajpcell.1996.270.3.C926; SPIELMAN AI, 1994, PHYSIOL BEHAV, V56, P1149, DOI 10.1016/0031-9384(94)90359-X; Spielman AI., 1995, EXPT CELL BIOL TASTE, P25; STRIEM JB, 1991, CELL PHYSIOL BIOCHEM, V1, P46; TAREILUS E, 1995, EXPT CELL BIOL TASTE, P193; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999	50	257	279	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1055	1062		10.1038/15981	http://dx.doi.org/10.1038/15981			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570481				2022-12-24	WOS:000085810100008
J	Yee, KT; Simon, HH; Tessier-Lavigne, M; O'Leary, DDM				Yee, KT; Simon, HH; Tessier-Lavigne, M; O'Leary, DDM			Extension of long leading processes and neuronal migration in the mammalian brain directed by the chemoattractant netrin-1	NEURON			English	Article							HORMONE-RELEASING HORMONE; CELL-ADHESION MOLECULE; PIONEER AXON MIGRATIONS; C-ELEGANS; OLFACTORY-BULB; SUBVENTRICULAR ZONE; COMMISSURAL AXONS; NERVOUS-SYSTEM; GROWTH-FACTOR; CHICK-EMBRYO	Long distance cell migration occurs throughout the developing CNS, but the underlying cellular and molecular mechanisms are poorly understood. We show that the directed circumferential migration of basilar pontine neurons from their origin in the neuroepithelium of the dorsal hindbrain to the ventral midline involves the extension of long (>1 mm) leading processes, which marker analyses suggest are molecularly distinct from axons. In vivo analysis of knockout mice implicates the axonal chemoattractant netrin-1, functioning via its receptor Deleted in Colorectal Cancer (DCC), in attracting the leading process to the ventral midline. Direct evidence for this chemoattractant mechanism is provided, using explant cultures and time-lapse analysis in vitro. Our results demonstrate the attraction of migrating neurons in the mammalian brain by an axon guidance molecule and the chemotactic responsiveness of their leading processes.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Salk Institute; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	oleary@qm.salk.edu						ALTMAN J, 1987, J COMP NEUROL, V257, P529, DOI 10.1002/cne.902570405; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BOOK KJ, 1991, EXP NEUROL, V111, P228, DOI 10.1016/0014-4886(91)90011-Z; BOURRAT F, 1988, DEV BRAIN RES, V39, P19, DOI 10.1016/0165-3806(88)90064-8; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; DANI JW, 1991, NEUROSCIENCE, V40, P277, DOI 10.1016/0306-4522(91)90190-Y; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Essick CR, 1912, AM J ANAT, V13, P25, DOI 10.1002/aja.1000130103; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUSKIN MB, 1994, CHEM SENSES, V19, P695, DOI 10.1093/chemse/19.6.695; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCGUIRE CB, 1988, DEV BRAIN RES, V41, P277, DOI 10.1016/0165-3806(88)90189-7; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Metin C, 1997, DEVELOPMENT, V124, P5063; MILLER J, 1995, DEVELOPMENT, V121, P2501; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; NORGREN RB, 1991, ENDOCRINOLOGY, V128, P1676, DOI 10.1210/endo-128-3-1676; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; ONO K, 1990, ANAT EMBRYOL, V182, P11; ONO K, 1992, NEUROSCI RES, V15, P221, DOI 10.1016/0168-0102(92)90008-Z; ORourke NA, 1997, DEVELOPMENT, V124, P997; Przyborski SA, 1998, DEVELOPMENT, V125, P41; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; ROUSSELOT P, 1995, J COMP NEUROL, V351, P51, DOI 10.1002/cne.903510106; SCHWANZELFUKUDA M, 1994, J COMP NEUROL, V342, P174, DOI 10.1002/cne.903420203; SCHWANZELFUKUDA M, 1992, J COMP NEUROL, V321, P1, DOI 10.1002/cne.903210102; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; SINGER SJ, 1986, ANNU REV CELL BIOL, V2, P337, DOI 10.1146/annurev.cb.02.110186.002005; TABERPIERCE E, 1966, J COMP NEUROL, V126, P219; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 1999, NEURON, V22, P649, DOI 10.1016/S0896-6273(00)80723-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	64	213	215	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					607	622		10.1016/S0896-6273(00)81116-2	http://dx.doi.org/10.1016/S0896-6273(00)81116-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595513	Bronze			2022-12-24	WOS:000083913000017
J	Cameron, HA; McKay, RDG				Cameron, HA; McKay, RDG			Restoring production of hippocampal neurons in old age	NATURE NEUROSCIENCE			English	Article							RAT DENTATE GYRUS; ADULT-RAT; PYRAMIDAL NEURONS; ADRENAL-STEROIDS; CORTISOL-LEVELS; INDUCED ATROPHY; GRANULE CELLS; NEUROGENESIS; STRESS; PROLIFERATION	The production of hippocampal granule neurons continues throughout adulthood but dramatically decreases in old age. Here we show that reducing corticosteroid levels in aged rats restored the rate of cell proliferation, resulting in increased numbers of new granule neurons. This result indicates that the neuronal precursor population in the dentate gyrus remains stable into old age, but that neurogenesis is normally slowed by high levels of corticosteroids. The findings further suggest that decreased neurogenesis may contribute to age-related memory deficits associated with high corticosteroids, and that these deficits may be reversible.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Cameron, HA (corresponding author), NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Cameron, Heather/E-6221-2011	Cameron, Heather/0000-0002-3245-5777				Bye N, 1998, NEUROREPORT, V9, P1179, DOI 10.1097/00001756-199804200-00040; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GOULD E, 1991, J COMP NEUROL, V313, P486, DOI 10.1002/cne.903130309; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Kempermann G, 1998, J NEUROSCI, V18, P3206; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LANDFIELD PW, 1994, ANN NY ACAD SCI, V746, P308; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Magarinos AM, 1999, EUR J PHARMACOL, V371, P113, DOI 10.1016/S0014-2999(99)00163-6; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MINTURN JE, 1995, J COMP NEUROL, V355, P369, DOI 10.1002/cne.903550304; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; SAPOLSKY RM, 1992, NEUROBIOL AGING, V13, P171, DOI 10.1016/0197-4580(92)90025-S; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; SERESS L, 1981, J ANAT, V133, P181; SLOVITER RS, 1993, J COMP NEUROL, V330, P337, DOI 10.1002/cne.903300305; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A	38	571	592	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					894	897		10.1038/13197	http://dx.doi.org/10.1038/13197			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491610				2022-12-24	WOS:000083883200015
J	Hyman, SE				Hyman, SE			Selective gene expression increases behavioral sensitivity to cocaine	NATURE NEUROSCIENCE			English	News Item							NUCLEUS-ACCUMBENS; ADDICTION	Addictive drugs induce a truncated form of fosB in the striatum. A new study shows that mice engineered to mimic this expression pattern are abnormally sensitive to cocaine.	NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hyman, SE (corresponding author), NIMH, NIH, 6001 Execut Blvd,Room 8235,MSC 9669, Bethesda, MD 20892 USA.							Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; KELZ MB, IN PRESS NATURE, V401; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Robinson TE, 1997, J NEUROSCI, V17, P8491; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x	9	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					855	856		10.1038/13147	http://dx.doi.org/10.1038/13147			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FE	10491599				2022-12-24	WOS:000083883200004
J	Matulef, K; Flynn, GE; Zagotta, WN				Matulef, K; Flynn, GE; Zagotta, WN			Molecular rearrangements in the ligand-binding domain of cyclic nucleotide-gated channels	NEURON			English	Article							ROD PHOTORECEPTORS; SUBUNIT STOICHIOMETRY; MEMBRANE PATCHES; ION CHANNELS; MECHANISM; RECEPTOR; PROTEIN; SITE; GMP; ACTIVATION	Cyclic nucleotide-gated (CNG) channels are activated in response to the direct binding of cyclic nucleotides to an intracellular domain. This domain is thought to contain a beta roll and two alpha helices, designated the B and C helices. To probe the conformational changes occurring in the ligand-binding domain during channel activation, we used the substituted cysteine accessibility method (SCAM). We found that a residue in the beta roll, C505, is more accessible in unliganded channels than in liganded channels, whereas a residue in the C helix, G597C, is more accessible in closed channels than in open channels. These results support a molecular mechanism for channel activation in which the ligand initially binds to the beta roll, followed by an opening allosteric transition involving the relative movement of the C helix toward the beta roll.	Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98105 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98105 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98105 USA.				NEI NIH HHS [R01 EY010329, T32 EY07031, R01 EY010329-06, EY10329] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007031, R01EY010329] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ALTENHOFEN W, 1991, P NATL ACAD SCI USA, V88, P9868, DOI 10.1073/pnas.88.21.9868; BROCKLEHURST K, 1979, INT J BIOCHEM, V10, P259, DOI 10.1016/0020-711X(79)90088-0; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; CHIAMVIMONVAT N, 1995, CIRC RES, V76, P325, DOI 10.1161/01.RES.76.3.325; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Fodor AA, 1997, J GEN PHYSIOL, V109, P3, DOI 10.1085/jgp.109.1.3; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P177; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; Molokanova E, 1997, J NEUROSCI, V17, P9068; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J BIOL CHEM, V262, P5630; WOHLFART P, 1992, J BIOL CHEM, V267, P644; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; ZIMMERMAN AL, 1988, BIOPHYS J, V54, P351, DOI 10.1016/S0006-3495(88)82966-7	32	60	61	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					443	452		10.1016/S0896-6273(00)80857-0	http://dx.doi.org/10.1016/S0896-6273(00)80857-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571237	Bronze			2022-12-24	WOS:000083423700018
J	Brefczynski, JA; DeYoe, EA				Brefczynski, JA; DeYoe, EA			A physiological correlate of the 'spotlight' of visual attention	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; FUNCTIONAL MRI; RETINOTOPIC ORGANIZATION; CEREBRAL-CORTEX; BRAIN ACTIVITY; AREA V4; COLOR; PET; MT; SENSITIVITY	Here we identify a neural correlate of the ability to precisely direct visual attention to locations other than the center of gaze. Human subjects performed a task requiring shifts of visual attention (but not of gaze) from one location to the next within a dense array of targets and distracters while functional MRI was used to map corresponding displacements of neural activation within visual cortex. The cortical topography of the purely attention-driven activity precisely matched the topography of activity evoked by the cued targets when presented in isolation. Such retinotopic mapping of attention-related activation was found in primary visual cortex, as well as in dorsomedial and ventral occipital visual areas previously implicated in processing the attended target features. These results identify a physiological basis for the effects of spatially directed visual attention.	Med Coll Wisconsin, Dept Cellular Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	DeYoe, EA (corresponding author), Med Coll Wisconsin, Dept Cellular Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NATIONAL EYE INSTITUTE [R01EY010244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH051358] Funding Source: NIH RePORTER; NEI NIH HHS [EY10244] Funding Source: Medline; NIMH NIH HHS [MH51358] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BEAUCHAMP MS, IN PRESS CEREB CORTE; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Crick F., 1994, ASTONISHING HYPOTHES; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1993, P SOC MAGN RESON MED, V3, P1394; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; James W, 1890, PRINCIPLES PSYCHOL, V1; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; LUCK SJ, 1995, INT J NEUROSCI, V80, P281, DOI 10.3109/00207459508986105; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MOTTER BC, 1994, J NEUROSCI, V14, P2178; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Saad Z. S., 1997, Proceedings of the 19th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. `Magnificent Milestones and Emerging Opportunities in Medical Engineering' (Cat. No.97CH36136), P460, DOI 10.1109/IEMBS.1997.754579; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; von Helmholtz H., 1910, TREATISE PHYSL OPTIC, V3; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	37	551	554	2	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					370	374		10.1038/7280	http://dx.doi.org/10.1038/7280			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204545				2022-12-24	WOS:000080532000017
J	Alagarsamy, S; Marino, MJ; Rouse, ST; Gereau, RW; Heinemann, SF; Conn, PJ				Alagarsamy, S; Marino, MJ; Rouse, ST; Gereau, RW; Heinemann, SF; Conn, PJ			Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-KINASE-C; RAT HIPPOCAMPAL SLICES; PHOSPHATIDYLINOSITOL TURNOVER; CEREBRAL-CORTEX; STRIATAL SLICES; MICE LACKING; RESPONSES; BRAIN	The metabotropic glutamate receptor, mGluR5, has a critical role in induction of NMDA-receptor-dependent forms of synaptic plasticity and excitotoxicity. This is likely mediated by a reciprocal positive-feedback interaction between these two glutamate receptor subtypes in which activation of mGluR5 potentiates NMDA receptor currents and NMDA receptor activation potentiates mGluR5-mediated responses. We have investigated the mechanism by which NMDA receptor activation modulates mGluR5 function and find evidence that this response is mediated by activation of a protein phosphatase and a resultant dephosphorylation of protein kinase C phosphorylation sites on mGluR5. This form of neuromodulation may be important in a number of normal and pathological processes that involve activation of the NMDA receptor.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Emory University; Baylor College of Medicine; Salk Institute	Conn, PJ (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	jconn@pharm.emory.edu	Conn, Peter/D-7848-2012					Angenstein F, 1997, PROG NEURO-PSYCHOPH, V21, P427, DOI 10.1016/S0278-5846(97)00012-2; ANIKSZTEJN L, 1992, EUR J NEUROSCI, V4, P500, DOI 10.1111/j.1460-9568.1992.tb00900.x; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BORTOLOTTO ZA, 1995, J NEUROSCI METH, V59, P19, DOI 10.1016/0165-0270(94)00189-N; BRODIN L, 1994, ACTA PHYSIOL SCAND, V150, P1, DOI 10.1111/j.1748-1716.1994.tb09653.x; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; CHALLISS RAJ, 1994, BRIT J PHARMACOL, V112, P231, DOI 10.1111/j.1476-5381.1994.tb13057.x; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; COLLINS DR, 1995, BRAIN RES, V684, P165, DOI 10.1016/0006-8993(95)00410-R; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Doherty AJ, 1997, NEUROPHARMACOLOGY, V36, P265, DOI 10.1016/S0028-3908(97)00001-4; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; Fitzjohn SM, 1996, NEUROSCI LETT, V203, P211, DOI 10.1016/0304-3940(96)12301-6; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; HARVEY J, 1993, BRIT J PHARMACOL, V109, P1085, DOI 10.1111/j.1476-5381.1993.tb13733.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lu YM, 1997, J NEUROSCI, V17, P5196; LUTHI A, 1994, PFLUG ARCH EUR J PHY, V427, P197, DOI 10.1007/BF00585965; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MORARI M, 1991, BRAIN RES, V553, P14, DOI 10.1016/0006-8993(91)90223-I; MORARI M, 1994, NEUROCHEM INT, V24, P191, DOI 10.1016/0197-0186(94)90106-6; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; PALMER E, 1988, MOL BRAIN RES, V4, P161, DOI 10.1016/0169-328X(88)90008-3; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; SACAAN AI, 1992, NEUROSCI LETT, V139, P77, DOI 10.1016/0304-3940(92)90862-2; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; WANG JH, 1994, NEUROREPORT, V5, P2377, DOI 10.1097/00001756-199411000-00041; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8	39	178	181	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					234	240		10.1038/6338	http://dx.doi.org/10.1038/6338			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195215				2022-12-24	WOS:000081684500010
J	Siegler, MVS; Jia, XX				Siegler, MVS; Jia, XX			Engrailed negatively regulates the expression of cell adhesion molecules connectin and neuroglian in embryonic Drosophila nervous system	NEURON			English	Article							GROWTH CONE GUIDANCE; IMAGINAL DISKS; SEQUENCE HOMOLOGY; GENE-EXPRESSION; HOMEOBOX GENES; MOTOR-NEURONS; FASCICLIN-II; PROTEIN; EN-2; EMBRYOGENESIS	Engrailed is expressed in subsets of interneurons that do not express Connectin or appreciable Neuroglian, whereas other neurons that are Engrailed negative strongly express these adhesion molecules. Connectin and Neuroglian expression are virtually eliminated in interneurons when engrailed expression is driven ubiquitously in neurons, and greatly increased when engrailed genes are lacking in mutant embryos. The data suggest that Engrailed is normally a negative regulator of Connectin and neuroglian. These are the first two "effector" genes identified in the nervous system of Drosophila as regulatory targets for Engrailed. We argue that differential Engrailed expression is crucial in determining the pattern of expression of cell adhesion molecules and thus constitutes an important determinant of neuronal shape and perhaps connectivity.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Emory Univ, Grad Program Neurosci, Atlanta, GA 30322 USA	Emory University; Emory University	Siegler, MVS (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032684, K04NS001481] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS32684, K04 NS01481] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baader SL, 1998, J NEUROSCI, V18, P1763; Bhat KM, 1997, DEVELOPMENT, V124, P1675; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Botas J, 1996, MECH DEVELOP, V56, P129, DOI 10.1016/0925-4773(96)00519-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWER DL, 1984, NATURE, V310, P496, DOI 10.1038/310496a0; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CUI X, 1992, DEVELOPMENT, V116, P943; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516; FJOSE A, 1988, FEBS LETT, V231, P355, DOI 10.1016/0014-5793(88)80849-4; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; GOULD AP, 1990, NATURE, V348, P308, DOI 10.1038/348308a0; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Hall SG, 1997, J NEUROBIOL, V32, P325, DOI 10.1002/(SICI)1097-4695(199703)32:3<325::AID-NEU6>3.3.CO;2-N; HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079; Hidalgo A, 1996, TRENDS GENET, V12, P1, DOI 10.1016/0168-9525(96)81373-4; HOLLAND P, 1992, BIOESSAYS, V14, P267, DOI 10.1002/bies.950140412; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KOHL A, 1992, J NEUROSCI RES, V32, P167, DOI 10.1002/jnr.490320206; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; LOGAN C, 1993, DEVELOPMENT, V117, P905; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007; MANN RS, 1994, DEVELOPMENT, V120, P3205; MEADOWS LA, 1994, J CELL SCI, V107, P321; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; Nonchev S, 1997, COLD SPRING HARB SYM, V62, P313; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Nose A, 1997, DEVELOPMENT, V124, P1433; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; POOLE SJ, 1988, DEVELOPMENT, V104, P85; RAFTERY LA, 1991, DEVELOPMENT, V113, P27; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; RATHJEN FG, 1984, EMBO J, V3, P1; Retaux S, 1996, TRENDS NEUROSCI, V19, P542, DOI 10.1016/S0166-2236(96)10062-X; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; SERRANO N, 1995, DEVELOPMENT, V121, P1691; Serrano N, 1998, EMBO J, V17, P3704, DOI 10.1093/emboj/17.13.3704; Serrano N, 1997, DEVELOPMENT, V124, P2527; Siegler MVS, 1997, J COMP NEUROL, V388, P658; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; THOMPSON KJ, 1991, J COMP NEUROL, V305, P659, DOI 10.1002/cne.903050409; THOMPSON KJ, 1993, J NEUROSCI, V13, P3309; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; WURST W, 1994, DEVELOPMENT, V120, P2065; Zhao GY, 1998, GENE, V215, P47, DOI 10.1016/S0378-1119(98)00273-X	62	43	44	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					265	276		10.1016/S0896-6273(00)81088-0	http://dx.doi.org/10.1016/S0896-6273(00)81088-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069333	Bronze			2022-12-24	WOS:000078875200012
J	Feldmeyer, D; Kask, K; Brusa, R; Kornau, HC; Kolhekar, R; Rozov, A; Burnashev, N; Jensen, V; Hvalby, O; Sprengel, R; Seeburg, PH				Feldmeyer, D; Kask, K; Brusa, R; Kornau, HC; Kolhekar, R; Rozov, A; Burnashev, N; Jensen, V; Hvalby, O; Sprengel, R; Seeburg, PH			Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B	NATURE NEUROSCIENCE			English	Article							LONG-LASTING POTENTIATION; SINGLE-CHANNEL PROPERTIES; GLUTAMATE-GATED CHANNELS; RECEPTOR CHANNELS; CALCIUM PERMEABILITY; TERM POTENTIATION; GERM-CELLS; NEURONS; DEFICIENT; NMDA	We generated mouse mutants with targeted AMPA receptor (AMPAR) GluR-B subunit alleles, functionally expressed at different levels and deficient in Q/R-site editing. All mutant lines had increased AMPAR calcium permeabilities in pyramidal neurons, and one showed elevated macroscopic conductances of these channels. The AMPAR-mediated calcium influx induced NMDA-receptor-independent long-term potentiation (LTP) in hippocampal pyramidal cell connections. Calcium-triggered neuronal death was not observed, but mutants had mild to severe neurological dysfunctions, including epilepsy and deficits in dendritic architecture. The seizure-prone phenotype correlated with an increase in the macroscopic conductance, as independently revealed by the effect of a transgene for a Q/R-site-altered GluR-B subunit. Thus, changes in GluR-B gene expression and Q/R site editing can affect critical architectural and functional aspects of excitatory principal neurons.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, Dept Mol Cell Physiol, D-69120 Heidelberg, Germany; Univ Oslo, Inst Neurophysiol, N-0317 Oslo, Norway	Max Planck Society; Max Planck Society; University of Oslo	Sprengel, R (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.		Burnashev, Nail/G-4056-2013; Rozov, Andrei/C-1997-2015; Feldmeyer, Dirk/H-5940-2013	Feldmeyer, Dirk/0000-0002-1716-8972				ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Burnashev N, 1996, CURR OPIN NEUROBIOL, V6, P311, DOI 10.1016/S0959-4388(96)80113-9; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; DUNWIDDIE TV, 1979, BRAIN RES, V169, P103, DOI 10.1016/0006-8993(79)90377-9; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; Kamal A, 1998, NEUROSCIENCE, V83, P707, DOI 10.1016/S0306-4522(97)00394-1; KASK K, IN PRESS P NATL ACAD; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; KOHLER M, 1994, J BIOL CHEM, V269, P17367; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; Lin JW, 1998, NEURON, V21, P267, DOI 10.1016/S0896-6273(00)80534-6; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Myers SJ, 1998, J NEUROSCI, V18, P6723; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WIGSTROM H, 1979, ACTA PHYSIOL SCAND, V105, P126, DOI 10.1111/j.1748-1716.1979.tb06323.x; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9	47	204	207	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					57	64		10.1038/4561	http://dx.doi.org/10.1038/4561			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195181				2022-12-24	WOS:000078409300014
J	Rasika, S; Alvarez-Buylla, A; Nottebohm, F				Rasika, S; Alvarez-Buylla, A; Nottebohm, F			BDNF mediates the effects of testosterone on the survival of new neurons in an adult brain	NEURON			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR PREVENTS; FEMALE CANARY BRAIN; HIGHER VOCAL CENTER; RAT-BRAIN; ANDROGEN RECEPTORS; PROJECTION NEURONS; AVIAN BRAIN; CELL-DEATH	New neurons are incorporated into the high vocal center (HVC), a nucleus of the adult canary (Serinus canaria) brain that plays a critical role in the acquisition and production of learned song. Recruitment of new neurons in the HVC is seasonally regulated and depends upon testosterone levels. We show here that brain-derived neurotrophic factor (BDNF) is present in the HVC of adult males but is not detectable in that of females, though the HVC of both sexes has BDNF receptors (TrkB). Testosterone treatment increases the levels of BDNF protein in the female HVC, and BDNF infused into the HVC of adult females triples the number of new neurons. Infusion of a neutralizing antibody to BDNF blocks the testosterone-induced increase in new neurons. Our results demonstrate that BDNF is involved in the regulation of neuronal replacement in the adult canary brain and suggest that the effects of testosterone are mediated through BDNF.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Nottebohm, F (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.			Alvarez-Buylla, Arturo/0000-0003-4426-8925				ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AlShamma HA, 1997, P NATL ACAD SCI USA, V94, P1521, DOI 10.1073/pnas.94.4.1521; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; ALVAREZBUYLLA A, 1990, SCIENCE, V250, P360, DOI 10.1126/science.250.4979.360-b; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; ARNOLD AP, 1976, J COMP NEUROL, V165, P487, DOI 10.1002/cne.901650406; BALTHAZART J, 1992, J COMP NEUROL, V317, P407, DOI 10.1002/cne.903170407; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; BARBANY G, 1992, EUR J NEUROSCI, V4, P396, DOI 10.1111/j.1460-9568.1992.tb00888.x; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; BARDE YA, 1994, J NEUROBIOL, V25, P1329, DOI 10.1002/neu.480251102; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BRENOWITZ EA, 1992, J NEUROBIOL, V23, P871, DOI 10.1002/neu.480230708; BRENOWITZ EA, 1990, J NEUROBIOL, V21, P837, DOI 10.1002/neu.480210602; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CASTREN E, 1993, NEUROREPORT, V4, P895, DOI 10.1097/00001756-199307000-00014; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; CLARK SJ, 1990, J COMP NEUROL, V301, P114, DOI 10.1002/cne.903010111; CRUZORIVE LM, 1983, J MICROSC-OXFORD, V131, P265, DOI 10.1111/j.1365-2818.1983.tb04255.x; DRAGUNOW M, 1993, NEUROSCI LETT, V160, P232, DOI 10.1016/0304-3940(93)90420-P; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FRIEDMAN WJ, 1993, EXP NEUROL, V119, P72, DOI 10.1006/exnr.1993.1007; GAHR M, 1993, J COMP NEUROL, V327, P112, DOI 10.1002/cne.903270109; GAHR M, 1987, BRAIN RES, V402, P173, DOI 10.1016/0006-8993(87)91063-8; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; HERRERA DG, 1993, BRAIN RES, V602, P99, DOI 10.1016/0006-8993(93)90247-K; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; JOHNSON F, 1993, J NEUROBIOL, V24, P400, DOI 10.1002/neu.480240311; JOHNSON F, 1995, J NEUROBIOL, V26, P87, DOI 10.1002/neu.480260108; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KIM JR, 1991, J NEUROSCI, V11, P1756; KIRN J, 1994, P NATL ACAD SCI USA, V91, P7844, DOI 10.1073/pnas.91.17.7844; KIRN JR, 1993, J NEUROSCI, V13, P1654; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KNUSEL B, 1992, J NEUROSCI, V12, P4391; KOKAIA Z, 1993, MOL BRAIN RES, V19, P277, DOI 10.1016/0169-328X(93)90126-A; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; Li X.-C., 1997, Society for Neuroscience Abstracts, V23, P1331; LINDSAY RM, 1984, NEUROSCIENCE, V12, P45, DOI 10.1016/0306-4522(84)90136-2; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; MARLER P, 1988, NATURE, V336, P770, DOI 10.1038/336770a0; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; MUFSON EJ, 1994, EXP NEUROL, V130, P414; MUFSON EJ, 1994, EXP NEUROL, V129, P15, DOI 10.1006/exnr.1994.1143; NAKAYAMA M, 1994, MOL BRAIN RES, V21, P206, DOI 10.1016/0169-328X(94)90251-8; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; NOTTEBOHM F, 1987, BEHAV NEURAL BIOL, V47, P197, DOI 10.1016/S0163-1047(87)90327-X; NOTTEBOHM F, 1978, Z TIERPSYCHOL, V46, P298; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; PATON JA, 1985, J NEUROSCI, V5, P3088; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; RASIKA S, 1994, P NATL ACAD SCI USA, V91, P7854, DOI 10.1073/pnas.91.17.7854; RASIKA S, 1998, THESIS ROCKEFELLER U; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; SINGH M, 1995, ENDOCRINOLOGY, V136, P2320, DOI 10.1210/en.136.5.2320; Siuciak JA, 1996, BRAIN RES, V710, P11, DOI 10.1016/0006-8993(95)01289-3; Smith GT, 1996, J HISTOCHEM CYTOCHEM, V44, P1075, DOI 10.1177/44.9.8773574; Sobreviela T, 1996, J COMP NEUROL, V375, P417; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; SOHRABJI F, 1989, BRAIN RES, V488, P253, DOI 10.1016/0006-8993(89)90715-4; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; VAHLSING HL, 1989, EXP NEUROL, V105, P233, DOI 10.1016/0014-4886(89)90125-8; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; WEICHEL K, 1986, ETHOLOGY, V73, P281; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yurek DM, 1996, EXP NEUROL, V137, P105, DOI 10.1006/exnr.1996.0011; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZHOU XF, 1994, J NEUROSCI METH, V54, P95, DOI 10.1016/0165-0270(94)90163-5	90	220	226	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					53	62		10.1016/S0896-6273(00)80678-9	http://dx.doi.org/10.1016/S0896-6273(00)80678-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027289	Bronze			2022-12-24	WOS:000078410300012
J	Wu, L; Wells, D; Tay, J; Mendis, D; Abbott, MA; Barnitt, A; Quinlan, E; Heynen, A; Fallon, JR; Richter, JD				Wu, L; Wells, D; Tay, J; Mendis, D; Abbott, MA; Barnitt, A; Quinlan, E; Heynen, A; Fallon, JR; Richter, JD			CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of alpha-CaMKII mRNA at synapses	NEURON			English	Article							XENOPUS-OOCYTE MATURATION; MATERNAL MESSENGER-RNAS; LONG-TERM POTENTIATION; LOCAL PROTEIN-SYNTHESIS; SHORT SEQUENCE ELEMENT; II MUTANT MICE; KINASE-II; HIPPOCAMPAL-NEURONS; PHOSPHATIDYLINOSITOL 3-KINASE; SYNAPTIC PLASTICITY	Long-term changes in synaptic efficacy may require the regulated translation of dendritic mRNAs. While the basis of such regulation is unknown, it seemed possible that some features of translational control in development could be recapitulated in neurons. Polyadenylation-induced translation of oocyte mRNAs requires the cis-acting CPE sequence and the CPE-binding protein CPEB. CPEB is also present in the dendritic layers of the hippocampus, at synapses in cultured neurons, and in postsynaptic densities of adult brain. alpha-CaMKII mRNA, which is localized in dendrites and is necessary for synaptic plasticity and LTP, contains two CPEs. These CPEs are bound by CPEB and mediate polyadenylation-induced translation in injected Xenopus oocytes. In the intact brain, visual experience induces alpha-CaMKII mRNA polyadenylation and translation, suggesting that this process likely occurs at synapses.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of Massachusetts System; University of Massachusetts Worcester; Brown University	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	joel.richter@.ummed.edu			NICHD NIH HHS [HD07439, R01 HD052083] Funding Source: Medline; NIGMS NIH HHS [GM17932] Funding Source: Medline; NINDS NIH HHS [P01 NS039321, NS10343] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007439] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Banker G., 1991, CULTURING NERVE CELL; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; BOUVET P, 1994, MOL CELL BIOL, V14, P1893, DOI 10.1128/MCB.14.3.1893; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHICUREL ME, 1993, J NEUROSCI, V13, P4054; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; FOX CA, 1990, GENE DEV, V4, P2287, DOI 10.1101/gad.4.12b.2287; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; GEBAUER F, 1994, EMBO J, V13, P5712, DOI 10.1002/j.1460-2075.1994.tb06909.x; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Harlow E., 1988, ANTIBODIES LAB MANUA; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; HYMAN LE, 1988, GENE DEV, V2, P598, DOI 10.1101/gad.2.5.598; Jacobson A, 1996, TRANSLATIONAL CONTRO; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kuge H, 1995, EMBO J, V14, P6301, DOI 10.1002/j.1460-2075.1995.tb00320.x; LIU XJ, 1995, MOL CELL BIOL, V15, P3563; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Maller J L, 1980, Curr Top Cell Regul, V16, P271; MALLER JL, 1981, DEV BIOL, V85, P309, DOI 10.1016/0012-1606(81)90262-1; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MUSLIN AJ, 1993, MOL CELL BIOL, V13, P6661, DOI 10.1128/MCB.13.11.6661; Ouyang Y, 1997, J NEUROSCI, V17, P5416; PARIS J, 1991, GENE DEV, V5, P1697, DOI 10.1101/gad.5.9.1697; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; RICHTER JD, 1996, TRANSLATIONAL CONTRO; SALLES FJ, 1992, GENE DEV, V6, P1202, DOI 10.1101/gad.6.7.1202; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; SHEETS MD, 1995, NATURE, V374, P511, DOI 10.1038/374511a0; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SIMON R, 1994, MOL CELL BIOL, V14, P7867, DOI 10.1128/MCB.14.12.7867; SIMON R, 1992, GENE DEV, V6, P2580, DOI 10.1101/gad.6.12b.2580; Simon R, 1996, DEV BIOL, V179, P239, DOI 10.1006/dbio.1996.0254; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; StebbinsBoaz B, 1997, CRIT REV EUKAR GENE, V7, P73, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.50; STEBBINSBOAZ B, 1994, MOL CELL BIOL, V14, P5870, DOI 10.1128/MCB.14.9.5870; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; STEWARD O, 1986, J NEUROSCI, V6, P412; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; STRICKLAND S, 1988, SCIENCE, V241, P680, DOI 10.1126/science.2456615; Tiedge H, 1996, J NEUROSCI, V16, P7171; VARNUM SM, 1990, GENE DEV, V4, P2278, DOI 10.1101/gad.4.12b.2278; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu L, 1997, MOL CELL BIOL, V17, P6402, DOI 10.1128/MCB.17.11.6402	64	394	401	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1998	21	5					1129	1139		10.1016/S0896-6273(00)80630-3	http://dx.doi.org/10.1016/S0896-6273(00)80630-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856468	Bronze			2022-12-24	WOS:000077386100023
J	Tong, F; Nakayama, K; Vaughan, JT; Kanwisher, N				Tong, F; Nakayama, K; Vaughan, JT; Kanwisher, N			Binocular rivalry and visual awareness in human extrastriate cortex	NEURON			English	Article							PERCEPTION	We used functional magnetic resonance imaging (fMRI) to monitor stimulus-selective responses of the human fusiform face area (FFA) and parahippocampal place area (PPA) during binocular rivalry in which, a face and a house stimulus were presented to different eyes. Though retinal stimulation remained constant, subjects perceived changes from house to face that were accompanied by increasing FFA and decreasing PPA activity; perceived changes from face to house led to the opposite pattern of responses. These responses during rivalry were equal in magnitude to those evoked by nonrivalrous stimulus alternation, suggesting that activity in the FFA and PPA reflects the perceived rather than the retinal stimulus, and that neural competition during binocular rivalry has been resolved by these stages of visual processing.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Tong, F (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	frank@wjh.harvard.edu						BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; COBB WA, 1967, NATURE, V216, P1123, DOI 10.1038/2161123b0; Crick F, 1996, NATURE, V379, P485, DOI 10.1038/379485a0; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LANSING RW, 1964, SCIENCE, V146, P1325, DOI 10.1126/science.146.3649.1325; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Levelt W., 1965, BINOCULAR RIVALRY; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; SENGPIEL F, 1994, NATURE, V368, P847, DOI 10.1038/368847a0; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574	16	575	586	3	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					753	759		10.1016/S0896-6273(00)80592-9	http://dx.doi.org/10.1016/S0896-6273(00)80592-9			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808462	Bronze			2022-12-24	WOS:000076697300019
J	Crabtree, JW; Collingridge, GL; Isaac, JTR				Crabtree, JW; Collingridge, GL; Isaac, JTR			A new intrathalamic pathway linking modality-related nuclei in the dorsal thalamus	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; GLUTAMIC-ACID DECARBOXYLASE; RETICULAR NUCLEUS; SOMATOTOPIC ORGANIZATION; RAT THALAMUS; FUNCTIONAL-ORGANIZATION; ELECTRON-MICROSCOPE; GABAERGIC NEURONS; POSTERIOR GROUP; COMPLEX	Transmission of sensory information through the dorsal thalamus involves two types of modality-related nuclei, first order and higher order, between which there are thought to be no intrathalamic interactions. We now show that within the somatosensory thalamus, cells in one nucleus, the ventrobasal complex, can influence activity in another nucleus, the medial division of the posterior complex. Stimulation of ventrobasal complex cells evoked inhibitory postsynaptic currents in cells of the medial division of the posterior complex. These currents exhibited the reversal potential and pharmacology of a GABAA receptor-mediated chloride conductance, indicating that they result from the activation of a disynaptic pathway involving the GABAergic cells of the thalamic reticular nucleus. These findings provide the first direct evidence for intrathalamic interactions between dorsal thalamic nuclei.	Univ Bristol, Sch Med Sci, Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Crabtree, JW (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, Bristol BS8 1TD, Avon, England.	J.W.Crabtree@bris.ac.uk	Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020	Collingridge, Graham L/0000-0002-9572-5359; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTMAN J, 1961, J COMP NEUROL, V116, P157, DOI 10.1002/cne.901160206; BARBARESI P, 1986, BRAIN RES, V382, P305, DOI 10.1016/0006-8993(86)91340-5; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; CICIRATA F, 1990, EXP BRAIN RES, V79, P325, DOI 10.1007/BF00608242; Coleman KA, 1996, EUR J NEUROSCI, V8, P388, DOI 10.1111/j.1460-9568.1996.tb01222.x; CONLEY M, 1990, EUR J NEUROSCI, V2, P211, DOI 10.1111/j.1460-9568.1990.tb00414.x; CONLEY M, 1991, EUR J NEUROSCI, V3, P1089, DOI 10.1111/j.1460-9568.1991.tb00044.x; CORNWALL J, 1988, NEUROSCIENCE, V24, P1035, DOI 10.1016/0306-4522(88)90085-1; Cox CL, 1996, J COMP NEUROL, V366, P416; CRABTREE JW, 1992, EUR J NEUROSCI, V4, P1343, DOI 10.1111/j.1460-9568.1992.tb00159.x; Crabtree JW, 1996, J COMP NEUROL, V366, P207; CRABTREE JW, 1992, EUR J NEUROSCI, V4, P1352, DOI 10.1111/j.1460-9568.1992.tb00160.x; Crabtree JW, 1998, J COMP NEUROL, V390, P167; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; EMMERS R, 1965, J COMP NEUROL, V124, P215, DOI 10.1002/cne.901240207; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; GONZALORUIZ A, 1995, BRAIN RES BULL, V37, P17, DOI 10.1016/0361-9230(94)00252-5; Guillery RW, 1995, J ANAT, V187, P583; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; HARTING JK, 1991, J COMP NEUROL, V310, P411, DOI 10.1002/cne.903100310; HENDRICKSON AE, 1983, J NEUROSCI, V3, P1245; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; JONES EG, 1971, J COMP NEUROL, V143, P185, DOI 10.1002/cne.901430204; JONES EG, 1975, J COMP NEUROL, V162, P285, DOI 10.1002/cne.901620302; Kolmac CI, 1997, J COMP NEUROL, V377, P165, DOI 10.1002/(SICI)1096-9861(19970113)377:2<165::AID-CNE2>3.0.CO;2-1; Lizier C, 1997, J COMP NEUROL, V377, P217, DOI 10.1002/(SICI)1096-9861(19970113)377:2<217::AID-CNE5>3.0.CO;2-6; LOZSADI DA, 1995, J COMP NEUROL, V358, P233, DOI 10.1002/cne.903580206; LU SM, 1993, VISUAL NEUROSCI, V10, P631, DOI 10.1017/S0952523800005332; MACLEOD NK, 1980, EXP BRAIN RES, V40, P55; MESULAM MM, 1976, J HISTOCHEM CYTOCHEM, V24, P1273, DOI 10.1177/24.12.63512; MONTERO VM, 1981, NEUROSCIENCE, V6, P2561, DOI 10.1016/0306-4522(81)90102-0; MONTERO VM, 1983, EXP BRAIN RES, V51, P338; OERTEL WH, 1983, J NEUROSCI, V3, P1322; OHARA PT, 1993, J NEUROCYTOL, V22, P815, DOI 10.1007/BF01181326; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PESCHANSKI M, 1983, BRAIN RES, V270, P325, DOI 10.1016/0006-8993(83)90607-8; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; PINAULT D, 1995, EUR J NEUROSCI, V7, P31, DOI 10.1111/j.1460-9568.1995.tb01017.x; ROSE JE, 1949, ELECTROEN CLIN NEURO, V1, P391, DOI 10.1016/0013-4694(49)90212-6; ROSE JE, 1942, J COMP NEUROL, V7, P61; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SHOSAKU A, 1984, BRAIN RES, V311, P57, DOI 10.1016/0006-8993(84)91398-2; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; STERIADE M, 1984, J COMP NEUROL, V229, P531, DOI 10.1002/cne.902290407; SUGITANI M, 1979, J PHYSIOL-LONDON, V290, P79, DOI 10.1113/jphysiol.1979.sp012761; WAITE PME, 1973, J PHYSIOL-LONDON, V228, P527, DOI 10.1113/jphysiol.1973.sp010098	50	82	83	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					389	394		10.1038/1603	http://dx.doi.org/10.1038/1603			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196529				2022-12-24	WOS:000076361400017
J	D'Arcangelo, G; Homayouni, R; Keshvara, L; Rice, DS; Sheldon, M; Curran, T				D'Arcangelo, G; Homayouni, R; Keshvara, L; Rice, DS; Sheldon, M; Curran, T			Reelin is a ligand for lipoprotein receptors	NEURON			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; MONOCLONAL-ANTIBODIES; SPECIALIZED CHAPERONE; LAMINAR ORGANIZATION; ENDOCYTIC RECEPTORS; ALZHEIMERS-DISEASE; MESSENGER-RNA; E APOPROTEIN; PROTEIN; BINDING	A signaling pathway involving the extracellular protein Reelin and the intracellular adaptor protein Disabled-1 (Dab1) controls cell positioning during mammalian brain development. Here, we demonstrate that Reelin binds directly to lipoprotein receptors, preferably the very low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2). Binding requires calcium, and it is inhibited in the presence of apoE. Furthermore, the CR-50 monoclonal antibody, which inhibits Reelin function, blocks the association of Reelin with VLDLR. After binding to VLDLR on the cell surface, Reelin is internalized into vesicles. In dissociated neurons, apoE reduces the level of Reelin-induced tyrosine phosphorylation of Dab1. These data suggest that Reelin directs neuronal migration by binding to VLDLR and ApoER2.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Curran, T (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Curran, Thomas/AAE-7631-2019; Curran, Tom/F-5234-2018; Homayouni, Ramin/U-2837-2019; Homayouni, Ramin/B-3547-2009; Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Homayouni, Ramin/0000-0003-0186-5076; Homayouni, Ramin/0000-0003-0186-5076; Curran, Tom/0000-0003-1444-7551; D'Arcangelo, Gabriella/0000-0003-1575-1010	NATIONAL CANCER INSTITUTE [T32CA009346, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036558] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765, T32 CA09346] Funding Source: Medline; NINDS NIH HHS [R01 NS36558] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Borrell V, 1999, J NEUROSCI, V19, P1345; Brandes C, 1997, GENOMICS, V42, P185, DOI 10.1006/geno.1997.4702; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; DEROUVROIT CL, 1998, ADV ANAT EMBRYOL CEL, V750, P1; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gliemann J, 1998, BIOL CHEM, V379, P951; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Iijima H, 1998, J BIOCHEM-TOKYO, V124, P747, DOI 10.1093/oxfordjournals.jbchem.a022175; Ikeda Y, 1997, DEV DYNAM, V210, P157, DOI 10.1002/(SICI)1097-0177(199710)210:2<157::AID-AJA8>3.0.CO;2-F; Imahori K, 1997, J BIOCHEM, V121, P179; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Miyata T, 1997, J NEUROSCI, V17, P3599; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; Nimpf J, 1998, ATHEROSCLEROSIS, V141, P191, DOI 10.1016/S0021-9150(98)00172-5; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; POIRIER J, 1991, MOL BRAIN RES, V11, P97, DOI 10.1016/0169-328X(91)90111-A; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rice DS, 1998, DEVELOPMENT, V125, P3719; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Schneider Wolfgang J., 1995, Current Opinion in Lipidology, V6, P92, DOI 10.1097/00041433-199504000-00006; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; SKENE JHP, 1983, P NATL ACAD SCI-BIOL, V80, P4169, DOI 10.1073/pnas.80.13.4169; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; Willnow TE, 1998, BIOL CHEM, V379, P1025; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x	47	656	669	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					471	479		10.1016/S0896-6273(00)80860-0	http://dx.doi.org/10.1016/S0896-6273(00)80860-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571240	Bronze			2022-12-24	WOS:000083423700021
J	Fischer, AJ; McGuire, JJ; Schaeffel, F; Stell, WK				Fischer, AJ; McGuire, JJ; Schaeffel, F; Stell, WK			Light- and focus-dependent expression of the transcription factor ZENK in the chick retina	NATURE NEUROSCIENCE			English	Article							FORM-DEPRIVATION MYOPIA; ASPARTATE-INDUCED EXCITOTOXICITY; FOS MESSENGER-RNA; C-FOS; BIPOLAR CELLS; AMACRINE CELLS; RAT RETINA; GROWTH; NEURONS; NERVE	Ocular growth and refraction are regulated by visual processing in the retina. We identified candidate regulatory neurons by immunocytochemistry for immediate-early gene products, ZENK (zif268, Egr-1) and Fos, after appropriate visual stimulation. ZENK synthesis was enhanced by conditions that suppress ocular elongation (plus defocus, termination of form deprivation) and suppressed by conditions that enhance ocular elongation (minus defocus, form deprivation), particularly in glucagon-containing amacrine cells. Fos synthesis was enhanced by termination of visual deprivation, but not by defocus and not in glucagon-containing amacrine cells. We conclude that glucagon-containing amacrine cells respond differentially to the sign of defocus and may mediate lens-induced changes in ocular growth and refraction.	Univ Calgary, Fac Med, Dept Anat & Cell Biol, Neurosci Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Lions Sight Ctr, Calgary, AB T2N 4N1, Canada; Univ Tubingen, Hosp Eye, Div Expt Ophthalmol, D-72076 Tubingen, Germany	University of Calgary; University of Calgary; Eberhard Karls University of Tubingen	Fischer, AJ (corresponding author), Univ Washington, Sch Med, Dept Biol Struct, Hlth Sci Ctr, PO 357420, Seattle, WA 98195 USA.		Fischer, Andrew J/E-3061-2011; Fischer, Andy J./AAE-9817-2022; Fischer, Andy J./AFF-1827-2022	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405				Araki CM, 1998, BRAIN RES, V794, P333, DOI 10.1016/S0006-8993(98)00307-2; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BRANDSTATTER JH, 1994, EUR J NEUROSCI, V6, P1100, DOI 10.1111/j.1460-9568.1994.tb00607.x; CAJAL SR, 1972, STRUCTURE RETINA, P76; Chaudhuri A, 1997, NEUROREPORT, V8, pR3, DOI 10.1097/00001756-199709080-00002; CROSSLAND WJ, 1978, BRAIN RES, V145, P239, DOI 10.1016/0006-8993(78)90860-0; CURTIN BJ, 1985, MYOPIAS BASIC SCI CL; DELAVILLA P, 1995, J NEUROSCI, V15, P3571; Dowling J. E., 1987, RETINA APPROACHABLE; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fischer AJ, 1999, J COMP NEUROL, V405, P1, DOI 10.1002/(SICI)1096-9861(19990301)405:1<1::AID-CNE1>3.0.CO;2-U; Fischer AJ, 1999, VISION RES, V39, P685, DOI 10.1016/S0042-6989(98)00178-3; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 1998, BRAIN RES, V794, P48, DOI 10.1016/S0006-8993(98)00188-7; Fischer AJ, 1997, CAN J OPHTHALMOL, V32, P373; FISCHER AJ, 1998, VISUAL NEUROSCI, V15, P685; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; GUDEHITHLU KP, 1993, BRAIN RES, V631, P77, DOI 10.1016/0006-8993(93)91189-Y; HARTVEIT E, 1994, J COMP NEUROL, V348, P570, DOI 10.1002/cne.903480407; KOISTINAHO J, 1994, NEUROSCI LETT, V177, P15, DOI 10.1016/0304-3940(94)90033-7; KOLB H, 1993, VISUAL NEUROSCI, V10, P341, DOI 10.1017/S0952523800003734; KUWAYAMA Y, 1982, INVEST OPHTH VIS SCI, V22, P681; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; Long KD, 1998, MOL BIOL EVOL, V15, P284, DOI 10.1093/oxfordjournals.molbev.a025925; Masana MI, 1996, MOL BRAIN RES, V42, P193, DOI 10.1016/S0169-328X(96)00031-9; MCBRIEN NA, 1995, VISION RES, V35, P1141, DOI 10.1016/0042-6989(94)00237-G; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; OWUSUYAW V, 1992, BRAIN RES, V576, P220, DOI 10.1016/0006-8993(92)90684-2; ROHRER B, 1993, VISUAL NEUROSCI, V10, P447, DOI 10.1017/S0952523800004673; ROHRER B, 1995, BRAIN RES, V686, P169, DOI 10.1016/0006-8993(95)00370-6; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; Schaeffel F, 1999, VISION RES, V39, P1585, DOI 10.1016/S0042-6989(98)00304-6; Schmid KL, 1996, VISION RES, V36, P1023, DOI 10.1016/0042-6989(95)00191-3; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; UCHIYAMA H, 1993, NEUROSCI LETT, V154, P35, DOI 10.1016/0304-3940(93)90165-H; Ueda Y, 1997, J NEUROSCI, V17, P3014; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; WALLMAN J, 1993, PROG RETIN RES, V12, P133, DOI 10.1016/0278-4327(93)90007-G; WALLMAN J, 1994, NATURE, V371, P201, DOI 10.1038/371201a0; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; WILDSOET CF, 1988, INVEST OPHTH VIS SCI, V29, P311; YAQUB A, 1995, J COMP NEUROL, V354, P481, DOI 10.1002/cne.903540402; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T	44	177	183	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					706	712		10.1038/11167	http://dx.doi.org/10.1038/11167			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412059				2022-12-24	WOS:000083882800009
J	Hahnloser, R; Douglas, RJ; Mahowald, M; Hepp, K				Hahnloser, R; Douglas, RJ; Mahowald, M; Hepp, K			Feedback interactions between neuronal pointers and maps for attentional processing	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; ORIENTATION SELECTIVITY; PARIETAL CORTEX; SIMPLE CELLS; AREAS V1; V2; MECHANISMS; RESPONSES; MACAQUE; MEMORY	Neural networks combining local excitatory feedback with recurrent inhibition are valuable models of neocortical processing. However, incorporating the attentional modulation observed in cortical neurons is problematic. We propose a simple architecture for attentional processing. Our network consists of two reciprocally connected populations of excitatory neurons; a large population (the map) processes a feedforward sensory input, and a small population (the pointer) modulates location and intensity of this processing in an attentional manner dependent on a control input to the pointer. This pointer-map network has rich dynamics despite its simple architecture and explains general computational features related to attention/intention observed in neocortex, making it interesting both theoretically and experimentally.	Univ Zurich, ETHZ, Inst Neuroinformat, CH-8057 Zurich, Switzerland; ETHZ, Inst Theoret Phys, CH-8093 Zurich, Switzerland; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT)	Hahnloser, R (corresponding author), Univ Zurich, ETHZ, Inst Neuroinformat, CH-8057 Zurich, Switzerland.			Hahnloser, Richard/0000-0002-4039-7773				AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; Ballard DH, 1997, BEHAV BRAIN SCI, V20, P723, DOI 10.1017/S0140525X97001611; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; COHEN M, 1983, IEEE T SYST MAN CYB, V13, P288; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Douglas RJ, 1989, NEURAL COMPUT, V1, P480, DOI 10.1162/neco.1989.1.4.480; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FUSTER JM, 1990, J NEUROPHYSIOL, V64, P681, DOI 10.1152/jn.1990.64.3.681; GALLETTI C, 1989, J NEUROSCI, V9, P1112; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Groh JM, 1997, J NEUROSCI, V17, P4312; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; HAHNLOSER RHR, 1998, THESIS EIDGENOSSISCH; HANSEL D, 1997, METHODS NEURONAL MOD, pCH13; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; Luck SJ, 1998, P NATL ACAD SCI USA, V95, P825, DOI 10.1073/pnas.95.3.825; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Nicholas D., 1978, LIT BIBLIOMETRICS; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; POUGET A, 1995, HDB BRAIN THEORY NEU, P335; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0	41	48	49	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					746	752		10.1038/11219	http://dx.doi.org/10.1038/11219			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412065				2022-12-24	WOS:000083882800015
J	Stemmler, M; Koch, C				Stemmler, M; Koch, C			How voltage-dependent conductances can adapt to maximize the information encoded by neuronal firing rate	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; PYRAMIDAL NEURONS; CULTURED NEURONS; RESPONSES; DENDRITES; CONTRAST; SLICES	Information from the senses must be compressed into the limited range of responses that spiking neurons can generate. For optimal compression, the neuron's response should match the statistics of stimuli encountered in nature. Given a maximum firing rate, a nerve cell should learn to use each available firing rate equally often. Given a set mean firing rate, it should self-organize to respond with high firing rates only to comparatively rare events. Here we derive an unsupervised learning rule that continuously adapts membrane conductances of a Hodgkin-Huxley model neuron to optimize the representation of sensory information in the firing rate. Maximizing information transfer between the stimulus and the cell's firing rate can be interpreted as a non-Hebbian developmental mechanism.	Innovat Kolleg Theoret Biol, D-10115 Berlin, Germany; CALTECH, Computat & Neurol Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Stemmler, M (corresponding author), Innovat Kolleg Theoret Biol, Invalidenstr 43, D-10115 Berlin, Germany.			Koch, Christof/0000-0001-6482-8067				Ahmed B, 1997, CEREB CORTEX, V7, P559, DOI 10.1093/cercor/7.6.559; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; BADDELEY RJ, 1991, P ROY SOC B-BIOL SCI, V246, P219, DOI 10.1098/rspb.1991.0147; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BELL AJ, 1992, NEURAL INFORMATION P, V4, P59; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Gabbiani F, 1996, NEURAL COMPUT, V8, P44, DOI 10.1162/neco.1996.8.1.44; GRANIT R, 1963, J PHYSIOL-LONDON, V168, P911, DOI 10.1113/jphysiol.1963.sp007230; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hebb Donald O., 1949, ORG BEHAV; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JAGADEESH B, 1992, SCIENCE, V257, P552, DOI 10.1126/science.1636094; Koch C., 1998, BIOPHYSICS COMPUTATI; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; LINSKER R, 1992, NEURAL COMPUT, V4, P691, DOI 10.1162/neco.1992.4.5.691; MASON A, 1990, J NEUROSCI, V10, P1415; MOYER JR, 1996, J NEUROSCI, V16, P5546; PINSKER MS, 1964, INFORMATION INFORMAT; Purves D, 1994, NEURAL ACTIVITY GROW; Reif F., 1965, FUNDAMENTALS STAT TH; Rieke F., 1997, SPIKES EXPLORING NEU; RUDERMAN DL, 1995, NETWORK, V5, P517; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; Tsypkin Y, 1971, ADAPTATION LEARNING; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157	37	166	167	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					521	527		10.1038/9173	http://dx.doi.org/10.1038/9173			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448216				2022-12-24	WOS:000084735900011
J	Burgess, RW; Nguyen, QT; Son, YJ; Lichtman, JW; Sanes, JR				Burgess, RW; Nguyen, QT; Son, YJ; Lichtman, JW; Sanes, JR			Alternatively spliced isoforms of nerve- and muscle-derived agrin: Their roles at the neuromuscular junction	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR ACCUMULATION; HEPARAN-SULFATE PROTEOGLYCAN; POSTSYNAPTIC-LIKE APPARATUS; CELL-ADHESION MOLECULE; ADULT-RAT BRAIN; SKELETAL-MUSCLE; GENE-EXPRESSION; BASAL LAMINA; IN-VIVO; PRESYNAPTIC DIFFERENTIATION	Agrin induces synaptic differentiation at the skeletal neuromuscular junction (NMJ); both pre- and postsynaptic differentiation are drastically impaired in its absence. Multiple alternatively spliced forms of agrin that differ in binding characteristics and bioactivity are synthesized by nerve and muscle cells. We used surgical chimeras, isoform-specific mutant mice, and nerve-muscle cocultures to determine the origins and nature of the agrin required for synaptogenesis. We show that agrin containing Z exons (Z(+)) is a critical nerve-derived inducer of postsynaptic differentiation, whereas neural isoforms containing a heparin binding site (Y+) and all muscle-derived isoforms are dispensable for major steps in synaptogenesis. Our results also suggest that the requirement of agrin for presynaptic differentiation is mediated indirectly by its ability to promote postsynaptic production or localization of appropriate retrograde signals.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.			Burgess, Robert/0000-0002-9229-3407				BIROC SL, 1993, DEV BRAIN RES, V75, P119, DOI 10.1016/0165-3806(93)90071-H; BIXBY JL, 1985, J NEUROSCI, V5, P3070; BIXBY JL, 1987, DEV BIOL, V119, P363, DOI 10.1016/0012-1606(87)90041-8; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; Campagna JA, 1997, EUR J NEUROSCI, V9, P2269, DOI 10.1111/j.1460-9568.1997.tb01645.x; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; Campanelli JT, 1996, DEVELOPMENT, V122, P1663; Chang D, 1997, DEV BIOL, V181, P21, DOI 10.1006/dbio.1996.8435; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623; Cohen NA, 1997, NEUROSCIENCE, V76, P581, DOI 10.1016/S0306-4522(96)00345-4; COVAULT J, 1987, J CELL BIOL, V105, P2479, DOI 10.1083/jcb.105.6.2479; Dai ZS, 1996, SEMIN NEUROSCI, V8, P97, DOI 10.1006/smns.1996.0013; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; Halfter W, 1997, J COMP NEUROL, V383, P1; HIRANO Y, 1989, J NEUROSCI, V9, P1555; HOCH W, 1994, EMBO J, V13, P2814, DOI 10.1002/j.1460-2075.1994.tb06575.x; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hopf C, 1997, EUR J NEUROSCI, V9, P1170, DOI 10.1111/j.1460-9568.1997.tb01471.x; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Jones G, 1996, P NATL ACAD SCI USA, V93, P5985, DOI 10.1073/pnas.93.12.5985; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li Z, 1997, NEUROSCIENCE, V79, P191, DOI 10.1016/S0306-4522(96)00654-9; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; Martin PT, 1997, DEVELOPMENT, V124, P3909; McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Meier T, 1998, MOL CELL NEUROSCI, V11, P206, DOI 10.1006/mcne.1998.0685; Meier T, 1997, J NEUROSCI, V17, P6534; Meier T, 1998, J CELL BIOL, V141, P715, DOI 10.1083/jcb.141.3.715; MookJung I, 1996, J NEUROBIOL, V31, P210, DOI 10.1002/(SICI)1097-4695(199610)31:2<210::AID-NEU6>3.0.CO;2-E; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OCONNOR LT, 1994, J NEUROSCI, V14, P1141, DOI 10.1523/JNEUROSCI.14-03-01141.1994; OToole JJ, 1996, P NATL ACAD SCI USA, V93, P7369, DOI 10.1073/pnas.93.14.7369; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Pin CL, 1997, DEV DYNAM, V208, P299; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Rimer M, 1997, MOL CELL NEUROSCI, V9, P254, DOI 10.1006/mcne.1997.0622; ROLE LW, 1985, J NEUROSCI, V5, P2197; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; SANES JR, 1998, IN PRESS ANN REV NEU; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; SMITH MA, 1994, NEURON, V12, P795, DOI 10.1016/0896-6273(94)90332-8; STONE DM, 1995, J NEUROSCI, V15, P6767; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLACE BG, 1990, J NEUROSCI, V10, P3576	60	199	203	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					33	44		10.1016/S0896-6273(00)80751-5	http://dx.doi.org/10.1016/S0896-6273(00)80751-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402191	Bronze			2022-12-24	WOS:000080681200008
J	Koos, T; Tepper, JM				Koos, T; Tepper, JM			Inhibitory control of neostriatal projection neurons by GABAergic interneurons	NATURE NEUROSCIENCE			English	Article							PARVALBUMIN-IMMUNOREACTIVE NEURONS; JUNCTION POTENTIAL CORRECTIONS; INVITRO SLICE PREPARATION; MEDIUM SPINY NEURONS; RAT NEOSTRIATUM; MEMBRANE-PROPERTIES; STRIATAL NEURONS; POSTNATAL-DEVELOPMENT; SYNAPTIC CONNECTIONS; NUCLEUS-ACCUMBENS	The basal ganglia are a highly interconnected network of nuclei essential for the modulation and execution of voluntary behavior. The neostriatum is the principal input and one of the principal controllers of the output of the basal ganglia. Neostriatal projection neurons seem to be dynamically and powerfully controlled by GABAergic inputs, but the source(s) and physiological properties of these inputs remain unclear. Here we use paired whole-cell recordings to show that this inhibition derives from small populations of GABAergic interneurons that are themselves interconnected through functional electrotonic synapses. Inhibitory synaptic potentials generated from single interneurons are sufficiently powerful to delay or entirely block the generation of action potentials in a large number of projection neurons simultaneously.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Rutgers State Univ, Program Cellular & Mol Biodynam, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Tepper, JM (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.		Tepper, James/AAA-3828-2019	Tepper, James/0000-0002-8643-4082	NIMH NIH HHS [MH58885] Funding Source: Medline; NINDS NIH HHS [NS34865] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH058885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034865] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bevan MD, 1998, J NEUROSCI, V18, P9438; BOLAM JP, 1993, MOL CELLULAR MECH NE, P1; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P651, DOI 10.1152/jn.1990.63.4.651; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; GROVES PM, 1983, BRAIN RES REV, V5, P109, DOI 10.1016/0165-0173(83)90011-5; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; JAEER D, 1994, J NEUROPHYSIOL, V72, P1; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kincaid AE, 1998, J NEUROSCI, V18, P4722, DOI 10.1523/jneurosci.18-12-04722.1998; KITA H, 1985, EXP BRAIN RES, V60, P54; KITA H, 1993, PROG BRAIN RES, V99, P51; Kita H, 1996, NEUROSCIENCE, V70, P925, DOI 10.1016/0306-4522(95)00410-6; KITA H, 1990, BRAIN RES, V536, P1, DOI 10.1016/0006-8993(90)90002-S; KITA T, 1984, BRAIN RES, V300, P129, DOI 10.1016/0006-8993(84)91347-7; LENZ S, 1994, SYNAPSE, V18, P55, DOI 10.1002/syn.890180108; LIGHTHALL JW, 1981, BRAIN RES, V212, P182, DOI 10.1016/0006-8993(81)90048-2; LIGHTHALL JW, 1983, BRAIN RES BULL, V11, P103, DOI 10.1016/0361-9230(83)90058-8; Miles R, 1996, CURR OPIN NEUROBIOL, V6, P387, DOI 10.1016/S0959-4388(96)80124-3; NG B, 1995, J NEUROSCI METH, V56, P37, DOI 10.1016/0165-0270(94)00087-W; Nicola SM, 1997, J NEUROSCI, V17, P5697; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; NISENBAUM ES, 1992, NEUROSCIENCE, V48, P561, DOI 10.1016/0306-4522(92)90402-N; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; PENNARTZ CMA, 1992, J NEUROPHYSIOL, V67, P1325, DOI 10.1152/jn.1992.67.5.1325; Plenz D, 1998, J NEUROSCI, V18, P266; Rinzel J, 1998, SCIENCE, V279, P1351, DOI 10.1126/science.279.5355.1351; TEPPER JM, 1993, PROG BRAIN RES, V99, P35; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WICKENS JR, 1995, SYNAPSE, V20, P281, DOI 10.1002/syn.890200402; Wilson C. J., 1992, SINGLE NEURON COMPUT, P141, DOI [10.1016/B978-0-12-484815-3.50012-8, DOI 10.1016/B978-0-12-484815-3.50012-8]; WILSON CJ, 1983, EXP BRAIN RES, V51, P217; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON CJ, 1980, J COMP NEUROL, V194, P599, DOI 10.1002/cne.901940308; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; YAMADA H, 1995, BRAIN RES, V677, P333, DOI 10.1016/0006-8993(95)00190-2; YOSHIDA M, 1991, NEUROSCI RES, V10, P34, DOI 10.1016/0168-0102(91)90018-T	48	641	651	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					467	472		10.1038/8138	http://dx.doi.org/10.1038/8138			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321252				2022-12-24	WOS:000084609400018
J	Peterson, BZ; DeMaria, CD; Yue, DT				Peterson, BZ; DeMaria, CD; Yue, DT			Calmodulin is the Ca2+ sensor for Ca2+-dependent inactivation of 1-type calcium channels	NEURON			English	Article							GATED CATION CHANNEL; SKELETAL-MUSCLE; CA2+-SENSITIVE INACTIVATION; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; SARCOPLASMIC-RETICULUM; DEPENDENT INACTIVATION; REGULATORY DOMAIN; BINDING DOMAINS; SCALLOP MYOSIN	Elevated intracellular Ca2+ triggers inactivation of L-type calcium channels, providing negative Ca2+ feedback in many cells. Ca2+ binding to the main alpha(1C) channel subunit has been widely proposed to initiate such Ca2+-dependent inactivation. Here, we find that overexpression of mutant, Ca2+-insensitive calmodulin (CaM) ablates Ca2+-dependent inactivation in a "dominant-negative" manner. This result demonstrates that CaM is the actual Ca2+ sensor for inactivation and suggests that CaM is constitutively tethered to the channel complex. Inactivation is likely to occur via Ca2+-dependent interaction of tethered CaM with an IQ-like motif on the carboxyl tail of alpha(1C). CaM also binds to analogous IQ regions of N-, P/Q-, and R-type calcium channels, suggesting that CaM-mediated effects may be widespread in the calcium channel family.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Program Mol & Cellular Syst Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Program Mol & Cellular Syst Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Program Mol & Cellular Syst Physiol, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu						BAHLER M, 1994, J CELL BIOL, V126, P375, DOI 10.1083/jcb.126.2.375; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; FABIATO A, 1979, ANNU REV PHYSIOL, V41, P473, DOI 10.1146/annurev.ph.41.030179.002353; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FUJITA Y, 1993, NEURON, V10, P585, DOI 10.1016/0896-6273(93)90162-K; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Grunwald ME, 1998, J BIOL CHEM, V273, P9148, DOI 10.1074/jbc.273.15.9148; HAACK JA, 1994, BIOPHYS J, V66, P1051, DOI 10.1016/S0006-3495(94)80886-0; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IMREDY JP, 1992, NEURON, V9, P197, DOI 10.1016/0896-6273(92)90159-B; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X; Krupp JJ, 1999, J NEUROSCI, V19, P1165; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MEANS AR, 1988, RECENT PROG HORM RES, V44, P223; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NEELY A, 1994, BIOPHYS J, V66, P1895, DOI 10.1016/S0006-3495(94)80983-X; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; SAIMI Y, 1994, FEBS LETT, V350, P155, DOI 10.1016/0014-5793(94)00782-9; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHIROKOV R, 1993, J GEN PHYSIOL, V102, P1005, DOI 10.1085/jgp.102.6.1005; SMITH JS, 1989, CIRC RES, V64, P352, DOI 10.1161/01.RES.64.2.352; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Victor RG, 1997, J MEMBRANE BIOL, V156, P53, DOI 10.1007/s002329900187; WEI XY, 1991, J BIOL CHEM, V266, P21943; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yue DT, 1997, SCIENCE, V276, P755, DOI 10.1126/science.276.5313.755; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	57	674	685	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					549	558		10.1016/S0896-6273(00)80709-6	http://dx.doi.org/10.1016/S0896-6273(00)80709-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197534	hybrid			2022-12-24	WOS:000079483900018
J	van Praag, H; Kempermann, G; Gage, FH				van Praag, H; Kempermann, G; Gage, FH			Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus	NATURE NEUROSCIENCE			English	Article							FIBROBLAST GROWTH-FACTOR; HIPPOCAMPAL THETA-RHYTHM; RAT HIPPOCAMPUS; ENRICHED ENVIRONMENT; SPATIAL MEMORY; MESSENGER-RNA; NEURONS; BRAIN; EXPERIENCE; FOREBRAIN	Exposure to an enriched environment increases neurogenesis in the dentate gyrus of adult rodents. Environmental enrichment, however, typically consists of many components, such as expanded learning opportunities, increased social interaction, more physical activity and larger housing. We attempted to separate components by assigning adult mice to various conditions: water-maze learning (learner), swim-time-yoked control (swimmer), voluntary wheel running (runner), and enriched (enriched) and standard housing (control) groups. Neither maze training nor yoked swimming had any effect on bromodeoxyuridine (BrdU)-positive cell number. However, running doubled the number of surviving newborn cells, in amounts similar to enrichment conditions. Our findings demonstrate that voluntary exercise is sufficient for enhanced neurogenesis in the adult mouse dentate gyrus.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany	Salk Institute; University of Regensburg	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fgage@salk.edu	Kempermann, Gerd/F-5416-2010; van Praag, Henriette/F-3939-2015	Kempermann, Gerd/0000-0002-5304-4061; van Praag, Henriette/0000-0002-5727-434X				Adams RD, 1991, PRINCIPLES NEUROLOGY; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Barnea A, 1996, P NATL ACAD SCI USA, V93, P714, DOI 10.1073/pnas.93.2.714; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BENNETT EL, 1979, BEHAV NEURAL BIOL, V26, P1, DOI 10.1016/S0163-1047(79)92842-5; BLOMQUIST KB, 1987, PERCEPT MOTOR SKILL, V65, P175, DOI 10.2466/pms.1987.65.1.175; BOYES BE, 1986, NEUROSCIENCE, V17, P857, DOI 10.1016/0306-4522(86)90050-3; CAMERON HA, 1995, J NEUROSCI, V15, P4687; CONRAD CD, 1993, J NEUROSCI, V13, P2582, DOI 10.1523/JNEUROSCI.13-06-02582.1993; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; DUDAR JD, 1979, NEUROPHARMACOLOGY, V18, P673, DOI 10.1016/0028-3908(79)90034-0; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; Gomez-Pinilla F, 1998, NEUROSCIENCE, V85, P53, DOI 10.1016/S0306-4522(97)00576-9; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Gould E, 1996, DEV NEUROSCI-BASEL, V18, P22, DOI 10.1159/000111392; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GREENOUGH WT, 1975, AM SCI, V63, P37; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; JURASKA JM, 1985, BRAIN RES, V333, P73, DOI 10.1016/0006-8993(85)90125-8; JURASKA JM, 1989, BRAIN RES, V479, P115, DOI 10.1016/0006-8993(89)91341-3; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 1997, J NEUROSCI, V17, P3727; PARK GAS, 1992, NEUROSCI LETT, V143, P259, DOI 10.1016/0304-3940(92)90278-F; Patel SN, 1997, BEHAV BRAIN RES, V89, P115, DOI 10.1016/S0166-4328(97)00051-X; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; STAUBLI U, 1995, J NEUROSCI, V15, P2445, DOI 10.1523/JNEUROSCI.15-03-02445.1995; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; vanPraag H, 1997, BRAIN RES, V768, P233, DOI 10.1016/S0006-8993(97)00647-1	49	2836	2890	12	330	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					266	270		10.1038/6368	http://dx.doi.org/10.1038/6368			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195220				2022-12-24	WOS:000081684500015
J	Ilardi, JM; Mochida, S; Sheng, ZH				Ilardi, JM; Mochida, S; Sheng, ZH			Snapin: a SNARE-associated protein implicated in synaptic transmission	NATURE NEUROSCIENCE			English	Article							RAT SYMPATHETIC NEURONS; NEUROTRANSMITTER RELEASE; MEMBRANE-PROTEIN; SYNTAXIN; IDENTIFICATION; INHIBITION; PEPTIDES; FUSION; SYNAPTOTAGMIN; EXOCYTOSIS	Synaptic vesicle docking and fusion are mediated by the assembly of a stable SNARE core complex of proteins, which include the synaptic vesicle membrane protein VAMP/synaptobrevin and the plasmalemmal proteins syntaxin and SNAP-25. We have now identified another SNAP-25-binding protein, called Snapin. Snapin was enriched in neurons and exclusively located on synaptic vesicle membranes. It associated with the SNARE complex through direct interaction with SNAP-25. Binding of recombinant Snapin-CT to SNAP-25 blocked the association of the SNARE complex with synaptotagmin. Introduction of Snapin-CT and peptides containing the SNAP-25 binding sequence into presynaptic superior cervical ganglion neurons in culture reversibly inhibited synaptic transmission. These results suggest that Snapin is an important component of the neurotransmitter release process through its modulation of the sequential interactions between the SNAREs and synaptotagmin.	NINDS, Synapt Funct Unit, NIH, Bethesda, MD 20892 USA; Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Tokyo Medical University	Sheng, ZH (corresponding author), NINDS, Synapt Funct Unit, NIH, Bldg 36,Room 5A23,9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002946, Z01NS002946] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; Doussau F, 1998, J NEUROSCI, V18, P3147; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Hunter J. S., 1994, HDB STAT, V12, P1, DOI [10.1016/S0169-7161(05)80003-3, DOI 10.1016/S0169-7161(05)80003-3]; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1410, DOI 10.1152/jn.1979.42.5.1410; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	31	179	196	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					119	124		10.1038/5673	http://dx.doi.org/10.1038/5673			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195194				2022-12-24	WOS:000078231600009
J	Rocha, BA; Fumagalli, F; Gainetdinov, RR; Jones, SR; Ator, R; Giros, B; Miller, GW; Caron, MG				Rocha, BA; Fumagalli, F; Gainetdinov, RR; Jones, SR; Ator, R; Giros, B; Miller, GW; Caron, MG			Cocaine self-administration in dopamine-transporter knockout mice	NATURE NEUROSCIENCE			English	Article							PROGRESSIVE RATIO SCHEDULE; DISCRIMINATIVE STIMULUS; I-125 RTI-55; SEROTONIN TRANSPORTERS; C-FOS; REINFORCING PROPERTIES; INTRAVENOUS COCAINE; NUCLEUS ACCUMBENS; SQUIRREL-MONKEYS; BRAIN REGIONS	The plasma membrane dopamine transporter (DAT) is responsible for clearing dopamine from the synapse. Cocaine blockade of DAT leads to increased extracellular dopamine, an effect widely considered to be the primary cause of the reinforcing and addictive properties of cocaine. In this study we tested whether these properties are limited to the dopaminergic system in mice lacking DAT. In the absence of DAT, these mice exhibit high levels of extracellular dopamine, but paradoxically still self-administer cocaine. Mapping of the sites of cocaine binding and neuronal activation suggests an involvement of serotonergic brain regions in this response. These results demonstrate that the interaction of cocaine with targets other than DAT, possibly the serotonin transporter, can initiate and sustain cocaine self-administration in these mice.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA; Univ N Texas, Ctr Hlth Sci, Dept Pharmacol, Ft Worth, TX 76107 USA	Duke University; Duke University; University of North Texas System; University of North Texas Health Science Center	Caron, MG (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA.	caron002@mc.duke.edu	GIROS, Bruno/ABD-5790-2021; Gainetdinov, Raul R/G-5875-2011; Fumagalli, Fabio/E-8992-2012; Jones, Sara R/K-4816-2014	GIROS, Bruno/0000-0001-5876-9822; Gainetdinov, Raul R/0000-0003-2951-6038; Jones, Sara R/0000-0002-3424-7576; Fumagalli, Fabio/0000-0002-8814-7706	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH040159, P30MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA010457] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-10457A] Funding Source: Medline; NIEHS NIH HHS [ES-09248] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BARR GA, 1986, DEV BRAIN RES, V24, P193, DOI 10.1016/0165-3806(86)90187-2; BENDOTTI C, 1990, MOL BRAIN RES, V8, P343, DOI 10.1016/0169-328X(90)90048-I; BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150; BOJA JW, 1992, SYNAPSE, V12, P27, DOI 10.1002/syn.890120104; BROADBENT J, 1991, BEHAV PHARMACOL, V2, P187; CARROLL ME, 1990, PHARMACOL BIOCHEM BE, V35, P237, DOI 10.1016/0091-3057(90)90232-7; CLINE EJ, 1992, SYNAPSE, V12, P37, DOI 10.1002/syn.890120105; CRAWFORD CA, 1995, PSYCHOPHARMACOLOGY, V120, P392, DOI 10.1007/BF02245810; DICHIARA G, 1995, DRUG ALCOHOL DEPEN, V38, P95, DOI 10.1016/0376-8716(95)01118-I; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; FUJITA M, 1994, J CHEM NEUROANAT, V7, P13, DOI 10.1016/0891-0618(94)90004-3; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GU H, 1994, J BIOL CHEM, V269, P7124; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; Howell LL, 1995, J PHARMACOL EXP THER, V275, P1551; JOHANSON CE, 1989, PHARMACOL REV, V41, P3; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; LAMB RJ, 1990, PSYCHOPHARMACOLOGY, V102, P183, DOI 10.1007/BF02245920; LOH EA, 1990, PSYCHOPHARMACOLOGY, V101, P262, DOI 10.1007/BF02244137; MADRAS BK, 1989, MOL PHARMACOL, V36, P518; Marek GJ, 1996, J PHARMACOL EXP THER, V278, P1373; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NESTLER EJ, 1993, CRIT REV NEUROBIOL, V7, P23; ORGEN SO, 1984, J NEURAL T, V59, P264; Pagliusi SR, 1996, EUR J NEUROSCI, V8, P2247, DOI 10.1111/j.1460-9568.1996.tb01188.x; Parsons LH, 1996, PSYCHOPHARMACOLOGY, V128, P150, DOI 10.1007/s002130050120; PELTIER R, 1993, PSYCHOPHARMACOLOGY, V110, P390, DOI 10.1007/BF02244643; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; ROBERTS DCS, 1994, PHARMACOL BIOCHEM BE, V49, P177, DOI 10.1016/0091-3057(94)90473-1; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; ROBERTS DCS, 1980, PHARMACOL BIOCHEM BE, V12, P781, DOI 10.1016/0091-3057(80)90166-5; ROBERTS DCS, 1993, PSYCHOPHARMACOLOGY, V111, P202, DOI 10.1007/BF02245524; ROCHA BA, 1997, PHARM BIOCH BEHAV, V57, P1; ROCHA BA, 1998, IN PRESS NATURE; Shearman LP, 1996, J PHARMACOL EXP THER, V277, P1770; SNODDY AM, 1983, PHARMACOL BIOCHEM BE, V19, P205, DOI 10.1016/0091-3057(83)90040-0; SPEALMAN RD, 1995, J PHARMACOL EXP THER, V275, P53; STALEY JK, 1994, J NEUROCHEM, V62, P549; Sugita S, 1996, NEUROCHEM INT, V28, P545, DOI 10.1016/0197-0186(95)00127-1; TEJANIBUTT SM, 1992, J PHARMACOL EXP THER, V260, P427; UMINO A, 1995, NEUROCHEM INT, V26, P85, DOI 10.1016/0197-0186(94)00096-D; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 1997, NATURE, V386, P827, DOI 10.1038/386827a0; Walsh SL, 1997, PSYCHOPHARMACOLOGY, V130, P41, DOI 10.1007/s002130050210; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	49	429	436	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					132	137		10.1038/381	http://dx.doi.org/10.1038/381			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195128				2022-12-24	WOS:000076361100014
J	Yan, W; Suga, N				Yan, W; Suga, N			Corticofugal modulation of the midbrain frequency map in the bat auditory system	NATURE NEUROSCIENCE			English	Article							INTRACOCHLEAR ELECTRICAL-STIMULATION; NEONATALLY DEAFENED CAT; BIG BROWN BAT; INFERIOR COLLICULUS; INTRACORTICAL MICROSTIMULATION; EPTESICUS-FUSCUS; ADULT MAMMALS; CORTEX; REPRESENTATION; PLASTICITY	The auditory system, like the visual and somatosensory systems, contains topographic maps in its central neural pathways. These maps can be modified by sensory deprivation, injury and experience in both young and adult animals. Such plasticity has been explained by changes in the divergent and convergent projections of the ascending sensory system. Another possibility, however, is that plasticity may be mediated by descending corticofugal connections. We have investigated the role of descending connections from the cortex to the inferior colliculus of the big brown bat. Electrical stimulation of the auditory cortex causes a downward shift in the preferred frequencies of collicular neurons toward that of the stimulated cortical neurons. This results in a change in the frequency map within the colliculus. Moreover, similar changes can be induced by repeated bursts of sound at moderate intensities. Thus, one role of the mammalian corticofugal system may be to modify subcortical sensory maps in response to sensory experience.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Suga, N (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	suga@biodec.wustl.edu			NIDCD NIH HHS [DC 00175] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000175] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AMATO G, 1969, Archivio Italiano di Scienze Mediche Tropicali e di Parassitologia, V53, P291; ANDERSEN P, 1973, BRAIN BEHAV EVOLUT, V6, P170, DOI 10.1159/000123705; ANDERSEN RA, 1980, J COMP NEUROL, V191, P479, DOI 10.1002/cne.901910310; CASSEDAY JH, 1992, J COMP NEUROL, V319, P34, DOI 10.1002/cne.903190106; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; DEAR SP, 1993, NATURE, V364, P620, DOI 10.1038/364620a0; EVANS EF, 1975, AUDIOLOGY, V14, P419; He JF, 1997, J NEUROPHYSIOL, V77, P896, DOI 10.1152/jn.1997.77.2.896; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Irvine DRF, 1996, CLIN EXP PHARMACOL P, V23, P939, DOI 10.1111/j.1440-1681.1996.tb01146.x; JEN PHS, 1989, J COMP PHYSIOL A, V165, P1, DOI 10.1007/BF00613794; JENKINS WM, 1990, NEUROPSYCHOLOGIA, V28, P573, DOI 10.1016/0028-3932(90)90035-M; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KATSUKI Y., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1396, DOI 10.1121/1.1918357; KELLY JP, 1981, BRAIN RES, V212, P1, DOI 10.1016/0006-8993(81)90027-5; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; MASSOPUST LC, 1962, EXP NEUROL, V6, P465, DOI 10.1016/0014-4886(62)90072-9; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, CEREB CORTEX, V2, P181, DOI 10.1093/cercor/2.3.181; RYUGO DK, 1976, EXP NEUROL, V51, P377, DOI 10.1016/0014-4886(76)90262-4; Saldana E, 1996, J COMP NEUROL, V371, P15, DOI 10.1002/(SICI)1096-9861(19960715)371:1<15::AID-CNE2>3.0.CO;2-O; SNYDER RL, 1991, HEARING RES, V56, P246, DOI 10.1016/0378-5955(91)90175-9; SNYDER RL, 1990, HEARING RES, V50, P7, DOI 10.1016/0378-5955(90)90030-S; SPENGLER F, 1994, NEUROREPORT, V5, P949, DOI 10.1097/00001756-199404000-00024; SUGA N, 1964, J PHYSIOL-LONDON, V172, P449, DOI 10.1113/jphysiol.1964.sp007432; SUGA N, 1977, J EXP BIOL, V69, P207; SUN X, 1989, BRAIN RES, V495, P1, DOI 10.1016/0006-8993(89)91212-2; Sun XD, 1996, NEUROSCI LETT, V212, P131, DOI 10.1016/0304-3940(96)12788-9; SYKA J, 1984, NEUROSCI LETT, V51, P235, DOI 10.1016/0304-3940(84)90557-3; VILLA AEP, 1991, EXP BRAIN RES, V86, P506, DOI 10.1007/BF00230524; WATANABE T, 1966, EXP BRAIN RES, V2, P302; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180	39	172	178	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					54	58		10.1038/255	http://dx.doi.org/10.1038/255			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195109				2022-12-24	WOS:000076361000018
J	Huang, DW; McKerracher, L; Braun, PE; David, S				Huang, DW; McKerracher, L; Braun, PE; David, S			A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE GROWTH-INHIBITORS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CORTICOSPINAL TRACT AXONS; AUTOIMMUNE ENCEPHALOMYELITIS; WHITE-MATTER; INJURY; RATS; NEURONS	Axon growth inhibitors associated with myelin play an important role in the failure of axon regeneration in the adult mammalian central nervous system (CNS). Several inhibitors are present in the mature CNS. We now present a novel therapeutic vaccine approach in which the animals' own immune system is stimulated to produce polyclonal antibodies that block myelin-associated inhibitors without producing any detrimental cellular inflammatory responses. Adult mice immunized in this manner showed extensive regeneration of large numbers of axons of the corticospinal tracts after dorsal hemisection of the spinal cord. The anatomical regeneration led to recovery of certain hind limb motor functions. Furthermore, antisera from immunized mice were able to block myelin-derived inhibitors and promote neurite growth on myelin in vitro.	Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; McGill Univ, Montreal, PQ H3G 1A4, Canada; Univ Montreal, Dept Pathol, Montreal, PQ H3T 1J8, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; Universite de Montreal; McGill University	David, S (corresponding author), Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	mcsl@musica.mcgill.ca						AKINTUNDE A, 1992, BRAIN RES, V575, P86, DOI 10.1016/0006-8993(92)90427-B; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; David S, 1998, MENT RETARD DEV D R, V4, P171, DOI 10.1002/(SICI)1098-2779(1998)4:3<171::AID-MRDD4>3.0.CO;2-R; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; GAUR A, 1992, SCIENCE, V258, P1491, DOI 10.1126/science.1279812; Goverman J, 1997, CRIT REV IMMUNOL, V17, P469; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; KEIRSTEAD HS, 1995, J NEUROSCI, V15, P6963; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Li M, 1996, J NEUROSCI RES, V46, P404, DOI 10.1002/(SICI)1097-4547(19961115)46:4<404::AID-JNR2>3.3.CO;2-W; Li MS, 1996, GLIA, V18, P306, DOI 10.1002/(SICI)1098-1136(199612)18:4<306::AID-GLIA5>3.0.CO;2-V; Marusic S, 1997, J EXP MED, V186, P507, DOI 10.1084/jem.186.4.507; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; ONEILL JK, 1992, J NEUROIMMUNOL, V41, P177, DOI 10.1016/0165-5728(92)90068-V; PINDZOLA RR, 1993, DEV BIOL, V156, P34, DOI 10.1006/dbio.1993.1057; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rivero VE, 1997, J NEUROIMMUNOL, V72, P3, DOI 10.1016/S0165-5728(96)00117-8; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHMUED LC, 1986, BRAIN RES, V377, P147, DOI 10.1016/0006-8993(86)91199-6; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHWAB ME, 1991, J NEUROSCI, V11, P709; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tavares I, 1996, J COMP NEUROL, V374, P84; TETZLAFF W, 1991, J NEUROSCI, V11, P2528; TRAUGOTT U, 1985, CELL IMMUNOL, V91, P240, DOI 10.1016/0008-8749(85)90047-4; Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702; WEINER HL, 1994, ANNU REV IMMUNOL, V12, P809, DOI 10.1146/annurev.immunol.12.1.809; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353	37	249	262	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					639	647		10.1016/S0896-6273(00)81118-6	http://dx.doi.org/10.1016/S0896-6273(00)81118-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595515	Bronze			2022-12-24	WOS:000083913000019
J	Polley, DB; Chen-Bee, CH; Frostig, RD				Polley, DB; Chen-Bee, CH; Frostig, RD			Two directions of plasticity in the sensory-deprived adult cortex	NEURON			English	Article							RAT BARREL CORTEX; PRIMARY SOMATOSENSORY CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; FUNCTIONAL-ORGANIZATION; RECEPTIVE-FIELDS; OWL MONKEYS; TOPOGRAPHIC REORGANIZATION; CORTICAL PLASTICITY; SYNAPTIC PLASTICITY; TACTILE STIMULATION	Damage or deprivation of a localized region of the skin surface has been shown to induce a selective expansion of adjacent skin surface representations in the adult somatosensory cortex. Here, we use repeated optical imaging in conjunction with single unit recordings to assess the plasticity of a single whisker's functional representation in the adult rat. We observed a large-scale expansion of a single whisker's functional representation following innocuous removal of all neighboring whiskers. Surprisingly, the same manipulation can also induce a large-scale contraction of the representation if the animal is removed from its home cage and given a brief opportunity to use its whiskers for active exploration of a different environment. Both the expansion and contraction reverse upon regrowth of the deprived whiskers. Thus, allowing the animal to use its deprived receptor organ in active exploration can determine the direction of plasticity in the adult cortex.	Univ Calif Irvine, Dept Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Behav Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Polley, DB (corresponding author), Univ Calif Irvine, Dept Neurobiol, Irvine, CA 92697 USA.			Polley, Daniel/0000-0002-5120-2409	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034519] Funding Source: NIH RePORTER; NIMH NIH HHS [MH014599-23] Funding Source: Medline; NINDS NIH HHS [NS-34519] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; ALLARD T, 1991, J NEUROPHYSIOL, V66, P1048, DOI 10.1152/jn.1991.66.3.1048; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1991, J COMP NEUROL, V303, P193, DOI 10.1002/cne.903030203; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CALFORD MB, 1991, J NEUROPHYSIOL, V65, P178, DOI 10.1152/jn.1991.65.2.178; Chenbee CH, 1996, J NEUROPHYSIOL, V76, P884, DOI 10.1152/jn.1996.76.2.884; ChenBee CH, 1996, J NEUROSCI METH, V68, P27, DOI 10.1016/0165-0270(96)00056-8; Coq JO, 1998, EXP BRAIN RES, V121, P191, DOI 10.1007/s002210050452; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Dolan S, 1996, NEUROSCIENCE, V70, P79, DOI 10.1016/0306-4522(95)00375-S; Faggin BM, 1997, P NATL ACAD SCI USA, V94, P9428, DOI 10.1073/pnas.94.17.9428; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; FOX K, 1992, J NEUROSCI, V12, P1826; FOX K, 1994, J NEUROSCI, V14, P7665; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GARRAGHTY PE, 1991, P NATL ACAD SCI USA, V88, P6976, DOI 10.1073/pnas.88.16.6976; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hand P.J., 1982, PLASTICITY NERVOUS S, P49; HOEFLINGER BF, 1995, J COMP NEUROL, V354, P551, DOI 10.1002/cne.903540406; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; JULIANO SL, 1995, CEREBR CORT, V11, P411; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KALASKA J, 1979, J NEUROPHYSIOL, V42, P618, DOI 10.1152/jn.1979.42.2.618; KILLACKEY HP, 1973, BRAIN RES, V51, P326, DOI 10.1016/0006-8993(73)90383-1; KOSSUT M, 1985, PHYSIOL BOHEMOSLOV, V34, P79; Kossut M, 1998, EXP BRAIN RES, V123, P110, DOI 10.1007/s002210050551; LEVIN BE, 1988, BRAIN RES, V443, P261, DOI 10.1016/0006-8993(88)91620-4; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Masino SA, 1996, P NATL ACAD SCI USA, V93, P4942, DOI 10.1073/pnas.93.10.4942; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MILANI H, 1989, BEHAV NEUROSCI, V103, P1067, DOI 10.1037/0735-7044.103.5.1067; MOGILNER A, 1993, P NATL ACAD SCI USA, V90, P3593, DOI 10.1073/pnas.90.8.3593; ORBACH HS, 1985, J NEUROSCI, V5, P1886; Polley DB, 1999, J NEUROPHYSIOL, V81, P692, DOI 10.1152/jn.1999.81.2.692; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Prakash N, 1996, NATURE, V381, P702, DOI 10.1038/381702a0; RASMUSSON DD, 1982, J COMP NEUROL, V205, P313, DOI 10.1002/cne.902050402; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; RIDDLE DR, 1995, J NEUROSCI, V15, P4184; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; WALL JT, 1983, SCIENCE, V221, P771, DOI 10.1126/science.6879175; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WELKER E, 1989, EXP BRAIN RES, V78, P659, DOI 10.1007/BF00230256; WELKER E, 1992, J NEUROSCI, V12, P153; WIESEI TN, 1963, J NEUROPHYSIOL, V28, P1103; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994	61	119	119	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					623	637		10.1016/S0896-6273(00)81117-4	http://dx.doi.org/10.1016/S0896-6273(00)81117-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595514	Bronze			2022-12-24	WOS:000083913000018
J	Chun, MM; Phelps, EA				Chun, MM; Phelps, EA			Memory deficits for implicit contextual information in amnesic subjects with hippocampal damage	NATURE NEUROSCIENCE			English	Article							EXPLICIT MEMORY; ASSOCIATIONS; MONKEYS; MODEL; DISSOCIATION; IMPAIRMENT; SYSTEMS	The role of the hippocampus and adjacent medial temporal lobe structures in memory systems has long been debated. Here we show in humans that these neural structures are important for encoding implicit contextual information from the environment. We used a contextual cuing task in which repeated visual context facilitates visual search for embedded target objects. An important feature of our task is that memory traces for contextual information were not accessible to conscious awareness, and hence could be classified as implicit. Amnesic patients with medial temporal system damage showed normal implicit perceptual/skill learning but were impaired on implicit contextual learning. Our results demonstrate that the human medial temporal memory system is important for learning contextual information, which requires the binding of multiple cues.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Chun, MM (corresponding author), Vanderbilt Univ, Dept Psychol, 531 Wilson Hall, Nashville, TN 37240 USA.			Chun, Marvin/0000-0003-1070-7993	NIMH NIH HHS [MH50812] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050812] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CORKIN S, 1968, NEUROPSYCHOLOGIA, V6, P255, DOI 10.1016/0028-3932(68)90024-9; Dore FY, 1998, HIPPOCAMPUS, V8, P323, DOI 10.1002/(SICI)1098-1063(1998)8:4<323::AID-HIPO2>3.0.CO;2-I; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Gabrieli JDE, 1997, PSYCHOL SCI, V8, P326, DOI 10.1111/j.1467-9280.1997.tb00447.x; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; Johnson Marcia K., 1994, P311; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KNOWLTON BJ, 1992, PSYCHOL SCI, V3, P172, DOI 10.1111/j.1467-9280.1992.tb00021.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; MAYES AR, 1995, BEHAV BRAIN RES, V66, P29, DOI 10.1016/0166-4328(94)00120-5; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MUSEN G, 1993, J EXP PSYCHOL LEARN, V19, P789, DOI 10.1037/0278-7393.19.4.789; Musen G., 1993, NEUROPSYCHOLOGY, V7, P119, DOI DOI 10.1037/0894-4105.7.2.119; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; SCHACTER DL, 1995, PSYCHOL SCI, V6, P20, DOI 10.1111/j.1467-9280.1995.tb00299.x; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHIMAMURA AP, 1989, J EXP PSYCHOL LEARN, V15, P721, DOI 10.1037/0278-7393.15.4.721; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SUTHERLAND RJ, 1989, PSYCHOBIOLOGY, V17, P129; TREISMAN A, 1992, AM J PSYCHOL, V105, P341, DOI 10.2307/1423032; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	34	404	410	2	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					844	847		10.1038/12222	http://dx.doi.org/10.1038/12222			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FB	10461225				2022-12-24	WOS:000083882900017
J	McAdams, CJ; Maunsell, JHR				McAdams, CJ; Maunsell, JHR			Effects of attention on the reliability of individual neurons in monkey visual cortex	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; STATE DEPENDENT ACTIVITY; ORIENTATION DISCRIMINATION; STRIATE CORTEX; RESPONSE VARIABILITY; CORTICAL-NEURONS; CEREBRAL-CORTEX; SINGLE NEURONS; MACAQUE MONKEY; CELLS	To determine the physiological mechanisms underlying the enhancement of performance by attention, we examined how attention affects the ability of isolated neurons to discriminate orientation by investigating the reliability of responses with and without attention. Recording from 262 neurons in cortical area V4 while two rhesus macaques did a delayed match-to-sample task with oriented stimuli, we found that attention did not produce detectable changes in the variability of neuronal responses but did improve the orientation discriminability of the neurons. We also found that attention did not change the relationship between burst rate and response rate. Our results are consistent with the idea that attention selects groups of neurons for a multiplicative enhancement in response strength.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Maunsell, JHR (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.		McAdams, Carrie J./M-6822-2017; Maunsell, John/G-5702-2010	McAdams, Carrie J./0000-0002-4768-6703; Maunsell, John/0000-0003-0018-4439	NATIONAL EYE INSTITUTE [R01EY005911, T32EY007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY05911, T32 EY07001] Funding Source: Medline; NIGMS NIH HHS [T32 GM07330] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADLEY A, 1987, J NEUROPHYSIOL, V57, P755, DOI 10.1152/jn.1987.57.3.755; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CARNEY LH, 1988, J NEUROPHYSIOL, V60, P1653, DOI 10.1152/jn.1988.60.5.1653; DEAN AF, 1981, EXP BRAIN RES, V44, P437; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DeWeerd P, 1996, VISUAL NEUROSCI, V13, P529, DOI 10.1017/S0952523800008208; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; GREEN DM, 1966, SIGNAL DETECTION THE; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HEGGELUND P, 1978, EXP BRAIN RES, V32, P197; HENRY GH, 1973, VISION RES, V13, P1771, DOI 10.1016/0042-6989(73)90094-1; Lee DK, 1997, VISION RES, V37, P2409, DOI 10.1016/S0042-6989(97)00055-2; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; MATTHEWS PB, 1969, J PHYSIOL-LONDON, V202, P59, DOI 10.1113/jphysiol.1969.sp008795; MAUNSELL JHR, 1991, VISUAL NEUROSCI, V7, P561, DOI 10.1017/S095252380001035X; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOTTER BC, 1994, J NEUROSCI, V14, P2190; MOUNTCASTLE VB, 1981, J NEUROSCI, V1, P1218; PARKER A, 1985, J OPT SOC AM A, V2, P1101, DOI 10.1364/JOSAA.2.001101; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P147, DOI 10.1152/jn.1987.57.1.147; SCOBEY RP, 1989, EXP BRAIN RES, V77, P398, DOI 10.1007/BF00274997; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHADLEN MN, 1995, CURR OPIN NEUROBIOL, V4, P569; SHAPLEY R, 1986, SCIENCE, V231, P999, DOI 10.1126/science.3945816; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STREHLER BL, 1989, SYNAPSE, V3, P19, DOI 10.1002/syn.890030104; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; TOMKO GJ, 1984, EXP BRAIN RES, V79, P405; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; VOGELS R, 1991, EXP BRAIN RES, V84, P1; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; WHITSEL BL, 1977, J NEUROPHYSIOL, V40, P589, DOI 10.1152/jn.1977.40.3.589; WOLBARSHT ML, 1960, SCIENCE, V132, P1309, DOI 10.1126/science.132.3436.1309; Zar JH., 1999, BIOSTAT ANAL	48	212	213	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					765	773		10.1016/S0896-6273(01)80034-9	http://dx.doi.org/10.1016/S0896-6273(01)80034-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482242	Bronze			2022-12-24	WOS:000082280900019
J	Nicolelis, MAL; Ghazanfar, AA; Stambaugh, CR; Oliveira, LMO; Laubach, M; Chapin, JK; Nelson, RJ; Kaas, JH				Nicolelis, MAL; Ghazanfar, AA; Stambaugh, CR; Oliveira, LMO; Laubach, M; Chapin, JK; Nelson, RJ; Kaas, JH			Simultaneous encoding of tactile information by three primate cortical areas	NATURE NEUROSCIENCE			English	Article							SOMATOSENSORY CORTEX; VISUAL-SYSTEM; NEURONS; DISCRIMINATION; REPRESENTATION; ORGANIZATION; COMPUTATION; ENSEMBLES; MONKEYS; PATTERN	We used simultaneous multi-site neural ensemble recordings to investigate the representation of tactile information in three areas of the primate somatosensory cortex (areas 3b, SII and 2). Small neural ensembles (30-40 neurons) of broadly tuned somatosensory neurons were able to identify correctly the location of a single tactile stimulus on a single trial, almost simultaneously. Furthermore, each of these cortical areas could use different combinations of encoding strategies, such as mean firing rate (areas 3b and 2) or temporal patterns of ensemble firing (area SII), to represent the location of a tactile stimulus. Based on these results, we propose that ensembles of broadly tuned neurons, located in three distinct areas of the primate somatosensory cortex, obtain information about the location of a tactile stimulus almost concurrently.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Allegheny Univ Hlth Sci, Dept Neurobiol & Anat, Philadelphia, PA 17129 USA; Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Duke University; Drexel University; University of Tennessee System; University of Tennessee Health Science Center; Vanderbilt University	Nicolelis, MAL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209,101 Res Dr,Bryan Res Bldg, Durham, NC 27710 USA.			Laubach, Mark/0000-0002-2403-4497				ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bishop C. M., 1995, NEURAL NETWORKS PATT; BULLIER J, 1995, CURR OPIN NEUROBIOL, V5, P497, DOI 10.1016/0959-4388(95)80011-5; CHAPMAN CE, 1991, EXP BRAIN RES, V87, P319; Churchland P. S., 1992, COMPUTATIONAL BRAIN, DOI 10.7551/mitpress/2010.001.0001; ERICKSON RP, 1968, PSYCHOL REV, V75, P447, DOI 10.1037/h0026752; FERRINGTON DG, 1980, J NEUROPHYSIOL, V43, P310, DOI 10.1152/jn.1980.43.2.310; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1995, P NATL ACAD SCI USA, V92, P6655, DOI 10.1073/pnas.92.15.6655; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; IWAMURA Y, 1980, BRAIN RES, V197, P516, DOI 10.1016/0006-8993(80)91139-7; JOHNSON KO, 1997, COGNITIVE NEUROSCIEN, P253; Kaas J.H., 1988, P421; Kaas J H, 1991, Curr Opin Neurobiol, V1, P248, DOI 10.1016/0959-4388(91)90085-L; KAAS JH, 1994, AOTUS OWL MONKEY, P322; KOHONEN T, 1997, SELFORGANIZING MAPS; McClurkin JW, 1996, J NEUROPHYSIOL, V75, P481, DOI 10.1152/jn.1996.75.1.481; MERZENICH MM, 1980, PROGR PSYCHOBIOL PHY, V9, P1; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Nicolelis MAL, 1997, NEURON, V19, P219, DOI 10.1016/S0896-6273(00)80932-0; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Nicolelis MAL, 1997, J NEUROPHYSIOL, V78, P1691, DOI 10.1152/jn.1997.78.3.1691; NICOLELIS MAL, IN PRESS METHODS NEU; SARLE WS, 1995, P 27 S INT COMP SCI, V1, P352; Schiller PH, 1996, BEHAV BRAIN RES, V76, P21, DOI 10.1016/0166-4328(95)00186-7; Seidemann E, 1996, J NEUROSCI, V16, P752; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; WISE SP, 1988, SCIENCE, V242, P736, DOI 10.1126/science.3187520; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	38	131	142	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					621	630		10.1038/2855	http://dx.doi.org/10.1038/2855			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196571				2022-12-24	WOS:000077437100019
J	Schmidt, MF; Konishi, M				Schmidt, MF; Konishi, M			Gating of auditory responses in the vocal control system of awake songbirds	NATURE NEUROSCIENCE			English	Article							WHITE-CROWNED SPARROW; ADULT ZEBRA FINCHES; SONG SYSTEM; CONTROL NUCLEUS; MAINTENANCE; PATHWAYS; FEEDBACK; NEURONS; BIRDS; ORGANIZATION	Nucleus HVc of the avian song system is a forebrain structure critical in song production, perception and learning. Here we show that most HVc neurons that respond to auditory stimuli under anesthesia show no responses to the same stimulus in the awake, unrestrained bird. This suppression of auditory responses in awake birds does not occur in the forebrain field L complex, which is one of the auditory input stages for HVc. Gating of auditory input at the junction between the auditory and vocal control system may be essential for regulating auditory feedback signals necessary for song learning and maintenance.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Schmidt, MF (corresponding author), CALTECH, Div Biol, M-C 216-76, Pasadena, CA 91125 USA.	schmidt@etho.caltech.edu	Schmidt, Marc/B-1597-2008		NIDCD NIH HHS [DC00125, R03 DC03041] Funding Source: Medline; NIH HHS [NH55984] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003041] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Capsius B, 1996, HEARING RES, V96, P59, DOI 10.1016/0378-5955(96)00038-X; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Doupe A J, 1993, Curr Opin Neurobiol, V3, P104, DOI 10.1016/0959-4388(93)90043-X; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Lewicki MS, 1996, J NEUROSCI, V16, P5854; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Li R, 1997, BRAIN RES, V763, P239, DOI 10.1016/S0006-8993(97)00417-4; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; METZNER W, 1993, J NEUROSCI, V13, P1899; MUELLER-PREUSS P, 1981, Brain Research, V215, P61; Newsome WT, 1996, CURR BIOL, V6, P357, DOI 10.1016/S0960-9822(02)00494-3; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Okanoya K, 1997, J NEUROBIOL, V33, P343; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; Reinke H, 1998, J COMP NEUROL, V391, P147; Schmidt MF, 1998, J NEUROSCI, V18, P895; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; TENCATE C, 1984, BEHAVIOUR, V91, P263, DOI 10.1163/156853984X00100; TODT D, 1986, VERHALTENSBIOLOGIE, P22; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vates GE, 1997, J COMP NEUROL, V380, P275; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VICARIO DS, 1993, J NEUROBIOL, V24, P488, DOI 10.1002/neu.480240407; Volman SF, 1996, J COMP PHYSIOL A, V178, P849; VU ET, 1994, J NEUROSCI, V14, P6924; WASER MS, 1976, J COMP PHYSIOL PSYCH, V91, P28; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	40	146	147	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					513	518		10.1038/2232	http://dx.doi.org/10.1038/2232			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196550				2022-12-24	WOS:000076406900017
J	Hofman, PM; Van Riswick, JGA; Van Opstal, AJ				Hofman, PM; Van Riswick, JGA; Van Opstal, AJ			Relearning sound localization with new ears	NATURE NEUROSCIENCE			English	Article							BARN OWLS; AUDITORY SPACE; EYE-MOVEMENTS; OPTIC TECTUM; PLASTICITY; CUES; ADJUSTMENT; AGE; MAP	Because the inner ear is not organized spatially, sound localization relies on the neural processing of implicit acoustic cues. To determine a sound's position, the brain must learn and calibrate these cues, using accurate spatial feedback from other sensorimotor systems. Experimental evidence for such a system has been demonstrated in barn owls, but not in humans. Here, we demonstrate the existence of ongoing spatial calibration in the adult human auditory system. The spectral elevation cues of human subjects were disrupted by modifying their outer ears (pinnae) with molds. Although localization of sound elevation was dramatically degraded immediately after the modification, accurate performance was steadily reacquired. Interestingly, learning the new spectral cues did not interfere with the neural representation of the original cues, as subjects could localize sounds with both normal and modified pinnae.	Univ Nijmegen, Dept Med Phys & Biophys, NL-6525 EZ Nijmegen, Netherlands	Radboud University Nijmegen	Van Opstal, AJ (corresponding author), Univ Nijmegen, Dept Med Phys & Biophys, Geert Grooteplein 21, NL-6525 EZ Nijmegen, Netherlands.	johnvo@mbfys.kun.nl	van Opstal, John/D-1907-2010; Hofman, Paul/P-7654-2018	Hofman, Paul/0000-0003-0431-9353; van Opstal, John/0000-0001-5957-5712				BATTEAU DW, 1967, PROC R SOC SER B-BIO, V168, P158, DOI 10.1098/rspb.1967.0058; Blauert J, 1996, SPATIAL HEARING PSYC; BRAINARD MS, 1993, J NEUROSCI, V13, P4590; COLLEWIJN H, 1975, VISION RES, V15, P447, DOI 10.1016/0042-6989(75)90098-X; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; FRENS MA, 1995, EXP BRAIN RES, V107, P103, DOI 10.1007/BF00228022; Hofman PM, 1998, J ACOUST SOC AM, V103, P2634, DOI 10.1121/1.422784; JAVER AR, 1995, J OTOLARYNGOL, V24, P111; KING AJ, 1991, TRENDS NEUROSCI, V14, P31, DOI 10.1016/0166-2236(91)90181-S; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KNUDSEN EI, 1994, J NEUROPHYSIOL, V71, P79, DOI 10.1152/jn.1994.71.1.79; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; KNUDSEN EI, 1992, J NEUROSCI, V12, P3485; KNUDSEN EI, 1986, J NEUROSCI, V6, P1918; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; LopezPoveda EA, 1996, J ACOUST SOC AM, V100, P3248, DOI 10.1121/1.417208; MIDDLEBROOKS JC, 1992, J ACOUST SOC AM, V92, P2607, DOI 10.1121/1.404400; OLDFIELD SR, 1984, PERCEPTION, V13, P581, DOI 10.1068/p130581; OLDFIELD SR, 1984, PERCEPTION, V13, P601, DOI 10.1068/p130601; Perrett S, 1997, PERCEPT PSYCHOPHYS, V59, P1018, DOI 10.3758/BF03205517; Press W. H., 1992, ART SCI COMPUTING; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SCHROEDER MR, 1970, IEEE T INFORM THEORY, V16, P85, DOI 10.1109/TIT.1970.1054411; Stein BE., 1993, MERGING SENSES; TERANISHI R, 1968, J ACOUST SOC AM, V44, P257, DOI 10.1121/1.1911061; WENZEL EM, 1993, J ACOUST SOC AM, V94, P111, DOI 10.1121/1.407089; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P858, DOI 10.1121/1.397557; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P682, DOI 10.1111/j.1460-9568.1990.tb00458.x; ZAKARAUSKAS P, 1993, J ACOUST SOC AM, V94, P1323, DOI 10.1121/1.408160	31	268	302	1	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					417	421		10.1038/1633	http://dx.doi.org/10.1038/1633			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196533				2022-12-24	WOS:000076361400021
J	Yakovlev, V; Fusi, S; Berman, E; Zohary, E				Yakovlev, V; Fusi, S; Berman, E; Zohary, E			Inter-trial neuronal activity in inferior temporal cortex: a putative vehicle to generate long-term visual associations	NATURE NEUROSCIENCE			English	Article							PRIMATE PREFRONTAL CORTEX; WORKING-MEMORY; OBJECT; REVERBERATIONS; RECOGNITION; STIMULI; MONKEYS; TASK	When monkeys perform a delayed match-to-sample task, some neurons in the anterior inferotemporal cortex show sustained activity following the presentation of specific visual stimuli, typically only those that are shown repeatedly. When sample stimuli are shown in a fixed temporal order, the few images that evoke delay activity in a given neuron are often neighboring stimuli in the sequence, suggesting that this delay activity may be the neural correlate of associative long-term memory. Here we report that stimulus-selective sustained activity is also evident following the presentation of the test stimulus in the same task. We use a neural network model to demonstrate that persistent stimulus-selective activity across the intertrial interval can lead to similar mnemonic representations (distributions of delay activity across the neural population) for neighboring visual stimuli. Thus, inferotemporal cortex may contain neural machinery for generating long-term stimulus-stimulus associations.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Hadassah Univ Hosp, Human Biol Res Ctr, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel; Univ Roma La Sapienza, Ist Nazl Fis Nucl, Rome, Italy	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome	Zohary, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	udiz@lobster.huji.ac.il	Fusi, Stefano/E-9109-2011	Fusi, Stefano/0000-0002-3035-6652				Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Amit DJ, 1997, NEURAL COMPUT, V9, P1071, DOI 10.1162/neco.1997.9.5.1071; AMIT DJ, 1994, J NEUROSCI, V14, P6435; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; BARTLETT M, IN PRESS NETWORK; Brunel N, 1996, NEURAL COMPUT, V8, P1677, DOI 10.1162/neco.1996.8.8.1677; DERENZI E, 1977, J NEUROL NEUROSUR PS, V40, P498, DOI 10.1136/jnnp.40.5.498; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; FUSTER JM, 1990, J NEUROPHYSIOL, V64, P681, DOI 10.1152/jn.1990.64.3.681; GRINIASTY M, 1993, NEURAL COMPUT, V5, P1, DOI 10.1162/neco.1993.5.1.1; Gutnikov SA, 1997, EUR J NEUROSCI, V9, P1524, DOI 10.1111/j.1460-9568.1997.tb01507.x; LANDIS T, 1986, ARCH NEUROL-CHICAGO, V43, P132, DOI 10.1001/archneur.1986.00520020026011; Maguire EA, 1996, NEUROPSYCHOLOGIA, V34, P993, DOI 10.1016/0028-3932(96)00022-X; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; MURRAY EA, 1993, J NEUROSCI, V13, P4549; NAKAMURA K, 1995, J NEUROPHYSIOL, V74, P162, DOI 10.1152/jn.1995.74.1.162; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; WHITELEY AM, 1978, J NEUROL NEUROSUR PS, V41, P575, DOI 10.1136/jnnp.41.6.575; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	26	89	90	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					310	317		10.1038/1131	http://dx.doi.org/10.1038/1131			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195165				2022-12-24	WOS:000076361300015
J	Gardner, JD; Rothwell, NJ; Luheshi, GN				Gardner, JD; Rothwell, NJ; Luheshi, GN			Leptin affects food intake via CRF-receptor-mediated pathways	NATURE NEUROSCIENCE			English	Article							GENE		Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Luheshi, GN (corresponding author), Univ Manchester, Sch Biol Sci, 1124 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.							Behan DP, 1996, MOL PSYCHIATR, V1, P265; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Grunfeld C, 1996, J CLIN INVEST, V97, P2152, DOI 10.1172/JCI118653; Hakansson ML, 1998, J NEUROSCI, V18, P559; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; MENZAGHI F, 1994, J PHARMACOL EXP THER, V269, P564; ROTHWELL NJ, 1990, NEUROSCI BIOBEHAV R, V14, P263, DOI 10.1016/S0149-7634(05)80037-5; Sahu A, 1998, ENDOCRINOLOGY, V139, P795, DOI 10.1210/en.139.2.795; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	13	79	79	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					103	103		10.1038/353	http://dx.doi.org/10.1038/353			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195123	Bronze			2022-12-24	WOS:000076361100009
J	Konishi, S; Nakajima, K; Uchida, I; Kameyama, M; Nakahara, K; Sekihara, K; Miyashita, Y				Konishi, S; Nakajima, K; Uchida, I; Kameyama, M; Nakahara, K; Sekihara, K; Miyashita, Y			Transient activation of inferior prefrontal cortex during cognitive set shifting	NATURE NEUROSCIENCE			English	Article							CARD SORTING TEST; WORKING-MEMORY TASK; POSITRON EMISSION TOMOGRAPHY; PERFORMANCE; SYSTEM; AREAS; FMRI; PET; MRI	The Wisconsin Card Sorting Test, which probes the ability to shift attention from one category of stimulus attributes to another (shifting cognitive sets), is the most common paradigm used to detect human frontal lobe pathology. However, the exact relationship of this card test to prefrontal function and the precise anatomical localization of the cognitive shifts involved are controversial. By isolating shift-related signals using the temporal resolution of functional magnetic resonance imaging, we reproducibly found transient activation of the posterior part of the bilateral inferior frontal sulci, This activation was larger as the number of dimensions (relevant stimulus attributes that had to be recognized) were increased, These results suggest that the inferior frontal areas play an essential role in the flexible shifting of cognitive sets.	Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; Japan Sci & Technol Corp, Tokyo 113, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 444, Japan	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Konishi, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	konishi@m.u-tokyo.ac.jp	Miyashita, Yasushi/B-7171-2019; Kameyama, Masashi/E-1113-2017	Miyashita, Yasushi/0000-0003-3496-8637; Kameyama, Masashi/0000-0001-9496-2590; Nakahara, Kiyoshi/0000-0001-6701-6216				Baker SC, 1996, CEREB CORTEX, V6, P612, DOI 10.1093/cercor/6.4.612; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; BLAMIRE AM, 1992, P NATL ACAD SCI USA, V89, P11069, DOI 10.1073/pnas.89.22.11069; Buckner RL, 1996, J NEUROSCI, V16, P6219; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Damasio AR, 1995, ANN NY ACAD SCI, V769, P241, DOI 10.1111/j.1749-6632.1995.tb38142.x; Dehaene S, 1996, NEUROPSYCHOLOGIA, V34, P1097, DOI 10.1016/0028-3932(96)00027-9; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DREWE E A, 1974, Cortex, V10, P159; Fiez JA, 1996, J NEUROSCI, V16, P808; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; FUSTERJM, 1997, PREFRONTAL CORTEX; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Heaton R.K., 1993, WISCONSIN CARD SORTI; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Kim SG, 1997, MAGNET RESON MED, V37, P631, DOI 10.1002/mrm.1910370427; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Konishi S, 1996, NEUROREPORT, V8, P19, DOI 10.1097/00001756-199612200-00005; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MCCARTHY G, 1994, P NATL ACAD SCI USA, V91, P8690, DOI 10.1073/pnas.91.18.8690; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Milner B., 1964, FRONTAL GRANULAR COR, P313; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; Nagahama Y, 1996, BRAIN, V119, P1667, DOI 10.1093/brain/119.5.1667; NARAYAN SM, 1994, CEREB CORTEX, V4, P195, DOI 10.1093/cercor/4.2.195; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASSINGHAM RE, 1972, NEUROPSYCHOLOGIA, V10, P41, DOI 10.1016/0028-3932(72)90041-3; Passingham RE., 1993, FRONTAL LOBES VOLUNT; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; PETRIDES M, 1989, HDB NEUROPSYCHOLOGY, V3, P75; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; SAKAI K, 1995, MAGNET RESON MED, V33, P736, DOI 10.1002/mrm.1910330521; SAVOY RL, 1995, P SMR 3 ANN M, V450; Talairach J., 1988, COPLANAR STEREOTAXIC; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	50	322	328	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					80	84		10.1038/283	http://dx.doi.org/10.1038/283			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QA	10195114				2022-12-24	WOS:000076361000023
J	Hu, HY				Hu, HY			Chemorepulsion of neuronal migration by Slit2 in the developing mammalian forebrain	NEURON			English	Article							GROWTH CONE GUIDANCE; NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; CEREBRAL-CORTEX; CELL-MIGRATION; POLYSIALIC ACID; OLFACTORY-BULB; AXON GUIDANCE; C-ELEGANS; PRECURSORS	Newborn cerebral cortical neurons migrate along radial glia to the cortical plate. Experiments using a collagen gel assay revealed that the choroid plexus repelled cerebral cortical neurons and olfactory interneuron precursors, which were mimicked by Neuro-2A cells. Fractionation of Neuro-2A-conditioned medium identified a protein of 190 kDa, equivalent to full-length Slit proteins. Indeed, it cross-reacted with an antibody against Slit2, suggesting that it is either Slit2 or another Slit protein. Further, Slit2, expressed in COS cells, repelled cerebral cortical neurons and olfactory interneuron precursors. Thus, Slit2, which is expressed by the choroid plexus and the septum, acts as a chemorepulsive factor for neuronal migration. These results suggest chemorepulsion as a guidance mechanism for neuronal migration in the developing forebrain.	Metrohlth Med Ctr, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	MetroHealth System	Hu, HY (corresponding author), Metrohlth Med Ctr, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA.	hhu@research.mhmc.org						Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; GOTZ M, 1992, J NEUROBIOL, V23, P783, DOI 10.1002/neu.480230702; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KISHI K, 1990, ARCH HISTOL CYTOL, V53, P219, DOI 10.1679/aohc.53.219; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; McConnell S K, 1992, Curr Opin Neurobiol, V2, P23, DOI 10.1016/0959-4388(92)90156-F; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MCCONNELL SK, 1990, EXPERIENTIA, V46, P922, DOI 10.1007/BF01939385; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PRICE RR, 1993, J MICROENCAPSUL, V10, P215, DOI 10.3109/02652049309104387; RAKIC P, 1988, PROG BRAIN RES, V73, P15; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; ROBERTS JS, 1993, DEV BIOL, V155, P396, DOI 10.1006/dbio.1993.1038; RUDOLPH AS, 1992, BIOMATERIALS, V13, P1085, DOI 10.1016/0142-9612(92)90141-A; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SPARGO BJ, 1995, J MICROENCAPSUL, V12, P247, DOI 10.3109/02652049509010293; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Thomas LB, 1996, GLIA, V17, P1; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	43	206	220	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1999	23	4					703	711		10.1016/S0896-6273(01)80029-5	http://dx.doi.org/10.1016/S0896-6273(01)80029-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482237	Bronze			2022-12-24	WOS:000082280900014
J	Kakita, A; Goldman, JE				Kakita, A; Goldman, JE			Patterns and dynamics of SVZ cell migration in the postnatal forebrain: Monitoring living progenitors in slice preparations	NEURON			English	Article							GREEN-FLUORESCENT PROTEIN; DEVELOPING CEREBRAL-CORTEX; SUBVENTRICULAR ZONE CELLS; RAT OPTIC-NERVE; NEURONAL MIGRATION; GLIAL-CELLS; MAMMALIAN FOREBRAIN; DEVELOPMENTAL FATES; BLOOD-VESSELS; CHICK-EMBRYO	Glial progenitors colonize the CNS widely in the perinatal period, but the pathways and mechanisms of migration are not well understood. We investigated the migration of progenitors from the neonatal rat forebrain subventricular zone (SVZ) by labeling them in vivo with a retrovirus encoding green fluorescent protein and visualizing movements by time lapse microscopy in slices. Cells within the dorsolateral SVZ moved in an undirected fashion but migrated radially and tangentially after emigration into white matter, cortex, and striatum. Cells in the striatal SVZ migrated parallel to the ventricular surface. During migration, elongation of the leading process and nuclear translocation were independent or linked. Orthogonal turning involved either cessation of cell body movement and formation of a new leading process or continuous cell body movement and bending of the leading process.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Kakita, A (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.				NINDS NIH HHS [NS17125] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; AUSTIN CP, 1990, DEVELOPMENT, V110, P713; BAYER SA, 1991, J COMP NEUROL, V307, P499, DOI 10.1002/cne.903070312; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BOOK KJ, 1991, EXP NEUROL, V111, P228, DOI 10.1016/0014-4886(91)90011-Z; BULFONE A, 1993, J NEUROSCI, V13, P3155; CALEY DW, 1970, J COMP NEUROL, V138, P31, DOI 10.1002/cne.901380104; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; Frost E, 1996, DEV NEUROSCI-BASEL, V18, P266, DOI 10.1159/000111416; FUESHKO S, 1994, DEV BIOL, V166, P331, DOI 10.1006/dbio.1994.1319; FULTON BP, 1992, J NEUROSCI, V12, P4816; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Golden JA, 1997, DEVELOPMENT, V124, P3525; Gubin AN, 1997, BIOCHEM BIOPH RES CO, V236, P347, DOI 10.1006/bbrc.1997.6963; HAGER G, 1995, J NEUROSCI RES, V40, P207, DOI 10.1002/jnr.490400209; HALLIDAY AL, 1992, NEURON, V9, P15, DOI 10.1016/0896-6273(92)90216-Z; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; HATTEN ME, 1984, J CELL BIOL, V98, P193, DOI 10.1083/jcb.98.1.193; HEMOND SG, 1993, J NEUROSCI, V13, P1387; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; KOMURO H, 1995, J NEUROSCI, V15, P1110; Komuro H, 1998, J NEUROSCI, V18, P1478; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; KRUSHEL LA, 1993, NEUROSCIENCE, V53, P1035, DOI 10.1016/0306-4522(93)90487-Z; LEBER SM, 1995, J NEUROSCI, V15, P1236; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVISON SW, 1993, DEVELOPMENT, V119, P611; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Luskin MB, 1998, J NEUROBIOL, V36, P221; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Mason CA, 1997, J NEUROSCI, V17, P1086; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Neyt C, 1997, J NEUROSCI, V17, P9194; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; ORourke NA, 1997, DEVELOPMENT, V124, P997; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; Phelps PE, 1996, DEVELOPMENT, V122, P2013; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; RIVAS RJ, 1995, J NEUROSCI, V15, P981; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; SKOFF RP, 1991, GLIA, V4, P165, DOI 10.1002/glia.440040208; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1995, DEVELOPMENT, V121, P1029; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Yoshida K, 1995, J NEUROSCI, V15, P7769; Zerlin M, 1997, J COMP NEUROL, V387, P537, DOI 10.1002/(SICI)1096-9861(19971103)387:4<537::AID-CNE5>3.0.CO;2-3; ZERLIN M, 1995, J NEUROSCI, V15, P7238; Zhang L, 1996, J COMP NEUROL, V370, P536, DOI 10.1002/(SICI)1096-9861(19960708)370:4<536::AID-CNE9>3.0.CO;2-5; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	70	184	188	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					461	472		10.1016/S0896-6273(00)80800-4	http://dx.doi.org/10.1016/S0896-6273(00)80800-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433259	hybrid			2022-12-24	WOS:000081701000011
J	Sanchez, I; Xu, CJ; Juo, P; Kakizaka, A; Blenis, J; Yuan, JY				Sanchez, I; Xu, CJ; Juo, P; Kakizaka, A; Blenis, J; Yuan, JY			Caspase-8 is required for cell death induced by expanded polyglutamine repeats	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MACHADO-JOSEPH DISEASE; HUNTINGTONS-DISEASE; DRPLA PROTEIN; SERPIN CRMA; FAS LIGAND; APOPTOSIS; CLEAVAGE; AGGREGATION; BCL-2	We show here that caspase-8 is required for the death of primary rat neurons induced by an expanded polyglutamine repeat (Q79). Expression of Q79 recruited and activated caspase-8. Inhibition of caspase-8 blocked polyglutamine-induced cell death. Coexpression of Q79 with the caspase inhibitor CrmA, a dominant-negative mutant of FADD (FADD DN), Bcl-2, or Bcl-x(L), but not an N-terminally tagged Bcl-x(L), prevented the recruitment of caspase-8 and inhibited polyglutamine-induced cell death. Furthermore, Western blot analysis revealed the presence of activated caspase-8 in the insoluble fraction of affected brain regions from Huntington's disease (HD) patients but not in those from neurologically unremarkable controls, suggesting the relocation and activation of caspase-8 during the pathogenesis of HD. These results suggest an essential role of caspase-8 in HD-related neural degenerative diseases.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Osaka Biosci Inst, Dept 4, Osaka 5650874, Japan	Harvard University; Harvard Medical School	Yuan, JY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	jyuan@hms.harvard.edu	Juo, Peter/CJY-3695-2022; Sanchez, Ivelisse/E-3856-2010; Sánchez, Ivelisse/H-8765-2013	Juo, Peter/0000-0002-3039-2266; Sanchez, Ivelisse/0000-0002-7605-5337; Sánchez, Ivelisse/0000-0002-7605-5337	NINDS NIH HHS [NS31862] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Bates GP, 1997, MOL MED TODAY, V3, P508, DOI 10.1016/S1357-4310(97)01142-8; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gourfinkel-An I, 1998, NEUROREPORT, V9, P1823, DOI 10.1097/00001756-199806010-00028; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kim M, 1999, J NEUROSCI, V19, P964; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kitamura Y, 1998, BRAIN RES, V780, P260, DOI 10.1016/S0006-8993(97)01202-X; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; Miller TM, 1996, J NEUROSCI, V16, P7487; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Miyashita T, 1997, J BIOL CHEM, V272, P29238, DOI 10.1074/jbc.272.46.29238; Moulder KL, 1999, J NEUROSCI, V19, P705; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Oyaizu N, 1997, J IMMUNOL, V158, P2456; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paulson HL, 1996, ANNU REV NEUROSCI, V19, P79; Perez D, 1998, J CELL BIOL, V141, P1255, DOI 10.1083/jcb.141.5.1255; SANDOU F, 1998, CELL, V95, P55; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	48	337	351	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	1999	22	3					623	633		10.1016/S0896-6273(00)80716-3	http://dx.doi.org/10.1016/S0896-6273(00)80716-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197541	Bronze			2022-12-24	WOS:000079483900025
J	Kim, JN; Shadlen, MN				Kim, JN; Shadlen, MN			Neural correlates of a decision in the dorsolateral prefrontal cortex of the macaque	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE FIELD; POSTERIOR PARIETAL CORTEX; PRIMARY MOTOR CORTEX; VISUAL AREA MT; FUNCTIONAL-PROPERTIES; MOTION PERCEPTION; WORKING-MEMORY; MONKEY; NEURONS; PERFORMANCE	To make a visual discrimination, the brain must extract relevant information from the retina, represent appropriate variables in the visual cortex and read out this representation to decide which of two or more alternatives is more likely. We recorded from neurons in the dorsolateral prefrontal cortex (areas 8 and 46) of the rhesus monkey while it performed a motion discrimination task. The monkey indicated its judgment of direction by making appropriate eye movements. As the monkey viewed the motion stimulus, the neural response predicted the monkey's subsequent gaze shift, hence its judgment of direction. The response comprised a mixture of high-level oculomotor signals and weaker visual sensory signals that reflected the strength and direction of motion. This combination of sensory integration and motor planning could reflect the conversion of visual motion information into a categorical decision about direction and thus give insight into the neural computations behind a simple cognitive act.	Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Sch Med, Reg Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Kim, Jong nam/0000-0003-0991-7731; Shadlen, Michael/0000-0002-2002-2210	NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; Boes, 1963, INTRO THEORY STAT; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; COMMENGES D, 1986, MATH BIOSCI, V80, P81, DOI 10.1016/0025-5564(86)90068-4; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; DRAPER N, 1966, APPL REGRESION ANAL; FRIEDMAN HR, 1994, J NEUROSCI, V14, P2775; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J.M., 1989, PREFRONTAL CORTEX; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1987, HDB PHYSL NERVOUS SY, P373; Goodale MA, 1998, CURR BIOL, V8, pR489, DOI 10.1016/S0960-9822(98)70314-8; GREEN DM, 1966, SIGNAL DETECTION THE; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Hays AV, 1982, WESCON C P, V2, P1; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Jacobsen CF, 1935, ARCH NEURO PSYCHIATR, V33, P558, DOI 10.1001/archneurpsyc.1935.02250150108009; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Miller EK, 1996, J NEUROSCI, V16, P5154; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Newsome WT, 1997, J COMP PHYSIOL A, V181, P5, DOI 10.1007/s003590050087; Press W. H., 1992, ART SCI COMPUTING; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; RIEHLE A, 1994, NEUROREPORT, V5, P2462, DOI 10.1097/00001756-199412000-00014; ROMO R, 1993, J NEUROPHYSIOL, V70, P2690, DOI 10.1152/jn.1993.70.6.2690; Salinas E, 1998, J NEUROSCI, V18, P499; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SEAL J, 1985, EXP BRAIN RES, V58, P144; SEAL J, 1989, BRAIN BEHAV EVOLUT, V33, P113, DOI 10.1159/000115911; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Seidemann E, 1998, NATURE, V394, P72, DOI 10.1038/27906; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Zhang J, 1997, J NEUROSCI, V17, P2227	49	666	671	1	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					176	185		10.1038/5739	http://dx.doi.org/10.1038/5739			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195203				2022-12-24	WOS:000078231600018
J	Cha, A; Ruben, PC; George, AL; Fujimoto, E; Bezanilla, F				Cha, A; Ruben, PC; George, AL; Fujimoto, E; Bezanilla, F			Voltage sensors in domains III and IV, but not I and II, are immobilized by Na+ channel fast inactivation	NEURON			English	Article							SHAKER K+ CHANNEL; SQUID GIANT-AXON; SODIUM-CHANNEL; ELECTROPHORUS-ELECTRICUS; GATING CURRENTS; POSITIVE CHARGES; SINGLE-CHANNEL; SEGMENT IVS6; S4 SEGMENT; ACTIVATION	Using site-directed fluorescent labeling, we examined conformational changes in the S4 segment of each domain of the human skeletal muscle sodium channel (hSkM1). The fluorescence signals from S4 segments in domains I and II follow activation and are unaffected as fast inactivation settles. In contrast, the fluorescence signals from S4 segments in domains III and IV show kinetic components during activation and deactivation that correlate with fast inactivation and charge immobilization. These results indicate that in hSkM1, the S4 segments in domains III and IV are responsible for voltage-sensitive conformational changes linked to fast inactivation and are immobilized by fast inactivation, while the S4 segments in domains I and II are unaffected by fast inactivation.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; Utah State Univ, Dept Biol, Logan, UT 84322 USA; Vanderbilt Univ, Sch Med, Dept Nephrol, Nashville, TN 37232 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; Utah State University; Vanderbilt University	Bezanilla, F (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS032387, R01NS029204, R01NS032387] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-30376] Funding Source: Medline; NINDS NIH HHS [NS-29204, NS-32387] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; Chen LQ, 1996, J GEN PHYSIOL, V108, P549, DOI 10.1085/jgp.108.6.549; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; HO HN, 1989, GENE, V77, P51; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HORN R, 1984, J GEN PHYSIOL, V84, P505, DOI 10.1085/jgp.84.4.505; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Kontis KJ, 1997, J GEN PHYSIOL, V110, P403, DOI 10.1085/jgp.110.4.403; KOSOWER EM, 1985, FEBS LETT, V182, P234, DOI 10.1016/0014-5793(85)80306-9; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; MCPHEE JC, 1995, J BIOL CHEM, V270, P12025, DOI 10.1074/jbc.270.20.12025; Mitrovic N, 1998, J GEN PHYSIOL, V111, P451, DOI 10.1085/jgp.111.3.451; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; PATLAK J, 1991, PHYSIOL REV, V71, P1047, DOI 10.1152/physrev.1991.71.4.1047; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHAO XM, 1993, NEURON, V11, P343, DOI 10.1016/0896-6273(93)90189-X; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; STIMERS JR, 1985, J GEN PHYSIOL, V85, P65, DOI 10.1085/jgp.85.1.65; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANDENBERG CA, 1991, BIOPHYS J, V60, P1511, DOI 10.1016/S0006-3495(91)82186-5; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	38	224	226	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					73	87		10.1016/S0896-6273(00)80680-7	http://dx.doi.org/10.1016/S0896-6273(00)80680-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027291	Bronze			2022-12-24	WOS:000078410300014
J	Hooper, SL				Hooper, SL			Transduction of temporal patterns by single neurons	NATURE NEUROSCIENCE			English	Article							LOBSTER STOMATOGASTRIC GANGLION; TRANSIENT POTASSIUM CURRENT; PANULIRUS-INTERRUPTUS; SELECTIVE INACTIVATION; IDENTIFIED NEURONS; PYLORIC PATTERN; HOMARUS-AMERICANUS; CULTURED NEURONS; CANCER-BOREALIS; NEURAL NETWORKS	As our ability to communicate by Morse code illustrates, nervous systems can produce motor outputs, and identify sensory inputs, based on temporal patterning alone. Although this ability is central to a wide range of sensory and motor tasks, the ways in which nervous systems represent temporal patterns are not well understood. I show here that individual neurons of the lobster pyloric network can integrate rhythmic patterned input over the long times (hundreds of milliseconds) characteristic of many behaviorally relevant patterns, and that their firing delays vary as a graded function of the pattern's temporal character. These neurons directly transduce temporal patterns into a neural code, and constitute a novel biological substrate for temporal pattern detection and production. The combined activities of several such neurons can encode simple rhythmic patterns, and I provide a model illustrating how this could be achieved.	Ohio Univ, Dept Biol Sci, Neurobiol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University	Hooper, SL (corresponding author), Ohio Univ, Dept Biol Sci, Neurobiol Program, Athens, OH 45701 USA.	Hooper@ohiou.edu						Abbott LF, 1991, NEURAL COMPUT, V3, P487, DOI 10.1162/neco.1991.3.4.487; BELTZ B, 1984, J EXP BIOL, V109, P35; BIDAUT M, 1980, J NEUROPHYSIOL, V44, P1089, DOI 10.1152/jn.1980.44.6.1089; BLITZ DM, 1995, J COMP NEUROL, V354, P282, DOI 10.1002/cne.903540209; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; EISEN JS, 1982, J NEUROPHYSIOL, V48, P1392, DOI 10.1152/jn.1982.48.6.1392; EISEN JS, 1984, J NEUROPHYSIOL, V51, P1375, DOI 10.1152/jn.1984.51.6.1375; FLAMM RE, 1986, J NEUROPHYSIOL, V55, P847, DOI 10.1152/jn.1986.55.5.847; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; HARRISWARRICK RM, 1986, TRENDS NEUROSCI, V9, P432, DOI 10.1016/0166-2236(86)90139-6; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARTLINE DK, 1979, BIOL CYBERN, V33, P223, DOI 10.1007/BF00337411; Hartline DK, 1987, CRUSTACEAN STOMATOGA, P75; HOOPER SL, 1987, J NEUROSCI, V7, P2097; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P191, DOI 10.1023/A:1008822218061; HOOPER SL, 1984, BRAIN RES, V305, P186, DOI 10.1016/0006-8993(84)91138-7; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P207, DOI 10.1023/A:1008867702131; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; KATZ PS, 1990, TRENDS NEUROSCI, V13, P367, DOI 10.1016/0166-2236(90)90021-2; Konishi M., 1988, AUDITORY FUNCTION NE, P721; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MAYNARD DM, 1974, PHILOS T ROY SOC B, V268, P161, DOI 10.1098/rstb.1974.0024; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; MILLER JP, 1979, SCIENCE, V206, P702, DOI 10.1126/science.386514; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1378, DOI 10.1152/jn.1982.48.6.1378; NAGY F, 1983, J EXP BIOL, V105, P33; Norris BJ, 1996, J NEUROPHYSIOL, V75, P97, DOI 10.1152/jn.1996.75.1.97; NUSBAUM MP, 1988, J EXP BIOL, V135, P165; NUSBAUM MP, 1989, J NEUROSCI, V9, P1600; REZER E, 1983, J COMP PHYSIOL, V153, P17, DOI 10.1007/BF00610338; RUSSELL DF, 1978, SCIENCE, V200, P453, DOI 10.1126/science.644309; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; SIGVARDT KA, 1982, J EXP BIOL, V97, P153; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TREISMAN M, 1992, Q J EXP PSYCHOL-A, V45, P235, DOI 10.1080/14640749208401326; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; TURRIGIANO GG, 1989, J NEUROSCI, V9, P2486; TURRIGIANO GG, 1990, NATURE, V344, P866, DOI 10.1038/344866a0; WANG DL, 1995, HDB BRAIN THEORY NEU, P967	46	47	48	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					720	726		10.1038/3721	http://dx.doi.org/10.1038/3721			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196589				2022-12-24	WOS:000077323400017
J	Tate, S; Benn, S; Hick, C; Trezise, D; John, V; Mannion, RJ; Costigan, M; Plumpton, C; Grose, D; Gladwell, Z; Kendall, G; Dale, K; Bountra, C; Woolf, CJ				Tate, S; Benn, S; Hick, C; Trezise, D; John, V; Mannion, RJ; Costigan, M; Plumpton, C; Grose, D; Gladwell, Z; Kendall, G; Dale, K; Bountra, C; Woolf, CJ			Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS		Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Gene Funct Unit, Stevenage SG1 2NY, Herts, England; Glaxo Wellcome Res & Dev Ltd, Neurosci Unit, Stevenage SG1 2NY, Herts, England; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Univ London Univ Coll, Dept Anat & Dev Biol, London WC1E 6BT, England	GlaxoSmithKline; GlaxoSmithKline; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of London; University College London	Tate, S (corresponding author), Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Gene Funct Unit, Stevenage SG1 2NY, Herts, England.		Woolf, Clifford/A-9784-2010		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; CAFFREY JM, 1992, BRAIN RES, V592, P283, DOI 10.1016/0006-8993(92)91687-A; CATTERALL WA, 1992, PHYSIOL REV, V72, P15; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; Novakovic SD, 1998, J NEUROSCI, V18, P2174; RIZZO MA, 1994, J NEUROPHYSIOL, V72, P2796, DOI 10.1152/jn.1994.72.6.2796; ROY ML, 1992, J NEUROSCI, V12, P2104; Rush AM, 1997, NEUROSCI LETT, V226, P95, DOI 10.1016/S0304-3940(97)00258-9; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Scholz A, 1998, EUR J NEUROSCI, V10, P2547, DOI 10.1046/j.1460-9568.1998.t01-1-00268.x; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1	13	250	258	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					653	655		10.1038/3652	http://dx.doi.org/10.1038/3652			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196578				2022-12-24	WOS:000077323400006
J	Zylka, MJ; Shearman, LP; Levine, JD; Jin, XW; Weaver, DR; Reppert, SM				Zylka, MJ; Shearman, LP; Levine, JD; Jin, XW; Weaver, DR; Reppert, SM			Molecular analysis of mammalian timeless	NEURON			English	Article							DROSOPHILA CIRCADIAN CLOCK; POSITIONAL CLONING; PERIOD GENE; PROTEIN; LIGHT; TRANSLATION; ENTRAINMENT; EXPRESSION; MECHANISM; RHYTHMS	We cloned the mouse cDNA of a mammalian homolog of the Drosophila timeless (tim) gene and designated it mTim. The mTim protein shows five homologous regions with Drosophila TIM. mTim is weakly expressed in the suprachiasmatic nuclei (SCN) but exhibits robust expression in the hypophyseal pars tuberalis (PT). mTim RNA levels do not oscillate in the SCN nor are they acutely altered by light exposure during subjective night, mTim RNA is expressed at low levels in several peripheral tissues, including eyes, and is heavily expressed in spleen and testis. Yeast two-hybrid assays revealed an array of interactions between the various mPER proteins but no mPER-mTIM interactions. The data suggest that PER-PER interactions have replaced the function of PER-TIM dimers in the molecular workings of the mammalian circadian clock.	Massachusetts Gen Hosp, Serv Pediat, Lab Dev Chronobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Serv Pediat, Lab Dev Chronobiol, Boston, MA 02114 USA.			Weaver, David/0000-0001-7941-6719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011547, F32MH012067] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD14427] Funding Source: Medline; NIMH NIH HHS [MH12067, MH11547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1998, CURR OPIN GENET DEV, V8, P400, DOI 10.1016/S0959-437X(98)80109-3; FINLEY RL, 1995, DNA CLONING EXPRESSI, P169; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; LINCOLN GA, 1994, J NEUROENDOCRINOL, V6, P251, DOI 10.1111/j.1365-2826.1994.tb00580.x; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reppert SM, 1995, CELL, V83, P1059, DOI 10.1016/0092-8674(95)90131-0; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Sharman AC, 1996, NETH J ZOOL, V46, P47, DOI 10.1163/156854295X00050; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahata S, 1998, BIOCHEM BIOPH RES CO, V248, P789, DOI 10.1006/bbrc.1998.9012; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; WEAVER DR, 1993, MOL BRAIN RES, V20, P313, DOI 10.1016/0169-328X(93)90058-W; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	43	145	148	1	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1115	1122		10.1016/S0896-6273(00)80628-5	http://dx.doi.org/10.1016/S0896-6273(00)80628-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856466	Bronze			2022-12-24	WOS:000077386100021
J	Baranes, D; Lederfein, D; Huang, YY; Chen, M; Bailey, CH; Kandel, ER				Baranes, D; Lederfein, D; Huang, YY; Chen, M; Bailey, CH; Kandel, ER			Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway	NEURON			English	Article							LONG-TERM POTENTIATION; CAMP-RESPONSIVE ELEMENT; FACTOR SCATTER FACTOR; DEPENDENT LATE-PHASE; STRUCTURAL-CHANGES; NEURITE OUTGROWTH; CYCLIC-AMP; C-MET; NEURONAL DEGENERATION; AXOSPINOUS SYNAPSES	The expression of tissue plasminogen activator (tPA) is increased during activity-dependent forms of synaptic plasticity. We have found that inhibitors of tPA inhibit the late phase of long-term potentiation (L-LTP) induced by either forskolin or tetanic stimulation in the hippocampal mossy fiber and Schaffer collateral pathways. Moreover, application of tPA enhances L-LTP induced by a single tetanus. Exposure of granule cells in culture to forskolin results in secretion of tPA, elongation of mossy fiber axons, and formation of new, active presynaptic varicosities contiguous to dendritic clusters of the glutamate receptor R1. These structural changes are blocked by tPA inhibitors and induced by application of tPA. Thus, tPA may be critically involved in the production of L-LTP and specifically in synaptic growth.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.	erk5@columbia.edu			NIGMS NIH HHS [GM32099] Funding Source: Medline; NIMH NIH HHS [MH37134] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH037134] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P2373, DOI 10.1073/pnas.85.7.2373; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Baranes D, 1996, P NATL ACAD SCI USA, V93, P4706, DOI 10.1073/pnas.93.10.4706; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BREWER GJ, 1995, BRAIN RES, V683, P258, DOI 10.1016/0006-8993(95)00332-K; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Frey U, 1996, J NEUROSCI, V16, P2057; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; Gualandris A, 1996, J NEUROSCI, V16, P2220; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; LEE K, 1980, J NEUROPHYSIOL, V4, P247; LEPRINCE P, 1991, J NEUROCHEM, V57, P665, DOI 10.1111/j.1471-4159.1991.tb03798.x; LopezGarcia JC, 1996, P NATL ACAD SCI USA, V93, P4712, DOI 10.1073/pnas.93.10.4712; MAYER M, 1990, CLIN BIOCHEM, V23, P197, DOI 10.1016/0009-9120(90)90601-P; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; OHLSSON M, 1993, MOL CELL BIOL, V13, P266, DOI 10.1128/MCB.13.1.266; OKAZAKI MM, 1988, NEUROSCIENCE, V26, P763, DOI 10.1016/0306-4522(88)90097-8; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RAYPORT S, 1992, J NEUROSCI, V12, P4264; RICKLES RJ, 1988, J BIOL CHEM, V263, P1563; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; SEEDS NW, 1990, NATO ADV SCI I A-LIF, V191, P173; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Sorra KE, 1998, J NEUROSCI, V18, P658; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; SUMI Y, 1992, DEVELOPMENT, V116, P625; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Thewke DP, 1996, J NEUROSCI, V16, P6933; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Tsirka SE, 1997, J NEUROSCI, V17, P543; VERRALL S, 1989, J CELL BIOL, V109, P265, DOI 10.1083/jcb.109.1.265; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y	55	335	343	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					813	825		10.1016/S0896-6273(00)80597-8	http://dx.doi.org/10.1016/S0896-6273(00)80597-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808467	hybrid			2022-12-24	WOS:000076697300024
J	Carroll, P; Lewin, GR; Koltzenburg, M; Toyka, KV; Thoenen, H				Carroll, P; Lewin, GR; Koltzenburg, M; Toyka, KV; Thoenen, H			A role for BDNF in mechanosensation	NATURE NEUROSCIENCE			English	Article							SENSORY NEURONS; NERVOUS-SYSTEM; CUTANEOUS MECHANORECEPTORS; NEUROTROPHIC FACTOR; MESSENGER-RNA; TRK RECEPTORS; TOUCH DOMES; EXPRESSION; RAT; HIPPOCAMPAL	Brain-derived neurotrophic factor (BDNF) is a survival factor for certain sensory neurons during development. Using electrophysiology in BDNF-deficient mice, we show here that slowly adapting mechanoreceptors (SAM), but not other types of cutaneous afferents, require BDNF in postnatal life for normal mechanotransduction. Neurons lacking BDNF did not die, but instead showed a profound and specific reduction in their mechanical sensitivity, which was quantitatively the same in BDNF -/- and BDNF +/- animals. Postnatal treatment of BDNF +/- mice with recombinant BDNF completely rescued the mechanosensitivity deficit. Therefore BDNF is important for regulating SAM mechanosensitivity, independent of any survival-promoting function.	Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Planegg Martinsried, Germany; Max Delbruck Ctr Mol Med, Growth Factor & Regenerat Grp, D-13122 Berlin, Germany	University of Wurzburg; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Koltzenburg, M (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.		Carroll, Patrick/AAL-7773-2021; Lewin, Gary R/B-8028-2011; Koltzenburg, Martin/C-1349-2008	Koltzenburg, Martin/0000-0001-9181-5966; Lewin, Gary/0000-0002-2890-6352				Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Apfel SC, 1996, MOL CELL NEUROSCI, V7, P134, DOI 10.1006/mcne.1996.0010; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; EMFORS P, 1994, CELL, V77, P503; EMFORS P, 1994, NATURE, V368, P147; Fundin BT, 1997, DEV BIOL, V190, P94, DOI 10.1006/dbio.1997.8658; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; MICHAEL GJ, 1997, J NEUROSCI, V17, P8479; MILLS LR, 1989, DEV BIOL, V136, P61, DOI 10.1016/0012-1606(89)90130-9; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; NURSE CA, 1984, NEUROSCIENCE, V11, P521, DOI 10.1016/0306-4522(84)90042-3; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Stucky CL, 1997, J NEUROSCI, V17, P4398; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302	27	145	150	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					42	46		10.1038/242	http://dx.doi.org/10.1038/242			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195107				2022-12-24	WOS:000076361000016
J	Hodgson, JG; Agopyan, N; Gutekunst, CA; Leavitt, BR; LePiane, F; Singaraja, R; Smith, DJ; Bissada, N; McCutcheon, K; Nasir, J; Jamot, L; Li, XJ; Stevens, ME; Rosemond, E; Roder, JC; Phillips, AG; Rubin, EM; Hersch, SM; Hayden, MR				Hodgson, JG; Agopyan, N; Gutekunst, CA; Leavitt, BR; LePiane, F; Singaraja, R; Smith, DJ; Bissada, N; McCutcheon, K; Nasir, J; Jamot, L; Li, XJ; Stevens, ME; Rosemond, E; Roder, JC; Phillips, AG; Rubin, EM; Hersch, SM; Hayden, MR			A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration	NEURON			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; TRANSGENIC MICE; NUCLEAR-LOCALIZATION; POSTSYNAPTIC CALCIUM; POLYGLUTAMINE TRACT; EMBRYONIC LETHALITY; GENE HOMOLOG; PROTEIN; BRAIN; POTENTIATION	We have produced yeast artificial chromosome (YAC) transgenic mice expressing normal (YAC18) and mutant (YAC46 and YAC72) huntingtin (htt) in a developmental and tissue-specific manner identical to that observed in Huntington's disease (HD). YAC46 and YAC72 mice show early electrophysiological abnormalities, indicating cytoplasmic dysfunction prior to observed nuclear inclusions or neurodegeneration. By 12 months of age, YAC72 mice have a selective degeneration of medium spiny neurons in the lateral striatum associated with the translocation of N-terminal htt fragments to the nucleus. Neurodegeneration can be present in the absence of macro- or microaggregates, clearly showing that aggregates are not essential to initiation of neuronal death. These mice demonstrate that initial neuronal cytoplasmic toxicity is followed by cleavage of htt, nuclear translocation of htt N-terminal fragments, and selective neurodegeneration.	Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; Univ Toronto, Fac Pharm, Toronto, ON L4V 1V7, Canada; Univ Toronto, Dept Mol Immunol & Neurobiol, Toronto, ON M5G 1X5, Canada; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Human Genome, Berkeley, CA 94720 USA	University of British Columbia; University of British Columbia; University of Toronto; University of Toronto; Emory University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubo.ca	Roder, John/G-6468-2013; Leavitt, Blair R/G-1934-2012; Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Nasir, Jamal/0000-0001-6378-5616; Rosemond, Erica/0000-0002-9188-7713; Singaraja, Roshni/0000-0002-3418-3867; leavitt, Blair/0000-0002-4532-766X	NINDS NIH HHS [NS35255, NS36232] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036232, R01NS035255] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; BEAL MF, 1989, SYNAPSE, V3, P38, DOI 10.1002/syn.890030106; Becher MW, 1997, MOVEMENT DISORD, V12, P519, DOI 10.1002/mds.870120408; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Chen NS, 1999, J NEUROCHEM, V72, P1890, DOI 10.1046/j.1471-4159.1999.0721890.x; COHEN J, 1995, NEURAL CELL CULTURE; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; COYLE JT, 1993, ANN NEUROL, V38, P357; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dingledine R., 1984, BRAIN SLICES; DUFF K, 1994, GENE THER, V1, P70; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Hackam AS, 1999, HUM MOL GENET, V8, P25, DOI 10.1093/hmg/8.1.25; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Harper PS, 1991, HUNTINGTONS DIS; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; KAICHMAN MA, 1997, NAT GENET, V16, P44; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SPARGO E, 1993, J NEUROL NEUROSUR PS, V56, P487, DOI 10.1136/jnnp.56.5.487; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	46	666	694	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1999	23	1					181	192		10.1016/S0896-6273(00)80764-3	http://dx.doi.org/10.1016/S0896-6273(00)80764-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402204	Bronze			2022-12-24	WOS:000080681200021
J	Davenne, M; Maconochie, MK; Neun, R; Pattyn, A; Chambon, P; Krumlauf, R; Rijli, FM				Davenne, M; Maconochie, MK; Neun, R; Pattyn, A; Chambon, P; Krumlauf, R; Rijli, FM			Hoxa2 and Hoxb2 control dorsoventral patterns of neuronal development in the rostral hindbrain	NEURON			English	Article							CHICK-EMBRYO HINDBRAIN; DEVELOPING SPINAL-CORD; RHOMBOMERE-SPECIFIC ORIGIN; NERVOUS-SYSTEM; SEGMENTAL EXPRESSION; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; PARAXIAL MESODERM; BRANCHIAL REGION; DEVELOPING CNS	Little is known about how the generation of specific neuronal types at stereotypic positions within the hindbrain is linked to Hox gene-mediated patterning. Here, we show that during neurogenesis, Hox paralog group 2 genes control both anteroposterior (A-P) and dorsoventral (D-V) patterning. Hoxa2 and Hoxb2 differentially regulate, in a rhombomere-specific manner, the expression of several genes in broad D-V-restricted domains or narrower longitudinal columns of neuronal progenitors, immature neurons, and differentiating neuronal subtypes. Moreover, Hoxa2 and Hoxb2 can functionally synergize in controlling the development of ventral neuronal subtypes in rhombomere 3 (r3). Thus, in addition to their roles in A-P patterning, Hoxa2 and Hoxb2 have distinct and restricted functions along the D-V axis during neurogenesis, providing insights into how neuronal fates are assigned at stereotypic positions within the hindbrain.	Univ Louis Pasteur, Coll France, INSERM, CNRS,Inst Genet & Biol Molec & Cellullaire, F-67404 Strasbourg, France; Natl Inst Med Res, MRC, Lab Dev Neurobiol, London NW7 1AA, England; Univ Mediterranee, INSERM, CNRS, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Rijli, FM (corresponding author), Univ Louis Pasteur, Coll France, INSERM, CNRS,Inst Genet & Biol Molec & Cellullaire, BP 163, F-67404 Strasbourg, France.	rijli@igbmc.u-strasbg.fr	Alexandre, Pattyn/ABF-1346-2020; RIJLI, Filippo/AAP-2516-2020; Krumlauf, Robb/AAH-5012-2019	RIJLI, Filippo/0000-0003-0515-0182; Krumlauf, Robb/0000-0001-9102-7927; Pattyn, Alexandre/0000-0003-1215-1482	NICHD NIH HHS [N01-HD-7-3263] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Auclair F, 1996, J COMP NEUROL, V369, P451; Barrow JR, 1996, DEVELOPMENT, V122, P3817; Burrill JD, 1997, DEVELOPMENT, V124, P4493; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; CLARKE JDW, 1993, DEVELOPMENT, V118, P151; Clarke JDW, 1998, DEV DYNAM, V212, P14, DOI 10.1002/(SICI)1097-0177(199805)212:1<14::AID-AJA2>3.0.CO;2-5; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goddard JM, 1996, DEVELOPMENT, V122, P3217; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GRAHAM A, 1991, DEVELOPMENT, V112, P255; GrapinBotton A, 1997, DEVELOPMENT, V124, P849; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; Hirsch MR, 1998, DEVELOPMENT, V125, P599; Irving C, 1996, DEV BIOL, V173, P26, DOI 10.1006/dbio.1996.0004; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1994, DEVELOPMENT, V120, P1581; Ma QF, 1997, J NEUROSCI, V17, P3644; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; MARK M, 1993, DEVELOPMENT, V119, P319; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; McKay IJ, 1997, EUR J NEUROSCI, V9, P1499, DOI 10.1111/j.1460-9568.1997.tb01504.x; Nonchev S, 1996, DEVELOPMENT, V122, P543; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Rijli FM, 1998, INT J DEV BIOL, V42, P393; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SchneiderMaunoury S, 1997, DEVELOPMENT, V124, P1215; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SIMON H, 1995, CURR BIOL, V5, P205, DOI 10.1016/S0960-9822(95)00041-8; SIMON H, 1993, NEURON, V11, P209, DOI 10.1016/0896-6273(93)90179-U; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Stoykova A, 1997, DEVELOPMENT, V124, P3765; STUART ET, 1994, ANNU REV GENET, V28, P219, DOI 10.1146/annurev.ge.28.120194.001251; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Studer M, 1998, DEVELOPMENT, V125, P1025; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Theil T, 1998, DEVELOPMENT, V125, P443; Tiret L, 1998, DEVELOPMENT, V125, P279; Wizenmann A, 1997, MOL CELL NEUROSCI, V9, P448, DOI 10.1006/mcne.1997.0642; XU Q, 1995, LDEVELOPMENT, V121, P4005; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; ZHANG MB, 1994, DEVELOPMENT, V120, P2431	59	149	149	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					677	691		10.1016/S0896-6273(00)80728-X	http://dx.doi.org/10.1016/S0896-6273(00)80728-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230789	Bronze			2022-12-24	WOS:000079976200012
J	Lo, LC; Morin, X; Brunet, JF; Anderson, DJ				Lo, LC; Morin, X; Brunet, JF; Anderson, DJ			Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells	NEURON			English	Article							TYROSINE-HYDROXYLASE GENE; DEVELOPING SYMPATHETIC NEURONS; NEGATIVE REGULATORY ELEMENT; RESTRICTIVE SILENCER FACTOR; PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE HOMOLOG-1; CAMP-RESPONSE ELEMENT; HOMEODOMAIN PROTEIN; TRANSGENIC MICE; CYCLIC-AMP	We have investigated the specification of noradrenergic neurotransmitter identity in neural crest stem cells (NCSCs). Retroviral expression of both wild-type and dominant-negative forms of the paired homeodomain transcription factor Phox2a indicates a crucial and direct role for this protein (and/or the closely related Phox2b) in the regulation of endogenous tyrosine hydroxylase (TH) and dopamine-beta hydroxylase (DBH) gene expression in these cells. In collaboration with cAMP, Phox2a can induce expression of TH but not of DBH or of panneuronal genes. Phox2 proteins are, moreover, necessary for the induction of both TH and DBH by bone morphogenetic protein 2 (BMP2) (which induces Phox2a/b) and forskolin. They are also necessary for neuronal differentiation. These data suggest that Phox2a/b coordinates the specification of neurotransmitter identity and neuronal fate by cooperating environmental signals in sympathetic neuroblasts.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Mediterranee, INSERM, CNRS, Inst Biol Dev Marseille,Lab Genet & Physiol Dev, Marseille, France	California Institute of Technology; Howard Hughes Medical Institute; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.		morin, xavier/AAI-3306-2020	Brunet, Jean-Francois/0000-0002-1985-6103; Morin, Xavier/0000-0001-9999-0355				Afar R, 1996, MOL BRAIN RES, V36, P79, DOI 10.1016/0169-328X(95)00247-P; Anderson D, 1997, MOL CELLULAR APPROAC, P26; BADIANI P, 1994, GENE DEV, V8, P770, DOI 10.1101/gad.8.7.770; BANERJEE SA, 1992, J NEUROSCI, V12, P4460; BANERJEE SA, 1994, MOL BRAIN RES, V24, P89, DOI 10.1016/0169-328X(94)90121-X; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; CHEN ZF, 1998, IN PRESS NAT GENET, V20; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FUNG BP, 1992, J NEUROCHEM, V58, P2044, DOI 10.1111/j.1471-4159.1992.tb10945.x; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; GANDELMAN KY, 1990, J NEUROCHEM, V55, P2149, DOI 10.1111/j.1471-4159.1990.tb05811.x; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; GROVES AK, 1995, DEVELOPMENT, V121, P887; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hirsch MR, 1998, DEVELOPMENT, V125, P599; ISHIGURO H, 1993, J BIOL CHEM, V268, P17987; Ishiguro H, 1995, MOL BRAIN RES, V34, P251, DOI 10.1016/0169-328X(95)00170-W; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Kim HS, 1998, J NEUROSCI, V18, P8247; KIM KS, 1993, J BIOL CHEM, V268, P15689; LAZAROFF M, 1995, J BIOL CHEM, V270, P21579, DOI 10.1074/jbc.270.37.21579; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Lindsay RM, 1996, NEURON, V17, P571, DOI 10.1016/S0896-6273(00)80189-0; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; LO LC, 1990, DEV BIOL, V145, P139; MANDEL G, 1993, ANNU REV NEUROSCI, V16, P323, DOI 10.1146/annurev.ne.16.030193.001543; Maxwell GD, 1996, P NATL ACAD SCI USA, V93, P13274, DOI 10.1073/pnas.93.23.13274; MIN N, 1994, MOL BRAIN RES, V27, P281, DOI 10.1016/0169-328X(94)90011-6; MITANI S, 1993, DEVELOPMENT, V119, P773; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Osaka H, 1997, MOL BRAIN RES, V49, P222, DOI 10.1016/S0169-328X(97)00148-4; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Quinn JP, 1996, PROG NEUROBIOL, V50, P363, DOI 10.1016/S0301-0082(96)00041-X; Reissmann E, 1996, DEVELOPMENT, V122, P2079; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SHASKUS J, 1995, J NEUROCHEM, V64, P52; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SMITH J, 1984, J NEUROSCI, V4, P2160; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STERN CD, 1991, DEVELOPMENT, V113, P207; STRUDEL G, 1977, CR ACAD SCI D NAT, V284, P967; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; VALARCHE I, 1993, DEVELOPMENT, V119, P881; VARLEY JE, 1995, DEV DYNAM, V203, P434, DOI 10.1002/aja.1002030406; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; WONG SC, 1995, J NEUROCHEM, V65, P23; Yang CY, 1998, J NEUROCHEM, V71, P1813; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; YOON SO, 1992, NEURON, V9, P55, DOI 10.1016/0896-6273(92)90220-8; Zellmer E, 1995, J NEUROSCI, V15, P8109; ZHANG JM, 1992, BRAIN RES, V570, P251, DOI 10.1016/0006-8993(92)90588-Z; Zhang JM, 1997, J NEUROBIOL, V32, P262, DOI 10.1002/(SICI)1097-4695(199703)32:3<262::AID-NEU2>3.0.CO;2-5	67	144	155	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					693	705		10.1016/S0896-6273(00)80729-1	http://dx.doi.org/10.1016/S0896-6273(00)80729-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230790	Bronze			2022-12-24	WOS:000079976200013
J	Chapman, PF; White, GL; Jones, MW; Cooper-Blacketer, D; Marshall, VJ; Irizarry, M; Younkin, L; Good, MA; Bliss, TVP; Hyman, BT; Younkin, SG; Hsiao, KK				Chapman, PF; White, GL; Jones, MW; Cooper-Blacketer, D; Marshall, VJ; Irizarry, M; Younkin, L; Good, MA; Bliss, TVP; Hyman, BT; Younkin, SG; Hsiao, KK			Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; FAMILIAL ALZHEIMERS-DISEASE; PATHOGENIC MUTATION; BETA-PROTEIN; APP GENE; MEMORY; PRESENILIN-1; HIPPOCAMPUS; INCREASES; PLAQUES	We investigated synaptic communication and plasticity in hippocampal slices from mice overexpressing mutated 695-amino-acid human amyloid precursor protein (APP(695)SWE), which show behavioral and histopathological abnormalities simulating Alzheimer's disease. Although aged APP transgenic mice exhibit normal fast synaptic transmission and short term plasticity, they are severely impaired in in-vitro and in-vivo long-term potentiation (LTP) in both the CA1 and dentate gyrus regions of the hippocampus. The LTP deficit was correlated with impaired performance in a spatial working memory task in aged transgenics. These deficits are accompanied by minimal or no loss of presynaptic or postsynaptic elementary structural elements in the hippocampus, suggesting that impairments in functional synaptic plasticity may underlie some of the cognitive deficits in these mice and, possibly, in Alzheimer's patients.	Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Cardiff Univ, Cardiff Business Sch, Cardiff CF1 3US, S Glam, Wales; Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Cardiff Univ, Sch Psychol, Cardiff CF1 3US, S Glam, Wales	University of Minnesota System; University of Minnesota Twin Cities; Cardiff University; MRC National Institute for Medical Research; Harvard University; Massachusetts General Hospital; Mayo Clinic; Cardiff University	Hsiao, KK (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA.	hsiao005@maroon.tc.umn.edu	Sancheti, Harsh/H-3538-2012	Jones, Matthew/0000-0001-5396-3108	NIA NIH HHS [AG08487, K08-AG00793] Funding Source: Medline; NINDS NIH HHS [NS33249] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, R29AG008487, K08AG000793] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Errington ML, 1997, NATURE, V387, P666, DOI 10.1038/42625; FINCH CE, 1993, TRENDS NEUROSCI, V16, P104, DOI 10.1016/0166-2236(93)90134-8; Frautschy SA, 1998, AM J PATHOL, V152, P307; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Ikezu T, 1996, EMBO J, V15, P2468, DOI 10.1002/j.1460-2075.1996.tb00604.x; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KLANN E, 1991, J BIOL CHEM, V266, P24253; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	32	771	812	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					271	276		10.1038/6374	http://dx.doi.org/10.1038/6374			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195221				2022-12-24	WOS:000081684500016
J	Williamson, TL; Cleveland, DW				Williamson, TL; Cleveland, DW			Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN SUPEROXIDE-DISMUTASE; NEUROFILAMENT TRANSPORT; TRANSGENIC MICE; RADIAL GROWTH; BETA-TUBULIN; MOUSE MODEL; DISEASE; MUTATION; DAMAGE	Mutations in copper/zinc superoxide dismutase 1 (SOD1), primary causes of human amyotrophic lateral sclerosis (ALS), provoke motor neuron death through an unidentified toxic property. The known neurofilament-dependent slowing of axonal transport, combined with the prominent misaccumulation of neurofilaments in ALS, suggests that an important aspect of toxicity may arise from damage to transport. Here we verify this hypothesis for two SOD1 mutations linked to familial ALS. Reduced transport of selective cargoes of slow transport, especially tubulin, arises months before neurodegeneration. For one mutant, this represents the earliest detectable abnormality. Th:us, damage to the cargoes or machinery of slow transport is an early feature of toxicity mediated by mutant SOD1.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	NINDS NIH HHS [NS 27036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; BANKER BQ, 1986, MYOLOGY 2, P2031; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CLEVELAND DW, 1995, NATURE, V378, P342, DOI 10.1038/378342a0; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Hirokawa N, 1997, CURR OPIN NEUROBIOL, V7, P605, DOI 10.1016/S0959-4388(97)80079-7; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; HOFFMAN PN, 1983, J NEUROSCI, V3, P1694; HOFFMAN PN, 1985, J NEUROSCI, V5, P2920; HOFFMAN PN, 1985, J CELL BIOL, V101, P1332, DOI 10.1083/jcb.101.4.1332; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; LEE MK, 1990, P NATL ACAD SCI USA, V87, P7195, DOI 10.1073/pnas.87.18.7195; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; MITSUMOTO H, 1993, MUSCLE NERVE, V16, P542, DOI 10.1002/mus.880160517; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; WILLARD M, 1983, CELL, V35, P551, DOI 10.1016/0092-8674(83)90189-7; WILLIAMS DB, 1993, PERIPHERAL NEUROPATH, P1028; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1996, COLD SPRING HARB SYM, V61, P709; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	43	484	493	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					50	56		10.1038/4553	http://dx.doi.org/10.1038/4553			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195180				2022-12-24	WOS:000078409300013
J	Blair, HT; Cho, JW; Sharp, PE				Blair, HT; Cho, JW; Sharp, PE			Role of the lateral mammillary nucleus in the rat head direction circuit: A combined single unit recording and lesion study	NEURON			English	Article							FREELY MOVING RATS; ANTERIOR THALAMUS; PATH INTEGRATION; FIRING PATTERNS; MAMILLARY BODY; CELLS; PROJECTIONS; NEURONS; COMPLEX; CORTEX	We recorded head direction (HD) cells from the lateral mammillary nucleus (LMN) and anterior thalamus (ATN) of freely behaving rats and also made bilateral lesions of LMN while recording HD cells from ATN. We discovered that the tuning functions of LMN HD cells become narrower during contraversive head turns, but not ipsiversive head turns, compared to when the head is not turning. This narrowing effect does not occur for ATN HD cells. We also found that the HD signal in LMN leads that in ATN by about 15-20 ms. When LMN was lesioned bilaterally, HD cells in ATN immediately lost their directional firing properties and never recovered them. Based on these findings, we argue that LMN may be an essential component of an attractor-integrator network that participates in generating the HD signal.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Blair, HT (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	tad@cns.nyu.edu		Blair, Hugh/0000-0001-8256-5109	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035191] Funding Source: NIH RePORTER; NIMH NIH HHS [1F31 MH11102-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS35191-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLEN GV, 1989, J COMP NEUROL, V286, P311, DOI 10.1002/cne.902860303; ALLEN GV, 1990, J COMP NEUROL, V301, P214, DOI 10.1002/cne.903010206; Blair HT, 1997, J NEUROPHYSIOL, V78, P145, DOI 10.1152/jn.1997.78.1.145; BLAIR HT, 1995, J NEUROSCI, V15, P6260; Blair HT, 1996, BEHAV NEUROSCI, V110, P643, DOI 10.1037/0735-7044.110.4.643; Blair HT, 1996, ADV NEUR IN, V8, P152; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; GONZALORUIZ A, 1992, J COMP NEUROL, V321, P277, DOI 10.1002/cne.903210208; Goodridge JP, 1997, J NEUROSCI, V17, P9315; HAYAKAWA T, 1992, ANAT EMBRYOL, V185, P547; KIRK IJ, 1991, NEUROREPORT, V2, P723, DOI 10.1097/00001756-199111000-00023; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; KOCSIS B, 1994, J NEUROSCI, V14, P7040; LANNOU J, 1984, BRAIN RES, V301, P39, DOI 10.1016/0006-8993(84)90400-1; LIU R, 1984, BRAIN RES, V310, P123, DOI 10.1016/0006-8993(84)90015-5; MCNAUGHTON BL, 1991, J COGNITIVE NEUROSCI, V3, P192, DOI 10.1162/jocn.1991.3.2.190; MIZUMORI SJY, 1993, J NEUROSCI, V13, P4015; MULLER RU, 1987, J NEUROSCI, V7, P1935; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SHARP PE, 1994, J NEUROSCI, V14, P2339; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Stackman RW, 1997, J NEUROSCI, V17, P4349; Stackman RW, 1998, J NEUROSCI, V18, P9020; Taube JS, 1998, HIPPOCAMPUS, V8, P87, DOI 10.1002/(SICI)1098-1063(1998)8:2<87::AID-HIPO1>3.0.CO;2-4; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; VANGROEN T, 1990, BRAIN RES, V529, P165, DOI 10.1016/0006-8993(90)90824-U; WIENER SI, 1993, J NEUROSCI, V13, P3802; Zhang K, 1996, J NEUROSCI, V16, P2112	32	150	150	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1387	1397		10.1016/S0896-6273(00)80657-1	http://dx.doi.org/10.1016/S0896-6273(00)80657-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883731	hybrid			2022-12-24	WOS:000077910600020
J	Cook, PB; McReynolds, JS				Cook, PB; McReynolds, JS			Lateral inhibition in the inner retina is important for spatial tuning of ganglion cells	NATURE NEUROSCIENCE			English	Article							TIGER SALAMANDER RETINA; MUDPUPPY RETINA; HORIZONTAL CELLS; PLEXIFORM LAYER; AMACRINE CELLS; SYNAPTIC INPUTS; RECEPTIVE-FIELD; RABBIT RETINA; GABA RECEPTOR; BIPOLAR CELL	The center-surround receptive-field organization in retinal ganglion cells is widely believed to result mainly from lateral inhibition at the first synaptic lever (in the outer retina). Inhibition at the second synaptic level (in the inner retina) is thought to mediate more complex response properties. Here we show that much of the sustained surround antagonism in certain on-center ganglion cells results from lateral inhibition in the inner retina, via GABAergic amacrine cells, and that the lateral conduction of this signal requires voltage-gated sodium currents. Blocking lateral inhibition in the inner retina eliminates the preference of small-center ganglion cells for small stimuli but has little effect on ganglion cells with large receptive-field centers. These results illustrate how lateral inhibition at successive synaptic stages can selectively control the size of neural receptive-field centers.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cook, PB (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.	pcook@umich.edu			NEI NIH HHS [EY07003, EY01653] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001653] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARKIN MS, 1988, J NEUROPHYSIOL, V60, P1122, DOI 10.1152/jn.1988.60.3.1122; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BELGUM JH, 1983, J PHYSIOL-LONDON, V340, P599, DOI 10.1113/jphysiol.1983.sp014782; BELGUM JH, 1982, J PHYSIOL-LONDON, V326, P91, DOI 10.1113/jphysiol.1982.sp014179; BELGUM JH, 1987, J PHYSIOL-LONDON, V388, P233, DOI 10.1113/jphysiol.1987.sp016612; Bloomfield SA, 1996, J NEUROPHYSIOL, V75, P1878, DOI 10.1152/jn.1996.75.5.1878; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Cook PB, 1998, J NEUROSCI, V18, P2301; Cook PB, 1998, J NEUROPHYSIOL, V79, P197, DOI 10.1152/jn.1998.79.1.197; DAW NW, 1990, TRENDS NEUROSCI, V13, P110, DOI 10.1016/0166-2236(90)90187-F; DJAMGOZ MBA, 1984, NEUROSCI LETT, V49, P233, DOI 10.1016/0304-3940(84)90295-7; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V302, P49; GILBERTSON TA, 1991, J NEUROPHYSIOL, V66, P2002, DOI 10.1152/jn.1991.66.6.2002; GOLARD A, 1992, J NEUROPHYSIOL, V68, P351, DOI 10.1152/jn.1992.68.2.351; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; Jacobs AL, 1998, J NEUROPHYSIOL, V80, P447, DOI 10.1152/jn.1998.80.1.447; KARWOSKI CJ, 1976, VISION RES, V16, P1483, DOI 10.1016/0042-6989(76)90169-3; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1213, DOI 10.1523/JNEUROSCI.14-03-01213.1994; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1202, DOI 10.1523/JNEUROSCI.14-03-01202.1994; MANGEL SC, 1991, J PHYSIOL-LONDON, V442, P211, DOI 10.1113/jphysiol.1991.sp018790; MCREYNOLDS JS, 1989, NEUROBIOLOGY INNER R, P209; MILLER RF, 1976, BRAIN RES, V104, P157, DOI 10.1016/0006-8993(76)90657-0; NAKA K, 1972, J PHYSIOL-LONDON, V223, P449, DOI 10.1113/jphysiol.1972.sp009857; SCHWARTZ EA, 1973, J PHYSIOL-LONDON, V230, P1; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P79, DOI 10.1113/jphysiol.1978.sp012294; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P101, DOI 10.1113/jphysiol.1978.sp012295; TORIS CB, 1995, J COMP NEUROL, V352, P535, DOI 10.1002/cne.903520405; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; WERBLIN F, 1988, VISUAL NEUROSCI, V1, P317, DOI 10.1017/S0952523800001978; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P88, DOI 10.1085/jgp.63.1.88; WERBLIN FS, 1974, J GEN PHYSIOL, V63, P62, DOI 10.1085/jgp.63.1.62; WERBLIN FS, 1972, SCIENCE, V175, P1008, DOI 10.1126/science.175.4025.1008; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P331; YANG CY, 1991, J COMP NEUROL, V312, P19, DOI 10.1002/cne.903120103	38	160	161	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					714	719		10.1038/3714	http://dx.doi.org/10.1038/3714			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196588				2022-12-24	WOS:000077323400016
J	Jeong, SW; Ikeda, SR				Jeong, SW; Ikeda, SR			G protein alpha subunit G alpha(z) couples neurotransmitter receptors to ion channels in sympathetic neurons	NEURON			English	Article							CATALYZED ADP-RIBOSYLATION; BINDING REGULATORY PROTEIN; GTPASE-ACTIVATING PROTEIN; BETA-GAMMA-SUBUNITS; PERTUSSIS TOXIN; CA2+ CHANNELS; RGS PROTEINS; CALCIUM CHANNELS; K+-CHANNEL; HETEROLOGOUS EXPRESSION	The functional roles subserved by G alpha(z), a G protein alpha subunit found predominantly in neuronal tissues, have remained largely undefined. Here, we report that G alpha(z) coupled neurotransmitter receptors to N-type Ca2+ channels when transiently overexpressed in rat sympathetic neurons. The G alpha(z)-mediated inhibition was voltage dependent and PTX insensitive. Recovery from G alpha(z)-mediated inhibition was extremely slow but accelerated by coexpression with RGS proteins. G alpha(z) selectively interacted with a subset of receptors that ordinarily couple to N-type Ca2+ channels via PTX-sensitive G(o/i) proteins. In addition, G alpha(z) rescued the activation of heterologously expressed GIRK channels in PTX-treated neurons. These results suggest that G alpha(z) is capable of coupling receptors to ion channels and might underlie PTX-insensitive ion channel modulation observed in neurons under physiological and pathological conditions.	Guthrie Res Inst, Lab Mol Physiol, Sayre, PA 18840 USA		Ikeda, SR (corresponding author), Guthrie Res Inst, Lab Mol Physiol, 1 Guthrie Sq, Sayre, PA 18840 USA.	sikeda@inet.guthrie.org		Ikeda, Stephen/0000-0002-4088-9508	NIGMS NIH HHS [GM 56180] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056180] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVIGAN J, 1992, BIOCHEMISTRY-US, V31, P7736, DOI 10.1021/bi00148a039; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; Bunemann M, 1998, BIOPHYS J, V74, pA198; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; CANTIELLO HF, 1989, J BIOL CHEM, V264, P20867; CARLSON KE, 1989, J BIOL CHEM, V264, P13298; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FIELDS TA, 1995, J BIOL CHEM, V270, P23119, DOI 10.1074/jbc.270.39.23119; Fields TA, 1998, CELL SIGNAL, V10, P43, DOI 10.1016/S0898-6568(97)00071-5; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Glick J, 1996, J BIOL CHEM, V271, P2949, DOI 10.1074/jbc.271.6.2949; Gold SJ, 1997, J NEUROSCI, V17, P8024; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Ikeda S R, 1997, Methods Mol Biol, V83, P191; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; IKEDA SR, 1992, J PHYSIOL-LONDON, V458, P339, DOI 10.1113/jphysiol.1992.sp019421; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; IKEDA SR, 1995, NEURON, V14, P1029, DOI 10.1016/0896-6273(95)90341-0; Iyengar R, 1997, SCIENCE, V275, P42, DOI 10.1126/science.275.5296.42; Jeong S. W., 1997, Society for Neuroscience Abstracts, V23, P1183; Jeong SW, 1997, J NEUROPHYSIOL, V78, P1476, DOI 10.1152/jn.1997.78.3.1476; JONES SB, 1991, MOL PHARMACOL, V39, P239; Kalkbrenner F, 1996, BBA-MOL CELL RES, V1314, P125, DOI 10.1016/S0167-4889(96)00072-9; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; Koelle MR, 1997, CURR OPIN CELL BIOL, V9, P143, DOI 10.1016/S0955-0674(97)80055-5; Kozasa T, 1996, J BIOL CHEM, V271, P12562, DOI 10.1074/jbc.271.21.12562; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Liao YJ, 1996, J NEUROSCI, V16, P7137; LOUNSBURY KM, 1991, J BIOL CHEM, V266, P22051; LOUNSBURY KM, 1993, J BIOL CHEM, V268, P3494; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; NAKAJIMA Y, 1988, P NATL ACAD SCI USA, V85, P3643, DOI 10.1073/pnas.85.10.3643; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; SATOSHI N, 1997, BIOCHEM BIOPH RES CO, V241, P281; Saugstad JA, 1998, J NEUROSCI, V18, P905; SCHOFIELD GG, 1991, EUR J PHARM-MOLEC PH, V207, P195, DOI 10.1016/0922-4106(91)90031-C; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Sowell MO, 1997, P NATL ACAD SCI USA, V94, P7921, DOI 10.1073/pnas.94.15.7921; STRAIN JJ, 1991, GEN HOSP PSYCHIAT, V13, P88, DOI 10.1016/0163-8343(91)90019-S; Tsu RC, 1997, MOL PHARMACOL, V52, P38, DOI 10.1124/mol.52.1.38; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Wang J, 1997, J BIOL CHEM, V272, P5732, DOI 10.1074/jbc.272.9.5732; WEST RE, 1985, J BIOL CHEM, V260, P4428; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WOLLMUTH LP, 1995, J NEUROPHYSIOL, V73, P1323, DOI 10.1152/jn.1995.73.3.1323; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; ZHU Y, 1993, J NEUROPHYSIOL, V70, P610, DOI 10.1152/jn.1993.70.2.610; ZHU Y, 1994, NEURON, V13, P657, DOI 10.1016/0896-6273(94)90033-7	70	87	87	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1201	1212		10.1016/S0896-6273(00)80636-4	http://dx.doi.org/10.1016/S0896-6273(00)80636-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856474	Bronze			2022-12-24	WOS:000077386100029
J	Yantis, S; Nakama, T				Yantis, S; Nakama, T			Visual interactions in the path of apparent motion	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL ORGANIZATION; VISIBLE PERSISTENCE; SHORT-RANGE; CORTEX; ATTENTION; ORIENTATION; INTEGRATION; SELECTIVITY; SIMULATION; RESPONSES	When two stationary visual objects appear in alternating sequence, they evoke the perception of a single object moving back and forth between them. This is known as stroboscopic or apparent motion and forms the basis of perceived continuity in, for example, motion pictures. When the spatiotemporal separation between the inducing objects is optimal, the subjective appearance of apparent motion is nearly indistinguishable from that of real motion. Here we report that the detection and identification of a simple visual form in the path of apparent motion is impaired by the illusory perception of an object moving through the empty space between the locations at which the inducing objects are presented. This observation may be a manifestation of perceptual completion of 'filling in' during apparent motion perception. We propose that feedback from higher to lower visual cortical areas activates an explicit neural representation of a moving object, which can then disrupt the representation of visual stimuli in the path of the movement.	Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA	Johns Hopkins University	Yantis, S (corresponding author), Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA.	yantis@jhu.edu	Yantis, Steven/A-7488-2009		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043924] Funding Source: NIH RePORTER; NIMH NIH HHS [R01-MH43924] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; ATTNEAVE F, 1974, PERCEPT PSYCHOPHYS, V16, P205, DOI 10.3758/BF03203929; Baloch AA, 1997, VISION RES, V37, P3037, DOI 10.1016/S0042-6989(97)00103-X; BECK J, 1977, PERCEPT PSYCHOPHYS, V21, P33, DOI 10.3758/BF03199464; BREITMEYER B, 1974, VISION RES, V14, P1451, DOI 10.1016/0042-6989(74)90020-0; BREITMEYER BG, 1984, VISUAL MASKING; BUNDESEN C, 1983, PERCEPTION, V12, P549, DOI 10.1068/p120549; BURT P, 1981, PSYCHOL REV, V88, P171, DOI 10.1037/0033-295X.88.2.171; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Crabbe, 1991, MICHOTTES EXPT PHENO, P140; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; FARRELL JE, 1981, J EXP PSYCHOL HUMAN, V7, P477, DOI 10.1037/0096-1523.7.2.477; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FINKEL LH, 1989, J NEUROSCI, V9, P3188; GROSSBERG S, 1992, PSYCHOL REV, V99, P78, DOI 10.1037/0033-295X.99.1.78; HOCK HS, 1993, J EXP PSYCHOL HUMAN, V19, P63, DOI 10.1037/0096-1523.19.1.63; HOGBEN JH, 1985, PERCEPT PSYCHOPHYS, V38, P450, DOI 10.3758/BF03207176; HOROWITZ T, 1994, SPATIAL VISION, V8, P193, DOI 10.1163/156856894X00332; Kanizsa G., 1979, ORG VISION; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; Kolers P. A., 1972, ASPECTS MOTION PERCE; KOLERS PA, 1963, VISION RES, V3, P191, DOI 10.1016/0042-6989(63)90053-1; Korte A., 1915, Z PSYCHOL, V72, P194; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; MIKAMI A, 1991, INT J NEUROSCI, V61, P101, DOI 10.3109/00207459108986278; Neuhaus W, 1930, ARCH GESAMTE PSYCHOL, V75, P315; NEWSOME WT, 1986, J NEUROPHYSIOL, V55, P1340, DOI 10.1152/jn.1986.55.6.1340; RAMACHANDRAN VS, 1983, NATURE, V304, P529, DOI 10.1038/304529a0; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; ROBINS C, 1977, PERCEPT PSYCHOPHYS, V22, P12, DOI 10.3758/BF03206075; Rock I., 1983, LOGIC PERCEPTION; SHEPARD RN, 1983, SCIENCE, V220, P632, DOI 10.1126/science.6836307; SHEPARD RN, 1976, SCIENCE, V191, P952, DOI 10.1126/science.1251207; SHIMOJO S, 1990, PERCEPTION, V19, P285, DOI 10.1068/p190285; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; TONONI G, 1992, CEREB CORTEX, V2, P310, DOI 10.1093/cercor/2.4.310; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; WATAMANIUK SNJ, 1992, PERCEPTION, V21, P791, DOI 10.1068/p210791; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0	43	77	77	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					508	512		10.1038/2226	http://dx.doi.org/10.1038/2226			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	128LE	10196549				2022-12-24	WOS:000076406900016
J	Kawagoe, R; Takikawa, Y; Hikosaka, O				Kawagoe, R; Takikawa, Y; Hikosaka, O			Expectation of reward modulates cognitive signals in the basal ganglia	NATURE NEUROSCIENCE			English	Article							SELECTIVE VISUAL-ATTENTION; LOCAL DOPAMINE DEPLETION; SACCADIC EYE-MOVEMENTS; MONKEY CAUDATE NEURONS; NIGRA PARS RETICULATA; DELAYED-RESPONSE TASK; FUNCTIONAL-PROPERTIES; OCULOMOTOR FUNCTIONS; PREFRONTAL CORTEX; STRIATUM	Action is controlled by both motivation and cognition. The basal ganglia may be the site where these kinds of information meet. Using a memory-guided saccade task with an asymmetric reward schedule, we show that visual and memory responses of caudate neurons are modulated by expectation of reward so profoundly that a neuron's preferred direction often changed with the change in the rewarded direction. The subsequent saccade to the target was earlier and faster for the rewarded direction. Our results indicate that the caudate contributes to the determination of oculomotor outputs by connecting motivational values (for example, expectation of reward) to visual information.	Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1138421, Japan	Juntendo University	Hikosaka, O (corresponding author), Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hikosaka@med.juntendo.ac.jp						ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AOSAKI T, 1994, J NEUROSCI, V14, P3969; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Calabresi P, 1997, NEUROSCIENCE, V78, P39; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; CRAWFORD TJ, 1989, BRAIN, V112, P1573, DOI 10.1093/brain/112.6.1573; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; GROVES PM, 1994, NEUROSCIENCE, V58, P593, DOI 10.1016/0306-4522(94)90084-1; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1992, VESTIBULAR BRAIN STE, P405; HIKOSAKA O, 1994, BASAL GANGLIA, V4, P589; HIKOSAKA O, 1989, NEUROBIOLOGY SACCADI, P257; HILLYARD SA, 1985, TRENDS NEUROSCI, V8, P400, DOI 10.1016/0166-2236(85)90142-0; HOUK IC, 1995, MODELS INFORMATION P, P249; KATO M, 1995, J NEUROSCI, V15, P912; KATO M, 1995, MG NEUR SCI, V14, P178; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Konorski J., 1967, INTEGRATIVE ACTIVITY; KORI A, 1995, J NEUROSCI, V15, P928; MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615, DOI 10.1152/jn.1992.67.6.1615; MIYASHITA N, 1995, NEUROREPORT, V6, P1257, DOI 10.1097/00001756-199506090-00007; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; PRESTON RJ, 1980, BRAIN RES, V183, P253, DOI 10.1016/0006-8993(80)90462-X; RIBAK CE, 1979, J COMP NEUROL, V187, P261, DOI 10.1002/cne.901870203; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WICKENS I, 1995, MODELS INFORMATION P, P187; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; WURTZ RH, 1982, SCI AM, V246, P124, DOI 10.1038/scientificamerican0682-124	45	473	482	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					411	416		10.1038/1625	http://dx.doi.org/10.1038/1625			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196532				2022-12-24	WOS:000076361400020
J	Lisman, JE; Fellous, JM; Wang, XJ				Lisman, JE; Fellous, JM; Wang, XJ			A role for NMDA-receptor channels in working memory	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; MODULATION; DOPAMINE; SCHIZOPHRENIA; INHIBITION; MODEL		Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA; Salk Inst Biol Sci, La Jolla, CA 92037 USA	Brandeis University; Salk Institute	Lisman, JE (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA.	lisman@binah.cc.brandeis.edu	Fellous, Jean-Marc/AAP-3117-2021; Wang, Xiao-Jing/D-2722-2009					Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; AMIT DJ, 1994, J NEUROSCI, V14, P6435; CAMPERI M, 1998, IN PRESS J COMPUTATI; CARAMANOS Z, 1994, BEHAV NEUROSCI, V108, P30, DOI 10.1037/0735-7044.108.1.30; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; FLOHR H, 1995, NEUROPSYCHOLOGIA, V33, P1169, DOI 10.1016/0028-3932(95)00056-9; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Grunze HCR, 1996, J NEUROSCI, V16, P2034; HANSE E, 1994, NEUROSCI RES, V20, P15, DOI 10.1016/0168-0102(94)90018-3; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; Jensen O, 1996, LEARN MEMORY, V3, P264, DOI 10.1101/lm.3.2-3.264; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; TSAI GC, 1995, ARCH GEN PSYCHIAT, V52, P829; Verma A, 1996, J NEUROSCI, V16, P373; WANG XJ, 1995, P NATL ACAD SCI USA, V92, P5577, DOI 10.1073/pnas.92.12.5577; Wang XJ, 1996, J NEUROSCI, V16, P6402; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	20	282	285	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					273	275		10.1038/1086	http://dx.doi.org/10.1038/1086			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195158				2022-12-24	WOS:000076361300008
J	Schoenbaum, G; Chiba, AA; Gallagher, M				Schoenbaum, G; Chiba, AA; Gallagher, M			Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning	NATURE NEUROSCIENCE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FRONTAL-CORTEX; INFORMATION; LESIONS; RAT; REINFORCEMENT; PROJECTIONS; MONKEYS; MEMORY	Reciprocal connections between the orbitofrontal cortex and the basolateral nucleus of the amygdala may provide a critical circuit for the learning that underlies goal-directed behavior. We examined neural activity in rat orbitofrontal cortex and basolateral amygdala during instrumental learning in an olfactory discrimination task. Neurons in both regions fired selectively during the anticipation of rewarding or aversive outcomes. This selective activity emerged early in training, before the rats had learned reliably to avoid the aversive outcome. The results support the concept that the basolateral amygdala and orbitofrontal cortex cooperate to encode information that may be used to guide goal-directed behavior.	Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	Johns Hopkins University; University of California System; University of California San Diego	Schoenbaum, G (corresponding author), Johns Hopkins Univ, Dept Psychol, 3400 N Charles St,25 Ames Hall, Baltimore, MD 21218 USA.	schoenbg@jhu.edu						Balleine B. W., 1997, Society for Neuroscience Abstracts, V23, P786; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Brown S., 1888, PHILOS T R SOC LON B, V179, P303; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Damasio A. R., 1994, DECARTES ERROR; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J.M., 1985, CEREB CORTEX, V4, P151; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Hatfield T, 1996, J NEUROSCI, V16, P5256; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; KLING A, 1972, NEUROBIOLOGY AMYGDAL, P611; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Kolb B., 1990, CEREBRAL CORTEX RAT, P437; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; Malkova L, 1997, J NEUROSCI, V17, P6011; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Miller EK, 1996, J NEUROSCI, V16, P5154; NIKI H, 1974, BRAIN RES, V70, P346, DOI 10.1016/0006-8993(74)90324-2; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Price J. L., 1987, HDB CHEM NEUROANATOM, V5, P279; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	30	643	649	3	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					155	159		10.1038/407	http://dx.doi.org/10.1038/407			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195132				2022-12-24	WOS:000076361100018
J	Griffiths, TD; Rees, G; Rees, A; Green, GGR; Witton, C; Rowe, D; Buchel, C; Turner, R; Frackowiak, RSJ				Griffiths, TD; Rees, G; Rees, A; Green, GGR; Witton, C; Rowe, D; Buchel, C; Turner, R; Frackowiak, RSJ			Right parietal cortex is involved in the perception of sound movement in humans	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; AUDITORY-CORTEX; RIGHT-HEMISPHERE; ATTENTION; LOCATION; NEURONS; BRAIN; TIME; INTENSITY; MOTION	Changes in the delay (phase) and amplitude of sound at the ears are cues for the analysis of sound movement. The detection of these cues depends on the convergence of the inputs to each ear, a process that first occurs in the brainstem. The conscious perception of these cues is likely to involve higher centers. Using novel stimuli that produce different perceptions of movement in the presence of identical phase and amplitude modulation components, we have demonstrated human brain areas that are active specifically during the perception of sound movement. Both functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) demonstrated the involvement of the right parietal cortex in sound movement perception with these stimuli.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Med Sch Newcastle Upon Tyne, Dept Physiol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Med Sch Newcastle Upon Tyne, Dept Clin Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; UCL Natl Hosp Neurol, London WC1N 3BG, England	University of London; University College London; Newcastle University - UK; Newcastle University - UK; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Griffiths, TD (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	t.griffiths@fil.ion.ucl.ac.uk	Frackowiak, Richard S/I-1809-2013; Frackowiak, Richard/H-4383-2011; Rowe, Dominic B/B-6661-2011; Rees, Geraint/C-1493-2008; Green, Gary GR/D-3543-2009; Rees, Adrian/H-2200-2012; Turner, Robert/C-1820-2008	Frackowiak, Richard/0000-0002-3151-822X; Rowe, Dominic B/0000-0003-0912-2146; Rees, Geraint/0000-0002-9623-7007; Green, Gary GR/0000-0003-1977-7509; Rees, Adrian/0000-0003-3313-8375; Turner, Robert/0000-0001-5055-9644; Griffiths, Timothy/0000-0001-8066-4381; Witton, Caroline/0000-0002-5610-4234	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; ALTMAN JA, 1986, HEARING RES, V24, P243, DOI 10.1016/0378-5955(86)90023-7; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; BANDETTINI PA, 1998, IN PRESS MAG RES MED; BISIACH E, 1984, BRAIN, V107, P37, DOI 10.1093/brain/107.1.37; Bregman A.S., 1990, AUDITORY SCENE ANAL; BRUGGE JF, 1996, ACOUSTICAL SIGNAL PR; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GOLDBERG JAY M., 1968, J NEUROPHYSIOL, V31, P639; GREEN GGR, 1976, J PHYSIOL-LONDON, V260, pP49; Griffiths TD, 1997, J NEUROL NEUROSUR PS, V62, P522, DOI 10.1136/jnnp.62.5.522; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; GRIFFITHS TD, 1994, CURR BIOL, V4, P892, DOI 10.1016/S0960-9822(00)00198-6; Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0; HAFTER ER, 1972, J ACOUST SOC AM, V51, P1852, DOI 10.1121/1.1913044; IRVINE DRF, 1986, AUDITORY BRAINSTEM R, V7; Makela JP, 1996, EXP BRAIN RES, V110, P446; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; MOUNTCASTLE VB, 1995, CEREB CORTEX, V5, P377, DOI 10.1093/cercor/5.5.377; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; PETRIDES M, 1984, J COMP NEUROL, V20, P249; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SPITZER MW, 1993, J NEUROPHYSIOL, V69, P1245, DOI 10.1152/jn.1993.69.4.1245; STRYBEL TZ, 1989, PERCEPT PSYCHOPHYS, V45, P371, DOI 10.3758/BF03204951; STUMPF E, 1992, EXP BRAIN RES, V88, P158, DOI 10.1007/BF02259137; Talairach P., 1988, STEREOTACTIC COPLANA; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; ZAKARAUSKAS P, 1991, HEARING RES, V52, P233, DOI 10.1016/0378-5955(91)90203-L	40	218	230	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					74	79		10.1038/276	http://dx.doi.org/10.1038/276			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195113				2022-12-24	WOS:000076361000022
J	Berglund, EO; Murai, KK; Fredette, B; Sekerkova, G; Marturano, B; Weber, L; Mugnaini, E; Ranscht, B				Berglund, EO; Murai, KK; Fredette, B; Sekerkova, G; Marturano, B; Weber, L; Mugnaini, E; Ranscht, B			Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression	NEURON			English	Article							ADHESION MOLECULE F3; PROMOTES NEURITE OUTGROWTH; TYROSINE PHOSPHATASE-BETA; IMMUNOGLOBULIN SUPERFAMILY; PURKINJE-CELLS; NERVOUS-SYSTEM; GRANULE CELLS; RAT-BRAIN; AXONAL GROWTH; STEM-CELLS	Axon guidance and target recognition depend on neuronal cell surface receptors that recognize and elicit selective growth cone responses to guidance cues in the environment. Contactin, a cell adhesion/recognition molecule of the immunoglobulin gene superfamily, regulates axon growth and fasciculation in vitro, but its role in vivo is unknown. To assess its function in the developing nervous system, we have ablated contactin gene expression in mice. Contactin(-/-) mutants displayed a severe ataxic phenotype consistent with defects in the cerebellum and survived only until postnatal day 18. Analysis of the contactin(-/-) mutant cerebellum revealed defects in granule cell axon guidance and in dendritic projections from granule and Golgi cells. These results demonstrate that contactin controls axonal and dendritic interactions of cerebellar interneurons and contributes to cerebellar microorganization.	Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Northwestern University	Ranscht, B (corresponding author), Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA.	ranscht@burnham-inst.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038297] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 25938] Funding Source: Medline; NINDS NIH HHS [NS 09904, NS 38297] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altman J, 1997, DEV CEREBELLAR SYSTE; ALVARADOMALLART RM, 1982, J COMP NEUROL, V212, P247, DOI 10.1002/cne.902120304; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; BERGLUND E, 1991, BRAIN RES, V549, P292, DOI 10.1016/0006-8993(91)90470-G; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; BRUMMENDORF T, 1995, PROTEIN PROFILE, V2, P963; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BRUMMENDORF T, 1993, NEURON, V10, P711; BUTTIGLIONE M, 1995, MOL BRAIN RES, V29, P297, DOI 10.1016/0169-328X(94)00262-D; Buttiglione M, 1996, MOL CELL NEUROSCI, V8, P53, DOI 10.1006/mcne.1996.0043; Buttiglione M, 1998, J NEUROSCI, V18, P6853; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; Cohen D, 1998, P NATL ACAD SCI USA, V95, P15032, DOI 10.1073/pnas.95.25.15032; COHENCORY S, 1991, J NEUROSCI, V11, P462; Cremer H, 1997, MOL CELL NEUROSCI, V8, P323, DOI 10.1006/mcne.1996.0588; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DURBEC P, 1992, J CELL BIOL, V117, P877, DOI 10.1083/jcb.117.4.877; ECCLES J, 1964, NATURE, V204, P1265, DOI 10.1038/2041265a0; FAIVRESARRAILH C, 1992, J NEUROSCI, V12, P257; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Friedrich Jr VL, 1981, NEUROANATOMICAL TRAC, P345; FRIEDRICH VL, 1980, INSERM S, V14, P141; GAO WQ, 1995, J NEUROSCI, V15, P2656; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HAMORI J, 1966, EXP BRAIN RES, V2, P35; HEINTZ N, 1993, GENOME ANAL, V6, P19; HOSOYA H, 1995, NEUROSCI LETT, V186, P83, DOI 10.1016/0304-3940(95)11287-7; JAKAB R L, 1989, Acta Morphologica Hungarica, V37, P11; Koch T, 1997, GLIA, V19, P199, DOI 10.1002/(SICI)1098-1136(199703)19:3<199::AID-GLIA3>3.0.CO;2-V; LIM DJ, 1978, VESTIBULAR MECH HLTH; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MORALES G, 1993, NEURON, V11, P1113, DOI 10.1016/0896-6273(93)90224-F; Mugnaini E, 1972, COMP ANATOMY HISTOLO, P201; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Neki A, 1996, NEUROSCI LETT, V202, P197, DOI 10.1016/0304-3940(95)12248-6; Palay S, 1974, CEREBELLAR CORTEX CY, p[63, 242]; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; PELLEGRINO LJ, 1979, J COMP PHYSIOL PSYCH, V93, P1, DOI 10.1037/h0077589; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Pierre K, 1998, J NEUROSCI, V18, P5333, DOI 10.1523/JNEUROSCI.18-14-05333.1998; RANSCHT B, 1984, J CELL BIOL, V99, P1803, DOI 10.1083/jcb.99.5.1803; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; RATHJEN FG, 1991, DEVELOPMENT, V113, P151; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; RATHJEN FG, 1991, SEMINARS NEUROSCIENC, P297; REID RA, 1994, MOL BRAIN RES, V21, P1, DOI 10.1016/0169-328X(94)90372-7; RODRIGUEZBOULAN E, 1989, METHOD CELL BIOL, V32, P37; ROSENFELD J, 1983, NEUROSCIENCE, V10, P959, DOI 10.1016/0306-4522(83)90233-6; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Seki T, 1998, J NEUROSCI, V18, P3757; SIDMAN R L, 1968, PHYSIOLOGICAL AND BIOCHEMICAL ASPECTS OF NERVOUS INTEGRATION, P163; SORIANO P, 1995, ANNU REV NEUROSCI, V18, P1; SPACEK J, 1989, J NEUROCYTOL, V18, P27, DOI 10.1007/BF01188421; STALLCUP WB, 1985, J NEUROSCI, V5, P1090; SUZUKI K, 1975, BRAIN RES, V85, P38, DOI 10.1016/0006-8993(75)91001-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Vos BP, 1999, J NEUROSCI, V19; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; WOLLNER DA, 1992, J CELL BIOL, V116, P889, DOI 10.1083/jcb.116.4.889; YOSHIHARA Y, 1995, J NEUROBIOL, V28, P51, DOI 10.1002/neu.480280106; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203	70	181	185	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					739	750		10.1016/S0896-6273(00)81126-5	http://dx.doi.org/10.1016/S0896-6273(00)81126-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595523	Bronze			2022-12-24	WOS:000083913000027
J	Winder, DG; Martin, KC; Muzzio, IA; Rohrer, D; Chruscinski, A; Kobilka, B; Kandel, ER				Winder, DG; Martin, KC; Muzzio, IA; Rohrer, D; Chruscinski, A; Kobilka, B; Kandel, ER			ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; HIPPOCAMPAL CA1 REGION; PYRAMIDAL NEURONS; CYCLIC-AMP; MAP KINASE; RAT-BRAIN; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MESSENGER-RNA	MAP kinase (ERK) translates cell surface signals into alterations in transcription. We have found that ERK also regulates hippocampal neuronal excitability during 5 Hz stimulation and thereby regulates forms of long-term potentiation (LTP) that do not require macromolecular synthesis. Moreover, ERK-mediated changes in excitability are selectively required for some forms of LTP but not others. ERK is required for the early phase of LTP elicited by brief 5 Hz stimulation, as well as for LTP elicited by more prolonged 5 Hz stimulation when paired with beta 1-adrenergic receptor activation. By contrast, ERK plays no role in LTP elicited by a single 1 s 100 Hz train. Consistent with these results, we find that ERK is activated by beta-adrenergic receptors in CA1 pyramidal cell somas and dendrites.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York State Psychiat Inst, Howard Hughes Med Inst, New York, NY 10032 USA; Stanford Univ, Howard Hughes Med Inst, Dept Med, Stanford, CA 94305 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Howard Hughes Medical Institute; Stanford University	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York State Psychiat Inst, Howard Hughes Med Inst, 722 W 168th St, New York, NY 10032 USA.		Winder, Danny G./H-4857-2013	Kobilka, Brian/0000-0001-5958-3990				Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FOWLER JC, 1988, EUR J PHARMACOL, V153, P105, DOI 10.1016/0014-2999(88)90593-6; GEREAU RW, 1994, J NEUROPHYSIOL, V72, P1438, DOI 10.1152/jn.1994.72.3.1438; GEREAU RW, 1994, J NEUROSCI, V14, P3310; HEGINBOTHAM LR, 1991, J NEUROSCI, V11, P2519; Hoffman DA, 1999, J NEUROPHYSIOL, V81, P408, DOI 10.1152/jn.1999.81.1.408; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Iwasaki H, 1998, ENDOCRINOLOGY, V139, P3432, DOI 10.1210/en.139.8.3432; Kainu T, 1995, NEUROREPORT, V6, P2557, DOI 10.1097/00001756-199512150-00026; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; Oddie SD, 1998, NEUROSCI BIOBEHAV R, V22, P221, DOI 10.1016/S0149-7634(97)00003-1; Olsen MK, 1998, J CELL PHYSIOL, V176, P525, DOI 10.1002/(SICI)1097-4652(199809)176:3<525::AID-JCP9>3.0.CO;2-Q; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Reiners JJ, 1998, MOL PHARMACOL, V53, P438, DOI 10.1124/mol.53.3.438; Roberson ED, 1999, J NEUROSCI, V19, P4337; Rohrer D K, 1998, Adv Pharmacol, V42, P499; Rohrer DK, 1998, ANNU REV PHARMACOL, V38, P351, DOI 10.1146/annurev.pharmtox.38.1.351; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Runden E, 1998, J NEUROSCI, V18, P7296; Sah P, 1996, J NEUROSCI, V16, P4537; SUMMERS RJ, 1995, BRIT J PHARMACOL, V116, P2547, DOI 10.1111/j.1476-5381.1995.tb17205.x; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X	54	272	284	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1999	24	3					715	726		10.1016/S0896-6273(00)81124-1	http://dx.doi.org/10.1016/S0896-6273(00)81124-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595521	hybrid			2022-12-24	WOS:000083913000025
J	Fortin, G; Jungbluth, S; Lumsden, A; Champagnat, J				Fortin, G; Jungbluth, S; Lumsden, A; Champagnat, J			Segmental specification of GABAergic inhibition during development of hindbrain neural networks	NATURE NEUROSCIENCE			English	Article							CHICK HINDBRAIN; RHYTHM GENERATION; I-H; EXPRESSION; GABA; GENE; RECEPTORS; EMBRYOS; BLOCKER; ZD-7288	A primordial rhythm-generating neural network emerges during the segmental period of vertebrate hindbrain development, suggesting a common genetic basis to both the structure and network activity of the region. We show here that segmentation influenced a postsegmental developmental step by which a GABAergic rhythm generator was incorporated into the primordial network and increased rhythm frequency to near mature values. This process depended on specifications in r3 and r5 that controlled, on the basis of a two-segment repeat, later maturation of GABAergic inhibition.	CNRS, Inst Alfred Fessard, F-91198 Gif Sur Yvette, France; Univ London Kings Coll, Dept Dev Neurobiol, MRC, Brain Dev Programme, London SE1 9RT, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; King's College London	Fortin, G (corresponding author), CNRS, Inst Alfred Fessard, 1 Av de la Terrasse, F-91198 Gif Sur Yvette, France.		Lumsden, Andrew/C-5146-2009	Fortin, Gilles/0000-0002-2123-8603				Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Champagnat J, 1997, TRENDS NEUROSCI, V20, P119, DOI 10.1016/S0166-2236(96)10078-3; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fenelon VS, 1998, CURR OPIN NEUROBIOL, V8, P705, DOI 10.1016/S0959-4388(98)80111-6; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FORTIN G, 1995, J PHYSIOL-LONDON, V486, P735, DOI 10.1113/jphysiol.1995.sp020849; FORTIN G, 1994, NEUROREPORT, V5, P1149, DOI 10.1097/00001756-199405000-00032; FORTIN G, 1994, NEUROREPORT, V5, P1137, DOI 10.1097/00001756-199405000-00029; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Jacquin TD, 1996, NEURON, V17, P747, DOI 10.1016/S0896-6273(00)80206-8; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Seitanidou T, 1997, MECH DEVELOP, V65, P31, DOI 10.1016/S0925-4773(97)00051-8; Taneja R, 1996, DEV BIOL, V177, P397, DOI 10.1006/dbio.1996.0173; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P1; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	29	59	60	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					873	877		10.1038/13172	http://dx.doi.org/10.1038/13172			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491606	Green Submitted			2022-12-24	WOS:000083883200011
J	Crestani, F; Lorez, M; Baer, K; Essrich, C; Benke, D; Laurent, JP; Belzung, C; Fritschy, JM; Luscher, B; Mohler, H				Crestani, F; Lorez, M; Baer, K; Essrich, C; Benke, D; Laurent, JP; Belzung, C; Fritschy, JM; Luscher, B; Mohler, H			Decreased GABA(A)-receptor clustering results in enhanced anxiety and a bias for threat cues	NATURE NEUROSCIENCE			English	Article							BENZODIAZEPINE RECEPTOR-BINDING; PANIC DISORDER; IOMAZENIL-SPECT; MICE; BEHAVIOR; HIPPOCAMPUS; PLASTICITY; SUBTYPES; EMOTION; SUBUNIT	Patients with panic disorders show a deficit of GABA(A) receptors in the hippocampus, parahippocampus and orbitofrontal cortex. Synaptic clustering of GABA(A) receptors in mice heterozygous for the gamma 2 subunit was reduced, mainly in hippocampus and cerebral cortex. The gamma 2(+/-) mice showed enhanced behavioral inhibition toward natural aversive stimuli and heightened responsiveness in trace fear conditioning and ambiguous cue discrimination learning. Implicit and spatial memory as well as long-term potentiation in hippocampus were unchanged. Thus gamma 2(+/-) mice represent a model of anxiety characterized by harm avoidance behavior and an explicit memory bias for threat cues, resulting in heightened sensitivity to negative associations. This model implicates GABA(A)-receptor dysfunction in patients as a causal predisposition to anxiety disorders.	Swiss Fed Inst Technol, Inst Pharmacol, CH-8057 Zurich, Switzerland; Univ Zurich, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mohler, H (corresponding author), Swiss Fed Inst Technol, Inst Pharmacol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Belzung, Catherine/P-6512-2016; Luscher, Bernhard/C-3528-2009	Belzung, Catherine/0000-0001-6095-5974; Luscher, Bernhard/0000-0003-1375-1906; Fritschy, Jean-Marc/0000-0002-8552-3702				Abadie P, 1999, EUR J NEUROSCI, V11, P1470, DOI 10.1046/j.1460-9568.1999.00556.x; ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; Beracochea D J, 1990, J Cogn Neurosci, V2, P133, DOI 10.1162/jocn.1990.2.2.133; BEUZEN A, 1995, PHYSIOL BEHAV, V58, P111, DOI 10.1016/0031-9384(95)00013-9; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carlson S, 1996, HEARING RES, V99, P168, DOI 10.1016/S0378-5955(96)00098-6; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; EYSENCK MW, 1992, HDB INDIVIDUAL DIFFE, P157; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GLUE P, 1995, J ANXIETY DISORD, V9, P33, DOI 10.1016/0887-6185(94)00026-7; Gray J A, 1996, Nebr Symp Motiv, V43, P61; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; HAEFELY WE, 1994, CHALLENGE NEUROPHARM, P15; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Holland PC, 1983, QUANTITATIVE ANAL BE, V4, P183; KASCHKA W, 1995, J PSYCHIAT RES, V29, P427, DOI 10.1016/0022-3956(95)00019-2; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Ledoux Joseph E., 1995, P1049; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; MCGAUGH JL, 1990, PSYCHOL SCI, V1, P15, DOI 10.1111/j.1467-9280.1990.tb00060.x; McNally R J, 1996, Nebr Symp Motiv, V43, P211; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; NORDAHL TE, 1990, NEUROPSYCHOPHARMACOL, V3, P261; OBOYLE CA, 1986, PSYCHOPHARMACOLOGY, V88, P226, DOI 10.1007/BF00652245; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; REIMAN EM, 1984, NATURE, V310, P683, DOI 10.1038/310683a0; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; SCHLEGEL S, 1994, EUR ARCH PSY CLIN N, V244, P49, DOI 10.1007/BF02279812; Tiihonen J, 1997, MOL PSYCHIATR, V2, P463, DOI 10.1038/sj.mp.4000329; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; [No title captured]	39	392	402	3	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					833	839		10.1038/12207	http://dx.doi.org/10.1038/12207			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FB	10461223				2022-12-24	WOS:000083882900015
J	Michikawa, T; Hirota, J; Kawano, S; Hiraoka, M; Yamada, M; Furuichi, T; Mikoshiba, K				Michikawa, T; Hirota, J; Kawano, S; Hiraoka, M; Yamada, M; Furuichi, T; Mikoshiba, K			Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1,14,5-trisphosphate receptor	NEURON			English	Article							RECONSTITUTED LIPID VESICLES; LONG-TERM DEPRESSION; SMOOTH-MUSCLE CELLS; 1,4,5-TRISPHOSPHATE RECEPTOR; 1,4,5,-TRISPHOSPHATE RECEPTOR; SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; PURKINJE NEURONS; MOUSE CEREBELLUM; CA2+ FLUX	The dependency of purified mouse cerebellar type 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1)/Ca2+ channel function on cytoplasmic Ca2+ was examined. In contrast to the channels in crude systems, the purified IP(3)R1 reconstituted into planar lipid bilayers did not show the bell-shaped dependence on Ca2+. It was activated with increasing Ca2+ sublinearly without inhibition even up to 200 mu M. The addition of calmodulin to the cytoplasmic side inhibited the channel at high Ca2+ concentrations. Calmodulin antagonists reversed the Ca2+-dependent inactivation of the native channels in cerebellar microsomes. These results indicate that the bell-shaped dependence on cytoplasmic Ca2+ is not an intrinsic property of the IP(3)R1, and the Ca2+-dependent inactivation is directly mediated by calmodulin.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo 1088639, Japan; Japan Sci & Technol Corp, Exploratory Res Adv Technol, Mikoshiba Calciosignal Net Project, Tokyo 1130021, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Cardiovasc Dis, Tokyo 1138510, Japan; Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); RIKEN	Michikawa, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo 1088639, Japan.	takamich@lms.u-tokyo.ac.jp	Yamada, Maki K./A-1573-2015; Hirota, Junji/G-1357-2019; Mikoshiba, Katsuhiko/N-7943-2015; Yamada, Maki/U-5251-2019; Hirota, Junji/O-9315-2019; Furuichi, Teiichi/B-5086-2014	Yamada, Maki K./0000-0002-1956-6069; Hirota, Junji/0000-0002-5741-0655; Hirota, Junji/0000-0002-5741-0655; Furuichi, Teiichi/0000-0002-9676-1888				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ASHLEY RH, 1990, J GEN PHYSIOL, V95, P981, DOI 10.1085/jgp.95.5.981; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BERS DM, 1982, AM J PHYSIOL, V242, pC404, DOI 10.1152/ajpcell.1982.242.5.C404; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Colquhoun David, 1995, P483; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Hagar RE, 1998, NATURE, V396, P81, DOI 10.1038/23954; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HIROTA J, 1995, J BIOL CHEM, V270, P19046, DOI 10.1074/jbc.270.32.19046; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; LIN CT, 1980, J CELL BIOL, V85, P473, DOI 10.1083/jcb.85.2.473; LUBYPHELPS K, 1995, J BIOL CHEM, V270, P21532, DOI 10.1074/jbc.270.37.21532; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1993, METH NEUROSCI, V18, P247; MIKOSHIBA K, 1993, TRENDS PHARMACOL SCI, V14, P86, DOI 10.1016/0165-6147(93)90069-V; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; NAKADE S, 1994, J BIOL CHEM, V269, P6735; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; WATRAS J, 1991, J NEUROSCI, V11, P3239; WORLEY PF, 1989, J NEUROSCI, V9, P339; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083	60	146	148	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG	1999	23	4					799	808		10.1016/S0896-6273(01)80037-4	http://dx.doi.org/10.1016/S0896-6273(01)80037-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482245	Bronze			2022-12-24	WOS:000082280900022
J	Whistler, JL; Chuang, HH; Chu, P; Jan, LY; von Zastrow, M				Whistler, JL; Chuang, HH; Chu, P; Jan, LY; von Zastrow, M			Functional dissociation of mu opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction	NEURON			English	Article							DOWN-REGULATION; BETA-ARRESTIN; BRAIN-CELLS; DESENSITIZATION; MORPHINE; PHOSPHORYLATION; EFFICACY; INTERNALIZATION; RESENSITIZATION; EXPRESSION	Opiate analgesia, tolerance, and addiction are mediated by drug-induced activation of the mu opioid receptor. A fundamental question in addiction biology is why exogenous opiate drugs have a high liability for inducing tolerance and addiction while native ligands do not. Studies indicate that highly addictive opiate drugs such as morphine are deficient in their ability to induce the desensitization and endocytosis of receptors. Here, we demonstrate that this regulatory mechanism reveals an independent functional property of opiate drugs that can be distinguished from previously established agonist properties. Moreover, this property correlates with agonist propensity to promote physiological tolerance, suggesting a fundamental revision of our understanding of the role of receptor endocytosis in the biology of opiate drug action and addiction.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.			Jan, Lily/0000-0003-3938-8498				Afify EA, 1998, MOL BRAIN RES, V54, P24, DOI 10.1016/S0169-328X(97)00315-X; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; CHAKRABARTI S, 1995, J NEUROCHEM, V64, P2534; CHAVKIN C, 1984, P NATL ACAD SCI-BIOL, V81, P7253, DOI 10.1073/pnas.81.22.7253; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; COSTA T, 1992, MOL PHARMACOL, V41, P549; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kovoor A, 1998, MOL PHARMACOL, V54, P704; Kovoor A, 1997, J BIOL CHEM, V272, P27605, DOI 10.1074/jbc.272.44.27605; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; LENOIR D, 1984, BRAIN RES, V304, P285, DOI 10.1016/0006-8993(84)90332-9; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mercadante S, 1998, J CLIN ONCOL, V16, P3656, DOI 10.1200/JCO.1998.16.11.3656; Murray SR, 1998, J BIOL CHEM, V273, P24987, DOI 10.1074/jbc.273.39.24987; PEI G, 1995, MOL PHARMACOL, V48, P173; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; REZVANI A, 1983, J PHARMACOL EXP THER, V225, P251; SIMANTOV R, 1984, NEUROPEPTIDES, V5, P197, DOI 10.1016/0143-4179(84)90061-1; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Szekeres PG, 1998, MOL PHARMACOL, V53, P759, DOI 10.1124/mol.53.4.759; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; TRAYNOR JR, 1995, MOL PHARMACOL, V47, P848; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Yu YK, 1997, J BIOL CHEM, V272, P28869, DOI 10.1074/jbc.272.46.28869; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang L, 1996, J BIOL CHEM, V271, P11449, DOI 10.1074/jbc.271.19.11449	31	355	373	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					737	746		10.1016/S0896-6273(01)80032-5	http://dx.doi.org/10.1016/S0896-6273(01)80032-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482240	Bronze			2022-12-24	WOS:000082280900017
J	Jones, SR; Gainetdinov, RR; Hu, XT; Cooper, DC; Wightman, RM; White, FJ; Caron, MG				Jones, SR; Gainetdinov, RR; Hu, XT; Cooper, DC; Wightman, RM; White, FJ; Caron, MG			Loss of autoreceptor functions in mice lacking the dopamine transporter	NATURE NEUROSCIENCE			English	Article							RECEPTOR MUTANT MICE; SUSTAINED ACTIVATION; CONSCIOUS RATS; IN-VIVO; NEURONS; D-2; RELEASE; COCAINE; AGONISTS; SYSTEM	Autoreceptors provide an important inhibitory feedback mechanism for dopamine neurons by altering neuronal functions in response to changes in extracellular levels of dopamine. Elevated dopamine may be a component of several neuropsychiatric disorders. However, evidence concerning the state of autoreceptors in such conditions has remained elusive. The function of dopamine autoreceptors was assessed in mice lacking the dopamine transporter (DAT). Genetic deletion of the DAT gene in mice results in a persistent elevation in levels of extracellular dopamine. Direct assessment of impulse-, synthesis- and release-regulating autoreceptors in these mice reveals a nearly complete loss of function. These findings may provide insight into the neurochemical consequences of hyperdopaminergia.	Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst, Durham, NC 27710 USA; Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA	Duke University; Howard Hughes Medical Institute; Chicago Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst, Box 3287,487 CARL Bldg, Durham, NC 27710 USA.		Jones, Sara R/K-4816-2014; Gainetdinov, Raul R/G-5875-2011	Jones, Sara R/0000-0002-3424-7576; Gainetdinov, Raul R/0000-0003-2951-6038	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA005794] Funding Source: NIH RePORTER; NIDA NIH HHS [F31 DA005794] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANNON MJ, 1983, PHARMACOL REV, V35, P53; BATESON G, 1955, Psychiatr Res Rep Am Psychiatr Assoc, P39; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; BURRIS KD, 1995, NEUROPSYCHOPHARMACOL, V12, P335, DOI 10.1016/0893-133X(94)00099-L; COOK EH, 1995, AM J HUM GENET, V56, P993; Cragg SJ, 1997, J NEUROSCI, V17, P5738; DRUKARCH B, 1990, LIFE SCI, V47, P361, DOI 10.1016/0024-3205(90)90293-Z; DRUKARCH B, 1991, EUR J PHARMACOL, V196, P209, DOI 10.1016/0014-2999(91)90431-O; ELSWORTH JD, 1997, DOPAMINE RECEPTORS, P223; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; GAINETDINOV RR, 1994, EUR J PHARMACOL, V261, P327, DOI 10.1016/0014-2999(94)90125-2; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Henry DJ, 1998, PSYCHOPHARMACOLOGY, V140, P233, DOI 10.1007/s002130050762; IVINS KJ, 1991, MOL PHARMACOL, V39, P531; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; JONES SR, 1995, J NEUROCHEM, V64, P2581; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Koeltzow TE, 1998, J NEUROSCI, V18, P2231; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; PITTS DK, 1995, J PHARMACOL EXP THER, V275, P412; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tepper JM, 1997, J NEUROSCI, V17, P2519; TIMMERMAN W, 1990, N-S ARCH PHARMACOL, V342, P650, DOI 10.1007/BF00175707; VANMUISWINKEL FL, 1994, EXP NEUROL, V125, P218, DOI 10.1006/exnr.1994.1025; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; WALTERS JR, 1976, N-S ARCH PHARMACOL, V296, P5, DOI 10.1007/BF00498834; WESTERINK BHC, 1990, J NEUROCHEM, V54, P381, DOI 10.1111/j.1471-4159.1990.tb01884.x; WHITE FJ, 1983, LIFE SCI, V32, P983, DOI 10.1016/0024-3205(83)90929-3; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; WOOLVERTON WL, 1992, TRENDS PHARMACOL SCI, V13, P193, DOI 10.1016/0165-6147(92)90063-C; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; Zoli M, 1998, BRAIN RES REV, V26, P136, DOI 10.1016/S0165-0173(97)00048-9	41	193	203	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					649	655		10.1038/10204	http://dx.doi.org/10.1038/10204			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404198				2022-12-24	WOS:000083882600016
J	Naisbitt, S; Kim, E; Tu, JC; Xiao, B; Sala, C; Valtschanoff, J; Weinberg, RJ; Worley, PF; Sheng, M				Naisbitt, S; Kim, E; Tu, JC; Xiao, B; Sala, C; Valtschanoff, J; Weinberg, RJ; Worley, PF; Sheng, M			Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TUMOR-SUPPRESSOR PROTEIN; RAT-BRAIN; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; WW DOMAINS; INTERACTS; ACTIN; PDZ; RECOGNITION	NMDA receptors are linked to intracellular cytoskeletal and signaling molecules via the PSD-95 protein complex. We report a novel family of postsynaptic density (PSD) proteins, termed Shank, that binds via its PDZ domain to the C terminus of PSD-95-associated protein GKAP. A ternary complex of Shank/GKAP/PSD-95 assembles in heterologous cells and can be coimmunoprecipitated from rat brain. Synaptic localization of Shank in neurons is inhibited by a GKAP splice variant that lacks the Shank-binding C terminus. In addition to its PDZ domain, Shank contains a proline-rich region that binds to cortactin and a SAM domain that mediates multimerization. Shank may function as a scaffold protein in the PSD, potentially cross-linking NMDA receptor/PSD-95 complexes and coupling them to regulators of the actin cytoskeleton.	Massachusetts Gen Hosp, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA 02114 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA; Pusan Natl Univ, Dept Pharmacol, Pusan 609735, South Korea	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Pusan National University	Sheng, M (corresponding author), Massachusetts Gen Hosp, Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02114 USA.	sheng@helix.mgh.harvard.edu	Sala, Carlo/A-2493-2009; Weinberg, Richard/AAC-1898-2020; Kim, Eunjoon/C-1566-2011	Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050, R01NS029879] Funding Source: NIH RePORTER; NIDA NIH HHS [DA103009] Funding Source: Medline; NINDS NIH HHS [NS35050, NS29879] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; Banker G., 1991, CULTURING NERVE CELL; BARTEL PL, 1993, USING 2 HYBRID SYSTE; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Naisbitt S, 1997, J NEUROSCI, V17, P5687; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; Niethammer M, 1998, METHOD ENZYMOL, V293, P104; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Rao A, 1998, J NEUROSCI, V18, P1217; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Sheng M, 1997, NATURE, V386, P221, DOI 10.1038/386221a0; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Weed SA, 1998, J CELL SCI, V111, P2433; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	53	748	766	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1999	23	3					569	582		10.1016/S0896-6273(00)80809-0	http://dx.doi.org/10.1016/S0896-6273(00)80809-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433268	Green Published, Bronze			2022-12-24	WOS:000081701000020
J	Arnold, DB; Clapham, DE				Arnold, DB; Clapham, DE			Molecular determinants for subcellular localization of PSD-95 with an interacting K+ channel	NEURON			English	Article							PDZ-DOMAIN PROTEIN; NMDA RECEPTOR; POSTSYNAPTIC DENSITY; RAT-BRAIN; GUANYLATE KINASES; FASCICLIN-II; DISCS-LARGE; IN-VIVO; BINDING; EXPRESSION	ion channels and PSD-95 are colocalized in specific neuronal subcellular locations by an unknown mechanism. To investigate mechanisms of localization, we used biolistic techniques to express GFP-tagged PSD-95 (PSD-95:GFP) and the K+-selective channel Kv1.4 in slices of rat cortex. In pyramidal cells, PSD-95:GFP required a single PDZ domain and a region including the SH3 domain for localization to postsynaptic sites. When transfected alone, PSD-95:GFP was present in dendrites but absent from axons. When cotransfected with Kv1.4, PSD-95:GFP appeared in both axons and dendrites, while Kv1.4 was restricted to axons. When domains that mediate the interaction of Kv1.4 and PSD-95 were disrupted, Kv1.4 localized nonspecifically. Our results provide evidence that Kv1.4 itself may determine its subcellular location, while an associated MAGUK protein is a necessary but not sufficient cofactor.	Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital	Clapham, DE (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				ARNOLD D, 1994, P NATL ACAD SCI USA, V91, P9970, DOI 10.1073/pnas.91.21.9970; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Cooper EC, 1998, J NEUROSCI, V18, P965; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Hunt CA, 1996, J NEUROSCI, V16, P1380; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Rao A, 1998, J NEUROSCI, V18, P1217; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; WANG H, 1994, J NEUROSCI, V14, P4588; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	40	101	107	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					149	157		10.1016/S0896-6273(00)80761-8	http://dx.doi.org/10.1016/S0896-6273(00)80761-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402201	Bronze			2022-12-24	WOS:000080681200018
J	Boulanger, L; Poo, M				Boulanger, L; Poo, M			Presynaptic depolarization facilitates neurotrophin-induced synaptic potentiation	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; DENDRITIC GROWTH; MESSENGER-RNA; TRANSMISSION; BDNF; PLASTICITY; TRKB	Neurotrophins have been proposed to participate in activity-dependent modifications of neuronal connectivity and synaptic efficacy. Preferential strengthening of active inputs requires restriction of putative neurotrophin-mediated synaptic potentiation to active synapses. Here we report that potentiation of synaptic efficacy by brain-derived neurotrophic factor (BDNF) is greatly facilitated by presynaptic depolarization at developing neuromuscular synapses. Brief depolarization In the presence of low-level BDNF results in a marked potentiation of both evoked and spontaneous synaptic transmission, whereas exposure to either BDNF or depolarization alone is without effect. This potentiation depends on the relative timing of depolarization and reflects an enhancement of transmitter secretion from the presynaptic neuron. Thus synapses made by active inputs may be selectively strengthened by secreted neurotrophins as part of activity-dependent refinement of developing connections or of mature synapses.	Univ Calif San Diego, Dept Biol 0357, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Poo, M (corresponding author), Univ Calif San Diego, Dept Biol 0357, 9500 Gilman Dr, La Jolla, CA 92093 USA.			Boulanger, Lisa/0000-0002-6578-7890				BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; BIFFO S, 1995, DEVELOPMENT, V121, P2461; BIRREN SJ, 1992, SCIENCE, V257, P395, DOI 10.1126/science.1321502; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CARTER BD, 1995, J BIOL CHEM, V270, P21751, DOI 10.1074/jbc.270.37.21751; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; CONNOLLY JL, 1985, J NEUROSCI RES, V13, P183, DOI 10.1002/jnr.490130113; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frank L, 1996, EUR J NEUROSCI, V8, P1220, DOI 10.1111/j.1460-9568.1996.tb01290.x; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gottschalk W, 1998, J NEUROSCI, V18, P6830; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KATZ B, 1962, PROC R SOC SER B-BIO, V155, P455, DOI 10.1098/rspb.1962.0012; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ming GL, 1997, J NEUROSCI, V17, P7860; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; REDDY R, 1995, J CELL BIOL, V24, P14340; SCHWARTZ LM, 1985, NATURE, V314, P747, DOI 10.1038/314747a0; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stoop R, 1996, J NEUROSCI, V16, P3256; Tabti N, 1998, CULTURING NERVE CELL, P237; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; Wang XH, 1998, J NEUROSCI, V18, P4985; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2	50	134	137	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					346	351		10.1038/7258	http://dx.doi.org/10.1038/7258			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204541				2022-12-24	WOS:000080532000013
J	Giuffrida, A; Parsons, LH; Kerr, TM; de Fonseca, FR; Navarro, M; Piomelli, D				Giuffrida, A; Parsons, LH; Kerr, TM; de Fonseca, FR; Navarro, M; Piomelli, D			Dopamine activation of endogenous cannabinoid signaling in dorsal striatum	NATURE NEUROSCIENCE			English	Article							RAT-BRAIN MICROSOMES; RECEPTOR-LIGAND; TOURETTES-SYNDROME; BASAL GANGLIA; ANANDAMIDE; AGONIST; IDENTIFICATION; INHIBITION; SR141716A; NEURONS	We measured endogenous cannabinoid release in dorsal striatum of freely moving rats by microdialysis and gas chromatography/mass spectrometry. Neural activity stimulated the release of anandamide, but not of other endogenous cannabinoids such as 2-arachidonylglycerol. Moreover, anandamide release was increased eightfold over baseline after local administration of the D-2-like (D-2, D-3, D-4) dopamine receptor agonist quinpirole, a response that was prevented by the D-2-like receptor antagonist raclopride. Administration of the D-1-like (D-1, D-5) receptor agonist SKF38393 had no such effect. These results suggest that functional interactions between endocannabinoid and dopaminergic systems may contribute to striatal signaling. In agreement with this hypothesis, pretreatment with the cannabinoid antagonist SR141716A enhanced the stimulation of motor behavior elicited by systemic administration of quinpirole. The endocannabinoid system therefore may act as an inhibitory feedback mechanism countering dopamine-induced facilitation of motor activity.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Univ Complutense, Dept Psychobiol, Madrid 28233, Spain	University of California System; University of California Irvine; Scripps Research Institute; Complutense University of Madrid	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	poimelli@uci.edu	Giuffrida, Andrea/H-3770-2013; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012	Giuffrida, Andrea/0000-0002-3773-0694; 	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012447, R01DA012413] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Chase TN, 1996, ADV NEUROL, V69, P497; Civelli Olivier, 1995, P155; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Eidelberg D, 1997, NEUROLOGY, V48, P927, DOI 10.1212/WNL.48.4.927; EILAM D, 1989, EUR J PHARMACOL, V161, P151, DOI 10.1016/0014-2999(89)90837-6; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; FRIDE E, 1993, EUR J PHARMACOL, V231, P313, DOI 10.1016/0014-2999(93)90468-W; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Giuffrida A, 1998, FEBS LETT, V422, P373, DOI 10.1016/S0014-5793(98)00046-5; GOUGH AL, 1978, NEUROPHARMACOLOGY, V17, P137, DOI 10.1016/0028-3908(78)90126-0; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HEMMING M, 1993, J PSYCHOPHARMACOL, V7, P389, DOI 10.1177/026988119300700411; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HILLARD CJ, 1995, BBA-LIPID LIPID MET, V1257, P249, DOI 10.1016/0005-2760(95)00087-S; Kondo S, 1998, FEBS LETT, V429, P152, DOI 10.1016/S0014-5793(98)00581-X; Landsman RS, 1997, EUR J PHARMACOL, V334, pR1, DOI 10.1016/S0014-2999(97)01160-6; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Matsuda LA, 1997, CRIT REV NEUROBIOL, V11, P143, DOI 10.1615/CritRevNeurobiol.v11.i2-3.30; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MULLERVAHL KR, IN PRESS AM J PSYCHI; NAVARRO M, 1993, PHARMACOL BIOCHEM BE, V45, P291, DOI 10.1016/0091-3057(93)90241-K; PARSONS LH, 1994, CRIT REV NEUROBIOL, V8, P189; Parsons LH, 1996, J NEUROCHEM, V67, P1078; Piomelli Daniele, 1995, P595; PRYOR GT, 1978, PHARMACOL BIOCHEM BE, V8, P295, DOI 10.1016/0091-3057(78)90320-9; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; SanudoPena MC, 1996, NEUROSCI LETT, V206, P21, DOI 10.1016/0304-3940(96)12436-8; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Sim LJ, 1996, EUR J PHARMACOL, V307, P97, DOI 10.1016/0014-2999(96)00211-7; SOUILHAC J, 1995, PHARMACOL BIOCHEM BE, V51, P3, DOI 10.1016/0091-3057(94)00396-Z; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; Sugiura T, 1996, BIOCHEM BIOPH RES CO, V218, P113, DOI 10.1006/bbrc.1996.0020; Surmeier D J, 1998, Adv Pharmacol, V42, P1020; Szabo B, 1998, NEUROSCIENCE, V85, P395, DOI 10.1016/S0306-4522(97)00597-6; Thorn L, 1997, NEUROPHARMACOLOGY, V36, P787, DOI 10.1016/S0028-3908(97)00033-6; UEDA N, 1995, J BIOL CHEM, V270, P23823, DOI 10.1074/jbc.270.40.23823; WADDINGTON JL, 1990, NEUROBIOLOGY STEREOT, P64; Wolf SS, 1996, SCIENCE, V273, P1225, DOI 10.1126/science.273.5279.1225	50	620	636	2	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					358	363		10.1038/7268	http://dx.doi.org/10.1038/7268			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204543	Green Submitted			2022-12-24	WOS:000080532000015
J	Hu, SC; Chrivia, J; Ghosh, A				Hu, SC; Chrivia, J; Ghosh, A			Regulation of CBP-mediated transcription by neuronal calcium signaling	NEURON			English	Article							LONG-TERM-MEMORY; CREB-BINDING PROTEIN; CAMP-RESPONSIVE ELEMENT; APLYSIA SENSORY NEURONS; C-FOS TRANSCRIPTION; NUCLEAR-PROTEIN; HISTONE ACETYLTRANSFERASES; SYNAPTIC PLASTICITY; GENE-EXPRESSION; KINASE-IV	The transcription factor CREB is involved in mediating many of the long-term effects of activity-dependent plasticity at glutamatergic synapses. Here, we show that activation of NMDA receptors and voltage-sensitive calcium channels leads to CREB-mediated transcription in cortical neurons via a mechanism regulated by CREB-binding protein (CBP). Recruitment of CBP to the promoter is not sufficient for transactivation, but calcium influx can induce CBP-mediated transcription via two distinct transactivation domains. CBP-mediated transcription is stimulus strength-dependent and can be induced by activation of CaM kinase II, CaM kinase IV, and protein kinase A, but not by activation of the Ras-MAP kinase pathway. These observations indicate that CBP can function as a calcium-sensitive transcriptional coactivator that may act as a regulatory switch for glutamate-induced CREB-mediated transcription.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	Johns Hopkins University; Saint Louis University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	aghosh@jhmi.edu						ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bisotto S, 1996, J BIOL CHEM, V271, P17746, DOI 10.1074/jbc.271.30.17746; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MARTIN KJ, 1990, NATURE, V346, P147, DOI 10.1038/346147a0; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; NORDHEIM A, 1994, NATURE, V370, P177, DOI 10.1038/370177a0; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Park IK, 1995, J BIOL CHEM, V270, P30464, DOI 10.1074/jbc.270.51.30464; Parker D, 1996, MOL CELL BIOL, V16, P694; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Wright JH, 1997, MOL BIOL CELL, V8, P1575, DOI 10.1091/mbc.8.8.1575; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yoshida E, 1998, GENE, V208, P307, DOI 10.1016/S0378-1119(98)00008-0	49	199	201	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					799	808		10.1016/S0896-6273(00)80738-2	http://dx.doi.org/10.1016/S0896-6273(00)80738-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230799	hybrid			2022-12-24	WOS:000079976200022
J	Lieberman, DN; Mody, I				Lieberman, DN; Mody, I			Casein kinase-II regulates NMDA channel function in hippocampal neuron	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; D-ASPARTATE RECEPTOR; RAT CEREBRAL-CORTEX; KAPPA-B; POLYAMINES; CALMODULIN; PHOSPHORYLATION; SPERMINE; BLOCK; BRAIN	Several second-messenger-regulated protein kinases have been implicated in the regulation of N-methyl-D-aspartate (NMDA) channel function. Yet the role of calcium and cyclic-nucleotide-independent kinases, such as casein kinase II (CKII), has remained unexplored. Here we identify CKII as an endogenous Ser/Thr protein kinase that potently regulates NMDA channel function and mediates intracellular actions of spermine on the channel. The activity of NMDA channels in cell-attached and inside-out recordings was enhanced by CKII or spermine and was decreased by selective inhibition of CKII. In hippocampal slices, inhibitors of CKII reduced synaptic transmission mediated by NMDA but not AMPA receptors. The dependence of NMDA receptor channel activity on tonically active CKII thus permits changes in intracellular spermine levels or phosphatase activities to effectively control channel function.	Stanford Univ, Sch Med, Grad Program Neurosci, Stanford, CA 94305 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lieberman, DN (corresponding author), Stanford Univ, Sch Med, Grad Program Neurosci, Stanford, CA 94305 USA.	liebdude@leland.stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027528] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 27528] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APEL ED, 1991, J BIOL CHEM, V266, P10544; Bahring R, 1997, J PHYSIOL-LONDON, V502, P575, DOI 10.1111/j.1469-7793.1997.575bj.x; BARROGA CF, 1995, P NATL ACAD SCI USA, V92, P7637, DOI 10.1073/pnas.92.17.7637; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BENVENISTE M, 1993, J PHYSIOL-LONDON, V464, P131, DOI 10.1113/jphysiol.1993.sp019627; Blanquet PR, 1998, NEUROSCIENCE, V86, P739, DOI 10.1016/S0306-4522(98)00087-6; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; CHARRIAUTMARLANGUE C, 1991, P NATL ACAD SCI USA, V88, P10232, DOI 10.1073/pnas.88.22.10232; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; Critchfield JW, 1997, P NATL ACAD SCI USA, V94, P6110, DOI 10.1073/pnas.94.12.6110; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; EHRLICH BE, 1994, TRENDS PHARMACOL SCI, V15, P145, DOI 10.1016/0165-6147(94)90074-4; GILAD GM, 1991, EUR J PHARMACOL, V193, P41, DOI 10.1016/0014-2999(91)90198-Y; GILAD GM, 1993, MOL CHEM NEUROPATHOL, V18, P197, DOI 10.1007/BF03160034; GIRAULT JA, 1990, J NEUROCHEM, V55, P1772, DOI 10.1111/j.1471-4159.1990.tb04968.x; GOTO S, 1993, NEUROSCI LETT, V149, P189, DOI 10.1016/0304-3940(93)90768-G; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HARMAN RJ, 1981, J NEUROCHEM, V36, P1609, DOI 10.1111/j.1471-4159.1981.tb00409.x; HERMAN MD, 1993, J PHYSIOL-LONDON, V462, P645, DOI 10.1113/jphysiol.1993.sp019574; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; ISHIKAWA N, 1990, J PHARMACOL EXP THER, V254, P598; Johnson TD, 1998, PROG DRUG RES, V50, P193; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOHR G, 1993, J NEUROSCI, V13, P3612; KOLAJ M, 1994, J NEUROPHYSIOL, V72, P2525, DOI 10.1152/jn.1994.72.5.2525; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; LERMA J, 1992, NEURON, V8, P343, DOI 10.1016/0896-6273(92)90300-3; LI GD, 1992, MOL PHARMACOL, V42, P489; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; SACKS DB, 1992, BIOCHEM J, V283, P21, DOI 10.1042/bj2830021; SHAW GG, 1973, J NEUROCHEM, V20, P1225, DOI 10.1111/j.1471-4159.1973.tb00091.x; SOKABE M, 1990, J CELL BIOL, V111, P599, DOI 10.1083/jcb.111.2.599; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Tuazon P. T., 1991, ADV 2 MESSENGER PHOS, V23, P123; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; WILLUWEIT B, 1988, BIOCHEM J, V249, P857, DOI 10.1042/bj2490857; Ye CP, 1996, BIOCHEM BIOPH RES CO, V224, P271, DOI 10.1006/bbrc.1996.1019; ZANDOMENI R, 1984, J BIOL CHEM, V259, P4804; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414	50	60	63	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					125	132		10.1038/5680	http://dx.doi.org/10.1038/5680			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195195				2022-12-24	WOS:000078231600010
J	Lewin, MR; Walters, ET				Lewin, MR; Walters, ET			Cyclic GMP pathway is critical for inducing long-term sensitization of nociceptive sensory neurons	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE; GENE-EXPRESSION; SYNAPTIC CONNECTIONS; CATALYTIC SUBUNIT; NERVOUS-SYSTEM; AXONAL INJURY; C-FOS; APLYSIA; CAMP	Noxious stimulation can trigger persistent sensitization of somatosensory systems that involves memory-like mechanisms. Here we report that noxious stimulation of the mollusc Aplysia produces transcription-dependent, long-term hyperexcitability (LTH) of nociceptive sensory neurons that requires a nitric oxide (NO)-cyclic GMP-protein kinase C (PKG) pathway. Injection of cGMP induced LTH, whereas antagonists of the NO-cGMP-PKG pathway prevented pinch-induced LTH. Co-injection of calcium/cAMP-responsive-element (CRE) blocked both pinch-induced LTH and cAMP-induced LTH, but antagonists of protein kinase A (PKA) failed to block pinch-induced LTH. Thus the NO-cGMP-PKG pathway and at least one other pathway, but not the cAMP-PKA pathway, are critical for inducing LTH after brief, noxious stimulation.	Univ Texas, Dept Integrat Biol Physiol & Pharmacol, Houston, TX 77030 USA	University of Texas System	Walters, ET (corresponding author), Univ Texas, Dept Integrat Biol Physiol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.			Walters, Edgar/0000-0003-0718-102X; Lewin, Matthew/0000-0003-4480-9891	NINDS NIH HHS [NS35979, NS35882] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035882, R01NS035979] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; AMBRON RT, 1995, J NEUROSCI, V15, P3440; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Belsham DD, 1996, EMBO J, V15, P538, DOI 10.1002/j.1460-2075.1996.tb00386.x; Bernabeu R, 1997, NEUROREPORT, V8, P2221, DOI 10.1097/00001756-199707070-00026; BILLY AJ, 1989, J NEUROSCI, V9, P1254; CLATWORTHY AL, 1993, J NEUROPHYSIOL, V70, P1181, DOI 10.1152/jn.1993.70.3.1181; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; DALE N, 1987, J NEUROSCI, V7, P2232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; FANTOZZI DA, 1994, J BIOL CHEM, V269, P2676; Floyd PD, 1998, ANAL CHEM, V70, P2243, DOI 10.1021/ac9713013; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; Gudi T, 1996, J BIOL CHEM, V271, P4597; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; GUNSTREAM JD, 1995, J NEUROSCI, V15, P439; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JACKLET JW, 1995, J NEUROPHYSIOL, V74, P891, DOI 10.1152/jn.1995.74.2.891; JOHNSTON HM, 1995, MOL BRAIN RES, V31, P141, DOI 10.1016/0169-328X(95)00046-U; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; Kendrick KM, 1997, NATURE, V388, P670, DOI 10.1038/41765; LAIO X, IN PRESS NEUROSCIENC; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Manseau F, 1998, J NEUROPHYSIOL, V79, P1210, DOI 10.1152/jn.1998.79.3.1210; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MEULEMANS A, 1995, NEUROSCIENCE, V69, P985, DOI 10.1016/0306-4522(95)00316-B; NAKAZAWA K, 1993, NEUROREPORT, V4, P1275, DOI 10.1097/00001756-199309000-00017; NIEDBALA B, 1995, NEUROSCI LETT, V188, P57, DOI 10.1016/0304-3940(95)11394-C; NOVAKHOFER I, 1985, J NEUROSCI, V5, P151; OCORR KA, 1985, NEUROSCI LETT, V55, P113, DOI 10.1016/0304-3940(85)90004-7; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHOLZ KP, 1988, SCIENCE, V240, P1664, DOI 10.1126/science.2837826; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; WALTERS ET, 1987, J NEUROSCI, V7, P408; WALTERS ET, 1994, INT REV NEUROBIOL, V36, P325, DOI 10.1016/S0074-7742(08)60307-4; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1522, DOI 10.1152/jn.1983.50.6.1522; WALTERS ET, 1991, SCIENCE, V253, P797, DOI 10.1126/science.1652154; Wang X, 1997, J NEUROCHEM, V68, P443; WOODY CD, 1978, BRAIN RES, V158, P373, DOI 10.1016/0006-8993(78)90682-0	47	118	129	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					18	23		10.1038/4520	http://dx.doi.org/10.1038/4520			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195175				2022-12-24	WOS:000078409300008
J	Chuang, RSI; Jaffe, H; Cribbs, L; Perez-Reyes, E; Swartz, KJ				Chuang, RSI; Jaffe, H; Cribbs, L; Perez-Reyes, E; Swartz, KJ			Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin	NATURE NEUROSCIENCE			English	Article							VERTEBRATE SENSORY NEURONS; HIGH-AFFINITY BINDING; FUNCTIONAL EXPRESSION; SODIUM-CHANNEL; ALPHA-SUBUNIT; BETA-SUBUNIT; CA-CHANNEL; K+ CHANNEL; CELLS; CURRENTS	The biophysical properties of T-type voltage-gated calcium channels are well suited to pacemaking and to supporting calcium flux near the resting membrane potential in both excitable and nonexcitable cells. We have identified a new scorpion toxin (kurtoxin) that binds to the alpha(1G) T-type calcium channel with high affinity and inhibits the channel by modifying voltage-dependent gating. This toxin distinguishes between alpha(1G) T-type calcium channels and other types of voltage-gated calcium channels, including alpha(1A), alpha(1B), alpha(1C) and alpha(1E). Like the other alpha-scorpion toxins to which it is related, kurtoxin also interacts with voltage-gated sodium channels and slows their inactivation. Kurtoxin will facilitate characterization of the subunit composition of T-type calcium channels and help determine their involvement in electrical and biochemical signaling.	NINDS, Mol Physiol & Biophys Unit, NIH, Bethesda, MD 20892 USA; NINDS, Prot Peptide Sequencing Facil, NIH, Bethesda, MD 20892 USA; Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Loyola University Chicago	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Unit, NIH, Bldg 36,Rm 2CI9,36 Convent Dr,MSC 4066, Bethesda, MD 20892 USA.	kjswartz@codon.nih.gov	Tuluc, Petronel/C-2527-2011		Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Bean BP, 1998, NEURON, V20, P825, DOI 10.1016/S0896-6273(00)80463-8; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; BEZPROZVANNY L, 1995, MOL PHARMACOL, V48, P540; BOSSU JL, 1985, PFLUG ARCH EUR J PHY, V403, P360, DOI 10.1007/BF00589247; Bourinet E, 1996, J NEUROSCI, V16, P4983; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CATTERALL WA, 1979, J GEN PHYSIOL, V74, P375, DOI 10.1085/jgp.74.3.375; CHEN CF, 1990, J GEN PHYSIOL, V96, P603, DOI 10.1085/jgp.96.3.603; CHEN CF, 1988, SCIENCE, V239, P1024, DOI 10.1126/science.2449730; COHEN CJ, 1988, P NATL ACAD SCI USA, V85, P2412, DOI 10.1073/pnas.85.7.2412; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Jaffe H, 1998, BIOCHEMISTRY-US, V37, P3931, DOI 10.1021/bi972518u; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KOSTYUK PG, 1988, PFLUGERS ARCH, V411, P611; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; McDonough SI, 1997, BIOPHYS J, V72, P2117, DOI 10.1016/S0006-3495(97)78854-4; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; Meir A, 1998, NEURON, V20, P341, DOI 10.1016/S0896-6273(00)80461-4; MEVES H, 1986, ANN NY ACAD SCI, V479, P113, DOI 10.1111/j.1749-6632.1986.tb15565.x; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; Stone K. L., 1993, PRACTICAL GUIDE PROT, P43; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; WANG GK, 1985, J GEN PHYSIOL, V86, P739, DOI 10.1085/jgp.86.5.739; Wei X, 1996, RECEPTOR CHANNEL, V4, P205; WEI XY, 1991, J BIOL CHEM, V266, P21943	44	154	164	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					668	674		10.1038/3669	http://dx.doi.org/10.1038/3669			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196582				2022-12-24	WOS:000077323400010
J	Kang, J; Jiang, L; Goldman, SA; Nedergaard, M				Kang, J; Jiang, L; Goldman, SA; Nedergaard, M			Astrocyte-mediated potentiation of inhibitory synaptic transmission	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED ASTROCYTES; HIPPOCAMPUS INVITRO; CALCIUM WAVES; IN-SITU; NEURONS; CELLS; STIMULATION; SYNAPSES	We investigated the role of astrocytes in activity-dependent modulation of inhibitory synaptic transmission in hippocampal slices. Repetitive firing of an interneuron decreased the probability of synaptic failures in spike-evoked inhibitory postsynaptic currents (unitary IPSCs) in CA1 pyramidal neurons. The GABA(B)-receptor antagonist CCP55845A abolished this effect. Direct stimulation of astrocytes, or application of the GABA(B)-receptor agonist baclofen, potentiated miniature inhibitory postsynaptic currents (mIPSCs) in pyramidal neurons. These effects were blocked by inhibition of astrocytic calcium signaling with the calcium chelator BAPTA or by antagonists of the ionotropic glutamate receptors. These observations suggest that interneuronal firing elicits a GABA(B)-receptor-mediated elevation of calcium in surrounding astrocytes, which in turn potentiates inhibitory transmission. Astrocytes may therefore be a necessary intermediary in activity-dependent modulation of inhibitory synapses in the hippocampus.	New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY 10021 USA	New York Medical College; Cornell University	Kang, J (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Basic Sci Bldg,Room 204, Valhalla, NY 10595 USA.	jian_kang@NYMC.edu		Goldman, Steven/0000-0002-5498-4303	NINDS NIH HHS [R01NS35011, IR29NS37349-01, R01NS30007] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035011, R29NS037349, R01NS030007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DAVIES CH, 1993, J PHYSIOL-LONDON, V472, P245, DOI 10.1113/jphysiol.1993.sp019945; FLEIDERVISH IA, 1995, J NEUROPHYSIOL, V73, P2591, DOI 10.1152/jn.1995.73.6.2591; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Kang J, 1996, J NEUROPHYSIOL, V76, P188, DOI 10.1152/jn.1996.76.1.188; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; KORN H, 1992, P NATL ACAD SCI USA, V89, P440, DOI 10.1073/pnas.89.1.440; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1991, J PHYSIOL-LONDON, V443, P669, DOI 10.1113/jphysiol.1991.sp018857; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 1997, J NEUROSCI, V17, P7817; Porter JT, 1996, J NEUROSCI, V16, P5073; Pouzat C, 1997, J NEUROSCI, V17, P9104; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; THOMPSON SM, 1985, J NEUROSCI, V5, P817; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; WONG RKS, 1982, J NEUROPHYSIOL, V48, P938, DOI 10.1152/jn.1982.48.4.938; Xie Z, 1995, CAN J PHYSIOL PHARM, V73, P1706, DOI 10.1139/y95-734	35	641	660	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					683	692		10.1038/3684	http://dx.doi.org/10.1038/3684			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196584				2022-12-24	WOS:000077323400012
J	Kilgard, MP; Merzenich, MM				Kilgard, MP; Merzenich, MM			Plasticity of temporal information processing in the primary auditory cortex	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; FREQUENCY-DISCRIMINATION TASK; RECEPTIVE-FIELD PLASTICITY; ADULT OWL MONKEYS; CORTICAL-NEURONS; VISUAL-CORTEX; CONTRAST SENSITIVITY; NUCLEUS BASALIS; GUINEA-PIG; RAT	Neurons in the rat primary auditory cortex (Al) generally cannot respond to tone sequences faster than 12 pulses per second (pps). To test whether experience can modify this maximum following rate in adult rats, trains of brief tones with random carrier frequency but fixed repetition rate were paired with electrical stimulation of the nucleus basalis (NB) 300 to 400 times per day for 20-25 days. Pairing NE stimulation with 5-pps stimuli markedly decreased the cortical response to rapidly presented stimuli, whereas pairing with 15-pps stimuli significantly increased the maximum cortical following rate. In contrast, pairing with fixed carrier frequency 15-pps trains did not significantly increase the mean maximum following rate. Thus this protocol elicits extensive cortical remodeling of temporal response properties and demonstrates that simple differences in spectral and temporal features of the sensory input can drive very different cortical reorganizations.	Univ Calif San Francisco, Dept Otolaryngol, Coleman Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, Coleman Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Sci Learning Corp, Berkeley, CA 94104 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kilgard, MP (corresponding author), Univ Calif San Francisco, Dept Otolaryngol, Coleman Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	kilgard@phy.ucsf.edu		Kilgard, Michael/0000-0002-6699-1818	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS010414, F32NS010414] Funding Source: NIH RePORTER; NINDS NIH HHS [F32 NS010414, NS-10414, R01 NS010414, R01 NS010414-27] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; BEAULIEU C, 1990, DEV BRAIN RES, V53, P82, DOI 10.1016/0165-3806(90)90126-J; Bjordahl TS, 1998, BEHAV NEUROSCI, V112, P467, DOI 10.1037/0735-7044.112.3.467; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Buonomano DV, 1997, P NATL ACAD SCI USA, V94, P10403, DOI 10.1073/pnas.94.19.10403; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Cartling B, 1997, BIOL CYBERN, V76, P383, DOI 10.1007/s004220050352; Chance FS, 1998, J NEUROSCI, V18, P4785; CHARPIER S, 1995, P NATL ACAD SCI USA, V92, P117, DOI 10.1073/pnas.92.1.117; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; Dinse HR, 1997, INT J PSYCHOPHYSIOL, V26, P205, DOI 10.1016/S0167-8760(97)00765-4; EGGERMONT JJ, 1995, J NEUROPHYSIOL, V73, P227, DOI 10.1152/jn.1995.73.1.227; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; Grabauskas G, 1998, J NEUROPHYSIOL, V79, P595, DOI 10.1152/jn.1998.79.2.595; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Hollrigel GS, 1998, P ROY SOC B-BIOL SCI, V265, P63, DOI 10.1098/rspb.1998.0265; JimenezCapdeville ME, 1997, J COMP NEUROL, V381, P53, DOI 10.1002/(SICI)1096-9861(19970428)381:1<53::AID-CNE5>3.0.CO;2-J; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; Kenmochi M, 1997, NEUROREPORT, V8, P1589, DOI 10.1097/00001756-199705060-00008; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MCKENNA TM, 1989, SYNAPSE, V4, P30, DOI 10.1002/syn.890040105; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; METHERATE R, 1989, BRAIN RES, V480, P372, DOI 10.1016/0006-8993(89)90210-2; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; NEISSER U, 1974, PERCEPT PSYCHOPHYS, V15, P391, DOI 10.3758/BF03213964; Pizzorusso T, 1997, VISION RES, V37, P389, DOI 10.1016/S0042-6989(96)00172-1; RASMUSSON DD, 1992, BRAIN RES, V594, P150, DOI 10.1016/0006-8993(92)91041-C; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1015, DOI 10.1152/jn.1992.67.5.1015; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057, DOI 10.1152/jn.1992.67.5.1057; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Schreiner CE, 1997, ACTA OTO-LARYNGOL, P54; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; SCHREINER CE, 1986, AUDITORY FUNCTION, P337; TOLHURST DJ, 1975, NATURE, V257, P674, DOI 10.1038/257674a0; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; Woodrow H, 1935, PSYCHOL REV, V42, P127, DOI 10.1037/h0063696; Wright BA, 1997, J NEUROSCI, V17, P3956; Xerri C, 1996, J PHYSIOLOGY-PARIS, V90, P277, DOI 10.1016/S0928-4257(97)81438-6	50	234	235	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					727	731		10.1038/3729	http://dx.doi.org/10.1038/3729			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196590	Green Accepted			2022-12-24	WOS:000077323400018
J	Lee, CG; Bae, KH; Edery, I				Lee, CG; Bae, KH; Edery, I			The Drosophila CLOCK protein undergoes daily rhythms in abundance, phosphorylation, and interactions with the PER-TIM complex	NEURON			English	Article							CIRCADIAN BEHAVIORAL RHYTHMS; NUCLEAR ENTRY; GENE; TIMELESS; MELANOGASTER; FREQUENCY; AUTOREGULATION; OSCILLATION; ENTRAINMENT; MUTAGENESIS	We report the in vivo characterization of the Drosophila CLOCK protein (dCLOCK), a transcription factor that is required for the expression of the circadian clock genes period (per) and timeless (tim). dCLOCK undergoes circadian fluctuations in abundance, is phosphorylated throughout a daily cycle, and interacts with PER, TIM, and/or the PER-TIM complex during the night but not during most of the day. Our results suggest that PER and TIM participate in transcriptional autoinhibition by physically interacting with dCLOCK or a dCLOCK-containing complex. Nevertheless, in the absence of PER or TIM, the levels of dCLOCK are constitutively low, indicating that PER and TIM also act as positive elements in the feedback loop by stimulating the production of dCLOCK.	Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Grad Program Microbiol & Mol Genet, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Edery, I (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.							Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap J, 1998, SCIENCE, V280, P1548, DOI 10.1126/science.280.5369.1548; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; EWER J, 1992, J NEUROSCI, V12, P3321; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hastings J.W., 1991, NEURAL INTEGRATIVE A, P435; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Majercak J, 1997, MOL CELL BIOL, V17, P5915, DOI 10.1128/MCB.17.10.5915; Merrow MW, 1997, P NATL ACAD SCI USA, V94, P3877, DOI 10.1073/pnas.94.8.3877; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Rosbash M, 1996, COLD SPRING HARB SYM, V61, P265; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sauman I, 1996, NEURON, V17, P901, DOI 10.1016/S0896-6273(00)80221-4; Sauman I, 1998, NEURON, V20, P741, DOI 10.1016/S0896-6273(00)81012-0; Schibler U, 1998, NATURE, V393, P620, DOI 10.1038/31337; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	53	198	199	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					857	867		10.1016/S0896-6273(00)80601-7	http://dx.doi.org/10.1016/S0896-6273(00)80601-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808471	Bronze			2022-12-24	WOS:000076697300028
J	Ergenzinger, ER; Glasier, MM; Hahm, JO; Pons, TP				Ergenzinger, ER; Glasier, MM; Hahm, JO; Pons, TP			Cortically induced thalamic plasticity in the primate somatosensory system	NATURE NEUROSCIENCE			English	Article							MACAQUE MONKEYS; RELAY NEURONS; ADULT MONKEYS; CORTEX; DEAFFERENTATION; REORGANIZATION; ORGANIZATION; NUCLEUS; CAT; RAT	The influence of cortical feedback on receptive field organization in the thalamus was assessed in the primate somatosensory system. Chronic and acute suppression of neuronal activity in primary somatosensory cortex resulted in a striking enlargement of receptive fields in the ventroposterior thalamus. This finding demonstrates a dramatic 'top-down' influence of cortex on receptive field size in the somatosensory thalamus. In addition, this result has important implications for studies of adult neuronal plasticity because it indicates that changes in 'higher-order' areas of the brain can trigger extensive changes in the receptive field characteristics of neurons located earlier in the processing pathway.	Wake Forest Univ, Sch Med, Dept Neurosurg, Winston Salem, NC 27127 USA; Wake Forest Univ, Sch Med, Program Neurosci, Winston Salem, NC 27127 USA; Georgetown Univ, Dept Neurosurg, Washington, DC 20057 USA	Wake Forest University; Wake Forest University; Georgetown University	Pons, TP (corresponding author), Wake Forest Univ, Sch Med, Dept Neurosurg, Winston Salem, NC 27127 USA.	tpons@wfubmc.edu			NIMH NIH HHS [MH53369-02, MH11950-01] Funding Source: Medline; NINDS NIH HHS [NS35246-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011950, R01MH053369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035246] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAVA A, 1968, ARCH ITAL BIOL, V106, P204; BURCHFIEL JL, 1974, BRAIN RES, V70, P395, DOI 10.1016/0006-8993(74)90251-0; CONTI F, 1996, EXCITATORY AMINO ACI, P81; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; DOSTROVSKY JO, 1976, EXP NEUROL, V52, P480, DOI 10.1016/0014-4886(76)90219-3; GARRAGHTY PE, 1991, NEUROREPORT, V2, P747, DOI 10.1097/00001756-199112000-00004; Garraghty PE, 1996, J COMP NEUROL, V367, P319, DOI 10.1002/(SICI)1096-9861(19960401)367:2<319::AID-CNE12>3.0.CO;2-L; GHOSH S, 1994, EXP BRAIN RES, V100, P276; Jones EG, 1985, THALAMUS; Kaas J.H., 1988, P421; LIU XB, 1995, J COMP NEUROL, V352, P69, DOI 10.1002/cne.903520106; LOE PR, 1977, J NEUROPHYSIOL, V40, P1339, DOI 10.1152/jn.1977.40.6.1339; MCMAHON SB, 1983, EXP NEUROL, V80, P195, DOI 10.1016/0014-4886(83)90016-X; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; POGGIO GF, 1963, J NEUROPHYSIOL, V26, P775, DOI 10.1152/jn.1963.26.5.775; POLLIN B, 1979, BRAIN RES, V173, P431, DOI 10.1016/0006-8993(79)90240-3; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; PONS TP, 1985, J COMP NEUROL, V241, P445, DOI 10.1002/cne.902410405; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; PONS TP, 1987, SOMATOSENS MOT RES, V4, P309, DOI 10.3109/07367228709144612; PONS TP, 1996, SOMESTHESIS NEUROBIO, P187; SHIN HC, 1990, SOMATOSENS MOT RES, V7, P421, DOI 10.3109/08990229009144717; TSUMOTO T, 1974, EXP BRAIN RES, V21, P195; YUAN B, 1985, J NEUROSCI, V5, P2971	25	126	126	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					226	229		10.1038/673	http://dx.doi.org/10.1038/673			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195147				2022-12-24	WOS:000076361200013
J	Archie, KA; Mel, BW				Archie, KA; Mel, BW			A model for intradendritic computation of binocular disparity	NATURE NEUROSCIENCE			English	Article							CATS STRIATE CORTEX; VISUAL CORTICAL-NEURONS; ORIENTATION SELECTIVITY; COMPLEX CELLS; DISCRIMINATION; INTEGRATION; MECHANISMS; SPINES; MONKEY; SENSITIVITY	Many complex cells in mammalian primary visual cortex are finely tuned to binocular disparity. in the prevailing model, several binocular simple cells drive each disparity-tuned complex cell. However, some cat complex cells receive direct LGN input, and binocular simple cells are rare in macaque. In our biophysically detailed compartmental model, active dendrites of a single neuron perform the multiple simple-cell-like subunit computations that underlie both orientation and disparity tuning. The responses of our detailed model could be predicted by a simple algebraic formula closely related to an 'energy' model. Adding inhibitory synapses led to sharper, more contrast-invariant tuning curves. Thus active dendrites could contribute to binocular-disparity tuning in complex cells.	Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Archie, KA (corresponding author), Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA.							Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Fleet DJ, 1996, VISION RES, V36, P1839, DOI 10.1016/0042-6989(95)00313-4; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1982, NATURE, V299, P515, DOI 10.1038/299515a0; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOCH C, 1993, J NEUROSCI, V13, P413; KOCH C, 1986, TRENDS NEUROSCI, V9, P204, DOI 10.1016/0166-2236(86)90060-3; KOCH C, 1987, SYNAPTIC FUNCTION, P637; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; Livingstone MS, 1999, NAT NEUROSCI, V2, P825, DOI 10.1038/12199; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mel B. W., 1999, DENDRITES, P271; MEL BW, 1992, ADV NEUR IN, V4, P35; Mel BW, 1998, ADV NEUR IN, V10, P208; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Mel BW, 1998, J NEUROSCI, V18, P4325; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; PETERHANS E, 1989, J NEUROSCI, V9, P1749; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1369, DOI 10.1152/jn.1977.40.6.1369; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Vidyasagar TR, 1996, TRENDS NEUROSCI, V19, P272, DOI 10.1016/S0166-2236(96)20027-X; WOOLF TB, 1991, J NEUROSCI, V11, P1837; WORGOTTER F, 1991, J NEUROSCI, V11, P1959; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; Zhu YD, 1996, NEURAL COMPUT, V8, P1611, DOI 10.1162/neco.1996.8.8.1611	50	103	105	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					54	63		10.1038/71125	http://dx.doi.org/10.1038/71125			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607395				2022-12-24	WOS:000085810200012
J	Stellwagen, D; Shatz, CJ; Feller, MB				Stellwagen, D; Shatz, CJ; Feller, MB			Dynamics of retinal waves are controlled by cyclic AMP	NEURON			English	Article							DEVELOPING MAMMALIAN RETINA; STARBURST AMACRINE CELLS; LATERAL GENICULATE-NUCLEUS; LARVAL FROG RETINA; PROTEIN-KINASE-A; GANGLION-CELLS; BURSTING ACTIVITY; RABBIT RETINA; MEDIATED ENHANCEMENT; PRENATAL DEVELOPMENT	Waves of spontaneous activity sweep across the developing mammalian retina and influence the pattern of central connections made by ganglion cell axons. These waves are driven by synaptic input from amacrine cells. We show that cholinergic synaptic transmission during waves is not blocked by TTX, indicating that release from starburst amacrine cells is independent of sodium action potentials. The spatiotemporal properties of the waves are regulated by endogenous release of adenosine, which sets intracellular cAMP levels through activation of A2 receptors present on developing amacrine and ganglion cells. Increasing cAMP levels increase the size, speed, and frequency of the waves. Conversely, inhibiting adenylate cyclase or PKA prevents wave activity. Together, these results imply a novel mechanism in which levels of cAMP within an immature retinal circuit regulate the precise spatial and temporal patterns of spontaneous neural activity.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stellwagen, D (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	stell@aclink4.berkeley.edu			NIGMS NIH HHS [GM0748] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAHRING R, 1994, EUR J NEUROSCI, V6, P1089, DOI 10.1111/j.1460-9568.1994.tb00606.x; Baldridge WH, 1998, SEMIN CELL DEV BIOL, V9, P311, DOI 10.1006/scdb.1998.0235; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bieda MC, 1999, J NEUROPHYSIOL, V81, P3092, DOI 10.1152/jn.1999.81.6.3092; BLAZYNSKI C, 1986, BRAIN RES, V366, P224, DOI 10.1016/0006-8993(86)91299-0; BLAZYNSKI C, 1990, J NEUROCHEM, V54, P648, DOI 10.1111/j.1471-4159.1990.tb01920.x; BLAZYNSKI C, 1993, EXP EYE RES, V56, P585, DOI 10.1006/exer.1993.1072; BLAZYNSKI C, 1989, VISUAL NEUROSCI, V3, P425, DOI 10.1017/S0952523800005927; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; BRAAS KM, 1987, P NATL ACAD SCI USA, V84, P3906, DOI 10.1073/pnas.84.11.3906; Butts DA, 1999, J NEUROSCI, V19, P3580; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Chen CF, 1997, J NEUROSCI, V17, P8687; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Dale N, 1996, NATURE, V383, P259, DOI 10.1038/383259a0; DECARVALHO RP, 1982, J NEUROCHEM, V38, P493; DOWLING JE, 1987, RETIAN APPROACHABLE; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Fischer KF, 1998, J NEUROSCI, V18, P3767; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; GURANTZ D, 1994, J NEUROSCI, V14, P3540; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; Hanson MG, 1998, J NEUROSCI, V18, P7361; HENDERSON Z, 1988, J NEUROSCI, V8, P1194; Huang B, 1996, VISUAL NEUROSCI, V13, P441, DOI 10.1017/S0952523800008117; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kondo S, 1997, J PHYSIOL-LONDON, V498, P165, DOI 10.1113/jphysiol.1997.sp021849; LAM K, 1982, DEV BRAIN RES, V3, P487, DOI 10.1016/0165-3806(82)90014-1; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; Lukasiewicz PD, 1998, SEMIN CELL DEV BIOL, V9, P293, DOI 10.1006/scdb.1998.0238; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; MCINTOSH HH, 1994, J NEUROCHEM, V62, P992; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; MITROFANIS J, 1989, J COMP NEUROL, V289, P228, DOI 10.1002/cne.902890205; Obrietan K, 1997, J NEUROSCI, V17, P4785; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; PENN AA, 1994, J NEUROSCI, V14, P3805; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; POTTS RA, 1982, DEV BRAIN RES, V3, P481, DOI 10.1016/0165-3806(82)90013-X; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Rathouz MM, 1996, MOL NEUROBIOL, V12, P117, DOI 10.1007/BF02740649; REH TA, 1987, J NEUROSCI, V7, P3317; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; RODRIGUEZTEBAR A, 1989, DEV BIOL, V136, P296, DOI 10.1016/0012-1606(89)90256-X; Schmid S, 1999, J NEUROSCI, V19, P3486; SCHMIDT JT, 1993, J NEUROBIOL, V24, P384, DOI 10.1002/neu.480240310; Sernagor E, 1999, J NEUROSCI, V19, P3874; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; TAYLOR M, 1990, J NEUROBIOL, V21, P470, DOI 10.1002/neu.480210308; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wong WT, 1998, J NEUROSCI, V18, P8839; WULLE I, 1989, DEV BRAIN RES, V48, P59, DOI 10.1016/0165-3806(89)90093-X; YAMASHITA M, 1993, J NEUROBIOL, V24, P1600, DOI 10.1002/neu.480241205; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhou ZJ, 1998, J NEUROSCI, V18, P4155; Zhou ZJ, 1996, P NATL ACAD SCI USA, V93, P8057, DOI 10.1073/pnas.93.15.8057	86	108	110	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					673	685		10.1016/S0896-6273(00)81121-6	http://dx.doi.org/10.1016/S0896-6273(00)81121-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595518	Bronze			2022-12-24	WOS:000083913000022
J	Sterling, P				Sterling, P			Deciphering the retina's wiring diagram	NATURE NEUROSCIENCE			English	News Item							GANGLION-CELL; PRIMATE RETINA; SIGNALS; SIZE	By simultaneously recording from retinal ganglion cells while stimulating a single cane, Chichilnisky and Baylor demonstrate that the strength of physiological connections within a retinal microcircuit is linearly proportional to the number of anatomically defined synapses.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Sterling, P (corresponding author), Univ Penn, Dept Neurosci, 123 Anat Chem Bldg, Philadelphia, PA 19104 USA.							Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; FREED MA, 1992, P NATL ACAD SCI USA, V89, P236, DOI 10.1073/pnas.89.1.236; KIER CK, 1995, J NEUROSCI, V15, P7673; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; PEICHL L, 1979, J PHYSIOL-LONDON, V291, P117, DOI 10.1113/jphysiol.1979.sp012803; STERLING P, 1998, SYNAPTIC ORG BRAIN, P205; TSUKAMOTO Y, 1990, P NATL ACAD SCI USA, V87, P1860, DOI 10.1073/pnas.87.5.1860; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; WILLIAMS DR, 1981, VISION RES, V21, P1357, DOI 10.1016/0042-6989(81)90242-X	15	6	6	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					851	853		10.1038/13142	http://dx.doi.org/10.1038/13142			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491597				2022-12-24	WOS:000083883200002
J	Sengpiel, F; Stawinski, P; Bonhoeffer, T				Sengpiel, F; Stawinski, P; Bonhoeffer, T			Influence of experience on orientation maps in cat visual cortex	NATURE NEUROSCIENCE			English	Article							MONKEY STRIATE CORTEX; POSTSYNAPTIC ACTIVITY; CORTICAL-CELLS; KITTENS; ORGANIZATION; SELECTIVITY; CONTOURS; AREA-18; COLUMNS	Experience is known to affect the development of ocular dominance maps in visual cortex, but it has remained controversial whether orientation preference maps are similarly affected by limiting visual experience to a single orientation early in life. Here we used optical imaging based on intrinsic signals to show that the visual cortex of kittens reared in a striped environment responded to all orientations, but devoted up to twice as much surface area to the experienced orientation as the orthogonal one. This effect is due to an instructive role of visual experience whereby some neurons shift their orientation preferences toward the experienced orientation. Thus, although cortical orientation maps are remarkably rigid in the sense that orientations that have never been seen by the animal occupy a large portion of the cortical territory, visual experience can nevertheless alter neuronal responses to oriented contours.	Max Planck Inst Neurobiol, D-82152 Munich, Germany	Max Planck Society	Sengpiel, F (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Munich, Germany.		Bonhoeffer, Tobias/B-9481-2009; Sengpiel, Frank/A-4682-2010	Bonhoeffer, Tobias/0000-0001-7897-6634; Sengpiel, Frank/0000-0002-7060-1851				BLAKEMORE C, 1977, PHILOS T ROY SOC B, V278, P425, DOI 10.1098/rstb.1977.0052; BLAKEMORE C, 1973, NATURE, V241, P467, DOI 10.1038/241467a0; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1977, J PHYSIOL-LONDON, V265, P615, DOI 10.1113/jphysiol.1977.sp011734; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Bonhoeffer Tobias, 1996, P55; COLEMAN PD, 1981, BRAIN RES, V214, P1, DOI 10.1016/0006-8993(81)90435-2; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CYNADER M, 1977, NATURE, V270, P177, DOI 10.1038/270177a0; Freeman, 1979, DEV NEUROBIOLOGY VIS, P31; FREEMAN RD, 1973, NATURE, V246, P359, DOI 10.1038/246359a0; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; GORDON B, 1982, EXP BRAIN RES, V46, P144; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; RAUSCHECKER JP, 1979, NATURE, V280, P58, DOI 10.1038/280058a0; RAUSCHECKER JP, 1981, J PHYSIOL-LONDON, V310, P215, DOI 10.1113/jphysiol.1981.sp013545; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; SINGER W, 1981, EXP BRAIN RES, V41, P199; STRYKER MP, 1975, SCIENCE, V190, P904, DOI 10.1126/science.1188372; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; SWINDALE NV, 1982, TRENDS NEUROSCI, V5, P235, DOI 10.1016/0166-2236(82)90135-7; TIEMAN SB, 1982, J COMP NEUROL, V211, P353, DOI 10.1002/cne.902110403; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980	35	149	153	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					727	732		10.1038/11192	http://dx.doi.org/10.1038/11192			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412062				2022-12-24	WOS:000083882800012
J	Voets, T; Neher, E; Moser, T				Voets, T; Neher, E; Moser, T			Mechanisms underlying phasic and sustained secretion in chromaffin cells from mouse adrenal slices	NEURON			English	Article							PROTEIN-KINASE-C; RETINAL BIPOLAR CELLS; TRANSMITTER RELEASE; NEUROENDOCRINE CELLS; RAPID EXOCYTOSIS; CENTRAL SYNAPSE; 2 COMPONENTS; VESICLE POOL; CA2+; CALCIUM	Many neurosecretory preparations display two components of depolarization-induced exocytosis: a phasic component synchronized with Ca2+ channel opening, followed by a slower sustained component. We evaluated possible mechanisms underlying this biphasic behavior by stimulating mouse chromaffin cells in situ with both depolarizations and flash photolysis of caged Ca2+. From a direct comparison of the secretory responses to both stimuli, we conclude that phasic and sustained release components originate from a readily releasable pool (RRP) of equally fusion-competent vesicles, suggesting that differences in the vesicles' proximity to Ca2+ channels underlie the biphasic secretory behavior. An intermediate pool in dynamic equilibrium with the RRP ensures rapid recruitment of release-ready vesicles after RRP depletion. Our results are discussed in terms of a refined model for secretion in chromaffin cells.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Voets, T (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Am Fassberg 11, D-37077 Gottingen, Germany.		Moser, Tobias/L-5068-2014; Voets, Thomas/AAD-4389-2019; Neher, Erwin/A-2109-2013; Oka, Yoshitaka/C-9670-2010; Voets, Thomas/E-2466-2012	Moser, Tobias/0000-0001-7145-0533; Voets, Thomas/0000-0001-5526-5821; Oka, Yoshitaka/0000-0002-3482-3051; Voets, Thomas/0000-0001-5526-5821				CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; HEINEMANN C, 1993, PFLUG ARCH EUR J PHY, V424, P105, DOI 10.1007/BF00374600; Hilfiker S, 1999, NAT NEUROSCI, V2, P104, DOI 10.1038/5659; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; Moser T, 1997, J NEUROSCI, V17, P2314; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; Oheim M, 1999, EUR BIOPHYS J BIOPHY, V28, P91, DOI 10.1007/s002490050188; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; RAHAMIMOFF R, 1973, J PHYSIOL-LONDON, V228, P241, DOI 10.1113/jphysiol.1973.sp010084; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Ryan TA, 1998, NAT NEUROSCI, V1, P175, DOI 10.1038/621; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; Seward EP, 1996, J NEUROSCI, V16, P553; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yawo H, 1999, J PHYSIOL-LONDON, V516, P461, DOI 10.1111/j.1469-7793.1999.0461v.x	42	208	208	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					607	615		10.1016/S0896-6273(00)80812-0	http://dx.doi.org/10.1016/S0896-6273(00)80812-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433271	Green Published, Bronze			2022-12-24	WOS:000081701000023
J	Akopian, AN; Souslova, V; England, S; Okuse, K; Ogata, N; Ure, J; Smith, A; Kerr, BJ; McMahon, SB; Boyce, S; Hill, R; Stanfa, LC; Dickenson, AH; Wood, JN				Akopian, AN; Souslova, V; England, S; Okuse, K; Ogata, N; Ure, J; Smith, A; Kerr, BJ; McMahon, SB; Boyce, S; Hill, R; Stanfa, LC; Dickenson, AH; Wood, JN			The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; PRIMARY SENSORY NEURONS; TTX-RESISTANT; NERVE INJURY; NA+ CURRENTS; SMALL-CELLS; RAT; EXPRESSION; DISRUPTION; POTENTIALS	Many damage-sensing neurons express tetrodotoxin (TTX)-resistant voltage-gated sodium channels. Here we examined the role of the sensory-neuron-specific (SNS) TTX-resistant sodium channel a subunit in nociception and pain by constructing sns-null mutant mice. These mice expressed only TTX-sensitive sodium currents on step depolarizations from normal resting potentials, showing that all slow TTX-resistant currents are encoded by the sns gene. Null mutants were viable, fertile and apparently normal, although lowered thresholds of electrical activation of C-fibers and increased current densities of TTX-sensitive channels demonstrated compensatory upregulation of TTX-sensitive currents in sensory neurons. Behavioral studies demonstrated a pronounced analgesia to noxious mechanical stimuli, small deficits in noxious thermoreception and delayed development of inflammatory hyperalgesia. These data show that SNS is involved in pain pathways and suggest that blockade of SNS expression or function may produce analgesia without side effects.	UCL, Dept Biol, Mol Nocicept Grp, London WC1E 6BT, England; Hiroshima Univ, Fac Med, Dept Physiol 2, Hiroshima 734, Japan; Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; United Med & Dent Sch Guys & St Thomas Hosp, St Thomas Hosp, Sch Med, Dept Physiol, London SE1 7EH, England; Merck Sharp & Dohme Res Labs, Harlow CM20 2QR, Essex, England; UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London; Hiroshima University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Merck & Company; University of London; University College London	Wood, JN (corresponding author), UCL, Dept Biol, Mol Nocicept Grp, Medawar Bldg, London WC1E 6BT, England.	j.wood@ucl.ac.uk		McMahon, Stephen/0000-0003-4656-5536	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akopian AN, 1997, FEBS LETT, V400, P183, DOI 10.1016/S0014-5793(96)01389-0; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Boyce S, 1999, EXP NEUROL, V155, P49, DOI 10.1006/exnr.1998.6873; Brau ME, 1998, EUR J ANAESTH, V15, P80; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cummins TR, 1997, J NEUROSCI, V17, P3503; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; FUKUDA J, 1980, BRAIN RES, V182, P191, DOI 10.1016/0006-8993(80)90844-6; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gold MS, 1996, J NEUROPHYSIOL, V75, P2629, DOI 10.1152/jn.1996.75.6.2629; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JEFTINIJA S, 1994, BRAIN RES, V665, P69, DOI 10.1016/0006-8993(94)91153-3; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATSUDA Y, 1978, BRAIN RES, V154, P69, DOI 10.1016/0006-8993(78)91052-1; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; OGATA N, 1992, DEV BRAIN RES, V65, P93, DOI 10.1016/0165-3806(92)90012-L; Okuse K, 1997, PROG PAIN RES MANAG, V9, P239; PEARCE RJ, 1994, NEUROSCIENCE, V63, P1041, DOI 10.1016/0306-4522(94)90571-1; QUASTHOFF S, 1995, NEUROSCIENCE, V69, P955, DOI 10.1016/0306-4522(95)00307-5; RIZZO MA, 1994, J NEUROPHYSIOL, V72, P2796, DOI 10.1152/jn.1994.72.6.2796; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROY ML, 1992, J NEUROSCI, V12, P2104; Rupniak NMJ, 1997, PAIN, V71, P89, DOI 10.1016/S0304-3959(97)03343-5; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Scholz A, 1998, EUR J NEUROSCI, V10, P2547, DOI 10.1046/j.1460-9568.1998.t01-1-00268.x; Scholz A, 1998, J NEUROPHYSIOL, V79, P1746, DOI 10.1152/jn.1998.79.4.1746; Souslova VA, 1997, GENOMICS, V41, P201, DOI 10.1006/geno.1997.4669; Stanfa LC, 1996, BRAIN RES, V737, P92, DOI 10.1016/0006-8993(96)00629-4; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	39	644	678	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					541	548		10.1038/9195	http://dx.doi.org/10.1038/9195			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448219				2022-12-24	WOS:000084735900014
J	O'Brien, RJ; Xu, DS; Petralia, RS; Steward, O; Huganir, RL; Worley, P				O'Brien, RJ; Xu, DS; Petralia, RS; Steward, O; Huganir, RL; Worley, P			Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp	NEURON			English	Article							C-REACTIVE PROTEIN; METABOTROPIC GLUTAMATE RECEPTORS; ACUTE-PHASE PROTEINS; AMYLOID-P COMPONENT; RAT CEREBRAL-CORTEX; EXCITATORY SYNAPSES; POSTSYNAPTIC SITES; HIPPOCAMPAL-NEURONS; COMPLEMENT-SYSTEM; MESSENGER-RNA	Narp (neuronal activity-regulated pentraxin) is a secreted immediate-early gene (IEG) regulated by synaptic activity in brain. In this study, we demonstrate that Narp possesses several properties that make it likely to play a key role in excitatory synaptogenesis. Narp is shown to be selectively enriched at excitatory synapses on neurons from both the hippocampus and spinal cord. Overexpression of recombinant Narp increases the number of excitatory but not inhibitory synapses in cultured spinal neurons. In transfected HEK 293T cells, Narp interacts with itself, forming large surface clusters that coaggregate AMPA receptor subunits. Moreover, Narp-expressing HEK 293T cells can induce the aggregation of neuronal AMPA receptors. These studies support a model in which Narp functions as an extracellular aggregating factor for AMPA receptors.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Natl Inst Deafness & Commun Disorders, NIH, Neurochem Lab, Bethesda, MD 20892 USA; Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Virginia	Worley, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.			Steward, Oswald/0000-0001-7069-8756	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001652, R01NS036715] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH53608] Funding Source: Medline; NINDS NIH HHS [R01 NS036715, R01NS36715, K08NS01652] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Allison DW, 1998, J NEUROSCI, V18, P2423; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; BAYER SA, 1974, J COMP NEUROL, V158, P55, DOI 10.1002/cne.901580105; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; GEWURZ H, 1995, CURR OPIN IMMUNOL, V7, P54, DOI 10.1016/0952-7915(95)80029-8; Goodman Adam R., 1996, Cytokine and Growth Factor Reviews, V7, P191, DOI 10.1016/1359-6101(96)00019-6; GORDONWEEKS PR, 1992, EXP PHYSIOL, V77, P681, DOI 10.1113/expphysiol.1992.sp003634; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ingi T, 1998, J NEUROSCI, V18, P7178; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LEE GW, 1993, J IMMUNOL, V150, P1804; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mammen AL, 1997, J NEUROSCI, V17, P7351; Mano I, 1998, NEUROREPORT, V9, P327, DOI 10.1097/00001756-199801260-00027; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Rao A, 1998, J NEUROSCI, V18, P1217; REID MS, 1994, J BIOL CHEM, V269, P32615; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; SIEGEL J, 1974, J EXP MED, V140, P631, DOI 10.1084/jem.140.3.631; SIEGEL J, 1975, J EXP MED, V142, P709, DOI 10.1084/jem.142.3.709; SLOPER JJ, 1979, PHILOS T ROY SOC B, V285, P199, DOI 10.1098/rstb.1979.0005; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tsui CC, 1996, J NEUROSCI, V16, P2463; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Vissavajjhala P, 1996, EXP NEUROL, V142, P296, DOI 10.1006/exnr.1996.0199; Wallace CS, 1998, J NEUROSCI, V18, P26; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998	58	345	361	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					309	323		10.1016/S0896-6273(00)80782-5	http://dx.doi.org/10.1016/S0896-6273(00)80782-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399937	hybrid			2022-12-24	WOS:000081218600016
J	Angleson, JK; Cochilla, AJ; Kilic, G; Nussinovitch, I; Betz, WJ				Angleson, JK; Cochilla, AJ; Kilic, G; Nussinovitch, I; Betz, WJ			Regulation of dense cove release from neuroendocrine cells revealed by imaging single exocytic events	NATURE NEUROSCIENCE			English	Article							RAT ANTERIOR-PITUITARY; MOTOR-NERVE TERMINALS; PROLACTIN SECRETION; CHROMAFFIN CELLS; TRANSMITTER RELEASE; DOPAMINE; LACTOTROPHS; PROTEINS; RECEPTOR; HORMONE	Using FM1-43 fluorescence, we have optically detected single exocytic and endocytic events in rat pituitary lactotrophs. About fifty discrete fluorescent spots abruptly appear around the entire surface of a cell bathed in FM1-43 and high-potassium saline. The spots, which also immunostain for prolactin, reflect the labeling of dense cores as well as membranes of exocytosed secretory granules. Stained cores are not released, but remain attached to the cell and are eventually endocytosed. However, in cells exposed to dopamine (or an analog, bromocriptine), the cores dissolve and are secreted after several seconds. Solubilization of dense cores is mediated through a reduction in cytoplasmic cyclic AMP. Thus, the composition of secretions from individual secretory granules is regulated.	Univ Colorado, Sch Med, Dept Physiol & Biophys, Denver, CO 80262 USA; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Anat & Cell Biol, IL-91010 Jerusalem, Israel	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Hebrew University of Jerusalem	Betz, WJ (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, 4200 E 9th, Denver, CO 80262 USA.							Abraham EJ, 1998, ENDOCRINOLOGY, V139, P2988, DOI 10.1210/en.139.6.2988; Aspinwall CA, 1997, J BIOL CHEM, V272, P31308, DOI 10.1074/jbc.272.50.31308; BAUER CK, 1994, PFLUG ARCH EUR J PHY, V428, P17, DOI 10.1007/BF00374747; BENTABOU S, 1994, J PHYSIOL-LONDON, V476, P29; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BLASCHKO H, 1967, NATURE, V215, P58, DOI 10.1038/215058a0; BRUE T, 1992, J CLIN ENDOCR METAB, V75, P1338, DOI 10.1210/jc.75.5.1338; Carbajal ME, 1997, ENDOCRINOLOGY, V138, P5374, DOI 10.1210/en.138.12.5374; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; DECAMILLI P, 1979, NATURE, V278, P252, DOI 10.1038/278252a0; DELAESCALERA GM, 1992, ENDOCR REV, V13, P241, DOI 10.1210/er.13.2.241; DELAESCALERA GMM, 1988, NEUROENDOCRINOLOGYS, V47, P545; EINHORN LC, 1993, J PHYSIOL-LONDON, V462, P563, DOI 10.1113/jphysiol.1993.sp019569; FOMINA AF, 1995, J NEUROSCI, V15, P4982; Fox GQ, 1996, CELL TISSUE RES, V284, P303, DOI 10.1007/s004410050590; FUJITA H, 1983, CELL TISSUE RES, V229, P129; Haller T, 1998, P NATL ACAD SCI USA, V95, P1579, DOI 10.1073/pnas.95.4.1579; Han WP, 1999, J NEUROSCI, V19, P900; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; HORVATH E, 1974, ARCH PATHOL, V97, P221; INGRAM CD, 1988, CELL TISSUE RES, V252, P655, DOI 10.1007/BF00216653; JOURNOT L, 1987, J BIOL CHEM, V262, P1506; LAMBERTS SWJ, 1990, PHYSIOL REV, V70, P279, DOI 10.1152/physrev.1990.70.2.279; LEW AM, 1994, J BIOL CHEM, V269, P12007; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; MAEDA T, 1991, LAB INVEST, V65, P679; MALGAROLI A, 1987, J BIOL CHEM, V262, P13920; MARTIN TFJ, 1983, J BIOL CHEM, V258, P4816; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; RENDT J, 1994, ENDOCRINOLOGY, V135, P501, DOI 10.1210/en.135.2.501; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; SINHA YN, 1995, ENDOCR REV, V16, P354, DOI 10.1210/er.16.3.354; SINHA YN, 1980, ENDOCRINOLOGY, V107, P1959, DOI 10.1210/endo-107-6-1959; SINHA YN, 1981, ENDOCRINOLOGY, V108, P1091, DOI 10.1210/endo-108-3-1091; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; STJOHN PA, 1986, ENDOCRINOLOGY, V119, P2783; VANHAASTERT PJM, 1984, J BIOL CHEM, V259, P20; WHALLEY T, 1995, J CELL BIOL, V131, P1183, DOI 10.1083/jcb.131.5.1183; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; ZOREC R, 1991, J GEN PHYSIOL, V97, P473, DOI 10.1085/jgp.97.3.473	45	140	141	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					440	446		10.1038/8107	http://dx.doi.org/10.1038/8107			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321248				2022-12-24	WOS:000084609400014
J	Pinto, S; Quintana, DG; Smith, P; Mihalek, RM; Hou, ZH; Boynton, S; Jones, CJ; Hendricks, M; Velinzon, K; Wohlschlegel, JA; Austin, RJ; Lane, WS; Tully, T; Dutta, A				Pinto, S; Quintana, DG; Smith, P; Mihalek, RM; Hou, ZH; Boynton, S; Jones, CJ; Hendricks, M; Velinzon, K; Wohlschlegel, JA; Austin, RJ; Lane, WS; Tully, T; Dutta, A			latheo encodes a subunit of the origin recognition complex and disrupts neuronal proliferation and adult olfactory memory when mutant	NEURON			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; DROSOPHILA-MELANOGASTER; DNA-REPLICATION; GENE-EXPRESSION; NERVOUS-SYSTEM; XENOPUS; HOMOLOG; IDENTIFICATION; NEUROGENESIS	The Drosophila latheo (lat) gene was identified in a behavioral screen for olfactory memory mutants. The original hypomorphic lat(P1) mutant (Boynton and Tully, 1992) shows a structural defect in adult brain. Homozygous lethal lat mutants lack imaginal discs, show little cell proliferation in the CNS of third instar larvae, and die as early pupae. lat(P1) was cloned, and all of the above mentioned defects of hypomorphic or homozygous lethal lat mutants were rescued with a lat(+) transgene. lat encodes a novel protein with homology to a subunit of the origin recognition complex (ORC). Human and Drosophila LAT both associate with ORC2 and are related to yeast ORC3, suggesting that LAT functions in DNA replication during cell proliferation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Cornell Univ, Joan & Sanford I Weill Grad Sch Med Sci, Grad Program Neurosci, New York, NY 10021 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Harvard Microchem Facil, Cambridge, MA 02138 USA	Cold Spring Harbor Laboratory; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brandeis University; Massachusetts Institute of Technology (MIT); Harvard University	Tully, T (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	tully@cshl.org; adutta@rics.bwh.harvard.edu	Jones, Christopher J/B-5466-2009; Quintana, David G/M-5628-2018; Dutta, Anindya/P-3203-2016	Jones, Christopher J/0000-0001-5031-3839; Quintana, David G./0000-0002-4909-6686; Dutta, Anindya/0000-0002-4319-0073	NCI NIH HHS [R01 CA060499-06, CA60499, R01 CA060499] Funding Source: Medline; NIGMS NIH HHS [GM18170] Funding Source: Medline; NINDS NIH HHS [NS32480] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032480] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BOLWIG GM, 1995, NEURON, V15, P829, DOI 10.1016/0896-6273(95)90174-4; BOYNTON S, 1992, GENETICS, V131, P655; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Carpenter PB, 1998, J BIOL CHEM, V273, P24891, DOI 10.1074/jbc.273.38.24891; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; HARTENSTEIN V, 1985, ROUX ARCH DEV BIOL, V194, P181; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Ishiai M, 1997, GENOMICS, V46, P294, DOI 10.1006/geno.1997.5003; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lamprecht R, 1997, J NEUROSCI, V17, P8443; Landis G, 1997, P NATL ACAD SCI USA, V94, P3888, DOI 10.1073/pnas.94.8.3888; LASKO PF, 1988, GENETICS, V120, P495; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; SELLECK SB, 1991, NEURON, V6, P83, DOI 10.1016/0896-6273(91)90124-I; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; THUMMEL CS, 1991, TECHNICAL NOTES NEW; Truman James W., 1993, P1245; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tully T, 1997, P NATL ACAD SCI USA, V94, P4239, DOI 10.1073/pnas.94.9.4239; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Villacres EC, 1998, J NEUROSCI, V18, P3186; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	53	93	97	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1999	23	1					45	54		10.1016/S0896-6273(00)80752-7	http://dx.doi.org/10.1016/S0896-6273(00)80752-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402192	Bronze			2022-12-24	WOS:000080681200009
J	Lee, DK; Itti, L; Koch, C; Braun, J				Lee, DK; Itti, L; Koch, C; Braun, J			Attention activates winner-take-all competition among visual filters	NATURE NEUROSCIENCE			English	Article							CONTRAST DISCRIMINATION; SELECTIVE ATTENTION; HUMAN-VISION; SPATIAL-FREQUENCY; SIMPLE CELLS; AREAS V1; CORTEX; MECHANISMS; SEARCH; MODEL	Shifting attention away from a visual stimulus reduces, but does not abolish, visual discrimination performance. This residual vision with 'poor' attention can be compared to normal vision with 'full' attention to reveal how attention alters visual perception. We report large differences between residual and normal visual thresholds for discriminating the orientation or spatial frequency of simple patterns, and smaller differences for discriminating contrast. A computational model, in which attention activates a winner-take-all competition among overlapping visual filters, quantitatively accounts for all observations. Our model predicts that the effects of attention on visual cortical neurons include increased contrast gain as well as sharper tuning to orientation and spatial frequency.	CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Braun, J (corresponding author), CALTECH, Pasadena, CA 91125 USA.		Braun, Jochen/F-1370-2013	Braun, Jochen/0000-0002-8886-078X; Koch, Christof/0000-0001-6482-8067				BONNEL AM, 1994, PERCEPT PSYCHOPHYS, V55, P162, DOI 10.3758/BF03211664; BOWNE SF, 1990, VISION RES, V30, P449, DOI 10.1016/0042-6989(90)90086-Z; BRAUN J, 1994, J NEUROSCI, V14, P554; Braun J, 1998, NATURE, V393, P424, DOI 10.1038/30875; Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; BRAUN J, 1990, PERCEPT PSYCHOPHYS, V48, P45, DOI 10.3758/BF03205010; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Carandini M, 1997, J NEUROSCI, V17, P8621; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; DeValois RL, 1988, SPATIAL VISION; DOSHER BA, 1998, HDB PERCEPTION COGNI, P201; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Foley JM, 1998, J OPT SOC AM A, V15, P1036, DOI 10.1364/JOSAA.15.001036; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; ITTI L, 1997, ADV NEURAL INFORMATI, V9, P173; Lee DK, 1997, VISION RES, V37, P2409, DOI 10.1016/S0042-6989(97)00055-2; LEE DK, IN PRESS PERCEPT PSY, V61; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Morgan MJ, 1998, Q J EXP PSYCHOL-A, V51, P347, DOI 10.1080/713755766; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MUELLER HJ, 1987, PERCEPT PSYCHOPHYS, V42, P383; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; PALMER J, 1995, CURR DIR PSYCHOL SCI, V4, P118, DOI 10.1111/1467-8721.ep10772534; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pashler H., 1997, PSYCHOL ATTENTION; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Press W. H., 1992, ART SCI COMPUTING; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Solomon JA, 1997, J OPT SOC AM A, V14, P2443, DOI 10.1364/JOSAA.14.002443; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; TREISMAN A, 1988, PSYCHOL REV, V12, P97; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Tyler CW, 1997, SPATIAL VISION, V10, P369, DOI 10.1163/156856897X00294; Wilson H. R., 1990, VISUAL PERCEPTION NE, P231, DOI DOI 10.1016/B978-0-12-657675-7.50016-8; WILSON HR, 1980, BIOL CYBERN, V38, P171, DOI 10.1007/BF00337406; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; Wilson HR, 1997, PERCEPTION, V26, P939, DOI 10.1068/p260939; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Zenger B, 1996, VISION RES, V36, P2497, DOI 10.1016/0042-6989(95)00303-7	50	339	353	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					375	381		10.1038/7286	http://dx.doi.org/10.1038/7286			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	200GV	10204546				2022-12-24	WOS:000080532000018
J	Lee, T; Luo, LQ				Lee, T; Luo, LQ			Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis	NEURON			English	Article							GROWTH CONE GUIDANCE; DROSOPHILA-MELANOGASTER; BETA-GALACTOSIDASE; FLP RECOMBINASE; FUSION PROTEIN; GAL4; TRANSCRIPTION; CHROMOSOMES; EXPRESSION; MUTATIONS	We describe a genetic mosaic system in Drosophila, in which a dominant repressor of a cell marker is placed in trans to a mutant gene of interest. Mitotic recombination events between homologous chromosomes generate homozygous mutant cells, which are exclusively labeled due to loss of the repressor. Using this system, we are able to visualize axonal projections and dendritic elaboration in large neuroblast clones and single neuron clones with a membrane-targeted GFP marker. This new method allows for the study of gene functions in neuroblast proliferation, axon guidance, and dendritic elaboration in the complex central nervous system. As an example, we show that the short stop gene is required in mushroom body neurons for the extension and guidance of their axons.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.			Luo, Liqun/0000-0001-5467-9264	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036623] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS36623] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRAND AH, 1993, DEVELOPMENT, V118, P401; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chou TB, 1996, GENETICS, V144, P1673; COWAN, 1998, NEURON, V20, P413; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GINIGER E, 1993, ROUX ARCH DEV BIOL, V202, P112, DOI 10.1007/BF00636536; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Goodman Corey S., 1993, P1131; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; KOLODZIEJ PA, 1995, NEURON, V15, P273, DOI 10.1016/0896-6273(95)90033-0; LIAW CW, 1986, J IMMUNOL, V137, P1037; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; ODONNELL KH, 1994, MOL CELL BIOL, V14, P6398, DOI 10.1128/MCB.14.9.6398; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P689; Ramon y Cajal S, 1911, HIST NERVOUS SYSTEM; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SELLECK SB, 1992, NATURE, V355, P253, DOI 10.1038/355253a0; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; XU T, 1993, DEVELOPMENT, V117, P1223	34	1903	1926	4	101	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					451	461		10.1016/S0896-6273(00)80701-1	http://dx.doi.org/10.1016/S0896-6273(00)80701-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197526	Bronze			2022-12-24	WOS:000079483900010
J	Baloh, RH; Tansey, MG; Lampe, PA; Fahrner, TJ; Enomoto, H; Simburger, KS; Leitner, ML; Araki, T; Johnson, EM; Milbrandt, J				Baloh, RH; Tansey, MG; Lampe, PA; Fahrner, TJ; Enomoto, H; Simburger, KS; Leitner, ML; Araki, T; Johnson, EM; Milbrandt, J			Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFR alpha 3-RET receptor complex	NEURON			English	Article							MICE LACKING GDNF; C-RET PROTOONCOGENE; NEUROTROPHIC FACTOR; TYROSINE KINASE; SYMPATHETIC NEURONS; SURVIVAL FACTOR; SCHWANN-CELLS; NEURTURIN; PROTEIN; NERVE	The glial cell line-derived neurotrophic factor (GDNF) ligands (GDNF, Neurturin [NTN], and Persephin [PSP]) signal through a multicomponent receptor system composed of a high-affinity binding component (GFR alpha 1-GFR alpha 4) and a common signaling component (RET). Here, we report the identification of Artemin, a novel member of the GDNF family, and demonstrate that it is the ligand for the former orphan receptor GFR alpha 3-RET. Artemin is a survival factor for sensory and sympathetic neurons in culture, and its expression pattern suggests that it also influences these neurons in vivo. Artemin can also activate the GFR alpha 1-RET complex and supports the survival of dopaminergic midbrain neurons in culture, indicating that like GDNF (GFR alpha 1-RET) and NTN (GFR alpha 2-RET), Artemin has a preferred receptor (GFR alpha 3-RET) but that alternative receptor interactions also occur.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	jeff@milbrandt.wustl.edu	Araki, Toshiyuki/H-4289-2019; Lampe, Patricia/AAH-9545-2020	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG13729, R01 AG13730] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; BUJBELLO A, 1995, NEURON, V15, P821, DOI 10.1016/0896-6273(95)90173-6; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; EBENDAL T, 1995, J NEUROSCI RES, V40, P276, DOI 10.1002/jnr.490400217; Enokido Y, 1998, CURR BIOL, V8, P1019, DOI 10.1016/S0960-9822(07)00422-8; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Golden JP, 1998, J COMP NEUROL, V398, P139, DOI 10.1002/(SICI)1096-9861(19980817)398:1<139::AID-CNE9>3.0.CO;2-2; Grondin R, 1998, J NEUROL, V245, pP35, DOI 10.1007/PL00007744; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Heuckeroth RO, 1998, DEV BIOL, V200, P116, DOI 10.1006/dbio.1998.8955; Hishiki T, 1998, CANCER RES, V58, P2158; Horger BA, 1998, J NEUROSCI, V18, P4929; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; KOTZBAUER PT, 1994, NEURON, V12, P763, DOI 10.1016/0896-6273(94)90329-8; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Trupp M, 1997, J NEUROSCI, V17, P3554; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Widenfalk J, 1998, EUR J NEUROSCI, V10, P1508, DOI 10.1046/j.1460-9568.1998.00192.x; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; Worby CA, 1996, J BIOL CHEM, V271, P23619, DOI 10.1074/jbc.271.39.23619; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yu T, 1998, J NEUROSCI, V18, P4684	54	468	514	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1291	1302		10.1016/S0896-6273(00)80649-2	http://dx.doi.org/10.1016/S0896-6273(00)80649-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883723	Bronze			2022-12-24	WOS:000077910600012
J	Siapas, AG; Wilson, MA				Siapas, AG; Wilson, MA			Coordinated interactions between hippocampal ripples and cortical spindles during slow-wave sleep	NEURON			English	Article							NUCLEUS RETICULARIS THALAMI; LESS-THAN-1 HZ OSCILLATION; LONG-TERM POTENTIATION; PREFRONTAL CORTEX; NEURONS; RAT; GENERATION; MECHANISMS; NETWORKS; MEMORY	Sleep is characterized by a structured combination of neuronal oscillations. In the hippocampus, slow-wave sleep (SWS) is marked by high-frequency network oscillations (similar to 200 Hz "ripples"), whereas neocortical SWS activity is organized into low-frequency delta (1-4 Hz) and spindle (7-14 Hz) oscillations. While these types of hippocampal and cortical oscillations have been studied extensively in isolation, the relationships between them remain unknown. Here, we demonstrate the existence of temporal correlations between hippocampal ripples and cortical spindles that are also reflected in the correlated activity of single neurons within these brain structures. Spindle-ripple episodes may thus constitute an important mechanism of cortico-hippocampal communication during sleep. This coactivation of hippocampal and neocortical pathways may be important for the process of memory consolidation, during which memories are gradually translated from short-term hippocampal to longer-term neocortical stores.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Siapas, AG (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.							BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; FUSTER JM, 1997, PREFRONTAL CORTEX; Hebb Donald O., 1949, ORG BEHAV; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Kandel A, 1997, J NEUROSCI, V17, P6783; Kolb B., 1990, CEREBRAL CORTEX RAT, P437; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; MARINI G, 1992, NEUROSCIENCE, V51, P759, DOI 10.1016/0306-4522(92)90516-5; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Morison RS, 1942, AM J PHYSIOL, V135, P0281, DOI 10.1152/ajplegacy.1941.135.2.281; Oppenheim A.V.B., 2001, DISCRETE TIME SIGNAL, VVolume 2; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; Press W. H., 1992, ART SCI COMPUTING; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P50, DOI 10.1152/jn.1961.24.1.50; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P26, DOI 10.1152/jn.1961.24.1.26; SQUIRE LR, 1992, PHYSIOL REV, V68, P649; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473, DOI 10.1152/jn.1985.54.6.1473; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STERIADE M, 1990, BRAIN CHOLINERGIC SY; Steriade M., 1990, BRAINSTEM CONTROL WA; Von Mises R., 1964, MATH THEORY PROBABIL; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, J NEUROSCI, V15, P30	33	637	644	1	34	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1123	1128		10.1016/S0896-6273(00)80629-7	http://dx.doi.org/10.1016/S0896-6273(00)80629-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856467	Bronze			2022-12-24	WOS:000077386100022
J	Sun, J; Perona, P				Sun, J; Perona, P			Where is the sun?	NATURE NEUROSCIENCE			English	Article							SHAPE; PERCEPTION; REFLECTANCE		CALTECH 136 93, Pasadena, CA 91125 USA; Univ Padua, I-35131 Padua, Italy	California Institute of Technology; University of Padua	Perona, P (corresponding author), CALTECH 136 93, Pasadena, CA 91125 USA.							BRAUN J, 1993, SPATIAL VISION, V7, P311, DOI 10.1163/156856893X00469; BRAUN J, 1990, PERCEPTION, V19, pA112; Brewster D., 1847, EDINBURGH PHILOS T, V15, P657, DOI [DOI 10.1017/S0080456800030234, 10.1017/S0080456800030234]; BULTHOFF HH, 1988, J OPT SOC AM A, V5, P1749, DOI 10.1364/JOSAA.5.001749; Durost WN, 1934, GENET PSYCHOL MONOG, V16, P225; ENNS JT, 1990, SCIENCE, V247, P721, DOI 10.1126/science.2300824; KLEFFNER DA, 1992, PERCEPT PSYCHOPHYS, V52, P18, DOI 10.3758/BF03206757; Metzger W, 1936, GESETZE SEHENS; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Rittenhouse D., 1786, T AM PHILOS SOC, V2, P37, DOI DOI 10.2307/1005164; Sun J, 1996, NATURE, V379, P165, DOI 10.1038/379165a0; Sun JY, 1996, VISION RES, V36, P2515, DOI 10.1016/0042-6989(95)00336-3; Todd JT, 1996, INVEST OPHTH VIS SCI, V37, P4282; VANFIEANDT K, 1938, PSYCHOL I MONOG	15	166	166	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					183	184		10.1038/630	http://dx.doi.org/10.1038/630			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195141				2022-12-24	WOS:000076361200007
J	Okabe, S; Kim, HD; Miwa, A; Kuriu, T; Okado, H				Okabe, S; Kim, HD; Miwa, A; Kuriu, T; Okado, H			Continual remodeling of postsynaptic density and its regulation by synaptic activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE DENSITY; HIPPOCAMPAL-NEURONS; NMDA RECEPTOR; RECOMBINANT ADENOVIRUS; AXOSPINOUS SYNAPSES; PROTEIN; RAT; SYNAPTOGENESIS; TRANSMISSION	A postsynaptic density (PSD) protein, PSD-95, was tagged with green fluorescent protein (GFP-PSD-95) and expressed in cultured hippocampal neurons using recombinant adenoviruses. CFP-PSD-95 was selectively localized to excitatory postsynaptic sites. Time-lapse fluorescence imaging of hippocampal neurons revealed that >20% of GFP-PSD-95 clusters turned over within 24 hours. The appearance rate of clusters was higher than the disappearance rate, and this difference accounted for the gradual increase of the cluster density observed in culture. Dynamics of PSD-95 clusters were also inhibited by blockers of excitatory synaptic transmission. Continual PSD turnover and its regulation by synaptic activity may be important in activity-dependent remodeling of neuronal connections.	Tokyo Med & Dent Univ, Sch Med, Dept Anat & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; Natl Inst Biosci & Human Technol, Mol Neurobiol Lab, Tsukuba, Ibaraki 3058566, Japan; Tokyo Metropolitan Inst Neurosci, Dept Neurobiol, Tokyo 1838526, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Okabe, S (corresponding author), Tokyo Med & Dent Univ, Sch Med, Dept Anat & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.			Okabe, Shigeo/0000-0003-1216-8890				Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fukaya M, 1999, NEUROSCI RES, V33, P111, DOI 10.1016/S0168-0102(98)00120-5; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Geinisman Y, 1996, J COMP NEUROL, V368, P413; GOULD E, 1990, J NEUROSCI, V10, P1286; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; Murphy DD, 1996, J NEUROSCI, V16, P4059; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe S, 1998, EUR J NEUROSCI, V10, P2192, DOI 10.1046/j.1460-9568.1998.00233.x; OKABE S, IN PRESS J NEUROSCI; PAPA M, 1995, J NEUROSCI, V15, P1; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sorra KE, 1998, J NEUROSCI, V18, P658; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	40	203	213	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					804	811		10.1038/12175	http://dx.doi.org/10.1038/12175			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10461219				2022-12-24	WOS:000083882900011
J	Gil, Z; Connors, BW; Amitai, Y				Gil, Z; Connors, BW; Amitai, Y			Efficacy of thalamocortical and intracortical synaptic connections: Quanta, innervation, and reliability	NEURON			English	Article							CAT VISUAL-CORTEX; CROSS-CORRELATION ANALYSIS; LONG-TERM POTENTIATION; EXCITATORY POSTSYNAPTIC POTENTIALS; PAIRED-PULSE FACILITATION; MOUSE BARREL CORTEX; CENTRAL SYNAPSES; PYRAMIDAL CELLS; HIPPOCAMPAL-NEURONS; RELEASE PROBABILITY	Thalamocortical (TC) synapses carry information into the neocortex, but they are far outnumbered by excitatory intracortical (IC) synapses. We measured the synaptic properties that determine the efficacy of TC and IC axons converging onto spiny neurons of layer 4 in the mouse somatosensory cortex. Quantal events from TC and IC synapses were indistinguishable. However, TC axons had, on average, about 3 times more release sites than IC axons, and the mean release probability at TC synapses was about 1.5 times higher than that at IC synapses. Differences of innervation ratio and release probability make the average TC connection several times more effective than the average IC connection, and may allow small numbers of TC axons to dominate the activity of cortical layer 4 cells during sensory inflow.	Brown Univ, Div Biol & Med, Dept Neurosci, Providence, RI 02912 USA; Ben Gurion Univ Negev, Fac Hlth Sci, Zlotowski Ctr Neurosci, Dept Physiol, IL-84105 Beer Sheva, Israel	Brown University; Ben Gurion University	Connors, BW (corresponding author), Brown Univ, Div Biol & Med, Dept Neurosci, Providence, RI 02912 USA.		Amitai, Yael/G-2791-2013; Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157; Amitai, Yael/0000-0001-6664-8705	FIC NIH HHS [TW00743] Funding Source: Medline; NINDS NIH HHS [NS25983] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; AGMON A, 1992, J NEUROSCI, V12, P319; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; CastroAlamancos MA, 1997, P NATL ACAD SCI USA, V94, P4161, DOI 10.1073/pnas.94.8.4161; CastroAlamancos MA, 1996, SCIENCE, V272, P274, DOI 10.1126/science.272.5259.274; Chance FS, 1998, J NEUROSCI, V18, P4785; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DODGE FA, 1969, J PHYSIOL-LONDON, V200, P267, DOI 10.1113/jphysiol.1969.sp008692; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gil Z, 1996, J NEUROSCI, V16, P6567; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Huang EP, 1997, J NEUROPHYSIOL, V78, P2870, DOI 10.1152/jn.1997.78.6.2870; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; Johnson MJ, 1996, J NEUROPHYSIOL, V75, P1444, DOI 10.1152/jn.1996.75.4.1444; KATZ B, 1969, RELEASE NEUROL TRANS; KELLER A, 1995, CEREBR CORT, V11, P221; KHARAZIA VN, 1994, J NEUROSCI, V14, P6021; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; MANABE T, 1994, SCIENCE, V265, P1888, DOI 10.1126/science.7916483; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PAULSEN O, 1994, J PHYSIOL-LONDON, V480, P505, DOI 10.1113/jphysiol.1994.sp020379; PETERS A, 1990, J NEUROCYTOL, V19, P154, DOI 10.1007/BF01217295; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Reid CA, 1997, J NEUROSCI, V17, P2738; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEGEV I, 1995, J COMPUT NEUROSCI, V2, P117, DOI 10.1007/BF00961883; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1995, CEREBR CORT, V11, P263; SOMERS DC, 1995, J NEUROSCI, V15, P6700; STERN P, 1992, J PHYSIOL-LONDON, V449, P247, DOI 10.1113/jphysiol.1992.sp019085; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 1998, J NEUROSCI METH, V79, P131, DOI 10.1016/S0165-0270(97)00176-3; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VanderKloot W, 1996, J NEUROSCI METH, V65, P151, DOI 10.1016/0165-0270(95)00159-X; VOLGUSHEV M, 1995, EUR J NEUROSCI, V7, P1751, DOI 10.1111/j.1460-9568.1995.tb00695.x; WALMSLEY B, 1991, PROG NEUROBIOL, V36, P391, DOI 10.1016/0301-0082(91)90017-U; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; White E.L., 1989, CORTICAL CIRCUITS SY; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	73	267	269	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					385	397		10.1016/S0896-6273(00)80788-6	http://dx.doi.org/10.1016/S0896-6273(00)80788-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399943	Bronze			2022-12-24	WOS:000081218600022
J	Choi, YB; Lipton, SA				Choi, YB; Lipton, SA			Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor	NEURON			English	Article							METHYL-D-ASPARTATE; ZINC INHIBITION; HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; CORTICAL-NEURONS; N-GLYCOSYLATION; BINDING-SITE; K+ CHANNEL; SENSITIVITY; MODULATION	Zinc (Zn2+) inhibition of N-methyl-D-aspartate receptor (NMDAR) activity involves both voltage-independent and voltage-dependent components. Recombinant NR1/NR2A and NR1/NR2B receptors exhibit similar voltage-dependent block, but voltage-independent Zn2+ inhibition occurs with much higher affinity for NR1/NR2A than NR1/NR2B receptors (nanomolar versus micromolar IC50, respectively). Here, we show that two neighboring histidine residues on NR2A represent the critical determinant (termed the "short spacer") for high-affinity, voltage-independent Zn2+ inhibition using the Xenopus oocyte expression system and site-directed mutagenesis. Mutation of either one of these two histidine residues (H42 and H44) in the extracellular N-terminal domain of NR2A shifted the IC50 for high-affinity Zn2+ inhibition similar to 200-fold without affecting the EC50 of the coagonists NMDA and glycine. We suggest that the mechanism of high-affinity Zn2+ inhibition on the NMDAR involves enhancement of proton inhibition.	Brigham & Womens Hosp, Cerebrovasc & NeuroSci Res Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lipton, SA (corresponding author), Brigham & Womens Hosp, Cerebrovasc & NeuroSci Res Inst, 75 Francis St, Boston, MA 02115 USA.			Lipton, Stuart/0000-0002-3490-1259	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY05477] Funding Source: Medline; NICHD NIH HHS [P01 HD29587] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; Fisher JL, 1998, J NEUROSCI, V18, P2944; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Horenstein J, 1998, MOL PHARMACOL, V53, P870; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; ISHII T, 1993, J BIOL CHEM, V268, P2836; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KOH JY, 1988, J NEUROSCI, V8, P2164; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Martell A. E., 1974, CRITICAL STABILITY C; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; Means G.E., 1971, CHEM MODIFICATION PR; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORI H, 1992, NATURE, V358, P673, DOI 10.1038/358673a0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Paoletti P, 1997, J NEUROSCI, V17, P5711; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; SAKURADA K, 1993, J BIOL CHEM, V268, P410; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; WAFFORD KA, 1993, NEUROREPORT, V4, P1347, DOI 10.1097/00001756-199309150-00015; WANG TL, 1995, J NEUROSCI, V15, P7684; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; XIE XM, 1991, NATURE, V349, P521, DOI 10.1038/349521a0; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634	47	151	155	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					171	180		10.1016/S0896-6273(00)80763-1	http://dx.doi.org/10.1016/S0896-6273(00)80763-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402203	Bronze			2022-12-24	WOS:000080681200020
J	Miwa, JM; Ibanez-Tallon, I; Crabtree, GW; Sanchez, R; Sali, A; Role, LW; Heintz, N				Miwa, JM; Ibanez-Tallon, I; Crabtree, GW; Sanchez, R; Sali, A; Role, LW; Heintz, N			lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS	NEURON			English	Article							ATRA TAIWAN COBRA; ALPHA-BUNGAROTOXIN; SYNAPTIC TRANSMISSION; ALZHEIMERS-DISEASE; SNAKE TOXINS; MICE LACKING; SUBSTANCE-P; SEQUENCE; GENE; VENOM	Elapid snake venom neurotoxins exert their effects through high-affinity interactions with specific neurotransmitter receptors. A novel murine gene, lynx1, is highly expressed in the brain and contains the cysteine-rich motif characteristic of this class of neurotoxins. Primary sequence and gene structure analyses reveal an evolutionary relationship between lynx1 and the Ly-6/neurotoxin gene family, lynx1 is expressed in large projection neurons in the hippocampus, cortex, and cerebellum. In cerebellar neurons, lynx1 protein is localized to a specific subdomain including the soma and proximal dendrites. lynx1 binding to brain sections correlates with the distribution of nAChRs, and application of lynx1 to Xenopus oocytes expressing nAChRs results in an increase in acetylcholine-evoked macroscopic currents. These results identify lynx1 as a novel protein modulator for nAChRs in vitro, which could have important implications in the regulation of cholinergic function in vivo.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Mol Biophys Lab, New York, NY 10021 USA; Columbia Univ, Dept Anat, Ctr Neurobiol, New York, NY 10032 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Columbia University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	heintz@rockvax.rockefeller.edu	Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X; Miwa, Julie/0000-0002-4418-3756	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32 GM07524] Funding Source: Medline; NINDS NIH HHS [P01 NS30532] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adem A, 1997, LIFE SCI, V60, P1069, DOI 10.1016/S0024-3205(97)00049-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASUS VJ, 1993, BIOCHEMISTRY-US, V32, P12290, DOI 10.1021/bi00097a004; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Brakenhoff RH, 1997, J IMMUNOL, V159, P4879; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang LS, 1997, J BIOCHEM, V122, P1252, DOI 10.1093/oxfordjournals.jbchem.a021889; Chang LS, 1997, BIOCHEM BIOPH RES CO, V239, P756, DOI 10.1006/bbrc.1997.7549; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Contant C, 1996, NEUROSCIENCE, V71, P937, DOI 10.1016/0306-4522(95)00507-2; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Cousin X, 1998, J BIOL CHEM, V273, P9812, DOI 10.1074/jbc.273.16.9812; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; DELTORO ED, 1994, J COMP NEUROL, V349, P325, DOI 10.1002/cne.903490302; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; DUFTON MJ, 1989, TRENDS PHARMACOL SCI, V10, P258, DOI 10.1016/0165-6147(89)90019-9; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; FLETCHER CM, 1994, STRUCTURE, V2, P185, DOI 10.1016/S0969-2126(00)00020-4; FUSE N, 1990, EUR J BIOCHEM, V193, P629, DOI 10.1111/j.1432-1033.1990.tb19380.x; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; Garside S, 1997, SYNAPSE, V27, P161, DOI 10.1002/(SICI)1098-2396(199711)27:3<161::AID-SYN1>3.0.CO;2-B; Geula C, 1998, NEUROLOGY, V51, pS18, DOI 10.1212/WNL.51.1_Suppl_1.S18; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; GUMLEY TP, 1995, IMMUNOGENETICS, V42, P221, DOI 10.1007/BF00191229; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Hung CC, 1998, J PROTEIN CHEM, V17, P107, DOI 10.1023/A:1022523331321; IM WB, 1990, MOL PHARMACOL, V37, P429; INCUE S, 1991, FEBS LETT, V279, P38; JOHN TR, 1994, GENE, V139, P229, DOI 10.1016/0378-1119(94)90761-7; JOLKKONEN M, 1994, FEBS LETT, V352, P91, DOI 10.1016/0014-5793(94)00933-3; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; KOCHVA E, 1993, TOXICON, V31, P541, DOI 10.1016/0041-0101(93)90111-U; Kumar TKS, 1997, J BIOMOL STRUCT DYN, V15, P431, DOI 10.1080/07391102.1997.10508957; LARRAMENDL L. M. H., 1967, BRAIN RES, V5, P15, DOI 10.1016/0006-8993(67)90216-8; LEGOAS R, 1992, BIOCHEMISTRY-US, V31, P4867, DOI 10.1021/bi00135a018; MALEY BE, 1987, J COMP NEUROL, V260, P483, DOI 10.1002/cne.902600402; Matthes HWD, 1998, J NEUROSCI, V18, P7285; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Robbins TW, 1997, BEHAV BRAIN RES, V83, P15, DOI 10.1016/S0166-4328(97)86040-8; Robbins TW, 1997, BIOL PSYCHOL, V45, P57, DOI 10.1016/S0301-0511(96)05222-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Sanchez R, 1997, PROTEINS, P50; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STRYDOM DJ, 1979, HDB EXPT PHARM, V52, P258; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023	51	236	252	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	1999	23	1					105	114		10.1016/S0896-6273(00)80757-6	http://dx.doi.org/10.1016/S0896-6273(00)80757-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402197	Bronze			2022-12-24	WOS:000080681200014
J	Zhou, Y; Schopperie, WM; Murrey, H; Jaramillo, A; Dagan, D; Griffith, LC; Levitan, IB				Zhou, Y; Schopperie, WM; Murrey, H; Jaramillo, A; Dagan, D; Griffith, LC; Levitan, IB			A dynamically regulated 14-3-3, slob, and slowpoke potassium channel complex in Drosophila presynaptic nerve terminals	NEURON			English	Article							CA2+-ACTIVATED K+ CHANNELS; METABOTROPIC GLUTAMATE RECEPTORS; NICOTINIC ACETYLCHOLINE-RECEPTOR; DEPENDENT PROTEIN-KINASE; LARGE-CONDUCTANCE; TYROSINE KINASE; NEUROMUSCULAR-JUNCTION; SIGNAL-TRANSDUCTION; TRANSMITTER RELEASE; ION CHANNELS	Slob is a novel protein that binds to the carboxy-terminal domain of the Drosophila Slowpoke (dSlo) calcium-dependent potassium (K-Ca) channel. A yeast two-hybrid screen with Slob as bait identifies the zeta isoform of 14-3-3 as a Slob-binding protein. Coimmunoprecipitation experiments from Drosophila heads and transfected cells confirm that 14-3-3 interacts with dSlo via Slob. All three proteins are colocalized presynaptically at Drosophila neuromuscular junctions. Two serine residues in Slob are required for 14-3-3 binding, and the binding is dynamically regulated in Drosophila by calcium/calmodulin-dependent kinase II (CaMKII) phosphorylation. 14-3-3 coexpression dramatically alters dSlo channel properties when wild-type Slob is present but not when a double serine mutant Slob that is incapable of binding 14-3-3 is present. The results provide evidence for a dSlo/Slob/14-3-3 regulatory protein complex.	Brandeis Univ, Volen Ctr Complex Syst, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Levitan, IB (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Dept Biochem, Waltham, MA 02454 USA.			Griffith, Leslie/0000-0003-3164-9876	NIGMS NIH HHS [R01 GM054408] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BIELEFELDT K, 1994, J PHYSIOL-LONDON, V475, P241, DOI 10.1113/jphysiol.1994.sp020065; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; BROADIE KS, 1993, J NEUROSCI, V13, P144; Broughton SJ, 1996, J CELL BIOCHEM, V62, P484, DOI 10.1002/(SICI)1097-4644(19960915)62:4<484::AID-JCB6>3.3.CO;2-Z; BURBELO PD, 1995, CURR BIOL, V5, P95, DOI 10.1016/S0960-9822(95)00022-4; CATTERALL WA, 1993, ANN NY ACAD SCI, V707, P1, DOI 10.1111/j.1749-6632.1993.tb38038.x; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Colledge M, 1997, J NEUROSCI, V17, P5038; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Dichiara TJ, 1995, J PHYSIOL-LONDON, V489, P403, DOI 10.1113/jphysiol.1995.sp021061; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 1998, J NEUROSCI, V18, P720; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474; GHO M, 1992, J EXP BIOL, V170, P93; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; GuptaRoy B, 1996, J BIOL CHEM, V271, P19846, DOI 10.1074/jbc.271.33.19846; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Harlow E., 1988, ANTIBODIES LAB MANUA; Hilborn MD, 1998, J NEUROSCI, V18, P590; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Holmes TC, 1997, J NEUROSCI, V17, P8964; HUANG Y, 1994, J BIOL CHEM, V269, P31183; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Knaus HG, 1996, J NEUROSCI, V16, P955; Kockel L, 1997, GENE DEV, V11, P1140, DOI 10.1101/gad.11.9.1140; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Lin JW, 1998, J NEUROSCI, V18, P2017; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Moller P, 1996, CHEM-BIOL INTERACT, V102, P17, DOI 10.1016/0009-2797(96)03729-5; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; REINHART PH, 1991, J NEUROSCI, V11, P1627; REINHART PH, 1995, J NEUROSCI, V15, P4572; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Sambrook J., 2002, MOL CLONING LAB MANU; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shipston MJ, 1996, J PHYSIOL-LONDON, V493, P665, DOI 10.1113/jphysiol.1996.sp021413; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; SWANSON KD, 1992, GENE, V113, P183, DOI 10.1016/0378-1119(92)90394-5; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; SWOPE SL, 1994, J BIOL CHEM, V269, P29817; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Tian LJ, 1998, J BIOL CHEM, V273, P13531, DOI 10.1074/jbc.273.22.13531; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0; Xia XM, 1998, J NEUROSCI, V18, P2360; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	78	109	113	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	1999	22	4					809	818		10.1016/S0896-6273(00)80739-4	http://dx.doi.org/10.1016/S0896-6273(00)80739-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230800	Bronze			2022-12-24	WOS:000079976200023
J	Haxby, JV; Ungerleider, LG; Clark, VP; Schouten, JL; Hoffman, EA; Martin, A				Haxby, JV; Ungerleider, LG; Clark, VP; Schouten, JL; Hoffman, EA; Martin, A			The effect of face inversion on activity in human neural systems for face and object perception	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; HUMAN EXTRASTRIATE CORTEX; HUMAN VISUAL-CORTEX; RECOGNITION; PET; KNOWLEDGE	The differential effect of stimulus inversion on face and object recognition suggests that inverted faces are processed by mechanisms for the perception of other objects rather than by face perception mechanisms. We investigated the face inversion using functional magnetic resonance imaging (fMRI). The principal effect of face inversion on was an increased response in ventral extrastriate regions that respond preferentially to another class of objects (houses). In contrast, house inversion did not produce a similar change in face-selective regions. Moreover, stimulus inversion had equivalent, minimal effects for faces in in face-selective regions and for houses in house-selective regions. The results suggest that the failure of face perception systems with inverted faces leads to the recruitment of processing resources in object perception systems, but this failure is not reflected by altered activity in face perception systems.	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Connecticut	Haxby, JV (corresponding author), NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA.		martin, alex/B-6176-2009; Clark, Vincent P/B-3343-2010	Clark, Vincent P/0000-0002-9151-2102				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Clark VP, 1996, NEUROIMAGE, V4, P1, DOI 10.1006/nimg.1996.0025; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; de Gelder B, 1998, VISION RES, V38, P2855, DOI 10.1016/S0042-6989(97)00458-6; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1991, COGNITIVE NEUROPSYCH, V8, P1, DOI 10.1080/02643299108253364; Farah MJ, 1996, BEHAV BRAIN RES, V76, P181, DOI 10.1016/0166-4328(95)00198-0; FARAH MJ, 1995, VISION RES, V35, P2089, DOI 10.1016/0042-6989(94)00273-O; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; HAXBY JV, 1993, BEHAV RES METH INSTR, V25, P400, DOI 10.3758/BF03204531; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HAXBY JV, 1999, IN PRESS MAPPING MOD; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KOHLER S, 1995, NEUROREPORT, V6, P1865, DOI 10.1097/00001756-199510020-00011; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; Rencher A.C., 1995, METHODS MULTIVARIATE; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Talairach J., 1988, COPLANAR STEREOTAXIC; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; YIN RK, 1970, NEUROPSYCHOLOGIA, V8, P395, DOI 10.1016/0028-3932(70)90036-9; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	37	455	461	1	48	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					189	199		10.1016/S0896-6273(00)80690-X	http://dx.doi.org/10.1016/S0896-6273(00)80690-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	163MV	10027301	Bronze			2022-12-24	WOS:000078410300024
J	Kameyama, K; Lee, HK; Bear, MF; Huganir, RL				Kameyama, K; Lee, HK; Bear, MF; Huganir, RL			Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression	NEURON			English	Article							HIPPOCAMPAL CA1 REGION; CYCLIC-AMP; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; AREA CA1; REGULATORY PHOSPHORYLATION; DEPENDENT PHOSPHORYLATION; RAT HIPPOCAMPUS; OKADAIC ACID; CALYCULIN-A	Hippocampal N-methyl-D-aspartate (NMDA) receptor-dependent long-term synaptic depression (LTD) is associated with a persistent dephosphorylation of the GluR1 subunit of AMPA receptors at a site (Ser-845) phosphorylated by cAMP-dependent protein kinase (PKA). In the present study, we show that dephosphorylation of a postsynaptic PKA substrate may be crucial for LTD expression. PKA activators inhibited both AMPA receptor dephosphorylation and LTD. Injection of a cAMP analog into postsynaptic neurons prevented LTD induction and reversed previously established homosynaptic LTD without affecting baseline synaptic transmission. Moreover, infusing a PKA inhibitor into postsynaptic cells produced synaptic depression that occluded homosynaptic LTD. These findings suggest that dephosphorylation of a PKA site on AMPA receptors may be one mechanism for NMDA receptor-dependent homosynaptic LTD expression.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA	Howard Hughes Medical Institute; Johns Hopkins University; Brown University; Howard Hughes Medical Institute	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	rick.huganir@qmail.bs.jhu.edu		Bear, Mark/0000-0002-9903-2541; Lee, Hey-Kyoung/0000-0002-5554-983X				ABE H, 1992, MOL BRAIN RES, V13, P283, DOI 10.1016/0169-328X(92)90211-S; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COSTA MRC, 1984, J BIOL CHEM, V259, P8210; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; ENAN E, 1991, PESTIC BIOCHEM PHYS, V39, P182, DOI 10.1016/0048-3575(91)90138-C; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; GERSHON E, 1992, J NEUROSCI, V12, P3743; GLASS DB, 1989, J BIOL CHEM, V264, P14579; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HEI YJ, 1991, MOL PHARMACOL, V39, P233; HERRON CE, 1994, J NEUROSCI, V14, P6013; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; KEMP BE, 1988, METHOD ENZYMOL, V159, P173; KUNZ J, 1993, TRENDS BIOCHEM SCI, V18, P334, DOI 10.1016/0968-0004(93)90069-Y; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; STANTON PK, 1985, BRAIN RES, V358, P343, DOI 10.1016/0006-8993(85)90981-3; Staubli U, 1996, J NEUROSCI, V16, P853; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; YAKEL JL, 1995, P NATL ACAD SCI USA, V92, P1376, DOI 10.1073/pnas.92.5.1376; YUSTA B, 1988, J NEUROCHEM, V51, P1807, DOI 10.1111/j.1471-4159.1988.tb01162.x	60	225	230	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1998	21	5					1163	1175		10.1016/S0896-6273(00)80633-9	http://dx.doi.org/10.1016/S0896-6273(00)80633-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856471	hybrid			2022-12-24	WOS:000077386100026
J	Lonart, G; Janz, R; Johnson, KM; Sudhof, TC				Lonart, G; Janz, R; Johnson, KM; Sudhof, TC			Mechanism of action of rab3A in mossy fiber LTP	NEURON			English	Article							SYNAPTIC-VESICLE FUSION; LONG-TERM POTENTIATION; TRANSMITTER RELEASE; ADENYLATE-CYCLASE; CYCLIC-AMP; PROTEIN; ACTIVATION; SYNAPSES; RABPHILIN-3A; HIPPOCAMPUS	In mossy fiber synapses of the hippocampal CA3 region, LTP is induced by cAMP and requires the synaptic vesicle protein rab3A. In contrast, CA1-region synapses do not exhibit this type of LTP. We now show that cAMP enhances glutamate release from CA3 but not CA1 synaptosomes by (1) increasing the readily releasable pool as tested by hypertonic sucrose; (2) potentiating release evoked by KCl depolarization, which opens voltage-gated Ca2+ channels; and (3) by enhancing Ca2+ action on the secretory apparatus as monitored by the Ca2+-ionophore ionomycin. In rab3A-deficient synaptosomes, forskolin still enhances KCl- and sucrose-induced glutamate release but not ionomycin-induced release. Our results show that cAMP has multiple actions in mossy fiber synapses, of which only the direct activation of the secretory apparatus requires rab3A and functions in mfLTP.	Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci,Howard Hughes Med Inst, Dallas, TX 75235 USA; Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Medical Branch Galveston	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci,Howard Hughes Med Inst, Dallas, TX 75235 USA.	TSudho@Mednet.swmed.edu	Johnson, Kenneth/E-7944-2014	Janz, Roger/0000-0002-9872-0596	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001505, R01MH052804] Funding Source: NIH RePORTER; NIMH NIH HHS [KO1 MH01505, R01 MH52804] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bean AJ, 1997, NEURON, V19, P751, DOI 10.1016/S0896-6273(00)80957-5; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Chen CF, 1997, J NEUROSCI, V17, P8687; DEMONTIGNY P, 1987, ANAL CHEM, V59, P1096, DOI 10.1021/ac00135a007; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Goda Y, 1996, CURR BIOL, V6, P375, DOI 10.1016/S0960-9822(02)00499-2; HAJOS F, 1975, J NEUROCHEM, V24, P1277, DOI 10.1111/j.1471-4159.1975.tb03913.x; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HORTNAGL H, 1991, NEUROSCIENCE, V45, P261, DOI 10.1016/0306-4522(91)90224-C; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Lonart G, 1998, J NEUROSCI, V18, P634; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TERRIAN DM, 1988, BRAIN RES BULL, V21, P343, DOI 10.1016/0361-9230(88)90146-3; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482	28	99	100	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1998	21	5					1141	1150		10.1016/S0896-6273(00)80631-5	http://dx.doi.org/10.1016/S0896-6273(00)80631-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856469	Bronze			2022-12-24	WOS:000077386100024
J	von Gersdorff, H; Sakaba, T; Berglund, K; Tachibana, M				von Gersdorff, H; Sakaba, T; Berglund, K; Tachibana, M			Submillisecond kinetics of glutamate release from a sensory synapse	NEURON			English	Article							RETINAL BIPOLAR CELLS; ADRENAL CHROMAFFIN CELLS; FROG NEUROMUSCULAR-JUNCTION; SQUID GIANT SYNAPSE; TRANSMITTER RELEASE; RECEPTOR DESENSITIZATION; HORIZONTAL CELLS; CALCIUM CHANNELS; TIME-COURSE; NEUROTRANSMITTER RELEASE	Exocytosis-mediated glutamate release from ribbon-type synaptic terminals of retinal bipolar cells was studied using AMPA receptors and simultaneous membrane capacitance measurements. Release onset (delay <0.8 ms) and offset were closely tied to Ca2+ channel opening and closing. Asynchronous release was not copious and we estimate that there are similar to 5 Ca2+ channels per docked synaptic vesicle. Depending on Ca2+ current amplitude, release occurred in a single fast bout or in two successive bouts with fast and slow onset kinetics. The second, slower bout may reflect a mobilization rate of reserve vesicles toward fusion sites that is accelerated by increasing Ca2+ influx. Bipolar cell synaptic ribbons thus are remarkably versatile signal transducers, capable of transmitting rapidly changing sensory input, as well as sustained stimuli, due to their large pool of releasable vesicles.	Univ Tokyo, Dept Psychol, Grad Sch Humanities & Sociol, Bunkyo Ku, Tokyo 1130033, Japan; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	University of Tokyo; Max Planck Society	Tachibana, M (corresponding author), Univ Tokyo, Dept Psychol, Grad Sch Humanities & Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	itmasao@hongo.ecc.u-tokyo.ac.jp		Sakaba, Takeshi/0000-0003-0688-7717				ADLER EM, 1991, J NEUROSCI, V11, P1496; Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1990, J PHYSIOL-LONDON, V431, P343, DOI 10.1113/jphysiol.1990.sp018333; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; BAYLOR DA, 1977, J PHYSIOL-LONDON, V271, P425, DOI 10.1113/jphysiol.1977.sp012007; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; Cousin MA, 1997, J NEUROCHEM, V69, P1927; DACHEUX RF, 1986, J NEUROSCI, V6, P331; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FUKADA Y, 1971, VISION RES, V11, P227, DOI 10.1016/0042-6989(71)90187-8; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gillis Kevin D., 1995, P155; GLEASON E, 1994, NEURON, V13, P1109, DOI 10.1016/0896-6273(94)90049-3; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; ISHIDA AT, 1985, P NATL ACAD SCI USA, V82, P1837, DOI 10.1073/pnas.82.6.1837; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P483, DOI 10.1098/rspb.1965.0016; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KNAPP AG, 1987, NATURE, V325, P437, DOI 10.1038/325437a0; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V483, P79, DOI 10.1113/jphysiol.1995.sp020569; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; Lee BB, 1996, VISION RES, V36, P631, DOI 10.1016/0042-6989(95)00167-0; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; LUKASIEWICZ PD, 1995, J NEUROSCI, V15, P6189; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; Morgans CW, 1996, J NEUROSCI, V16, P6713; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NOWYCKY MC, 1985, P NATL ACAD SCI USA, V82, P2178, DOI 10.1073/pnas.82.7.2178; ODELL TJ, 1989, J NEUROPHYSIOL, V61, P1097, DOI 10.1152/jn.1989.61.6.1097; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; RAVIOLA E, 1982, J COMP NEUROL, V209, P233, DOI 10.1002/cne.902090303; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Roska B, 1998, J NEUROSCI, V18, P3451; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; SAITO T, 1979, J GEN PHYSIOL, V73, P73, DOI 10.1085/jgp.73.1.73; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; Schikorski T, 1997, J NEUROSCI, V17, P5858; SCHMIDT KF, 1994, P NATL ACAD SCI USA, V91, P8288, DOI 10.1073/pnas.91.17.8288; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; SHERRY DM, 1993, J COMP NEUROL, V329, P188, DOI 10.1002/cne.903290204; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; SPENCER AN, 1989, NATURE, V340, P636, DOI 10.1038/340636a0; STANLEY EF, 1993, NEURON, V11, P1007, DOI 10.1016/0896-6273(93)90214-C; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; Vincent P, 1996, J PHYSIOL-LONDON, V494, P183, DOI 10.1113/jphysiol.1996.sp021484; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yazejian B, 1997, J NEUROSCI, V17, P2990; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032	96	146	147	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1998	21	5					1177	1188		10.1016/S0896-6273(00)80634-0	http://dx.doi.org/10.1016/S0896-6273(00)80634-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856472	Bronze			2022-12-24	WOS:000077386100027
J	Cossart, R; Esclapez, M; Hirsch, JC; Bernard, C; Ben-Ari, Y				Cossart, R; Esclapez, M; Hirsch, JC; Bernard, C; Ben-Ari, Y			GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TEMPORAL-LOBE EPILEPSY; KAINIC ACID; SYNAPTIC TRANSMISSION; EPILEPTIFORM ACTIVITY; GABAERGIC INHIBITION; HIPPOCAMPAL-NEURONS; MONKEY HIPPOCAMPUS; RAT HIPPOCAMPUS; K+ CONDUCTANCE	We studied the modulation of GABAergic inhibition by glutamate and kainate acting on GluR5-containing kainate receptors in the CA1 hippocampal region. Glutamate, kainate or ATPA, a selective agonist of GluR5-containing receptors, generates an inward current in inhibitory interneurons and cause repetitive action potential firing. This results in a massive increase of tonic GABAergic inhibition in the somata and apical dendrites of pyramidal neurons. These effects are prevented by the GluR5 antagonist LY 293558. Electrical stimulation of excitatory afferents generates kainate receptor-mediated excitatory postsynaptic currents (EPSCs) and action potentials in identified interneurons that project to the dendrites and somata of pyramidal neurons. Therefore glutamate acting on kainate receptors containing the GluR5 subunit may provide a protective mechanism against hyperexcitability.	Hop Port Royal, INSERM, U29, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ben-Ari, Y (corresponding author), Hop Port Royal, INSERM, U29, 123 Bld Port Royal, F-75014 Paris, France.		Cossart, Rosa/E-7674-2014; bernard, christophe/S-5937-2016; Cossart, Rosa/AAT-7934-2020; Esclapez, Monique/O-6509-2016; bernard, christophe/A-4929-2012	Cossart, Rosa/0000-0003-2111-6638; bernard, christophe/0000-0003-3014-1966; Cossart, Rosa/0000-0003-2111-6638; Esclapez, Monique/0000-0002-8558-1363; bernard, christophe/0000-0003-3014-1966; Ben-Ari, Yehezkel/0000-0001-6208-8480				BAHN S, 1994, J NEUROSCI, V14, P5525; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; Bergles DE, 1996, J NEUROSCI, V16, P572; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Congar P, 1997, J NEUROSCI, V17, P5366; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; FISHER RS, 1984, J NEUROSCI, V4, P1312; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GAIARSA JL, 1994, J NEUROPHYSIOL, V71, P204, DOI 10.1152/jn.1994.71.1.204; GAIARSA JL, 1992, J COMP NEUROL, V321, P612, DOI 10.1002/cne.903210408; GOOD PF, 1993, BRAIN RES, V624, P347, DOI 10.1016/0006-8993(93)90102-S; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; HUNTLEY GW, 1993, J NEUROSCI, V13, P2965; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; Kondo S, 1998, J PHYSIOL-LONDON, V509, P233, DOI 10.1111/j.1469-7793.1998.233bo.x; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; Lerma J, 1997, TRENDS NEUROSCI, V20, P9, DOI 10.1016/S0166-2236(96)20055-4; Miller KK, 1997, J NEUROSCI, V17, P4994; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NADLER JV, 1981, LIFE SCI, V29, P2031; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; Radnikow G, 1998, J NEUROSCI, V18, P2009; REPRESA A, 1992, EXP BRAIN RES, V92, P69; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; ROVIRA C, 1990, PFLUG ARCH EUR J PHY, V415, P471, DOI 10.1007/BF00373625; SIEGEL SJ, 1995, J NEUROSCI, V15, P2707; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wang HL, 1997, BRAIN RES, V746, P294, DOI 10.1016/S0006-8993(96)00772-X; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3	38	270	274	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					470	478		10.1038/2185	http://dx.doi.org/10.1038/2185			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196544				2022-12-24	WOS:000076406900011
J	Joiner, WJ; Tang, MD; Wang, LY; Dworetzky, SI; Boissard, CG; Gan, L; Gribkoff, VK; Kaczmarek, LK				Joiner, WJ; Tang, MD; Wang, LY; Dworetzky, SI; Boissard, CG; Gan, L; Gribkoff, VK; Kaczmarek, LK			Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits	NATURE NEUROSCIENCE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-A; BETA-SUBUNIT; RAT-BRAIN; SMOOTH-MUSCLE; N-TERMINUS; VOLTAGE; EXPRESSION; MODULATION	Large-conductance calcium-activated potassium channels (maxi-K channels) have an essential role in the control of excitability and secretion. Only one gene Slo is known to encode maxi-K channels, which are sensitive to both membrane potential and intracellular calcium. We have isolated a potassium channel gene called Slack that is abundantly expressed in the nervous system. Slack channels rectify outwardly with a unitary conductance of about 25-65 pS and are inhibited by intracellular calcium. However, when Slack is co-expressed with Slo, channels with pharmacological properties and single-channel conductances that do not match either Slack or Slo are formed. The Slack/Slo channels have intermediate conductances of about 60-180 pS and are activated by cytoplasmic calcium. Our findings indicate that some intermediate-conductance channels in the nervous system may result from an interaction between Slack and Slo channel subunits.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Neurosci Drug Discovery, Wallingford, CT 06492 USA	Yale University; Yale University; Bristol-Myers Squibb	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	kaczmarek@yale.edu						ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chang CP, 1997, MOL BRAIN RES, V45, P33, DOI 10.1016/S0169-328X(96)00230-6; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; DRYER SE, 1991, J PHYSIOL-LONDON, V443, P601, DOI 10.1113/jphysiol.1991.sp018854; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; FARLEY J, 1988, BIOPHYS J, V53, P919, DOI 10.1016/S0006-3495(88)83173-4; Hanner M, 1997, P NATL ACAD SCI USA, V94, P2853, DOI 10.1073/pnas.94.7.2853; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hirsch JR, 1997, WIEN KLIN WOCHENSCHR, V109, P485; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Jones EMC, 1998, P ROY SOC B-BIOL SCI, V265, P685, DOI 10.1098/rspb.1998.0348; Kang J, 1996, J NEUROPHYSIOL, V76, P4194, DOI 10.1152/jn.1996.76.6.4194; Kanyicska B, 1997, ENDOCRINOLOGY, V138, P3141, DOI 10.1210/en.138.8.3141; Knaus HG, 1996, J NEUROSCI, V16, P955; LANCASTER B, 1991, J NEUROSCI, V11, P23; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Lingle C J, 1996, Ion Channels, V4, P261; MCCOBB DP, 1995, AM J PHYSIOL, V267, pH767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Mienville JM, 1996, PFLUG ARCH EUR J PHY, V431, P763, DOI 10.1007/s004240050063; Morita T, 1997, AM J PHYSIOL-RENAL, V273, pF615, DOI 10.1152/ajprenal.1997.273.4.F615; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; PACHA J, 1991, AM J PHYSIOL, V261, pF696, DOI 10.1152/ajprenal.1991.261.4.F696; Papazian DM, 1997, NEWS PHYSIOL SCI, V12, P203; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; REINHART PH, 1991, J NEUROSCI, V11, P1627; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; Sansom SC, 1997, J BIOL CHEM, V272, P9902; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; STORM JF, 1990, PROG BRAIN RES, V83, P161; TORO L, 1991, AM J PHYSIOL, V260, pH1779, DOI 10.1152/ajpheart.1991.260.6.H1779; TRAUTMANN A, 1984, P NATL ACAD SCI-BIOL, V81, P611, DOI 10.1073/pnas.81.2.611; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Xia XM, 1998, J NEUROSCI, V18, P2360	50	132	141	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					462	469		10.1038/2176	http://dx.doi.org/10.1038/2176			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196543				2022-12-24	WOS:000076406900010
J	Margrie, TW; Rostas, JAP; Sah, P				Margrie, TW; Rostas, JAP; Sah, P			Presynaptic long-term depression at a central glutamatergic synapse: a role for CaMKII	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; SQUID GIANT SYNAPSE; II INHIBITOR KN-93; CALCIUM CHANNELS; NEUROTRANSMITTER RELEASE; INTERACTION SITE; CALMODULIN; POTENTIATION; FLUORIDE; CELLS	CaMKII is a calcium-activated kinase that is abundant in neurons and has been strongly implicated in memory and learning. Here we show that low-frequency stimulation of glutamatergic afferents in hippocampal slices from juvenile domestic chicks results in long-term depression of synaptic transmission. This reduction does not require activation of NMDA or metabotropic glutamate receptors and does not require a rise in postsynaptic calcium. However, buffering presynaptic calcium prevents the reduction of the excitatory postsynaptic potential or current that is induced by low-frequency stimulation. in addition, application of the calmodulin antagonist calmidazolium, or the specific CaMKII antagonist KN-93, completely blocks long-term depression. These findings demonstrate a newsy discovered form of long-term synaptic depression in the avian hippocampus.	Univ Newcastle, Fac Med & Hlth Sci, Neurosci Grp, Callaghan, NSW 2308, Australia; Univ Newcastle, Fac Med & Hlth Sci, Disciplines Med Biochem & Human Physiol, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	Sah, P (corresponding author), John Curtin Sch Med Res, Div Neurosci, GPO Box 334, Canberra, ACT 2601, Australia.		Rostas, John/B-5089-2008; Sah, Pankaj/C-8175-2009	Sah, Pankaj/0000-0001-5063-1589				BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; KAY AR, 1986, J NEUROSCI, V6, P2915; KLEE CB, 1988, CALMODULIN; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; KOSTYUK PG, 1975, NATURE, V257, P691, DOI 10.1038/257691a0; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAMIYA N, 1993, BIOCHEM BIOPH RES CO, V195, P608, DOI 10.1006/bbrc.1993.2089; Margrie TW, 1998, J NEUROSCI, V18, P1207; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; NICHOLS RA, 1990, NATURE, V343, P647, DOI 10.1038/343647a0; POMPOLI M, 1992, FEBS LETT, V317, P85; Rettig J, 1997, J NEUROSCI, V17, P6647; ROSE SPR, 1991, TRENDS NEUROSCI, V14, P390, DOI 10.1016/0166-2236(91)90027-R; ROSTAS JAP, 1992, J NEUROCHEM, V59, P1191, DOI 10.1111/j.1471-4159.1992.tb08428.x; ROSTAS JAP, 1991, NEURAL BEHAV PLASTIC, P177; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; Weinberger R P, 1988, Brain Res, V471, P259; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wiseman A., 1970, PHARM FLUORIDES, P48; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Yokoyama CT, 1997, J NEUROSCI, V17, P6929	39	30	32	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					378	383		10.1038/1589	http://dx.doi.org/10.1038/1589			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196527				2022-12-24	WOS:000076361400015
J	Thallmair, M; Metz, GAS; Z'Graggen, WJ; Raineteau, O; Kartje, GL; Schwab, ME				Thallmair, M; Metz, GAS; Z'Graggen, WJ; Raineteau, O; Kartje, GL; Schwab, ME			Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions	NATURE NEUROSCIENCE			English	Article							HEMIPLEGIC CEREBRAL-PALSY; MONOCLONAL-ANTIBODY IN-1; RAT SENSORIMOTOR CORTEX; BASILAR PONTINE NUCLEI; SPINAL-CORD; NEURONAL PLASTICITY; MOTOR PERFORMANCE; NEONATAL LESIONS; NERVOUS-SYSTEM; AXON ARBORS	Anatomical plasticity and functional recovery after lesions of the rodent corticospinal tract (CST) decrease postnatally in parallel with myelin formation. Myelin-associated neurite growth inhibitory proteins prevent regenerative fiber growth, but whether they also prevent reactive sprouting of unlesioned fibers is less clear. Here we show that after unilateral CST lesion in the adult rat brainstem, both intact and lesioned tracts show topographically appropriate sprouting after treatment with a monoclonal antibody that neutralizes these inhibitory proteins. Antibody-treated animals showed full recovery in motor and sensory tests, whereas untreated lesioned rats exhibited persistent severe deficits. Neutralization of myelin-associated neurite growth inhibitors thus restores in adults the structural plasticity and functional recovery normally found only at perinatal ages.	Univ Zurich, Brain Res Inst, CH-8029 Zurich, Switzerland; Swiss Fed Inst Technol, CH-8029 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Thallmair, M (corresponding author), Univ Zurich, Brain Res Inst, August Forel Str 1, CH-8029 Zurich, Switzerland.		Raineteau, Olivier/I-1190-2014; Schwab, Martin E/B-6818-2016	Raineteau, Olivier/0000-0003-4294-2496; Metz, Gerlinde/0000-0002-5801-7716; Z'Graggen, Werner/0000-0002-5684-4419				AKINTUNDE A, 1992, BRAIN RES, V586, P208, DOI 10.1016/0006-8993(92)91629-S; ANTAL M, 1984, J HIRNFORSCH, V25, P647; Bandtlow C, 1996, EUR J BIOCHEM, V241, P468, DOI 10.1111/j.1432-1033.1996.00468.x; BARTH TM, 1990, J NEUROSCI, V10, P3449; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X; CAO Y, 1994, P NATL ACAD SCI USA, V91, P9612, DOI 10.1073/pnas.91.20.9612; CARLINI EA, 1967, MED PHARMACOL EXP, V17, P534; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CARR LJ, 1993, BRAIN, V116, P1223, DOI 10.1093/brain/116.5.1223; CASALE EJ, 1988, J COMP NEUROL, V278, P275, DOI 10.1002/cne.902780210; CASTRO AJ, 1972, BRAIN RES, V44, P313, DOI 10.1016/0006-8993(72)90305-8; CASTRO AJ, 1972, BRAIN RES, V37, P173, DOI 10.1016/0006-8993(72)90665-8; CASTRO AJ, 1983, J COMP NEUROL, V219, P112, DOI 10.1002/cne.902190111; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; ENDO K, 1973, BRAIN RES, V57, P484, DOI 10.1016/0006-8993(73)90154-6; Fagan AM, 1997, J NEUROSCI, V17, P2499; FARMER SF, 1991, NEUROLOGY, V41, P1505, DOI 10.1212/WNL.41.9.1505; FLUMERFELT BA, 1980, J ANAT, V131, P621; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; HICKS S P, 1970, Experimental Neurology, V29, P416, DOI 10.1016/0014-4886(70)90069-5; KALIL K, 1982, J COMP NEUROL, V211, P265, DOI 10.1002/cne.902110305; KALIL K, 1979, SCIENCE, V205, P1158, DOI 10.1126/science.472734; KALIL K, 1975, BRAIN RES, V100, P170, DOI 10.1016/0006-8993(75)90254-1; KAPFHAMMER JP, 1994, J COMP NEUROL, V340, P194, DOI 10.1002/cne.903400206; KARTJETILLOTSON G, 1980, PHYSIOL BEHAV, V24, P293, DOI 10.1016/0031-9384(80)90089-X; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; KUANG RZ, 1990, J COMP NEUROL, V302, P461, DOI 10.1002/cne.903020304; KUANG RZ, 1990, J COMP NEUROL, V292, P585, DOI 10.1002/cne.902920408; LEONG SK, 1973, BRAIN RES, V62, P218, DOI 10.1016/0006-8993(73)90630-6; LIANG F, 1991, J COMP NEUROL, V311, P356, DOI 10.1002/cne.903110306; MIHAILOFF GA, 1978, BRAIN RES, V145, P347, DOI 10.1016/0006-8993(78)90867-3; NAUS C, 1985, EXP BRAIN RES, V59, P365; NAUS CG, 1985, J COMP NEUROL, V239, P453, DOI 10.1002/cne.902390411; PANTO MR, 1995, J BRAIN RES, V36, P7; REH T, 1982, J COMP NEUROL, V211, P276, DOI 10.1002/cne.902110306; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; ROUILLER EM, 1991, EXP NEUROL, V114, P53, DOI 10.1016/0014-4886(91)90084-P; RUBIN BP, 1994, J NEUROCYTOL, V23, P209, DOI 10.1007/BF01275525; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Spillmann AA, 1997, EUR J NEUROSCI, V9, P549, DOI 10.1111/j.1460-9568.1997.tb01631.x; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VALVERDE F, 1966, Z ZELLFORSCH MIK ANA, V71, P297, DOI 10.1007/BF00332585; Vanek P, 1998, EUR J NEUROSCI, V10, P45, DOI 10.1046/j.1460-9568.1998.00018.x; WHISHAW IQ, 1988, BRAIN RES, V451, P97, DOI 10.1016/0006-8993(88)90753-6; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; WIESENDANGER R, 1982, J COMP NEUROL, V208, P227, DOI 10.1002/cne.902080303	50	321	329	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					124	131		10.1038/373	http://dx.doi.org/10.1038/373			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195127				2022-12-24	WOS:000076361100013
J	Ernst, MO; Banks, MS; Bulthoff, HH				Ernst, MO; Banks, MS; Bulthoff, HH			Touch can change visual slant perception	NATURE NEUROSCIENCE			English	Article							IDEAL OBSERVERS; TEXTURE; PSYCHOPHYSICS; SHAPE; CUES	The visual system uses several signals to deduce the three-dimensional structure of the environment, including binocular disparity, texture gradients, shading and motion parallax. Although each of these sources of information is independently insufficient to yield reliable three-dimensional structure from everyday scenes, the visual system combines them by weighting the available information; altering the weights would therefore change the perceived structure. We report that haptic feedback (active touch) increases the weight of a consistent surface-slant signal relative to inconsistent signals. Thus, appearance of a subsequently viewed surface is changed: the surface appears slanted in the direction specified by the haptically reinforced signal.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA	Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ernst, MO (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Ernst, Marc/0000-0003-4197-8569				Backus BT, 1999, PERCEPTION, V28, P217, DOI 10.1068/p2753; Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; BLAKE A, 1993, VISION RES, V33, P1723, DOI 10.1016/0042-6989(93)90037-W; Bradshaw MF, 1996, VISION RES, V36, P1255, DOI 10.1016/0042-6989(95)00190-5; BUCKLEY D, 1993, VISION RES, V33, P919, DOI 10.1016/0042-6989(93)90075-8; BULTHOFF HH, 1996, ATTENTION PERFORM, V16, P49; Clark J.J., 1990, DATA FUSION SENSORY; FESTINGER L, 1967, J EXPT PSYCHOL MONOG, V74; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; GILLAM B, 1993, PERCEPTION, V22, P1025, DOI 10.1068/p221025; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; JOHNSTON EB, 1993, VISION RES, V33, P813, DOI 10.1016/0042-6989(93)90200-G; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; LEDERMAN SJ, 1981, J EXP PSYCHOL HUMAN, V7, P902, DOI 10.1037/0096-1523.7.4.902; Massie TH, 1994, PHANTOM HAPTIC INTER, P295; Rock I., 1966, NATURE PERCEPTUAL AD; ROCK I, 1964, SCIENCE, V143, P595; ROGERS BJ, 1995, PERCEPTION, V24, P155, DOI 10.1068/p240155; Stratton G. M., 1897, PSYCHOL REV, V4, P463, DOI [10.1037/h0075482, DOI 10.1037/H0071173]; Stratton G.M., 1897, PSYCHOL REV, V4, P341, DOI [DOI 10.1037/H0075482, 10.1037/h0075482]; van Ee R, 1999, PERCEPTION, V28, P1121; VONHELMHOLTZ H, 1867, HDB PHYSIL OPTIK, V3; Walk R. D., 1981, INTERSENSORY PERCEPT; Welch R. B., 1978, PERCEPTUAL MODIFICAT; WELCH RB, 1986, HDB PERCEPTION HUMAN	26	151	153	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					69	73		10.1038/71140	http://dx.doi.org/10.1038/71140			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TB	10607397				2022-12-24	WOS:000085810200014
J	Kins, S; Betz, H; Kirsch, J				Kins, S; Betz, H; Kirsch, J			Collybistin, a newly identified brain-specific GEF, induces submembrane clustering of gephyrin	NATURE NEUROSCIENCE			English	Article							INHIBITORY GLYCINE RECEPTOR; TUBULIN LINKER PROTEIN; RAT SPINAL-CORD; ACTIN CYTOSKELETON; BETA SUBUNIT; EXPRESSION; GTPASES; NEURONS; FAMILY; RHO	The formation of postsynaptic GABA(A) and glycine receptor clusters requires the receptor-associated peripheral membrane protein gephyrin. Here we describe two splice variants of a novel gephyrin-binding protein, termed collybistin I and II, which belong to the family of dbl-like GDP/GTP exchange factors (GEFs). Co-expression of collybistin II with gephyrin induced the formation of submembrane gephyrin aggregates that accumulate hetero-oligomeric glycine receptors. Our data suggest that collybistin II regulates the membrane deposition of gephyrin by activating a GTPase of the Rho/Rac family. Therefore, this protein may be an important determinant of inhibitory postsynaptic membrane formation and plasticity.	Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; Univ Ulm, Dept Anat & Cellular Neurobiol, D-89069 Ulm, Germany	Max Planck Society; Ulm University	Betz, H (corresponding author), Max Planck Inst Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de						AKAGI H, 1988, SCIENCE, V242, P270, DOI 10.1126/science.2845580; Bechade C, 1996, EUR J NEUROSCI, V8, P429, DOI 10.1111/j.1460-9568.1996.tb01226.x; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FROEHNER SC, 1993, ANNU REV NEUROSCI, V16, P347, DOI 10.1146/annurev.ne.16.030193.002023; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARLAN JE, 1994, NATURE, V372, P375; HARPER JW, 1993, CELL, V75, P805; HART MJ, 1994, J BIOL CHEM, V269, P62; HATEBOER G, 1995, EMBO J, V14, P3159, DOI 10.1002/j.1460-2075.1995.tb07318.x; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kins S, 1999, EUR J NEUROSCI, V11, P740, DOI 10.1046/j.1460-9568.1999.00527.x; KIRSCH J, 1993, EUR J NEUROSCI, V5, P1109, DOI 10.1111/j.1460-9568.1993.tb00965.x; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, BRAIN RES, V621, P301, DOI 10.1016/0006-8993(93)90120-C; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Krisch J, 1999, CURR OPIN NEUROBIOL, V9, P329, DOI 10.1016/S0959-4388(99)80048-8; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; Levi S, 1998, J CELL SCI, V111, P335; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Mammoto A, 1998, BIOCHEM BIOPH RES CO, V243, P86, DOI 10.1006/bbrc.1997.8068; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Todd AJ, 1996, J NEUROSCI, V16, P974	50	216	222	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					22	29		10.1038/71096	http://dx.doi.org/10.1038/71096			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TB	10607391				2022-12-24	WOS:000085810200008
J	Degterev, A; Yuan, JY				Degterev, A; Yuan, JY			A new savior for neurons	NATURE NEUROSCIENCE			English	News Item							PROGRAMMED CELL-DEATH; SYMPATHETIC NEURONS; APOPTOSIS; GENE	How NGF promotes neuronal survival is unclear. New findings suggest that the mechanism involves induction of an antiapoptotic protein called ITA.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Degterev, A (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.							Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Deshmukh M, 1997, MOL PHARMACOL, V51, P897, DOI 10.1124/mol.51.6.897; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; Ozes ON, 1999, NATURE, V401, P82; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Troy CM, 1997, J NEUROSCI, V17, P1911; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777	15	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					930	932		10.1038/14712	http://dx.doi.org/10.1038/14712			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526325				2022-12-24	WOS:000083883300004
J	Dolan, RI				Dolan, RI			On the neurology of morals	NATURE NEUROSCIENCE			English	News Item							DAMAGE; CORTEX	Patients with medial prefrontal lesions often display irresponsible behavior, despite being Intellectually unimpaired. But similar lesions occurring in early childhood can also prevent the acquisition of factual knowledge about accepted standards of moral behavior.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London	Dolan, RI (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.			Dolan, Ray/0000-0001-9356-761X				Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Damasio A. R., 1983, NEUROPSYCHOLOGY HUMA, P85; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAMASIO AR, 1994, DESCARTES ERROR; Elliott R, 1997, NEUROPSYCHOLOGIA, V35, P1395, DOI 10.1016/S0028-3932(97)00055-9; Gallagher M, 1999, J NEUROSCI, V19, P6610; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Luria A. R., 2012, HIGHER CORTICAL FUNC; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525	12	58	60	2	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					927	929		10.1038/14707	http://dx.doi.org/10.1038/14707			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FF	10526323	Green Published			2022-12-24	WOS:000083883300002
J	Wu, LG; Borst, JGG				Wu, LG; Borst, JGG			The reduced release probability of releasable vesicles during recovery from short-term synaptic depression	NEURON			English	Article							SQUID GIANT SYNAPSE; PRESYNAPTIC CALCIUM CURRENT; RAT BRAIN-STEM; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; GLUTAMATE RECEPTORS; NERVE-TERMINALS; TIME-COURSE; FACILITATION	Recovery from synaptic depression is believed to depend mainly on replenishment of the releasable pool of vesicles. We observed that during recovery from depression in a calyx-type synapse, part of the releasable pool was replenished rapidly. Half recovery occurred within 1 s, even in the absence of residual calcium. Vesicles that had recently entered the releasable pool had a 7- to 8-fold lower release probability than those that had been in the pool for more than 30 s. These results suggest that the reduction in the release probability of releasable vesicles contributes greatly to the level of depression. How synapses maintain transmission during repetitive firing is in debate. We propose that during repetitive firing, accumulation of intracellular Ca2+ may facilitate release of the rapidly replenished but reluctant vesicles, making them available for sustaining synaptic transmission.	Max Planck Inst Med Forsch, Zellphysiol Abt, D-69120 Heidelberg, Germany	Max Planck Society	Wu, LG (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.							Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; BENNETT MR, 1990, PROC R SOC SER B-BIO, V239, P329, DOI 10.1098/rspb.1990.0020; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Blank PS, 1998, J GEN PHYSIOL, V112, P559, DOI 10.1085/jgp.112.5.559; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; CHARLTON MP, 1982, J PHYSIOL-LONDON, V323, P173, DOI 10.1113/jphysiol.1982.sp014067; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P586, DOI 10.1113/jphysiol.1954.sp005131; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HOCHNER B, 1991, NEUROSCI LETT, V125, P215, DOI 10.1016/0304-3940(91)90032-O; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; TAKEUCHI AKIRA, 1958, JAPANESE JOUR PHYSIOL, V8, P102; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1994, PHYSIOL REV, V74, P899, DOI 10.1152/physrev.1994.74.4.899; Varela JA, 1997, J NEUROSCI, V17, P7926; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	53	248	249	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG	1999	23	4					821	832		10.1016/S0896-6273(01)80039-8	http://dx.doi.org/10.1016/S0896-6273(01)80039-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	230ZE	10482247	Bronze			2022-12-24	WOS:000082280900024
J	Hessler, NA; Doupe, AJ				Hessler, NA; Doupe, AJ			Social context modulates singing-related neural activity in the songbird forebrain	NATURE NEUROSCIENCE			English	Article							ZEBRA FINCH; LESIONS; SYSTEM; BIRDS		Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hessler, NA (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.		hessler, neal/A-7328-2010		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009913] Funding Source: NIH RePORTER; NIMH NIH HHS [MH55987] Funding Source: Medline; NINDS NIH HHS [NS09913] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Catchpole C., 1995, BIRD SONG BIOL THEME; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Dunn AM, 1996, ETHOLOGY, V102, P540; Fox HE, 1997, J NEUROSCI, V17, P6463; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MORRIS D, 1954, BEHAVIOUR, V7, P1, DOI 10.1163/156853955X00012; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	15	210	211	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					209	211		10.1038/6306	http://dx.doi.org/10.1038/6306			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195211				2022-12-24	WOS:000081684500006
J	Clyne, PJ; Certel, SJ; de Bruyne, M; Zaslavsky, L; Johnson, WA; Carlson, JR				Clyne, PJ; Certel, SJ; de Bruyne, M; Zaslavsky, L; Johnson, WA; Carlson, JR			The odor specificities of a subset of olfactory receptor neurons are governed by Acj6, a POU-domain transcription factor	NEURON			English	Article							RETINAL GANGLION-CELLS; DROSOPHILA-MELANOGASTER; C-ELEGANS; CHEMOSENSORY NEURONS; GENE-EXPRESSION; MAXILLARY PALP; SENSE-ORGANS; BRN-3 FAMILY; I-POU; PROTEIN	Little is known about how the odor specificities of olfactory neurons are generated, a process essential to olfactory coding. We have found that neuronal identity relies on the abnormal chemosensory jump 6 (acj6) gene, originally identified by a defect in olfactory behavior. Physiological analysis of individual olfactory neurons shows that in acj6 mutants, a subset of neurons acquires a different odorant response profile. Certain other neurons do not respond to any tested odors in acj6. Molecular analysis of acj6 shows that it encodes a POU-domain transcription factor expressed in olfactory neurons. Our data suggest that the odor response spectrum of an olfactory neuron, and perhaps the choice of receptor genes, is determined through a process requiring the action of Acj6.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Iowa, Coll Med, Genet Program, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	Yale University; University of Iowa; University of Iowa	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.			Johnson, Wayne/0000-0002-6961-5498	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123; ARORA K, 1987, NATURE, V330, P62, DOI 10.1038/330062a0; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; BANERJEE U, 1987, CELL, V51, P151, DOI 10.1016/0092-8674(87)90020-1; BILLIN AN, 1991, MECH DEVELOP, V34, P75, DOI 10.1016/0925-4773(91)90045-8; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DECICCO DV, 1984, CELL, V38, P45, DOI 10.1016/0092-8674(84)90525-7; DICK T, 1991, P NATL ACAD SCI USA, V88, P7645, DOI 10.1073/pnas.88.17.7645; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Getz WM, 1997, J COMP PHYSIOL A, V180, P701, DOI 10.1007/s003590050084; GUILLET JC, 1972, J INSECT PHYSIOL, V18, P2155, DOI 10.1016/0022-1910(72)90246-6; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Innis MA, 1990, PCR PROTOCOLS GUIDE; LIENHARD MC, 1991, DEVELOPMENT, V112, P1063; LLOYD A, 1991, MECH DEVELOP, V36, P87, DOI 10.1016/0925-4773(91)90075-H; Maniatis T., 1982, MOL CLONING LAB MANU; MCKENNA M, 1989, P NATL ACAD SCI USA, V86, P8118, DOI 10.1073/pnas.86.20.8118; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; POOLE SJ, 1995, MECH DEVELOP, V49, P107, DOI 10.1016/0925-4773(94)00307-9; RAHA D, 1994, J NEUROBIOL, V25, P169, DOI 10.1002/neu.480250208; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Reddy GV, 1997, DEVELOPMENT, V124, P703; RUVKUN G, 1991, CELL, V64, P475, DOI 10.1016/0092-8674(91)90227-P; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; SINGH RN, 1985, INT J INSECT MORPHOL, V14, P291; THEIL T, 1993, NUCLEIC ACIDS RES, V21, P5921, DOI 10.1093/nar/21.25.5921; TREACY MN, 1992, CELL, V68, P491, DOI 10.1016/0092-8674(92)90186-G; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; VOSS JW, 1991, GENE DEV, V5, P1309, DOI 10.1101/gad.5.7.1309; Wang SS, 1997, J NEUROSCI, V17, P4149; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P596, DOI 10.1073/pnas.93.2.596; YANG XH, 1993, GENE DEV, V7, P504, DOI 10.1101/gad.7.3.504	51	133	140	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					339	347		10.1016/S0896-6273(00)81094-6	http://dx.doi.org/10.1016/S0896-6273(00)81094-6			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069339	hybrid			2022-12-24	WOS:000078875200018
J	Yan, Z; Hsieh-Wilson, L; Feng, JA; Tomizawa, K; Allen, PB; Fienberg, AA; Nairn, AC; Greengard, P				Yan, Z; Hsieh-Wilson, L; Feng, JA; Tomizawa, K; Allen, PB; Fienberg, AA; Nairn, AC; Greengard, P			Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin	NATURE NEUROSCIENCE			English	Article							TERM SYNAPTIC DEPRESSION; REDUCE N-TYPE; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; BASAL GANGLIA; CHOLINERGIC INTERNEURONS; DOPAMINE-RECEPTORS; DENDRITIC SPINES; CA2+ CURRENTS; KINASE	Modulation of AMPA-type glutamate channels is important for synaptic plasticity. Here we provide physiological evidence that the activity of AMPA channels is regulated by protein phosphatase 1 (PP-1) in neostriatal neurons and identify two distinct molecular mechanisms of this regulation. One mechanism involves control of PP-1 catalytic activity by DARPP-32, a dopamine- and cAMP-regulated phosphoprotein highly enriched in neostriatum. The other involves binding of PP-1 to spinophilin, a protein that colocalizes PP-1 with AMPA receptors in postsynaptic densities. The results suggest that regulation of anchored PP-1 is important for AMPA-receptor-mediated synaptic transmission and plasticity.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Rockefeller University	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.			Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 10044, P01 DA010044] Funding Source: Medline; NIMH NIH HHS [MH 40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Beal M F, 1992, Curr Opin Neurobiol, V2, P657, DOI 10.1016/0959-4388(92)90035-J; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; COHEN P, 1988, METHOD ENZYMOL, V159, P390; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Goslin K., 1991, CULTURING NERVE CELL, P251; Gotz T, 1997, J NEUROSCI, V17, P204; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; WALAAS SI, 1983, NATURE, V301, P69; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Yan Z, 1996, J NEUROSCI, V16, P2592; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yan Z, 1997, NEURON, V19, P1115, DOI 10.1016/S0896-6273(00)80402-X	40	240	248	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					13	17		10.1038/4516	http://dx.doi.org/10.1038/4516			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195174				2022-12-24	WOS:000078409300007
J	Muller, U; Carew, TJ				Muller, U; Carew, TJ			Serotonin induces temporally and mechanistically distinct phases of persistent PKA activity in Aplysia sensory neurons	NEURON			English	Article							LONG-TERM FACILITATION; DEPENDENT PROTEIN-KINASE; CAMP-RESPONSIVE ELEMENT; SYNAPTIC FACILITATION; HETEROSYNAPTIC FACILITATION; MACROMOLECULAR-SYNTHESIS; TRANSMITTER RELEASE; CELLULAR MECHANISM; WITHDRAWAL REFLEX; MEMORY FORMATION	The cAMP signaling cascade has been implicated in several stages of memory formation. We have examined activation of this cascade by serotonin (5-HT) in the sensory neurons of Aplysia. We find that different patterns of 5-HT exposure induce three distinct modes of PKA activation. First, a single 5 min pulse induces transient (5 min) PKA activation that requires neither transcription nor translation. Second, 4-5 pulses induce intermediate-term persistent activation (3 hr duration) that requires translation but not transcription. Third, 5 pulses of 5-HT, as well as continuous (90 min) exposure, induce long-term persistent activation 20 hr later, which requires both transcription and translation. Thus, in the sensory neurons, different patterns of 5-HT give rise to three independent phases of PKA activation that differ in their induction requirements, their temporal profiles, and their molecular mechanisms.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Free Univ Berlin, Inst Neurobiol, D-14195 Berlin, Germany	Yale University; Yale University; Free University of Berlin	Carew, TJ (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	tcarew@pantheon.yale.edu			NIMH NIH HHS [R01 MH-14-1083] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; AGRANOFF BERNARD W., 1966, BRAIN RES, V1, P303, DOI 10.1016/0006-8993(66)90095-3; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Atkinson R. C., 1968, PSYCHOL LEARN MOTIVA, V2, P89, DOI 10.1016/S0079-7421(08)60422-3; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BERGOLD PJ, 1990, P NATL ACAD SCI USA, V87, P3788, DOI 10.1073/pnas.87.10.3788; BERNIER L, 1982, J NEUROSCI, V2, P1682; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BUONOMANO DV, 1990, SCIENCE, V249, P420, DOI 10.1126/science.2165631; BYRNE JH, 1987, PHYSIOL REV, V67, P329, DOI 10.1152/physrev.1987.67.2.329; Byrne JH, 1996, J NEUROSCI, V16, P425; Carew T. J., 1987, NEURAL MOL BASES LEA, P177; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; Carew TJ, 1996, NEURON, V16, P5, DOI 10.1016/S0896-6273(00)80016-1; CHAIN DG, 1995, J NEUROSCI, V15, P7592; CLARK GA, 1993, P NATL ACAD SCI USA, V90, P11411, DOI 10.1073/pnas.90.23.11411; COHEN HD, 1968, NATURE, V218, P271, DOI 10.1038/218271a0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GOLDMAN-RAKIC P S, 1992, Scientific American, V267, P110; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HAWKINS RD, 1987, HDB PHYSL 1, P25; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HILDEBRANDT H, 1995, J NEUROBIOL, V27, P44, DOI 10.1002/neu.480270105; HILDEBRANDT H, 1995, BRAIN RES, V679, P281, DOI 10.1016/0006-8993(95)00246-M; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mauelshagen J, 1998, LEARN MEMORY, V5, P246; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; MERCER AR, 1991, SCIENCE, V254, P1811, DOI 10.1126/science.1662413; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 1996, NEURON, V16, P541, DOI 10.1016/S0896-6273(00)80073-2; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Schacher S, 1997, J NEUROSCI, V17, P597; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318	55	111	115	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1423	1434		10.1016/S0896-6273(00)80660-1	http://dx.doi.org/10.1016/S0896-6273(00)80660-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883734	hybrid			2022-12-24	WOS:000077910600023
J	Cameron, JS; Lhuillier, L; Subramony, P; Dryer, SE				Cameron, JS; Lhuillier, L; Subramony, P; Dryer, SE			Developmental regulation of neuronal K+ channels by target-derived TGF beta in vivo and in vitro	NEURON			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; CILIARY-GANGLION NEURONS; GROWTH-FACTOR-BETA; PARASYMPATHETIC NEURONS; SYNAPTIC TRANSMISSION; NEUROTROPHIC FACTORS; EPITHELIAL-CELLS; CHICKEN-EMBRYO; CA2+ CHANNELS; IN-SITU	The functional expression of Ca2+-activated K+ channels (K-Ca) in developing chick ciliary ganglion (CG) neurons requires interactions with target tissues and preganglionic innervation. Here, we show that the stimulatory effects of target tissues are mediated by an isoform of TGF beta. Exposure of cultured CG neurons to TGF beta 1, but not TGF beta 2 or TGF beta 3, caused robust stimulation of K-Ca. The K-Ca stimulatory effects of target tissue extracts were blocked by a neutralizing pan-TGF beta antiserum but not by specific TGF beta 2 or TGF beta 3 antisera. Intraocular injection of TGF beta 1 caused robust stimulation of K-Ca, whereas intraocular injection of pan-TGF beta antiserum inhibited expression of K-Ca in CG neurons developing in vivo. The effects of TGF beta 1 were potentiated by beta-neuregulin-1, a differentiation factor expressed in preganglionic neurons.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Dryer, SE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	SDryer@uh.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032748] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32748] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atfi A, 1995, P NATL ACAD SCI USA, V92, P12110, DOI 10.1073/pnas.92.26.12110; Baker JC, 1997, CURR OPIN GENET DEV, V7, P467, DOI 10.1016/S0959-437X(97)80072-X; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; BURT DW, 1992, MOL ENDOCRINOL, V6, P989, DOI 10.1210/me.6.6.989; BURT DW, 1992, DNA CELL BIOL, V11, P497, DOI 10.1089/dna.1992.11.497; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Commissiong JW, 1997, NEUROCHEM INT, V30, P393, DOI 10.1016/S0197-0186(96)00074-5; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; DOURADO MM, 1992, J PHYSIOL-LONDON, V449, P411, DOI 10.1113/jphysiol.1992.sp019093; DOURADO MM, 1994, J NEUROSCI, V14, P3156; DRYER SE, 1991, J PHYSIOL-LONDON, V443, P601, DOI 10.1113/jphysiol.1991.sp018854; Dryer SE, 1998, J NEUROBIOL, V37, P23, DOI 10.1002/(SICI)1097-4695(199810)37:1<23::AID-NEU3>3.0.CO;2-A; DRYER SE, 1991, J PHYSIOL-LONDON, V435, P513, DOI 10.1113/jphysiol.1991.sp018522; DRYER SE, 1994, PROG NEUROBIOL, V43, P281, DOI 10.1016/0301-0082(94)90003-5; DUNN BE, 1981, ANAT REC, V199, P33, DOI 10.1002/ar.1091990105; Finn TP, 1998, J NEUROBIOL, V34, P283, DOI 10.1002/(SICI)1097-4695(19980215)34:3<283::AID-NEU7>3.0.CO;2-Z; FLANDERS KC, 1993, MOL CELL NEUROSCI, V4, P406, DOI 10.1006/mcne.1993.1051; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Ghosh S, 1996, DEV DYNAM, V205, P126; GOLA M, 1993, NEURON, V10, P689, DOI 10.1016/0896-6273(93)90170-V; Gribkoff V K, 1997, Adv Pharmacol, V37, P319; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harpel John G., 1992, Progress in Growth Factor Research, V4, P321, DOI 10.1016/0955-2235(92)90014-9; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; IWASAKI Y, 1997, J NEUROL SCI, V20, P9; JAKOWLEW SB, 1992, DEV DYNAM, V195, P276, DOI 10.1002/dvdy.1001950406; KACZOROWSKI GJ, 1996, J BIOENERG BIOMEMBR, V28, P691; Kane CJM, 1996, DEV BRAIN RES, V96, P46, DOI 10.1016/S0165-3806(96)00092-2; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; LANDMESSER L, 1974, J PHYSIOL-LONDON, V241, P737, DOI 10.1113/jphysiol.1974.sp010681; LANDMESSER L, 1978, FED PROC, V37, P2016; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MERINEY SD, 1987, J NEUROSCI, V7, P3827; NARAYANAN Y, 1981, J EMBRYOL EXP MORPH, V62, P117; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; RAUCHER S, 1995, J PHYSIOL-LONDON, V486, P605, DOI 10.1113/jphysiol.1995.sp020838; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Sieber-Blum M, 1997, J ANAT, V191, P493, DOI 10.1046/j.1469-7580.1997.19140493.x; Subramony P, 1996, NEURON, V17, P115, DOI 10.1016/S0896-6273(00)80285-8; Subramony P, 1996, DEV BRAIN RES, V91, P149, DOI 10.1016/0165-3806(95)00174-3; Subramony P, 1997, P NATL ACAD SCI USA, V94, P5934, DOI 10.1073/pnas.94.11.5934; Unsicker K, 1996, CIBA F SYMP, V196, P70; WISGIRDA ME, 1994, P NATL ACAD SCI USA, V91, P2858, DOI 10.1073/pnas.91.7.2858; Xia XM, 1998, J NEUROSCI, V18, P2360; YAN ZF, 1994, J BIOL CHEM, V269, P13231; Zhang JM, 1997, DEV DYNAM, V208, P375	53	50	50	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1045	1053		10.1016/S0896-6273(00)80622-4	http://dx.doi.org/10.1016/S0896-6273(00)80622-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856460	Bronze			2022-12-24	WOS:000077386100015
J	Muller, MM; Teder-Salejarvi, W; Hillyard, SA				Muller, MM; Teder-Salejarvi, W; Hillyard, SA			The time course of cortical facilitation during cued shifts of spatial attention	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; NEURAL MECHANISMS; VISUAL-ATTENTION; ALLOCATION; MEMORY; MODEL; BLINK; V4	Adaptive behavior requires the rapid switching of attention among potentially relevant stimuli that appear in the environment. The present study used an electrophysiological approach to continuously measure the time course of visual pathway facilitation in human subjects as attention was shifted from one location to another. Steady-state visual evoked potentials (SSVEPs) were recorded to rapidly flickering lights at attended and unattended locations, and variations in SSVEP amplitude over time were calculated after a cue to shift attention. The build-up of cortical facilitation reflected in SSVEP amplitude was found to bear a close temporal relationship with the emergence of accurate target discriminations at the newly attended location.	Univ Konstanz, Dept Psychol, D-78457 Constance, Germany; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Konstanz; University of California System; University of California San Diego	Muller, MM (corresponding author), Univ Konstanz, Dept Psychol, Fach D25, D-78457 Constance, Germany.				NIMH NIH HHS [MH-25594] Funding Source: Medline; NINDS NIH HHS [NS 17778] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH025594, R01MH025594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778, P01NS017778] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHEAL ML, 1994, Q J EXP PSYCHOL-A, V47, P699, DOI 10.1080/14640749408401134; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; HILLYARD SA, IN PRESS PHIL T R B; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; LaBerge D., 1995, ATTENTIONAL PROCESSI; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Morgan ST, 1996, P NATL ACAD SCI USA, V93, P4770, DOI 10.1073/pnas.93.10.4770; Motter BC, 1998, ATTENTIVE BRAIN, P51; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Regan D., 1989, HUMAN BRAIN ELECTROP, P70; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SPERLING G, 1971, SCIENCE, V174, P307, DOI 10.1126/science.174.4006.307; Stelmach LB, 1997, J EXP PSYCHOL HUMAN, V23, P823, DOI 10.1037/0096-1523.23.3.823; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; Ward R, 1996, COGNITIVE PSYCHOL, V30, P79, DOI 10.1006/cogp.1996.0003; YAMAGUCHI S, 1994, BRAIN, V117, P553, DOI 10.1093/brain/117.3.553	29	211	214	0	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					631	634		10.1038/2865	http://dx.doi.org/10.1038/2865			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	146NL	10196572				2022-12-24	WOS:000077437100020
J	Noordermeer, JN; Kopczynski, CC; Fetter, RD; Bland, KS; Chen, WY; Goodman, CS				Noordermeer, JN; Kopczynski, CC; Fetter, RD; Bland, KS; Chen, WY; Goodman, CS			Wrapper, a novel member of the Ig superfamily, is expressed by midline glia and is required for them to ensheath commissural axons in Drosophila	NEURON			English	Article							PROGRAMMED CELL-DEATH; CENTRAL-NERVOUS-SYSTEM; GENETIC-ANALYSIS; IMMUNOGLOBULIN SUPERFAMILY; SIGNAL PEPTIDE; CNS MIDLINE; PROTEIN; EMBRYOS; APOPTOSIS; FATE	The midline glia are specialized, nonneuronal cells at the midline of the Drosophila central nervous system (CNS). During development, the midline glia provide guidance cues for extending axons. At the same time, they migrate and help separate the two axon commissures. They then wrap around and ensheath the commissural axons. In many segments, a few of the glia do not enwrap the axons, and these cells die. The wrapper gene encodes a novel member of the immunoglobulin (ig) superfamily. Wrapper protein is expressed specifically on the surface of midline glia. In wrapper mutant embryos, the midline glia express their normal guidance cues and migrate normally. However, they do not ensheath the commissural axons, and as a result, the glia die. In the absence of Wrapper, the two axon commissures are not properly separated.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.			Bland, Kimberly/0000-0003-4863-6772				AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; BOSSING T, 1994, DEVELOPMENT, V120, P1895; BRAND AH, 1993, DEVELOPMENT, V118, P401; Butler SJ, 1997, DEVELOPMENT, V124, P781; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DALBY B, 1995, GENETICS, V139, P757; Dong R, 1997, DEV BIOL, V190, P165, DOI 10.1006/dbio.1997.8688; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GERBER LD, 1992, J BIOL CHEM, V267, P12168; Goodman Corey S., 1993, P1131; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JACOBS JR, 1989, J NEUROSCI, V9, P2402; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Klambt C, 1996, DEV GENET, V18, P40, DOI 10.1002/(SICI)1520-6408(1996)18:1&lt;40::AID-DVG5&gt;3.0.CO;2-1; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Menne TV, 1997, DEVELOPMENT, V124, P4949; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Reiter C, 1996, DEVELOPMENT, V122, P1931; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Scholz H, 1997, MECH DEVELOP, V62, P79, DOI 10.1016/S0925-4773(96)00652-1; Seaver EC, 1996, DEVELOPMENT, V122, P567; SONNENFELD MJ, 1995, DEVELOPMENT, V121, P569; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; TOWER J, 1993, GENETICS, V133, P347; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Wieschaus E., 1986, DROSOPHILA PRACTICAL; WOLFF T, 1991, DEVELOPMENT, V113, P825; ZAK NB, 1990, DEVELOPMENT, V109, P865; ZHOU L, 1995, CURR BIOL, V5, P784, DOI 10.1016/S0960-9822(95)00155-2; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	46	94	94	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					991	1001		10.1016/S0896-6273(00)80618-2	http://dx.doi.org/10.1016/S0896-6273(00)80618-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856456	Bronze			2022-12-24	WOS:000077386100011
J	O'Brien, RJ; Kamboj, S; Ehlers, MD; Rosen, KR; Fischbach, GD; Huganir, RL				O'Brien, RJ; Kamboj, S; Ehlers, MD; Rosen, KR; Fischbach, GD; Huganir, RL			Activity-dependent modulation of synaptic AMPA receptor accumulation	NEURON			English	Article							HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; ACETYLCHOLINE-RECEPTORS; NMDA RECEPTOR; TRANSMISSION; SYNAPSES; CULTURE; SUBUNIT	Both theoretical and experimental work have suggested that central neurons compensate for changes in excitatory synaptic input in order to maintain a relatively constant output. We report here that inhibition of excitatory synaptic transmission in cultured spinal neurons leads to an increase in mEPSC amplitudes, accompanied by an equivalent increase in the accumulation of AMPA receptors at synapses. Conversely, increasing excitatory synaptic activity leads to a decrease in synaptic AMPA receptors and a decline in mEPSC amplitude. The time course of this synaptic remodeling is slow, similar to the metabolic half-life of neuronal AMPA receptors. Moreover, inhibiting excitatory synaptic transmission significantly prolongs the half-life, of the AMPA receptor subunit GluR1, suggesting that synaptic activity modulates the size of the mEPSC by regulating the turnover of postsynaptic AMPA receptors.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Dept Neurosci, Boston, MA 02110 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rick.huganir@qmail.bs.jhu.edu		Kamboj, Sunjeev/0000-0003-2197-0826	NINDS NIH HHS [R01NS36715, K08NS01652, R01 NS036715] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001652, R01NS036715] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVILA OL, 1989, J NEUROSCI, V9, P2902; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BERG DK, 1975, J PHYSIOL-LONDON, V252, P771, DOI 10.1113/jphysiol.1975.sp011169; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHOI DW, 1981, J NEUROPHYSIOL, V45, P632, DOI 10.1152/jn.1981.45.4.632; CLINE HT, 1990, J NEUROSCI, V10, P1197; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; OBRIEN RJ, 1986, J NEUROSCI, V6, P3290; OBrien RJ, 1997, J NEUROSCI, V17, P7339; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; ROSEN KM, 1990, BIOTECHNIQUES, V8, P398; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vissavajjhala P, 1996, EXP NEUROL, V142, P296, DOI 10.1006/exnr.1996.0199; WALMSLEY B, 1995, P ROY SOC B-BIOL SCI, V261, P245, DOI 10.1098/rspb.1995.0144	31	517	524	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1067	1078		10.1016/S0896-6273(00)80624-8	http://dx.doi.org/10.1016/S0896-6273(00)80624-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856462	hybrid			2022-12-24	WOS:000077386100017
J	Phillips, TJ; Brown, KJ; Burkhart-Kasch, S; Wenger, CD; Kelly, MA; Rubinstein, M; Grandy, DK; Low, MJ				Phillips, TJ; Brown, KJ; Burkhart-Kasch, S; Wenger, CD; Kelly, MA; Rubinstein, M; Grandy, DK; Low, MJ			Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D-2 receptors	NATURE NEUROSCIENCE			English	Article							C57BL/6J INBRED MOUSE; NUCLEUS-ACCUMBENS; MOLECULAR MECHANISMS; D2 RECEPTOR; ETHANOL; GENE; RATS; CONSUMPTION; ASSOCIATION; STRAINS	Although dopaminergic transmission has been strongly implicated in alcohol self-administration, the involvement of specific dopamine receptor subtypes has not been well established. We studied the ethanol preference and sensitivity of D-2-receptor-deficient mice to directly evaluate whether dopamine D-2 receptors contribute to alcohol (ethanol) consumption. We report a marked aversion to ethanol in these mice, relative to the high preference and consumption exhibited by wild-type littermates. Sensitivity to ethanol-induced locomotor impairment was also reduced in these mutant mice, although they showed a normal locomotor depressant response to the dopamine D-1 antagonist SCH-23390, These data demonstrate that dopamine signaling via D-2 receptors is an essential component of the molecular pathway determining ethanol self-administration and sensitivity.	Dept Vet Affairs Med Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Portland Alcohol Res Ctr, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; CONICET, Inst Invest Ingn Genet & Biol Mol, RA-1033 Buenos Aires, DF, Argentina; Univ Buenos Aires, Dept Biol, Buenos Aires, DF, Argentina	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Phillips, TJ (corresponding author), Dept Vet Affairs Med Ctr, Portland, OR 97201 USA.			Low, Malcolm/0000-0002-9900-3708; Kelly, Michele/0000-0003-1799-055X	NIAAA NIH HHS [P50 AA10760, P60 AA010760, T32 AA07468] Funding Source: Medline; NIDA NIH HHS [T32 DA07262] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760, P50AA010760, T32AA007468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BALK JH, 1995, NATURE, V377, P424; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; CLONINGER CR, 1991, JAMA-J AM MED ASSOC, V266, P1833; Crabbe JC, 1996, NAT GENET, V14, P98, DOI 10.1038/ng0996-98; CRABBE JC, IN PRESS TRENDS NEUR; CUNNINGHAM CL, 1992, PSYCHOPHARMACOLOGY, V107, P385, DOI 10.1007/BF02245166; DICHIARA G, 1985, EUR J PHARMACOL, V115, P131, DOI 10.1016/0014-2999(85)90598-9; DUDEK BC, 1990, PSYCHOPHARMACOLOGY, V101, P93, DOI 10.1007/BF02253724; DUDEK BC, 1991, ALCOHOL CLIN EXP RES, V15, P262, DOI 10.1111/j.1530-0277.1991.tb01867.x; DUDEK BC, 1994, PHARMACOL BIOCHEM BE, V48, P593, DOI 10.1016/0091-3057(94)90319-0; DYR W, 1993, ALCOHOL, V10, P207, DOI 10.1016/0741-8329(93)90037-O; ERWIN VG, 1993, PHARMACOGENETICS, V3, P189, DOI 10.1097/00008571-199308000-00003; FROEHLICH JC, 1988, PHARMACOL BIOCHEM BE, V31, P215, DOI 10.1016/0091-3057(88)90336-X; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; GEORGE SR, 1995, J PHARMACOL EXP THER, V273, P373; GOLDMAN D, 1995, CLIN NEUROSCI, V3, P174; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Hodge C. W., 1996, PHARM EFFECTS ETHANO, P203; Hodge CW, 1997, ALCOHOL CLIN EXP RES, V21, P1083, DOI 10.1111/j.1530-0277.1997.tb04257.x; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kelly MA, 1998, J NEUROSCI, V18, P3470; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; LANCA AJ, 1994, NEUROSCIENCE, V58, P359, DOI 10.1016/0306-4522(94)90043-4; LEVY AD, 1991, ALCOHOL ALCOHOLISM, P417; Low MJ, 1998, MOL PSYCHIATR, V3, P375, DOI 10.1038/sj.mp.4000455; MCBRIDE WJ, 1993, ALCOHOL, V10, P387, DOI 10.1016/0741-8329(93)90025-J; MCCLEARN GE, 1959, Q J STUD ALCOHOL, V20, P691; Melo JA, 1996, NAT GENET, V13, P147, DOI 10.1038/ng0696-147; NG GYK, 1994, EUR J PHARM-MOLEC PH, V269, P349, DOI 10.1016/0922-4106(94)90043-4; NG GYK, 1994, EUR J PHARM-MOLEC PH, V269, P365, DOI 10.1016/0922-4106(94)90044-2; Orr TE, 1997, ALCOHOL CLIN EXP RES, V21, P1491; PATO CN, 1993, AM J MED GENET, V48, P78, DOI 10.1002/ajmg.1320480204; Phillips TJ, 1996, INT REV NEUROBIOL, V39, P243, DOI 10.1016/S0074-7742(08)60669-8; Phillips TJ, 1998, J NEUROSCI, V18, P3023; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; PHILLIPS TJ, 1995, ALCOHOL CLIN EXP RES, V19, P269, DOI 10.1111/j.1530-0277.1995.tb01502.x; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; STEFANINI E, 1992, ALCOHOL ALCOHOLISM, V27, P127; SUAREZ BK, 1994, GENOMICS, V19, P12, DOI 10.1006/geno.1994.1005; SYVALAHTI EKG, 1994, ALCOHOL CLIN EXP RES, V18, P1029, DOI 10.1111/j.1530-0277.1994.tb00078.x; Tarantino LM, 1998, ALCOHOL CLIN EXP RES, V22, P1099; TERDAL ES, 1994, ALCOHOL CLIN EXP RES, V18, P542, DOI 10.1111/j.1530-0277.1994.tb00907.x; TURNER E, 1992, BIOL PSYCHIAT, V31, P285, DOI 10.1016/0006-3223(92)90052-2; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	49	214	219	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					610	615		10.1038/2843	http://dx.doi.org/10.1038/2843			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196569				2022-12-24	WOS:000077437100017
J	Jarvis, ED; Scharff, C; Grossman, MR; Ramos, JA; Nottebohm, F				Jarvis, ED; Scharff, C; Grossman, MR; Ramos, JA; Nottebohm, F			For whom the bird sings: Context-dependent gene expression	NEURON			English	Article							MALE ZEBRA FINCHES; VOCAL CONTROL PATHWAYS; BASAL GANGLIA; SONG SYSTEM; POEPHILA-GUTTATA; AREA-X; SYNAPTIC CONNECTIONS; AXONAL CONNECTIONS; EUROPEAN STARLINGS; ANTERIOR FOREBRAIN	Male zebra finches display two song behaviors: directed and undirected singing. The two differ little in the vocalizations produced but greatly in how song is delivered. "Directed" song is usually accompanied by a courtship dance and is addressed almost exclusively to females. "Undirected" song is not accompanied by the dance and is produced when the male is in the presence of other males, alone, or outside a nest occupied by its mate. Here, we show that the anterior forebrain vocal pathway contains medial and lateral "cortical-basal ganglia" subdivisions that have differential ZENK gene activation depending on whether the bird sings female-directed or undirected song. Differences also occur in the vocal output nucleus, RA. Thus, although these two vocal behaviors are very similar, their brain activation patterns are dramatically different.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA	Rockefeller University	Jarvis, ED (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	jarvis@neuro.duke.edu	Jarvis, Erich D/A-2319-2008; Scharff, Constance/HHN-0673-2022	Jarvis, Erich D/0000-0001-8931-5049; 	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018343, R01MH018343] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH018343-29, MH18343] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aldridge JW, 1998, J NEUROSCI, V18, P2777; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; [Anonymous], [No title captured]; ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; ARNOLD AP, 1975, J EXP ZOOL, V191, P261, DOI 10.1002/jez.1401910212; Ball GF, 1997, NEUROREPORT, V8, P2965, DOI 10.1097/00001756-199709080-00032; BISCHOF HJ, 1981, Z TIERPSYCHOL, V57, P261; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; CARYL PG, 1981, Z TIERPSYCHOL, V57, P37; CASTO JM, 1994, J NEUROBIOL, V25, P767, DOI 10.1002/neu.480250703; Casto JM, 1996, HORM BEHAV, V30, P387, DOI 10.1006/hbeh.1996.0044; CATCHPOLE CK, 1995, BIRD SONG BIOL THEME, P185; DeLong M. R., 1981, HDB PHYSL NERVOUS SY, P1017; Doupe AJ, 1997, J NEUROBIOL, V33, P694; Dunn AM, 1997, BEHAVIOUR, V134, P127, DOI 10.1163/156853997X00313; Dunn AM, 1996, ETHOLOGY, V102, P529; Dunn AM, 1996, ETHOLOGY, V102, P540; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; HALL M. F., 1962, SYMPOSIA ZOOL SOC LONDON, V8, P37; HARDING CF, 1983, HORM BEHAV, V17, P111, DOI 10.1016/0018-506X(83)90021-1; Harding CF, 1998, J NEUROBIOL, V34, P329, DOI 10.1002/(SICI)1097-4695(199803)34:4<329::AID-NEU4>3.0.CO;2-8; Hinde R.A., 1969, BIRD VOCALIZATIONS, P64; Immelmann K., 1962, Zoologische Jahrbuecher Systematik, V90, P1; Jarvis ED, 1997, NEUROREPORT, V8, P2073, DOI 10.1097/00001756-199705260-00052; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Karten H J, 1989, J Cogn Neurosci, V1, P291, DOI 10.1162/jocn.1989.1.4.291; KARTEN HJ, 1991, BRAIN BEHAV EVOLUT, V38, P264, DOI 10.1159/000114393; KONISHI MASAKAZU, 1964, CONDOR, V66, P85, DOI 10.2307/1365388; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Li R, 1997, BRAIN RES, V763, P239, DOI 10.1016/S0006-8993(97)00417-4; LIDSKY TI, 1985, BRAIN RES REV, V9, P133, DOI 10.1016/0165-0173(85)90010-4; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Margoliash D, 1997, J NEUROBIOL, V33, P671, DOI 10.1002/(SICI)1097-4695(19971105)33:5<671::AID-NEU12>3.0.CO;2-C; MARLER P, 1970, AM SCI, V58, P669; Marler P, 1997, J NEUROBIOL, V33, P501; MARLER P, 1993, NETH J ZOOL, V43, P91, DOI 10.1163/156854293X00232; Marler P, 1982, ACOUSTIC COMMUNICATI, P25; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; Medina L, 1997, J COMP NEUROL, V384, P86; MEDINA L, 1995, BRAIN BEHAV EVOLUT, V46, P235, DOI 10.1159/000113277; Mello C V, 1997, Methods Mol Biol, V85, P205; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V400, P207; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; MORRIS D, 1954, BEHAVIOUR, V7, P1, DOI 10.1163/156853955X00012; NIXDORFBERGWEILER BE, 1995, NEUROREPORT, V6, P1729, DOI 10.1097/00001756-199509000-00006; NORDEEN KW, 1993, BEHAV NEURAL BIOL, V59, P79, DOI 10.1016/0163-1047(93)91215-9; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; Prove E., 1974, J ORNITHOLOGIE, V115, P338, DOI DOI 10.1007/BF01644328; ROMO R, 1992, EXP BRAIN RES, V91, P396, DOI 10.1007/BF00227836; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SCHULTZ W, 1995, MODELS INFORMATION P, P11; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Soha JA, 1996, J NEUROBIOL, V29, P473, DOI 10.1002/(SICI)1097-4695(199604)29:4<473::AID-NEU5>3.0.CO;2-5; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Striedter GF, 1997, BRAIN BEHAV EVOLUT, V49, P179, DOI 10.1159/000112991; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; Stripling R, 1997, J NEUROSCI, V17, P3883; THORPE W. H., 1958, BRIT BIRDS, V51, P509; VATES GE, 1995, P NATL ACAD SCI USA, V92, P5139, DOI 10.1073/pnas.92.11.5139; Vates GE, 1997, J COMP NEUROL, V380, P275; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VEENMAN CL, 1995, J COMP NEUROL, V354, P87, DOI 10.1002/cne.903540108; Veenman CL, 1997, BRAIN BEHAV EVOLUT, V49, P78, DOI 10.1159/000112983; VICARIO DS, 1993, NEUROREPORT, V4, P983, DOI 10.1097/00001756-199307000-00037; VU ET, 1994, J NEUROSCI, V14, P6924; WALTERS MJ, 1991, ANIM BEHAV, V42, P445, DOI 10.1016/S0003-3472(05)80043-0; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; WILD JM, 1993, J COMP NEUROL, V337, P32; WILLIAMS H, 1992, BEHAV NEURAL BIOL, V57, P67, DOI 10.1016/0163-1047(92)90768-Y; WILLIAMS H, 1989, ANN NY ACAD SCI, V563, P148, DOI 10.1111/j.1749-6632.1989.tb42196.x; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; Zann R. A., 1996, ZEBRA FINCH SYNTHESI, P157; [No title captured]; [No title captured]	91	358	361	1	49	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					775	788		10.1016/S0896-6273(00)80594-2	http://dx.doi.org/10.1016/S0896-6273(00)80594-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808464	Bronze			2022-12-24	WOS:000076697300021
J	Schiller, J; Schiller, Y; Clapham, DE				Schiller, J; Schiller, Y; Clapham, DE			NMDA receptors amplify calcium influx into dendritic spines during associative pre- and postsynaptic activation	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; LONG-TERM POTENTIATION; CA2+ CHANNELS; INTEGRATION; TRANSIENTS; SIGNAL; SOMA	Long-term potentiation (LTP) of synaptic strength can be induced by synchronous pre- and postsynaptic activation, and a rise in postsynaptic calcium is essential for induction of LTP. Calcium can enter through both voltage-dependent Ca2+ channels and NMDA-type glutamate receptors, but the relative contributions of these pathways is not known. We have examined this issue in layer V cortical pyramidal neurons, using focal flash photolysis of caged glutamate to mimic synaptic input and two-photon, laser-scanning microscopy to measure calcium levels in dendritic spines. Most of the calcium entry in response to glutamate alone was via voltage-dependent Ca2+ channels, and NMDA receptors accounted for less than 20% of total Ca2+ entry. When glutamate was paired with postsynaptic action potentials, however, the NMDA-receptor-dependent component was selectively amplified. The same is likely to occur during paired physiological pre- and postsynaptic activation, providing a mechanism for the input specificity and Hebbian behavior of LTP.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pharmacol, Rochester, MN 55905 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Mayo Clinic; Mayo Clinic	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.	clapham@rascal.med.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Eilers J, 1997, CURR OPIN NEUROBIOL, V7, P385, DOI 10.1016/S0959-4388(97)80067-0; EILERS J, 1995, NATURE, V373, P107; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Hebb Donald O., 1949, ORG BEHAV; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kirkwood Alfredo, 1995, Biological Research, V28, P73; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	29	184	186	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					114	118		10.1038/363	http://dx.doi.org/10.1038/363			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195125				2022-12-24	WOS:000076361100011
J	Miall, RC; Keating, JG; Malkmus, M; Thach, WT				Miall, RC; Keating, JG; Malkmus, M; Thach, WT			Simple spike activity predicts occurrence of complex spikes in cerebellar Purkinje cells	NATURE NEUROSCIENCE			English	Article							ORGANIZATION; MOVEMENT		Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Oxford; University of Pennsylvania; Washington University (WUSTL)	Miall, RC (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Miall, R. Chris/B-7449-2013	Miall, R. Chris/0000-0003-3002-1251	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; CARLTON LG, 1981, J EXP PSYCHOL HUMAN, V7, P1019, DOI 10.1037/0096-1523.7.5.1019; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; KEATING JG, 1995, J NEUROPHYSIOL, V73, P1329, DOI 10.1152/jn.1995.73.4.1329; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; NELSON B, 1989, EXP BRAIN RES SERIES, V17, P86; SUGIHARA I, 1993, J PHYSIOL-LONDON, V470, P243, DOI 10.1113/jphysiol.1993.sp019857; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; THACH WT, 1992, CEREBELLUM REVISITED, P427; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0	16	47	48	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					13	15		10.1038/212	http://dx.doi.org/10.1038/212			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195101				2022-12-24	WOS:000076361000010
J	Miller, KG; Emerson, MD; Rand, JB				Miller, KG; Emerson, MD; Rand, JB			G(o)alpha and diacylglycerol kinase negatively regulate the G(q)alpha pathway in C-elegans	NEURON			English	Article							PROTEIN ALPHA-SUBUNITS; NEMATODE CAENORHABDITIS-ELEGANS; GTPASE-ACTIVATING PROTEINS; SYNAPTIC TRANSMISSION; NEUROTRANSMITTER RELEASE; MUTANTS; PHOSPHORYLATION; ACETYLCHOLINESTERASE; SYNAPTOBREVIN; DEFECATION	We investigated the EGL-30 (G(q)alpha) pathway in C. elegans by using genetic screens to identify genes that confer phenotypes similar to egl-30 mutants. One such gene, egl-8, encodes a phospholipase CP that is present throughout the nervous system and near intestinal cell junctions. EGL-30 and EGL-8 appear to positively regulate synaptic transmission because reducing their function results in strong aldicarb resistance and slow locomotion rates. In contrast, GOA-1 (G(o)alpha) and DGK-1 (diacylglycerol kinase) appear to negatively regulate synaptic transmission, because reducing their function results in strong aldicarb hypersensitivity and hyperactive locomotion. A genetic analysis suggests that GOA-1 negatively regulates the EGL-30 pathway and that DGK-1 antagonizes the EGL-30 pathway.	Oklahoma Med Res Fdn, Program Mol & Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Rand, JB (corresponding author), Oklahoma Med Res Fdn, Program Mol & Cell Biol, 825 NE 13th St, Oklahoma City, OK 73104 USA.	randj@omrf.ouhsc.edu			NIGMS NIH HHS [R01 GM059642] Funding Source: Medline; NINDS NIH HHS [NS33187, F32 NS009565] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS009565, R01NS033187] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bargmann C. I., 1997, C ELEGANS, P717; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BERRIDGE MJ, 1997, J BIOL CHEM, V274, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CAMBON C, 1979, TOXICOL APPL PHARM, V49, P203, DOI 10.1016/0041-008X(79)90242-4; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LOCHRIE MA, 1991, CELL REGUL, V2, P135, DOI 10.1091/mbc.2.2.135; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; MENDEL JE, 1995, NATURE, V267, P1648; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; RISHER JF, 1987, ENVIRON HEALTH PERSP, V72, P267, DOI 10.1289/ehp.8772267; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sakane F, 1997, INT J BIOCHEM CELL B, V29, P1139, DOI 10.1016/S1357-2725(97)00037-X; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SEGALAT L, 1995, NATURE, V267, P1652; SHAPIRA R, 1987, NATURE, V325, P58, DOI 10.1038/325058a0; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Take-uchi M, 1998, P NATL ACAD SCI USA, V95, P11775, DOI 10.1073/pnas.95.20.11775; THOMAS JH, 1990, GENETICS, V124, P855; TRENT C, 1983, GENETICS, V104, P619; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; WATSON S, 1994, GPROTEIN LINKED RECE; White J., 1988, NEMATODE CAENORHABDI, V17, P81; WILLIAMS BD, 1992, GENETICS, V131, P609; Yokoyama CT, 1997, J NEUROSCI, V17, P6929	44	225	237	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1999	24	2					323	333		10.1016/S0896-6273(00)80847-8	http://dx.doi.org/10.1016/S0896-6273(00)80847-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571227	Green Accepted, Bronze			2022-12-24	WOS:000083423700008
J	Bains, JS; Longacher, JM; Staley, KJ				Bains, JS; Longacher, JM; Staley, KJ			Reciprocal interactions between CA3 network activity and strength of recurrent collateral synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SLICE CULTURES; SYNAPTIC PLASTICITY; EPILEPTIFORM ACTIVITY; PYRAMIDAL NEURONS; NEUROTRANSMITTER RELEASE; MODEL; DEPRESSION; CELLS; OSCILLATIONS	In hippocampal slices, synchronous CA3 network activity induced persistent strengthening of active positive-feedback synapses. This altered network operation by increasing probability of future synchronous network activation. Long-term depression of synaptic strength induced by partial blockade of NMDA receptors during synchronous network activity reversed changes in probability of spontaneous network activation. These results suggest that specific network activity patterns selectively alter strength of active synapses. Stable, reversible alterations in network activity can also be effected by corresponding alterations in synaptic strength. These findings confirm the Hebb memory model at the neural-network level and suggest new therapies for pathological patterns of network activity in epilepsy.	Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Staley, KJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol, B182,4200 E 9th Ave, Denver, CO 80262 USA.	kevin.staley@uchsc.edu		Bains, Jaideep/0000-0002-3634-6463				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CHAMBERLIN NL, 1990, J NEUROPHYSIOL, V64, P1000, DOI 10.1152/jn.1990.64.3.1000; CHURCHLAND PS, 1992, COMPUTATIONAL BRAIN, V1, P239; CLAIBORNE BJ, 1993, HIPPOCAMPUS, V3, P115, DOI 10.1002/hipo.450030202; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dobrunz LE, 1998, P NATL ACAD SCI USA, V95, P4086, DOI 10.1073/pnas.95.8.4086; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; GRIFFITH WH, 1988, BRAIN RES, V474, P155, DOI 10.1016/0006-8993(88)90678-6; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Jefferys JGR, 1998, CURR OPIN NEUROL, V11, P123, DOI 10.1097/00019052-199804000-00008; MACVICAR BA, 1982, BRAIN RES, V242, P341; Maeda E, 1998, EUR J NEUROSCI, V10, P488, DOI 10.1046/j.1460-9568.1998.00062.x; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; ODonovan MJ, 1997, SEMIN CELL DEV BIOL, V8, P21, DOI 10.1006/scdb.1996.0117; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; RAFIQ A, 1995, J NEUROPHYSIOL, V74, P2028, DOI 10.1152/jn.1995.74.5.2028; RUTECKI PA, 1985, J NEUROPHYSIOL, V54, P1363, DOI 10.1152/jn.1985.54.5.1363; SCANZIANI M, 1994, NEUROSCIENCE, V61, P823, DOI 10.1016/0306-4522(94)90405-7; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHNEIDERMAN JH, 1994, NEUROSCIENCE, V59, P259, DOI 10.1016/0306-4522(94)90594-0; Selig DK, 1999, J NEUROSCI, V19, P1236; Senn W, 1998, NEURAL COMPUT, V10, P815, DOI 10.1162/089976698300017494; Smith KL, 1999, NEUROSCIENCE, V89, P625, DOI 10.1016/S0306-4522(98)00651-4; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STASHEFF SF, 1989, SCIENCE, V245, P648, DOI 10.1126/science.2569762; SUPPES T, 1985, BRAIN RES, V326, P273, DOI 10.1016/0006-8993(85)90036-8; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; TRAUB RD, 1991, NEURONAL NETWORKS HI, pCH6; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; WILLIAMS SH, 1991, J NEUROPHYSIOL, V66, P1010, DOI 10.1152/jn.1991.66.3.1010; Xiang ZX, 1998, J NEUROPHYSIOL, V79, P2475, DOI 10.1152/jn.1998.79.5.2475; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	48	111	114	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					720	726		10.1038/11184	http://dx.doi.org/10.1038/11184			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412061				2022-12-24	WOS:000083882800011
J	Geleoc, GSG; Casalotti, SO; Forge, A; Ashmore, JF				Geleoc, GSG; Casalotti, SO; Forge, A; Ashmore, JF			A sugar transporter as a candidate for the outer hair cell motor	NATURE NEUROSCIENCE			English	Article							MOTILITY VOLTAGE SENSOR; GLUCOSE TRANSPORTERS; COCHLEAR AMPLIFIER; MEMBRANE CAPACITANCE; PLASMA-MEMBRANE; SHAPE CHANGES; PROTEINS; EXPRESSION; ERYTHROCYTE; MECHANISM	Forces developed by cochlear outer hair cells (OHCs) are responsible for the sharp tuning that underlies sensitivity and frequency selectivity in the ear. OHCs exhibit a voltage-dependent motility involving a 'motor' protein embedded in the basolateral membrane. The motor has so far resisted molecular identification. Here we provide evidence that it may be related to a fructose transporter. We show that OHCs are able to transport this sugar selectively and that the sugar alters electrical properties of the OHC motor. These data can be combined into an integrated model of a sugar carrier, that makes the novel prediction, demonstrated here, that such 'neutral' transporters can be voltage dependent.	Univ London Univ Coll, Dept Physiol, London WC1E 6BT, England; UCL, Inst Laryngol & Otol, London WC1 X8EE, England	University of London; University College London; University of London; University College London	Ashmore, JF (corresponding author), Univ London Univ Coll, Dept Physiol, Gower St, London WC1E 6BT, England.	j.ashmore@ucl.ac.uk	Casalotti, Stefano/P-7875-2018	Casalotti, Stefano/0000-0002-6306-789X; Forge, Andrew/0000-0002-0995-0219	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; ASHMORE JF, 1990, NEUROSCI RES       S, V12, P39; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; CARRUTHERS A, 1984, PROG BIOPHYS MOL BIO, V43, P33, DOI 10.1016/0079-6107(84)90003-8; COLVILLE CA, 1993, BIOCHEM J, V294, P753, DOI 10.1042/bj2940753; DALLOS P, 1995, SCIENCE, V267, P2006, DOI 10.1126/science.7701325; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FORGE A, 1991, CELL TISSUE RES, V265, P473, DOI 10.1007/BF00340870; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; Gale JE, 1997, NATURE, V389, P63, DOI 10.1038/37968; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Gale JE, 1997, PFLUG ARCH EUR J PHY, V434, P267, DOI 10.1007/s004240050395; GOULD GW, 1990, TRENDS BIOCHEM SCI, V15, P18, DOI 10.1016/0968-0004(90)90125-U; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLEY MC, 1988, PROC R SOC SER B-BIO, V232, P413, DOI 10.1098/rspb.1988.0004; HOLLEY MC, 1992, TISSUE CELL, V24, P613, DOI 10.1016/0040-8166(92)90032-3; HUANG GJ, 1994, P NATL ACAD SCI USA, V91, P12268, DOI 10.1073/pnas.91.25.12268; HUANG GJ, 1993, BIOPHYS J, V65, P2228, DOI 10.1016/S0006-3495(93)81248-7; IWASA KH, 1994, J ACOUST SOC AM, V96, P2216, DOI 10.1121/1.410094; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; IWASA KH, 1995, BIOPHYS J, V68, pS214; JOSHI C, 1988, BIOPHYS J, V53, P885, DOI 10.1016/S0006-3495(88)83169-2; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Kalinec F, 1997, HEARING RES, V110, P141, DOI 10.1016/S0378-5955(97)00076-2; KNIPPER M, 1995, HEARING RES, V86, P100, DOI 10.1016/0378-5955(95)00060-H; MIYAMOTO K, 1994, BIOCHEM J, V303, P877, DOI 10.1042/bj3030877; NAKAZAWA K, 1995, HEARING RES, V82, P93; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; PESSINO A, 1991, J BIOL CHEM, V266, P20213; RUSSELL IJ, 1986, CELLULAR MECHANISMS, P199; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Souter M, 1995, HEARING RES, V91, P43, DOI 10.1016/0378-5955(95)00163-8; WEISS TF, 1996, CELLULAR BIOPHYSICS, V1, P360; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	39	41	43	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					713	719		10.1038/11174	http://dx.doi.org/10.1038/11174			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412060				2022-12-24	WOS:000083882800010
J	Hahm, S; Mizuno, TM; Wu, TJ; Wisor, JP; Priest, CA; Kozak, CA; Boozer, CN; Peng, B; McEvoy, RC; Good, P; Kelley, KA; Takahashi, JS; Pintar, JE; Roberts, JL; Mobbs, CV; Salton, SRJ				Hahm, S; Mizuno, TM; Wu, TJ; Wisor, JP; Priest, CA; Kozak, CA; Boozer, CN; Peng, B; McEvoy, RC; Good, P; Kelley, KA; Takahashi, JS; Pintar, JE; Roberts, JL; Mobbs, CV; Salton, SRJ			Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance	NEURON			English	Article							NERVE GROWTH-FACTOR; MESSENGER-RNA; HYPOTHALAMIC EXPRESSION; CARBOXYPEPTIDASE-E; MOLECULAR-CLONING; SECRETOGRANIN-II; PROTEIN VGF; MICE; OBESITY; RAT	To determine the function of VGF, a secreted polypeptide that is synthesized by neurons, is abundant in the hypothalamus, and is regulated in the brain by electrical activity, injury, and the circadian clock, we generated knockout mice lacking Vgf. Homozygous mutants are small, hypermetabolic, hyperactive, and infertile, with markedly reduced leptin levels and fat stores and altered hypothalamic proopiomelanocortin (POMC), neuropeptide Y (NPY), and agouti-related peptide (AGRP) expression. Furthermore, VGF mRNA synthesis is induced in the hypothalamic arcuate nuclei of fasted normal mice. VGF therefore plays a critical role in the regulation of energy homeostasis, suggesting that the study of lean VGF mutant mice may provide insight into wasting disorders and, moreover, that pharmacological antagonism of VGF action(s) might constitute the basis for treatment of obesity.	Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Geriatr, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; Mt Sinai Sch Med, Div Pediat Endocrinol & Diabet, New York, NY 10029 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Northwestern Univ, Natl Sci Fdn Ctr Biol Timing, Dept Physiol & Neurobiol, Evanston, IL 60208 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; Columbia Univ, Coll Phys & Surg, Obes Res Ctr, St Lukes Roosevelt Hosp, New York, NY 10025 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; Northwestern University; National Science Foundation (NSF); NSF - Center for Biological Timing; Northwestern University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Salton, SRJ (corresponding author), Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA.	salton@neuro.mssm.edu	Takahashi, Joseph S/E-8482-2012; Mizuno, Tooru/AAM-1689-2020; Takahashi, Joseph S./Y-2781-2019; Wu, John/ABI-3578-2020	Takahashi, Joseph S/0000-0003-0384-8878; Mizuno, Tooru/0000-0002-0836-3506; Takahashi, Joseph S./0000-0003-0384-8878; Mobbs, Charles/0000-0002-5815-8711; Salton, Stephen/0000-0003-4087-8427; Wu, Tao-Yiao/0000-0002-8274-0226	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000301] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acampora D, 1998, DEVELOPMENT, V125, P1229; BEARD MD, 1987, DEV BRAIN RES, V36, P181, DOI 10.1016/0165-3806(87)90022-8; Benson DL, 1996, DEV BRAIN RES, V96, P219, DOI 10.1016/0165-3806(96)00108-3; BLOOM FE, 1997, NEUROINFORMATICS OVE, P83; Campfield LA, 1998, SCIENCE, V280, P1383, DOI 10.1126/science.280.5368.1383; Canu N, 1997, J NEUROCHEM, V68, P1390; Canu N, 1997, GENOMICS, V45, P443, DOI 10.1006/geno.1997.4945; Chung WK, 1998, AM J PHYSIOL-REG I, V274, pR985, DOI 10.1152/ajpregu.1998.274.4.R985; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Everts HGJ, 1997, HORM BEHAV, V31, P136, DOI 10.1006/hbeh.1997.1375; FERRI GL, 1995, ENDOCRINOLOGY, V136, P2244, DOI 10.1210/en.136.5.2244; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HAWLEY RJ, 1992, J NEUROSCI, V12, P2573; Howard C, 1998, UNBIASED STEREOLOGY; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KANEMASA K, 1995, MOL BRAIN RES, V32, P55, DOI 10.1016/0169-328X(95)00059-2; KOZAK CA, 1990, GENOMICS, V8, P519, DOI 10.1016/0888-7543(90)90039-W; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Levin BE, 1996, AM J PHYSIOL-REG I, V271, pR491, DOI 10.1152/ajpregu.1996.271.3.R491; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIU JW, 1994, ENDOCRINOLOGY, V135, P2742, DOI 10.1210/en.135.6.2742; LOMBARDO A, 1995, NEUROSCIENCE, V65, P997, DOI 10.1016/0306-4522(94)00538-G; MAHATA M, 1993, J NEUROCHEM, V61, P1648, DOI 10.1111/j.1471-4159.1993.tb09799.x; MATSON WR, 1987, LIFE SCI, V41, P905, DOI 10.1016/0024-3205(87)90192-5; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Mizuno TM, 1996, P NATL ACAD SCI USA, V93, P3434, DOI 10.1073/pnas.93.8.3434; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; POSSENTI R, 1989, EMBO J, V8, P2217, DOI 10.1002/j.1460-2075.1989.tb08345.x; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SALTON SRJ, 1991, MOL CELL BIOL, V11, P2335, DOI 10.1128/MCB.11.5.2335; SALTON SRJ, 1991, J NEUROCHEM, V57, P991, DOI 10.1111/j.1471-4159.1991.tb08248.x; SALTON SRJ, 1995, FEBS LETT, V360, P106, DOI 10.1016/0014-5793(95)00086-O; SARIA A, 1993, NEUROSCIENCE, V54, P1, DOI 10.1016/0306-4522(93)90377-R; SCHWARTZ MW, 1995, AM J PHYSIOL-REG I, V269, pR949, DOI 10.1152/ajpregu.1995.269.5.R949; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Snyder SE, 1998, NEUROSCIENCE, V82, P7; Snyder SE, 1998, J COMP NEUROL, V394, P64; Snyder SE, 1998, J COMP NEUROL, V394, P91; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; TRANI E, 1995, J NEUROCHEM, V65, P2441; VANDENPOL AN, 1994, J COMP NEUROL, V347, P455, DOI 10.1002/cne.903470311; VANDENPOL AN, 1989, J NEUROSCI, V9, P4122; Wisor JP, 1997, J COMP NEUROL, V378, P229; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; WU TJ, 1992, ENDOCRINOLOGY, V131, P2045, DOI 10.1210/en.131.5.2045; Yamada M, 1997, P NATL ACAD SCI USA, V94, P10862, DOI 10.1073/pnas.94.20.10862; ZHENG M, 1995, METH NEUROSCI, V23, P45; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	57	177	185	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL	1999	23	3					537	548		10.1016/S0896-6273(00)80806-5	http://dx.doi.org/10.1016/S0896-6273(00)80806-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433265	Bronze			2022-12-24	WOS:000081701000017
J	Devay, P; McGehee, DS; Yu, CR; Role, LW				Devay, P; McGehee, DS; Yu, CR; Role, LW			Target-specific control of nicotinic receptor expression at developing interneuronal synapses in chick	NATURE NEUROSCIENCE			English	Article							SUBUNIT GENE-EXPRESSION; ACETYLCHOLINE-RECEPTORS; SYMPATHETIC NEURONS; CILIARY GANGLION; FUNCTIONAL CONTRIBUTION; ANTISENSE OLIGONUCLEOTIDES; MULTIPLE CLASSES; ALPHA-5 SUBUNIT; SENSITIVITY; CHANNELS	Neuronal differentiation and development of synaptic specializations are strongly influenced by cellular interactions. We compared the effects of interaction with distinct autonomic targets on the molecular and biophysical differentiation of 'upstream' neuron-neuron synapses. Contact with cardiac tissue induced expression of nicotinic receptor channels (nAChRs) distinct from those induced by renal tissue in presynaptic autonomic neurons. The kinetics of cholinergic currents at interneuronal synapses are dictated by the peripheral target contacted. Analysis of the nAChR channel subtypes and subunits in individual neurons demonstrated that the profile of transmitter receptors expressed at mature neuron-neuron synapses develops from the convergent influences of input-derived (anterograde) and target-specific (retrograde) signals.	Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Devay, P (corresponding author), Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, 1051 Riverside Dr, New York, NY 10032 USA.		Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035090, R01NS029071] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029071-09, R01 NS029071-12, NS29071, R01 NS029071-13S1, R01 NS029071-17, R01 NS029071-13, R01 NS029071-15, R01 NS029071-10, NS35090, R01 NS029071, R01 NS029071-16, R01 NS029071-14, R01 NS029071-11] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANAND R, 1993, FEBS LETT, V327, P241, DOI 10.1016/0014-5793(93)80177-V; BRENNER HR, 1976, J PHYSIOL-LONDON, V260, P159, DOI 10.1113/jphysiol.1976.sp011509; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; DEVAY P, 1994, DEV BIOL, V162, P56, DOI 10.1006/dbio.1994.1066; GARDETTE R, 1991, DEV BIOL, V147, P83, DOI 10.1016/S0012-1606(05)80009-0; HALVORSEN SW, 1991, J NEUROSCI, V11, P2177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOGG RV, 1970, INTRO MATH STAT, P348; Horch HLW, 1995, J NEUROSCI, V15, P7778; JACOB MH, 1987, J CELL BIOL, V105, P1847, DOI 10.1083/jcb.105.4.1847; LEVEY MS, 1995, NEURON, V14, P153, DOI 10.1016/0896-6273(95)90249-X; LISTERUD M, 1991, SCIENCE, V254, P1518, DOI 10.1126/science.1720573; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MOSS BL, 1993, J NEUROSCI, V13, P13; MOSS BL, 1989, NEURON, V3, P597, DOI 10.1016/0896-6273(89)90270-5; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; ROLE LW, 1988, P NATL ACAD SCI USA, V85, P2825, DOI 10.1073/pnas.85.8.2825; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; YU C, 1993, DEV GENET, V14, P296, DOI 10.1002/dvg.1020140407; Yu CR, 1998, J PHYSIOL-LONDON, V509, P651, DOI 10.1111/j.1469-7793.1998.651bm.x; Yu CR, 1998, J PHYSIOL-LONDON, V509, P667, DOI 10.1111/j.1469-7793.1998.667bm.x	27	25	25	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					528	534		10.1038/9183	http://dx.doi.org/10.1038/9183			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448217	Green Accepted			2022-12-24	WOS:000084735900012
J	Morris, JK; Lin, WC; Hauser, C; Marchuk, Y; Getman, D; Lee, KF				Morris, JK; Lin, WC; Hauser, C; Marchuk, Y; Getman, D; Lee, KF			Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development	NEURON			English	Article							RECEPTOR GENE-EXPRESSION; SCHWANN-CELL PRECURSORS; DORSAL-ROOT-GANGLIA; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTIONS; CHICK FORELIMB; NEURAL CREST; GLIAL-CELLS; NEUREGULIN RECEPTOR; TRANSGENIC MICE	ErbB2 receptor tyrosine kinase plays a role in neuregulin signaling and is expressed in the developing nervous system. We genetically rescued the cardiac defect of erbB2 null mutant embryos, which otherwise died at E11. These rescued erbB2 mutant mice die at birth and display a severe loss of both motor and sensory neurons. Motor and sensory axons are severely defasciculated and aberrantly projected within their final target tissues. Schwann cells are completely absent in the peripheral nerves. Schwann cell precursors are present within the DRG and proliferate normally, but their ability to migrate is decreased. Acetylcholine receptors cluster within the central band of the mutant diaphragm muscle. However, these clusters are dispersed and morphologically different from those in control muscle. Our results reveal an important role for erbB2 during normal peripheral nervous system development.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Lee, KF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Morris, Jacqueline/0000-0002-3515-0821	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010435] Funding Source: NIH RePORTER; NIA NIH HHS [AG10435] Funding Source: Medline; NICHD NIH HHS [HD34534] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTIOK N, 1995, EMBO J, V14, P4258, DOI 10.1002/j.1460-2075.1995.tb00100.x; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; BHATTACHARYYA A, 1994, DEVELOPMENT, V120, P1411; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Busfield SJ, 1997, MOL CELL BIOL, V17, P4007, DOI 10.1128/MCB.17.7.4007; CARPENTER EM, 1992, DEV BIOL, V150, P144, DOI 10.1016/0012-1606(92)90014-8; CARR A, 1994, REV MED VIROL, V4, P5, DOI 10.1002/rmv.1980040104; Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0; Chang H, 1997, NATURE, V387, P509, DOI 10.1038/387509a0; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; DECHIARA TM, 1996, CELL, V85, P510; DONG Z, 1995, NEURON, V15, P689; Erickson SL, 1997, DEVELOPMENT, V124, P4999; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; FRANK E, 1991, DEVELOPMENT, V111, P895; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Harrison RG, 1924, J COMP NEUROL, V37, P123, DOI 10.1002/cne.900370107; HAYES C, 1992, J NEUROSCI RES, V31, P175, DOI 10.1002/jnr.490310123; HO WH, 1995, J BIOL CHEM, V270, P14523, DOI 10.1074/jbc.270.24.14523; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; JIN JJ, 1993, CELL GROWTH DIFFER, V4, P227; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; KARNOVSKY MJ, 1964, J CELL BIOL, V23, P217, DOI 10.1083/jcb.23.2.217; KEYNES RJ, 1987, TRENDS NEUROSCI, V10, P137, DOI 10.1016/0166-2236(87)90037-3; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; Mahanthappa NK, 1996, J NEUROSCI, V16, P4673; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Meier T, 1998, J CELL BIOL, V141, P715, DOI 10.1083/jcb.141.3.715; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; NOAKES PG, 1987, J COMP NEUROL, V259, P330, DOI 10.1002/cne.902590303; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; NOAKES PG, 1983, J COMP NEUROL, V218, P365, DOI 10.1002/cne.902180402; NOAKES PG, 1988, J COMP NEUROL, V277, P214, DOI 10.1002/cne.902770205; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; Pfrieger FW, 1996, CURR OPIN NEUROBIOL, V6, P615, DOI 10.1016/S0959-4388(96)80093-6; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; PIETTE J, 1993, DEV BIOL, V157, P205, DOI 10.1006/dbio.1993.1124; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SchneiderMaunoury S, 1997, DEVELOPMENT, V124, P1215; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Trachtenberg JT, 1997, J NEUROSCI, V17, P6243; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x	66	247	249	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					273	283		10.1016/S0896-6273(00)80779-5	http://dx.doi.org/10.1016/S0896-6273(00)80779-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399934	Bronze			2022-12-24	WOS:000081218600013
J	Schneggenburger, R; Meyer, AC; Neher, E				Schneggenburger, R; Meyer, AC; Neher, E			Released fraction and total size of a pool of immediately available transmitter quanta at a calyx synapse	NEURON			English	Article							SQUID GIANT SYNAPSE; NEUROTRANSMITTER RELEASE; RECEPTOR DESENSITIZATION; PRESYNAPTIC DEPRESSION; HIPPOCAMPAL SYNAPSES; GLUTAMATE RECEPTORS; CALCIUM-DEPENDENCE; CHROMAFFIN CELLS; GABA(B) RECEPTOR; MEDIAL NUCLEUS	The size of a pool of readily releasable vesicles at a giant brainstem synapse, the calyx of Held, was probed with three independent approaches. Using simultaneous pre- and postsynaptic whole-cell recordings, two forms of presynaptic Ca2+ stimuli were applied in rapid succession: uncaging of Ca2+ by flash photolysis and the opening of voltage-gated Ca2+ channels. The ensuing transmitter release showed a nearly complete cross-inhibition between the two stimuli, indicating the depletion of a limited pool of about 700 transmitter quanta. The pool size was confirmed in experiments using enhanced extracellular Ca2+ concentrations, as well as short, high-frequency stimulus trains. The results reveal a surprisingly large pool of functionally available vesicles, of which a fraction of about 0.2 is released by a single presynaptic action potential under physiological conditions.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany	Max Planck Society	Schneggenburger, R (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Am Fassberg 11, D-37077 Gottingen, Germany.	rschneg@gwdg.de	Meyer, Alexander/F-2479-2010; Neher, Erwin/A-2109-2013					AUGUSTINE GJ, 1985, J PHYSIOL-LONDON, V367, P163, DOI 10.1113/jphysiol.1985.sp015819; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Borst JGG, 1999, PHILOS T R SOC B, V354, P347, DOI 10.1098/rstb.1999.0386; Caicedo A, 1999, EUR J NEUROSCI, V11, P51, DOI 10.1046/j.1460-9568.1999.00410.x; Chuhma N, 1998, J NEUROSCI, V18, P512; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P245, DOI 10.1113/jphysiol.1957.sp005809; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Katz B., 1969, RELEASE NEURAL TRANS; KEMP JA, 1988, P NATL ACAD SCI USA, V85, P6547, DOI 10.1073/pnas.85.17.6547; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Otis T, 1996, J NEUROSCI, V16, P7496; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Reid CA, 1998, J NEUROSCI, V18, P2849; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryugo DK, 1996, J COMP NEUROL, V365, P141, DOI 10.1002/(SICI)1096-9861(19960129)365:1<141::AID-CNE11>3.0.CO;2-T; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Takahashi T, 1998, J NEUROSCI, V18, P3138; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, J NEUROSCI, V19, P726; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3; YAMADA KA, 1993, J NEUROSCI, V13, P3904; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	54	439	443	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	1999	23	2					399	409		10.1016/S0896-6273(00)80789-8	http://dx.doi.org/10.1016/S0896-6273(00)80789-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399944	Bronze, Green Published			2022-12-24	WOS:000081218600023
J	Blood, AJ; Zatorre, RJ; Bermudez, P; Evans, AC				Blood, AJ; Zatorre, RJ; Bermudez, P; Evans, AC			Emotional responses to pleasant and unpleasant music correlate with activity in paralimbic brain regions	NATURE NEUROSCIENCE			English	Article							CEREBRAL BLOOD-FLOW; FRONTAL-LOBE DAMAGE; PREFRONTAL CORTEX; HUMAN AMYGDALA; MEMORY; PITCH; IDENTIFICATION; MECHANISMS; ACTIVATION; PERCEPTION	Neural correlates of the often-powerful emotional responses to music are poorly understood. Here we used positron emission tomography to examine cerebral blood flow (CBF) changes related to affective responses to music. Ten volunteers were scanned while listening to six versions of a novel musical passage varying systematically in degree of dissonance. Reciprocal CBF covariations were observed in several distinct paralimbic and neocortical regions as a function of dissonance and of perceived pleasantness/unpleasantness. The findings suggest that music may recruit neural mechanisms similar to those previously associated with pleasant/unpleasant emotional states, but different from those underlying other components of music perception, and other emotions such as fear.	McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada	McGill University	Blood, AJ (corresponding author), McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	ablood@bic.mni.mcgill.ca	Evans, Alan C/B-2373-2013	Evans, Alan C/0000-0003-3841-6098; Bermudez, Patrick/0000-0002-0806-7352				ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Berthoz A, 1997, PHILOS T R SOC B, V352, P1437, DOI 10.1098/rstb.1997.0130; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BUNSEY M, 1993, BEHAV NEUROSCI, V107, P740, DOI 10.1037/0735-7044.107.5.740; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAVIS WB, 1989, J MUSIC THER, V26, P168, DOI 10.1093/jmt/26.4.168; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DOWLING WJ, 1986, MUSIC COGNITION, P62; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Erhan H, 1998, BRAIN COGNITION, V37, P286, DOI 10.1006/brcg.1998.0984; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; HUGDAHL K, 1995, NEUROREPORT, V6, P1723, DOI 10.1097/00001756-199509000-00005; Krumhansl C. L., 1990, OXFORD PSYCHOL SERIE, V17; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; LANE RD, 1995, NEUROPSYCHOLOGIA, V33, P525, DOI 10.1016/0028-3932(94)00131-8; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; MILNER B, 1962, INTERHEMISPHER RELAT, P177; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Paradiso S, 1997, AM J PSYCHIAT, V154, P384; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; RAICHLE ME, 1983, J NUCL MED, V24, P790; ROBAZZA C, 1994, PERCEPT MOTOR SKILL, V79, P939, DOI 10.2466/pms.1994.79.2.939; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Sokal R. R, 1981, BIOMETRY; Stefanacci L, 1996, J COMP NEUROL, V375, P552; Talairach J., 1988, COPLANAR STEREOTAXIC; WHEELER RE, 1993, PSYCHOPHYSIOLOGY, V30, P82, DOI 10.1111/j.1469-8986.1993.tb03207.x; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	47	659	678	2	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					382	387		10.1038/7299	http://dx.doi.org/10.1038/7299			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204547				2022-12-24	WOS:000080532000019
J	Chain, DG; Casadio, A; Schacher, S; Hegde, AN; Valbrun, M; Yamamoto, N; Goldberg, AL; Bartsch, D; Kandel, ER; Schwartz, JH				Chain, DG; Casadio, A; Schacher, S; Hegde, AN; Valbrun, M; Yamamoto, N; Goldberg, AL; Bartsch, D; Kandel, ER; Schwartz, JH			Mechanisms for generating the autonomous cAMP-dependent protein kinase required for long-term facilitation in Aplysia	NEURON			English	Article							SIPHON-WITHDRAWAL REFLEX; SENSORY NEURONS; REGULATORY SUBUNIT; PERSISTENT ACTIVATION; TRANSMITTER RELEASE; MOLECULAR MECHANISM; CATALYTIC SUBUNIT; CELL-CULTURE; SITE-A; UBIQUITIN	The formation of a persistently active cAMP-dependent protein kinase (PKA) is critical far establishing long-term synaptic facilitation (LTF) in Aplysia. The injection of bovine catalytic (C) subunits into sensory neurons is sufficient to produce protein synthesis-dependent LTF. Early in the LTF induced by serotonin (5-HT), an autonomous PKA is generated through the ubiquitin-proteasome-mediated proteolysis of regulatory (R) subunits. The degradation of R occurs during an early time window and appears to be a key function of proteasomes in LTF. Lactacystin, a specific proteasome inhibitor, blocks the facilitation induced by 5-HT, and this block is rescued by injecting C subunits. R is degraded through an allosteric mechanism requiring an elevation of cAMP coincident with the induction of a ubiquitin carboxy-terminal hydrolase.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Columbia University; Harvard University; Harvard Medical School	Schwartz, JH (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.	jhs6@columbia.edu	Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681	NIGMS NIH HHS [GM32099] Funding Source: Medline; NIMH NIH HHS [MH48850] Funding Source: Medline; NINDS NIH HHS [NS29255] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM032099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS029255, R01NS029255] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BARZILAI A, 1989, NEURON, V2, P1577, DOI 10.1016/0896-6273(89)90046-9; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BERGOLD PJ, 1990, P NATL ACAD SCI USA, V87, P3788, DOI 10.1073/pnas.87.10.3788; BERGOLD PJ, 1992, NEURON, V8, P387, DOI 10.1016/0896-6273(92)90304-V; BERNIER L, 1982, J NEUROSCI, V2, P1682; BUBIS J, 1988, J BIOL CHEM, V263, P9668; BYRNE JH, 1993, ADV SEC MESS PHOSPH, V27, P47; Byrne JH, 1996, J NEUROSCI, V16, P425; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CHAIN DG, 1995, J NEUROSCI, V15, P7592; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; DALE N, 1987, J NEUROSCI, V7, P2232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; Dohrman DP, 1996, P NATL ACAD SCI USA, V93, P10217, DOI 10.1073/pnas.93.19.10217; EYTAN E, 1993, J BIOL CHEM, V268, P4668; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; GREENBERG SM, 1987, NATURE, V329, P62, DOI 10.1038/329062a0; GREENBERG SM, 1987, J NEUROSCI, V7, P291; Haas AL, 1997, FASEB J, V11, P1257; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOFMANN F, 1977, J BIOL CHEM, V252, P1441; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; MCKNIGHT GS, 1988, RECENT PROG HORM RES, V44, P307; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; Mykles DL, 1998, INT REV CYTOL, V184, P157, DOI 10.1016/S0074-7696(08)62181-6; NEITZEL JJ, 1991, BIOCHEMISTRY-US, V30, P733, DOI 10.1021/bi00217a023; OH CE, 1994, J NEUROSCI, V14, P3166; OLEARY FA, 1995, J NEUROSCI, V15, P3519; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SACKTOR TC, 1990, P NATL ACAD SCI USA, V87, P2036, DOI 10.1073/pnas.87.5.2036; SAITOH T, 1983, P NATL ACAD SCI-BIOL, V80, P6708, DOI 10.1073/pnas.80.21.6708; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; Schwartz JH, 1989, NEURAL MODELS PLASTI, P46; Sossin W S, 1994, Learn Mem, V1, P189; SQUIRES L, 1987, MEMORY BRAIN; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Vanderklish P, 1996, LEARN MEMORY, V3, P209, DOI 10.1101/lm.3.2-3.209; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275	67	143	150	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN	1999	22	1					147	156		10.1016/S0896-6273(00)80686-8	http://dx.doi.org/10.1016/S0896-6273(00)80686-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027297	hybrid			2022-12-24	WOS:000078410300020
J	Stevens, CF; Wesseling, JF				Stevens, CF; Wesseling, JF			Augmentation is a potentiation of the exocytotic process	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; TERM SYNAPTIC ENHANCEMENT; RAT SYMPATHETIC NEURONS; SQUID GIANT SYNAPSE; HIPPOCAMPAL-NEURONS; TRANSMITTER RELEASE; PRESYNAPTIC CALCIUM; FIBER SYNAPSE; FACILITATION; MICROCULTURES	Short-term synaptic enhancement is caused by an increase in the probability with which synaptic terminals release transmitter in response to presynaptic action potentials. Since exocytosed vesicles are drawn from a readily releasable pool of packaged transmitter, enhancement must result either from an increase in the size of the pool or an elevation in the fraction of releasable vesicles that undergoes exocytosis with each action potential. We show here that at least one major component of enhancement, augmentation, is not caused by an increase in the size of the readily releasable pool but is instead associated with an increase in the efficiency with which action potentials induce the exocytosis of readily releasable vesicles.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Wesseling, John F/AAB-7941-2019	Wesseling, John F/0000-0002-7565-2594	NINDS NIH HHS [NS 12961] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; Banker G., 1991, CULTURING NERVE CELL; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; BLIOCH ZL, 1968, J PHYSIOL-LONDON, V199, P11, DOI 10.1113/jphysiol.1968.sp008637; BROOKS VB, 1962, J PHYSIOL-LONDON, V162, P298, DOI 10.1113/jphysiol.1962.sp006934; Cummings DD, 1996, J NEUROSCI, V16, P5312; DELANEY KR, 1994, J NEUROSCI, V14, P5885; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; FURSHPAN EJ, 1986, J NEUROSCI, V6, P1061; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HUBBARD JI, 1963, J PHYSIOL-LONDON, V169, P641, DOI 10.1113/jphysiol.1963.sp007286; HUBBARD JI, 1968, J PHYSIOL-LONDON, V197, P639, DOI 10.1113/jphysiol.1968.sp008579; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Katz B., 1969, RELEASE NEURAL TRANS; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; LIN JW, 1993, J GEN PHYSIOL, V101, P45, DOI 10.1085/jgp.101.1.45; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; MAGLEBY KL, 1976, J PHYSIOL-LONDON, V257, P449, DOI 10.1113/jphysiol.1976.sp011378; MAGLEBY KL, 1973, J PHYSIOL-LONDON, V234, P327, DOI 10.1113/jphysiol.1973.sp010348; MAGLEBY KL, 1973, J PHYSIOL-LONDON, V234, P353, DOI 10.1113/jphysiol.1973.sp010349; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; PERRY WLM, 1953, J PHYSL, V19, P439; REGEHR WG, 1994, J NEUROSCI, V14, P523; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SEGAL MM, 1990, J NEUROPHYSIOL, V64, P1390, DOI 10.1152/jn.1990.64.5.1390; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Tank DW, 1995, J NEUROSCI, V15, P7940; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; ZENGEL JE, 1980, J GEN PHYSIOL, V76, P213, DOI 10.1085/jgp.76.2.213; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	42	81	82	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					139	146		10.1016/S0896-6273(00)80685-6	http://dx.doi.org/10.1016/S0896-6273(00)80685-6			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027296	Bronze			2022-12-24	WOS:000078410300019
J	Drummond, HA; Price, MP; Welsh, MJ; Abboud, FM				Drummond, HA; Price, MP; Welsh, MJ; Abboud, FM			A molecular component of the arterial baroreceptor mechanotransducer	NEURON			English	Article							EPITHELIAL SODIUM-CHANNEL; MECHANOSENSITIVE ION CHANNELS; SENSITIVE NA+ CHANNEL; CAENORHABDITIS-ELEGANS; HOMOLOGOUS SUBUNITS; NEURONS; REFLEX; RAT; NEURODEGENERATION; EXPRESSION	Baroreceptor nerve endings detect acute fluctuations in arterial pressure. We tested the hypothesis that members of the DEG/ENaC family of cation channels, which are responsible for touch sensation in Caenorhabditis elegans, may be components of the baroreceptor mechanosensor. We found the gamma subunit of ENaC localized to the site of mechanotransduction in baroreceptor nerve terminals innervating the aortic arch and carotid sinus. A functional role for DEG/ENaC members was suggested by blockade of baroreceptor nerve activity and baroreflex control of blood pressure by an amiloride analog that inhibits DEG/ENaC channels. These data suggest that ENaC subunits may be components of the baroreceptor mechanotransducer and pave the way to a better definition of mechanisms responsible for blood pressure regulation and hypertension.	Univ Iowa, Coll Med, Dept Internal Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Howard Hughes Med Inst, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	mjwelsh@blue.weeg.uiowa.edu		Abboud, Francois/0000-0002-7284-9148; Welsh, Michael/0000-0002-1646-6206	NHLBI NIH HHS [HL14388, HL07121] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham A., 1969, INNERVATION HEART BL; Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; ANDRESEN MC, 1978, CIRC RES, V43, P728, DOI 10.1161/01.RES.43.5.728; BOYD IA, 1980, TRENDS NEUROSCI, V3, P258, DOI 10.1016/0166-2236(80)90096-X; BROWN AM, 1978, CIRC RES, V42, P694, DOI 10.1161/01.RES.42.5.694; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CLARK JD, 1991, AM J PHYSIOL, V261, pC945, DOI 10.1152/ajpcell.1991.261.6.C945; Corey DP, 1996, SCIENCE, V273, P323, DOI 10.1126/science.273.5273.323; COWLEY AW, 1973, CIRC RES, V32, P564, DOI 10.1161/01.RES.32.5.564; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Fazan VPS, 1997, HYPERTENSION, V30, P693, DOI 10.1161/01.HYP.30.3.693; Fyfe GK, 1998, SEMIN NEPHROL, V18, P138; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Ismailov II, 1997, AM J PHYSIOL-CELL PH, V272, pC1077, DOI 10.1152/ajpcell.1997.272.4.C1077; Ismailov II, 1996, J BIOL CHEM, V271, P807, DOI 10.1074/jbc.271.2.807; Ismailov II, 1997, J BIOL CHEM, V272, P21075, DOI 10.1074/jbc.272.34.21075; Kizer N, 1997, P NATL ACAD SCI USA, V94, P1013, DOI 10.1073/pnas.94.3.1013; KRAUHS JM, 1979, J NEUROCYTOL, V8, P401, DOI 10.1007/BF01214800; KUMADA M, 1990, PROG NEUROBIOL, V35, P331, DOI 10.1016/0301-0082(90)90036-G; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; LINGUEGLIA E, 1994, J BIOL CHEM, V269, P13736; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; MCDONALD DM, 1983, J NEUROCYTOL, V12, P345, DOI 10.1007/BF01159380; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; MENDELOWITZ D, 1992, J NEUROPHYSIOL, V68, P509, DOI 10.1152/jn.1992.68.2.509; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; PAINTAL AS, 1973, PHYSIOL REV, V53, P159, DOI 10.1152/physrev.1973.53.1.159; SACHS F, 1987, FASEB J, V46, P12; SAPRU HN, 1977, J APPL PHYSIOL, V42, P344, DOI 10.1152/jappl.1977.42.3.344; SEAGARD JL, 1990, CIRC RES, V66, P1499, DOI 10.1161/01.RES.66.6.1499; SHARMA RV, 1995, NEUROSCIENCE, V66, P433, DOI 10.1016/0306-4522(94)00560-R; Shepherd JT, 1986, REV PHYSIOL BIOCH P, V105, P3; Sullivan MJ, 1997, CIRC RES, V80, P861; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; XIE PL, 1990, J CLIN INVEST, V86, P625, DOI 10.1172/JCI114754; ZUCKER IH, 1985, FED PROC, V44, P2400	41	157	163	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1435	1441		10.1016/S0896-6273(00)80661-3	http://dx.doi.org/10.1016/S0896-6273(00)80661-3			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883735	Bronze			2022-12-24	WOS:000077910600024
J	Essrich, C; Lorez, M; Benson, JA; Fritschy, JM; Luscher, B				Essrich, C; Lorez, M; Benson, JA; Fritschy, JM; Luscher, B			Postsynaptic clustering of major GABA(A) receptor subtypes requires the gamma 2 subunit and gephyrin	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; GLYCINE-RECEPTOR; HIPPOCAMPAL-NEURONS; A RECEPTORS; GABA(A)-RECEPTOR; EXPRESSION; CELLS; COLOCALIZATION; SYNAPSES; RETINA	Most fast inhibitory neurotransmission in the brain is mediated by GABA(A) receptors, which are mainly postsynaptic and consist of diverse alpha and beta subunits together with the gamma 2 subunit. Although the gamma 2 subunit is not necessary for receptor assembly and translocation to the cell surface, we show here that it is required for clustering of major postsynaptic GABA(A) receptor subtypes. Loss of GABA(A) receptor clusters in mice deficient in the gamma 2 subunit, and in cultured cortical neurons from these mice, is paralleled by loss of the synaptic clustering molecule gephyrin and synaptic GABAergic function. Conversely, inhibiting gephyrin expression causes loss of GABA(A) receptor clusters. The gamma 2 subunit and gephyrin are thus interdependent components of the same synaptic complex that is critical for postsynaptic clustering of abundant subtypes of GABA(A) receptors in vivo.	Univ Zurich, Inst Pharmacol, CH-8057 Zurich, Switzerland	University of Zurich	Luscher, B (corresponding author), Univ Zurich, Inst Pharmacol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	luscher@pharma.unizh.ch	Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906; Fritschy, Jean-Marc/0000-0002-8552-3702				Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; BOHLHALTER S, 1994, BRAIN RES, V642, P59, DOI 10.1016/0006-8993(94)90905-9; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CABOT JB, 1995, J COMP NEUROL, V356, P418, DOI 10.1002/cne.903560309; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Craig AM, 1996, J NEUROSCI, V16, P3166; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Fritschy JM, 1997, NEUROSCIENCE, V81, P1043, DOI 10.1016/S0306-4522(97)00244-3; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Giustetto M, 1998, J COMP NEUROL, V395, P231, DOI 10.1002/(SICI)1096-9861(19980601)395:2<231::AID-CNE7>3.0.CO;2-3; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hedblom E, 1997, J BIOL CHEM, V272, P15346, DOI 10.1074/jbc.272.24.15346; HERB A, 1992, P NATL ACAD SCI USA, V89, P1433, DOI 10.1073/pnas.89.4.1433; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Jones A, 1997, J NEUROSCI, V17, P1350; Kannenberg K, 1997, J NEUROCHEM, V68, P1352; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KNOFLACH F, 1991, FEBS LETT, V293, P191, DOI 10.1016/0014-5793(91)81184-A; Koulen P, 1996, J NEUROSCI, V16, P2127; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Levi S, 1998, J CELL SCI, V111, P335; LUSCHER B, 1987, EMBO J, V6, P1721, DOI 10.1002/j.1460-2075.1987.tb02423.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mohler H, 1996, Ion Channels, V4, P89; Mohler H, 1998, LIFE SCI, V62, P1611, DOI 10.1016/S0024-3205(98)00116-7; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Todd AJ, 1996, J NEUROSCI, V16, P974; TODD AJ, 1995, EUR J NEUROSCI, V7, P1, DOI 10.1111/j.1460-9568.1995.tb01014.x; Whatley VJ, 1996, J NEUROCHEM, V66, P1318; Whiting PJ, 1997, J NEUROSCI, V17, P5027; Wisden W, 1997, BIOCHEM SOC T, V25, P820, DOI 10.1042/bst0250820; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x	48	681	696	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					563	571		10.1038/2798	http://dx.doi.org/10.1038/2798			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196563				2022-12-24	WOS:000077437100011
J	Golding, NL; Spruston, N				Golding, NL; Spruston, N			Dendritic sodium spikes are variable triggers of axonal action potentials in hippocampal CA1 pyramidal neurons	NEURON			English	Article							SOURCE-DENSITY ANALYSIS; APICAL DENDRITES; CELL DENDRITES; RAT HIPPOCAMPUS; CA2+ CHANNELS; EXCITABLE DENDRITES; CALCIUM SPIKES; MITRAL CELLS; PROPAGATION; EPSPS	Several early studies suggested that spikes can be generated in the dendrites of CA1 pyramidal neurons, but their functional significance and the conditions under which they occur remain poorly understood. Here, we provide direct evidence from simultaneous dendritic and somatic patch-pipette recordings that excitatory synaptic inputs can elicit dendritic sodium spikes prior to axonal action potential initiation in hippocampal CA1 pyramidal neurons. Both the probability and amplitude of dendritic spikes depended on the previous synaptic and firing history of the cell. Moreover, some dendritic spikes occurred in the absence of somatic action potentials, indicating that their propagation to the soma and axon is unreliable. We show that dendritic spikes contribute a variable depolarization that summates with the synaptic potential and can act as a trigger for action potential initiation in the axon.	Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, Evanston, IL 60208 USA	Northwestern University	Spruston, N (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Inst Neurosci, 2153 Sheridan Rd, Evanston, IL 60208 USA.			Spruston, Nelson/0000-0003-3118-1636	NINDS NIH HHS [NS-35180] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035180] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; ANDERSEN P, 1966, EXP BRAIN RES, V2, P247; ANDERSEN P, 1960, ACTA PHYSIOL SCAND, V48, P178, DOI 10.1111/j.1748-1716.1960.tb01856.x; Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; ANDREASEN M, 1995, BRAIN RES, V698, P193, DOI 10.1016/0006-8993(95)00910-I; BENARDO LS, 1982, J NEUROSCI, V2, P1614; Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Chen HM, 1997, J NEUROPHYSIOL, V78, P3484, DOI 10.1152/jn.1997.78.6.3484; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; COLLING SB, 1994, NEUROSCI LETT, V172, P73, DOI 10.1016/0304-3940(94)90665-3; CRAGG BG, 1955, J PHYSIOL-LONDON, V129, P608, DOI 10.1113/jphysiol.1955.sp005382; FUJITA Y, 1962, J NEUROPHYSIOL, V25, P209, DOI 10.1152/jn.1962.25.2.209; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HERRERAS O, 1990, J NEUROPHYSIOL, V64, P1429, DOI 10.1152/jn.1990.64.5.1429; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Jack J, 1983, ELECT CURRENT FLOW E; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Jung HY, 1997, J NEUROSCI, V17, P6639; Kamondi A, 1998, J NEUROSCI, V18, P3919; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Miura M, 1997, J NEUROPHYSIOL, V78, P2269, DOI 10.1152/jn.1997.78.5.2269; MIYAKAWA H, 1986, BRAIN RES, V399, P303, DOI 10.1016/0006-8993(86)91520-9; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; POCKBERGER H, 1991, BRAIN RES, V539, P181, DOI 10.1016/0006-8993(91)91619-C; POOLOS NP, 1990, BRAIN RES, V524, P342, DOI 10.1016/0006-8993(90)90714-M; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; REGEHR W, 1993, NEURON, V11, P145, DOI 10.1016/0896-6273(93)90278-Y; RICHARDSON TL, 1987, J NEUROPHYSIOL, V58, P981, DOI 10.1152/jn.1987.58.5.981; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SCHWARTZKROIN PA, 1977, BRAIN RES, V128, P53, DOI 10.1016/0006-8993(77)90235-9; SCHWARTZKROIN PA, 1977, BRAIN RES, V135, P157, DOI 10.1016/0006-8993(77)91060-5; Schwindt PC, 1998, J NEUROPHYSIOL, V79, P2432, DOI 10.1152/jn.1998.79.5.2432; Schwindt PC, 1997, J NEUROPHYSIOL, V77, P2466, DOI 10.1152/jn.1997.77.5.2466; Seamans JK, 1997, J NEUROSCI, V17, P5936; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURNER RW, 1989, J NEUROPHYSIOL, V62, P1375, DOI 10.1152/jn.1989.62.6.1375; TURNER RW, 1991, J NEUROSCI, V11, P2270; TURNER RW, 1993, NEUROSCIENCE, V53, P949, DOI 10.1016/0306-4522(93)90480-4; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; WONG RKS, 1992, J PHYSIOL-LONDON, V457, P675, DOI 10.1113/jphysiol.1992.sp019401; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	66	296	299	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV	1998	21	5					1189	1200		10.1016/S0896-6273(00)80635-2	http://dx.doi.org/10.1016/S0896-6273(00)80635-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145RX	9856473	Bronze			2022-12-24	WOS:000077386100028
J	Frerking, M; Malenka, RC; Nicoll, RA				Frerking, M; Malenka, RC; Nicoll, RA			Synaptic activation of kainate receptors on hippocampal interneurons	NATURE NEUROSCIENCE			English	Article							KAINIC ACID; GLUTAMATE RECEPTORS; EPILEPTIFORM ACTIVITY; RAT HIPPOCAMPUS; INHIBITION; NEURONS; AMPA; RESPONSES; CHANNELS; CELLS	Although kainate receptor activation has been known to evoke epileptiform activity, little is known about the role of kainate receptors in synaptic transmission. Here we report that kainate (KA) receptors are present on interneurons and, when activated, cause a large increase in the frequency of spontaneous inhibitory postsynaptic currents (IPSCs) driven by action potentials. Stimulation of excitatory afferents generates a pharmacologically identifiable synaptic current mediated by KA receptors in interneurons. This synaptic current is similar to that mediated by AM PA receptors in its response to short stimulus trains, current-voltage relations and coefficient of variation, but it is much smaller in peak amplitude and much slower. KA application also considerably depresses evoked IPSCs. This depression seems to be in large part an indirect consequence of the repetitive firing evoked by the activation of the interneuronal somatic/dendritic KA receptors.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.				NINDS NIH HHS [T32NS07067] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007067] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; ALGER BE, 1980, BRAIN RES, V200, P195, DOI 10.1016/0006-8993(80)91108-7; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; BEKKERS JM, 1994, ADV SEC MESS PHOSPH, V29, P261; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CORNISH SM, 1989, NEUROSCIENCE, V28, P563, DOI 10.1016/0306-4522(89)90005-5; FISHER RS, 1984, J NEUROSCI, V4, P1312; FRANCK JE, 1988, J NEUROSCI, V8, P1991; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howe JR, 1996, J NEUROPHYSIOL, V76, P510, DOI 10.1152/jn.1996.76.1.510; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; LANCASTER B, 1984, BRAIN RES, V295, P317, DOI 10.1016/0006-8993(84)90980-6; LERMA J, 1993, P NATL ACAD SCI USA, V90, P11688, DOI 10.1073/pnas.90.24.11688; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; Mayer M, 1997, NATURE, V389, P542, DOI 10.1038/39177; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; RUANO D, 1995, NEURON, V14, P1009, DOI 10.1016/0896-6273(95)90339-9; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SIK A, 1993, EUR J NEUROSCI, V5, P1719, DOI 10.1111/j.1460-9568.1993.tb00239.x; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P91; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; Wilding TJ, 1997, J NEUROSCI, V17, P2713; WILDING TJ, 1995, MOL PHARMACOL, V47, P582; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9	42	251	253	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					479	486		10.1038/2194	http://dx.doi.org/10.1038/2194			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196545				2022-12-24	WOS:000076406900012
J	Britten, KH; van Wezel, RJA				Britten, KH; van Wezel, RJA			Electrical microstimulation of cortical area MST biases heading perception in monkeys	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL AREA; PURSUIT EYE-MOVEMENTS; OPTIC FLOW STIMULI; MACAQUE MONKEY; VISUAL-CORTEX; EXPANSION CONTRACTION; ROTATION CELLS; IMAGE MOTION; DORSAL PART; NEURONS	As we move through the environment, the pattern of visual motion on the retina provides rich information about our movement through the scene. Human subjects can use this information, often termed "optic flow", to accurately estimate their direction of self movement (heading) from relatively sparse displays. Physiological observations on the motion-sensitive areas of monkey visual cortex suggest that the medial superior temporal area (MST) is well suited for the analysis of optic Row information. To test whether MST is involved in extracting heading from optic flow, we perturbed its activity in monkeys trained on a heading discrimination task. Electrical microstimulation of MST frequently biased the monkeys' decisions about their heading, and these induced biases were often quite large. This result suggests that MST has a direct role in the perception of heading from optic flow.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA; Univ Utrecht, Dept Comparat Physiol, Utrecht, Netherlands	University of California System; University of California Davis; University of California System; University of California Davis; Utrecht University	Britten, KH (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.		van Wezel, Richard R J/G-4455-2011	van Wezel, Richard R J/0000-0001-5753-7069	NEI NIH HHS [EY10562] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010562] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Banks MS, 1996, VISION RES, V36, P431, DOI 10.1016/0042-6989(95)00122-0; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; Bremmer I, 1997, J DEMOCR, V8, P77; BRITTEN KH, 1998, IN PRESS VISUAL NURO; CELEBRINI S, 1995, J NEUROPHYSIOL, V73, P437, DOI 10.1152/jn.1995.73.2.437; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Duffy CJ, 1997, J NEUROPHYSIOL, V77, P782, DOI 10.1152/jn.1997.77.2.782; Geesaman BJ, 1997, CEREB CORTEX, V7, P749, DOI 10.1093/cercor/7.8.749; Gibson JJ, 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; HEEGER DJ, 1992, INT J COMPUT VISION, V7, P95, DOI 10.1007/BF00128130; Hoel P. G., 1971, INTRO STAT THEORY; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; KOMATSU H, 1989, J NEUROPHYSIOL, V62, P31, DOI 10.1152/jn.1989.62.1.31; LAGAE L, 1993, J NEUROPHYSIOL, V69, P19, DOI 10.1152/jn.1993.69.1.19; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; RIEGER JH, 1985, J OPT SOC AM A, V2, P354, DOI 10.1364/JOSAA.2.000354; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; SAITO H, 1986, J NEUROSCI, V6, P145; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Squatrito S, 1997, J NEUROSCI, V17, P3847; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; TANAKA K, 1986, J NEUROSCI, V6, P134; vandenBerg AV, 1996, VISION RES, V36, P2337, DOI 10.1016/0042-6989(95)00247-2; WARREN WH, 1990, J OPT SOC AM A, V7, P160, DOI 10.1364/JOSAA.7.000160	36	220	227	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					59	63		10.1038/259	http://dx.doi.org/10.1038/259			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195110				2022-12-24	WOS:000076361000019
J	Nakamura, T; Barbara, JG; Nakamura, K; Ross, WN				Nakamura, T; Barbara, JG; Nakamura, K; Ross, WN			Synergistic release of Ca2+ from IP3-sensitive stores evoked by synaptic activation of mGluRs paired with backpropagating action potentials	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CA1 PYRAMIDAL NEURONS; CEREBELLAR PURKINJE NEURONS; INDUCED CALCIUM-RELEASE; PROPAGATING ACTION-POTENTIALS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; INOSITOL 1,4,5-TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; INTRACELLULAR STORES	Increases in postsynaptic [Ca2+](i) can result from Ca2+ entry through ligand-gated channels or voltage-gated Ca2+ channels, or through release from intracellular stores. Most attention has focused on entry through the N-methyl-D-aspartate (NMDA) receptor in causing [Ca2+](i) increases since this pathway requires both presynaptic stimulation and postsynaptic depolarization, making it a central component in models of synaptic plasticity. Here, we report that repetitive synaptic activation of metabotropic glutamate receptors (mGluRs), paired with backpropagating action potentials, causes large, wave-like increases in [Ca2+](i) predominantly in restricted regions of the proximal apical dendrites and soma of hippocampal CA1 pyramidal neurons. [Ca2+](i) changes of several micromolars can be reached by regenerative release caused by the synergistic effect of mGluR-generated inositol 1,4,5-trisphosphate (IP3) and spike-evoked Ca2+ entry acting on the IP3 receptor.	New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA	New York Medical College	Ross, WN (corresponding author), New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.	ross@nymc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016295] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16295, R01 NS016295] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bianchi R, 1999, J NEUROPHYSIOL, V81, P2903, DOI 10.1152/jn.1999.81.6.2903; CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; Congar P, 1997, J NEUROSCI, V17, P5366; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DAVIES CH, 1995, BRIT J PHARMACOL, V116, P1859, DOI 10.1111/j.1476-5381.1995.tb16674.x; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FRENGUELLI BG, 1993, NEUROPHARMACOLOGY, V32, P1229, DOI 10.1016/0028-3908(93)90017-W; FRIEL DD, 1992, J PHYSIOL-LONDON, V450, P217, DOI 10.1113/jphysiol.1992.sp019125; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; IINO M, 1992, NATURE, V360, P76, DOI 10.1038/360076a0; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JAFFE DB, 1994, J NEUROPHYSIOL, V72, P471, DOI 10.1152/jn.1994.72.1.471; Khodakhah K, 1997, BIOPHYS J, V73, P3349, DOI 10.1016/S0006-3495(97)78359-0; KOBAYASHI S, 1988, BIOCHEM BIOPH RES CO, V153, P625, DOI 10.1016/S0006-291X(88)81141-0; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; LASSERROSS N, 1991, J NEUROSCI METH, V36, P253, DOI 10.1016/0165-0270(91)90051-Z; LECHLEITER JD, 1992, CELL, V69, P283, DOI 10.1016/0092-8674(92)90409-6; LEVRAM V, 1992, J NEUROPHYSIOL, V68, P1167, DOI 10.1152/jn.1992.68.4.1167; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Miller LDP, 1996, J NEUROPHYSIOL, V76, P554, DOI 10.1152/jn.1996.76.1.554; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; Reyes M, 1996, J NEUROSCI, V16, P5951; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; Sakmann Bert, 1995, P199; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; SEYMOURLAURENT KJ, 1995, J NEUROSCI, V15, P2592; SHARP AH, 1993, J NEUROSCI, V13, P3051; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; TURNER RW, 1991, J NEUROSCI, V11, P2270; Usachev YM, 1997, J NEUROSCI, V17, P7404; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; Wang SSH, 1995, BIOPHYS J, V69, P1683, DOI 10.1016/S0006-3495(95)80086-X; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	55	266	268	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV	1999	24	3					727	737		10.1016/S0896-6273(00)81125-3	http://dx.doi.org/10.1016/S0896-6273(00)81125-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259UU	10595522	Bronze			2022-12-24	WOS:000083913000026
J	Hiesberger, T; Trommsdorff, M; Howell, BW; Goffinet, A; Mumby, MC; Cooper, JA; Herz, J				Hiesberger, T; Trommsdorff, M; Howell, BW; Goffinet, A; Mumby, MC; Cooper, JA; Herz, J			Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation	NEURON			English	Article							MONOCLONAL-ANTIBODIES; LAMINAR ORGANIZATION; NEURONAL MIGRATION; ADAPTER PROTEINS; MOUSE; BRAIN; SCRAMBLER; MOLECULE; MICE; GENE	The large extracellular matrix protein Reelin is produced by Cajal-Retzius neurons in specific regions of the developing brain, where it controls neuronal migration and positioning. Genetic evidence suggests that interpretation of the Reelin signal by migrating neurons involves two neuronal cell surface proteins, the very low density lipoprotein receptor (VLDLR) and the apoE receptor 2 (ApoER2) as well as a cytosolic adaptor protein, Disabled-1 (Dab1). We show that Reelin binds directly and specifically to the ectodomains of VLDLR and ApoER2 in vitro and that blockade of VLDLR and ApoER2 correlates with loss of Reelin-induced tyrosine phosphorylation of Disabled-1 in cultured primary embryonic neurons. Furthermore, mice that lack either Reelin or both VLDLR and ApoER2 exhibit hyperphosphorylation of the microtubule-stabilizing protein tau. Taken together, these findings suggest that Reelin acts via VLDLR and ApoER2 to regulate Disabled-1 tyrosine phosphorylation and microtubule function in neurons.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Namur, Sch Med, Neurobiol Unit, B-5000 Namur, Belgium	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Fred Hutchinson Cancer Center; University of Namur	Herz, J (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA.			Howell, Brian/0000-0002-0204-0773	NCI NIH HHS [CA41072] Funding Source: Medline; NHLBI NIH HHS [R37 HL063762, HL20948] Funding Source: Medline; NIGMS NIH HHS [GM49505] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041072, R37CA041072] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049505] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Curran T, 1998, BRAIN RES REV, V26, P285, DOI 10.1016/S0165-0173(97)00035-0; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hiesberger T, 1998, EMBO J, V17, P4617, DOI 10.1093/emboj/17.16.4617; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Howell BW, 1999, MOL CELL BIOL, V19, P5179; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MERCKEN M, 1992, ACTA NEUROPATHOL, V84, P265, DOI 10.1007/BF00227819; Merrick SE, 1997, J NEUROSCI, V17, P5726; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rice DS, 1998, DEVELOPMENT, V125, P3719; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sweet HO, 1996, MAMM GENOME, V7, P798, DOI 10.1007/s003359900240; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Yoneshima H, 1997, NEUROSCI RES, V29, P217, DOI 10.1016/S0168-0102(97)00088-6	42	744	772	1	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					481	489		10.1016/S0896-6273(00)80861-2	http://dx.doi.org/10.1016/S0896-6273(00)80861-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571241	Bronze			2022-12-24	WOS:000083423700022
J	Zheng, Y; Brockie, PJ; Mellem, JE; Madsen, DM; Maricq, AV				Zheng, Y; Brockie, PJ; Mellem, JE; Madsen, DM; Maricq, AV			Neuronal control of locomotion in C-elegans is modified by a dominant mutation in the GLR-1 ionotropic glutamate receptor	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CELL-DEATH; CHLORIDE CHANNEL; GENE-EXPRESSION; NEURAL NETWORKS; NERVOUS-SYSTEM; LURCHER MICE; BEHAVIOR; ENCODES; PERMEABILITY	How simple neuronal circuits control behavior is not well understood at the molecular or genetic level. In Caenorhabditis elegans, foraging behavior consists of long, forward movements interrupted by brief reversals. To determine how this pattern is generated and regulated, we have developed novel perturbation techniques that allow us to depolarize selected neurons in vivo using the dominant glutamate receptor mutation identified in the Lurcher mouse. Transgenic worms that expressed a mutated C. elegans glutamate receptor in interneurons that control locomotion displayed a remarkable and unexpected change in their behavior-they rapidly alternated between forward and backward coordinated movement. Our findings suggest that the gating of movement reversals is controlled in a partially distributed fashion by a small subset of interneurons and that this gating is modified by sensory input.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35812] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; BARGMANN CI, 1990, COLD SH Q B, V55, P529; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; BRENNER S, 1974, GENETICS, V77, P71; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cheng SSW, 1997, J NEUROSCI, V17, P2400, DOI 10.1523/jneurosci.17-07-02400.1997; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FROST WN, 1995, J NEUROPHYSIOL, V73, P1313; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Harlow E., 1988, ANTIBODIES LAB MANUA; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HORVITZ HR, 1994, COLD SPRING HARB SYM, V59, P377, DOI 10.1101/SQB.1994.059.01.042; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; KRISTAN WB, 1995, J NEUROBIOL, V27, P380, DOI 10.1002/neu.480270310; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; LOCKERY SR, 1993, TRENDS NEUROSCI, V16, P283, DOI 10.1016/0166-2236(93)90183-M; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MARCUSSEKURA CJ, 1987, GUIDE MOL CLONING TE, P284; MARDER E, 1994, CURR BIOL, V4, P752, DOI 10.1016/S0960-9822(00)00169-X; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NORMAN DJ, 1995, DEVELOPMENT, V121, P1183; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; Riddle DL, 1997, C ELEGANS, P739; ROBERTS A, 1995, J NEUROPHYSIOL, V73, P485, DOI 10.1152/jn.1995.73.2.485; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STRETTON AOW, 1985, TRENDS NEUROSCI, V8, P294, DOI 10.1016/0166-2236(85)90105-5; THOMAS JH, 1993, BIOESSAYS, V15, P791, DOI 10.1002/bies.950151204; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wicks SR, 1996, J NEUROSCI, V16, P4017; XUE D, 1992, EMBO J, V11, P4969, DOI 10.1002/j.1460-2075.1992.tb05604.x; YANDELL MD, 1994, P NATL ACAD SCI USA, V91, P1381, DOI 10.1073/pnas.91.4.1381; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	63	204	207	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1999	24	2					347	361		10.1016/S0896-6273(00)80849-1	http://dx.doi.org/10.1016/S0896-6273(00)80849-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	251BA	10571229	Bronze			2022-12-24	WOS:000083423700010
J	Deneve, S; Latham, PE; Pouget, A				Deneve, S; Latham, PE; Pouget, A			Reading population codes: a neural implementation of ideal observers	NATURE NEUROSCIENCE			English	Article							PSYCHOPHYSICAL PERFORMANCE; STRIATE CORTEX; VISUAL-MOTION; RESPONSES; DISCHARGE; NEURONS; MODEL	Many sensory and motor variables are encoded in the nervous system by the activities of large populations of neurons with bell-shaped tuning curves. Extracting information from these population codes is difficult because of the noise inherent in neuronal responses. In most cases of interest, maximum likelihood (ML) is the best read-out method and would be used by an ideal observer. Using simulations and analysis, we show that a close approximation to ML can be implemented in a biologically plausible model of cortical circuitry. Our results apply to a wide range of nonlinear activation functions, suggesting that cortical areas may, in general, function as ideal observers of activity in preceding areas.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of Rochester; University of California System; University of California Los Angeles	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365				Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; BARTO A, 1989, COMP NEUR S, P73; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; CARANDINI M, 1997, J NEUROSCI, V17, P3061; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Gershon ED, 1998, J NEUROPHYSIOL, V79, P1135, DOI 10.1152/jn.1998.79.3.1135; Hawken M.J., 1990, P103; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; MAUNSELL JH, 1985, J NEUROPHYSIOL, V49, P1127; MAZZONI P, 1991, P NATL ACAD SCI USA, V88, P4433, DOI 10.1073/pnas.88.10.4433; NELSON ME, 1994, NEURAL COMPUT, V6, P242, DOI 10.1162/neco.1994.6.2.242; Papoulis A., 1991, PROBABILITY RANDOM V; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	290	294	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					740	745		10.1038/11205	http://dx.doi.org/10.1038/11205			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412064				2022-12-24	WOS:000083882800014
J	Schnider, A; Ptak, R				Schnider, A; Ptak, R			Spontaneous confabulators fail to suppress currently irrelevant memory traces	NATURE NEUROSCIENCE			English	Article							ANTERIOR COMMUNICATING ARTERY; FRONTAL-LOBE; AMNESIC PATIENTS; TEMPORAL CONTEXT; LESIONS; RECOLLECTION; RECOGNITION; FAMILIARITY; DYSFUNCTION; ANTEROGRADE	Human actions require integration of past experiences, ongoing percepts and future concepts. To adapt behavior to reality, the brain must identify mental representations of current relevance. Occasional amnesic subjects act according to invented stories ('spontaneous confabulations'), disregarding present reality. We used repeated runs of a continuous recognition task to measure the ability to distinguish currently relevant from previously encountered but currently irrelevant information. Spontaneous confabulators detected target items as accurately as nonconfabulating amnesics, but increasingly failed to suppress false-positive responses, confusing presentation in previous runs with presentation in the current run. Lesions involved the anterior limbic system: medial orbitofrontal cortex, basal forebrain, amygdala and perirhinal cortex or medial hypothalamus. We suggest that the anterior limbic system represents 'now' in human thinking by suppressing currently irrelevant mental associations.	Univ Hosp Bern, Dept Neurol, Div Neuropsychol Rehabil, CH-3010 Bern, Switzerland; Hop Cantonal Geneva, Clin Reeduc, CH-1211 Geneva 14, Switzerland	University of Bern; University Hospital of Bern; University of Geneva	Schnider, A (corresponding author), Univ Hosp Bern, Dept Neurol, Div Neuropsychol Rehabil, CH-3010 Bern, Switzerland.	armin.schnider@hcuge.ch	Ptak, Radek/A-8661-2010	Ptak, Radek/0000-0003-4708-9201				Benson DF, 1996, NEUROLOGY, V46, P1239, DOI 10.1212/WNL.46.5.1239; BERLYNE N, 1972, BRIT J PSYCHIAT, V120, P31, DOI 10.1192/bjp.120.554.31; BOWERS D, 1988, BRAIN COGNITION, V8, P47, DOI 10.1016/0278-2626(88)90038-3; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Cunningham JM, 1997, J CLIN EXP NEUROPSYC, V19, P867, DOI 10.1080/01688639708403767; DALLABARBA G, 1993, CORTEX, V29, P567, DOI 10.1016/S0010-9452(13)80281-X; DALLABARBA G, 1993, COGN NEUROPSYCHOL, V10, P1; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Damasio H, 1989, LESION ANAL NEUROPSY; DELIS D, 1987, CALIFORNIA VERBAL LE; DELUCA J, 1991, CORTEX, V27, P417, DOI 10.1016/S0010-9452(13)80036-6; FISCHER RS, 1995, J CLIN EXP NEUROPSYC, V17, P20, DOI 10.1080/13803399508406577; Fuster JM, 1995, MEMORY CEREBRAL CORT; HANLEY JR, 1994, COGNITIVE NEUROPSYCH, V11, P543, DOI 10.1080/02643299408251985; HUPPERT FA, 1976, CORTEX, V12, P3, DOI 10.1016/S0010-9452(76)80024-X; Hurst W, 1982, Brain Cogn, V1, P294; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Johnson M. K., 1991, AWARENESS DEFICIT BR, P176; Johnson MK, 1997, BRAIN COGNITION, V34, P189, DOI 10.1006/brcg.1997.0873; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KESNER RP, 1994, NEUROPSYCHOLOGIA, V32, P881, DOI 10.1016/0028-3932(94)90040-X; Kinsbourne Marcel, 1995, P1321; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; Kopelman MD, 1997, COGNITIVE NEUROPSYCH, V14, P683, DOI 10.1080/026432997381411; KOPELMAN MD, 1987, J NEUROL NEUROSUR PS, V50, P1482, DOI 10.1136/jnnp.50.11.1482; MERCER B, 1977, ARCH NEUROL-CHICAGO, V34, P429, DOI 10.1001/archneur.1977.00500190063009; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; PARKIN AJ, 1993, CORTEX, V29, P267, DOI 10.1016/S0010-9452(13)80180-3; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schnider A, 1994, Behav Neurol, V7, P87, DOI 10.3233/BEN-1994-7207; Schnider A, 1996, J NEUROL NEUROSUR PS, V61, P186, DOI 10.1136/jnnp.61.2.186; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; SCHNIDER A, 1997, J INT NEUROPSYCH SOC, V4, P61; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHAPIRO BE, 1981, NEUROLOGY, V31, P1070, DOI 10.1212/WNL.31.9.1070; SHIMAMURA AP, 1991, PSYCHOBIOLOGY, V19, P1; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SQUIRE LR, 1981, NEUROPSYCHOLOGIA, V19, P141, DOI 10.1016/0028-3932(81)90054-3; SQUIRE LR, 1986, BEHAV NEUROSCI, V100, P866, DOI 10.1037/0735-7044.100.6.866; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; Thurstone L. L., 1963, CHICAGO TEST PRIMARY	49	178	182	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					677	681		10.1038/10236	http://dx.doi.org/10.1038/10236			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259EY	10404203				2022-12-24	WOS:000083882600021
J	Speca, DJ; Lin, DM; Sorensen, PW; Isacoff, EY; Ngai, J; Dittman, AH				Speca, DJ; Lin, DM; Sorensen, PW; Isacoff, EY; Ngai, J; Dittman, AH			Functional identification of a goldfish odorant receptor	NEURON			English	Article							PUTATIVE PHEROMONE RECEPTORS; BETA-GAMMA-SUBUNITS; OLFACTORY SYSTEM; MULTIGENE FAMILY; GLUTAMATE RECEPTOR; CHANNEL PROPERTIES; MOLECULAR-CLONING; CALCIUM RECEPTOR; AMINO-ACID; EXPRESSION	The vertebrate olfactory system utilizes odorant receptors to receive and discriminate thousands of different chemical stimuli. An understanding of how these receptors encode information about an odorant's molecular structure requires a characterization of their ligand specificities. We employed an expression cloning strategy to identify a goldfish odorant receptor that is activated by amino acids - potent odorants for fish. Structure-activity analysis indicates that the receptor is preferentially tuned to recognize basic amino acids. The receptor is a member of a multigene family of G protein-coupled receptors, sharing sequence similarities with the calcium sensing, metabotropic glutamate, and V2R class of vomeronasal receptors. The ligand tuning properties of the goldfish amino acid odorant receptor provide information for unraveling the molecular mechanisms underlying olfactory coding.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Minnesota, Dept Fisheries & Wildlife, St Paul, MN 55108 USA	University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities	Ngai, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		isacoff, ehud/AAP-1459-2020; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Sorensen, Peter/0000-0003-0321-1279; Isacoff, Ehud Y./0000-0003-4775-9359				ABE K, 1993, J BIOL CHEM, V268, P12033; ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; Barth AL, 1997, NEURON, V19, P359, DOI 10.1016/S0896-6273(00)80945-9; Barth AL, 1996, NEURON, V16, P23, DOI 10.1016/S0896-6273(00)80020-3; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; CAPRIO J, 1984, J GEN PHYSIOL, V84, P403, DOI 10.1085/jgp.84.3.403; COLLINS GGS, 1974, BRAIN RES, V76, P447, DOI 10.1016/0006-8993(74)90821-X; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; HEBERT SC, 1995, CURR OPIN CELL BIOL, V7, P484, DOI 10.1016/0955-0674(95)80004-2; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HUQUE T, 1986, BIOCHEM BIOPH RES CO, V137, P36, DOI 10.1016/0006-291X(86)91172-1; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; MARGOLIS FL, 1974, SCIENCE, V184, P909, DOI 10.1126/science.184.4139.909; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Michel WC, 1997, BRAIN RES, V764, P179, DOI 10.1016/S0006-8993(97)00454-X; Naito T, 1998, P NATL ACAD SCI USA, V95, P5178, DOI 10.1073/pnas.95.9.5178; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; Nevitt G, 1999, INTEGR BIOL ISSUES N, V1, P215; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; NICOLL RA, 1971, BRAIN RES, V35, P137, DOI 10.1016/0006-8993(71)90600-7; RESTREPO D, 1993, AM J PHYSIOL, V264, P906; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Sorensen Peter W., 1998, P375; SORENSEN PW, 1987, J COMP PHYSIOL A, V160, P305, DOI 10.1007/BF00613020; SORENSEN PW, 1988, BIOL REPROD, V39, P1039, DOI 10.1095/biolreprod39.5.1039; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Yamamoto M., 1982, CHEMORECEPTION FISHE, P39; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0	47	190	203	2	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL	1999	23	3					487	498		10.1016/S0896-6273(00)80802-8	http://dx.doi.org/10.1016/S0896-6273(00)80802-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221AA	10433261	Bronze			2022-12-24	WOS:000081701000013
J	Desai, NS; Rutherford, LC; Turrigiano, GG				Desai, NS; Rutherford, LC; Turrigiano, GG			Plasticity in the intrinsic excitability of cortical pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; RAT NEOCORTICAL NEURONS; ELECTRICAL-ACTIVITY; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; DEVELOPMENTAL-CHANGES; POTASSIUM CURRENTS; QUANTAL AMPLITUDE; CALCIUM CURRENTS; CULTURED NEURONS	During learning and development, the level of synaptic input received by cortical neurons may change dramatically. Given a limited range of possible firing rates, how do neurons maintain responsiveness to both small and large synaptic inputs? We demonstrate that in response to changes in activity, cultured cortical pyramidal neurons regulate intrinsic excitability to promote stability in firing. Depriving pyramidal neurons of activity for two days increased sensitivity to current injection by selectively regulating voltage-dependent conductances. This suggests that one mechanism by which neurons maintain sensitivity to different levels of synaptic input is by altering the function relating current to firing rate.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA.	turrigiano@binah.cc.brandeis.edu			NINDS NIH HHS [K02 NS01893, R01 NS36853] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS001893, R01NS036853] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BRODIE C, 1989, BRAIN RES, V488, P186, DOI 10.1016/0006-8993(89)90708-7; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DESARMENIEN MG, 1991, NEURON, V7, P797, DOI 10.1016/0896-6273(91)90282-5; FRANKLIN JL, 1992, J NEUROSCI, V12, P1726; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KLEE R, 1995, J NEUROPHYSIOL, V74, P1982, DOI 10.1152/jn.1995.74.5.1982; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; LINSDELL P, 1995, J NEUROSCI, V15, P4507; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Moody WJ, 1998, J NEUROBIOL, V37, P97, DOI 10.1002/(SICI)1097-4695(199810)37:1<97::AID-NEU8>3.0.CO;2-3; Moody WJ, 1998, CURR TOP DEV BIOL, V39, P159, DOI 10.1016/S0070-2153(08)60455-X; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; RAMAKERS GJA, 1990, EXP BRAIN RES, V79, P157; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Tarasenko AN, 1998, J PHYSIOL-LONDON, V509, P385, DOI 10.1111/j.1469-7793.1998.385bn.x; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; TURRIGIANO GG, IN PRESS TRENDS NEUR; YAARI Y, 1987, SCIENCE, V235, P680, DOI 10.1126/science.2433765; ZONA C, 1988, NEUROSCI LETT, V94, P285, DOI 10.1016/0304-3940(88)90032-8	42	554	558	4	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					515	520		10.1038/9165	http://dx.doi.org/10.1038/9165			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448215				2022-12-24	WOS:000084735900010
J	Rohrbough, J; Pinto, S; Mihalek, RM; Tully, T; Broadie, K				Rohrbough, J; Pinto, S; Mihalek, RM; Tully, T; Broadie, K			latheo, a Drosophila gene involved in learning, regulates functional synaptic plasticity	NEURON			English	Article							LONG-TERM-MEMORY; LARVAL NEUROMUSCULAR-JUNCTION; DEPENDENT PROTEIN-KINASE; MOTOR-NERVE TERMINALS; TRANSMITTER RELEASE; ADENYLYL-CYCLASE; LATE-PHASE; MUTANTS; MELANOGASTER; CAMP	Mutations in the latheo (laf) gene disrupt associative learning in Drosophila, but a role for LAT in regulating neuronal function has not been demonstrated. Here, we report that LAT plays a central role in regulating Ca2+- and activity-dependent synaptic plasticity. Immunological localization of the LAT protein indicates it is present at synaptic connections of the larval neuromuscular junction (NMJ) and is enriched in presynaptic boutons. Basal synaptic transmission amplitude at the laf mutant NMJ is elevated 3- to 4-fold, and Ca2+ dependence of transmission is significantly reduced. Multiple forms of synaptic facilitation and posttetanic potentiation (PTP) are strongly depressed or absent at the mutant synapse. Our results suggest that LAT is a novel presynaptic protein with a role in the Ca2+-dependent synaptic modulation mechanisms necessary for behavioral plasticity.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Cold Spring Harbor Lab, Ctr Learing & Memory, Cold Spring Harbor, NY 11724 USA; Cornell Univ, Joan & Sanford I Weill Grad Sch Med Sci, Grad Program Neurosci, New York, NY 10021 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Utah System of Higher Education; University of Utah; Cold Spring Harbor Laboratory; Cornell University; Brandeis University	Broadie, K (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.			Rohrbough, Jeffrey/0000-0001-6742-4543	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032480] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54544] Funding Source: Medline; NINDS NIH HHS [NS32480] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; ALNAES E, 1975, J PHYSIOL-LONDON, V248, P285, DOI 10.1113/jphysiol.1975.sp010974; ANDERSON MS, 1988, J NEUROSCI, V8, P242; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; BOLWIG GM, 1995, NEURON, V15, P829, DOI 10.1016/0896-6273(95)90174-4; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BOYNTON S, 1992, GENETICS, V131, P655; BOYNTON SC, 1993, THESIS BRANDEIS U WA; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; BROADIE KS, 1993, J NEUROSCI, V13, P144; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; David G, 1998, J PHYSIOL-LONDON, V509, P59, DOI 10.1111/j.1469-7793.1998.059bo.x; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; DELGADO R, 1992, P ROY SOC B-BIOL SCI, V250, P181, DOI 10.1098/rspb.1992.0147; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; DUBNAU J, 1998, IN PRESS ANN REV NEU; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; FOSSIER P, 1993, J PHYSIOLOGY-PARIS, V87, P3, DOI 10.1016/0928-4257(93)90019-P; Fossier P, 1998, NEUROSCIENCE, V85, P85, DOI 10.1016/S0306-4522(97)00591-5; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GODA Y, 1995, CURR BIOL, V5, P852, DOI 10.1016/S0960-9822(95)00171-0; GODA Y, 1995, CURR BIOL, V5, P136, DOI 10.1016/S0960-9822(95)00034-0; Goodwin SF, 1997, J NEUROSCI, V17, P8817; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHANSEN J, 1989, J NEUROSCI, V9, P710; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; LASKO PF, 1988, GENETICS, V120, P495; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Pinto S, 1999, NEURON, V23, P45, DOI 10.1016/S0896-6273(00)80752-7; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Tang YG, 1997, NEURON, V18, P483, DOI 10.1016/S0896-6273(00)81248-9; THUMMEL CS, 1991, TECHNICAL NOTES NEW; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Tully T, 1997, P NATL ACAD SCI USA, V94, P4239, DOI 10.1073/pnas.94.9.4239; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TULLY T, 1993, J NEUROGENET, V9, P65; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhao ML, 1997, J NEUROSCI, V17, P2187; ZHONG Y, 1993, J NEUROGENET, V9, P15, DOI 10.3109/01677069309167273; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1992, J NEUROSCI, V12, P644; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	68	77	80	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	1999	23	1					55	70		10.1016/S0896-6273(00)80753-9	http://dx.doi.org/10.1016/S0896-6273(00)80753-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	202ZA	10402193	Bronze			2022-12-24	WOS:000080681200010
J	Corringer, PJ; Bertrand, S; Galzi, JL; Devillers-Thiery, A; Changeux, JP; Bertrand, D				Corringer, PJ; Bertrand, S; Galzi, JL; Devillers-Thiery, A; Changeux, JP; Bertrand, D			Mutational analysis of the charge selectivity filter of the alpha 7 nicotinic acetylcholine receptor	NEURON			English	Article							TRANSMEMBRANE SEGMENT M2; CHANNEL-LINING RESIDUES; GAMMA-AMINOBUTYRIC-ACID; 4-HELIX BUNDLE PROTEINS; PORE-FORMING STRUCTURE; ION-CHANNEL; AMINO-ACIDS; SYNTHETIC PEPTIDES; DELTA-SUBUNIT; MODEL SYSTEMS	In the alpha 7 nicotinic acetylcholine receptors, we analyze the contribution of mutations E237A and V251T, together with the proline insertion P236', in the conversion of the charge selectivity from cationic to anionic. We show that the triple mutant exhibits spontaneous openings displaying anionic selectivity. Furthermore, at position 251, hydrophilic or even negatively charged residues are compatible with an anionic channel. In contrast, the additional proline yields an anionic channel only when inserted between positions 234 and 237; insertion before 234 yields a cationic channel and after 238 alters the receptor surface expression. The coiled 234-238 loop thus directly contributes to the charge selectivity filter of the alpha 7 channel.	Inst Pasteur, CNRS, URA D1284, F-75724 Paris 15, France; Ctr Med Univ Geneva, Fac Med, Dept Physiol, CH-1211 Geneva 4, Switzerland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva	Changeux, JP (corresponding author), Inst Pasteur, CNRS, URA D1284, 25 Rue Dr Roux, F-75724 Paris 15, France.	changeux@pasteur.fr						ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Adcock C, 1998, BIOPHYS J, V75, P1211, DOI 10.1016/S0006-3495(98)74040-8; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bertrand D, 1991, METHODS NEUROSCIENCE, V4, P174; Bertrand S, 1997, NEUROREPORT, V8, P3591, DOI 10.1097/00001756-199711100-00034; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; COHEN BN, 1992, J GEN PHYSIOL, V99, P545, DOI 10.1085/jgp.99.4.545; DEVILLERSTHIERY A, 1992, NEUROREPORT, V3, P1001, DOI 10.1097/00001756-199211000-00014; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GUNTHORPE MJ, 1994, BRIT J PHARMACOL, V119, pP259; Hille B., 1992, ION CHANNELS EXCITAB; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUCHO F, 1986, FEBS LETT, V205, P137, DOI 10.1016/0014-5793(86)80881-X; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; LENOVERE N, 1999, IN PRESS BIOPHYS J; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; Lindstrom J, 1996, Ion Channels, V4, P377; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; OBLATTMONTAL M, 1993, J BIOL CHEM, V268, P14601; PEDERSEN SE, 1990, BIOPHYS J, V57, pA126; REDDY GL, 1993, J BIOL CHEM, V268, P14608; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Tikhonov DB, 1998, BIOPHYS J, V74, P242, DOI 10.1016/S0006-3495(98)77783-5; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VILLARROEL A, 1992, BIOPHYS J, V62, P196, DOI 10.1016/S0006-3495(92)81805-2; VILLARROEL A, 1992, P ROY SOC B-BIOL SCI, V249, P317, DOI 10.1098/rspb.1992.0121; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; XU M, 1993, J BIOL CHEM, V268, P21505; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	48	117	119	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					831	843		10.1016/S0896-6273(00)80741-2	http://dx.doi.org/10.1016/S0896-6273(00)80741-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230802	Bronze			2022-12-24	WOS:000079976200025
J	Lanier, LM; Gates, MA; Witke, W; Menzies, AS; Wehman, AM; Macklis, JD; Kwiatkowski, D; Soriano, P; Gertler, FB				Lanier, LM; Gates, MA; Witke, W; Menzies, AS; Wehman, AM; Macklis, JD; Kwiatkowski, D; Soriano, P; Gertler, FB			Mena is required for neurulation and commissure formation	NEURON			English	Article							ABL TYROSINE KINASE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; GROWTH CONE FILOPODIA; ACTIN-BASED MOTILITY; NEURAL-TUBE DEFECTS; HUMAN-PLATELETS; LISTERIA-MONOCYTOGENES; EMBRYONIC LETHALITY; CORPUS-CALLOSUM; FOCAL CONTACTS	Mammalian enabled (Mena) is a member of a protein family thought to link signal transduction pathways to localized remodeling of the actin cytoskeleton. Mena binds directly to Profilin, an actin-binding protein that modulates actin polymerization. In primary neurons, Mena is concentrated at the tips of growth cone filopodia. Mena-deficient mice are viable; however, axons projecting from interhemispheric cortico-cortical neurons are misrouted in early neonates, and failed decussation of the corpus callosum as well as defects in the hippocampal commissure and the pontocerebellar pathway are evident in the adult. Mena-deficient mice that are heterozygous for a Profilin I deletion die in utero and display defects in neurulation, demonstrating an important functional role for Mena in regulation of the actin cytoskeleton.	MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; European Mol Biol Lab, Mouse Biol Programme, I-00016 Monterotondo, Italy; Harvard Univ, Sch Med, Div Hematol, Genet Lab, Boston, MA 02115 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Harvard University; Harvard Medical School; Fred Hutchinson Cancer Center	Gertler, FB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Wehman, Ann M/J-7860-2019; Soriano, Philippe M/E-5797-2015	Wehman, Ann M/0000-0001-9826-4132; Soriano, Philippe M/0000-0002-0427-926X	NICHD NIH HHS [HD18655, HD28478] Funding Source: Medline; NIGMS NIH HHS [GM53236] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD028478, R01HD028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ahern-Djamali SM, 1998, MOL BIOL CELL, V9, P2157, DOI 10.1091/mbc.9.8.2157; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; BUTT E, 1994, J BIOL CHEM, V269, P14509; Caroni P, 1998, SCIENCE, V281, P1465, DOI 10.1126/science.281.5382.1465; Chen JM, 1996, P NATL ACAD SCI USA, V93, P6275, DOI 10.1073/pnas.93.13.6275; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; COPP AJ, 1994, CIBA F SYMP, V181, P118; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FINK ROBERT P., 1967, BRAIN RES, V4, P369, DOI 10.1016/0006-8993(67)90166-7; Flanagan JG, 1998, CELL, V92, P429, DOI 10.1016/S0092-8674(00)80935-6; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; GERTLER FB, 1993, GENE DEV, V7, P441, DOI 10.1101/gad.7.3.441; Gomez TM, 1996, J NEUROBIOL, V29, P18, DOI 10.1002/(SICI)1097-4695(199601)29:1<18::AID-NEU2>3.0.CO;2-A; GOSLIN K, 1989, J CELL BIOL, V109, P1621, DOI 10.1083/jcb.109.4.1621; Goslin K., 1991, CULTURING NERVE CELL, P251; HALBRUGGE M, 1989, EUR J BIOCHEM, V185, P41, DOI 10.1111/j.1432-1033.1989.tb15079.x; HOGAN B, 1994, MANIPULATING MOUSE E, P340; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; KARFUNKEL P, 1971, DEV BIOL, V25, P30, DOI 10.1016/0012-1606(71)90018-2; Keynes R, 1996, NEURON, V17, P1031, DOI 10.1016/S0896-6273(00)80235-4; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KOESTER SE, 1994, J NEUROSCI, V14, P6608; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; OZAKI HS, 1993, J COMP NEUROL, V336, P595, DOI 10.1002/cne.903360411; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; POLLARD TD, 1995, CURR BIOL, V5, P837, DOI 10.1016/S0960-9822(95)00167-9; Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; Smith JL, 1997, TRENDS NEUROSCI, V20, P510, DOI 10.1016/S0166-2236(97)01121-1; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Sydor AM, 1996, J CELL BIOL, V134, P1197, DOI 10.1083/jcb.134.5.1197; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; TSENG PCH, 1984, J CELL BIOL, V98, P214, DOI 10.1083/jcb.98.1.214; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; WAHLSTEN D, 1982, BRAIN RES, V239, P329, DOI 10.1016/0006-8993(82)90513-3; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; WOODHAMS PL, 1989, J NEUROSCI, V9, P2170; WU DY, 1993, J CELL BIOL, V123, P653, DOI 10.1083/jcb.123.3.653; Wu DY, 1996, J NEUROSCI, V16, P1470; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	59	333	342	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	1999	22	2					313	325		10.1016/S0896-6273(00)81092-2	http://dx.doi.org/10.1016/S0896-6273(00)81092-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069337	Green Published, Bronze			2022-12-24	WOS:000078875200016
J	Lipton, PA; Alvarez, P; Eichenbaum, H				Lipton, PA; Alvarez, P; Eichenbaum, H			Crossmodal associative memory representations in rodent orbitofrontal cortex	NEURON			English	Article							OLFACTORY DISCRIMINATION; PREFRONTAL CORTEX; FRONTAL-CORTEX; NEURONS; RAT; MONKEY; TASK; HIPPOCAMPUS; RESPONSES; CELLS	Firing patterns of neurons in the orbitofrontal cortex (OF) were analyzed in rats trained to perform a task that encouraged incidental associations between distinct odors and the places where their occurrence was detected. Many of the neurons fired differentially when the animals were at a particular location or sampled particular odors. Furthermore, a substantial fraction of the cells exhibited odor-specific firing patterns prior to odor presentation, when the animal arrived at a location associated with that odor. These findings suggest that neurons in the OF encode cross-modal associations between odors and locations within long-term memory.	Boston Univ, Dept Psychol, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Dept Psychol, Lab Cognit Neurobiol, 64 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER; NIA NIH HHS [AG09973] Funding Source: Medline; NIMH NIH HHS [MH51570] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARBAS H, 1993, NEUROSCIENCE, V56, P841, DOI 10.1016/0306-4522(93)90132-Y; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; DEACON TW, 1983, J COMP NEUROL, V220, P168, DOI 10.1002/cne.902200205; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; EICHENBAUM H, 1983, EXP NEUROL, V79, P434, DOI 10.1016/0014-4886(83)90224-8; EICHENBAUM H, 1980, BRAIN BEHAV EVOLUT, V17, P255, DOI 10.1159/000121803; HAMPSON RE, 1993, BEHAV NEUROSCI, V107, P715, DOI 10.1037/0735-7044.107.5.715; Hebb Donald O., 1949, ORG BEHAV; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; PRICE JL, 1991, OLFACTION, P101; Rolls ET, 1997, EUR J NEUROSCI, V9, P1789, DOI 10.1111/j.1460-9568.1997.tb01538.x; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; ROLLS ET, 1994, J NEUROSCI, V14, P5437; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; TANABE T, 1975, J NEUROPHYSIOL, V38, P1269, DOI 10.1152/jn.1975.38.5.1269; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WIENER SI, 1989, J NEUROSCI, V9, P2737; Young BJ, 1997, J NEUROSCI, V17, P5183; ZATORRE RJ, 1991, BRAIN, V114, P71; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	30	77	77	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					349	359		10.1016/S0896-6273(00)81095-8	http://dx.doi.org/10.1016/S0896-6273(00)81095-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069340	hybrid			2022-12-24	WOS:000078875200019
J	Landgraf, M; Roy, S; Prokop, A; VijayRaghavan, K; Bate, M				Landgraf, M; Roy, S; Prokop, A; VijayRaghavan, K; Bate, M			Even-skipped determines the dorsal growth of motor axons in Drosophila	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-ADHESION MOLECULE; EMBRYONIC-DEVELOPMENT; FATE SPECIFICATION; CONE GUIDANCE; GENE; EXPRESSION; MELANOGASTER; CONNECTIN; CNS	Axon pathfinding and target choice are governed by cell type-specific responses to external cues. Here, we show that in the Drosophila embryo, motorneurons with targets in the dorsal muscle field express the homeobox gene even-skipped and that this expression is necessary and sufficient to direct motor axons into the dorsal muscle field. Previously, it was shown that motorneurons projecting to ventral targets express the LIM homeobox gene islet, which is sufficient to direct axons to the ventral muscle field. Thus, even-skipped complements the function of islet, and together these two genes constitute a bimodal switch regulating axonal growth and directing motor axons to ventral or to dorsal regions of the muscle field.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560012, Karnataka, India	University of Cambridge; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Landgraf, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.			Landgraf, Matthias/0000-0001-5142-1997; Prokop, Andreas/0000-0001-8482-3298	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Appel B, 1995, DEVELOPMENT, V121, P4117; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BATE M, 1990, DEVELOPMENT, V110, P791; Bate Michael, 1993, P1013; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1995, DROSOPHILA MELANOGAS, P635; BROADIE KS, 1993, J NEUROSCI, V13, P144; BROADUS J, 1995, MECH DEVELOP, V54, P1; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CHULAGRAFF Q, 1995, NEURON, V15, P1041, DOI 10.1016/0896-6273(95)90093-4; Crossley AC, 1978, GENETICS BIOL DROS B, V2, P499; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DOE CQ, 1992, DEVELOPMENT, V116, P855; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FRASCH M, 1988, GENE DEV, V2, P1824, DOI 10.1101/gad.2.12b.1824; GALAY FR, 1966, J ULTRASTRUCT RES, V14, P405; Goodman Corey S., 1993, P1131; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; JACOBS JR, 1989, J NEUROSCI, V9, P2412; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Landgraf M, 1997, J NEUROSCI, V17, P9642; LANDGRAF M, 1996, THESIS U CAMBRIDGE C; LIN DM, 1995, NEURON, V14, P707, DOI 10.1016/0896-6273(95)90215-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; MEADOWS LA, 1994, J CELL SCI, V107, P321; Nieto MA, 1996, NEURON, V17, P1039, DOI 10.1016/S0896-6273(00)80237-8; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; Nose A, 1997, DEVELOPMENT, V124, P1433; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; ROMER AS, 1989, VERTEBRATE BODY; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; WEIGMANN K, 1995, DEVELOPMENT, V121, P3713	58	92	92	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN	1999	22	1					43	52		10.1016/S0896-6273(00)80677-7	http://dx.doi.org/10.1016/S0896-6273(00)80677-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MV	10027288	Bronze			2022-12-24	WOS:000078410300011
J	Tootell, RBH; Hadjikhani, N; Hall, EK; Marrett, S; Vanduffel, W; Vaughan, JT; Dale, AM				Tootell, RBH; Hadjikhani, N; Hall, EK; Marrett, S; Vanduffel, W; Vaughan, JT; Dale, AM			The retinotopy of visual spatial attention	NEURON			English	Article							POSITRON EMISSION TOMOGRAPHY; SELECTIVE ATTENTION; NEURAL MECHANISMS; CEREBRAL-CORTEX; HUMAN BRAIN; VISUOSPATIAL ATTENTION; EXTRASTRIATE CORTEX; FUNCTIONAL-ANALYSIS; BLOOD-FLOW; AREAS V1	We used high-field (3T) functional magnetic resonance imaging (fMRI) to label cortical activity due to visual spatial attention, relative to flattened cortical maps of the retinotopy and visual areas from the same human subjects. In the main task, the visual stimulus remained constant, but covert visual spatial attention was varied in both location and load. In each of the extrastriate retinotopic areas, we found MR increases at the representations of the attended target. Similar but smaller increases were found in V1. Decreased MR levels were found in the same cortical locations when attention was directed at retinotopically different locations. In and surrounding area MT+, MR increases were lateralized but not otherwise retinotopic. At the representation of eccentricities central to that of the attended targets, prominent MR decreases occurred during spatial attention.	Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tootell, RBH (corresponding author), Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA.	tootell@nmr.mgh.harvard.edu	Hadjikhani, Nouchine/C-2018-2008; Dale, Anders M/A-5180-2010	Hadjikhani, Nouchine/0000-0003-4075-3106; Marrett, Sean/0000-0001-8179-6511	NEI NIH HHS [EY07980] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007980] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aine C J, 1995, Int J Neurosci, V80, P79, DOI 10.3109/00207459508986095; ANDERSEN RA, 1985, J COMP NEUROL, V232, P443, DOI 10.1002/cne.902320403; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; COLBY CL, 1991, J CHILD NEUROL, V6, pS90, DOI 10.1177/0883073891006001S11; Conner CE, 1997, J NEUROSCI, V17, P3201; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DREVETS WC, 1995, NATURE, V373, P249, DOI 10.1038/373249a0; DUFFY FH, 1975, BRAIN RES, V89, P121; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; ERIKSEN CW, 1973, PERCEPT PSYCHOPHYS, V14, P155, DOI 10.3758/BF03198630; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GATTASS R, 1988, J NEUROSCI, V8, P1831; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MAY JG, 1986, EXP BRAIN RES, V63, P265; McCarthy G., 1994, HUM BRAIN MAPP, V2, P234, DOI [10.1002/hbm.460020405, DOI 10.1002/HBM.460020405]; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; PAUS T, 1995, J NEUROPHYSIOL, V74, P2179, DOI 10.1152/jn.1995.74.5.2179; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; POSNER MI, 1988, MASTER LECT CLIN NEU, P00173; ROELFSEMA PR, 1998, IN PRESS NATURE; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; VANESSEN DC, 1978, J PHYSIOL-LONDON, V277, P193; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I; WURTZ RH, 1980, PSYCHOBIOL PHYSL PSY, V9, P42; ZEKI S, 1991, J NEUROSCI, V11, P641	64	541	548	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC	1998	21	6					1409	1422		10.1016/S0896-6273(00)80659-5	http://dx.doi.org/10.1016/S0896-6273(00)80659-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883733	Bronze, Green Published			2022-12-24	WOS:000077910600022
J	Torres, R; Firestein, BL; Dong, HL; Staudinger, J; Olson, EN; Huganir, RL; Bredt, DS; Gale, NW; Yancopoulos, GD				Torres, R; Firestein, BL; Dong, HL; Staudinger, J; Olson, EN; Huganir, RL; Bredt, DS; Gale, NW; Yancopoulos, GD			PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands	NEURON			English	Article							ELEGANS VULVAR INDUCTION; POSTSYNAPTIC DENSITY PROTEIN; TYROSINE KINASE FAMILY; GUANYLATE KINASES; NEUROMUSCULAR-JUNCTION; TRANSMEMBRANE LIGANDS; PSD-95 FAMILY; RAT-BRAIN; HOMOLOG; ENCODES	Localizing cell surface receptors to specific subcellular positions can be critical for their proper functioning, as most notably demonstrated at neuronal synapses. PDZ proteins apparently play critical roles in such protein localizations. Receptor tyrosine kinases have not been previously shown to interact with PDZ proteins in vertebrates. We report that Eph receptors and their membrane-linked ligands all contain PDZ recognition motifs and can bind and be clustered by PDZ proteins. In addition, we find that Eph receptors and ligands colocalize with PDZ proteins at synapses. Thus, PDZ proteins may play critical roles in localizing vertebrate receptor tyrosine kinases and/or their ligands and may be particularly important for Eph function in guidance or patterning or at the synapse.	Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Glaxo Wellcome Inc, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA; Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75235 USA	Regeneron; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Johns Hopkins University; GlaxoSmithKline; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Yancopoulos, GD (corresponding author), Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA.			Firestein, Bonnie/0000-0002-1679-3565				AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; Banker G., 1991, CULTURING NERVE CELL; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1996, ONCOGENE, V13, P1343; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GOLDENRING JR, 1984, J NEUROCHEM, V42, P1077, DOI 10.1111/j.1471-4159.1984.tb12713.x; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Hata Y, 1996, J NEUROSCI, V16, P2488; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Hoskins R, 1996, DEVELOPMENT, V122, P97; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; KOMAU HC, 1995, SCIENCE, V269, P1737; Li XJ, 1996, P NATL ACAD SCI USA, V93, P4839, DOI 10.1073/pnas.93.10.4839; MAISONPIERRE PC, 1993, ONCOGENE, V8, P3277; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; SUZUKI T, 1995, NEUROSCI RES, V22, P277, DOI 10.1016/0168-0102(95)00902-6; VALENZUELA DM, 1995, ONCOGENE, V10, P1573; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9; ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	55	386	402	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC	1998	21	6					1453	1463		10.1016/S0896-6273(00)80663-7	http://dx.doi.org/10.1016/S0896-6273(00)80663-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	154VR	9883737	hybrid			2022-12-24	WOS:000077910600026
J	Cestele, S; Qu, YS; Rogers, JC; Rochat, H; Scheuer, T; Catterall, WA				Cestele, S; Qu, YS; Rogers, JC; Rochat, H; Scheuer, T; Catterall, WA			Voltage sensor-trapping: Enhanced activation of sodium channels by beta-scorpion toxin bound to the S3-S4 loop in domain II	NEURON			English	Article							HIGH-AFFINITY BINDING; SHAKER K+ CHANNEL; PROTEIN-KINASE-C; ALPHA-SCORPION; NA+-CHANNEL; CENTRUROIDES-SCULPTURATUS; RAT-BRAIN; NEUROTOXIN RECEPTORS; POSITIVE CHARGES; INACTIVATION	Polypeptide neurotoxins alter ion channel gating by binding to extracellular receptor sites, even though the voltage sensors are in their S4 transmembrane segments. By analysis of sodium channel chimeras, a beta-scorpion toxin is shown here to negatively shift voltage dependence of activation and enhance closed state inactivation by binding to a receptor site that requires glycine 845 (Gly-845) in the S3-S4 loop at the extracellular end of the S4 segment in domain II of the alpha subunit. Toxin action requires prior depolarization to drive the S4 voltage sensors outward, but these effects are lost in the mutant G845N. The results reveal a voltage sensor-trapping model of toxin action in which the IlS4 voltage sensor is trapped in its outward, activated position by toxin binding.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Mediterranee, Fac Med Nord, Biochim Lab, CNRS UMR 6560,IFR Jean Roche, F-13916 Marseille, France	University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.		Cestèle, Sandrine/O-7657-2016	Cestèle, Sandrine/0000-0002-5982-1562	NINDS NIH HHS [NS15751] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGELIDES KJ, 1985, J BIOL CHEM, V260, P3431; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; BARHANIN J, 1983, J BIOL CHEM, V258, P700; BARHANIN J, 1982, J BIOL CHEM, V257, P2553; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BENESKI DA, 1980, P NATL ACAD SCI-BIOL, V77, P639, DOI 10.1073/pnas.77.1.639; CAHALAN MD, 1975, J PHYSIOL-LONDON, V244, P511, DOI 10.1113/jphysiol.1975.sp010810; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; CATTERALL WA, 1977, J BIOL CHEM, V252, P8660; CATTERALL WA, 1992, PHYSIOL REV, V72, P15; Cestele S, 1997, EUR J BIOCHEM, V243, P93, DOI 10.1111/j.1432-1033.1997.93_1a.x; Chen LQ, 1996, J GEN PHYSIOL, V108, P549, DOI 10.1085/jgp.108.6.549; DARBON H, 1983, BIOCHEM BIOPH RES CO, V115, P415, DOI 10.1016/S0006-291X(83)80160-0; DELIMA ME, 1988, BIOCHEM BIOPH RES CO, V151, P187, DOI 10.1016/0006-291X(88)90577-3; DUFTON MJ, 1984, J MOL EVOL, V20, P120, DOI 10.1007/BF02257372; Fozzard HA, 1996, PHYSIOL REV, V76, P887, DOI 10.1152/physrev.1996.76.3.887; GORDON D, 1992, BIOCHEMISTRY-US, V31, P7622, DOI 10.1021/bi00148a025; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JAIMOVICH E, 1982, P NATL ACAD SCI-BIOL, V79, P3896, DOI 10.1073/pnas.79.12.3896; JONAS P, 1986, PFLUG ARCH EUR J PHY, V407, P92, DOI 10.1007/BF00580727; JOVER E, 1980, BIOCHEM BIOPH RES CO, V95, P1607, DOI 10.1016/S0006-291X(80)80082-9; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Kontis KJ, 1997, J GEN PHYSIOL, V110, P403, DOI 10.1085/jgp.110.4.403; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; MARTIN MF, 1987, J BIOL CHEM, V262, P4452; McDonough SI, 1997, BIOPHYS J, V72, P2117, DOI 10.1016/S0006-3495(97)78854-4; MEVES H, 1982, PFLUG ARCH EUR J PHY, V393, P56, DOI 10.1007/BF00582392; MEVES H, 1987, EUR J PHYSL, V409, P381; Mitrovic N, 1998, J GEN PHYSIOL, V111, P451, DOI 10.1085/jgp.111.3.451; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Nonner W, 1979, Adv Cytopharmacol, V3, P345; QU YS, 1994, P NATL ACAD SCI USA, V91, P3289, DOI 10.1073/pnas.91.8.3289; Rochat H, 1979, Adv Cytopharmacol, V3, P325; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; SEAGAR M J, 1986, P117; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHARKEY RG, 1984, BIOCHEMISTRY-US, V23, P6078, DOI 10.1021/bi00320a027; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; TEJEDOR FJ, 1988, P NATL ACAD SCI USA, V85, P8742, DOI 10.1073/pnas.85.22.8742; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; THOMSEN W, 1995, J NEUROCHEM, V65, P1358; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; VIJVERBERG HPM, 1984, PFLUG ARCH EUR J PHY, V401, P297; WANG GK, 1983, MOL PHARMACOL, V23, P519; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	58	296	302	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT	1998	21	4					919	931		10.1016/S0896-6273(00)80606-6	http://dx.doi.org/10.1016/S0896-6273(00)80606-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808476	Bronze			2022-12-24	WOS:000076697300033
J	Hamdy, S; Rothwell, JC; Aziz, Q; Singh, KD; Thompson, DG				Hamdy, S; Rothwell, JC; Aziz, Q; Singh, KD; Thompson, DG			Long-term reorganization of human motor cortex driven by short-term sensory stimulation	NATURE NEUROSCIENCE			English	Article							MONKEYS; OUTPUT	Removal of sensory input can induce changes in cortical motor representation that reverse when sensation is restored. Here we ask whether manipulation of sensory input can induce long-term reorganization in human motor cortex that outlasts the initial conditioning. We report that for at least 30 minutes after pharyngeal stimulation, motor cortex excitability and area of representation for the pharynx increased, while esophagus representation decreased, without parallel changes in the excitability of brainstem-mediated reflexes. Therefore increased sensory input can drive long-term cross-system changes in motor areas of the cerebral cortex, which suggests that sensory stimulation might rehabilitate dysphagia, a frequent consequence of cerebral injury.	Univ Manchester, Hope Hosp, Dept Gastroenterol, Salford M6 8HD, Lancs, England; Inst Neurol, MRC, Human Movement & Balance Unit, London WC1N 3BG, England; Univ London, Royal Holloway & Bedford New Coll, Dept Psychol, Egham TW20 0EX, Surrey, England	University of Manchester; University of London; University College London; University of London; Royal Holloway University London	Thompson, DG (corresponding author), Univ Manchester, Hope Hosp, Dept Gastroenterol, Salford M6 8HD, Lancs, England.		Hamdy, Shaheen/O-5039-2014; Singh, Krish/D-1066-2009; Aziz, Qasim/AAC-4730-2020	Hamdy, Shaheen/0000-0001-9640-7427; Aziz, Qasim/0000-0002-2718-2065; Rothwell, John/0000-0003-1367-6467; Singh, Krishna/0000-0002-3094-2475	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARER DH, 1989, J NEUROL NEUROSUR PS, V52, P236, DOI 10.1136/jnnp.52.2.236; BRASILNETO JP, 1993, BRAIN, V116, P511, DOI 10.1093/brain/116.3.511; Cohen L G, 1993, Adv Neurol, V63, P187; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Hamdy S, 1996, NAT MED, V2, P1217, DOI 10.1038/nm1196-1217; Hamdy S, 1997, AM J PHYSIOL-GASTR L, V272, pG802, DOI 10.1152/ajpgi.1997.272.4.G802; Jean A., 1990, NEUROPHYSIOLOGY JAWS, P294; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; MANSSON I, 1974, LARYNGOSCOPE, V84, P427; Martin Ruth E., 1993, Dysphagia, V8, P195, DOI 10.1007/BF01354538; MILLER AJ, 1982, PHYSIOL REV, V62, P129, DOI 10.1152/physrev.1982.62.1.129; Nudo RJ, 1996, J NEUROSCI, V16, P785; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; SANES JN, 1992, CEREB CORTEX, V2, P141, DOI 10.1093/cercor/2.2.141; Singh KD, 1997, ELECTROMYOGR MOTOR C, V105, P345, DOI 10.1016/S0924-980X(97)96699-6; SUMI T, 1972, BRAIN RES, V46, P43, DOI 10.1016/0006-8993(72)90004-2; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Ziemann U, 1998, J NEUROSCI, V18, P1115	19	315	335	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					64	68		10.1038/264	http://dx.doi.org/10.1038/264			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195111				2022-12-24	WOS:000076361000020
J	Guzowski, JF; McNaughton, BL; Barnes, CA; Worley, PF				Guzowski, JF; McNaughton, BL; Barnes, CA; Worley, PF			Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles	NATURE NEUROSCIENCE			English	Article							LONG-TERM STABILITY; MESSENGER-RNA; RAT-BRAIN; PLACE CELLS; CA1; ACTIVATION; DENDRITES; PATTERNS; ENCODES; PROTEIN	We used fluorescent in-situ hybridization and confocal microscopy to monitor the subcellular distribution of the immediate-early gene Arc. Arc RNA appeared in discrete intranuclear foci within minutes of neuronal activation and subsequently disappeared from the nucleus and accumulated in the cytoplasm by 30 minutes. The time course of nuclear versus cytoplasmic Arc RNA accumulation was distinct, and could therefore be used to infer the activity history of individual neurons at two times. Following sequential exposure of rats to two different environments or to the same environment twice, the proportion of CA1 neurons with cytoplasmic, nuclear or overlapping Are expression profiles matched predictions derived from ensemble neurophysiological recordings of hippocampal neuronal ensembles. Are gene induction is thus specifically linked to neural encoding processes.	Virion Syst Inc, Rockville, MD 20850 USA; Univ Arizona, Dept Psychol, Tucson, AZ 85724 USA; Univ Arizona, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	University of Arizona; University of Arizona; Johns Hopkins University; Johns Hopkins University	Guzowski, JF (corresponding author), Virion Syst Inc, 9610 Med Ctr Dr,Suite 100, Rockville, MD 20850 USA.							CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CIRELLI C, 1995, REGUL PEPTIDES, V59, P151, DOI 10.1016/0167-0115(95)00097-U; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gothard KM, 1996, J NEUROSCI, V16, P823; Grimm R, 1997, BEHAV BRAIN RES, V84, P109, DOI 10.1016/S0166-4328(97)83330-X; HESS US, 1995, J NEUROSCI, V15, P4786; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Kubie J. L., 1983, NEUROBIOLOGY HIPPOCA, P433; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tanila H, 1997, HIPPOCAMPUS, V7, P613, DOI 10.1002/(SICI)1098-1063(1997)7:6<613::AID-HIPO4>3.0.CO;2-F; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Trembleau A, 1998, BIOL CELL, V90, P39, DOI 10.1016/S0248-4900(98)80231-1; Wallace CS, 1998, J NEUROSCI, V18, P26; Wan HM, 1999, J NEUROSCI, V19, P1142; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	28	750	761	0	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1120	1124		10.1038/16046	http://dx.doi.org/10.1038/16046			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570490				2022-12-24	WOS:000085810100017
J	Gottlieb, J; Goldberg, ME				Gottlieb, J; Goldberg, ME			Activity of neurons in the lateral intraparietal area of the monkey during an antisaccade task	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SINGLE NEURONS; MOTOR PLAN; EYE FIELD; SACCADES; CONNECTIONS; INTENTION; PATTERNS; MACAQUE; LESIONS	The close relationship between saccadic eye movements and vision complicates the identification of neural responses associated with each function. Visual and saccade-related responses are especially closely intertwined in a subdivision of posterior parietal cortex, the lateral parietal area (LIP). We analyzed LIP neurons using an antisaccade task in which monkeys made saccades away from a salient visual cue. The vast majority of neurons reliably signaled the location of the visual cue. In contrast, most neurons had only weak, if any, saccade-related activity independent of visual stimulation. Thus, whereas the great majority of LIP neurons reliably encoded cue location, only a small minority encoded the direction of the upcoming saccade.	NEI, Lab Sensorimotor Res, Bethesda, MD 20892 USA; Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Georgetown University	Gottlieb, J (corresponding author), NEI, Lab Sensorimotor Res, Bethesda, MD 20892 USA.							Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; BAIZER JS, 1993, VISUAL NEUROSCI, V10, P59, DOI 10.1017/S0952523800003229; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; CHEEORTS MN, 1993, BIOL CYBERN, V69, P29, DOI 10.1007/BF00201406; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 1999, J NEUROSCI, V19, P2740; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Gaymard B, 1998, EXP BRAIN RES, V123, P159, DOI 10.1007/s002210050557; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hays AV, 1982, WESCON C P, V2, P1; Heide W, 1998, EXP BRAIN RES, V123, P164, DOI 10.1007/s002210050558; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Pare M, 1997, J NEUROPHYSIOL, V78, P3493, DOI 10.1152/jn.1997.78.6.3493; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; YANTIS S, 1996, ATTENTIONAL CAPTURE, P45	29	198	198	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					906	912		10.1038/13209	http://dx.doi.org/10.1038/13209			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491612				2022-12-24	WOS:000083883200017
J	Whitlock, GG; Lamb, TD				Whitlock, GG; Lamb, TD			Variability in the time course of single photon responses from toad rods: Termination of rhodopsin's activity	NEURON			English	Article							PHOTORECEPTOR LIGHT ADAPTATION; RETINAL RODS; OUTER SEGMENTS; PHOSPHODIESTERASE ACTIVATION; PHOTOEXCITED RHODOPSIN; DARK NOISE; CALCIUM; PHOTOTRANSDUCTION; PHOSPHORYLATION; RECOVERIN	We examined the responses of toad rod photoreceptors to single photons of light. To minimize the effects of variability in the early rising phase, we selected sets of responses that closely matched the rise of the mean single photon response. Responses selected in this way showed substantial variations in kinetics, appearing to peel off from a common time course after different delays. Following incorporation of the calcium buffer BAPTA, the time to peeling off was retarded. Our analysis indicates that it is not necessary to invoke a long series of reaction steps to explain the shutoff of rhodopsin activity. Instead, our results suggest that the observed behavior is explicable by the presently known shutoff reactions of activated rhodopsin, modulated by feedback.	Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Cambridge	Lamb, TD (corresponding author), Univ Cambridge, Physiol Lab, Downing St, Cambridge CB2 3EG, England.		Lamb, Trevor/C-9755-2009	Whitlock, Gary/0000-0003-3070-1281	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; LAMB TD, 1986, J PHYSIOL-LONDON, V372, P315, DOI 10.1113/jphysiol.1986.sp016011; LEIBROCK CS, 1994, VISION RES, V34, P2787, DOI 10.1016/0042-6989(94)90048-5; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; MATTHEWS HR, 1991, J PHYSIOL-LONDON, V436, P93, DOI 10.1113/jphysiol.1991.sp018541; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MILLER JL, 1986, BIOCHEMISTRY-US, V25, P4983, DOI 10.1021/bi00366a002; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; PULVERMULLER A, 1993, BIOCHEMISTRY-US, V32, P14082, DOI 10.1021/bi00214a002; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; SCHNAPF JL, 1983, J PHYSIOL-LONDON, V343, P147, DOI 10.1113/jphysiol.1983.sp014886; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; WHITLOCK GG, 1998, THESIS U CAMBRIDGE C; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; YAU KW, 1985, NATURE, V313, P579, DOI 10.1038/313579a0	29	75	78	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	1999	23	2					337	351		10.1016/S0896-6273(00)80784-9	http://dx.doi.org/10.1016/S0896-6273(00)80784-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212LR	10399939	Bronze			2022-12-24	WOS:000081218600018
J	Hornberger, MR; Dutting, D; Ciossek, T; Yamada, T; Handwerker, C; Lang, S; Weth, F; Huf, J; Wessel, R; Logan, C; Tanaka, H; Drescher, U				Hornberger, MR; Dutting, D; Ciossek, T; Yamada, T; Handwerker, C; Lang, S; Weth, F; Huf, J; Wessel, R; Logan, C; Tanaka, H; Drescher, U			Modulation of EphA receptor function by coexpressed EphrinA ligands on retinal ganglion cell axons	NEURON			English	Article							GPI-ANCHORED PROTEINS; GROWTH-CONE COLLAPSE; TYROSINE KINASE; VISUAL-SYSTEM; IN-VITRO; RETROVIRAL VECTORS; GENE-EXPRESSION; CHICK-EMBRYO; GUIDANCE; ELF-1	The Eph family is thought to exert its function through the complementary expression of receptors and ligands. Here, we show that EphA receptors colocalize on retinal ganglion cell (RGC) axons with EphA ligands, which are expressed in a high-nasal-to-low-temporal pattern. In the stripe assay, only temporal axons are normally sensitive for repellent axon guidance cues of the caudal tectum. However, overexpression of ephrinA ligands on temporal axons abolishes this sensitivity, whereas treatment with PI-PLC both removes ephrinA ligands from retinal axons and induces a striped outgrowth of formerly insensitive nasal axons. In vivo, retinal overexpression of ephrinA2 leads to topographic targeting errors of temporal axons. These data suggest that differential ligand expression on retinal axons is a major determinant of topographic targeting in the retinotectal projection.	Max Planck Inst Dev Biol, Dept Phys Biol, D-72076 Tubingen, Germany; Kumamoto Univ, Grad Sch Med Sci, Dept Neurosci, Div Dev Neurobiol, Kuhonji, Kumamoto 862, Japan; Guys Hosp, United Med & Dent Sch, Dept Dev Neurobiol, London SE1 9RT, England	Max Planck Society; Kumamoto University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Drescher, U (corresponding author), Max Planck Inst Dev Biol, Dept Phys Biol, Spemannstr 35, D-72076 Tubingen, Germany.	uwe.drescher@tuebingen.mpg.de	Drescher, Uwe/C-5438-2009	Weth, Franco/0000-0002-6819-7028				Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; BAIER H, 1994, NEUROPROTOCOLS, V4, P96; Brennan C, 1997, DEVELOPMENT, V124, P655; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Ciossek T, 1998, EUR J NEUROSCI, V10, P1574, DOI 10.1046/j.1460-9568.1998.00180.x; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Davenport RW, 1998, J NEUROSCI, V18, P975; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; FEKETE DM, 1993, MOL CELL BIOL, V13, P2604, DOI 10.1128/MCB.13.4.2604; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Herzog KH, 1998, J NEUROSCI, V18, P2891; HOLT CE, 1993, J NEUROBIOL, V24, P1400, DOI 10.1002/neu.480241011; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; MEY J, 1992, J HIRNFORSCH, V33, P673; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Mueller BK, 1998, MECH DEVELOP, V74, P15, DOI 10.1016/S0925-4773(98)00058-6; MULLER B, 1990, J EXP BIOL, V153, P29; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Ohta K, 1997, MECH DEVELOP, V64, P127, DOI 10.1016/S0925-4773(97)00056-7; Ohta K, 1996, MECH DEVELOP, V54, P59, DOI 10.1016/0925-4773(95)00461-0; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; ROSKIES A, 1995, PERSPECT DEV NEUROBI, V3, P63; SOANS C, 1994, ONCOGENE, V9, P3353; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; VIELMETTER J, 1990, EXP BRAIN RES, V81, P283; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1990, TRENDS NEUROSCI, V13, P447, DOI 10.1016/0166-2236(90)90097-T	39	286	290	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	1999	22	4					731	742		10.1016/S0896-6273(00)80732-1	http://dx.doi.org/10.1016/S0896-6273(00)80732-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190QR	10230793	Bronze			2022-12-24	WOS:000079976200016
J	Debby-Brafman, A; Burstyn-Cohen, T; Klar, A; Kalcheim, C				Debby-Brafman, A; Burstyn-Cohen, T; Klar, A; Kalcheim, C			F-spondin, expressed in somite regions avoided by neural crest cells, mediates inhibition of distinct somite domains to neural crest migration	NEURON			English	Article							EPH-RELATED RECEPTORS; AVIAN EMBRYO; DORSAL-ROOT; EXTRACELLULAR-MATRIX; AXON OUTGROWTH; CHICK-EMBRYO; EPITHELIOMESENCHYMAL TRANSFORMATION; NERVOUS-SYSTEM; MOTOR AXONS; TRUNK	Neural crest (NC) cells migrate exclusively into the rostral half of each sclerotome, where they avoid the dermomyotome and the paranotochordal sclerotome. F-spondin is expressed in these inhibitory regions and throughout the caudal halves. In vitro bioassays of NC spreading on substrates of rostral or caudal epithelial-half somites (RS or CS, respectively) revealed that NC cells adopt on RS a fibroblastic morphology, whereas on CS they fail to flatten. F-spondin inhibited flattening of NC cells on RS. Conversely, F-spondin antibodies prevented rounding up of NC cells on CS. Addition of F-spondin to trunk explants inhibited NC migration into the sclerotome, and treatment of embryos with anti-F-spondin antibodies yielded migration into otherwise inhibitory sites. Thus, somite-derived F-spondin is an inhibitory signal involved in patterning the segmental migration of NC cells and their topographical segregation within the RS.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Anat & Cell Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kalcheim, C (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Anat & Cell Biol, IL-91120 Jerusalem, Israel.		Klar, Avihu/AHC-4770-2022; Burstyn-Cohen, Tal/A-2848-2011; Burstyn-Cohen, Tal/K-8846-2012	Burstyn-Cohen, Tal/0000-0002-2324-2921				Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; BORNSTEIN P, 1991, J BIOL CHEM, V266, P12821; Borycki AG, 1997, DEV BIOL, V185, P185, DOI 10.1006/dbio.1997.8555; BRONNERFRASER M, 1986, DEV BIOL, V115, P44, DOI 10.1016/0012-1606(86)90226-5; Burstyn-Cohen T, 1998, J NEUROSCI, V18, P8875; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Duband JL, 1995, ACTA ANAT, V154, P63; ERICKSON CA, 1992, DEV BIOL, V151, P251, DOI 10.1016/0012-1606(92)90231-5; Frotscher M, 1997, CELL TISSUE RES, V290, P315, DOI 10.1007/s004410050936; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GOLDSTEIN RS, 1991, DEVELOPMENT, V112, P327; GOLDSTEIN RS, 1992, DEVELOPMENT, V116, P441; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Henderson DJ, 1997, J ANAT, V191, P507, DOI 10.1046/j.1469-7580.1997.19140507.x; Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760; Kahane N, 1998, MECH DEVELOP, V74, P59, DOI 10.1016/S0925-4773(98)00066-5; KALCHEIM C, 1989, DEVELOPMENT, V106, P85; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kerr RSE, 1997, DEV BIOL, V192, P108, DOI 10.1006/dbio.1997.8731; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; KRULL CE, 1995, DEVELOPMENT, V121, P3733; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; LALLIER TE, 1988, DEV BIOL, V127, P99, DOI 10.1016/0012-1606(88)90192-3; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LORING J, 1981, DEV BIOL, V82, P86, DOI 10.1016/0012-1606(81)90430-9; LORING JF, 1987, DEV BIOL, V121, P220, DOI 10.1016/0012-1606(87)90154-0; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NEWGREEN DF, 1986, CELL TISSUE RES, V244, P299; Newgreen DF, 1996, DEV BIOL, V176, P300, DOI 10.1006/dbio.1996.0135; NEWGREEN DF, 1995, DEV BIOL, V170, P91, DOI 10.1006/dbio.1995.1198; OAKLEY RA, 1994, DEVELOPMENT, V120, P103; PERRIS R, 1991, DEVELOPMENT, V111, P583; Perris R, 1997, TRENDS NEUROSCI, V20, P23, DOI 10.1016/S0166-2236(96)10063-1; Pettway Z, 1996, EXP CELL RES, V225, P195, DOI 10.1006/excr.1996.0170; PETTWAY Z, 1990, DEV BIOL, V142, P335, DOI 10.1016/0012-1606(90)90354-L; PINCO O, 1993, J NEUROBIOL, V24, P1626, DOI 10.1002/neu.480241207; RANSCHT B, 1991, DEVELOPMENT, V111, P15; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; Ring C, 1996, DEV BIOL, V180, P41, DOI 10.1006/dbio.1996.0283; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Tannahill D, 1997, CELL TISSUE RES, V290, P275, DOI 10.1007/s004410050932; TEILLET MA, 1987, DEV BIOL, V120, P329, DOI 10.1016/0012-1606(87)90236-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1990, EXP NEUROL, V109, P75, DOI 10.1016/S0014-4886(05)80010-X; Tucker RP, 1997, DEV DYNAM, V208, P326, DOI 10.1002/(SICI)1097-0177(199703)208:3<326::AID-AJA4>3.0.CO;2-K; Umemiya T, 1997, DEV BIOL, V186, P165, DOI 10.1006/dbio.1997.8591; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Xu QL, 1997, J MOL MED-JMM, V75, P576, DOI 10.1007/s001090050142; Xu QL, 1995, DEVELOPMENT, V121, P4005	57	95	97	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	1999	22	3					475	488		10.1016/S0896-6273(00)80703-5	http://dx.doi.org/10.1016/S0896-6273(00)80703-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	182DU	10197528	Bronze			2022-12-24	WOS:000079483900012
J	Cash, S; Yuste, R				Cash, S; Yuste, R			Linear summation of excitatory inputs by CA1 pyramidal neurons	NEURON			English	Article							POSTSYNAPTIC POTENTIALS; MAMMALIAN NEURONS; APICAL DENDRITES; VISUAL-CORTEX; CELLS; RAT; INTEGRATION; SLICES; AMPLIFICATION; HIPPOCAMPUS	A fundamental problem in neurobiology is understanding the arithmetic that dendrites use to integrate inputs. The impact of dendritic morphology and active conductances on input summation is still unknown. To study this, we use glutamate iontophoresis and synaptic stimulation to position pairs of excitatory inputs throughout the apical, oblique, and basal dendrites of CA1 pyramidal neurons in rat hippocampal slices. Under a variety of stimulation regimes, we find a linear summation of most input combinations that is implemented by a surprising balance of boosting and shunting mechanisms. Active conductances in dendrites paradoxically serve to make summation linear. This "active linearity" can reconcile predictions from cable theory with the observed linear summation in vivo and suggests that a simple arithmetic is used by apparently complex dendritic trees.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Cash, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.				NEI NIH HHS [EY 111787-01A1] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Brown T., 1990, SYNAPTIC ORG BRAIN, P346; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BURKE RE, 1967, J NEUROPHYSIOL, V30, P1114, DOI 10.1152/jn.1967.30.5.1114; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; Cash S, 1998, J NEUROSCI, V18, P10; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KUNO M, 1969, J PHYSIOL-LONDON, V201, P465, DOI 10.1113/jphysiol.1969.sp008767; LANGMOEN IA, 1983, J NEUROPHYSIOL, V50, P1320, DOI 10.1152/jn.1983.50.6.1320; LARKMAN AU, 1991, J COMP NEUROL, V306, P307, DOI 10.1002/cne.903060207; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MAJOR G, 1994, J NEUROSCI, V14, P4613; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MONAGHAN DT, 1983, NATURE, V306, P176, DOI 10.1038/306176a0; OTMAKHOV N, 1993, NEURON, V10, P1101, DOI 10.1016/0896-6273(93)90058-Y; Rall W., 1995, THEORETICAL FDN DEND; Rall W, 1964, NEURAL THEORY MODELI, P73; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Scheenen WJJM, 1996, CHEM BIOL, V3, P765, DOI 10.1016/S1074-5521(96)90253-7; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SKYDSGAARD M, 1994, J PHYSIOL-LONDON, V479, P233, DOI 10.1113/jphysiol.1994.sp020291; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stuart G, 1998, J NEUROSCI, V18, P3501; THOMSON AM, 1988, J NEUROPHYSIOL, V60, P1896, DOI 10.1152/jn.1988.60.6.1896; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wandell B.A., 1995, FDN VISION; WONG RKS, 1979, P NATL ACAD SCI USA, V76, P986, DOI 10.1073/pnas.76.2.986; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1999, J NEUROSCI, V19, P1976; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	46	232	234	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					383	394		10.1016/S0896-6273(00)81098-3	http://dx.doi.org/10.1016/S0896-6273(00)81098-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069343	Bronze			2022-12-24	WOS:000078875200022
J	Liu, GS; Choi, SW; Tsien, RW				Liu, GS; Choi, SW; Tsien, RW			Variability of neurotransmitter concentration and nonsaturation of postsynaptic AMPA receptors at synapses in hippocampal cultures and slices	NEURON			English	Article							INHIBITORY SYNAPTIC TRANSMISSION; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; QUANTAL ANALYSIS; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; NEURONS; SINGLE	To understand the elementary unit of synaptic communication between CNS neurons, one must know what causes the variability of quantal postsynaptic currents and whether unitary packets of transmitter saturate postsynaptic receptors. We studied single excitatory synapses between hippocampal neurons in culture. Focal glutamate application at individual postsynaptic sites evoked currents (I-glu) with little variability compared with quantal excitatory postsynaptic currents (EPSCs). The maximal I-glu was >2-fold larger than the median EPSC. Thus, variations in [glu](cleft) are the main source of variability in EPSC size, and glutamate receptors are generally far from saturation during quantal transmission. This conclusion was verified by molecular antagonism experiments in hippocampal cultures and slices. The general lack of glutamate recepor saturation leaves room for increases in [glu](cleft) as a mechanism for synaptic plasticity.	MIT, Dept Brain & Cognit Sci, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Stanford Univ, Med Ctr, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Stanford University	Liu, GS (corresponding author), MIT, Dept Brain & Cognit Sci, Ctr Learning & Memory, E25-618, Cambridge, MA 02139 USA.	liu@mit.edu						BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Diamond JS, 1997, J NEUROSCI, V17, P4672; EDWARDS F, 1991, NATURE, V350, P271, DOI 10.1038/350271a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Holmes WR, 1995, BIOPHYS J, V69, P1734, DOI 10.1016/S0006-3495(95)80043-3; JACK JJB, 1994, ADV SEC MESS PHOSPH, V29, P275; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Lewis CA, 1996, J NEUROPHYSIOL, V76, P461, DOI 10.1152/jn.1996.76.1.461; LIU G, 1995, NEUROPHARMACOLOGY, V34, P1407, DOI 10.1016/0028-3908(95)00143-T; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PALAY SL, 1973, J MICROSC-OXFORD, V97, P41, DOI 10.1111/j.1365-2818.1973.tb03759.x; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Richmond SA, 1996, NEUROSCIENCE, V75, P69, DOI 10.1016/0306-4522(96)00217-5; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rusakov DA, 1998, J NEUROSCI, V18, P3158; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Uteshev VV, 1996, BIOPHYS J, V71, P1256, DOI 10.1016/S0006-3495(96)79325-6; Wahl LM, 1996, J NEUROPHYSIOL, V75, P597, DOI 10.1152/jn.1996.75.2.597; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; WATKINS JC, 1990, EXCITATORY AMINO ACI, P49	43	272	275	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	1999	22	2					395	409		10.1016/S0896-6273(00)81099-5	http://dx.doi.org/10.1016/S0896-6273(00)81099-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171QN	10069344	Bronze			2022-12-24	WOS:000078875200023
J	Trivedi, B; Kramer, RH				Trivedi, B; Kramer, RH			Real-time patch-cram detection of intracellular cGMP reveals long-term suppression of responses to NO and muscarinic agonists	NEURON			English	Article							NITRIC-OXIDE SYNTHASE; NUCLEOTIDE-GATED CHANNEL; NEURO-BLASTOMA CELLS; N1E-115 NEUROBLASTOMA-CELLS; SUPERIOR CERVICAL-GANGLION; DEPENDENT PROTEIN-KINASE; RAT SYMPATHETIC NEURONS; CYCLIC-GMP; GUANYLATE-CYCLASE; FUNCTIONAL EXPRESSION	Cyclic GMP (cGMP) is a crucial intracellular messenger in neuronal, muscle, and endocrine cells. The intracellular concentration of cGMP is regulated by various neurotransmitters, including acetylcholine (ACh) and nitric oxide (NO). While much is known about the biochemical steps leading to cGMP synthesis, little is known about cGMP kinetics in intact cells. Here, we use "patch-cramming," in which an excised, inside-out membrane patch containing cyclic nucleotide-gated ion channels is used as a biosensor, to obtain the first real-time measurements of cGMP in intact cells. Patch-cramming experiments on neuroblastoma cells show that both muscarinic agonists and NO rapidly elevate cGMP. NO elicits cGMP responses repeatedly without decrement, whereas responses to muscarinic agonists exhibit a profound and prolonged desensitization. Remarkably, muscarinic agonists also cause long-term (>30 min) suppression (LTS) of cGMP responses elicited by NO. Biochemical measurements reveal that rat sympathetic neurons also exhibit LTS of cGMP, suggesting that LTS is a widespread mechanism that may contribute to synaptic plasticity.	Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA	University of Miami	Kramer, RH (corresponding author), Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA.	rkramer@chroma.med.miami.edu						ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258; ANDERSON CR, 1993, BRAIN RES, V614, P78, DOI 10.1016/0006-8993(93)91020-S; ANDO M, 1994, BRAIN RES, V650, P283, DOI 10.1016/0006-8993(94)91793-0; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BRIGGS CA, 1985, J NEUROCHEM, V44, P731, DOI 10.1111/j.1471-4159.1985.tb12876.x; BRIGGS CA, 1992, BRAIN RES, V573, P139, DOI 10.1016/0006-8993(92)90123-Q; Broillet MC, 1996, NEURON, V16, P377, DOI 10.1016/S0896-6273(00)80055-0; Brown DA, 1997, LIFE SCI, V60, P1137, DOI 10.1016/S0024-3205(97)00058-1; BURGESS GM, 1989, J NEUROCHEM, V53, P1212, DOI 10.1111/j.1471-4159.1989.tb07417.x; CAULFIELD MP, 1994, J PHYSIOL-LONDON, V477, P415, DOI 10.1113/jphysiol.1994.sp020203; CIOFFI CL, 1989, BIOCHEM PHARMACOL, V38, P1827, DOI 10.1016/0006-2952(89)90418-8; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DUN NJ, 1993, NEUROSCI LETT, V158, P51, DOI 10.1016/0304-3940(93)90610-W; FEIGENBAUM P, 1985, J PHARMACOL EXP THER, V233, P134; FORSTERMANN U, 1990, MOL PHARMACOL, V38, P7; Francis S H, 1994, Adv Pharmacol, V26, P115, DOI 10.1016/S1054-3589(08)60053-8; Gage AT, 1997, HIPPOCAMPUS, V7, P286; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GOULDING EH, 1992, NEURON, V8, P45, DOI 10.1016/0896-6273(92)90107-O; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; GOY MF, 1991, TRENDS NEUROSCI, V14, P293, DOI 10.1016/0166-2236(91)90140-P; Grady EF, 1997, AM J PHYSIOL-GASTR L, V273, pG586, DOI 10.1152/ajpgi.1997.273.3.G586; GRAEFF RM, 1987, NEUROCHEM RES, V12, P551, DOI 10.1007/BF01000240; HAGA T, 1993, LIFE SCI, V52, P421, DOI 10.1016/0024-3205(93)90297-G; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Harrington MA, 1996, CELL CALCIUM, V19, P399, DOI 10.1016/S0143-4160(96)90113-X; HASHIGUCHI T, 1982, BRAIN RES, V242, P378, DOI 10.1016/0006-8993(82)90329-8; HAWKINS RD, 1994, J NEUROBIOL, V25, P652, DOI 10.1002/neu.480250607; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HU JG, 1993, J NEUROCHEM, V61, P578; IGNARRO LJ, 1990, PHARMACOL TOXICOL, V67, P1, DOI 10.1111/j.1600-0773.1990.tb00772.x; Jaffrey SR, 1995, ANNU REV CELL DEV BI, V11, P417; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KIMHI Y, 1976, P NATL ACAD SCI USA, V73, P462, DOI 10.1073/pnas.73.2.462; KOBAYASHI H, 1982, COMP BIOCHEM PHYS C, V72, P197, DOI 10.1016/0306-4492(82)90084-3; KOBAYASHI H, 1992, CAN J PHYSIOL PHARM, V70, pS44, DOI 10.1139/y92-242; KRAMER RH, 1990, NEURON, V4, P335, DOI 10.1016/0896-6273(90)90046-I; LAI WS, 1990, BIOCHEM J, V267, P23, DOI 10.1042/bj2670023; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LILES WC, 1986, J BIOL CHEM, V261, P5307; Linden D J, 1993, Curr Opin Neurobiol, V3, P401, DOI 10.1016/0959-4388(93)90133-J; Mathes C, 1996, J NEUROSCI, V16, P1702; MATHES C, 1994, J GEN PHYSIOL, V104, P107, DOI 10.1085/jgp.104.1.107; MATHES C, 1992, BRAIN RES, V585, P307, DOI 10.1016/0006-8993(92)91225-4; MATHIE A, 1992, NEURON, V8, P907, DOI 10.1016/0896-6273(92)90205-R; McDonald LJ, 1996, P SOC EXP BIOL MED, V211, P1; Molday RS, 1996, CURR OPIN NEUROBIOL, V6, P445, DOI 10.1016/S0959-4388(96)80048-1; Molokanova E, 1997, J NEUROSCI, V17, P9068; MOOLENAAR WH, 1978, J PHYSIOL-LONDON, V278, P265, DOI 10.1113/jphysiol.1978.sp012303; MOORE PK, 1993, BRIT J PHARMACOL, V108, P296, DOI 10.1111/j.1476-5381.1993.tb12798.x; Muller F, 1998, J NEUROSCI, V18, P164; PUGH EN, 1990, VISION RES, V30, P1923, DOI 10.1016/0042-6989(90)90013-B; ROSS CA, 1990, TRENDS NEUROSCI, V13, P216, DOI 10.1016/0166-2236(90)90163-5; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; SCHMIDT RE, 1993, BRAIN RES, V617, P343, DOI 10.1016/0006-8993(93)91103-Y; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SHENG H, 1993, J NEUROCHEM, V61, P1120, DOI 10.1111/j.1471-4159.1993.tb03628.x; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; SILVA MT, 1993, BRIT J PHARMACOL, V114, P257; Southam E, 1996, BRIT J PHARMACOL, V119, P527, DOI 10.1111/j.1476-5381.1996.tb15703.x; STUDY RE, 1978, P NATL ACAD SCI USA, V75, P6295, DOI 10.1073/pnas.75.12.6295; Thompson SH, 1997, J GEN PHYSIOL, V110, P155, DOI 10.1085/jgp.110.2.155; THOMPSON SH, 1995, AM J PHYSIOL-CELL PH, V269, pC979, DOI 10.1152/ajpcell.1995.269.4.C979; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	69	45	45	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					895	906		10.1016/S0896-6273(00)80604-2	http://dx.doi.org/10.1016/S0896-6273(00)80604-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808474	hybrid			2022-12-24	WOS:000076697300031
J	Tzounopoulos, T; Janz, R; Sudhof, TC; Nicoll, RA; Malenka, RC				Tzounopoulos, T; Janz, R; Sudhof, TC; Nicoll, RA; Malenka, RC			A role for cAMP in long-term depression at hippocampal mossy fiber synapses	NEURON			English	Article							SYNAPTIC PLASTICITY; TRANSMITTER RELEASE; EXCITATORY SYNAPSES; ADENYLATE-CYCLASE; GUINEA-PIG; 2 FORMS; POTENTIATION; PROTEIN; NEURONS; LTP	Mossy fiber synapses on hippocampal CA3 pyramidal cells, in addition to expressing an NMDA receptor-independent form of long-term potentiation (LTP), have recently been shown to express a novel presynaptic form of long-term depression (LTD). We have studied the mechanisms underlying mossy fiber LTD and present evidence that it is triggered, at least in part, by a metabotropic glutamate receptor-mediated decrease in adenylyl cyclase activity, which leads to a decrease in the activity of the cAMP-dependent protein kinase (PKA) and a reversal of the presynaptic processes responsible for mossy fiber LTP. The bidirectional control of synaptic strength at mossy fiber synapses by activity therefore appears to be due to modulation of the cAMP-PKA signaling pathway in mossy fiber boutons.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Malenka, RC (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	malenka@itsa.ucsf.edu		Janz, Roger/0000-0002-9872-0596				ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Castillo PE, 1996, J NEUROSCI, V16, P5942; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; DIXON D, 1989, J NEUROSCI, V9, P4246; DUDEK SM, 1993, J NEUROSCI, V13, P2910; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kamiya H, 1997, NEUROSCIENCE, V80, P89, DOI 10.1016/S0306-4522(97)00098-5; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Lonart G, 1998, J NEUROSCI, V18, P634; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Tong G, 1996, NEURON, V16, P1147, DOI 10.1016/S0896-6273(00)80141-5; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Willshaw D, 1990, NEURAL COMPUT, V2, P85, DOI 10.1162/neco.1990.2.1.85; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	37	140	141	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT	1998	21	4					837	845		10.1016/S0896-6273(00)80599-1	http://dx.doi.org/10.1016/S0896-6273(00)80599-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133QM	9808469	Bronze			2022-12-24	WOS:000076697300026
J	McDonald, BJ; Amato, A; Connolly, CN; Benke, D; Moss, SJ; Smart, TG				McDonald, BJ; Amato, A; Connolly, CN; Benke, D; Moss, SJ; Smart, TG			Adjacent phosphorylation sites on GABA(A) receptor beta subunits determine regulation by cAMP-dependent protein kinase	NATURE NEUROSCIENCE			English	Article							A RECEPTOR; INTRACELLULAR DOMAINS; REBOUND POTENTIATION; MEDIATED CURRENTS; CYCLIC-AMP; ACTIVATION; EXPRESSION; MODULATION; CHANNELS	Activation of cAMP-dependent protein kinase (PKA) can enhance or reduce the function of neuronal GABA, receptors, the major sites of fast synaptic inhibition in the brain. This differential regulation depends on PKA-induced phosphorylation of adjacent conserved sites in the receptor beta subunits. Phosphorylation of beta 3 subunit-containing receptors at S408 and S409 enhanced the GABA-activated response, whereas selectively mutating S408 to alanine converted the potentiation into an inhibition, comparable to that of beta 1 subunits, which are phosphorylated solely on S409. These distinct modes of regulation were interconvertible between beta 1 and beta 3 subunits and depended upon the presence of S408 in either subunit, In contrast, beta 2 subunit-containing receptors were not phosphorylated or affected by PKA. Differential regulation by PKA of postsynaptic GABA(A) receptors containing different beta subunits may have profound effects on neuronal excitability.	Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Univ London Univ Coll, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; Univ London Univ Coll, Dept Pharmacol, London WC1E 6BT, England; Univ Zurich, Inst Pharmacol, CH-8057 Zurich, Switzerland	University of London; University College London; University of London School of Pharmacy; University of London; University College London; University of London; University College London; University of Zurich	Smart, TG (corresponding author), Univ London, Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	steve.moss@ucl.ac.uk; tsmart@ulsop.ac.uk		Connolly, Christopher/0000-0002-0445-8874	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANGELOTTI TP, 1993, MOL PHARMACOL, V44, P1202; BENKE D, 1994, J BIOL CHEM, V269, P27100; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEIGENSPAN A, 1994, P NATL ACAD SCI USA, V91, P10893, DOI 10.1073/pnas.91.23.10893; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; KANO M, 1992, NEUROREPORT, V3, P563, DOI 10.1097/00001756-199207000-00004; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kapur J, 1996, J NEUROPHYSIOL, V76, P2626, DOI 10.1152/jn.1996.76.4.2626; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; McDonald BJ, 1997, NEUROPHARMACOLOGY, V36, P1377, DOI 10.1016/S0028-3908(97)00111-1; MOSS SJ, 1995, NATURE, V377, P344, DOI 10.1038/377344a0; MOSS SJ, 1992, J BIOL CHEM, V267, P14470; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; NAYEEM N, 1994, J NEUROCHEM, V62, P815; PORTER NM, 1990, NEURON, V5, P789, DOI 10.1016/0896-6273(90)90338-G; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; VERUKI ML, 1994, VISUAL NEUROSCI, V11, P899, DOI 10.1017/S0952523800003850; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	27	188	193	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					23	28		10.1038/223	http://dx.doi.org/10.1038/223			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195104				2022-12-24	WOS:000076361000013
J	Magee, JC				Magee, JC			Dendritic I-h normalizes temporal summation in hippocampal CA1 neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; PACEMAKER; INTEGRATION; SYNAPSES; EFFICACY; ZD-7288; DISTAL; VITRO	Most mammalian central neurons receive synaptic input over complicated dendritic arbors. Therefore, timing of synaptic information should vary with synapse location. However, I report that temporal summation at CA1 pyramidal somata does not depend on the location of synaptic input. This spatial normalization of temporal integration requires a dendritic hyperpolarization-activated current (I-h). Shaping of synaptic activity by deactivating a nonuniform lh could counterbalance filtering by dendrites and effectively remove location-dependent variability in temporal integration, thus enhancing synchronization of neuronal populations and functional capabilities of the hippocampal CA1 region.	Louisiana State Univ, Med Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Louisiana State University System	Magee, JC (corresponding author), Louisiana State Univ, Med Ctr, Ctr Neurosci, 2020 Gravier St, New Orleans, LA 70112 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035865, R29NS035865] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35865] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; BUZSAKI G, 1982, BRAIN RES, V237, P283, DOI 10.1016/0006-8993(82)90442-5; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Colbert CM, 1996, J NEUROSCI, V16, P6676; Cook EP, 1997, J NEUROPHYSIOL, V78, P2116, DOI 10.1152/jn.1997.78.4.2116; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; LAURBERG S, 1979, J COMP NEUROL, V184, P685, DOI 10.1002/cne.901840405; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; NICOLL A, 1993, J PHYSIOL-LONDON, V468, P693, DOI 10.1113/jphysiol.1993.sp019795; OKEFFE J, 1993, HIPPOCAMPUS, V3, P317; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1964, NEURAL THEORY MODELI, P5; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P468, DOI 10.1152/jn.1988.59.2.468; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; TSUBAKAWA H, IN PRESS J PHYSL LON; WILSON CJ, 1995, J COMPUT NEUROSCI, V2, P91, DOI 10.1007/BF00961882; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	30	484	489	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					508	514		10.1038/9158	http://dx.doi.org/10.1038/9158			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448214				2022-12-24	WOS:000084735900009
J	Nilsen, KE; Russell, IJ				Nilsen, KE; Russell, IJ			Timing of cochlear feedback: spatial and temporal representation of a tone across the basilar membrane	NATURE NEUROSCIENCE			English	Article							OUTER HAIR-CELLS; GUINEA-PIG; INNER-EAR; MECHANICAL RESPONSES; CHINCHILLA COCHLEA; ACTIVE PROCESS; HOOK REGION; AMPLIFIER; BASE; TRANSDUCTION	Electromotile outer hair cell (OHC) feedback provides the sensitivity and sharp frequency tuning of the cochlea. Basilar membrane displacements in response to characteristic frequency (CF) tones were measured with an interferometer at up to 15 locations across the basilar membrane width in the basal turn of the guinea pig cochlea. For CF tones, basilar membrane vibrations were largest beneath the OHCs; these phase-led vibrations beneath outer pillar cells and adjacent to the spiral ligament by similar to 90 degrees. Post mortem, responses measured beneath the OHCs were reduced by up to 65 dB, and the basilar membrane moved with similar phase across its entire width. We suggest OHCs amplify basilar membrane responses to CF tones when the basilar membrane moves at maximum velocity.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Russell, IJ (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.			Russell, Ian/0000-0002-4915-2772				ALLEN JB, 1980, J ACOUST SOC AM, V68, P1660, DOI 10.1121/1.385198; ALLEN JB, 1992, J ACOUST SOC AM, V92, P178, DOI 10.1121/1.404281; ALLEN JB, 1996, DIVERSITY AUDITORY M, P167; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; BROWN AM, 1992, P ROY SOC B-BIOL SCI, V250, P29, DOI 10.1098/rspb.1992.0126; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Bukusy GV., 1960, EXPT HEARING, P403; CODY AR, 1992, HEARING RES, V62, P166, DOI 10.1016/0378-5955(92)90182-M; COOPER NP, 1992, HEARING RES, V63, P191, DOI 10.1016/0378-5955(92)90084-Z; COOPER NP, 1992, HEARING RES, V63, P163, DOI 10.1016/0378-5955(92)90083-Y; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DALLOS P, 1995, SCIENCE, V267, P2006, DOI 10.1126/science.7701325; DAVIS H, 1958, Laryngoscope, V68, P359; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; GEISLER CD, 1995, HEARING RES, V86, P132, DOI 10.1016/0378-5955(95)00064-B; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; Hallworth R, 1995, J NEUROPHYSIOL, V74, P2319, DOI 10.1152/jn.1995.74.6.2319; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kolston PJ, 1999, P NATL ACAD SCI USA, V96, P3676, DOI 10.1073/pnas.96.7.3676; KOLSTON PJ, 1995, TRENDS NEUROSCI, V18, P427, DOI 10.1016/0166-2236(95)90091-8; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1995, PFLUG ARCH EUR J PHY, V430, P745, DOI 10.1007/BF00386170; MARKIN VS, 1995, BIOPHYS J, V69, P138, DOI 10.1016/S0006-3495(95)79883-6; Mills DM, 1998, HEARING RES, V122, P82, DOI 10.1016/S0378-5955(98)00079-3; Mogensen MM, 1998, CELL MOTIL CYTOSKEL, V41, P138, DOI 10.1002/(SICI)1097-0169(1998)41:2<138::AID-CM5>3.0.CO;2-A; Murugasu E, 1996, J NEUROSCI, V16, P325; Murugasu E., 1995, AUDIT NEUROSCI, V1, P139; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; Nuttall AL, 1996, J ACOUST SOC AM, V99, P1556, DOI 10.1121/1.414732; ROBLES L, 1986, J ACOUST SOC AM, V80, P1364, DOI 10.1121/1.394389; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Russell IJ, 1997, J ACOUST SOC AM, V102, P1734, DOI 10.1121/1.420083; RUSSELL IJ, 1983, J PHYSIOL-LONDON, V338, P179, DOI 10.1113/jphysiol.1983.sp014668; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; RUSSELL IJ, 1995, ADV HEARING RES, P125; Russell IJ, 1995, AUDITORY NEUROSCI, V1, P309; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Tolomeo JA, 1997, BIOPHYS J, V73, P2241, DOI 10.1016/S0006-3495(97)78255-9	42	64	67	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					642	648		10.1038/10197	http://dx.doi.org/10.1038/10197			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404197				2022-12-24	WOS:000083882600015
J	Narasimhan, K				Narasimhan, K			Signaling myopia	NATURE NEUROSCIENCE			English	News Item																			0	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					691	691		10.1038/11150	http://dx.doi.org/10.1038/11150			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412055	Bronze			2022-12-24	WOS:000083882800006
J	Vaccarino, FM; Schwartz, ML; Raballo, R; Nilsen, J; Rhee, J; Zhou, M; Doetschman, T; Coffin, JD; Wyland, JJ; Hung, YTE				Vaccarino, FM; Schwartz, ML; Raballo, R; Nilsen, J; Rhee, J; Zhou, M; Doetschman, T; Coffin, JD; Wyland, JJ; Hung, YTE			Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; CLONAL HETEROGENEITY; PROGENITOR CELLS; CYCLE PARAMETERS; PRECURSOR CELLS; GERMINAL ZONE; MESSENGER-RNA; FGF-RECEPTOR; RAT-BRAIN	We show that fibroblast growth factor 2 (FGF2) and FGF receptors are transiently expressed by cells of the pseudostratified ventricular epithelium (PVE) during early neurogenesis. A single microinjection of FGF2 into cerebral ventricles of rat embryos at E15.5 increased the volume and total number of neurons in the adult cerebral cortex by 18% and 87%, respectively. Microinjection of FGF2, by the end of neurogenesis, at E20.5, selectively increased the number of glia. Mice lacking the FGF2 gene had fewer cortical neurons and glia at maturity. BrdU studies in FGF2-microinjected and FGF2-null animals suggested that FGF2 increases the proportion of dividing cells in the PVE without affecting the cell-cycle length. Thus, FGF2 increases the number of rounds of division of cortical progenitors.	Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Neurobiol Sect, New Haven, CT 06520 USA; Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA	Yale University; Yale University; University System of Ohio; University of Cincinnati; McLaughlin Research Institute for Biomedical Sciences, Inc.	Vaccarino, FM (corresponding author), Yale Univ, Ctr Child Study, 230 S Frontage Rd, New Haven, CT 06520 USA.		Nilsen, Jon/A-3082-2008	Vaccarino, Flora/0000-0003-2167-981X; Nilsen, Jon/0000-0002-9305-7799				ACKLIN SE, 1993, DEVELOPMENT, V118, P175; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Bayer S.A., 1991, NEOCORTICAL DEV; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; BOHEN P, 1985, FEBS LETT, V185, P177; BROWN NA, 1990, POSTIMPLANTATION MAM; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Cavanagh JFR, 1997, CEREB CORTEX, V7, P293, DOI 10.1093/cercor/7.4.293; DEHAMER MK, 1994, NEURON, V13, P1083, DOI 10.1016/0896-6273(94)90047-7; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; ENGELE J, 1992, DEV BIOL, V152, P363, DOI 10.1016/0012-1606(92)90143-5; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; FUJITA S, 1963, J COMP NEUROL, V120, P37, DOI 10.1002/cne.901200104; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIORDANO S, 1992, DEV BIOL, V152, P293, DOI 10.1016/0012-1606(92)90136-5; KILPATRICK TJ, 1995, J NEUROSCI, V15, P3653; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; PARTANEN J, 1993, PHILOS T R SOC B, V340, P297, DOI 10.1098/rstb.1993.0071; PATSTONE G, 1993, DEV BIOL, V155, P107, DOI 10.1006/dbio.1993.1011; POWELL PP, 1991, MOL BRAIN RES, V11, P71, DOI 10.1016/0169-328X(91)90023-Q; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; RAY J, 1995, J NEUROCHEM, V64, P503; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Reznikov K, 1997, DEV DYNAM, V210, P328, DOI 10.1002/(SICI)1097-0177(199711)210:3<328::AID-AJA12>3.0.CO;2-6; Robel L, 1995, J NEUROSCI, V15, P7879; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; TAKAHASHI T, 1993, J NEUROSCI, V13, P820; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takahashi T, 1996, J NEUROSCI, V16, P6183; TAKAHASHI T, 1994, P NATL ACAD SCI USA, V91, P373; TAKAUWA N, 1993, J BIOL CHEM, V268, P138; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; VACCARINO FM, 1995, CEREB CORTEX, V1, P64; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WEISE B, 1993, J NEUROSCI RES, V34, P442, DOI 10.1002/jnr.490340409; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILLIAMS BP, 1985, DEV BIOL, V112, P126, DOI 10.1016/0012-1606(85)90126-5; ZHAN X, 1993, J BIOL CHEM, V268, P9611; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	48	287	295	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					246	253		10.1038/6350	http://dx.doi.org/10.1038/6350			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10461229				2022-12-24	WOS:000081684500012
